furosemide has been researched along with Heart Failure in 1245 studies
Furosemide: A benzoic-sulfonamide-furan. It is a diuretic with fast onset and short duration that is used for EDEMA and chronic RENAL INSUFFICIENCY.
furosemide : A chlorobenzoic acid that is 4-chlorobenzoic acid substituted by a (furan-2-ylmethyl)amino and a sulfamoyl group at position 2 and 5 respectively. It is a diuretic used in the treatment of congestive heart failure.
Heart Failure: A heterogeneous condition in which the heart is unable to pump out sufficient blood to meet the metabolic need of the body. Heart failure can be caused by structural defects, functional abnormalities (VENTRICULAR DYSFUNCTION), or a sudden overload beyond its capacity. Chronic heart failure is more common than acute heart failure which results from sudden insult to cardiac function, such as MYOCARDIAL INFARCTION.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The haemodynamic effects of high or low doses of furosemide used to prevent overt left heart failure (LHF) in acute myocardial infarction (AMI) were studied." | 10.16 | Haemodynamic effects of high or low doses of furosemide in acute myocardial infarction. ( Larsen, FF, 1988) |
| "Although furosemide is the most commonly used loop diuretic in patients with heart failure, some studies suggest a potential benefit for torsemide." | 9.69 | Effect of Torsemide vs Furosemide After Discharge on All-Cause Mortality in Patients Hospitalized With Heart Failure: The TRANSFORM-HF Randomized Clinical Trial. ( Anstrom, KJ; Desvigne-Nickens, P; Eisenstein, EL; Greene, SJ; Harrington, AH; Ketema, F; Kim, DY; Mentz, RJ; Morgan, S; Pitt, B; Sachdev, V; Sapp, S; Testani, JM; Velazquez, EJ, 2023) |
| "To examine the decongestive effect of the sodium-glucose cotransporter 2 inhibitor dapagliflozin compared to the thiazide-like diuretic metolazone in patients hospitalized for heart failure and resistant to treatment with intravenous furosemide." | 9.69 | Dapagliflozin vs. metolazone in heart failure resistant to loop diuretics. ( Brooksbank, KJM; Campbell, RT; Clark, AL; Docherty, KF; Foley, PWX; Guha, K; Halliday, CA; Jhund, PS; Kalra, PR; Lang, NN; Lee, MMY; McConnachie, A; McDermott, JJ; McKinley, G; McMurray, JJV; Osmanska, J; Petrie, MC; Platz, E; Sartipy, P; Seed, A; Stanley, B; Weir, RAP; Welsh, P; Yeoh, SE, 2023) |
| "Loop diuretics are a primary therapy for the symptomatic treatment of heart failure (HF), but whether torsemide improves patient symptoms and quality of life better than furosemide remains unknown." | 9.69 | Effect of Torsemide Versus Furosemide on Symptoms and Quality of Life Among Patients Hospitalized for Heart Failure: The TRANSFORM-HF Randomized Clinical Trial. ( Alexy, T; Ambrosy, AP; Anstrom, KJ; Clare, RM; Desvigne-Nickens, P; DeWald, TA; Eisenstein, EL; Greene, SJ; Ketema, F; Kim, DY; Mentz, RJ; Pitt, B; Psotka, MA; Rommel, JJ; Stevens, GR; Velazquez, EJ, 2023) |
| "In the EARLIER (Efficacy and Safety of Early Initiation of Eplerenone Treatment in Patients with Acute Heart Failure) trial, eplerenone did not reduce heart failure (HF) hospitalizations or all-cause mortality in 300 patients admitted for acute HF (AHF)." | 9.41 | Effect of eplerenone on clinical stability of Japanese patients with acute heart failure. ( Asakura, M; Chikamori, T; Ferreira, JP; Ito, S; Kitakaze, M; Kobayashi, M; Matsue, Y; Yamashina, A, 2023) |
| "We conducted a prospective, observational study of 50 patients with acute heart failure patients divided into two groups based on previous furosemide use (furosemide naïve: n = 28 [56%] and chronic furosemide users: n = 22 [44%])." | 9.41 | The blunted loop diuretic response in acute heart failure is driven by reduced tubular responsiveness rather than insufficient tubular delivery. The role of furosemide urine excretion on diuretic and natriuretic response in acute heart failure. ( Biegus, J; Cox, ZL; Fudim, M; Guzik, M; Hurkacz, M; Iwanek, G; Marciniak, D; Ponikowska, B; Ponikowski, P; Raj, D; Testani, J; Zymliński, R, 2023) |
| "This is a prospective randomized controlled trial to study the efficacy and safety of Shenfu injection combined with furosemide in the treatment of coronary heart disease and chronic heart failure." | 9.41 | Shenfu injection combined with furosemide in the treatment of chronic heart failure in patients with coronary heart disease: A protocol of randomized controlled trial. ( Gao, Y; Tan, X; Zhu, R, 2021) |
| "We sought to compare the effects of furosemide + hypertonic saline solution (HSS) treatment in patients with acute decompensated heart failure in comparison with furosemide alone and the response in a compensated state after an acute saline load with regard to serum levels of heart failure biomarkers." | 9.41 | Effects of intravenous furosemide plus small-volume hypertonic saline solutions on markers of heart failure. ( Casuccio, A; Daidone, M; Del Cuore, A; Di Chiara, T; Di Raimondo, D; Fonte, R; Maida, C; Mogavero, A; Ortello, A; Pinto, A; Puleo, MG; Tuttolomondo, A; Vassallo, V, 2021) |
| "Oral tolvaptan was associated with similar, but not superior, diuresis compared with intravenous furosemide for acute heart failure with concomitant hyponatremia." | 9.34 | Tolvaptan vs. furosemide-based diuretic regimens in patients hospitalized for heart failure with hyponatremia (AQUA-AHF). ( Elkayam, U; Fong, MW; Grazette, LP; Han, EE; Kuo, A; Lou, M; Mehra, A; Ng, TMH; Upadhyay, RY; Yoon, AJ, 2020) |
| "Tolvaptan has been shown to improve congestion in heart failure patients." | 9.34 | Differences in pharmacological property between combined therapy of the vasopressin V2-receptor antagonist tolvaptan plus furosemide and monotherapy of furosemide in patients with hospitalized heart failure. ( Amitani, K; Iha, H; Imura, H; Ishihara, S; Ishikawa, M; Ishizuka, A; Ito, Y; Kikuchi, A; Kobayashi, N; Maruyama, Y; Mitsuishi, T; Nakama, K; Nakamura, S; Nohara, T; Ohkuma, S; Omote, T; Sato, N; Shigihara, S; Shimizu, W; Sone, M; Takagi, K; Takahashi, N; Tokuyama, H; Yamamoto, E, 2020) |
| "To compare efficacy and safety of indapamide-furosemide combination against metolazone-furosemide combination in refractory heart failure patients." | 9.30 | Comparing the sodium excreting efficacy of furosemide and indapamide combination against furosemide and metolazone combination in congestive heart failure patients: A randomized control trial. ( Altaf, A; Jan, MU; Salahudin, M; Shah, H, 2019) |
| "Recent reports suggest that torasemide might be more beneficial than furosemide in patients with symptomatic heart failure (HF)." | 9.30 | Comparative effectiveness of torasemide versus furosemide in symptomatic therapy in heart failure patients: Preliminary results from the randomized TORNADO trial. ( Bakuła, E; Balsam, P; Bednarski, J; Cacko, A; Filipiak, KJ; Fojt, A; Gawałko, M; Grabowski, M; Główczyńska, R; Kowalik, R; Marchel, M; Markulis, M; Niedziela, Ł; Niewiński, G; Opolski, G; Ozierański, K; Peller, M; Sieradzki, B; Sieradzki, M; Tymińska, A, 2019) |
| "We attempted to identify the difference in diuretic properties between tolvaptan (TLV) and furosemide (FUR) in congestive heart failure (CHF) patients with loop diuretic resistance and renal impairment." | 9.30 | Different diuretic properties between tolvaptan and furosemide in congestive heart failure patients with diuretic resistance and renal impairment: a subanalysis of the K-STAR. ( Ako, J; Ikeda, Y; Inomata, T; Izumi, T; Kida, K; Sato, N; Shibagaki, Y, 2019) |
| "This study sought to determine the efficacy and safety of a novel, pH-neutral formulation of furosemide administered subcutaneously (SC) for treatment of acute decompensated heart failure (HF)." | 9.27 | Efficacy of Intravenous Furosemide Versus a Novel, pH-Neutral Furosemide Formulation Administered Subcutaneously in Outpatients With Worsening Heart Failure. ( Almansa, J; Chambers, J; Chasler, J; Cummings, A; Cuomo, K; Gilotra, NA; Marino, B; Okwuosa, IS; Princewill, O; Rhodes, P; Russell, SD, 2018) |
| "This study suggests that spironolactone is well tolerated, and preliminary results support further investigation to evaluate the efficacy of spironolactone in the treatment of cats with cardiac failure due to cardiomyopathy." | 9.27 | The SEISICAT study: a pilot study assessing efficacy and safety of spironolactone in cats with congestive heart failure secondary to cardiomyopathy. ( Cobb, M; Garelli-Paar, C; Grassi, V; Guillot, E; Huxley, J; James, R, 2018) |
| " This subanalysis investigated the effect of add-on TLV compared to increased furosemide (FUR) on both electrolyte-free water and electrolyte clearance in patients with congestive heart failure (CHF) complicated by advanced chronic kidney disease (CKD)." | 9.27 | Comparison of the effects of tolvaptan and furosemide on renal water and sodium excretion in patients with heart failure and advanced chronic kidney disease: a subanalysis of the K-STAR study. ( Akashi, YJ; Inomata, T; Izumi, T; Kida, K; Sato, N; Shibagaki, Y; Tominaga, N, 2018) |
| "The aim of this study was to determine the diuretic effect of acetazolamide in patients with exacerbations of chronic heart failure, in addition to their stable diuretic therapy." | 9.24 | Acetazolamide as Add-on Diuretic Therapy in Exacerbations of Chronic Heart Failure: a Pilot Study. ( Budaj, A; Imiela, T, 2017) |
| "The change (Δ) in urine volume (ΔUV) and Δurine osmolality were greater in the tolvaptan group than in the furosemide group; however, ΔUV and Δurine osmolality did not show significant differences between the normonatremia subgroup and the hyponatremia subgroup in each group." | 9.24 | Effects of Tolvaptan Addition to Furosemide in Normo- and Hyponatremia Patients with Heart Failure and Chronic Kidney Disease Stages G3b-5: A Subanalysis of the K-STAR Study. ( Akashi, YJ; Inomata, T; Izumi, T; Kida, K; Sato, N; Shibagaki, Y; Tominaga, N, 2017) |
| "Furosemide is commonly prescribed for symptom relief in heart failure (HF) patients." | 9.24 | Rational and design of a randomized, double-blind, multicenter trial to evaluate the safety and tolerability of furosemide withdrawal in stable chronic outpatients with heart failure: The ReBIC-1 trial. ( Beck-da-Silva, L; Bertoldi, EG; Biolo, A; da Rosa, PR; Danzmann, LC; Doebber, M; Figueiredo Neto, JA; Kohler, I; Moura, LZ; Prado, DP; Ribeiro, ALP; Rohde, LE; Rover, M; Sant'Anna, RT; Simões, MV, 2017) |
| " While furosemide remains the dominant diuretic utilized in current practice, increasing evidence supports potential advantages of torsemide in heart failure (HF) and/or renal disease." | 9.22 | An evaluation of torsemide in patients with heart failure and renal disease. ( DeWald, TA; Greene, SJ; Mentz, RJ; Peters, AE, 2022) |
| "To compare the effects of different dosing schemes of furosemide on acute heart failure (AHF)." | 9.22 | Comparison of Different Furosemide Regimens in the Treatment of Acute Heart Failure: A Meta-Analysis. ( Chen, D; Guo, F; Huang, J; Huang, Y; Lin, H, 2022) |
| "The efficacy of hypertonic saline solution (HSS) combined with furosemide in treating acute heart failure is controversial." | 9.22 | Effect of Hypertonic Saline Solution Combined with Furosemide on Acute Heart Failure: A Meta-Analysis. ( Li, H; Li, Z; Liu, N; Wang, Z, 2022) |
| "Furosemide is the most commonly used loop diuretic in patients with heart failure (HF) despite data suggesting potential pharmacologic and antifibrotic benefits with torsemide." | 9.22 | Torsemide Versus Furosemide in Patients With Acute Heart Failure (from the ASCEND-HF Trial). ( Anstrom, KJ; Armstrong, PW; DeVore, AD; Ezekowitz, JA; Hasselblad, V; Hernandez, AF; Mentz, RJ; Metra, M; O'Connor, CM; Schulte, PJ; Tang, WH; Velazquez, EJ; Voors, AA, 2016) |
| "5 or 15 mg/day) in combination with furosemide have been investigated in heart failure (HF) patients with normal kidney function but not in HF patients with advanced kidney dysfunction." | 9.20 | Efficacy of tolvaptan added to furosemide in heart failure patients with advanced kidney dysfunction: a pharmacokinetic and pharmacodynamic study. ( Akashi, YJ; Kida, K; Kimura, K; Matsumoto, N; Miyake, F; Shibagaki, Y; Tominaga, N, 2015) |
| "Treatment of congestive heart failure (CHF) with loop diuretics, such as furosemide, may be associated with complications, including worsening renal function and metabolic or electrolyte disturbances." | 9.20 | Safety of add-on tolvaptan in patients with furosemide-resistant congestive heart failure complicated by advanced chronic kidney disease: a sub-analysis of a pharmacokinetics/ pharmacodynamics study. ( Akashi, YJ; Kida, K; Kimura, K; Matsumoto, N; Miyake, F; Shibagaki, Y; Tominaga, N, 2015) |
| " Patients in group 1 (125 mg furosemide) had a mean age of 77 ± 17 years, 43% were male, 6 (43%) had heart failure with a preserved ejection fraction (HFpEF), and 64% were in New York Heart Association (NYHA) class IV; the mean age of patients in group 2 (250 mg furosemide) was 80 ± 8." | 9.20 | Hypertonic Saline in Conjunction with High-Dose Furosemide Improves Dose-Response Curves in Worsening Refractory Congestive Heart Failure. ( Balistreri, F; Butler, J; Cuttitta, F; Di Gaudio, F; di Pasquale, P; Greco, M; Indelicato, S; La Rocca, V; Lupo, U; Parrinello, G; Paterna, S; Rizzo, G; Torres, D, 2015) |
| "The Answering question on tolvaptan's efficacy for patients with acute decompensated heart failure and renal failure (AQUAMARINE) is a multicenter, randomized controlled clinical trial, which will enroll 220 patients from 17 hospitals in Japan." | 9.19 | Clinical effectiveness of tolvaptan in patients with acute decompensated heart failure and renal failure: design and rationale of the AQUAMARINE study. ( Fujii, H; Matsue, Y; Nagahori, W; Nishioka, T; Noda, M; Okishige, K; Onishi, Y; Ono, Y; Sakurada, H; Satoh, Y; Sugi, K; Suzuki, M; Takahashi, A; Tejima, T; Torii, S; Yamaguchi, S; Yoshida, K, 2014) |
| "Spironolactone, not furosemide, improved insulin resistance in CHF patients probably by the inhibition of inflammatory cytokines and MMPs." | 9.19 | Spironolactone, not furosemide, improved insulin resistance in patients with chronic heart failure. ( Anker, SD; Doehner, W; Hisatome, I; Kato, M; Kinugasa, Y; Ogino, K; Yamamoto, K, 2014) |
| "Theoretically, salt supplementation should promote diuresis through increasing the glomerular filtration rate (GFR) during treatment of acute decompensated heart failure (ADHF) even with low-dose furosemide; however, there is little evidence to support this idea." | 9.19 | Intravenous salt supplementation with low-dose furosemide for treatment of acute decompensated heart failure. ( Ando, T; Eguchi, A; Hirotani, S; Iwasaku, T; Manabe, E; Masuyama, T; Morisawa, D; Naito, Y; Nakabo, A; Okuhara, Y; Sawada, H, 2014) |
| "In a subset analysis of the Efficacy of Vasopressin Antagonism in Heart Failure Outcome Study with Tolvaptan trial, 759 patients (18% of total) had elevated blood urea nitrogen (BUN) (> 20 mg/dl) and low SBP (<105 mmHg) at admission." | 9.16 | Efficacy of oral tolvaptan in acute heart failure patients with hypotension and renal impairment. ( Blair, J; Burnett, JC; Gheorghiade, M; Grinfeld, L; Konstam, MA; Krasa, HB; Maggioni, AP; Ouyang, J; Pang, PS; Swedberg, K; Vaduganathan, M; Zannad, F; Zimmer, C, 2012) |
| "The role of repeated infusions of Levosimendan (LEVO) in patients with chronic advanced heart failure is still unclear." | 9.16 | Intermittent levosimendan infusions in advanced heart failure: favourable effects on left ventricular function, neurohormonal balance, and one-year survival. ( Branzi, G; Della Rosa, F; Facchini, M; Malfatto, G; Parati, G; Rella, V; Villani, A, 2012) |
| "The aim of the study was to verify the effects of hypertonic saline solution (HSS) plus a high furosemide dose and light restriction of sodium intake compared with a high-dose infusion of furosemide alone on pulmonary capillary wedge pressure (PCWP), as determined by Doppler echocardiography and tissue Doppler imaging in patients suffering from decompensated heart failure." | 9.15 | Changes in estimating echocardiography pulmonary capillary wedge pressure after hypersaline plus furosemide versus furosemide alone in decompensated heart failure. ( Cardillo, M; Di Pasquale, P; Fasullo, S; La Rocca, G; Licata, G; Mezzero, M; Parrinello, G; Paterna, S; Torres, D, 2011) |
| "The aim of this study was to evaluate the effects of both the prolonged-release (PR) formulation of torasemide (torasemide-PR) and furosemide on myocardial fibrosis in hypertensive patients with chronic HF." | 9.15 | Effects of prolonged-release torasemide versus furosemide on myocardial fibrosis in hypertensive patients with chronic heart failure: a randomized, blinded-end point, active-controlled study. ( , 2011) |
| "The decrease in body weight from baseline to the day after the final dose with 15, 30 or 45 mg tolvaptan (-1." | 9.15 | Effects of tolvaptan on volume overload in Japanese patients with heart failure: results of a phase II, multicenter, randomized, double-blind, placebo-controlled, parallel-group study. ( Asanoi, H; Hori, M; Izumi, T; Matsuzaki, M; Tsutamoto, T, 2011) |
| "Loop diuretics, such as torasemide and furosemide, are important agents in the treatment of chronic heart failure." | 9.14 | TORAFIC study protocol: torasemide prolonged release versus furosemide in patients with chronic heart failure. ( Anguita, M; Castro-Beiras, A; Cobo, E; Coca, A; Conthe, P; de Teresa, E; Díez, J; Fernández, E, 2009) |
| "This study was designed to evaluate the consequences of ultrafiltration (UF) and standard intravenous diuretic (furosemide) therapy on glomerular filtration rate (GFR) and renal plasma flow in patients with acute decompensated heart failure." | 9.13 | A randomized, controlled trial of the renal effects of ultrafiltration as compared to furosemide in patients with acute decompensated heart failure. ( Bock, J; Dowling, TC; Feller, E; Gottlieb, SS; Marshall, J; Robinson, S; Rogers, HL, 2008) |
| "Four ambulatory patients with compensated chronic cardiac failure (NYHA Class III) of ischemic and nonischemic origin and systolic dysfunction (ejection fraction <35%), who were receiving a stable regimen of oral furosemide and angiotensin-converting enzyme inhibitor, were enrolled into the study." | 9.12 | Effect of timed semirecumbency and furosemide dosing on urinary sodium excretion in patients with compensated heart failure. ( Khouzam, RN; Klemis, JE; Mangold, TA; Nelson, MD; Wall, BM; Weber, KT, 2006) |
| "To evaluate short-term effects of tolvaptan when added to standard therapy in patients hospitalized with heart failure." | 9.12 | Short-term clinical effects of tolvaptan, an oral vasopressin antagonist, in patients hospitalized for heart failure: the EVEREST Clinical Status Trials. ( Burnett, JC; Cook, T; Gheorghiade, M; Grinfeld, L; Konstam, MA; Maggioni, AP; Orlandi, C; Ouyang, J; Swedberg, K; Udelson, JE; Zannad, F; Zimmer, C, 2007) |
| "A 24-hour infusion of levosimendan was added to dobutamine in 18 patients (aged 63 +/- 9 years) hospitalized for management of decompensated New York Heart Association functional class IV heart failure refractory to a continuous 24-hour infusion of dobutamine (10 microg/kg/min) and furosemide (10 mg/hour); the primary study end point was a >or=40% increase in cardiac index and a >or=25% decrease in pulmonary capillary wedge pressure compared with pretreatment measurements." | 9.11 | Hemodynamic effects of levosimendan added to dobutamine in patients with decompensated advanced heart failure refractory to dobutamine alone. ( Agrios, N; Anastasiou-Nana, MI; Christodoulou, K; Dalianis, A; Kanakakis, J; Nanas, JN; Papazoglou, PP; Terrovitis, JV; Tsagalou, EP; Tsolakis, E, 2004) |
| "To retrospectively investigate elevation of serum potassium when spironolactone (25 or 50 mg/day) and furosemide were administered concomitantly with an angiotensin II converting enzyme inhibitor (ACE-I) or angiotensin II receptor blocker (ARB) to patients with chronic heart failure for 12 months and occurrence of hyperkalemia and hypokalemia because of concomitant administration of spironolactone plus an ACE-I or ARB and furosemide." | 9.11 | Serum concentration of potassium in chronic heart failure patients administered spironolactone plus furosemide and either enalapril maleate, losartan potassium or candesartan cilexetil. ( Hirooka, K; Isobe, F; Saito, M; Takada, M; Yasumura, Y, 2005) |
| "Elderly patients with heart failure are at risk of postprandial hypotension (PPH), orthostatic hypotension (OH), and concomitant cerebral oxygenation changes because of altered cardiovascular balance and the use of cardiovascular medications, such as furosemide and captopril." | 9.10 | Effects of furosemide versus captopril on postprandial and orthostatic blood pressure and on cerebral oxygenation in patients > or = 70 years of age with heart failure. ( Colier, WN; Hoefnagels, WH; Jansen, RW; Mehagnoul-Schipper, DJ; Verheugt, FW, 2002) |
| " In protocol 1, plasma level of thiobarbituric acid-reactive substances (TBARS) and renal function were assessed before and after intravenous infusion of vitamin C or placebo in 8 patients with moderate congestive heart failure (CHF) treated with enalapril." | 9.10 | Reduction of oxidative stress augments natriuretic effect of furosemide in moderate heart failure. ( Doba, N; Tomiyama, H; Watanabe, G; Yamashina, A; Yoshida, H, 2003) |
| "To determine changes in RAS activation and clinical correlates following furosemide withdrawal in elderly heart failure patients without left ventricular systolic dysfunction." | 9.10 | Neurohormonal effects of furosemide withdrawal in elderly heart failure patients with normal systolic function. ( Hoefnagels, WH; Jansen, RW; Sweep, FC; van Kraaij, DJ, 2003) |
| "In patients with CHF, tolvaptan was well tolerated; it reduced body weight and edema and normalized serum sodium in the hyponatremic patients." | 9.10 | Vasopressin V2-receptor blockade with tolvaptan in patients with chronic heart failure: results from a double-blind, randomized trial. ( Czerwiec, F; Gheorghiade, M; Kambayashi, J; Niazi, I; Orlandi, C; Ouyang, J; Zampino, M, 2003) |
| "The hypothesis was that torasemide, due to more predictable pharmacokinetics/pharmacodynamics, induces greater improvements in functional and social limitation than furosemide and reduces the frequency of hospitalisations in primary care patients with chronic heart failure (CHF)." | 9.10 | Torasemide vs. furosemide in primary care patients with chronic heart failure NYHA II to IV--efficacy and quality of life. ( Gamba, G; Hess, B; Jaquet, F; Müller, K, 2003) |
| "Oral isosorbide-5-mononitrate (ISMN) (50 mg once daily) or placebo was administered to 136 patients (NYHA Class 2-3) treated for heart failure, all receiving captopril and most also furosemide." | 9.09 | Effect of isosorbide-5-mononitrate on exercise performance and clinical status in patients with congestive heart failure. Results of the Nitrates in Congestive Heart Failure (NICE) Study. ( Caspi, A; Ermer, W; Lewis, BS; Markiewicz, W; Rabinowitz, B; Rosenfeld, T; Schlesinger, Z; Sclarovsky, S, 1999) |
| "To assess the effects of furosemide withdrawal on postprandial blood pressure (BP) in elderly patients with heart failure and preserved left ventricular systolic function." | 9.09 | Furosemide withdrawal improves postprandial hypotension in elderly patients with heart failure and preserved left ventricular systolic function. ( Bouwels, LH; Hoefnagels, WH; Jansen, RW; van Kraaij, DJ, 1999) |
| "Male patients with mild heart failure were randomly assigned to 9 days of therapy with 20 mg frusemide twice a day, 200 mg candoxatril twice a day, or 400 mg candoxatril twice a day (n = 10 per group) after a 14-day placebo washout phase." | 9.09 | Comparison of the short-term effects of candoxatril, an orally active neutral endopeptidase inhibitor, and frusemide in the treatment of patients with chronic heart failure. ( Dargie, HJ; Newby, DE; Norrie, J; Northridge, DB; Rooney, E, 1999) |
| "The study aimed to assess the hemodynamic and neuroendocrine effects of candoxatril and frusemide compared with placebo in patients with mild chronic heart failure." | 9.09 | Hemodynamic and neuroendocrine effects for candoxatril and frusemide in mild stable chronic heart failure. ( Bostrøm, P; Christensen, CC; Parikka, H; Rykke, EO; Toivonen, L; Westheim, AS, 1999) |
| "To determine the effects of furosemide and the selective A1 adenosine receptor BG9719 on renal function in patients with congestive heart failure (CHF)." | 9.09 | Effects of BG9719 (CVT-124), an A1-adenosine receptor antagonist, and furosemide on glomerular filtration rate and natriuresis in patients with congestive heart failure. ( Beckman, E; Bennett, D; Cines, M; Fisher, ML; Freudenberger, R; Gladwell, T; Gottlieb, SS; Liittschwager, EB; Marshall, J; Skettino, SL; Wolff, A, 2000) |
| " All patients underwent at entry a physical examination, measurement of body weight (BW), blood pressure (BP), heart rate (HR), evaluation of signs of CHF, and controls of serum Na, K, Cl, bicarbonate, albumin, uric acid, creatinine, urea and glycemia and daily during hospitalization, as well as the daily output of urine for, Na, K and Cl measurements." | 9.09 | Effects of high-dose furosemide and small-volume hypertonic saline solution infusion in comparison with a high dose of furosemide as a bolus, in refractory congestive heart failure. ( Amato, P; Cardinale, A; Di Pasquale, P; Follone, G; Giubilato, A; Licata, G; Parrinello, G; Paterna, S, 2000) |
| "To compare the direct healthcare costs of patients with congestive heart failure (CHF) prescribed torasemide (torsemide) or furosemide (frusemide)." | 9.09 | Healthcare costs of patients with heart failure treated with torasemide or furosemide. ( Brater, DC; Forthofer, MM; Murray, MD; Stroupe, KT, 2000) |
| "We sought to determine the effect of aspirin on the venodilator effect of furosemide in patients with chronic heart failure (CHF) BACKGROUND: Furosemide has an acute venodilator effect preceding its diuretic action, which is blocked by nonsteroidal anti-inflammatory, drugs." | 9.09 | Aspirin inhibits the acute venodilator response to furosemide in patients with chronic heart failure. ( Davie, AP; Jhund, PS; McMurray, JJ, 2001) |
| "Because the bioavailability of oral furosemide is erratic and often incomplete, we tested the hypothesis that patients with heart failure who were treated with torsemide, a predictably absorbed diuretic, would have more favorable clinical outcomes than would those treated with furosemide." | 9.09 | Open-label randomized trial of torsemide compared with furosemide therapy for patients with heart failure. ( Adams, LD; Bennett, SJ; Brater, DC; Deer, MM; Dexter, PR; Ferguson, JA; Lane, KA; Murray, MD; Perkins, SM; Smith, FE; Tierney, WM, 2001) |
| "In patients with early stages of heart failure, digoxin may prevent a progressive deterioration in heart rate variability, whereas ibopamine does not show statistically significant effects." | 9.08 | Heart rate variability in patients with mild to moderate heart failure: effects of neurohormonal modulation by digoxin and ibopamine. The Dutch Ibopamine Multicenter Trial (DIMT) Study Group. ( Boomsma, F; Brouwer, J; Dunselman, PH; Haaksma, J; Lie, KI; Man in 't Veld, AJ; van Veldhuisen, DJ, 1995) |
| "We have previously found thiamine (vitamin B1) deficiency in patients with congestive heart failure (CHF) who had received long-term furosemide therapy." | 9.08 | Improved left ventricular function after thiamine supplementation in patients with congestive heart failure receiving long-term furosemide therapy. ( Almog, S; Ezra, D; Halkin, H; Motro, M; Peleg, E; Rosenthal, T; Seligmann, H; Shefi, M; Shimon, I; Vered, Z, 1995) |
| "The bioavailability, pharmacokinetics, and pharmacodynamics of torsemide (10 mg orally and intravenously) and furosemide (40 mg orally and 20 mg intravenously) were determined in a randomized crossover clinical trial in 16 patients with compensated congestive heart failure." | 9.08 | Bioavailability, pharmacokinetics, and pharmacodynamics of torsemide and furosemide in patients with congestive heart failure. ( Black, PK; Brater, DC; Kramer, WG; Serpas, T; Smith, WB; Vargo, DL, 1995) |
| "The effect of epoprostenol on the pharmacokinetics of furosemide was investigated in 23 patients with end-stage congestive heart failure (CHF) receiving conventional therapy alone or conventional therapy plus epoprostenol." | 9.08 | The effects of epoprostenol on drug disposition. II: A pilot study of the pharmacokinetics of furosemide with and without epoprostenol in patients with congestive heart failure. ( Carlton, LD; Mattson, CN; Patterson, JH; Schmith, VD, 1996) |
| "The efficacy of high dose furosemide as a continuous infusion was compared with a bolus injection of equal dose in patients with severe heart failure." | 9.08 | Diuretic efficacy of high dose furosemide in severe heart failure: bolus injection versus continuous infusion. ( Dormans, TP; Gerlag, PG; Russel, FG; Smits, P; Tan, Y; van Meyel, JJ, 1996) |
| "The objective of this study was to determine whether the addition of low-dose (renal-dose) dopamine to furosemide therapy enhances natriuresis in patients with compensated congestive heart failure, New York Heart Association Class II or III." | 9.08 | Dopamine does not enhance furosemide-induced natriuresis in patients with congestive heart failure. ( Brater, DC; Rudy, DW; Swan, SK; Vargo, DL, 1996) |
| "We studied the synergism between high-dose furosemide and hydrochlorothiazide in patients with severe congestive heart failure and impaired renal function showing diuretic resistance to a daily dose of furosemide of at least 250 mg." | 9.08 | Combination of high-dose furosemide and hydrochlorothiazide in the treatment of refractory congestive heart failure. ( Dormans, TP; Gerlag, PG, 1996) |
| "Previous studies have demonstrated that continuous infusion of furosemide results in increased diuresis and natriuresis compared with bolus administration of the drug in patients with severe heart failure." | 9.08 | Effect of bolus injection versus continuous infusion of furosemide on diuresis and neurohormonal activation in patients with severe congestive heart failure. ( Aaser, E; Djøseland, O; Forfang, K; Gullestad, L; Hall, C; Kjekshus, J; Lundberg, J; Tølløfsrud, S, 1997) |
| "To evaluate the safety and efficacy of low-dose dopamine, high-dose furosemide, and their combination in the treatment of refractory congestive heart failure." | 9.08 | Increased toxicity of high-dose furosemide versus low-dose dopamine in the treatment of refractory congestive heart failure. ( Cotter, G; Golik, A; Litinski, I; Metzkor, E; Moshkovitz, Y; Perry, C; Tavori, U; Weissgarten, J; Zaidenstein, R, 1997) |
| "In a randomized, single-blind, crossover clinical trial, the diuretic efficacy of the same total dose of furosemide (2 x 40 mg) administered in either conventional intravenous bolus injection or continuous infusion was studied in 20 patients (nine males and 11 females), aged 37-75 years, with congestive heart failure." | 9.08 | Diuretic effects of furosemide infusion versus bolus injection in congestive heart failure. ( Bagatin, J; Capkun, V; Ljutić, D; Naranca, M; Pivac, N; Polić, S; Rumboldt, Z; Sardelić, S, 1998) |
| " All dogs entered in the study received standard heart failure treatment (furosemide with or without digoxin)." | 9.08 | Effects of enalapril maleate on survival of dogs with naturally acquired heart failure. The Long-Term Investigation of Veterinary Enalapril (LIVE) Study Group. ( Benitz, AM; Cifelli, S; Ericsson, GF; Ettinger, SJ; Hanson, PD; Jernigan, AD; Longhofer, SL; Trimboli, W, 1998) |
| "In a double-blind dose-response study, 49 patients with New York Heart Association functional class III or IV heart failure were randomized to receive a single intravenous dose of 5, 10, or 20 mg torsemide or 40 mg furosemide." | 9.07 | Dose-response study of intravenous torsemide in congestive heart failure. ( Bremner, S; Hariman, RJ; Jones, JP; Kostis, JB; Louie, EK; Nocero, MA; Rogers, WJ, 1994) |
| "To assess the value of treatment with continuous intravenous infusion of furosemide (F) in patients with refractory congestive heart failure." | 9.07 | Continuous infusion of furosemide in the treatment of patients with congestive heart failure and diuretic resistance. ( Dormans, T; Gerlag, PG; Gribnau, FW; Russel, FG; Smits, P; van Meyel, JJ, 1994) |
| "This study examined the effects of conventional doses of oral captopril on the renal responses to oral furosemide in ambulant patients with stable chronic heart failure." | 9.07 | Acute effects of captopril on the renal actions of furosemide in patients with chronic heart failure. ( Bridges, AB; Fraser, CG; McLay, JS; McMurray, JJ; Struthers, AD, 1993) |
| "The effect of ibopamine and furosemide in 130 patients with NYHA Class I and II heart failure were studied in a parallel, double-blind, randomized placebo-controlled multi-centre trial." | 9.07 | The effects of oral ibopamine in patients with mild heart failure--a double blind placebo controlled comparison to furosemide. The Ibopamine Study Group. ( Parker, JO, 1993) |
| "Furosemide is frequently administered intravenously to patients with chronic heart failure." | 9.07 | Interaction of intravenous atrial natriuretic factor with furosemide in patients with heart failure. ( Beltran, AM; Cohn, JN; Connelly, TP; Francis, GS; Williams, KJ, 1994) |
| "To analyze the physical performance of the patients with congestive heart failure (CHF), grades I and II of the New York Heart Association (NYHA), submitted to ergometric test: 1) under conventional treatment with digitalis and diuretic; 2) with an angiotensin converting enzyme inhibitor, captopril, associate with conventional treatment; 3) using captopril associated with digitalis or diuretic." | 9.07 | [Captopril in the treatment of patients with congestive heart failure. Its bicycle ergometry evaluation]. ( Benchimol, C; Ferreira Filho, SR; Hatab, SA; Nascimento, LO; Saragoça, MA, 1992) |
| " We performed a prospective randomized crossover study comparing intermittent intravenous administration (IA) of furosemide with continuous infusion following a single loading dose (LDCI) in nine patients with severe congestive heart failure." | 9.07 | Intermittent administration of furosemide vs continuous infusion preceded by a loading dose for congestive heart failure. ( Lahav, M; Ra'anani, P; Regev, A; Theodor, E, 1992) |
| "Ten chronic heart failure patients were studied on three occasions in randomized double-blind fashion to compare the acute hemodynamic, neurohormonal, and renal sodium-handling responses to 1 mg captopril versus 25 mg captopril, both in the absence of loop diuretic therapy and during furosemide-stimulated natriuresis." | 9.07 | Furosemide-induced natriuresis is augmented by ultra-low-dose captopril but not by standard doses of captopril in chronic heart failure. ( Fenwick, MK; Morton, JJ; Motwani, JG; Struthers, AD, 1992) |
| "18 patients with II NYHA class chronic congestive heart failure (CCHF) had been given nifedipine (Cordipin) 54." | 9.06 | [Evaluation of the effect of nifedipine in patients with chronic congestive heart failure]. ( Bechler-Lisińska, J; Broks-Bratkowska, B; Cholewa, M; Dryjański, T; Gawor, Z; Górski, L; Markiewicz, K, 1989) |
| "Ten patients with moderate heart failure who still had symptoms despite 40 mg frusemide daily were treated with increased doses of frusemide and the addition of captopril in randomised order." | 9.06 | Symptomatic assessment of patients with heart failure: double-blind comparison of increasing doses of diuretics and captopril in moderate heart failure. ( Cowley, AJ; Hampton, JR; Rowley, JM; Stainer, K; Wynne, RD, 1986) |
| "Captopril alone as therapy for mild heart failure was compared with a combination of frusemide and amiloride in a double-blind randomised crossover trial in 14 patients who had previously been treated with diuretics." | 9.06 | Double-blind comparison of captopril alone against frusemide plus amiloride in mild heart failure. ( Bayliss, J; Parameshwar, J; Poole-Wilson, PA; Richardson, A; Scriven, AJ; Sutton, GC, 1987) |
| "The effects of ibopamine and furosemide on renal function given alone and in combination at single doses were studied in 6 men and 6 women aged 45 to 73 years with chronic congestive heart failure of NYHA class II." | 9.06 | Effects of ibopamine in combination with furosemide on renal function in patients with chronic congestive heart failure. ( Carini, L; Castini, D; Mazzola, C; Moreo, A; Salvadeo, A; Segagni, S; Segalini, G; Villa, G; Vitolo, E, 1988) |
| "A double-blind parallel group study was carried out to compare the effects of piretanide on daily glucose profiles, symptoms of congestive heart failure and serum electrolytes with those of furosemide in 24 diabetic in-patients suffering from congestive heart failure." | 9.06 | The effects of piretanide in patients with congestive heart failure and diabetes mellitus: a double-blind comparison with furosemide. ( Car, N; Skrabalo, Z; Verho, M, 1988) |
| "Renal function and excretion of water, salt, and the prostacyclin hydration product (6-keto-PGF1 alpha) were evaluated in 10 furosemide-treated patients with well-controlled congestive heart failure." | 9.06 | Renal function and tubular transport effects of sulindac and naproxen in chronic heart failure. ( Beermann, B; Eriksson, LO; Kallner, M, 1987) |
| "Forty elderly patients, aged 68 to 89 years, with congestive cardiac failure, who were attending a hospital out-patients department, entered an open, parallel group, comparative study of two diuretic combinations, 40 mg frusemide plus 5 mg amiloride per tablet and 0." | 9.06 | An open comparative study of two diuretic combinations, frusemide/amiloride ('Frumil') and bumetanide/potassium chloride ('Burinex' K), in the treatment of congestive cardiac failure in hospital out-patients. ( Allman, S; Bailey, R; Crawford, RJ; Martin, A; Ramsay, F, 1988) |
| "In 15 patients with moderate congestive heart failure not completely controlled on digoxin (0." | 9.06 | Addition of captopril versus increasing diuretics in moderate but deteriorating heart failure: a double-blind comparative trial. ( Boccanelli, A; Carboni, GP; Liberatore, SM; Prati, PL; Zachara, E, 1986) |
| "The diuretic effects of torasemide and of furosemide were compared in a double blind cross-over study in 13 patients with stable chronic heart failure." | 9.06 | Diuretic activity of torasemide and furosemide in chronic heart failure: a comparative double blind cross-over study. ( Delarge, J; Luyckx, AS; Scheen, AJ; Vancrombreucq, JC, 1986) |
| " English articles comparing intermittent boluses and continuous infusion of furosemide in treating acute heart failure were included." | 9.05 | Continuous Infusion Versus Intermittent Boluses of Furosemide in Acute Heart Failure: A Systematic Review and Meta-Analysis. ( Chan, JSK; Harky, A; Kot, TKM; Ng, M, 2020) |
| "The immediate haemodynamic effects of intravenous frusemide (1 mg/kg) and intravenous isosorbide dinitrate (50-200 micrograms/kg/h) were compared in a prospective, randomised, between-group study in 28 men with radiographic and haemodynamic evidence of left ventricular failure following acute myocardial infarction." | 9.05 | Haemodynamic advantages of isosorbide dinitrate over frusemide in acute heart-failure following myocardial infarction. ( Ahuja, RC; Hussain, M; Nelson, GI; Silke, B; Taylor, SH, 1983) |
| "To assess the effect of furosemide and captopril on renal function and hyponatremia in patients with severe heart failure, we studied two groups of patients with hyponatremia who were receiving digoxin therapy and whose sodium intake was 40 meq/d." | 9.05 | Renal response to captopril in severe heart failure: role of furosemide in natriuresis and reversal of hyponatremia. ( Dzau, VJ; Hollenberg, NK, 1984) |
| "In a double blind study of metoprolol in the treatment of suspected acute myocardial infarction 698 patients (study group) received metoprolol and 697 a placebo (control group)." | 9.05 | Development of congestive heart failure after treatment with metoprolol in acute myocardial infarction. ( Herlitz, J; Hjalmarson, A; Holmberg, S; Swedberg, K; Vedin, A; Waagstein, F; Waldenström, A; Wedel, H; Wilhelmsen, L; Wilhelmsson, C, 1984) |
| "The efficacy and safety of oral bumetanide, a pharmacologically new diuretic was compared with that of furosemide in 30 patients suffering from congestive cardiac failure and other edema states." | 9.05 | A comparative randomized double-blind clinical trial of bumetanide and furosemide in congestive cardiac failure and other edema states. ( Sagar, S; Sharma, BK; Sharma, PL; Wahi, PL, 1984) |
| "A total of 95 patients seen in general practice with oedema associated with heart failure took part in an open study of the efficacy and tolerability of a combination tablet containing 40 mg frusemide and 5 mg amiloride." | 9.05 | Frusemide/amiloride combination ('Frumil') in heart failure: an open, multi-centre study in general practice. ( Eason, CT; Richards, HH; Townsend, HA; Waddy, AL, 1984) |
| "0 mg) and to furosemide (40 and 80 mg) in 20 patients with stable, compensated congestive heart failure (CHF), comparing the two drugs and, in addition, examining differences from normal subjects." | 9.05 | Bumetanide and furosemide in heart failure. ( Anderson, S; Brater, DC; Burdette, A; Day, B, 1984) |
| "The hemodynamic effect of venous dilatation (intravenous isosorbide dinitrate [ISDN]) and arteriolar dilatation (intravenous hydralazine), both as firstline treatment and then combined with intravenous furosemide, were evaluated in a randomized, between-group comparison in 20 men with severe acute left-sided cardiac failure after myocardial infarction (MI)." | 9.05 | Hemodynamic comparison of primary venous or arteriolar dilatation and the subsequent effect of furosemide in left ventricular failure after acute myocardial infarction. ( Forsyth, DR; Hussain, M; Nelson, GI; Silke, B; Taylor, SH; Verma, SP, 1983) |
| "The immediate hemodynamic effects of intravenous frusemide (1 mg/kg) and intravenous isosorbide dinitrate (50-200 micrograms/kg/h) were compared in a prospective, randomized, between-group study in 28 men with radiographic and hemodynamic evidence of left ventricular failure following acute myocardial infarction." | 9.05 | Management of acute heart failure following myocardial infarction: hemodynamic advantages of isosorbide dinitrate over frusemide. ( Ahuja, RC; Hussain, M; Nelson, GI; Silke, B; Taylor, SH, 1983) |
| "Serum potassium levels, weight, heart function and patient's opinion of therapy were assessed in a study comparing 40 mg of frusemide and 600 mg of controlled-release potassium chloride in a combined tablet to frusemide and potassium supplements given as separate tablets in thirty elderly patients in cardiac failure." | 9.05 | A comparison of the effect of combined frusemide and controlled-release potassium tablets (Diumide-K continus tablets) and frusemide and slow-K tablets in elderly patients with cardiac failure. ( Rao, CR, 1982) |
| "Torasemide 60 mg and furosemide 120 mg were administered intravenously in a randomized double blind study in twelve patients with acute heart failure." | 9.05 | Clinical efficacy of torasemide, a new diuretic agent, in patients with acute heart failure: a double blind comparison with furosemide. ( Dodion, L; Kesteloot, H; Stroobandt, R, 1982) |
| "Twenty-four-hour Holter electrocardiographic recordings were used to measure the effects of a converting-enzyme inhibitor, enalapril, given for 12 weeks, on the frequency of cardiac arrhythmias in 10 patients with congestive heart failure (New York Heart Association functional class II to III) receiving maintenance therapy with digoxin and furosemide." | 9.05 | Effect of enalapril on ventricular arrhythmias in congestive heart failure. ( Fitzpatrick, MA; Ikram, H; Nicholls, MG; Webster, MW; Wells, JE, 1985) |
| "The effects of slow-release furosemide and bendroflumethiazide in the ambulatory treatment of mild to moderate congestive heart failure were compared in a controlled multicentre study using a randomized, double-blind procedure." | 9.05 | Multicentre comparison between slow-release furosemide and bendroflumethiazide in congestive heart failure. ( Pehrsson, SK, 1985) |
| "Since patients vary in their response to furosemide, a pharmacokinetic study of this drug was undertaken in 7 patients with severe congestive heart failure." | 9.04 | Pharmacokinetics of furosemide in patients with congestive heart failure. ( Benet, LZ; Cohn, K; Edelen, JS; Goldman, S; Greither, A, 1979) |
| "Extra potassium supplements, spironolactone or amiloride were given for 5 months to forty-nine patients with heart failure who were taking furosemide and were in a steady state." | 9.04 | The effects of potassium supplements, spironolactone of amiloride on the potassium status of patients with heart failure. ( Burkinshaw, L; Davidson, C; Morgan, DB, 1978) |
| "A dose of 20 mg furosemide in congestive heart failure patients produces a significant diuretic and natriuretic effect." | 9.04 | Diuretic and clinical effects of low-dose furosemide in congestive heart failure patients. ( Bacchus, R; Mahabir, RN, 1976) |
| "Medline and Cochrane Databases were systemically reviewed for randomized and observational studies comparing patients with chronic heart failure on oral torsemide versus oral furosemide and their association with intermediate-term outcomes (5-12 months) through May 2018." | 9.01 | Torsemide versus furosemide and intermediate-term outcomes in patients with heart failure: an updated meta-analysis. ( Chen, M; Hanumanthu, BK; Kokkinidis, DG; Miles, JA; Patel, K; Siegel, RM, 2019) |
| "It is not known whether older patients with acute heart failure (HF) receiving tolvaptan have decreased mortality rates and a better long-term prognosis than patients who receive furosemide." | 8.98 | Use of tolvaptan vs. furosemide in older patients with heart failure : Meta-analysis of randomized controlled trials. ( Huang, WL; Wang, HB; Xiong, XL; Yang, J; Yang, Y; Zhang, YF, 2018) |
| "We conducted a meta-analysis of pharmacogenomic substudies of three randomized trials conducted in patients with decompensated heart failure (HF) that were led by National Heart Lung and Blood Institute (NHLBI)-funded HF Network to test the hypothesis that candidate genes modulate net fluid loss and weight change in patients with decompensated HF treated with a furosemide-based diuretic regimen." | 8.95 | A pharmacogenetic investigation of intravenous furosemide in decompensated heart failure: a meta-analysis of three clinical trials. ( Bardhadi, A; Cappola, TP; de Denus, S; Dubé, MP; Huggins, GS; Keleti, J; Mann, DL; Mongrain, I; Normand, V; Phillips, MS; Provost, S; Rouleau, JL; Shah, SH; Zada, YF, 2017) |
| "Continuous versus bolus dosing of furosemide has been a longstanding debate for clinicians treating patients with acute decompensated heart failure." | 8.95 | Which dosing of furosemide is better in acute decompensated heart failure? ( Budavari, AI; Jalaba, S; Palermo, J, 2017) |
| " Most studies assessing body thiamine status have reported variable degrees of thiamine deficiency in patients with heart failure, particularly those treated chronically with high doses of furosemide." | 8.93 | Does Long-Term Furosemide Therapy Cause Thiamine Deficiency in Patients with Heart Failure? A Focused Review. ( Alpert, MA; Balla, S; Katta, N, 2016) |
| " furosemide for diuretic-resistant CHF patients led to a better renal safety profile and improved clinical endpoints such as mortality and heart failure-related hospitalizations." | 8.91 | Hypertonic saline plus i.v. furosemide improve renal safety profile and clinical outcomes in acute decompensated heart failure: A meta-analysis of the literature. ( Ariano, C; Cantatrione, S; De Vecchis, R; Esposito, C, 2015) |
| "Use of intravenous furosemide rather than oral administration in acute decompensated congestive cardiac failure is universally recommended in international guidelines." | 8.91 | Intravenous Furosemide for Acute Decompensated Congestive Heart Failure: What Is the Evidence? ( MacAllister, R; Owen, DR; Sofat, R, 2015) |
| " Our group has shown that treatment of patients with diuretic-resistant heart failure with high-dose furosemide plus hypertonic saline is effective and well tolerated, improving symptoms of congestion, reducing plasma levels of markers of neurohormonal and inflammatory activation, decreasing hospital readmission rates, and reducing long-term mortality." | 8.87 | Intravenous high-dose furosemide and hypertonic saline solutions for refractory heart failure and ascites. ( Licata, G; Parrinello, G; Pinto, A; Tuttolomondo, A, 2011) |
| "The impact of tolvaptan on the long-term outcomes of patients with heart failure (HF) remains inconclusive." | 8.31 | Impact of tolvaptan add-on treatment on patients with heart failure requiring long-term congestion management: A retrospective cohort study using a medical claim database in Japan. ( Aihara, M; Kinugawa, K; Matsukawa, M; Nakamura, Y; Sano, H, 2023) |
| "Door-to-furosemide ≤1 h was associated with a lower short-term risk of heart failure hospitalizations or cardiovascular death in AHF patients." | 8.31 | Door-to-furosemide time and clinical outcomes in acute heart failure. ( Almeida, J; Besteiro, B; Bettencourt, P; Brito, MT; Ferreira, JP; Friões, F; Gomes, F; Gouveia, R; Jardim, AL; Leite-Moreira, A; Marques, P; Vasques-Nóvoa, F; Vieira, JT, 2023) |
| "Dapagliflozin reduced the combined risk of worsening heart failure or cardiovascular death among patients with heart failure with mildly reduced or preserved ejection fraction." | 8.31 | Dapagliflozin and diuretic utilization in heart failure with mildly reduced or preserved ejection fraction: the DELIVER trial. ( Chatur, S; Claggett, B; de Boer, RA; Desai, AS; Haddad, T; Hernandez, AF; Inzucchi, SE; Jhund, PS; Kosiborod, MN; Lam, CSP; Maria Langkilde, A; Martinez, F; McMurray, JJV; Miao, ZM; Mitter, SS; Petersson, M; Shah, SJ; Solomon, SD; Vaduganathan, M; Vardeny, O, 2023) |
| "A new delivery mechanism provides subcutaneous infusion of furosemide to treat fluid overload in adults with heart failure." | 8.31 | New Delivery Route for Furosemide in Heart Failure. ( Aschenbrenner, DS, 2023) |
| "Furosemide is a diuretic and is used for the treatment of patients with heart failure (HF)." | 8.31 | Il-6 and UGT1A1 variations may related to furosemide resistance in heart failure patients. ( Guctekin, T; Guney, AI; Kirac, D; Koç, G; Koprululu Kucuk, G; Sunbul, M, 2023) |
| "Furosemide, a loop diuretic, is often empirically used to treat acute decompensated heart failure (ADHF) initially." | 8.31 | Tolvaptan's Association with Low Risk of Acute Kidney Injury in Patients with Advanced Chronic Kidney Disease and Acute Decompensated Heart Failure. ( Hasegawa, M; Hayashi, H; Inaguma, D; Koide, S; Ogata, S; Tagaya, T; Takahashi, K; Tsuboi, N; Yuzawa, Y, 2023) |
| "Furosemide, a frequently prescribed diuretic for managing congestive heart failure and edema, remains a topic of debate regarding its potential risk of inducing acute kidney injury (AKI) in patients." | 8.31 | Hospitalized patients received furosemide undergoing acute kidney injury: the risk and prediction tool. ( Che, L; Guan, C; Li, C; Liu, Z; Luan, H; Man, X; Wang, Y; Xu, L; Xu, Y; Yang, C; Zhang, N; Zhao, L; Zhou, B, 2023) |
| " The heart failure nurse specialist, supported by the heart failure-palliative care multidisciplinary team, works with the community or hospice staff who administer the CSCI-furosemide." | 8.31 | Subcutaneous furosemide in advanced heart failure: service improvement project. ( Birch, F; Boam, E; Ghosh, J; Johnson, MJ; Parsons, S, 2023) |
| "The combination of oral tolvaptan and IV furosemide is effective in augmenting diuresis and reducing weight in patients with furosemide refractory edema but requires monitoring of electrolytes and volume status." | 8.12 | Efficacy and Safety of Combination Therapy with Tolvaptan and Furosemide in Children with Nephrotic Syndrome and Refractory Edema: A Prospective Interventional Study. ( Bagga, A; Hari, P; Meena, J; Sinha, A, 2022) |
| "Metolazone and intravenous (IV) chlorothiazide are commonly used diuretics for sequential nephron blockade (SNB) in patients with acute decompensated heart failure (ADHF)." | 8.12 | Metolazone Versus Intravenous Chlorothiazide for Decompensated Heart Failure Sequential Nephron Blockade: A Retrospective Cohort Study. ( Biskupiak, J; Cisowska, T; Fang, JC; Jacobs, JA; Pan, IZ; Shah, KS, 2022) |
| "Kidney injury (KI) has been documented in dogs treated with furosemide for left-sided congestive heart failure (CHF)." | 8.12 | Retrospective evaluation of risk factors for development of kidney injury after parenteral furosemide treatment of left-sided congestive heart failure in dogs. ( Adin, DB; Giorgi, ME; Mochel, JP; Ward, JL; Yuan, L, 2022) |
| "Background and Objectives: The aim of this paper is to evaluate the impact of humoral substance mid-regional pro-adrenomedullin (MR-proADM) on the two-year survival of patients with chronic heart failure and relate it to the dosage of furosemide." | 8.12 | Relation between Mid-Regional Pro-Adrenomedullin in Patients with Chronic Heart Failure and the Dose of Diuretics in 2-Year Follow-Up-Data from FAR NHL Registry. ( Benešová, K; Goldbergová-Pávková, M; Jarkovský, J; Krejčí, J; Lábr, K; Ludka, O; Málek, F; Ošťádal, P; Pařenica, J; Špinar, J; Špinarová, L; Špinarová, M, 2022) |
| "We initiated a community-based continuous subcutaneous infusion (CSCI) furosemide service for the treatment of advanced heart failure." | 8.12 | Furosemide in end-stage heart failure: community subcutaneous infusions. ( Armstrong, L; Brown, A; Matthews, I; Ripley, D; Robson, J; Runnett, C; Thomas, H; Westley, K, 2022) |
| "The effect of early administration of intravenous (IV) furosemide in the emergency department (ED) on short-term outcomes of acute heart failure (AHF) patients remains controversial, with one recent Japanese study reporting a decrease of in-hospital mortality and one Korean study reporting a lack of clinical benefit." | 8.02 | The FAST-FURO study: effect of very early administration of intravenous furosemide in the prehospital setting to patients with acute heart failure attending the emergency department. ( Aguiló, S; Álvarez Pérez, JM; Chioncel, O; Fuentes, M; Gil, V; Harjola, P; Harjola, VP; Herrero, P; Jacob, J; Llauger, L; Llorens, P; López-Grima, ML; Martín-Sánchez, FJ; Martínez-Nadal, G; Masip, J; Mebazaa, A; Mir, M; Miró, Ò; Mullens, W; Müller, C; Peacock, WF; Rodríguez-Adrada, E; Rossello, X; Ruschitzka, F; Tost, J, 2021) |
| "Currently, there are no meta-analyses evaluating the efficacy and safety of intermittent vs continuous furosemide for heart failure concomitant renal dysfunction." | 8.02 | Efficacy and safety of intermittent vs continuous furosemide for heart failure concomitant renal dysfunction: A protocol for systematic review and meta-analysis. ( Chen, S; Lin, Y; Zhou, C; Zhou, M, 2021) |
| "Although tolvaptan has been reported to prevent worsening renal function (WRF) in patients with advanced acute heart failure (AHF), evidence regarding the effect of tolvaptan on renal function in patients with new-onset AHF is not available." | 7.96 | Renoprotective effect of tolvaptan in patients with new-onset acute heart failure. ( Fujii, K; Kin, H; Matsumura, K; Otagaki, M; Park, H; Shiojima, I; Sugiura, T; Takahashi, H; Yamamoto, Y; Yokoi, M; Yoshioka, K, 2020) |
| " We investigated the association of clinical variables and cardiovascular drugs, including furosemide, hydrochlorothiazide, spironolactone, and their doses, with the presence of hyponatremia at admission." | 7.96 | Furosemide and spironolactone doses and hyponatremia in patients with heart failure. ( Bušić, Ž; Čulić, V; Jurić Paić, M; Velat, I, 2020) |
| " This study aimed to compare the effect of torasemide and furosemide on long-term outcomes and New York Heart Association (NYHA) class change in patients with chronic heart failure (HF)." | 7.91 | Comparative Analysis of Long-Term Outcomes of Torasemide and Furosemide in Heart Failure Patients in Heart Failure Registries of the European Society of Cardiology. ( Balsam, P; Crespo-Leiro, MG; Drożdż, J; Filipiak, KJ; Grabowski, M; Kapłon-Cieślicka, A; Kowalik, R; Maggioni, AP; Marchel, M; Opolski, G; Ozierański, K; Peller, M; Tymińska, A; Wancerz, A, 2019) |
| "A long-acting loop diuretic, azosemide, has been shown to improve long-term prognosis in patients with heart failure compared with a short-acting loop diuretic, furosemide." | 7.91 | Patients With CONgestive Heart Failure Benefit From Long-Term Treatment Effects With Novel Treatment Using Azosemide Compared With Furosemide Derived From Existing Retrospective Study Data: CONTENTED. ( Abe, S; Arikawa, T; Inami, S; Inoue, T; Kanaya, T; Nishikawa, R; Saito, F; Sakuma, M; Toyoda, S; Watanabe, R, 2019) |
| "Continuous intravenous (IV) infusion bumetanide has been associated with severe myalgia in case reports, and the package labeling lists a reported incidence of 0." | 7.91 | Evaluation of Severe Myalgia Induced by Continuous-Infusion Bumetanide in Patients with Acute Heart Failure. ( Chinaeke, EE; Cox, ZL; Lenihan, DJ; Lu, K; Merritt, TE; Xiong, L, 2019) |
| "The aim of this study was to investigate the effect on mortality of torsemide and a combination of loop diuretics (furosemide + torsemide) in contemporary practice in patients with chronic heart failure (HF)." | 7.88 | Can Torsemide and Combination of Loop Diuretics Improve Mortality in Patients with Chronic Heart Failure After Discharge? ( Yao, Y; Zhang, J; Zhang, R; Zhang, Y, 2018) |
| "We sought to examine whether factors impacting the time to emergency department (ED) administration of intravenous (IV) furosemide were associated with the duration of hospital admission for patients with acute heart failure (AHF)." | 7.88 | Preventable delays to intravenous furosemide administration in the emergency department prolong hospitalization for patients with acute heart failure. ( Collins, SP; Froehle, CM; Liu, D; Ward, MJ, 2018) |
| "The aim of this study was to determine whether the addition of constant rate infusion (CRI) to intermittent intravenous bolus (IVB) administration of furosemide resulted in an improvement in medical outcomes in dogs and cats with acute left-sided congestive heart failure (L-CHF)." | 7.88 | Constant rate infusion vs. intermittent bolus administration of IV furosemide in 100 pets with acute left-sided congestive heart failure: A retrospective study. ( Aroch, I; Bdolah-Abram, T; Kelmer, E; Klainbart, S; Ohad, DG; Segev, G; Segev, Y, 2018) |
| " We present the case of a patient with hypoxic hepatitis in the setting of heart failure and dehydration from furosemide as a reminder of an important clinical lesson." | 7.88 | Hypoxic hepatitis and furosemide. ( Pizzarossa, AC; Rebella, M, 2018) |
| "A severe shortage of injectable furosemide did not increase the risk of adverse outcomes among patients who presented to the hospital with congestive heart failure." | 7.85 | Impact of Injectable Furosemide Hospital Shortage on Congestive Heart Failure Outcomes: A Time Series Analysis. ( Garg, AX; Jain, AK; Juurlink, DN; McArthur, E; Nash, DM; Tan, VS; Weir, MA, 2017) |
| "Hypertonic saline with furosemide has been proposed for a long time as an effective therapeutic option for the treatment of acute decompensated heart failure (ADHF)." | 7.85 | Comparison of salt with low-dose furosemide and carperitide for treating acute decompensated heart failure: a single-center retrospective cohort study. ( Ando, T; Hirotani, S; Komamura, K; Mano, T; Masuyama, T; Naito, Y; Nishimura, K; Okuhara, Y; Orihara, Y, 2017) |
| "Our previous study indicates that hydrochlorothiazide inhibits transforming growth factor (TGF)-β/Smad signaling pathway, improves cardiac function and reduces fibrosis." | 7.85 | Hydrochlorothiazide modulates ischemic heart failure-induced cardiac remodeling via inhibiting angiotensin II type 1 receptor pathway in rats. ( Chen, X; Gao, X; Lu, G; Luo, C; Luo, J; Peng, L; Zuo, Z, 2017) |
| " An infant affected by initial congestive cardiac failure, after starting the treatment with enalapril in association with furosemide, developed acute kidney injury (AKI)." | 7.83 | Enalapril Associated with Furosemide Induced Acute Kidney Injury in an Infant with Heart Failure. A Case Report, a Revision of the Literature and a Pharmacovigilance Database Analysis. ( Carnovale, C; Clementi, E; Fabiano, V; Gentili, M; Mameli, C; Perrotta, C; Radice, S; Zuccotti, GV, 2016) |
| "The prevalence of thiamine deficiency in heart failure (HF) patients has been reported to be as high as 50% in outpatient settings and has been found to be as high as 96% in the inpatient setting." | 7.83 | Prevalence of thiamine deficiency in a stable heart failure outpatient cohort on standard loop diuretic therapy. ( Miller, WL; Teigen, LM; Twernbold, DD, 2016) |
| " Physician investigators performed IVC ultrasonography on a convenience sample of 70 hospitalized adults who were prescribed intravenous furosemide for the diagnosis of acute decompensated heart failure." | 7.81 | Inferior vena cava diameter change after intravenous furosemide in patients diagnosed with acute decompensated heart failure. ( Athavale, A; Candotti, C; Katz, A; Kumapley, R; Lucas, BP; Margeta, B; Tchernodrinski, S, 2015) |
| "The most effective dose of prehospital furosemide in acute decompensated heart failure (ADHF) has not yet been identified and concerns of worsening renal function have limited its use." | 7.81 | The Effect of Furosemide Dose Administered in the Out-of-hospital Setting on Renal Function Among Patients with Suspected Acute Decompensated Heart Failure. ( Chuang, M; Mehrtens, GM; Merlin, MA; Nieves, LC; Pickrell, C; Pores, N; Satty, T; Tanis, J; Young, TC, 2015) |
| "Furosemide has historically been the primary loop diuretic in heart failure patients despite data suggesting potential advantages with torsemide." | 7.81 | Torsemide versus furosemide in heart failure patients: insights from Duke University Hospital. ( Anstrom, KJ; Buggey, J; DeVore, AD; Eisenstein, EL; Ersbøll, MK; Fiuzat, M; Mentz, RJ; OʼConnor, CM; Schulte, PJ; Velazquez, EJ, 2015) |
| "Treatment of acute decompensated heart failure (ADHF) with loop diuretics, such as furosemide, is frequently complicated by insufficient urine sodium excretion." | 7.80 | Insufficient natriuretic response to continuous intravenous furosemide is associated with poor long-term outcomes in acute decompensated heart failure. ( Dupont, M; Mullens, W; Shrestha, K; Singh, D; Tang, WH; Testani, JM; Verbrugge, FH, 2014) |
| "To compare the effects of combination diuretic therapy with oral hydrochlorothiazide or intravenous chlorothiazide added to background intravenous loop diuretic therapy among patients hospitalized with heart failure." | 7.80 | Comparison of the effects of combination diuretic therapy with oral hydrochlorothiazide or intravenous chlorothiazide in patients receiving intravenous furosemide therapy for the treatment of heart failure. ( Kissling, KT; Pickworth, KK, 2014) |
| "Limited data exist comparing the efficacy and safety of bumetanide- or metolazone-based diuretic regimens to furosemide in acute heart failure (HF)." | 7.79 | Comparison of bumetanide- and metolazone-based diuretic regimens to furosemide in acute heart failure. ( Elkayam, U; Han, SY; Hshieh, S; Hyderi, AF; Jeng, AI; Kim, BJ; Konopka, E; Lou, M; Ng, TM; Phan, DH; Tsuji, Y, 2013) |
| "Although tolvaptan is a recently approved drug for heart failure and causes aquaresis without affecting renal function, its clinical efficacy for patients with acute decompensated heart failure (ADHF) is yet to be elucidated." | 7.79 | Tolvaptan reduces the risk of worsening renal function in patients with acute decompensated heart failure in high-risk population. ( Hashimoto, Y; Iwatsuka, R; Matsue, Y; Matsumura, A; Mizukami, A; Nagahori, W; Ohno, M; Seya, M; Suzuki, M, 2013) |
| "In an experimental heart failure model, we tested the hypothesis that furosemide causes excess mortality." | 7.78 | Furosemide induces mortality in a rat model of chronic heart failure. ( Anker, SD; Bauersachs, J; Bockmeyer, B; Doehner, W; Hocher, B; Rokutan, H; Springer, J; Strassburg, S; Suckow, C; von Haehling, S; von Websky, K; Waller, C, 2012) |
| "Clinical data are scarce for furosemide administered as a low-dose (<160 mg/24 hours) continuous intravenous infusion in acute heart failure (HF)." | 7.78 | Clinical experience with low-dose continuous infusion of furosemide in acute heart failure: assessment of efficacy and safety. ( Chan, CY; Elkayam, U; Hshieh, S; Ng, TM, 2012) |
| " We hypothesized that TRV120027 would elicit beneficial cardiorenal actions when added to furosemide in experimental heart failure." | 7.78 | TRV120027, a novel β-arrestin biased ligand at the angiotensin II type I receptor, unloads the heart and maintains renal function when added to furosemide in experimental heart failure. ( Boerrigter, G; Burnett, JC; Lark, MW; Soergel, DG; Violin, JD, 2012) |
| "In a comparative clinical trial in 308 patients with acute decompensated heart failure, the relief achieved with intravenous furosemide at a dose equivalent to the daily oral dose patients were receiving prior to the acute episode was very similar to that obtained with higher doses of intravenous furosemide." | 7.78 | Furosemide in acute decompensated heart failure. ( , 2012) |
| "120 patients with heart failure treated with high-dose furosemide+HSS (Furosemide/HSS group) were matched with: 30 subjects with heart failure treated with high-dose furosemide (furosemide group), 30 controls with asymptomatic left-ventricular dysfunction (ALVD) (asymptomatic group) and 30 controls without heart failure or ALVD (Healthy group)." | 7.77 | Changes in natriuretic peptide and cytokine plasma levels in patients with heart failure, after treatment with high dose of furosemide plus hypertonic saline solution (HSS) and after a saline loading. ( Caruso, C; Corrao, S; Di Raimondo, D; Di Sciacca, R; Licata, G; Pinto, A; Scaglione, R; Tuttolomondo, A, 2011) |
| "We cannot support the use of the furosemide test as an ancillary diagnostic test in patients suspected of new, slow-onset heart failure." | 7.77 | The furosemide diagnostic test in suspected slow-onset heart failure: popular but not useful. ( Cramer, MJ; Grobbee, DE; Hoes, AW; Kelder, JC; Plokker, HW; Rutten, FH, 2011) |
| "We investigated the effects of tolvaptan, a vasopressin V(2)-receptor antagonist, on diuretic response and systemic and renal hemodynamic characteristics in conscious dogs with congestive heart failure (CHF)." | 7.77 | Effects of tolvaptan on systemic and renal hemodynamic function in dogs with congestive heart failure. ( Fujiki, H; Nakamura, S; Nakayama, S; Onogawa, T; Sakamoto, Y; Yamamura, Y, 2011) |
| "Ucn2 and furosemide were administered for 3 hours, both singly and combined, in 7 sheep with pacing-induced heart failure." | 7.75 | Urocortin 2 inhibits furosemide-induced activation of renin and enhances renal function and diuretic responsiveness in experimental heart failure. ( Charles, CJ; Nicholls, MG; Rademaker, MT; Richards, AM, 2009) |
| "To retrospectively investigate the effect of carvedilol and spironolactone plus furosemide, administered concomitantly with an angiotensin II converting enzyme inhibitor (ACE-I) or an angiotensin II receptor blocker (ARB) to patients with chronic heart failure (CHF)." | 7.73 | Carvedilol accelerate elevation of serum potassium in chronic heart failure patients administered spironolactone plus furosemide and either enalapril maleate or candesartan cilexetil. ( Hirooka, K; Nakayama, D; Saito, M; Takada, M; Yasumura, Y, 2006) |
| "404 consecutive patients admitted with congestive heart failure as one of the diagnoses and previously treated with furosemide (frusemide) for at least three months." | 7.72 | Serum magnesium aberrations in furosemide (frusemide) treated patients with congestive heart failure: pathophysiological correlates and prognostic evaluation. ( Almoznino-Sarafian, D; Alon, I; Averbukh, Z; Chachashvily, S; Chen-Levy, Z; Cohen, N; Golik, A; Gorelik, O; Modai, D; Shteinshnaider, M; Zaidenstein, R, 2003) |
| "To assess the presence of thiamine deficiency in congestive heart failure patients receiving furosemide therapy." | 7.72 | Thiamine deficiency in congestive heart failure patients receiving long term furosemide therapy. ( Almalki, Y; Donnelly, J; Healey, J; Smith, S; Vaillancourt, R; Zenuk, C, 2003) |
| "This study was performed to examine the safety of reducing the long-term doses of furosemide administered to patients with congestive heart failure (CHF) stabilized on a standard medical treatment." | 7.72 | Lowering of furosemide dosage after clinical stabilization in patients with congestive heart failure. ( Alexopoulos, GP; Anastasiou-Nana, MI; Makri, S; Margari, ZJ; Mitsibounas, D; Nanas, JN; Rapti, ACh; Terrovitis, JV, 2003) |
| "Furosemide shortened the time to left ventricular dysfunction (35." | 7.72 | Furosemide and the progression of left ventricular dysfunction in experimental heart failure. ( Haigney, MC; Hanlon, SU; McCurley, JM; Michalski, M; Wedam, EF; Wei, SK, 2004) |
| "The effect of enalapril, digoxin and frusemide combination on clinical, biochemical and anthropometric indices were determined in eight cachectic Nigerians with chronic congestive heart failure [body mass index (BMI) 20." | 7.71 | The effects of enalapril-digoxin-diuretic combination therapy on nutritional and anthropometric indices in chronic congestive heart failure: preliminary findings in cardiac cachexia. ( Adigun, AQ; Ajayi, AA, 2001) |
| "The purpose of this study was to estimate the cost-effectiveness of beta-blocker therapy with either metoprolol or carvedilol in addition to conventional therapy for patients with heart failure (HF) in Canada." | 7.71 | Cost-effectiveness of beta-blocker therapy with metoprolol or with carvedilol for treatment of heart failure in Canada. ( Briggs, AH; Demers, C; Levy, AR; O'Brien, BJ, 2001) |
| "In order to study the incidence and course of nephrocalcinosis in full-term infants with congestive heart failure receiving long-term furosemide treatment, 36 such infants (median age 2." | 7.70 | Nephrocalcinosis in full-term infants receiving furosemide treatment for congestive heart failure: a study of the incidence and 2-year follow up. ( Koivisto, M; Lanning, P; Paavilainen, T; Saarela, T, 1999) |
| "This observational study compared patients suffering from congestive heart failure (CHF) who were treated with loop diuretics torasemide or furosemide." | 7.70 | Comparison of therapies with torasemide or furosemide in patients with congestive heart failure from a pharmacoeconomic viewpoint. ( Dreckmann-Behrendt, B; Goertz, A; Spannheimer, A, 1998) |
| "To measure the concentrations of thiamine and thiamine esters by high-pressure liquid chromatography (HPLC) in elderly patients treated with furosemide for heart failure and in a control group." | 7.70 | Reduced thiamine phosphate, but not thiamine diphosphate, in erythrocytes in elderly patients with congestive heart failure treated with furosemide. ( Bohmer, T; Daae, C; Dellborg, M; Härdig, L; Kontny, F, 2000) |
| "We report 2 patients with congestive heart failure and concomitant toxic serum digoxin levels in whom cholestyramine administration increased clearance of digoxin and decreased serum digoxin elimination half-lives." | 7.70 | Congestive heart failure and toxic digoxin levels: role of cholestyramine. ( Roberge, RJ; Sorensen, T, 2000) |
| "To explore the possibilities of furosemide withdrawal in elderly heart failure (HF) patients with intact left ventricular (LV) systolic function and assess its effects on functional status and orthostatic blood pressure homeostasis, we performed a placebo-controlled pilot trial of furosemide withdrawal with 3 months of follow-up in 32 HF patients (aged 75." | 7.70 | Furosemide withdrawal in elderly heart failure patients with preserved left ventricular systolic function. ( Bouwels, LH; Gribnau, FW; Hoefnagels, WH; Jansen, RW; van Kraaij, DJ, 2000) |
| "Magnesium depletion and hypomagnesemia are common among furosemide-treated patients with chronic congestive heart failure." | 7.70 | Metabolic and clinical effects of oral magnesium supplementation in furosemide-treated patients with severe congestive heart failure. ( Almoznino-Sarafian, D; Alon, I; Berman, S; Cohen, N; Golik, A; Gorelik, O; Modai, D; Weissgarten, J; Zaidenstein, R, 2000) |
| "The efficacy and side effects of the combination therapy of thiazide and furosemide administered to patients with refractory heart failure, for a prolonged period of time, were assessed." | 7.69 | Prolonged therapy by the combination of furosemide and thiazides in refractory heart failure and other fluid retaining conditions. ( Brif, I; Farfel, Z; Mayan, H; Mouallem, M, 1995) |
| "Nephrocalcinosis and nephrolithiasis developed in five children after furosemide therapy for congestive heart failure." | 7.69 | Nephrocalcinosis and nephrolithiasis in infants with congestive heart failure treated with furosemide. ( Alon, US; Garola, RE; Scagliotti, D, 1994) |
| "We studied the effects of inhaled furosemide (40 mg) on bronchial responsiveness to acetylcholine (ACh) in patients with chronic congestive heart failure who had been premedicated with indomethacin (75 mg/day) for five days." | 7.69 | [Effects of inhaled furosemide after indomethacin premedication on bronchial hyperresponsiveness in patients with chronic congestive heart failure]. ( Ishizaki, T; Kanamori, K; Mifune, J; Miyabo, S; Nakai, T; Saitoh, Y; Sakai, T; Sasaki, F, 1994) |
| "Oral furosemide solution was claimed to produce a greater diuretic response than furosemide tablets in patients with congestive heart failure." | 7.69 | Effect of furosemide oral solution versus furosemide tablets on diuresis and electrolytes in patients with moderate congestive heart failure. ( Averbukh, Z; Cohen, N; Dishi, V; Golik, A; Modai, D; Weissgarten, J; Zaidenstein, R, 1996) |
| "The effect of digoxin therapy on the survival of heart failure patients in sinus rhythm was assessed using a retrospective case control study." | 7.69 | Digoxin therapy and survival in heart failure in sinus rhythm. ( Banerjee, AK; Campbell, RW, 1996) |
| "11 inhibition and furosemide were compared in the pacing model of ovine heart failure (HF)." | 7.69 | Comparison of chronic neutral endopeptidase inhibition and furosemide in an ovine model of heart failure. ( Charles, CJ; Espiner, EA; Fitzpatrick, MA; Nicholls, MG; Rademaker, MT; Richards, AM; Sybertz, E, 1996) |
| "The effect on heart rate variability of adding digoxin to a diuretic and ACE inhibitor was studied in patients with chronic stable cardiac failure." | 7.69 | Effects of digoxin on time domain measures of heart rate variability in patients with stable chronic cardiac failure: withdrawal and comparison group studies. ( Flapan, AD; Francis, CM; Goodfield, NE; Neilson, JM; Wright, RA, 1997) |
| "To determine whether furosemide treatment in congestive heart failure (CHF) patients is associated with thiamine deficiency." | 7.69 | No difference in blood thiamine diphosphate levels between Swedish Caucasian patients with congestive heart failure treated with furosemide and patients without heart failure. ( Beermann, B; Lindström, B; Nyquist, O; Yue, QY, 1997) |
| "We studied the effects of inhaled and intravenous furosemide (40 mg) on bronchial responsiveness to acetylcholine (ACh) in patients with chronic congestive heart failure." | 7.68 | [Effects of inhaled and intravenous furosemide on bronchial hyperresponsiveness in patients with chronic congestive heart failure]. ( Fujimura, M; Hifumi, S; Ishizaki, T; Mifune, J; Miyabo, S; Nakai, T; Sakai, T; Sasaki, F; Takahashi, H, 1992) |
| " We therefore measured lymphocyte free Mg2+ concentrations in patients with congestive cardiac failure treated with loop diuretics or a frusemide/amiloride mixture (Frumil) and compared them with control subjects." | 7.68 | Intracellular free magnesium in lymphocytes from patients with congestive cardiac failure treated with loop diuretics with and without amiloride. ( Brochwicz-Lewinski, MJ; Davies, JE; Garrido, MC; Ng, LL; Tan, LB, 1992) |
| "To investigate the influence of the presence of oedema on the pharmacokinetics and pharmacodynamics of furosemide (frusemide) we selected 9 hospitalised patients (mean age 70." | 7.68 | Absorption of high dose furosemide (frusemide) in congestive heart failure. ( Gerlag, PG; Gribnau, FW; Russel, FG; Smits, P; Tan, Y; Van Ginneken, CA; Van Meyel, JJ, 1992) |
| "Lymphocyte potassium and magnesium were measured before and 3 months after the introduction of captopril in 18 patients taking diuretics for congestive heart failure." | 7.68 | Effect of captopril therapy on lymphocyte potassium and magnesium concentrations in patients with congestive heart failure. ( Daly, K; Finn, J; Grimes, H; McMurrough, P; O'Keeffe, S, 1992) |
| "The effect of diuretic dose on the haemodynamic response to captopril was assessed in nine patients with chronic cardiac failure." | 7.68 | The relationship between diuretic dose, and the haemodynamic response to captopril in patients with cardiac failure. ( Davies, E; Edwards, CR; Flapan, AD; Shaw, TR; Williams, BC, 1992) |
| "Eleven patients with congestive heart failure class II-IV (NYHA) caused by ischemic heart disease were studied before and three months after adding enalapril to their treatment with furosemide." | 7.68 | Cardiac remodelling and myocardial contractility in patients with congestive heart failure treated with furosemide and enalapril. ( Bann, J; Baur, LH; Bruschke, AV; Buis, B; Manger Cats, V; Schipperheyn, JJ; van der Laarse, A; van der Wall, EE; van Dijk, AD, 1991) |
| "The influence of two cardiac inotropic drugs, dobutamine and salbutamol, on plasma atrial natriuretic factor (ANF) was investigated in 20 patients with congestive heart failure." | 7.68 | Effects of dobutamine and salbutamol on haemodynamics and atrial natriuretic factor in patients with severe congestive heart failure. ( Keller, N; Larsen, J; Sykulski, R, 1991) |
| "To test the hypothesis that long-term furosemide therapy in patients with congestive heart failure (CHF) is associated with clinically significant thiamine deficiency via urinary loss." | 7.68 | Thiamine deficiency in patients with congestive heart failure receiving long-term furosemide therapy: a pilot study. ( Ezra, D; Halkin, H; Kaufmann, N; Motro, M; Rauchfleisch, S; Seligmann, H; Vered, Z, 1991) |
| "21 patients with symptoms of chronic congestive heart failure, NYHA classes II-IV, were treated with digoxin and furosemide for at least 14 days." | 7.68 | [The effect of combined treatment in chronic congestive heart failure with digoxin, furosemide and pentoxifylline upon blood viscosity]. ( Kochmański, M; Zochowski, RJ, 1990) |
| "Clinical, hemodynamic and neurohumoral data are available supporting the validity of a differentiated approach to administration of combined treatment with furosemide, digoxin and calcium antagonists nifedipine and verapamil in advanced-aged patients with hypertension complicated by circulatory disorders." | 7.68 | [Evaluation of the effectiveness of calcium antagonists combined with digoxin and furosemide in hypertension complicated by circulatory insufficiency in elderly patients]. ( Orynchak, MA, 1990) |
| "1 yrs) with III or IV NYHa class congestive heart failure after 2-week therapy with digoxin (D) and furosemide (F) underwent two-dimensional echocardiographic examination to assess left ventricular function." | 7.68 | [Changes in left-ventricular function in chronic congestive heart failure treated with digoxin, furosemide and vasodilators]. ( Cholewa, M; Dryjański, T; Gawor, Z; Markiewicz, K, 1990) |
| "In 61 patients with class IV (NYHA) of chronic congestive cardiac failure treated for 2 weeks with digoxin (0." | 7.68 | [Results of treatment for severe congestive heart failure with digoxin, furosemide and vasodilating agents]. ( Bubiński, R; Cholewa, M; Dryjański, T; Gawor, Z; Górski, L; Kaczkowska-Marusik, E; Markiewicz, K, 1990) |
| "Hemodynamic and neurohumoral responses to acute diuretic therapy were measured in 15 patients with severe chronic heart failure given intravenous furosemide, 1." | 7.67 | Acute vasoconstrictor response to intravenous furosemide in patients with chronic congestive heart failure. Activation of the neurohumoral axis. ( Cohn, JN; Francis, GS; Goldsmith, SR; Levine, TB; Olivari, MT; Siegel, RM, 1985) |
| "A patient with congestive heart failure and moderate renal insufficiency developed severe reversible non-oliguric renal failure while on frusemide and enalapril." | 7.67 | Reversible renal failure after combined treatment with enalapril and frusemide in a patient with congestive heart failure. ( Alexandre, JM; Chatellier, G; Funck-Brentano, C, 1986) |
| " The renal and metabolic effects of the sulphamoylbenzoic acid diuretic, piretanide, have been studied, under controlled dietary conditions, in 39 patients with congestive cardiac failure." | 7.67 | Acute and long-term renal and metabolic effects of piretanide in congestive cardiac failure. ( Lant, AF; McNabb, WR; Noormohamed, FH, 1988) |
| "To compare the hemodynamic mode of action of captopril in patients with Congestive Heart Failure (CHF) with high- or low-plasma renin activity, we studied the systemic and renal hemodynamic changes induced by this drug in patients with refractory CHF (Group I) or untreated CHF (Group II)." | 7.67 | Acute hemodynamic action of captopril in congestive heart failure: contrasts between refractory and untreated patients. ( Ajzen, H; Draibe, SA; Ferreira, SR; Homsi, E; Ramos, OL; Ribeiro, AB; Saragoça, MA, 1987) |
| "Thirty-five patients with severe chronic congestive heart failure that was refractory to conventional therapy were given high dosages of furosemide (250 to 4000 mg/d) because of significantly reduced renal function (mean endogenous creatinine clearance, 0." | 7.67 | High-dose furosemide in the treatment of refractory congestive heart failure. ( Gerlag, PG; van Meijel, JJ, 1988) |
| "Twenty-seven patients (mean age 72 years) with symptoms of congestive cardiac failure who had been controlled by treatment with 1 to 2 tablets per day of a combination preparation of frusemide (40 mg) and amiloride (5 mg) for at least 12 weeks were studied." | 7.67 | A long-term open study of a frusemide/amiloride combination ('Frumil') in elderly patients with congestive cardiac failure. ( Allman, S; Crawford, RJ; Kitchen, SP; Richards, HH, 1988) |
| "We studied the effects of furosemide on plasma renin and plasma aldosterone in 8 patients with mild to moderate congestive heart failure." | 7.67 | Acute changes in plasma renin activity, plasma aldosterone concentration and plasma electrolyte concentrations following furosemide administration in patients with congestive heart failure--interrelationships and diuretic response. ( Mulder, H; Schopman, W; van der Lely, AJ, 1987) |
| "Furosemide, a potent loop diuretic, is commonly used in the treatment of congestive heart failure (CHF)." | 7.67 | Steady state absorption kinetics and pharmacodynamics of furosemide in congestive heart failure. ( Chaturvedi, PR; Gwilt, PR; Nicholas, JM; O'Donnell, JP; Shoenthal, DR; Waters, DH, 1987) |
| "We have studied the efficiency of urea in the treatment of hyponatremia and hydrosaline retention in a 76-year-old man with chronic ischemic congestive heart failure." | 7.67 | Urea treatment for water retention in hyponatremic congestive heart failure. ( Cauchie, P; Decaux, G; Vincken, W, 1987) |
| "Twenty-three optimally digitalized patients with congestive heart failure completed a 4-week treatment period with a fixed-drug association of 20 mg furosemide plus 50 mg spironolactone." | 7.67 | A fixed-dose combination of furosemide and spironolactone in digitalized congestive heart failure patients. ( Collia, LF; Ledesma, GA; Tutera, A; Yasky, J, 1986) |
| "Seventeen non-digitalized congestive heart failure patients were treated with only the fixed-dose combinations of 20 mg furosemide and 50 mg spironolactone or 20 mg furosemide and 100 mg spironolactone, in a daily dose of 1 or 2 capsules, over a 4-week period." | 7.67 | The treatment of non-digitalized congestive heart failure patients with a fixed-dose combination of furosemide and spironolactone. ( Collia, LF; Ledesma, GA; Tutera, A; Yasky, J, 1986) |
| "The aims of this study were to investigate the influence of heart failure and dietary sodium content on the natriuretic effect of furosemide." | 7.67 | Influence of heart failure and sodium content in the diet on the natriuretic response to furosemide in hamsters. ( du Souich, P; Gutkowska, J; Lambert, C; Larose, P; Ong, H, 1985) |
| "We assessed whether patients with decompensated congestive heart failure had altered absorption of oral furosemide." | 7.67 | Furosemide absorption altered in decompensated congestive heart failure. ( Brater, DC; Cartwright, DB; Knochel, JP; Nixon, JV; Vasko, MR, 1985) |
| "Eight patients suffering from congestive heart failure (NYHA III-IV) and pretreated with digoxin received muzolimine over 14 days in an open clinical study." | 7.67 | Muzolimine therapy in patients with congestive heart failure in comparison with furosemide pretreatment. Effect on digoxin plasma concentration. ( Ertl, G; Kahles, H; Kochsiek, K; Liebau, G; Riegger, G, 1985) |
| "High dose furosemide is commonly used in renal failure to induce diuresis but rarely employed in cardiac failure." | 7.67 | High dose furosemide in refractory cardiac failure. ( Kuchar, DL; O'Rourke, MF, 1985) |
| "To define the short-term haemodynamic, hormonal and electrolyte effects of enalapril in chronic heart failure, we administered it to nine patients." | 7.66 | Acute haemodynamic, hormonal and electrolyte effects and short-term clinical response to enalapril in heart failure. ( Espiner, EA; Fitzpatrick, D; Ikram, H; Nicholls, MG, 1983) |
| "Twenty patients with severe hypertension and chronic renal failure were given Captopril during a one year period." | 7.66 | [Long-term treatment with captopril in arterial hypertension complicated by renal failure]. ( Ader, JL; Bories, P; Durand, D; Emal, V; Girolami, JP; Suc, JM, 1982) |
| "Changes in response to furosemide and other diuretics in patients with congestive heart failure (CHF) could occur because of disease-induced changes in absorption of the drug or changes in disposition which affect its access to its site of action." | 7.66 | Absorption and disposition of furosemide in congestive heart failure. ( Anderson, S; Brater, DC; Burdette, A; Chennavasin, P; Dehmer, GJ; Seiwell, R, 1982) |
| "A wide interindividual variation in the degree of diuresis produced following treatment with furosemide has been observed in infants with congestive heart failure." | 7.66 | Determinants of the diuretic response to furosemide in infants with congestive heart failure. ( Green, TP; Mirkin, BL, 1982) |
| "The diuretic effect of furosemide was studied in 18 patients with congestive heart failure." | 7.66 | Effect of furosemide in congestive heart failure. ( Akimoto, T; Arita, T; Minami, M; Miyazaki, K; Nomura, A; Yasuda, H, 1981) |
| "Clinical and cardiovascular responses to drug therapy with furosemide were compared with those to furosemide plus digoxin in 15 heart patients with sinus rhythm admitted to the hospital for the management of congestive heart failure." | 7.66 | The role of furosemide alone and in combination with digoxin in the relief of symptoms of congestive heart failure. ( Hutcheon, D; Nemeth, E; Quinlan, D, 1980) |
| "We studied 10 patients with congestive heart failure to assess the dynamics of their response to 40 mg of furosemide." | 7.66 | Furosemide in patients with heart failure: shift in dose-response curves. ( Brater, DC; Chennavasin, P; Seiwell, R, 1980) |
| " This report describes 74 patients who had severe congestive heart failure treated with a combination of furosemide and spironolactone in whom this complication developed." | 7.66 | Treatment of refractory congestive heart failure and normokalemic hypochloremic alkalosis with acetazolamide and spironolactone. ( Khan, MI, 1980) |
| "Sudden withdrawal of oral therapy with hydralazine for reduction of afterload in a patient precipitated severe congestive heart failure." | 7.66 | Precipitation of heart failure following sudden withdrawal of hydralazine. ( Black, JR; Mehta, J, 1979) |
| "Severe tachycardia, ventricular ectopy, and sodium retention manifested by hemodynamic deterioration developed with hydralazine hydrochloride therapy in chronic coronary heart disease with congestive failure refractory to digitalis, diuretics, and nitrates." | 7.66 | Hydralazine-induced tachycardia and sodium retention in heart failure. Hemodynamic and symptomatic correction by prazosin therapy. ( Amsterdam, EA; DeMaria, AN; Laslett, LJ; Mason, DT, 1978) |
| " Symptomatic relief occurred as body weight was reduced, and after a 'dry' basal weight had been achieved, progressive-load exercise testing was done to examine any benefit that derived from adding oral digoxin to the diuretic." | 7.66 | The clinical value of digoxin in patients with heart failure and sinus rhythm. ( Guz, A; McHaffie, D; Mitchell-Heggs, P; Purcell, H, 1978) |
| "The renin-angiotensin-aldosterone system and electrolyte levels in 11 patients with heart failure controlled on digoxin and frusemide were investigated after separate periods of Slow K, spironolactone, and amiloride therapy." | 7.65 | Effect of potassium-sparing diuretics on the renin-angiotensin-aldosterone system and potassium retention in heart failure. ( Espiner, EA; Hughes, H; Nicholls, MG; Rogers, T, 1976) |
| "Twenty-six patients were selected for treatment with minoxidil on the basis of hypertension which could not be controlled either because of (1) drug failures and/or (2) side effects of drugs." | 7.65 | Minoxidil in severe hypertension: value when conventional drugs have failed. ( Dormois, JC; Nies, AS; Young, JL, 1975) |
| "31% of patients had type 2 diabetes mellitus (DM2)." | 7.30 | The use of Dapagliflozin in Acute Decompensated Heart Failure: Results of the Randomized Study. ( Andreev, DA; Charaya, KV; Dimchishina, AS; Kusova, ZR; Mesitskaya, DF; Nikiforova, TV; Novikova, NA; Schekochikhin, DIY; Shkliarov, AM; Soboleva, TV, 2023) |
| "31% of patients had type 2 diabetes mellitus (DM2)." | 7.30 | The use of Dapagliflozin in Acute Decompensated Heart Failure: Results of the Randomized Study. ( Andreev, DA; Charaya, KV; Dimchishina, AS; Kusova, ZR; Mesitskaya, DF; Nikiforova, TV; Novikova, NA; Schekochikhin, DY; Shkliarov, AM; Soboleva, TV, 2023) |
| "Acute heart failure is a frequent cause of hospital admission in Portugal, and has an increasing tendency given the aging population." | 7.01 | Co-Administration of Albumin and Furosemide in Acute Heart Failure with Diuretics Resistance. ( Araújo, I; Bonifácio, D; Branco, P; Costa, R; Fernandes, J; Fonseca, C; Guerreiro, R; Henriques, C; Rodrigues, A, 2023) |
| "Loop diuretics used in the treatment of heart failure often induce renal impairment." | 6.82 | Early administration of tolvaptan preserves renal function in elderly patients with acute decompensated heart failure. ( Hasegawa, T; Ikeda, U; Izawa, A; Kimura, K; Misawa, T; Momose, T; Morita, T; Motoki, H, 2016) |
| " Further studies are necessary to evaluate potential pharmacodynamic differences between torasemide formulations and to assess its impact on clinical therapeutics." | 6.80 | Randomized, open-label, blinded-endpoint, crossover, single-dose study to compare the pharmacodynamics of torasemide-PR 10 mg, torasemide-IR 10 mg, and furosemide-IR 40 mg, in patients with chronic heart failure. ( Antonijoan, RM; Ballester, MR; Delgadillo, J; Gich, I; Puntes, M; Roig, E; Santos, B, 2015) |
| " No significant differences in adverse events were noted." | 6.79 | Efficacy and safety of high dose versus low dose furosemide with or without dopamine infusion: the Dopamine in Acute Decompensated Heart Failure II (DAD-HF II) trial. ( Antoniou, CK; Butler, J; Chrysohoou, C; Filippatos, G; Giamouzis, G; Giannakoulas, G; Kalogeropoulos, AP; Karayannis, G; Karvounis, H; Koutrakis, K; Mantziari, L; Nastas, J; Parisis, C; Parissis, J; Pitsavos, C; Rovithis, D; Skoularigis, J; Starling, RC; Stefanadis, C; Triposkiadis, FK; Tsaknakis, T; Wolski, K, 2014) |
| "Mean furosemide dose on day 0 was 5." | 6.77 | Effect of torsemide and furosemide on clinical, laboratory, radiographic and quality of life variables in dogs with heart failure secondary to mitral valve disease. ( Machen, MC; Oyama, MA; Peddle, GD; Reynolds, CA; Singletary, GE; Trafny, DJ, 2012) |
| " Although loop diuretics are used in nearly all patients with ADHF to relieve congestive symptoms, optimal dosing strategies remain poorly defined." | 6.75 | Continuous versus intermittent infusion of furosemide in acute decompensated heart failure. ( Dunn, SP; Hollis, IB; Nappi, JM; Rodgers, JE; Thomson, MR; Van Bakel, AB, 2010) |
| " However, the limited clinical data comparing dosing schemes are confounded." | 6.75 | Continuous versus bolus dosing of Furosemide for patients hospitalized for heart failure. ( Allen, LA; Cotter, G; Dewald, T; O'Connor, CM; Stough, WG; Turer, AT, 2010) |
| "Thiamine levels were determined using the erythrocyte transketolase activity." | 6.73 | Influence of spironolactone therapy on thiamine blood levels in patients with heart failure. ( Albanesi Filho, FM; de Albuquerque, DC; Rocha, RM; Silva, GV; Tura, BR, 2008) |
| "In patients with decompensated chronic congestive heart failure (CHF), intensive unloading therapy allows an acute decrease in ventricular filling pressures and improves long-term prognosis." | 6.71 | Hemodynamic response to intensive unloading therapy (furosemide and nitroprusside) in patients >70 years of age with left ventricular systolic dysfunction and decompensated chronic heart failure. ( Cioffi, G; Opasich, C; Stefenelli, C; Tarantini, L, 2003) |
| "Metolazone is a potent thiazide-like diuretic." | 6.71 | Combination therapy with metolazone and loop diuretics in outpatients with refractory heart failure: an observational study and review of the literature. ( Galatius, S; Gustafsson, F; Hildebrandt, PR; Rosenberg, J, 2005) |
| "The management of patients with congestive heart failure (CHF) can place a significant economic burden on managed care organizations, leading providers to seek treatments that are cost-effective." | 6.69 | A pharmacoeconomic assessment of torsemide and furosemide in the treatment of patients with congestive heart failure. ( Noe, LL; Pezzella, SM; Trotter, JP; Vreeland, MG, 1999) |
| "Ventricular arrhythmias detected on 24 hour Holter monitoring didn't differ between the study groups." | 6.69 | [Comparison of the therapeutic efficacy of spironolactone and furosemide in patients with severe congestive heart failure]. ( Bednarz, B; Chamiec, T; Cybulski, J, 2000) |
| " All patients received three dosing regimens administered in random order: (a) intravenous frusemide: 40 mg bolus then 40 mg h-1 for 3 h, (b) captopril: two 12." | 6.68 | The renin angiotensin aldosterone system and frusemide response in congestive heart failure. ( Cerimele, B; Greene, P; Reed, S; Ryan, T; Schwertschlag, U; Voelker, J; Weinberger, M, 1995) |
| "Peak reactive hyperemia (mL." | 6.68 | Nonselective beta-adrenergic blockade with carvedilol does not hinder the benefits of exercise training in patients with congestive heart failure. ( Bijou, R; Demopoulos, L; Gentilucci, M; Jones, M; Katz, SD; LeJemtel, TH; Mancini, D; Testa, M; Yeh, M, 1997) |
| "In moderate congestive heart failure pulmonary overhydration may be detected at chest X-ray even if therapy is optimized to keep the urinary output normal and to prevent weight gain and dependent edema formation." | 6.67 | [Body fluid withdrawal with isolated ultrafiltration effects persistent improvement of functional capacity in patients with chronic congestive heart failure. Furosemide does not produce the same result]. ( Agostoni, P; Guazzi, M; Lauri, G; Marenzi, G; Perego, GB; Sganzerla, P, 1994) |
| "Prazosin pre-treatment did not alter any of the renal responses to frusemide treatment (mean dose 85 +/- 14 mg)." | 6.67 | Renal effects of low dose prazosin in patients with congestive heart failure. ( Choy, AM; Lang, CC; Rahman, AR; Struthers, AD, 1993) |
| "Thus, patients with severe chronic congestive heart failure display metabolic derangement in muscle, which, in this study, was not corrected by treatment with enalapril." | 6.67 | Muscle energy metabolism in severe chronic congestive heart failure--effect of treatment with enalapril. ( Broqvist, M; Dahlström, U; Karlsson, E; Larsson, J, 1992) |
| "Ibopamine is a novel oral dopamine analogue with positive inotropy and diuretic effects." | 6.67 | [Renal effects of ibopamine in comparison with furosemide in patients with mild heart failure]. ( Gerzer, R; Theisen, K; Wehling, M; Weil, J; Zimmermann, J, 1990) |
| "Mild congestive cardiac failure symptoms (raised jugular venous pressure, oedema and dyspnoea at rest and on effort) were controlled in 9/10 patients receiving frusemide/amiloride but two patients receiving bumetanide/potassium chloride still had mild oedema after 8 weeks." | 6.67 | An open, randomized comparative study of a low-strength frusemide/amiloride combination and bumetanide/potassium chloride in the treatment of mild congestive cardiac failure. ( Allman, S; Dalton, K; Finnamore, VP; Latta, D, 1990) |
| "A total of 71 patients with cardiac failure requiring diuretic treatment were randomly allocated to receive either 20 mg frusemide/2." | 6.67 | An open, parallel group study comparing a frusemide/amiloride diuretic and a diuretic containing cyclopenthiazide with sustained release potassium in the treatment of congestive cardiac failure--a multicentre general practice study. ( Allman, S; Norris, RJ, 1990) |
| "Ibopamine does not produce undesirable renal side effects, but affects the neurohumoral status favourably." | 6.67 | Extracardial effects of oral ibopamine versus furosemide in patients with mild or moderate heart failure. A double-blind, randomized trial. ( Theisen, K; Wehling, M; Zimmermann, J, 1990) |
| "Diuretics are a cornerstone in treatment of heart failure (HF)." | 6.66 | Torasemide versus furosemide in treatment of heart failure: A systematic review and meta-analysis of randomized controlled trials. ( Al-Habbaa, A; Eid, PS; Elkady, AH; Elsayed, GG; Elshafay, A; Hirayama, K; Huy, NT; Kien, ND; Minh, LHN; Mohammed, AT; Morra, ME; Nghia, TLB; Sherif, NA; Thanh, LV; Turk, T; Y, MN, 2020) |
| "Advanced congestive heart failure (CHF) therapies include intravenous inotropic agents, change in class of diuretics, and venous ultrafiltration or hemodialysis." | 6.50 | Hypertonic saline with furosemide for the treatment of acute congestive heart failure: a systematic review and meta-analysis. ( Gandhi, S; Mosleh, W; Myers, RB, 2014) |
| "The haemodynamic effects of high or low doses of furosemide used to prevent overt left heart failure (LHF) in acute myocardial infarction (AMI) were studied." | 6.16 | Haemodynamic effects of high or low doses of furosemide in acute myocardial infarction. ( Larsen, FF, 1988) |
| "The role of taurine in the treatment of congestive heart failure (CHF) in dogs without systemic deficiency is unexplored." | 5.91 | The effect of taurine supplementation on the renin-angiotensin-aldosterone system of dogs with congestive heart failure. ( Adin, D; Brethel, S; Girens, R; Locker, S; Meurs, K; Rivera, P, 2023) |
| " SCF was an effective and safe diuretic strategy for outpatient congestion management." | 5.72 | Efficacy and Safety of Subcutaneous Infusion of Non-formulated Furosemide in Patients with Worsening Heart Failure: a Real-World Study. ( Civera, J; Conesa, A; de la Espriella, R; Heredia, R; Martínez, A; Miñana, G; Mollar, A; Núñez, J; Santas, E; Sastre, C; Villaescusa, A, 2022) |
| "To evaluate whether the addition of hydrochlorothiazide (HCTZ) to intravenous furosemide is a safe and effective strategy for improving diuretic response in acute heart failure (AHF)." | 5.69 | Combining loop with thiazide diuretics for decompensated heart failure: the CLOROTIC trial. ( Carrera-Izquierdo, M; Casado, J; Cerqueiro, JM; Conde-Martel, A; Dávila-Ramos, MF; Formiga, F; Gil, P; Llácer, P; Manzano, L; Morales-Rull, JL; Pérez-Silvestre, J; Plasín, MÁ; Salamanca-Bautista, P; Sánchez-Marteles, M; Trullàs, JC, 2023) |
| "Although furosemide is the most commonly used loop diuretic in patients with heart failure, some studies suggest a potential benefit for torsemide." | 5.69 | Effect of Torsemide vs Furosemide After Discharge on All-Cause Mortality in Patients Hospitalized With Heart Failure: The TRANSFORM-HF Randomized Clinical Trial. ( Anstrom, KJ; Desvigne-Nickens, P; Eisenstein, EL; Greene, SJ; Harrington, AH; Ketema, F; Kim, DY; Mentz, RJ; Morgan, S; Pitt, B; Sachdev, V; Sapp, S; Testani, JM; Velazquez, EJ, 2023) |
| "To examine the decongestive effect of the sodium-glucose cotransporter 2 inhibitor dapagliflozin compared to the thiazide-like diuretic metolazone in patients hospitalized for heart failure and resistant to treatment with intravenous furosemide." | 5.69 | Dapagliflozin vs. metolazone in heart failure resistant to loop diuretics. ( Brooksbank, KJM; Campbell, RT; Clark, AL; Docherty, KF; Foley, PWX; Guha, K; Halliday, CA; Jhund, PS; Kalra, PR; Lang, NN; Lee, MMY; McConnachie, A; McDermott, JJ; McKinley, G; McMurray, JJV; Osmanska, J; Petrie, MC; Platz, E; Sartipy, P; Seed, A; Stanley, B; Weir, RAP; Welsh, P; Yeoh, SE, 2023) |
| "Loop diuretics are a primary therapy for the symptomatic treatment of heart failure (HF), but whether torsemide improves patient symptoms and quality of life better than furosemide remains unknown." | 5.69 | Effect of Torsemide Versus Furosemide on Symptoms and Quality of Life Among Patients Hospitalized for Heart Failure: The TRANSFORM-HF Randomized Clinical Trial. ( Alexy, T; Ambrosy, AP; Anstrom, KJ; Clare, RM; Desvigne-Nickens, P; DeWald, TA; Eisenstein, EL; Greene, SJ; Ketema, F; Kim, DY; Mentz, RJ; Pitt, B; Psotka, MA; Rommel, JJ; Stevens, GR; Velazquez, EJ, 2023) |
| "This study examined the combined effect of diuretic dosage and UNa concentration in chronic HF." | 5.62 | The ratio of furosemide dosage to urinary sodium concentration predicts mortality in patients with chronic stable heart failure. ( Amorim, M; Araújo, JP; Bettencourt, P; Elias, C; Lourenço, P; Oliveira, D; Soares-Carreira, M, 2021) |
| "Diabetes mellitus has been suggested as a determinant of diuretic resistance." | 5.56 | Diabetic patients need higher furosemide doses: a report on acute and chronic heart failure patients. ( Bettencourt, P; Cunha, FM; Lourenço, P; Marques, P; Pereira, J; Ribeiro, A, 2020) |
| "Eight healthy dogs, 6 dogs with congestive heart failure (CHF)." | 5.56 | Prediction and measurement of diuretic responsiveness after oral administration of furosemide to healthy dogs and dogs with congestive heart failure. ( Huh, T; Larouche-Lebel, É; Loughran, KA; Oyama, MA; Rao, VS; Testani, JM, 2020) |
| "We used blinded aggregate data from the ongoing ToRsemide comparison with furoSemide FOR Management of Heart Failure (TRANSFORM-HF) pragmatic clinical trial in patients with heart failure to evaluate the agreement between centralized call center death event identification and the United States National Death Index (NDI)." | 5.51 | Ascertaining Death Events in a Pragmatic Clinical Trial: Insights From the TRANSFORM-HF Trial. ( Anstrom, KJ; Eisenstein, EL; Greene, SJ; Harding, T; Harrington, A; Kim, DY; Mentz, RJ; Sachdev, V; Sapp, S; Velazquez, EJ, 2022) |
| " This study suggests that chronic administration of captopril, but not furosemide, could be beneficial in patients with HFpEF, particularly in those with comorbidities such as obesity, diabetes, and dyslipidemias." | 5.48 | Captopril Attenuates Cardiovascular and Renal Disease in a Rat Model of Heart Failure With Preserved Ejection Fraction. ( Bastacky, SI; Jackson, EK; Salah, EM; Tofovic, SP, 2018) |
| "Diuretics, such as furosemide, are routinely administered to dogs with congestive heart failure (CHF)." | 5.41 | Toward quantification of loop diuretic responsiveness for congestive heart failure. ( Adin, D; Oyama, MA, 2023) |
| "In the EARLIER (Efficacy and Safety of Early Initiation of Eplerenone Treatment in Patients with Acute Heart Failure) trial, eplerenone did not reduce heart failure (HF) hospitalizations or all-cause mortality in 300 patients admitted for acute HF (AHF)." | 5.41 | Effect of eplerenone on clinical stability of Japanese patients with acute heart failure. ( Asakura, M; Chikamori, T; Ferreira, JP; Ito, S; Kitakaze, M; Kobayashi, M; Matsue, Y; Yamashina, A, 2023) |
| "We conducted a prospective, observational study of 50 patients with acute heart failure patients divided into two groups based on previous furosemide use (furosemide naïve: n = 28 [56%] and chronic furosemide users: n = 22 [44%])." | 5.41 | The blunted loop diuretic response in acute heart failure is driven by reduced tubular responsiveness rather than insufficient tubular delivery. The role of furosemide urine excretion on diuretic and natriuretic response in acute heart failure. ( Biegus, J; Cox, ZL; Fudim, M; Guzik, M; Hurkacz, M; Iwanek, G; Marciniak, D; Ponikowska, B; Ponikowski, P; Raj, D; Testani, J; Zymliński, R, 2023) |
| "This is a prospective randomized controlled trial to study the efficacy and safety of Shenfu injection combined with furosemide in the treatment of coronary heart disease and chronic heart failure." | 5.41 | Shenfu injection combined with furosemide in the treatment of chronic heart failure in patients with coronary heart disease: A protocol of randomized controlled trial. ( Gao, Y; Tan, X; Zhu, R, 2021) |
| "We sought to compare the effects of furosemide + hypertonic saline solution (HSS) treatment in patients with acute decompensated heart failure in comparison with furosemide alone and the response in a compensated state after an acute saline load with regard to serum levels of heart failure biomarkers." | 5.41 | Effects of intravenous furosemide plus small-volume hypertonic saline solutions on markers of heart failure. ( Casuccio, A; Daidone, M; Del Cuore, A; Di Chiara, T; Di Raimondo, D; Fonte, R; Maida, C; Mogavero, A; Ortello, A; Pinto, A; Puleo, MG; Tuttolomondo, A; Vassallo, V, 2021) |
| " Subcutaneous dosing of furosemide has been explored as a potential alternative for management of CHF symptoms." | 5.39 | Intermittent subcutaneous furosemide: parenteral diuretic rescue for hospice patients with congestive heart failure resistant to oral diuretic. ( Bailey, FA; Farless, LB; Steil, N; Williams, BR, 2013) |
| "CHF was characterized by left ventricular remodeling and impaired systolic and diastolic function." | 5.35 | Effects of V2-receptor antagonist tolvaptan and the loop diuretic furosemide in rats with heart failure. ( Aizawa, Y; Kodama, M; Ma, M; Palaniyandi, SS; Veeraveedu, PT; Watanabe, K; Yamaguchi, K, 2008) |
| "In patients with ACHF and dilutional hyponatremia, low natriuresis after furosemide is an early marker of poor diuretic response and correlates with higher NT-proBNP and higher incidence of worsening renal function at 72 h." | 5.34 | Spot urinary sodium in acute decompensation of advanced heart failure and dilutional hyponatremia: insights from DRAIN trial. ( Bergerone, S; Boretto, P; Canavosio, FG; De Ferrari, GM; Frea, S; Galluzzo, A; Golzio, PG; Pidello, S; Volpe, A, 2020) |
| "Oral tolvaptan was associated with similar, but not superior, diuresis compared with intravenous furosemide for acute heart failure with concomitant hyponatremia." | 5.34 | Tolvaptan vs. furosemide-based diuretic regimens in patients hospitalized for heart failure with hyponatremia (AQUA-AHF). ( Elkayam, U; Fong, MW; Grazette, LP; Han, EE; Kuo, A; Lou, M; Mehra, A; Ng, TMH; Upadhyay, RY; Yoon, AJ, 2020) |
| "Tolvaptan has been shown to improve congestion in heart failure patients." | 5.34 | Differences in pharmacological property between combined therapy of the vasopressin V2-receptor antagonist tolvaptan plus furosemide and monotherapy of furosemide in patients with hospitalized heart failure. ( Amitani, K; Iha, H; Imura, H; Ishihara, S; Ishikawa, M; Ishizuka, A; Ito, Y; Kikuchi, A; Kobayashi, N; Maruyama, Y; Mitsuishi, T; Nakama, K; Nakamura, S; Nohara, T; Ohkuma, S; Omote, T; Sato, N; Shigihara, S; Shimizu, W; Sone, M; Takagi, K; Takahashi, N; Tokuyama, H; Yamamoto, E, 2020) |
| "Triple therapy (TT) consisting of furosemide, pimobendan, and an angiotensin-converting enzyme inhibitor (ACEI) frequently is recommended for the treatment of congestive heart failure (CHF) attributable to myxomatous mitral valve disease (MMVD)." | 5.34 | Efficacy of adding ramipril (VAsotop) to the combination of furosemide (Lasix) and pimobendan (VEtmedin) in dogs with mitral valve degeneration: The VALVE trial. ( Bauer, A; Gaugele, J; Glaus, T; Holler, P; Keller, L; Killich, M; Kresken, JG; Küchenhof, H; Simak, J; Wendt, R; Wess, G, 2020) |
| "Refractory congestive heart failure (CHF) with diuretic resistance is life-threatening and predicts a short life expectancy." | 5.34 | Potent diuretic effects of prednisone in heart failure patients with refractory diuretic resistance. ( Ji, Z; Liu, C; Liu, G; Liu, K; Zhen, Y; Zhou, C, 2007) |
| " Failed furosemide adherence (defined as < 10% of a dose excreted in 24 h urine where normal average excretion = 50% of an oral dose) during static prescribed dosing was infrequent relative to all days of therapy; yet was equally common across all outcome groups." | 5.32 | Furosemide responsiveness, non-adherence and resistance during the chronic treatment of heart failure: a longitudinal study. ( Brater, DC; Gorski, JC; MacFadyen, RJ; Struthers, AD, 2004) |
| "Torasemide with its more complete and less variable bioavailability offers potential clinical and economic advantages over furosemide in the long-term treatment in patients with CHF." | 5.31 | [Long-term diuretic treatment in heart failure: are there differences between furosemide and torasemide?]. ( Falkenstein, P; Follath, F; Gutzwiller, F; Müller, K; Reitberger, U; Spannheimer, A, 2002) |
| "To compare efficacy and safety of indapamide-furosemide combination against metolazone-furosemide combination in refractory heart failure patients." | 5.30 | Comparing the sodium excreting efficacy of furosemide and indapamide combination against furosemide and metolazone combination in congestive heart failure patients: A randomized control trial. ( Altaf, A; Jan, MU; Salahudin, M; Shah, H, 2019) |
| "Recent reports suggest that torasemide might be more beneficial than furosemide in patients with symptomatic heart failure (HF)." | 5.30 | Comparative effectiveness of torasemide versus furosemide in symptomatic therapy in heart failure patients: Preliminary results from the randomized TORNADO trial. ( Bakuła, E; Balsam, P; Bednarski, J; Cacko, A; Filipiak, KJ; Fojt, A; Gawałko, M; Grabowski, M; Główczyńska, R; Kowalik, R; Marchel, M; Markulis, M; Niedziela, Ł; Niewiński, G; Opolski, G; Ozierański, K; Peller, M; Sieradzki, B; Sieradzki, M; Tymińska, A, 2019) |
| "We attempted to identify the difference in diuretic properties between tolvaptan (TLV) and furosemide (FUR) in congestive heart failure (CHF) patients with loop diuretic resistance and renal impairment." | 5.30 | Different diuretic properties between tolvaptan and furosemide in congestive heart failure patients with diuretic resistance and renal impairment: a subanalysis of the K-STAR. ( Ako, J; Ikeda, Y; Inomata, T; Izumi, T; Kida, K; Sato, N; Shibagaki, Y, 2019) |
| "To assess differences in diuretic dose requirements in patients treated with sacubitril/valsartan compared with enalapril in the Prospective comparison of ARNI with ACEI to Determine Impact on Global Mortality and morbidity in Heart Failure (PARADIGM-HF) trial." | 5.30 | Reduced loop diuretic use in patients taking sacubitril/valsartan compared with enalapril: the PARADIGM-HF trial. ( Claggett, B; Desai, AS; Kachadourian, J; Lefkowitz, M; McMurray, JJV; Packer, M; Rouleau, J; Shi, V; Solomon, SD; Swedberg, K; Vardeny, O; Zile, MR, 2019) |
| "Oral furosemide or torsemide was administered before and after diuresis." | 5.30 | The effects of diuresis on the pharmacokinetics of the loop diuretics furosemide and torsemide in patients with heart failure. ( Fisher, ML; Gottlieb, SS; Khatta, M; Kramer, WG; Roffman, D; Wentworth, D, 1998) |
| "Furosemide was administered IV concurrently with IV administered digoxin every 12 hours." | 5.29 | Pharmacokinetics of digoxin administered to horses with congestive heart failure. ( Reef, VB; Reimer, JM; Sweeney, RW, 1993) |
| " Angiotensin-converting enzyme inhibitors cause an acute fall in creatinine clearance which may reduce the effects of loop diuretics and attention must be paid to diuretic dosage when initiating angiotensin-converting enzyme inhibitors for the treatment of cardiac failure." | 5.28 | Acute administration of captopril lowers the natriuretic and diuretic response to a loop diuretic in patients with chronic cardiac failure. ( Davies, E; Edwards, CR; Flapan, AD; Shaw, TR; Waugh, C; Williams, BC, 1991) |
| "This study sought to determine the efficacy and safety of a novel, pH-neutral formulation of furosemide administered subcutaneously (SC) for treatment of acute decompensated heart failure (HF)." | 5.27 | Efficacy of Intravenous Furosemide Versus a Novel, pH-Neutral Furosemide Formulation Administered Subcutaneously in Outpatients With Worsening Heart Failure. ( Almansa, J; Chambers, J; Chasler, J; Cummings, A; Cuomo, K; Gilotra, NA; Marino, B; Okwuosa, IS; Princewill, O; Rhodes, P; Russell, SD, 2018) |
| "This study suggests that spironolactone is well tolerated, and preliminary results support further investigation to evaluate the efficacy of spironolactone in the treatment of cats with cardiac failure due to cardiomyopathy." | 5.27 | The SEISICAT study: a pilot study assessing efficacy and safety of spironolactone in cats with congestive heart failure secondary to cardiomyopathy. ( Cobb, M; Garelli-Paar, C; Grassi, V; Guillot, E; Huxley, J; James, R, 2018) |
| " This subanalysis investigated the effect of add-on TLV compared to increased furosemide (FUR) on both electrolyte-free water and electrolyte clearance in patients with congestive heart failure (CHF) complicated by advanced chronic kidney disease (CKD)." | 5.27 | Comparison of the effects of tolvaptan and furosemide on renal water and sodium excretion in patients with heart failure and advanced chronic kidney disease: a subanalysis of the K-STAR study. ( Akashi, YJ; Inomata, T; Izumi, T; Kida, K; Sato, N; Shibagaki, Y; Tominaga, N, 2018) |
| "In a prospective, randomized, clinical trial, 90 HFpEF patients hospitalized with acute heart failure were randomized within 24 h of admission to 1 of 4 treatments: 1) intravenous bolus furosemide administered every 12 h; 2) continuous infusion furosemide; 3) intermittent bolus furosemide with low-dose dopamine; and 4) continuous infusion furosemide with low-dose dopamine." | 5.27 | Randomized Evaluation of Heart Failure With Preserved Ejection Fraction Patients With Acute Heart Failure and Dopamine: The ROPA-DOP Trial. ( Alexander, KM; Chasler, JE; Fine, DM; Gupta, R; Hill, T; Hu, JR; Kalathiya, R; Kass, DA; Kovell, L; Lee, YJ; Miller, J; Montemayor, K; Ndumele, CE; Russell, SD; Schulman, SP; Shah, N; Sharma, K; Sharp, M; Thiemann, DR; Tsao, A; Vaishnav, J; Weiss, RG, 2018) |
| "Ten patients with severe congestive heart failure (6 women and 4 men, aged 67 +/- 4." | 5.27 | Combination of furosemide and metolazone in the treatment of severe congestive heart failure. ( Grosskopf, I; Rabinovitz, M; Rosenfeld, JB, 1986) |
| " There was a preference for initiating treatment with a diuretic rather than digoxin and for commencing digoxin in daily maintenance dosage rather than with a loading dose." | 5.26 | Survey of cardiac failure therapy in Australian medical practice: dependence on digoxin level for diagnosis of toxicity. ( Read, TR; Schapel, GJ, 1980) |
| " In the final phase, dosage was lowered to 20 mg per day and 24 of the 39 patients, (62%), were successfully controlled for four weeks, while 14, (36%), were controlled for eight weeks." | 5.25 | Dosage titration with furosemide in congestive heart failure patients. ( Exaire, JE; Figueroa, G; Hamdan, G; Villalpando, J, 1975) |
| "The aim of the present study was to evaluate the effects of hypertonic saline solution (C-HSS) with high dose furosemide on hospitalization time, readmission, and mortality in patients with New York Heart Association (NYHA) class III heart failure." | 5.24 | Impact of Compound Hypertonic Saline Solution on Decompensated Heart Failure. ( Li, L; Ma, X; Mu, G; Niu, H; Wan, Y; Yang, J; Yuan, C; Zhang, J, 2017) |
| "The aim of this study was to determine the diuretic effect of acetazolamide in patients with exacerbations of chronic heart failure, in addition to their stable diuretic therapy." | 5.24 | Acetazolamide as Add-on Diuretic Therapy in Exacerbations of Chronic Heart Failure: a Pilot Study. ( Budaj, A; Imiela, T, 2017) |
| "Furosemide is the only loop diuretic recommended by the ACVIM consensus guidelines for treatment of congestive heart failure (CHF) in dogs related to degenerative mitral valve disease (DMVD)." | 5.24 | Short-Term Efficacy and Safety of Torasemide and Furosemide in 366 Dogs with Degenerative Mitral Valve Disease: The TEST Study. ( Blanc, J; Chetboul, V; Desquilbet, L; Lucats, L; Menard, J; Petit, A; Pouchelon, JL; Rougier, S; Woehrle, F, 2017) |
| " high diuretic dose of furosemide in patients with a diagnosis of acute heart failure, BNP ≥ 100 pg/mL, and specific chest X-ray signs." | 5.24 | Rationale and study design of intravenous loop diuretic administration in acute heart failure: DIUR-AHF. ( Di Somma, S; Nuti, R; Palazzuoli, A; Ruocco, G; Valle, R; Vescovo, G, 2017) |
| "The change (Δ) in urine volume (ΔUV) and Δurine osmolality were greater in the tolvaptan group than in the furosemide group; however, ΔUV and Δurine osmolality did not show significant differences between the normonatremia subgroup and the hyponatremia subgroup in each group." | 5.24 | Effects of Tolvaptan Addition to Furosemide in Normo- and Hyponatremia Patients with Heart Failure and Chronic Kidney Disease Stages G3b-5: A Subanalysis of the K-STAR Study. ( Akashi, YJ; Inomata, T; Izumi, T; Kida, K; Sato, N; Shibagaki, Y; Tominaga, N, 2017) |
| "Furosemide is commonly prescribed for symptom relief in heart failure (HF) patients." | 5.24 | Rational and design of a randomized, double-blind, multicenter trial to evaluate the safety and tolerability of furosemide withdrawal in stable chronic outpatients with heart failure: The ReBIC-1 trial. ( Beck-da-Silva, L; Bertoldi, EG; Biolo, A; da Rosa, PR; Danzmann, LC; Doebber, M; Figueiredo Neto, JA; Kohler, I; Moura, LZ; Prado, DP; Ribeiro, ALP; Rohde, LE; Rover, M; Sant'Anna, RT; Simões, MV, 2017) |
| "We have previously reported that a long-acting loop diuretic, azosemide, reduces cardiovascular risks in patients with chronic heart failure (CHF) as compared with a short-acting one, furosemide, in Japanese Multicenter Evaluation of LOng- versus short-acting Diuretics In Congestive heart failure (J-MELODIC)." | 5.24 | Changes in brain natriuretic peptide in chronic heart failure patients treated with long-acting versus short-acting loop diuretics: J-MELODIC subanalysis. ( Akasaka, T; Daimon, T; Fukui, M; Hirano, Y; Hirotani, S; Ito, H; Kawabata, M; Masuyama, T; Nakatani, S; Ohte, N; Tsujino, T; Yamamoto, K, 2017) |
| " The most widely used diuretic, furosemide, has a stormy pharmacokinetics and pharmacodynamics, and is associated with a high risk of mortality and hospitalization for worsening heart failure." | 5.24 | The impact of torasemide on haemodynamic and neurohormonal stress, and cardiac remodelling in heart failure - TORNADO: a study protocol for a randomized controlled trial. ( Bakuła, E; Balsam, P; Cacko, A; Filipiak, KJ; Fojt, A; Grabowski, M; Główczyńska, R; Huczek, Z; Kowalik, R; Markulis, M; Opolski, G; Ozierański, K; Peller, M; Sieradzki, B; Tymińska, A, 2017) |
| " While furosemide remains the dominant diuretic utilized in current practice, increasing evidence supports potential advantages of torsemide in heart failure (HF) and/or renal disease." | 5.22 | An evaluation of torsemide in patients with heart failure and renal disease. ( DeWald, TA; Greene, SJ; Mentz, RJ; Peters, AE, 2022) |
| "To compare the effects of different dosing schemes of furosemide on acute heart failure (AHF)." | 5.22 | Comparison of Different Furosemide Regimens in the Treatment of Acute Heart Failure: A Meta-Analysis. ( Chen, D; Guo, F; Huang, J; Huang, Y; Lin, H, 2022) |
| "The efficacy of hypertonic saline solution (HSS) combined with furosemide in treating acute heart failure is controversial." | 5.22 | Effect of Hypertonic Saline Solution Combined with Furosemide on Acute Heart Failure: A Meta-Analysis. ( Li, H; Li, Z; Liu, N; Wang, Z, 2022) |
| "Furosemide is the most commonly used loop diuretic in patients with heart failure (HF) despite data suggesting potential pharmacologic and antifibrotic benefits with torsemide." | 5.22 | Torsemide Versus Furosemide in Patients With Acute Heart Failure (from the ASCEND-HF Trial). ( Anstrom, KJ; Armstrong, PW; DeVore, AD; Ezekowitz, JA; Hasselblad, V; Hernandez, AF; Mentz, RJ; Metra, M; O'Connor, CM; Schulte, PJ; Tang, WH; Velazquez, EJ; Voors, AA, 2016) |
| " Analyses were performed in 1180 patients enrolled in the Placebo-Controlled Randomized Study of the Selective Adenosine Receptor Antagonist Rolofylline for Patients Hospitalized With Acute Decompensated Heart Failure and Volume Overload to Assess Treatment Effect on Congestion and Renal Function (PROTECT) trial and validated in 1776 patients enrolled in the Efficacy of Vasopressin Antagonism in Heart Failure Outcome Study With Tolvaptan (EVEREST) trial." | 5.22 | Combining Diuretic Response and Hemoconcentration to Predict Rehospitalization After Admission for Acute Heart Failure. ( Bloomfield, DM; Cleland, JG; Cotter, G; Damman, K; Davison, B; Gheorghiade, M; Givertz, MM; Hillege, HL; Metra, M; O'Connor, CM; Ponikowski, P; Subacius, H; Teerlink, JR; Ter Maaten, JM; Valente, MA; van der Meer, P; van Veldhuisen, DJ; Voors, AA, 2016) |
| "Two heart failure cohorts were included: (1) observational: patients receiving loop diuretics at the Yale Transitional Care Center (N=162) and (2) interventional pilot: stable outpatients receiving ≥80 mg furosemide equivalents were studied before and after 3 days of 115 mmol/d supplemental lysine chloride (N=10)." | 5.22 | Hypochloremia and Diuretic Resistance in Heart Failure: Mechanistic Insights. ( Ahmad, T; Assefa, M; Bellumkonda, L; Brisco, MA; Grodin, JL; Hanberg, JS; Laur, O; Parikh, CR; Perry Wilson, F; Planavsky, NJ; Rao, V; Samuel Broughton, J; Tang, WH; Ter Maaten, JM; Testani, JM, 2016) |
| "5 or 15 mg/day) in combination with furosemide have been investigated in heart failure (HF) patients with normal kidney function but not in HF patients with advanced kidney dysfunction." | 5.20 | Efficacy of tolvaptan added to furosemide in heart failure patients with advanced kidney dysfunction: a pharmacokinetic and pharmacodynamic study. ( Akashi, YJ; Kida, K; Kimura, K; Matsumoto, N; Miyake, F; Shibagaki, Y; Tominaga, N, 2015) |
| "Treatment of congestive heart failure (CHF) with loop diuretics, such as furosemide, may be associated with complications, including worsening renal function and metabolic or electrolyte disturbances." | 5.20 | Safety of add-on tolvaptan in patients with furosemide-resistant congestive heart failure complicated by advanced chronic kidney disease: a sub-analysis of a pharmacokinetics/ pharmacodynamics study. ( Akashi, YJ; Kida, K; Kimura, K; Matsumoto, N; Miyake, F; Shibagaki, Y; Tominaga, N, 2015) |
| " Patients in group 1 (125 mg furosemide) had a mean age of 77 ± 17 years, 43% were male, 6 (43%) had heart failure with a preserved ejection fraction (HFpEF), and 64% were in New York Heart Association (NYHA) class IV; the mean age of patients in group 2 (250 mg furosemide) was 80 ± 8." | 5.20 | Hypertonic Saline in Conjunction with High-Dose Furosemide Improves Dose-Response Curves in Worsening Refractory Congestive Heart Failure. ( Balistreri, F; Butler, J; Cuttitta, F; Di Gaudio, F; di Pasquale, P; Greco, M; Indelicato, S; La Rocca, V; Lupo, U; Parrinello, G; Paterna, S; Rizzo, G; Torres, D, 2015) |
| "The Answering question on tolvaptan's efficacy for patients with acute decompensated heart failure and renal failure (AQUAMARINE) is a multicenter, randomized controlled clinical trial, which will enroll 220 patients from 17 hospitals in Japan." | 5.19 | Clinical effectiveness of tolvaptan in patients with acute decompensated heart failure and renal failure: design and rationale of the AQUAMARINE study. ( Fujii, H; Matsue, Y; Nagahori, W; Nishioka, T; Noda, M; Okishige, K; Onishi, Y; Ono, Y; Sakurada, H; Satoh, Y; Sugi, K; Suzuki, M; Takahashi, A; Tejima, T; Torii, S; Yamaguchi, S; Yoshida, K, 2014) |
| "Spironolactone, not furosemide, improved insulin resistance in CHF patients probably by the inhibition of inflammatory cytokines and MMPs." | 5.19 | Spironolactone, not furosemide, improved insulin resistance in patients with chronic heart failure. ( Anker, SD; Doehner, W; Hisatome, I; Kato, M; Kinugasa, Y; Ogino, K; Yamamoto, K, 2014) |
| "Theoretically, salt supplementation should promote diuresis through increasing the glomerular filtration rate (GFR) during treatment of acute decompensated heart failure (ADHF) even with low-dose furosemide; however, there is little evidence to support this idea." | 5.19 | Intravenous salt supplementation with low-dose furosemide for treatment of acute decompensated heart failure. ( Ando, T; Eguchi, A; Hirotani, S; Iwasaku, T; Manabe, E; Masuyama, T; Morisawa, D; Naito, Y; Nakabo, A; Okuhara, Y; Sawada, H, 2014) |
| "We examined diuretic response (defined as Δ weight kg/40 mg furosemide) in 1745 hospitalized acute heart failure patients from the PROTECT trial." | 5.19 | Diuretic response in acute heart failure: clinical characteristics and prognostic significance. ( Bloomfield, DM; Cleland, JG; Cotter, G; Damman, K; Davison, B; Dittrich, HC; Fiuzat, M; Givertz, MM; Hillege, HL; Massie, BM; Metra, M; O'Connor, CM; Ponikowski, P; Teerlink, JR; Valente, MA; Van Veldhuisen, DJ; Voors, AA, 2014) |
| "In a subset analysis of the Efficacy of Vasopressin Antagonism in Heart Failure Outcome Study with Tolvaptan trial, 759 patients (18% of total) had elevated blood urea nitrogen (BUN) (> 20 mg/dl) and low SBP (<105 mmHg) at admission." | 5.16 | Efficacy of oral tolvaptan in acute heart failure patients with hypotension and renal impairment. ( Blair, J; Burnett, JC; Gheorghiade, M; Grinfeld, L; Konstam, MA; Krasa, HB; Maggioni, AP; Ouyang, J; Pang, PS; Swedberg, K; Vaduganathan, M; Zannad, F; Zimmer, C, 2012) |
| "The role of repeated infusions of Levosimendan (LEVO) in patients with chronic advanced heart failure is still unclear." | 5.16 | Intermittent levosimendan infusions in advanced heart failure: favourable effects on left ventricular function, neurohormonal balance, and one-year survival. ( Branzi, G; Della Rosa, F; Facchini, M; Malfatto, G; Parati, G; Rella, V; Villani, A, 2012) |
| "In a prospective, double-blind, randomized trial, we assigned 308 patients with acute decompensated heart failure to receive furosemide administered intravenously by means of either a bolus every 12 hours or continuous infusion and at either a low dose (equivalent to the patient's previous oral dose) or a high dose (2." | 5.15 | Diuretic strategies in patients with acute decompensated heart failure. ( Anstrom, KJ; Bart, BA; Braunwald, E; Bull, DA; Chen, HH; Deswal, A; Felker, GM; Givertz, MM; Goldsmith, SR; Hernandez, AF; Kfoury, AG; Lee, KL; LeWinter, MM; Mascette, AM; McNulty, SE; O'Connor, CM; Ofili, EO; Redfield, MM; Rouleau, JL; Semigran, MJ; Stevenson, LW; Velazquez, EJ, 2011) |
| "The aim of the study was to verify the effects of hypertonic saline solution (HSS) plus a high furosemide dose and light restriction of sodium intake compared with a high-dose infusion of furosemide alone on pulmonary capillary wedge pressure (PCWP), as determined by Doppler echocardiography and tissue Doppler imaging in patients suffering from decompensated heart failure." | 5.15 | Changes in estimating echocardiography pulmonary capillary wedge pressure after hypersaline plus furosemide versus furosemide alone in decompensated heart failure. ( Cardillo, M; Di Pasquale, P; Fasullo, S; La Rocca, G; Licata, G; Mezzero, M; Parrinello, G; Paterna, S; Torres, D, 2011) |
| "Hypertonic saline solution (HSS) and a moderate Na restriction plus high furosemide dose showed beneficial effects in compensated heart failure (HF), in short and long terms." | 5.15 | Short-term effects of hypertonic saline solution in acute heart failure and long-term effects of a moderate sodium restriction in patients with compensated heart failure with New York Heart Association class III (Class C) (SMAC-HF Study). ( Basile, I; Cannizzaro, S; Cice, G; Di Pasquale, P; Fasullo, S; Ganci, F; Maringhini, G; Parrinello, G; Paterna, S; Sarullo, FM; Scalzo, S; Terrazzino, G; Vitrano, G, 2011) |
| "The aim of this study was to evaluate the effects of both the prolonged-release (PR) formulation of torasemide (torasemide-PR) and furosemide on myocardial fibrosis in hypertensive patients with chronic HF." | 5.15 | Effects of prolonged-release torasemide versus furosemide on myocardial fibrosis in hypertensive patients with chronic heart failure: a randomized, blinded-end point, active-controlled study. ( , 2011) |
| "The decrease in body weight from baseline to the day after the final dose with 15, 30 or 45 mg tolvaptan (-1." | 5.15 | Effects of tolvaptan on volume overload in Japanese patients with heart failure: results of a phase II, multicenter, randomized, double-blind, placebo-controlled, parallel-group study. ( Asanoi, H; Hori, M; Izumi, T; Matsuzaki, M; Tsutamoto, T, 2011) |
| " We analyzed the degree of cross-linking and the expression of the enzyme lysyl oxidase, which regulates cross-linking, in the myocardium of patients with chronic heart failure at baseline and after 8 months of treatment with either torasemide or furosemide in addition to their standard heart failure therapy." | 5.14 | Impact of treatment on myocardial lysyl oxidase expression and collagen cross-linking in patients with heart failure. ( Beaumont, J; Díez, J; González, A; Larman, M; López, B; Querejeta, R, 2009) |
| "Loop diuretics, such as torasemide and furosemide, are important agents in the treatment of chronic heart failure." | 5.14 | TORAFIC study protocol: torasemide prolonged release versus furosemide in patients with chronic heart failure. ( Anguita, M; Castro-Beiras, A; Cobo, E; Coca, A; Conthe, P; de Teresa, E; Díez, J; Fernández, E, 2009) |
| "In patients with heart failure, few data describe the neurohormonal response to nesiritide and furosemide either alone or in combination." | 5.14 | Natriuretic and neurohormonal responses to nesiritide, furosemide, and combined nesiritide and furosemide in patients with stable systolic dysfunction. ( Gottwald, MD; Mills, RM; Oren, RM; Sica, D, 2010) |
| "This study was designed to evaluate the consequences of ultrafiltration (UF) and standard intravenous diuretic (furosemide) therapy on glomerular filtration rate (GFR) and renal plasma flow in patients with acute decompensated heart failure." | 5.13 | A randomized, controlled trial of the renal effects of ultrafiltration as compared to furosemide in patients with acute decompensated heart failure. ( Bock, J; Dowling, TC; Feller, E; Gottlieb, SS; Marshall, J; Robinson, S; Rogers, HL, 2008) |
| "Our aim was to conduct a meta-analysis to evaluate the efficiency of combination HSS plus furosemide therapy in patients with ADHF in terms of mortality, readmissions, length of hospital stay, kidney function, urine output, body weight, and B-type natriuretic peptide (BNP)." | 5.12 | Efficiency of Hypertonic Saline in the Management of Decompensated Heart Failure: A Systematic Review and Meta-Analysis of Clinical Studies. ( Afsar, B; Copur, S; Covic, A; Kanbay, M; Nistor, I; Siriopol, D; Tapoi, L; Ureche, C, 2021) |
| "To determine the effect of torasemide, a loop diuretic with antialdosteronergic properties, compared with furosemide on cardiac sympathetic nerve activity in patients with congestive heart failure (CHF)." | 5.12 | Effects of torasemide on cardiac sympathetic nerve activity and left ventricular remodelling in patients with congestive heart failure. ( Hatori, T; Ichikawa, S; Kasama, S; Kumakura, H; Kurabayashi, M; Sumino, H; Suzuki, T; Takayama, Y; Toyama, T, 2006) |
| "Four ambulatory patients with compensated chronic cardiac failure (NYHA Class III) of ischemic and nonischemic origin and systolic dysfunction (ejection fraction <35%), who were receiving a stable regimen of oral furosemide and angiotensin-converting enzyme inhibitor, were enrolled into the study." | 5.12 | Effect of timed semirecumbency and furosemide dosing on urinary sodium excretion in patients with compensated heart failure. ( Khouzam, RN; Klemis, JE; Mangold, TA; Nelson, MD; Wall, BM; Weber, KT, 2006) |
| "To evaluate short-term effects of tolvaptan when added to standard therapy in patients hospitalized with heart failure." | 5.12 | Short-term clinical effects of tolvaptan, an oral vasopressin antagonist, in patients hospitalized for heart failure: the EVEREST Clinical Status Trials. ( Burnett, JC; Cook, T; Gheorghiade, M; Grinfeld, L; Konstam, MA; Maggioni, AP; Orlandi, C; Ouyang, J; Swedberg, K; Udelson, JE; Zannad, F; Zimmer, C, 2007) |
| "A 24-hour infusion of levosimendan was added to dobutamine in 18 patients (aged 63 +/- 9 years) hospitalized for management of decompensated New York Heart Association functional class IV heart failure refractory to a continuous 24-hour infusion of dobutamine (10 microg/kg/min) and furosemide (10 mg/hour); the primary study end point was a >or=40% increase in cardiac index and a >or=25% decrease in pulmonary capillary wedge pressure compared with pretreatment measurements." | 5.11 | Hemodynamic effects of levosimendan added to dobutamine in patients with decompensated advanced heart failure refractory to dobutamine alone. ( Agrios, N; Anastasiou-Nana, MI; Christodoulou, K; Dalianis, A; Kanakakis, J; Nanas, JN; Papazoglou, PP; Terrovitis, JV; Tsagalou, EP; Tsolakis, E, 2004) |
| "To retrospectively investigate elevation of serum potassium when spironolactone (25 or 50 mg/day) and furosemide were administered concomitantly with an angiotensin II converting enzyme inhibitor (ACE-I) or angiotensin II receptor blocker (ARB) to patients with chronic heart failure for 12 months and occurrence of hyperkalemia and hypokalemia because of concomitant administration of spironolactone plus an ACE-I or ARB and furosemide." | 5.11 | Serum concentration of potassium in chronic heart failure patients administered spironolactone plus furosemide and either enalapril maleate, losartan potassium or candesartan cilexetil. ( Hirooka, K; Isobe, F; Saito, M; Takada, M; Yasumura, Y, 2005) |
| "Elderly patients with heart failure are at risk of postprandial hypotension (PPH), orthostatic hypotension (OH), and concomitant cerebral oxygenation changes because of altered cardiovascular balance and the use of cardiovascular medications, such as furosemide and captopril." | 5.10 | Effects of furosemide versus captopril on postprandial and orthostatic blood pressure and on cerebral oxygenation in patients > or = 70 years of age with heart failure. ( Colier, WN; Hoefnagels, WH; Jansen, RW; Mehagnoul-Schipper, DJ; Verheugt, FW, 2002) |
| " In protocol 1, plasma level of thiobarbituric acid-reactive substances (TBARS) and renal function were assessed before and after intravenous infusion of vitamin C or placebo in 8 patients with moderate congestive heart failure (CHF) treated with enalapril." | 5.10 | Reduction of oxidative stress augments natriuretic effect of furosemide in moderate heart failure. ( Doba, N; Tomiyama, H; Watanabe, G; Yamashina, A; Yoshida, H, 2003) |
| "To determine changes in RAS activation and clinical correlates following furosemide withdrawal in elderly heart failure patients without left ventricular systolic dysfunction." | 5.10 | Neurohormonal effects of furosemide withdrawal in elderly heart failure patients with normal systolic function. ( Hoefnagels, WH; Jansen, RW; Sweep, FC; van Kraaij, DJ, 2003) |
| "The effect of torasemide and furosemide therapy was compared in 50 patients who had chronic heart failure and symptoms [NYHA class II-III] despite long-term therapy with both low-dose furosemide and angiotensin-converting enzyme inhibitors." | 5.10 | Effects of torasemide on left ventricular function and neurohumoral factors in patients with chronic heart failure. ( Akutagawa, O; Fukuda, M; Hayashi, T; Honda, K; Okamoto, M; Sasaki, T; Yamato, M, 2003) |
| "In patients with CHF, tolvaptan was well tolerated; it reduced body weight and edema and normalized serum sodium in the hyponatremic patients." | 5.10 | Vasopressin V2-receptor blockade with tolvaptan in patients with chronic heart failure: results from a double-blind, randomized trial. ( Czerwiec, F; Gheorghiade, M; Kambayashi, J; Niazi, I; Orlandi, C; Ouyang, J; Zampino, M, 2003) |
| "The hypothesis was that torasemide, due to more predictable pharmacokinetics/pharmacodynamics, induces greater improvements in functional and social limitation than furosemide and reduces the frequency of hospitalisations in primary care patients with chronic heart failure (CHF)." | 5.10 | Torasemide vs. furosemide in primary care patients with chronic heart failure NYHA II to IV--efficacy and quality of life. ( Gamba, G; Hess, B; Jaquet, F; Müller, K, 2003) |
| "We investigated the effects of a short-acting loop diuretic (furosemide) and a long-acting loop diuretic (azosemide) on heart rate variability, fluid balance, and neurohormonal responses in patients with mild to moderate chronic congestive heart failure." | 5.09 | Effects of short-acting and long-acting loop diuretics on heart rate variability in patients with chronic compensated congestive heart failure. ( Doba, N; Imai, Y; Nakayama, T; Sakuma, Y; Shiojima, K; Tomiyama, H; Watanabe, G; Yamamoto, A; Yoshida, H, 1999) |
| "Oral isosorbide-5-mononitrate (ISMN) (50 mg once daily) or placebo was administered to 136 patients (NYHA Class 2-3) treated for heart failure, all receiving captopril and most also furosemide." | 5.09 | Effect of isosorbide-5-mononitrate on exercise performance and clinical status in patients with congestive heart failure. Results of the Nitrates in Congestive Heart Failure (NICE) Study. ( Caspi, A; Ermer, W; Lewis, BS; Markiewicz, W; Rabinowitz, B; Rosenfeld, T; Schlesinger, Z; Sclarovsky, S, 1999) |
| "To assess the effects of furosemide withdrawal on postprandial blood pressure (BP) in elderly patients with heart failure and preserved left ventricular systolic function." | 5.09 | Furosemide withdrawal improves postprandial hypotension in elderly patients with heart failure and preserved left ventricular systolic function. ( Bouwels, LH; Hoefnagels, WH; Jansen, RW; van Kraaij, DJ, 1999) |
| "Male patients with mild heart failure were randomly assigned to 9 days of therapy with 20 mg frusemide twice a day, 200 mg candoxatril twice a day, or 400 mg candoxatril twice a day (n = 10 per group) after a 14-day placebo washout phase." | 5.09 | Comparison of the short-term effects of candoxatril, an orally active neutral endopeptidase inhibitor, and frusemide in the treatment of patients with chronic heart failure. ( Dargie, HJ; Newby, DE; Norrie, J; Northridge, DB; Rooney, E, 1999) |
| "The study aimed to assess the hemodynamic and neuroendocrine effects of candoxatril and frusemide compared with placebo in patients with mild chronic heart failure." | 5.09 | Hemodynamic and neuroendocrine effects for candoxatril and frusemide in mild stable chronic heart failure. ( Bostrøm, P; Christensen, CC; Parikka, H; Rykke, EO; Toivonen, L; Westheim, AS, 1999) |
| "To determine the effects of furosemide and the selective A1 adenosine receptor BG9719 on renal function in patients with congestive heart failure (CHF)." | 5.09 | Effects of BG9719 (CVT-124), an A1-adenosine receptor antagonist, and furosemide on glomerular filtration rate and natriuresis in patients with congestive heart failure. ( Beckman, E; Bennett, D; Cines, M; Fisher, ML; Freudenberger, R; Gladwell, T; Gottlieb, SS; Liittschwager, EB; Marshall, J; Skettino, SL; Wolff, A, 2000) |
| "The predictive value of digoxin and furosemide treatment for identifying patients receiving treatment for congestive heart failure (CHF), the use of angiotensin-converting-enzyme (ACE) inhibitors in this population, and the ability of a pharmacist outreach program to address underutilization of ACE inhibitors were studied." | 5.09 | Community pharmacist outreach program directed at physicians treating congestive heart failure. ( Brown, A; Miller, R; Parfrey, P; Ryan, K; Turner, CJ, 2000) |
| " All patients underwent at entry a physical examination, measurement of body weight (BW), blood pressure (BP), heart rate (HR), evaluation of signs of CHF, and controls of serum Na, K, Cl, bicarbonate, albumin, uric acid, creatinine, urea and glycemia and daily during hospitalization, as well as the daily output of urine for, Na, K and Cl measurements." | 5.09 | Effects of high-dose furosemide and small-volume hypertonic saline solution infusion in comparison with a high dose of furosemide as a bolus, in refractory congestive heart failure. ( Amato, P; Cardinale, A; Di Pasquale, P; Follone, G; Giubilato, A; Licata, G; Parrinello, G; Paterna, S, 2000) |
| "To compare the direct healthcare costs of patients with congestive heart failure (CHF) prescribed torasemide (torsemide) or furosemide (frusemide)." | 5.09 | Healthcare costs of patients with heart failure treated with torasemide or furosemide. ( Brater, DC; Forthofer, MM; Murray, MD; Stroupe, KT, 2000) |
| "We sought to determine the effect of aspirin on the venodilator effect of furosemide in patients with chronic heart failure (CHF) BACKGROUND: Furosemide has an acute venodilator effect preceding its diuretic action, which is blocked by nonsteroidal anti-inflammatory, drugs." | 5.09 | Aspirin inhibits the acute venodilator response to furosemide in patients with chronic heart failure. ( Davie, AP; Jhund, PS; McMurray, JJ, 2001) |
| "Because the bioavailability of oral furosemide is erratic and often incomplete, we tested the hypothesis that patients with heart failure who were treated with torsemide, a predictably absorbed diuretic, would have more favorable clinical outcomes than would those treated with furosemide." | 5.09 | Open-label randomized trial of torsemide compared with furosemide therapy for patients with heart failure. ( Adams, LD; Bennett, SJ; Brater, DC; Deer, MM; Dexter, PR; Ferguson, JA; Lane, KA; Murray, MD; Perkins, SM; Smith, FE; Tierney, WM, 2001) |
| "In patients with early stages of heart failure, digoxin may prevent a progressive deterioration in heart rate variability, whereas ibopamine does not show statistically significant effects." | 5.08 | Heart rate variability in patients with mild to moderate heart failure: effects of neurohormonal modulation by digoxin and ibopamine. The Dutch Ibopamine Multicenter Trial (DIMT) Study Group. ( Boomsma, F; Brouwer, J; Dunselman, PH; Haaksma, J; Lie, KI; Man in 't Veld, AJ; van Veldhuisen, DJ, 1995) |
| "We have previously found thiamine (vitamin B1) deficiency in patients with congestive heart failure (CHF) who had received long-term furosemide therapy." | 5.08 | Improved left ventricular function after thiamine supplementation in patients with congestive heart failure receiving long-term furosemide therapy. ( Almog, S; Ezra, D; Halkin, H; Motro, M; Peleg, E; Rosenthal, T; Seligmann, H; Shefi, M; Shimon, I; Vered, Z, 1995) |
| "The bioavailability, pharmacokinetics, and pharmacodynamics of torsemide (10 mg orally and intravenously) and furosemide (40 mg orally and 20 mg intravenously) were determined in a randomized crossover clinical trial in 16 patients with compensated congestive heart failure." | 5.08 | Bioavailability, pharmacokinetics, and pharmacodynamics of torsemide and furosemide in patients with congestive heart failure. ( Black, PK; Brater, DC; Kramer, WG; Serpas, T; Smith, WB; Vargo, DL, 1995) |
| "The effect of epoprostenol on the pharmacokinetics of furosemide was investigated in 23 patients with end-stage congestive heart failure (CHF) receiving conventional therapy alone or conventional therapy plus epoprostenol." | 5.08 | The effects of epoprostenol on drug disposition. II: A pilot study of the pharmacokinetics of furosemide with and without epoprostenol in patients with congestive heart failure. ( Carlton, LD; Mattson, CN; Patterson, JH; Schmith, VD, 1996) |
| "The efficacy of high dose furosemide as a continuous infusion was compared with a bolus injection of equal dose in patients with severe heart failure." | 5.08 | Diuretic efficacy of high dose furosemide in severe heart failure: bolus injection versus continuous infusion. ( Dormans, TP; Gerlag, PG; Russel, FG; Smits, P; Tan, Y; van Meyel, JJ, 1996) |
| "The objective of this study was to determine whether the addition of low-dose (renal-dose) dopamine to furosemide therapy enhances natriuresis in patients with compensated congestive heart failure, New York Heart Association Class II or III." | 5.08 | Dopamine does not enhance furosemide-induced natriuresis in patients with congestive heart failure. ( Brater, DC; Rudy, DW; Swan, SK; Vargo, DL, 1996) |
| "We studied the synergism between high-dose furosemide and hydrochlorothiazide in patients with severe congestive heart failure and impaired renal function showing diuretic resistance to a daily dose of furosemide of at least 250 mg." | 5.08 | Combination of high-dose furosemide and hydrochlorothiazide in the treatment of refractory congestive heart failure. ( Dormans, TP; Gerlag, PG, 1996) |
| "We compared the effects of the orally active dopamine agonist ibopamine with the loop diuretic frusemide as first-line therapy in patients with mild congestive heart failure." | 5.08 | A double-blind, cross-over comparison of the effects of a loop diuretic and a dopamine receptor agonist as first line therapy in patients with mild congestive heart failure. ( Andrews, R; Charlesworth, A; Cowley, AJ; Evans, A, 1997) |
| "Previous studies have demonstrated that continuous infusion of furosemide results in increased diuresis and natriuresis compared with bolus administration of the drug in patients with severe heart failure." | 5.08 | Effect of bolus injection versus continuous infusion of furosemide on diuresis and neurohormonal activation in patients with severe congestive heart failure. ( Aaser, E; Djøseland, O; Forfang, K; Gullestad, L; Hall, C; Kjekshus, J; Lundberg, J; Tølløfsrud, S, 1997) |
| "To evaluate the safety and efficacy of low-dose dopamine, high-dose furosemide, and their combination in the treatment of refractory congestive heart failure." | 5.08 | Increased toxicity of high-dose furosemide versus low-dose dopamine in the treatment of refractory congestive heart failure. ( Cotter, G; Golik, A; Litinski, I; Metzkor, E; Moshkovitz, Y; Perry, C; Tavori, U; Weissgarten, J; Zaidenstein, R, 1997) |
| "Patients presenting to mobile emergency units with signs of congestive heart failure were treated with oxygen 10 L/min, intravenous furosemide 40 mg, and morphine 3 mg bolus." | 5.08 | Randomised trial of high-dose isosorbide dinitrate plus low-dose furosemide versus high-dose furosemide plus low-dose isosorbide dinitrate in severe pulmonary oedema. ( Blatt, A; Cotter, G; Faigenberg, Z; Golik, A; Kaluski, E; Koren, M; Marghitay, D; Metzkor, E; Miller, R; Moshkovitz, Y; Shaham, O; Simovitz, A; Zaidenstein, R, 1998) |
| "In a randomized, single-blind, crossover clinical trial, the diuretic efficacy of the same total dose of furosemide (2 x 40 mg) administered in either conventional intravenous bolus injection or continuous infusion was studied in 20 patients (nine males and 11 females), aged 37-75 years, with congestive heart failure." | 5.08 | Diuretic effects of furosemide infusion versus bolus injection in congestive heart failure. ( Bagatin, J; Capkun, V; Ljutić, D; Naranca, M; Pivac, N; Polić, S; Rumboldt, Z; Sardelić, S, 1998) |
| " All dogs entered in the study received standard heart failure treatment (furosemide with or without digoxin)." | 5.08 | Effects of enalapril maleate on survival of dogs with naturally acquired heart failure. The Long-Term Investigation of Veterinary Enalapril (LIVE) Study Group. ( Benitz, AM; Cifelli, S; Ericsson, GF; Ettinger, SJ; Hanson, PD; Jernigan, AD; Longhofer, SL; Trimboli, W, 1998) |
| "The short-term clinical efficacies of furosemide, 25 mg/day, and torasemide, 10 mg/day, have been compared in 2 groups of 12 patients with severe heart failure." | 5.07 | Symptomatic achievements with diuretics in congestive heart failure. ( Casali, E; Castellani, ET; Mattioli, AV; Mattioli, G, 1994) |
| "Contrary to expectation, most studies have demonstrated that initiation of an angiotensin-converting enzyme (ACE) inhibitor in conventional doses in patients with heart failure reduces the diuretic efficacy of furosemide." | 5.07 | Effect of intense angiotensin II suppression on the diuretic response to furosemide during chronic ACE inhibition. ( Brady, AJ; Cleland, JG; Good, JM; Noormohamed, FH; Oakley, CM, 1994) |
| "In a double-blind dose-response study, 49 patients with New York Heart Association functional class III or IV heart failure were randomized to receive a single intravenous dose of 5, 10, or 20 mg torsemide or 40 mg furosemide." | 5.07 | Dose-response study of intravenous torsemide in congestive heart failure. ( Bremner, S; Hariman, RJ; Jones, JP; Kostis, JB; Louie, EK; Nocero, MA; Rogers, WJ, 1994) |
| "To assess the value of treatment with continuous intravenous infusion of furosemide (F) in patients with refractory congestive heart failure." | 5.07 | Continuous infusion of furosemide in the treatment of patients with congestive heart failure and diuretic resistance. ( Dormans, T; Gerlag, PG; Gribnau, FW; Russel, FG; Smits, P; van Meyel, JJ, 1994) |
| "This study was designed to investigate whether a subclinical accumulation of fluid in the lung interstitium associated with moderate congestive heart failure interferes with the patient's functional capacity, and whether furosemide treatment can promote reabsorption of the excessive fluid." | 5.07 | Sustained improvement in functional capacity after removal of body fluid with isolated ultrafiltration in chronic cardiac insufficiency: failure of furosemide to provide the same result. ( Agostoni, P; Guazzi, MD; Lauri, G; Marenzi, G; Perego, G; Schianni, M; Sganzerla, P, 1994) |
| "This study examined the effects of conventional doses of oral captopril on the renal responses to oral furosemide in ambulant patients with stable chronic heart failure." | 5.07 | Acute effects of captopril on the renal actions of furosemide in patients with chronic heart failure. ( Bridges, AB; Fraser, CG; McLay, JS; McMurray, JJ; Struthers, AD, 1993) |
| "The effect of ibopamine and furosemide in 130 patients with NYHA Class I and II heart failure were studied in a parallel, double-blind, randomized placebo-controlled multi-centre trial." | 5.07 | The effects of oral ibopamine in patients with mild heart failure--a double blind placebo controlled comparison to furosemide. The Ibopamine Study Group. ( Parker, JO, 1993) |
| "Furosemide is frequently administered intravenously to patients with chronic heart failure." | 5.07 | Interaction of intravenous atrial natriuretic factor with furosemide in patients with heart failure. ( Beltran, AM; Cohn, JN; Connelly, TP; Francis, GS; Williams, KJ, 1994) |
| "To analyze the physical performance of the patients with congestive heart failure (CHF), grades I and II of the New York Heart Association (NYHA), submitted to ergometric test: 1) under conventional treatment with digitalis and diuretic; 2) with an angiotensin converting enzyme inhibitor, captopril, associate with conventional treatment; 3) using captopril associated with digitalis or diuretic." | 5.07 | [Captopril in the treatment of patients with congestive heart failure. Its bicycle ergometry evaluation]. ( Benchimol, C; Ferreira Filho, SR; Hatab, SA; Nascimento, LO; Saragoça, MA, 1992) |
| "In 61 patients with NYHA IV class chronic congestive heart failure, treated in succession with digoxin (D) and furosemide (F) for two weeks, with D+F and isosorbide dinitrate (S) or nifedipine (N) for two weeks, with D+F+S or N without C for two weeks, clinical status, chest X-ray picture and two dimensional echocardiography were evaluated at the end of each stage of the treatment." | 5.07 | [Results of conventional treatment of severe congestive heart failure with vasodilators]. ( Cholewa, M; Dryjański, T; Gawor, Z; Górski, L; Kaczkowska-Marusik, E; Kuś, W; Markiewicz, K, 1992) |
| " We performed a prospective randomized crossover study comparing intermittent intravenous administration (IA) of furosemide with continuous infusion following a single loading dose (LDCI) in nine patients with severe congestive heart failure." | 5.07 | Intermittent administration of furosemide vs continuous infusion preceded by a loading dose for congestive heart failure. ( Lahav, M; Ra'anani, P; Regev, A; Theodor, E, 1992) |
| "Ten chronic heart failure patients were studied on three occasions in randomized double-blind fashion to compare the acute hemodynamic, neurohormonal, and renal sodium-handling responses to 1 mg captopril versus 25 mg captopril, both in the absence of loop diuretic therapy and during furosemide-stimulated natriuresis." | 5.07 | Furosemide-induced natriuresis is augmented by ultra-low-dose captopril but not by standard doses of captopril in chronic heart failure. ( Fenwick, MK; Morton, JJ; Motwani, JG; Struthers, AD, 1992) |
| "18 patients with II NYHA class chronic congestive heart failure (CCHF) had been given nifedipine (Cordipin) 54." | 5.06 | [Evaluation of the effect of nifedipine in patients with chronic congestive heart failure]. ( Bechler-Lisińska, J; Broks-Bratkowska, B; Cholewa, M; Dryjański, T; Gawor, Z; Górski, L; Markiewicz, K, 1989) |
| "Ten patients with moderate heart failure who still had symptoms despite 40 mg frusemide daily were treated with increased doses of frusemide and the addition of captopril in randomised order." | 5.06 | Symptomatic assessment of patients with heart failure: double-blind comparison of increasing doses of diuretics and captopril in moderate heart failure. ( Cowley, AJ; Hampton, JR; Rowley, JM; Stainer, K; Wynne, RD, 1986) |
| "Captopril alone as therapy for mild heart failure was compared with a combination of frusemide and amiloride in a double-blind randomised crossover trial in 14 patients who had previously been treated with diuretics." | 5.06 | Double-blind comparison of captopril alone against frusemide plus amiloride in mild heart failure. ( Bayliss, J; Parameshwar, J; Poole-Wilson, PA; Richardson, A; Scriven, AJ; Sutton, GC, 1987) |
| "The effects of ibopamine and furosemide on renal function given alone and in combination at single doses were studied in 6 men and 6 women aged 45 to 73 years with chronic congestive heart failure of NYHA class II." | 5.06 | Effects of ibopamine in combination with furosemide on renal function in patients with chronic congestive heart failure. ( Carini, L; Castini, D; Mazzola, C; Moreo, A; Salvadeo, A; Segagni, S; Segalini, G; Villa, G; Vitolo, E, 1988) |
| "A double-blind parallel group study was carried out to compare the effects of piretanide on daily glucose profiles, symptoms of congestive heart failure and serum electrolytes with those of furosemide in 24 diabetic in-patients suffering from congestive heart failure." | 5.06 | The effects of piretanide in patients with congestive heart failure and diabetes mellitus: a double-blind comparison with furosemide. ( Car, N; Skrabalo, Z; Verho, M, 1988) |
| "Ten patients in heart failure of various etiologies underwent a placebo-controlled study to determine the effect of indomethacin (150 mg daily by mouth) on urine volume, sodium chloride excretion, glomerular filtration rate, renal prostaglandins, as well as plasma renin and aldosterone concentrations before and after administration of 40 mg frusemide by mouth." | 5.06 | [Indomethacin and furosemide in patients with cardiac insufficiency. Kidney function, the renin-angiotensin system and renal prostaglandins]. ( Kahles, H; Riegger, AJ, 1987) |
| "Renal function and excretion of water, salt, and the prostacyclin hydration product (6-keto-PGF1 alpha) were evaluated in 10 furosemide-treated patients with well-controlled congestive heart failure." | 5.06 | Renal function and tubular transport effects of sulindac and naproxen in chronic heart failure. ( Beermann, B; Eriksson, LO; Kallner, M, 1987) |
| "Forty elderly patients, aged 68 to 89 years, with congestive cardiac failure, who were attending a hospital out-patients department, entered an open, parallel group, comparative study of two diuretic combinations, 40 mg frusemide plus 5 mg amiloride per tablet and 0." | 5.06 | An open comparative study of two diuretic combinations, frusemide/amiloride ('Frumil') and bumetanide/potassium chloride ('Burinex' K), in the treatment of congestive cardiac failure in hospital out-patients. ( Allman, S; Bailey, R; Crawford, RJ; Martin, A; Ramsay, F, 1988) |
| "In 15 patients with moderate congestive heart failure not completely controlled on digoxin (0." | 5.06 | Addition of captopril versus increasing diuretics in moderate but deteriorating heart failure: a double-blind comparative trial. ( Boccanelli, A; Carboni, GP; Liberatore, SM; Prati, PL; Zachara, E, 1986) |
| "The diuretic effects of torasemide and of furosemide were compared in a double blind cross-over study in 13 patients with stable chronic heart failure." | 5.06 | Diuretic activity of torasemide and furosemide in chronic heart failure: a comparative double blind cross-over study. ( Delarge, J; Luyckx, AS; Scheen, AJ; Vancrombreucq, JC, 1986) |
| " English articles comparing intermittent boluses and continuous infusion of furosemide in treating acute heart failure were included." | 5.05 | Continuous Infusion Versus Intermittent Boluses of Furosemide in Acute Heart Failure: A Systematic Review and Meta-Analysis. ( Chan, JSK; Harky, A; Kot, TKM; Ng, M, 2020) |
| "The immediate haemodynamic effects of intravenous frusemide (1 mg/kg) and intravenous isosorbide dinitrate (50-200 micrograms/kg/h) were compared in a prospective, randomised, between-group study in 28 men with radiographic and haemodynamic evidence of left ventricular failure following acute myocardial infarction." | 5.05 | Haemodynamic advantages of isosorbide dinitrate over frusemide in acute heart-failure following myocardial infarction. ( Ahuja, RC; Hussain, M; Nelson, GI; Silke, B; Taylor, SH, 1983) |
| "To assess the effect of furosemide and captopril on renal function and hyponatremia in patients with severe heart failure, we studied two groups of patients with hyponatremia who were receiving digoxin therapy and whose sodium intake was 40 meq/d." | 5.05 | Renal response to captopril in severe heart failure: role of furosemide in natriuresis and reversal of hyponatremia. ( Dzau, VJ; Hollenberg, NK, 1984) |
| "In a double blind study of metoprolol in the treatment of suspected acute myocardial infarction 698 patients (study group) received metoprolol and 697 a placebo (control group)." | 5.05 | Development of congestive heart failure after treatment with metoprolol in acute myocardial infarction. ( Herlitz, J; Hjalmarson, A; Holmberg, S; Swedberg, K; Vedin, A; Waagstein, F; Waldenström, A; Wedel, H; Wilhelmsen, L; Wilhelmsson, C, 1984) |
| "The efficacy and safety of oral bumetanide, a pharmacologically new diuretic was compared with that of furosemide in 30 patients suffering from congestive cardiac failure and other edema states." | 5.05 | A comparative randomized double-blind clinical trial of bumetanide and furosemide in congestive cardiac failure and other edema states. ( Sagar, S; Sharma, BK; Sharma, PL; Wahi, PL, 1984) |
| "A total of 95 patients seen in general practice with oedema associated with heart failure took part in an open study of the efficacy and tolerability of a combination tablet containing 40 mg frusemide and 5 mg amiloride." | 5.05 | Frusemide/amiloride combination ('Frumil') in heart failure: an open, multi-centre study in general practice. ( Eason, CT; Richards, HH; Townsend, HA; Waddy, AL, 1984) |
| "0 mg) and to furosemide (40 and 80 mg) in 20 patients with stable, compensated congestive heart failure (CHF), comparing the two drugs and, in addition, examining differences from normal subjects." | 5.05 | Bumetanide and furosemide in heart failure. ( Anderson, S; Brater, DC; Burdette, A; Day, B, 1984) |
| "The hemodynamic effect of venous dilatation (intravenous isosorbide dinitrate [ISDN]) and arteriolar dilatation (intravenous hydralazine), both as firstline treatment and then combined with intravenous furosemide, were evaluated in a randomized, between-group comparison in 20 men with severe acute left-sided cardiac failure after myocardial infarction (MI)." | 5.05 | Hemodynamic comparison of primary venous or arteriolar dilatation and the subsequent effect of furosemide in left ventricular failure after acute myocardial infarction. ( Forsyth, DR; Hussain, M; Nelson, GI; Silke, B; Taylor, SH; Verma, SP, 1983) |
| "The immediate hemodynamic effects of intravenous frusemide (1 mg/kg) and intravenous isosorbide dinitrate (50-200 micrograms/kg/h) were compared in a prospective, randomized, between-group study in 28 men with radiographic and hemodynamic evidence of left ventricular failure following acute myocardial infarction." | 5.05 | Management of acute heart failure following myocardial infarction: hemodynamic advantages of isosorbide dinitrate over frusemide. ( Ahuja, RC; Hussain, M; Nelson, GI; Silke, B; Taylor, SH, 1983) |
| "Serum potassium levels, weight, heart function and patient's opinion of therapy were assessed in a study comparing 40 mg of frusemide and 600 mg of controlled-release potassium chloride in a combined tablet to frusemide and potassium supplements given as separate tablets in thirty elderly patients in cardiac failure." | 5.05 | A comparison of the effect of combined frusemide and controlled-release potassium tablets (Diumide-K continus tablets) and frusemide and slow-K tablets in elderly patients with cardiac failure. ( Rao, CR, 1982) |
| "Torasemide 60 mg and furosemide 120 mg were administered intravenously in a randomized double blind study in twelve patients with acute heart failure." | 5.05 | Clinical efficacy of torasemide, a new diuretic agent, in patients with acute heart failure: a double blind comparison with furosemide. ( Dodion, L; Kesteloot, H; Stroobandt, R, 1982) |
| "Twenty-four-hour Holter electrocardiographic recordings were used to measure the effects of a converting-enzyme inhibitor, enalapril, given for 12 weeks, on the frequency of cardiac arrhythmias in 10 patients with congestive heart failure (New York Heart Association functional class II to III) receiving maintenance therapy with digoxin and furosemide." | 5.05 | Effect of enalapril on ventricular arrhythmias in congestive heart failure. ( Fitzpatrick, MA; Ikram, H; Nicholls, MG; Webster, MW; Wells, JE, 1985) |
| "The effects of slow-release furosemide and bendroflumethiazide in the ambulatory treatment of mild to moderate congestive heart failure were compared in a controlled multicentre study using a randomized, double-blind procedure." | 5.05 | Multicentre comparison between slow-release furosemide and bendroflumethiazide in congestive heart failure. ( Pehrsson, SK, 1985) |
| "The efficacy and tolerability of two combinations, namely 50 mg spironolactone + 20 mg furosemide (SF) or 50 mg spironolactone + 5 mg butizide (SB), were compared in a randomised intraindividual trial in 22 patients with congestive heart failure." | 5.05 | [Comparative study of 2 diuretic-containing combination preparations in patients with edematous heart failure]. ( Ehrlich, E; Mauersberger, H; Rangoonwala, B, 1985) |
| "Since patients vary in their response to furosemide, a pharmacokinetic study of this drug was undertaken in 7 patients with severe congestive heart failure." | 5.04 | Pharmacokinetics of furosemide in patients with congestive heart failure. ( Benet, LZ; Cohn, K; Edelen, JS; Goldman, S; Greither, A, 1979) |
| "Extra potassium supplements, spironolactone or amiloride were given for 5 months to forty-nine patients with heart failure who were taking furosemide and were in a steady state." | 5.04 | The effects of potassium supplements, spironolactone of amiloride on the potassium status of patients with heart failure. ( Burkinshaw, L; Davidson, C; Morgan, DB, 1978) |
| "A dose of 20 mg furosemide in congestive heart failure patients produces a significant diuretic and natriuretic effect." | 5.04 | Diuretic and clinical effects of low-dose furosemide in congestive heart failure patients. ( Bacchus, R; Mahabir, RN, 1976) |
| "Medline and Cochrane Databases were systemically reviewed for randomized and observational studies comparing patients with chronic heart failure on oral torsemide versus oral furosemide and their association with intermediate-term outcomes (5-12 months) through May 2018." | 5.01 | Torsemide versus furosemide and intermediate-term outcomes in patients with heart failure: an updated meta-analysis. ( Chen, M; Hanumanthu, BK; Kokkinidis, DG; Miles, JA; Patel, K; Siegel, RM, 2019) |
| "It is not known whether older patients with acute heart failure (HF) receiving tolvaptan have decreased mortality rates and a better long-term prognosis than patients who receive furosemide." | 4.98 | Use of tolvaptan vs. furosemide in older patients with heart failure : Meta-analysis of randomized controlled trials. ( Huang, WL; Wang, HB; Xiong, XL; Yang, J; Yang, Y; Zhang, YF, 2018) |
| "We conducted a meta-analysis of pharmacogenomic substudies of three randomized trials conducted in patients with decompensated heart failure (HF) that were led by National Heart Lung and Blood Institute (NHLBI)-funded HF Network to test the hypothesis that candidate genes modulate net fluid loss and weight change in patients with decompensated HF treated with a furosemide-based diuretic regimen." | 4.95 | A pharmacogenetic investigation of intravenous furosemide in decompensated heart failure: a meta-analysis of three clinical trials. ( Bardhadi, A; Cappola, TP; de Denus, S; Dubé, MP; Huggins, GS; Keleti, J; Mann, DL; Mongrain, I; Normand, V; Phillips, MS; Provost, S; Rouleau, JL; Shah, SH; Zada, YF, 2017) |
| "Continuous versus bolus dosing of furosemide has been a longstanding debate for clinicians treating patients with acute decompensated heart failure." | 4.95 | Which dosing of furosemide is better in acute decompensated heart failure? ( Budavari, AI; Jalaba, S; Palermo, J, 2017) |
| " Most studies assessing body thiamine status have reported variable degrees of thiamine deficiency in patients with heart failure, particularly those treated chronically with high doses of furosemide." | 4.93 | Does Long-Term Furosemide Therapy Cause Thiamine Deficiency in Patients with Heart Failure? A Focused Review. ( Alpert, MA; Balla, S; Katta, N, 2016) |
| " furosemide for diuretic-resistant CHF patients led to a better renal safety profile and improved clinical endpoints such as mortality and heart failure-related hospitalizations." | 4.91 | Hypertonic saline plus i.v. furosemide improve renal safety profile and clinical outcomes in acute decompensated heart failure: A meta-analysis of the literature. ( Ariano, C; Cantatrione, S; De Vecchis, R; Esposito, C, 2015) |
| "Use of intravenous furosemide rather than oral administration in acute decompensated congestive cardiac failure is universally recommended in international guidelines." | 4.91 | Intravenous Furosemide for Acute Decompensated Congestive Heart Failure: What Is the Evidence? ( MacAllister, R; Owen, DR; Sofat, R, 2015) |
| "Furosemide is a loop diuretic frequently used to treat fluid overload conditions such as hepatic cirrhosis and congestive heart failure (CHF)." | 4.90 | Population-based meta-analysis of furosemide pharmacokinetics. ( Mager, DE; Mallikaarjun, S; Shoaf, SE; Van Wart, SA, 2014) |
| "Administering intermittent boluses of furosemide to patients with acute decompensated heart failure (ADHF) often leads to unfavorable hemodynamic changes." | 4.88 | Continuous infusion versus intermittent bolus furosemide in ADHF: an updated meta-analysis of randomized control trials. ( Adomaityte, J; Amer, M; Qayyum, R, 2012) |
| "We first consider the results obtained with furosemide administration, which is still the mainstay of treatment of congestion in patients with heart failure." | 4.87 | Can we improve the treatment of congestion in heart failure? ( Bettari, L; Bugatti, S; Carubelli, V; Cas, LD; Danesi, R; Lazzarini, V; Lombardi, C; Metra, M, 2011) |
| " Our group has shown that treatment of patients with diuretic-resistant heart failure with high-dose furosemide plus hypertonic saline is effective and well tolerated, improving symptoms of congestion, reducing plasma levels of markers of neurohormonal and inflammatory activation, decreasing hospital readmission rates, and reducing long-term mortality." | 4.87 | Intravenous high-dose furosemide and hypertonic saline solutions for refractory heart failure and ascites. ( Licata, G; Parrinello, G; Pinto, A; Tuttolomondo, A, 2011) |
| "In patients with heart failure (HF), torsemide demonstrated decreased mortality compared with furosemide in 1 study (2." | 4.85 | A comprehensive review of the loop diuretics: should furosemide be first line? ( Banta, WM; Wargo, KA, 2009) |
| "A mainstay of therapy for congestive heart failure has been the use of potent diuretic agents, such as furosemide, that target the kidney to enhance sodium and water excretion." | 4.84 | Targeting the kidney in acute decompensated heart failure: conventional diuretics and renal-acting vasodilators. ( Burnett, JC; Cataliotti, A; Chen, HH; Martin, FL, 2008) |
| "This case report describes a case of Sweet syndrome (SS) related to use of furosemide in a 46-year-old female who was admitted for treatment of congestive heart failure." | 4.82 | Sweet syndrome associated with furosemide. ( Bashir, Q; Brooks, C; Govindarajan, G; Kuppuswamy, S, 2005) |
| " Torsemide, and other loop diuretics such as furosemide, are indicated for the treatment of edema associated with congestive heart failure, renal disease, and hepatic disease." | 4.79 | Torsemide: a pyridine-sulfonylurea loop diuretic. ( Adams, KF; Blose, JS; Patterson, JH, 1995) |
| "Furosemide (frusemide) is a potent loop diuretic used in the treatment of oedematous states associated with cardiac, renal and hepatic failure, and for the treatment of hypertension." | 4.78 | Furosemide (frusemide). A pharmacokinetic/pharmacodynamic review (Part I). ( Ponto, LL; Schoenwald, RD, 1990) |
| " Some examples such as the modification of furosemide pharmacokinetics in acute renal failure, the impaired metabolism of opiate analgesics in hepatic insufficiency, the alterations of the usual disposition process in salicylic acid intoxication, and the influence of cardiac failure upon some drugs pharmacokinetics, have been chosen to illustrate some of the aspects discussed." | 4.76 | Disease-induced modifications of drug pharmacokinetics. ( Barre, J; Bree, F; Brunner, F; Houin, G; Tillement, JP, 1983) |
| "The impact of tolvaptan on the long-term outcomes of patients with heart failure (HF) remains inconclusive." | 4.31 | Impact of tolvaptan add-on treatment on patients with heart failure requiring long-term congestion management: A retrospective cohort study using a medical claim database in Japan. ( Aihara, M; Kinugawa, K; Matsukawa, M; Nakamura, Y; Sano, H, 2023) |
| "Furosemide, a loop diuretic, is commonly used to treat fluid overload symptoms and heart failure." | 4.31 | Furosemide-induced haemolytic anaemia in an extreme elderly patient. ( Ho, IW; Huang, CC, 2023) |
| "Door-to-furosemide ≤1 h was associated with a lower short-term risk of heart failure hospitalizations or cardiovascular death in AHF patients." | 4.31 | Door-to-furosemide time and clinical outcomes in acute heart failure. ( Almeida, J; Besteiro, B; Bettencourt, P; Brito, MT; Ferreira, JP; Friões, F; Gomes, F; Gouveia, R; Jardim, AL; Leite-Moreira, A; Marques, P; Vasques-Nóvoa, F; Vieira, JT, 2023) |
| "Dapagliflozin reduced the combined risk of worsening heart failure or cardiovascular death among patients with heart failure with mildly reduced or preserved ejection fraction." | 4.31 | Dapagliflozin and diuretic utilization in heart failure with mildly reduced or preserved ejection fraction: the DELIVER trial. ( Chatur, S; Claggett, B; de Boer, RA; Desai, AS; Haddad, T; Hernandez, AF; Inzucchi, SE; Jhund, PS; Kosiborod, MN; Lam, CSP; Maria Langkilde, A; Martinez, F; McMurray, JJV; Miao, ZM; Mitter, SS; Petersson, M; Shah, SJ; Solomon, SD; Vaduganathan, M; Vardeny, O, 2023) |
| "A new delivery mechanism provides subcutaneous infusion of furosemide to treat fluid overload in adults with heart failure." | 4.31 | New Delivery Route for Furosemide in Heart Failure. ( Aschenbrenner, DS, 2023) |
| "Furosemide is a diuretic and is used for the treatment of patients with heart failure (HF)." | 4.31 | Il-6 and UGT1A1 variations may related to furosemide resistance in heart failure patients. ( Guctekin, T; Guney, AI; Kirac, D; Koç, G; Koprululu Kucuk, G; Sunbul, M, 2023) |
| "Furosemide, a loop diuretic, is often empirically used to treat acute decompensated heart failure (ADHF) initially." | 4.31 | Tolvaptan's Association with Low Risk of Acute Kidney Injury in Patients with Advanced Chronic Kidney Disease and Acute Decompensated Heart Failure. ( Hasegawa, M; Hayashi, H; Inaguma, D; Koide, S; Ogata, S; Tagaya, T; Takahashi, K; Tsuboi, N; Yuzawa, Y, 2023) |
| "Furosemide, a frequently prescribed diuretic for managing congestive heart failure and edema, remains a topic of debate regarding its potential risk of inducing acute kidney injury (AKI) in patients." | 4.31 | Hospitalized patients received furosemide undergoing acute kidney injury: the risk and prediction tool. ( Che, L; Guan, C; Li, C; Liu, Z; Luan, H; Man, X; Wang, Y; Xu, L; Xu, Y; Yang, C; Zhang, N; Zhao, L; Zhou, B, 2023) |
| "Furosemide is a mainstay of treatment in congestive heart failure (CHF) and is widely prescribed to dogs and cats by several formulations, including the subcutaneous one." | 4.31 | Dermatologic adverse effect of subcutaneous furosemide administration in a cat. ( Aspidi, F; Mazzoldi, C; Romito, G, 2023) |
| " The heart failure nurse specialist, supported by the heart failure-palliative care multidisciplinary team, works with the community or hospice staff who administer the CSCI-furosemide." | 4.31 | Subcutaneous furosemide in advanced heart failure: service improvement project. ( Birch, F; Boam, E; Ghosh, J; Johnson, MJ; Parsons, S, 2023) |
| "The combination of oral tolvaptan and IV furosemide is effective in augmenting diuresis and reducing weight in patients with furosemide refractory edema but requires monitoring of electrolytes and volume status." | 4.12 | Efficacy and Safety of Combination Therapy with Tolvaptan and Furosemide in Children with Nephrotic Syndrome and Refractory Edema: A Prospective Interventional Study. ( Bagga, A; Hari, P; Meena, J; Sinha, A, 2022) |
| "Metolazone and intravenous (IV) chlorothiazide are commonly used diuretics for sequential nephron blockade (SNB) in patients with acute decompensated heart failure (ADHF)." | 4.12 | Metolazone Versus Intravenous Chlorothiazide for Decompensated Heart Failure Sequential Nephron Blockade: A Retrospective Cohort Study. ( Biskupiak, J; Cisowska, T; Fang, JC; Jacobs, JA; Pan, IZ; Shah, KS, 2022) |
| "Furosemide, a short-acting loop diuretic (SD), is the dominant agent prescribed for heart failure (HF) in clinical practice." | 4.12 | Use of short-acting vs. long-acting loop diuretics after heart failure hospitalization. ( Fukuda, K; Goda, A; Imaeda, S; Kohno, T; Kohsaka, S; Nagatomo, Y; Nakano, S; Niimi, N; Saji, M; Shiraishi, Y; Takei, M; Yoshikawa, T, 2022) |
| "Kidney injury (KI) has been documented in dogs treated with furosemide for left-sided congestive heart failure (CHF)." | 4.12 | Retrospective evaluation of risk factors for development of kidney injury after parenteral furosemide treatment of left-sided congestive heart failure in dogs. ( Adin, DB; Giorgi, ME; Mochel, JP; Ward, JL; Yuan, L, 2022) |
| "Background and Objectives: The aim of this paper is to evaluate the impact of humoral substance mid-regional pro-adrenomedullin (MR-proADM) on the two-year survival of patients with chronic heart failure and relate it to the dosage of furosemide." | 4.12 | Relation between Mid-Regional Pro-Adrenomedullin in Patients with Chronic Heart Failure and the Dose of Diuretics in 2-Year Follow-Up-Data from FAR NHL Registry. ( Benešová, K; Goldbergová-Pávková, M; Jarkovský, J; Krejčí, J; Lábr, K; Ludka, O; Málek, F; Ošťádal, P; Pařenica, J; Špinar, J; Špinarová, L; Špinarová, M, 2022) |
| "We initiated a community-based continuous subcutaneous infusion (CSCI) furosemide service for the treatment of advanced heart failure." | 4.12 | Furosemide in end-stage heart failure: community subcutaneous infusions. ( Armstrong, L; Brown, A; Matthews, I; Ripley, D; Robson, J; Runnett, C; Thomas, H; Westley, K, 2022) |
| "Previous literature has suggested a potential diuretic sparing effect as early as 6 months following sacubitril-valsartan initiation in patients with heart failure with reduced ejection fraction (HFrEF); however, whether this effect manifests earlier after initiation is unclear." | 4.12 | Acute Diuretic-Sparing Effects of Sacubitril-Valsartan: Staying in the Loop. ( Beavers, JC; Orvin, NJ; Russell, SD, 2022) |
| "Among 3426 US outpatients with chronic heart failure with reduced ejection fraction in the Change the Management of Patients with Heart Failure registry with complete medication data and who were prescribed a loop diuretic, diuretic dose increase was defined as: (1) change to a total daily dose higher than their previous total daily dose, (2) addition of metolazone to the regimen, (3) change from furosemide to either bumetanide or torsemide, and the change persists for at least 7 days." | 4.02 | Diuretic Changes, Health Care Resource Utilization, and Clinical Outcomes for Heart Failure With Reduced Ejection Fraction: From the Change the Management of Patients With Heart Failure Registry. ( Albert, NM; Butler, J; DeVore, AD; Fonarow, GC; Greene, SJ; Hellkamp, AS; Hernandez, AF; Khan, MS; Patterson, JH; Shen, X; Spertus, JA; Thomas, LE; Williams, FB, 2021) |
| "The effect of early administration of intravenous (IV) furosemide in the emergency department (ED) on short-term outcomes of acute heart failure (AHF) patients remains controversial, with one recent Japanese study reporting a decrease of in-hospital mortality and one Korean study reporting a lack of clinical benefit." | 4.02 | The FAST-FURO study: effect of very early administration of intravenous furosemide in the prehospital setting to patients with acute heart failure attending the emergency department. ( Aguiló, S; Álvarez Pérez, JM; Chioncel, O; Fuentes, M; Gil, V; Harjola, P; Harjola, VP; Herrero, P; Jacob, J; Llauger, L; Llorens, P; López-Grima, ML; Martín-Sánchez, FJ; Martínez-Nadal, G; Masip, J; Mebazaa, A; Mir, M; Miró, Ò; Mullens, W; Müller, C; Peacock, WF; Rodríguez-Adrada, E; Rossello, X; Ruschitzka, F; Tost, J, 2021) |
| " She was treated because of low left ventricular ejection fraction and impression of postpartum cardiomyopathy, and her severe dyspnea improved by intravenous furosemide." | 4.02 | Severe acute respiratory syndrome coronavirus-2- or pregnancy-related cardiomyopathy, a differential to be considered in the current pandemic: a case report. ( Hajizadeh, R; Kavandi, H; Khademolhosseini, S; Nejadrahim, R, 2021) |
| "Currently, there are no meta-analyses evaluating the efficacy and safety of intermittent vs continuous furosemide for heart failure concomitant renal dysfunction." | 4.02 | Efficacy and safety of intermittent vs continuous furosemide for heart failure concomitant renal dysfunction: A protocol for systematic review and meta-analysis. ( Chen, S; Lin, Y; Zhou, C; Zhou, M, 2021) |
| "The aim of this study was to evaluate the effects of Sacubitril/Valsartan (S/V) on clinical, laboratory and echocardiographic parameters and outcomes in a real-world population with heart failure with reduced ejection fraction (HFrEF)." | 3.96 | Clinical and echocardiographic benefit of Sacubitril/Valsartan in a real-world population with HF with reduced ejection fraction. ( Auria, F; Bonadies, D; Carrizzo, A; Ciccarelli, M; Citro, R; De Angelis, E; Galasso, G; Gigantino, A; Iaccarino, G; Loria, F; Polito, MV; Rispoli, A; Silverio, A; Vecchione, C; Vitulano, G, 2020) |
| "Although tolvaptan has been reported to prevent worsening renal function (WRF) in patients with advanced acute heart failure (AHF), evidence regarding the effect of tolvaptan on renal function in patients with new-onset AHF is not available." | 3.96 | Renoprotective effect of tolvaptan in patients with new-onset acute heart failure. ( Fujii, K; Kin, H; Matsumura, K; Otagaki, M; Park, H; Shiojima, I; Sugiura, T; Takahashi, H; Yamamoto, Y; Yokoi, M; Yoshioka, K, 2020) |
| "Our objective was to characterize cases of hospitalized heart failure (HHF) focusing on in-hospital resource utilization (particularly furosemide doses) and worsening heart failure (WHF), and identify which factors are associated with the length of stay (LOS)." | 3.96 | In-hospital resource utilization, worsening heart failure, and factors associated with length of hospital stay in patients with hospitalized heart failure: A Japanese database cohort study. ( Funakubo, M; Ishii, T; Matsui, N; Mitani, H; Murayama, H; Oyama, N; Rached, RA; Sato, N; Yoshida, S, 2020) |
| " We investigated the association of clinical variables and cardiovascular drugs, including furosemide, hydrochlorothiazide, spironolactone, and their doses, with the presence of hyponatremia at admission." | 3.96 | Furosemide and spironolactone doses and hyponatremia in patients with heart failure. ( Bušić, Ž; Čulić, V; Jurić Paić, M; Velat, I, 2020) |
| " This study aimed to compare the effect of torasemide and furosemide on long-term outcomes and New York Heart Association (NYHA) class change in patients with chronic heart failure (HF)." | 3.91 | Comparative Analysis of Long-Term Outcomes of Torasemide and Furosemide in Heart Failure Patients in Heart Failure Registries of the European Society of Cardiology. ( Balsam, P; Crespo-Leiro, MG; Drożdż, J; Filipiak, KJ; Grabowski, M; Kapłon-Cieślicka, A; Kowalik, R; Maggioni, AP; Marchel, M; Opolski, G; Ozierański, K; Peller, M; Tymińska, A; Wancerz, A, 2019) |
| " We propose a novel death identification and verification approach that is being used in the ToRsemide compArisoN with furoSemide FOR Management of Heart Failure (TRANSFORM-HF) PCT." | 3.91 | Death: The Simple Clinical Trial Endpoint. ( Anstrom, KJ; Eisenstein, EL; Gabriel, D; Greene, SJ; Harding, T; Harrington, A; Jones, I; Mentz, RJ; Prather, K; Velazquez, EJ, 2019) |
| " The goal of this study is to investigate the relationship between daily doses of furosemide and the outcomes of patients with left ventricular dysfunction (LVD) from the viewpoint of cardiac SNS abnormalities using iodine-123-labeled metaiodobenzylguanidine (l-MIBG) myocardial scintigraphy." | 3.91 | Impact of short-acting loop diuretic doses and cardiac sympathetic nerve abnormalities on outcomes of patients with reduced left ventricular function. ( Ideguchi, T; Ishikawa, T; Kitamura, K; Koyama, S; Nagamachi, S; Onitsuka, H, 2019) |
| "A long-acting loop diuretic, azosemide, has been shown to improve long-term prognosis in patients with heart failure compared with a short-acting loop diuretic, furosemide." | 3.91 | Patients With CONgestive Heart Failure Benefit From Long-Term Treatment Effects With Novel Treatment Using Azosemide Compared With Furosemide Derived From Existing Retrospective Study Data: CONTENTED. ( Abe, S; Arikawa, T; Inami, S; Inoue, T; Kanaya, T; Nishikawa, R; Saito, F; Sakuma, M; Toyoda, S; Watanabe, R, 2019) |
| "Continuous intravenous (IV) infusion bumetanide has been associated with severe myalgia in case reports, and the package labeling lists a reported incidence of 0." | 3.91 | Evaluation of Severe Myalgia Induced by Continuous-Infusion Bumetanide in Patients with Acute Heart Failure. ( Chinaeke, EE; Cox, ZL; Lenihan, DJ; Lu, K; Merritt, TE; Xiong, L, 2019) |
| "We prospectively followed 176 consecutive patients with advanced heart failure receiving intravenous furosemide for congestion in an ambulatory clinic." | 3.88 | Spot Urine Sodium as Triage for Effective Diuretic Infusion in an Ambulatory Heart Failure Unit. ( Brinkley, DM; Burpee, LJ; Chaudhry, SP; Desai, AS; Lakdawala, NK; Lindenfeld, J; Smallwood, JA; Stevenson, LW, 2018) |
| "For study purposes, advanced heart failure was defined as recurrence of congestive heart failure signs despite receiving the initially prescribed dose of pimobendan, angiotensin-converting-enzyme inhibitor (ACEI), and furosemide >4 mg/kg/day." | 3.88 | Clinical findings and survival time in dogs with advanced heart failure. ( Beaumier, A; Freeman, LM; Rush, JE; Yang, VK, 2018) |
| "The aim of this study was to investigate the effect on mortality of torsemide and a combination of loop diuretics (furosemide + torsemide) in contemporary practice in patients with chronic heart failure (HF)." | 3.88 | Can Torsemide and Combination of Loop Diuretics Improve Mortality in Patients with Chronic Heart Failure After Discharge? ( Yao, Y; Zhang, J; Zhang, R; Zhang, Y, 2018) |
| "We sought to examine whether factors impacting the time to emergency department (ED) administration of intravenous (IV) furosemide were associated with the duration of hospital admission for patients with acute heart failure (AHF)." | 3.88 | Preventable delays to intravenous furosemide administration in the emergency department prolong hospitalization for patients with acute heart failure. ( Collins, SP; Froehle, CM; Liu, D; Ward, MJ, 2018) |
| "The aim of this study was to determine whether the addition of constant rate infusion (CRI) to intermittent intravenous bolus (IVB) administration of furosemide resulted in an improvement in medical outcomes in dogs and cats with acute left-sided congestive heart failure (L-CHF)." | 3.88 | Constant rate infusion vs. intermittent bolus administration of IV furosemide in 100 pets with acute left-sided congestive heart failure: A retrospective study. ( Aroch, I; Bdolah-Abram, T; Kelmer, E; Klainbart, S; Ohad, DG; Segev, G; Segev, Y, 2018) |
| " We present the case of a patient with hypoxic hepatitis in the setting of heart failure and dehydration from furosemide as a reminder of an important clinical lesson." | 3.88 | Hypoxic hepatitis and furosemide. ( Pizzarossa, AC; Rebella, M, 2018) |
| "Furosemide is essential in the management of patients with congestive heart failure, and provides important iatrogenic complications." | 3.88 | [Prescription of furosemide in general medicine in Aquitaine: Prospective practice survey among universities general practitioners]. ( Boulestreau, R; Delarche, N; Durieux, W; Lalanne, P, 2018) |
| " We report on the availability of cardiac diagnostic technologies and select medications for heart failure (β-blockers, ACE inhibitors and furosemide)." | 3.85 | Capacity for diagnosis and treatment of heart failure in sub-Saharan Africa. ( Achan, J; Bukhman, G; Carlson, S; Duber, HC; Ikilezi, G; Mokdad, AH; Roth, GA; Stergachis, A; Wollum, A, 2017) |
| "A severe shortage of injectable furosemide did not increase the risk of adverse outcomes among patients who presented to the hospital with congestive heart failure." | 3.85 | Impact of Injectable Furosemide Hospital Shortage on Congestive Heart Failure Outcomes: A Time Series Analysis. ( Garg, AX; Jain, AK; Juurlink, DN; McArthur, E; Nash, DM; Tan, VS; Weir, MA, 2017) |
| "Hypertonic saline with furosemide has been proposed for a long time as an effective therapeutic option for the treatment of acute decompensated heart failure (ADHF)." | 3.85 | Comparison of salt with low-dose furosemide and carperitide for treating acute decompensated heart failure: a single-center retrospective cohort study. ( Ando, T; Hirotani, S; Komamura, K; Mano, T; Masuyama, T; Naito, Y; Nishimura, K; Okuhara, Y; Orihara, Y, 2017) |
| "Our previous study indicates that hydrochlorothiazide inhibits transforming growth factor (TGF)-β/Smad signaling pathway, improves cardiac function and reduces fibrosis." | 3.85 | Hydrochlorothiazide modulates ischemic heart failure-induced cardiac remodeling via inhibiting angiotensin II type 1 receptor pathway in rats. ( Chen, X; Gao, X; Lu, G; Luo, C; Luo, J; Peng, L; Zuo, Z, 2017) |
| "Approximately one-third of patients with acute decompensated heart failure (ADHF) treated with an intravenous (iv) loop diuretic at a relatively high dose (>80 mg/day of furosemide, or an equivalent dose of another loop diuretic), exhibit worsening renal function (WRF) after a single course of iv infusions or iv bolus injections maintained for several days." | 3.83 | Poor concordance between different definitions of worsening renal function in patients with acute exacerbation of chronic heart failure: a retrospective study. ( Baldi, C; De Vecchis, R; Di Biase, G, 2016) |
| " An infant affected by initial congestive cardiac failure, after starting the treatment with enalapril in association with furosemide, developed acute kidney injury (AKI)." | 3.83 | Enalapril Associated with Furosemide Induced Acute Kidney Injury in an Infant with Heart Failure. A Case Report, a Revision of the Literature and a Pharmacovigilance Database Analysis. ( Carnovale, C; Clementi, E; Fabiano, V; Gentili, M; Mameli, C; Perrotta, C; Radice, S; Zuccotti, GV, 2016) |
| "Medication included digitalis drugs for heart failure or potential heart failure, digoxin and furosemide for chronic congestive heart failure and beta blockers for arrhythmia." | 3.83 | Epidural anesthesia for cesarean section for pregnant women with rheumatic heart disease and mitral stenosis. ( Chen, Q; Chen, W; Wu, W; Zhang, L, 2016) |
| "The prevalence of thiamine deficiency in heart failure (HF) patients has been reported to be as high as 50% in outpatient settings and has been found to be as high as 96% in the inpatient setting." | 3.83 | Prevalence of thiamine deficiency in a stable heart failure outpatient cohort on standard loop diuretic therapy. ( Miller, WL; Teigen, LM; Twernbold, DD, 2016) |
| " Physician investigators performed IVC ultrasonography on a convenience sample of 70 hospitalized adults who were prescribed intravenous furosemide for the diagnosis of acute decompensated heart failure." | 3.81 | Inferior vena cava diameter change after intravenous furosemide in patients diagnosed with acute decompensated heart failure. ( Athavale, A; Candotti, C; Katz, A; Kumapley, R; Lucas, BP; Margeta, B; Tchernodrinski, S, 2015) |
| "The most effective dose of prehospital furosemide in acute decompensated heart failure (ADHF) has not yet been identified and concerns of worsening renal function have limited its use." | 3.81 | The Effect of Furosemide Dose Administered in the Out-of-hospital Setting on Renal Function Among Patients with Suspected Acute Decompensated Heart Failure. ( Chuang, M; Mehrtens, GM; Merlin, MA; Nieves, LC; Pickrell, C; Pores, N; Satty, T; Tanis, J; Young, TC, 2015) |
| "Furosemide has historically been the primary loop diuretic in heart failure patients despite data suggesting potential advantages with torsemide." | 3.81 | Torsemide versus furosemide in heart failure patients: insights from Duke University Hospital. ( Anstrom, KJ; Buggey, J; DeVore, AD; Eisenstein, EL; Ersbøll, MK; Fiuzat, M; Mentz, RJ; OʼConnor, CM; Schulte, PJ; Velazquez, EJ, 2015) |
| "Sequence symmetry analyses were undertaken to investigate the risk of peripheral oedema, as measured by incident furosemide dispensing, and risk of hospitalisations for heart failure." | 3.81 | Variation in Association Between Thiazolidinediones and Heart Failure Across Ethnic Groups: Retrospective analysis of Large Healthcare Claims Databases in Six Countries. ( Chan, EW; Choi, NK; Griffiths, J; Kimura, M; Kimura, T; Kubota, K; Lai, EC; Man, KK; Nguyen, TA; Ooba, N; Park, BJ; Pratt, NL; Roughead, EE; Sato, T; Shin, JY; Wang, T; Wong, IC; Yang, YH, 2015) |
| "A case in which aminophylline solution was administered to a patient with congestive heart failure is reported and the problems caused by administration were solved by subsequent experiments." | 3.80 | [Examination of the cause of changing solution color by mixing aminophylline and dopamine, the compatibility of which was indicated by the supplier]. ( Igarashi, K; Kawahara, M, 2014) |
| "Treatment of acute decompensated heart failure (ADHF) with loop diuretics, such as furosemide, is frequently complicated by insufficient urine sodium excretion." | 3.80 | Insufficient natriuretic response to continuous intravenous furosemide is associated with poor long-term outcomes in acute decompensated heart failure. ( Dupont, M; Mullens, W; Shrestha, K; Singh, D; Tang, WH; Testani, JM; Verbrugge, FH, 2014) |
| "To compare the effects of combination diuretic therapy with oral hydrochlorothiazide or intravenous chlorothiazide added to background intravenous loop diuretic therapy among patients hospitalized with heart failure." | 3.80 | Comparison of the effects of combination diuretic therapy with oral hydrochlorothiazide or intravenous chlorothiazide in patients receiving intravenous furosemide therapy for the treatment of heart failure. ( Kissling, KT; Pickworth, KK, 2014) |
| "Limited data exist comparing the efficacy and safety of bumetanide- or metolazone-based diuretic regimens to furosemide in acute heart failure (HF)." | 3.79 | Comparison of bumetanide- and metolazone-based diuretic regimens to furosemide in acute heart failure. ( Elkayam, U; Han, SY; Hshieh, S; Hyderi, AF; Jeng, AI; Kim, BJ; Konopka, E; Lou, M; Ng, TM; Phan, DH; Tsuji, Y, 2013) |
| "To ascertain whether increasing doses of orally administered furosemide are associated with impaired survival in outpatients with chronic heart failure (CHF) and left ventricular (LV) systolic dysfunction." | 3.79 | Effects on survival of loop diuretic dosing in ambulatory patients with chronic heart failure using a propensity score analysis. ( Cicoira, M; Dini, FL; Genta, FT; Ghio, S; Klersy, C; Rossi, A; Scelsi, L; Simioniuc, A; Tavazzi, L; Temporelli, PL, 2013) |
| "Although tolvaptan is a recently approved drug for heart failure and causes aquaresis without affecting renal function, its clinical efficacy for patients with acute decompensated heart failure (ADHF) is yet to be elucidated." | 3.79 | Tolvaptan reduces the risk of worsening renal function in patients with acute decompensated heart failure in high-risk population. ( Hashimoto, Y; Iwatsuka, R; Matsue, Y; Matsumura, A; Mizukami, A; Nagahori, W; Ohno, M; Seya, M; Suzuki, M, 2013) |
| "In an experimental heart failure model, we tested the hypothesis that furosemide causes excess mortality." | 3.78 | Furosemide induces mortality in a rat model of chronic heart failure. ( Anker, SD; Bauersachs, J; Bockmeyer, B; Doehner, W; Hocher, B; Rokutan, H; Springer, J; Strassburg, S; Suckow, C; von Haehling, S; von Websky, K; Waller, C, 2012) |
| "Clinical data are scarce for furosemide administered as a low-dose (<160 mg/24 hours) continuous intravenous infusion in acute heart failure (HF)." | 3.78 | Clinical experience with low-dose continuous infusion of furosemide in acute heart failure: assessment of efficacy and safety. ( Chan, CY; Elkayam, U; Hshieh, S; Ng, TM, 2012) |
| " We hypothesized that TRV120027 would elicit beneficial cardiorenal actions when added to furosemide in experimental heart failure." | 3.78 | TRV120027, a novel β-arrestin biased ligand at the angiotensin II type I receptor, unloads the heart and maintains renal function when added to furosemide in experimental heart failure. ( Boerrigter, G; Burnett, JC; Lark, MW; Soergel, DG; Violin, JD, 2012) |
| "In a comparative clinical trial in 308 patients with acute decompensated heart failure, the relief achieved with intravenous furosemide at a dose equivalent to the daily oral dose patients were receiving prior to the acute episode was very similar to that obtained with higher doses of intravenous furosemide." | 3.78 | Furosemide in acute decompensated heart failure. ( , 2012) |
| "120 patients with heart failure treated with high-dose furosemide+HSS (Furosemide/HSS group) were matched with: 30 subjects with heart failure treated with high-dose furosemide (furosemide group), 30 controls with asymptomatic left-ventricular dysfunction (ALVD) (asymptomatic group) and 30 controls without heart failure or ALVD (Healthy group)." | 3.77 | Changes in natriuretic peptide and cytokine plasma levels in patients with heart failure, after treatment with high dose of furosemide plus hypertonic saline solution (HSS) and after a saline loading. ( Caruso, C; Corrao, S; Di Raimondo, D; Di Sciacca, R; Licata, G; Pinto, A; Scaglione, R; Tuttolomondo, A, 2011) |
| "We cannot support the use of the furosemide test as an ancillary diagnostic test in patients suspected of new, slow-onset heart failure." | 3.77 | The furosemide diagnostic test in suspected slow-onset heart failure: popular but not useful. ( Cramer, MJ; Grobbee, DE; Hoes, AW; Kelder, JC; Plokker, HW; Rutten, FH, 2011) |
| "In this study, 30 patients with chronic systolic heart failure in a presumed euvolemic state and on standard oral furosemide therapy (40 to 80 mg) were examined." | 3.77 | Volume status and diuretic therapy in systolic heart failure and the detection of early abnormalities in renal and tubular function. ( Collinson, PO; Damman, K; Gaze, D; Hillege, HL; Lip, GY; MacFadyen, RJ; Ng Kam Chuen, MJ; van Oeveren, W; van Veldhuisen, DJ; Voors, AA, 2011) |
| "We investigated the effects of tolvaptan, a vasopressin V(2)-receptor antagonist, on diuretic response and systemic and renal hemodynamic characteristics in conscious dogs with congestive heart failure (CHF)." | 3.77 | Effects of tolvaptan on systemic and renal hemodynamic function in dogs with congestive heart failure. ( Fujiki, H; Nakamura, S; Nakayama, S; Onogawa, T; Sakamoto, Y; Yamamura, Y, 2011) |
| "This retrospective study reports the survival time [onset of congestive heart failure (CHF) to death from any cause] of 21 dogs with mitral regurgitation (MR) and CHF treated with a combination of furosemide, angiotensin-converting enzyme inhibitor (ACEI, benazepril, or enalapril), pimobendan, spironolactone, and amlodipine." | 3.77 | Survival and echocardiographic data in dogs with congestive heart failure caused by mitral valve disease and treated by multiple drugs: a retrospective study of 21 cases. ( de Madron, E; King, JN; Strehlau, G; White, RV, 2011) |
| "The array of outcomes according to longitudinal furosemide doses in heart failure (HF) have not been evaluated." | 3.76 | Diuretic dose and long-term outcomes in elderly patients with heart failure after hospitalization. ( Abdel-Qadir, HM; Austin, PC; Lee, DS; Newton, GE; Tu, JV; Yun, L, 2010) |
| "Treatment with enalapril, in the absence of frusemide, was associated with a fall in mean blood pressure from 89 +/- 5 mmHg to 85 +/- 4 mmHg (P less than 0." | 3.76 | The effects of frusemide and angiotensin-converting enzyme inhibitors and their combination on cardiac and renal haemodynamics in heart failure. ( Cleland, JG; Dargie, HJ; Gillen, G, 1988) |
| " Symptoms of heart failure were alleviated by water restriction and furosemide by the 9th POD." | 3.75 | [Suspected case of peripartum cardiomyopathy developed during elective cesarean section]. ( Aoyama, K; Fujimoto, A; Hasegawa-Moriyama, M; Imai, M; Inada, E; Kikutani, T; Oshima, M; Sonoda, S, 2009) |
| "Ucn2 and furosemide were administered for 3 hours, both singly and combined, in 7 sheep with pacing-induced heart failure." | 3.75 | Urocortin 2 inhibits furosemide-induced activation of renin and enhances renal function and diuretic responsiveness in experimental heart failure. ( Charles, CJ; Nicholls, MG; Rademaker, MT; Richards, AM, 2009) |
| "Fifteen patients with severe OSA, hypertension, and diastolic heart failure were hospitalized to receive IV furosemide, 20 mg, and spironolactone, 100 mg, bid for 3 days." | 3.74 | Diuretics in obstructive sleep apnea with diastolic heart failure. ( Battisti, A; Brussino, L; Bucca, CB; Cicolin, A; Mangiardi, L; Mutani, R; Rolla, G, 2007) |
| "The unique pattern of cardiac ascites should allow for rapid diagnosis and characterization: The clinical implications of furosemide use in its response and biochemical properties warrant further description." | 3.74 | Characteristics of ascitic fluid in cardiac ascites. ( Christou, L; Economou, G; Economou, M; Kolettis, TM; Tsianos, EV, 2007) |
| "We compared therapeutic effects of furosemide, a short-acting loop diuretic, and azosemide, a long-acting one, in hypertensive heart failure rats to test the hypothesis that long-acting diuretics are superior to short-acting types in heart failure." | 3.73 | Different effects of long- and short-acting loop diuretics on survival rate in Dahl high-salt heart failure model rats. ( Hori, M; Mano, T; Masuyama, T; Miwa, T; Nishio, M; Ohtani, T; Sakata, Y; Yamamoto, K; Yoshida, J, 2005) |
| " Despite treatment with digoxin, diuretics, and captopril he required hospitalization twice during his first 2 months of life for congestive heart failure (CHF)." | 3.73 | Congenital right ventricular diverticulum associated with a ventricular septal defect: a rare echocardiographic finding. ( Di Sessa, TG; Howard, SC; Salim, MA, 2006) |
| "To retrospectively investigate the effect of carvedilol and spironolactone plus furosemide, administered concomitantly with an angiotensin II converting enzyme inhibitor (ACE-I) or an angiotensin II receptor blocker (ARB) to patients with chronic heart failure (CHF)." | 3.73 | Carvedilol accelerate elevation of serum potassium in chronic heart failure patients administered spironolactone plus furosemide and either enalapril maleate or candesartan cilexetil. ( Hirooka, K; Nakayama, D; Saito, M; Takada, M; Yasumura, Y, 2006) |
| "404 consecutive patients admitted with congestive heart failure as one of the diagnoses and previously treated with furosemide (frusemide) for at least three months." | 3.72 | Serum magnesium aberrations in furosemide (frusemide) treated patients with congestive heart failure: pathophysiological correlates and prognostic evaluation. ( Almoznino-Sarafian, D; Alon, I; Averbukh, Z; Chachashvily, S; Chen-Levy, Z; Cohen, N; Golik, A; Gorelik, O; Modai, D; Shteinshnaider, M; Zaidenstein, R, 2003) |
| "To assess the presence of thiamine deficiency in congestive heart failure patients receiving furosemide therapy." | 3.72 | Thiamine deficiency in congestive heart failure patients receiving long term furosemide therapy. ( Almalki, Y; Donnelly, J; Healey, J; Smith, S; Vaillancourt, R; Zenuk, C, 2003) |
| "This study was performed to examine the safety of reducing the long-term doses of furosemide administered to patients with congestive heart failure (CHF) stabilized on a standard medical treatment." | 3.72 | Lowering of furosemide dosage after clinical stabilization in patients with congestive heart failure. ( Alexopoulos, GP; Anastasiou-Nana, MI; Makri, S; Margari, ZJ; Mitsibounas, D; Nanas, JN; Rapti, ACh; Terrovitis, JV, 2003) |
| "Two patients are reported, each with heart failure, who were treated with digoxin (case 1) and furosemide (case 2)." | 3.72 | Anesthesiology: perioperative medicine or "when the anesthetic is a diuretic". ( White, SE, 2004) |
| "Furosemide shortened the time to left ventricular dysfunction (35." | 3.72 | Furosemide and the progression of left ventricular dysfunction in experimental heart failure. ( Haigney, MC; Hanlon, SU; McCurley, JM; Michalski, M; Wedam, EF; Wei, SK, 2004) |
| "The objective of the TOrasemide In Congestive Heart Failure (TORIC) Study was to investigate the safety, tolerability and efficacy of torasemide in CHF patients compared to furosemide or other diuretics in an open-label, non-randomised, post-marketing surveillance trial." | 3.71 | Torasemide in chronic heart failure: results of the TORIC study. ( Cosín, J; Díez, J, 2002) |
| "To determine the efficacy, safety, and economic benefit of continuous IV infusion of furosemide as a treatment modality for elderly patients with class IV heart failure." | 3.71 | Aggressive diuresis for severe heart failure in the elderly. ( Dunn, MI; Howard, PA, 2001) |
| "The effect of enalapril, digoxin and frusemide combination on clinical, biochemical and anthropometric indices were determined in eight cachectic Nigerians with chronic congestive heart failure [body mass index (BMI) 20." | 3.71 | The effects of enalapril-digoxin-diuretic combination therapy on nutritional and anthropometric indices in chronic congestive heart failure: preliminary findings in cardiac cachexia. ( Adigun, AQ; Ajayi, AA, 2001) |
| "The purpose of this study was to estimate the cost-effectiveness of beta-blocker therapy with either metoprolol or carvedilol in addition to conventional therapy for patients with heart failure (HF) in Canada." | 3.71 | Cost-effectiveness of beta-blocker therapy with metoprolol or with carvedilol for treatment of heart failure in Canada. ( Briggs, AH; Demers, C; Levy, AR; O'Brien, BJ, 2001) |
| "We evaluated the comparative effects of furosemide, a short-acting loop diuretic, and azosemide, a long-acting loop diuretic, on neurohumoral factors and quality of life (QOL) in patients with congestive heart failure (CHF)." | 3.71 | Comparison of neurohumoral effects of short-acting and long-acting loop diuretics in patients with chronic congestive heart failure. ( Kinoshita, M; Maeda, K; Tsutamoto, T; Tsutsui, T, 2001) |
| "The pulmonary diffusing capacity for carbon monoxide (DLCO) is reduced in chronic heart failure and remains decreased after heart transplantation." | 3.70 | Lung membrane diffusing capacity, heart failure, and heart transplantation. ( Charloux, A; Epailly, E; Frans, A; Lampert, E; Lonsdorfer, J; Mettauer, B; Oswald, M; Piquard, F; Zhao, QM, 1999) |
| "In order to study the incidence and course of nephrocalcinosis in full-term infants with congestive heart failure receiving long-term furosemide treatment, 36 such infants (median age 2." | 3.70 | Nephrocalcinosis in full-term infants receiving furosemide treatment for congestive heart failure: a study of the incidence and 2-year follow up. ( Koivisto, M; Lanning, P; Paavilainen, T; Saarela, T, 1999) |
| "Prolonged furosemide treatment is associated with urinary loss of thiamine and thiamine deficiency in some patients with congestive heart failure and low dietary thiamine intake." | 3.70 | Urinary loss of thiamine is increased by low doses of furosemide in healthy volunteers. ( Almog, S; Ezra, D; Halkin, H; Lubetsky, A; Olchovsky, D; Rieck, J; Seligman, H, 1999) |
| "This observational study compared patients suffering from congestive heart failure (CHF) who were treated with loop diuretics torasemide or furosemide." | 3.70 | Comparison of therapies with torasemide or furosemide in patients with congestive heart failure from a pharmacoeconomic viewpoint. ( Dreckmann-Behrendt, B; Goertz, A; Spannheimer, A, 1998) |
| "To measure the concentrations of thiamine and thiamine esters by high-pressure liquid chromatography (HPLC) in elderly patients treated with furosemide for heart failure and in a control group." | 3.70 | Reduced thiamine phosphate, but not thiamine diphosphate, in erythrocytes in elderly patients with congestive heart failure treated with furosemide. ( Bohmer, T; Daae, C; Dellborg, M; Härdig, L; Kontny, F, 2000) |
| "We report 2 patients with congestive heart failure and concomitant toxic serum digoxin levels in whom cholestyramine administration increased clearance of digoxin and decreased serum digoxin elimination half-lives." | 3.70 | Congestive heart failure and toxic digoxin levels: role of cholestyramine. ( Roberge, RJ; Sorensen, T, 2000) |
| "To explore the possibilities of furosemide withdrawal in elderly heart failure (HF) patients with intact left ventricular (LV) systolic function and assess its effects on functional status and orthostatic blood pressure homeostasis, we performed a placebo-controlled pilot trial of furosemide withdrawal with 3 months of follow-up in 32 HF patients (aged 75." | 3.70 | Furosemide withdrawal in elderly heart failure patients with preserved left ventricular systolic function. ( Bouwels, LH; Gribnau, FW; Hoefnagels, WH; Jansen, RW; van Kraaij, DJ, 2000) |
| "Magnesium depletion and hypomagnesemia are common among furosemide-treated patients with chronic congestive heart failure." | 3.70 | Metabolic and clinical effects of oral magnesium supplementation in furosemide-treated patients with severe congestive heart failure. ( Almoznino-Sarafian, D; Alon, I; Berman, S; Cohen, N; Golik, A; Gorelik, O; Modai, D; Weissgarten, J; Zaidenstein, R, 2000) |
| "Thiamine deficiency as a cause for an elevated serum lactate or lactate acidosis with or without cardiovascular failure may not be overlooked." | 3.70 | [Unclear lactate acidosis in a patient with heart failure under long-term diuretic therapy]. ( Duell, T; Hiddemann, W; Mittermüller, J, 2000) |
| "The efficacy and side effects of the combination therapy of thiazide and furosemide administered to patients with refractory heart failure, for a prolonged period of time, were assessed." | 3.69 | Prolonged therapy by the combination of furosemide and thiazides in refractory heart failure and other fluid retaining conditions. ( Brif, I; Farfel, Z; Mayan, H; Mouallem, M, 1995) |
| " Furosemide was chosen because of its wide use in the management of heart failure in dogs." | 3.69 | Prolonged-release hard gelatin capsules of furosemide for the treatment of dogs. ( Haapala, O; Happonen, I; Kuusela, S; Marvola, M; Smal, J, 1995) |
| "Nephrocalcinosis and nephrolithiasis developed in five children after furosemide therapy for congestive heart failure." | 3.69 | Nephrocalcinosis and nephrolithiasis in infants with congestive heart failure treated with furosemide. ( Alon, US; Garola, RE; Scagliotti, D, 1994) |
| "We studied the effects of inhaled furosemide (40 mg) on bronchial responsiveness to acetylcholine (ACh) in patients with chronic congestive heart failure who had been premedicated with indomethacin (75 mg/day) for five days." | 3.69 | [Effects of inhaled furosemide after indomethacin premedication on bronchial hyperresponsiveness in patients with chronic congestive heart failure]. ( Ishizaki, T; Kanamori, K; Mifune, J; Miyabo, S; Nakai, T; Saitoh, Y; Sakai, T; Sasaki, F, 1994) |
| " After treatment of the cardiac failure with frusemide (up to 500 mg daily intravenously), nitrates and captopril (25 mg daily by mouth) the diagnosis was confirmed by transoesophageal echocardiography." | 3.69 | [Acute mitral insufficiency in osteogenesis imperfecta]. ( Borchard, F; Horstkotte, D; Kober, R; Königshausen, T; Krahwinkel, W; Strauer, BE; Winter, J, 1994) |
| "Three days of diuretic therapy with furosemide (oral and/or intravenous) for CHF was associated with a measured weight loss of 4." | 3.69 | Bioelectrical impedance analysis as an assessment of diuresis in congestive heart failure. ( Coodley, EL; Neutel, JM; Segal, JL; Smith, DH, 1995) |
| "Oral furosemide solution was claimed to produce a greater diuretic response than furosemide tablets in patients with congestive heart failure." | 3.69 | Effect of furosemide oral solution versus furosemide tablets on diuresis and electrolytes in patients with moderate congestive heart failure. ( Averbukh, Z; Cohen, N; Dishi, V; Golik, A; Modai, D; Weissgarten, J; Zaidenstein, R, 1996) |
| "The effect of digoxin therapy on the survival of heart failure patients in sinus rhythm was assessed using a retrospective case control study." | 3.69 | Digoxin therapy and survival in heart failure in sinus rhythm. ( Banerjee, AK; Campbell, RW, 1996) |
| "11 inhibition and furosemide were compared in the pacing model of ovine heart failure (HF)." | 3.69 | Comparison of chronic neutral endopeptidase inhibition and furosemide in an ovine model of heart failure. ( Charles, CJ; Espiner, EA; Fitzpatrick, MA; Nicholls, MG; Rademaker, MT; Richards, AM; Sybertz, E, 1996) |
| "The effect on heart rate variability of adding digoxin to a diuretic and ACE inhibitor was studied in patients with chronic stable cardiac failure." | 3.69 | Effects of digoxin on time domain measures of heart rate variability in patients with stable chronic cardiac failure: withdrawal and comparison group studies. ( Flapan, AD; Francis, CM; Goodfield, NE; Neilson, JM; Wright, RA, 1997) |
| "To determine whether furosemide treatment in congestive heart failure (CHF) patients is associated with thiamine deficiency." | 3.69 | No difference in blood thiamine diphosphate levels between Swedish Caucasian patients with congestive heart failure treated with furosemide and patients without heart failure. ( Beermann, B; Lindström, B; Nyquist, O; Yue, QY, 1997) |
| "In severe heart failure with peripheral and enterohepatic congestion resistance to diuretics with inactivation of oral furosemide is a common finding." | 3.68 | [Outpatient diuretic treatment of terminal heart failure by a completely implantable venous infusion system]. ( Carnarius, H; Kuck, KH; Langes, K; Nienaber, CA; Siebels, J; Weiss, C, 1993) |
| "We studied the effects of inhaled and intravenous furosemide (40 mg) on bronchial responsiveness to acetylcholine (ACh) in patients with chronic congestive heart failure." | 3.68 | [Effects of inhaled and intravenous furosemide on bronchial hyperresponsiveness in patients with chronic congestive heart failure]. ( Fujimura, M; Hifumi, S; Ishizaki, T; Mifune, J; Miyabo, S; Nakai, T; Sakai, T; Sasaki, F; Takahashi, H, 1992) |
| "Plasma ANF, renin activity, urinary aldosterone and catecholamine levels were evaluated in 10 patients with congestive heart failure (at baseline, after 15 days of adequate treatment with digoxin and diuretics, and after 45 days of enalapril) in order to assess the changes of ANF and vasoconstrictor neurohormones with chronic Ace inhibitor therapy." | 3.68 | [Atrial natriuretic factor in patients with cardiac decompensation before and after chronic therapy with an angiotensin-converting enzyme inhibitor]. ( Gribaldo, R; Lupia, M; Opocher, G; Pomini, G; Rugna, A, 1992) |
| " We therefore measured lymphocyte free Mg2+ concentrations in patients with congestive cardiac failure treated with loop diuretics or a frusemide/amiloride mixture (Frumil) and compared them with control subjects." | 3.68 | Intracellular free magnesium in lymphocytes from patients with congestive cardiac failure treated with loop diuretics with and without amiloride. ( Brochwicz-Lewinski, MJ; Davies, JE; Garrido, MC; Ng, LL; Tan, LB, 1992) |
| "To investigate the influence of the presence of oedema on the pharmacokinetics and pharmacodynamics of furosemide (frusemide) we selected 9 hospitalised patients (mean age 70." | 3.68 | Absorption of high dose furosemide (frusemide) in congestive heart failure. ( Gerlag, PG; Gribnau, FW; Russel, FG; Smits, P; Tan, Y; Van Ginneken, CA; Van Meyel, JJ, 1992) |
| "Lymphocyte potassium and magnesium were measured before and 3 months after the introduction of captopril in 18 patients taking diuretics for congestive heart failure." | 3.68 | Effect of captopril therapy on lymphocyte potassium and magnesium concentrations in patients with congestive heart failure. ( Daly, K; Finn, J; Grimes, H; McMurrough, P; O'Keeffe, S, 1992) |
| "The effect of diuretic dose on the haemodynamic response to captopril was assessed in nine patients with chronic cardiac failure." | 3.68 | The relationship between diuretic dose, and the haemodynamic response to captopril in patients with cardiac failure. ( Davies, E; Edwards, CR; Flapan, AD; Shaw, TR; Williams, BC, 1992) |
| "Ten healthy (aged 28 to 39) and ten heart failure NYHA II (aged 19 to 49) male subjects were prospectively studied under no drugs, under furosemide (40 mg/day), under captopril (150 mg/day) and under their association." | 3.68 | Effect of drugs on a noninvasive index of arterial compliance in healthy and heart failure patients. ( Alio, J; Angel, J; Domingo, E; Gilabert, MR; Soler-Soler, J, 1991) |
| "Eleven patients with congestive heart failure class II-IV (NYHA) caused by ischemic heart disease were studied before and three months after adding enalapril to their treatment with furosemide." | 3.68 | Cardiac remodelling and myocardial contractility in patients with congestive heart failure treated with furosemide and enalapril. ( Bann, J; Baur, LH; Bruschke, AV; Buis, B; Manger Cats, V; Schipperheyn, JJ; van der Laarse, A; van der Wall, EE; van Dijk, AD, 1991) |
| "The influence of two cardiac inotropic drugs, dobutamine and salbutamol, on plasma atrial natriuretic factor (ANF) was investigated in 20 patients with congestive heart failure." | 3.68 | Effects of dobutamine and salbutamol on haemodynamics and atrial natriuretic factor in patients with severe congestive heart failure. ( Keller, N; Larsen, J; Sykulski, R, 1991) |
| "To test the hypothesis that long-term furosemide therapy in patients with congestive heart failure (CHF) is associated with clinically significant thiamine deficiency via urinary loss." | 3.68 | Thiamine deficiency in patients with congestive heart failure receiving long-term furosemide therapy: a pilot study. ( Ezra, D; Halkin, H; Kaufmann, N; Motro, M; Rauchfleisch, S; Seligmann, H; Vered, Z, 1991) |
| "The aim was to study glomerular and vascular atrial natriuretic factor (ANF) receptors and their relationship with the post-receptor effects of the peptide in experimental heart failure." | 3.68 | Glomerular and vascular atrial natriuretic factor receptors in cardiomyopathic hamsters: correlation with the peptide biological effects. ( Cachofeiro, V; Cantin, M; Garcia, R; Schiffrin, EL, 1990) |
| "Transient pulsus alternans was induced by isosorbide dinitrate (ISDN) in a patient with postmyocarditis congestive heart failure under diuretic therapy." | 3.68 | Transient pulsus alternans induced by isosorbide dinitrate: echocardiographic and hemodynamic evidence of reduced venous return--a case report. ( Hasebe, N; Honda, H; Maruyama, J; Matsuhashi, H; Onodera, S; Tobise, K; Yamashita, H, 1991) |
| "21 patients with symptoms of chronic congestive heart failure, NYHA classes II-IV, were treated with digoxin and furosemide for at least 14 days." | 3.68 | [The effect of combined treatment in chronic congestive heart failure with digoxin, furosemide and pentoxifylline upon blood viscosity]. ( Kochmański, M; Zochowski, RJ, 1990) |
| "Clinical, hemodynamic and neurohumoral data are available supporting the validity of a differentiated approach to administration of combined treatment with furosemide, digoxin and calcium antagonists nifedipine and verapamil in advanced-aged patients with hypertension complicated by circulatory disorders." | 3.68 | [Evaluation of the effectiveness of calcium antagonists combined with digoxin and furosemide in hypertension complicated by circulatory insufficiency in elderly patients]. ( Orynchak, MA, 1990) |
| "1 yrs) with III or IV NYHa class congestive heart failure after 2-week therapy with digoxin (D) and furosemide (F) underwent two-dimensional echocardiographic examination to assess left ventricular function." | 3.68 | [Changes in left-ventricular function in chronic congestive heart failure treated with digoxin, furosemide and vasodilators]. ( Cholewa, M; Dryjański, T; Gawor, Z; Markiewicz, K, 1990) |
| "In 61 patients with class IV (NYHA) of chronic congestive cardiac failure treated for 2 weeks with digoxin (0." | 3.68 | [Results of treatment for severe congestive heart failure with digoxin, furosemide and vasodilating agents]. ( Bubiński, R; Cholewa, M; Dryjański, T; Gawor, Z; Górski, L; Kaczkowska-Marusik, E; Markiewicz, K, 1990) |
| "The acute hemodynamic response to captopril (8 patients) and enalapril (8 patients) was evaluated in congestive heart failure patients in NYHA functional class III." | 3.67 | Hemodynamic results of perorally administered converting enzyme inhibitors in congestive heart failure. ( Enghoff, E; Hägg, A; Hedlund, A; Lantz, P, 1984) |
| " A positive correlation was found between serum enzyme activity and most of the clinical variables studied, such as incidence of congestive heart failure, treatment with furosemide, incidence of hypotension, cardiogenic shock, pericarditis, post myocardial infarction syndrome, AV block III, and the duration of hospitalization." | 3.67 | Relationship between the enzymatically estimated infarct size and clinical findings in acute myocardial infarction. ( Herlitz, J; Hjalmarson, A; Waldenström, J, 1984) |
| "A patient with a history of diabetes mellitus and congestive heart failure was taking furosemide and metolazone as diuretics." | 3.67 | Alkalemia in diabetic ketoacidosis. ( Cronin, JW; Diamond, J; Kroop, SF; Rolla, AR, 1984) |
| "The acute and chronic hemodynamic effects of the "basic regimen" for congestive heart failure (CHF), consisting of diuretics (furosemide) low salt diet and bed rest, was studied in 10 patients with CHF (all in NYHA class IV initially)." | 3.67 | Acute and chronic hemodynamic effects of the basic therapeutic regimen for congestive heart failure. Diuretics, low salt diet and bed rest. ( Hattori, T; Hayashi, K; Ito, K; Murakami, R; Nishijima, H; Yamazaki, M; Yasuda, H, 1984) |
| "Changes in blood volume were investigated following intravenous injection of a single dose of furosemide in 21 patients with pulmonary edema." | 3.67 | Blood volume following diuresis induced by furosemide. ( Besso, J; Carpio, M; Henning, RJ; Schuster, CJ; Weil, MH, 1984) |
| "As many as 52 patients with essential hypertension aggravated by circulatory failure were examined for the clinical, hemodynamic and neurohumoral parameters during furosemide stimulation." | 3.67 | [The efficacy of calcium antagonists in circulatory failure in elderly patients with hypertension]. ( Orynchak, MA, 1989) |
| "To evaluate efficacy of the association furosemide-metolazona in ten retrospective cases of Congestive heart failure, furosemide resistant." | 3.67 | [Metolazone in the treatment of refractory heart insufficiency. Experience of 10 cases]. ( Correia, JM; Loureiro, PA, 1989) |
| "Hemodynamic and neurohumoral responses to acute diuretic therapy were measured in 15 patients with severe chronic heart failure given intravenous furosemide, 1." | 3.67 | Acute vasoconstrictor response to intravenous furosemide in patients with chronic congestive heart failure. Activation of the neurohumoral axis. ( Cohn, JN; Francis, GS; Goldsmith, SR; Levine, TB; Olivari, MT; Siegel, RM, 1985) |
| "A patient with congestive heart failure and moderate renal insufficiency developed severe reversible non-oliguric renal failure while on frusemide and enalapril." | 3.67 | Reversible renal failure after combined treatment with enalapril and frusemide in a patient with congestive heart failure. ( Alexandre, JM; Chatellier, G; Funck-Brentano, C, 1986) |
| " The renal and metabolic effects of the sulphamoylbenzoic acid diuretic, piretanide, have been studied, under controlled dietary conditions, in 39 patients with congestive cardiac failure." | 3.67 | Acute and long-term renal and metabolic effects of piretanide in congestive cardiac failure. ( Lant, AF; McNabb, WR; Noormohamed, FH, 1988) |
| "To compare the hemodynamic mode of action of captopril in patients with Congestive Heart Failure (CHF) with high- or low-plasma renin activity, we studied the systemic and renal hemodynamic changes induced by this drug in patients with refractory CHF (Group I) or untreated CHF (Group II)." | 3.67 | Acute hemodynamic action of captopril in congestive heart failure: contrasts between refractory and untreated patients. ( Ajzen, H; Draibe, SA; Ferreira, SR; Homsi, E; Ramos, OL; Ribeiro, AB; Saragoça, MA, 1987) |
| "Thirty-five patients with severe chronic congestive heart failure that was refractory to conventional therapy were given high dosages of furosemide (250 to 4000 mg/d) because of significantly reduced renal function (mean endogenous creatinine clearance, 0." | 3.67 | High-dose furosemide in the treatment of refractory congestive heart failure. ( Gerlag, PG; van Meijel, JJ, 1988) |
| "Twenty-seven patients (mean age 72 years) with symptoms of congestive cardiac failure who had been controlled by treatment with 1 to 2 tablets per day of a combination preparation of frusemide (40 mg) and amiloride (5 mg) for at least 12 weeks were studied." | 3.67 | A long-term open study of a frusemide/amiloride combination ('Frumil') in elderly patients with congestive cardiac failure. ( Allman, S; Crawford, RJ; Kitchen, SP; Richards, HH, 1988) |
| "We studied the effects of furosemide on plasma renin and plasma aldosterone in 8 patients with mild to moderate congestive heart failure." | 3.67 | Acute changes in plasma renin activity, plasma aldosterone concentration and plasma electrolyte concentrations following furosemide administration in patients with congestive heart failure--interrelationships and diuretic response. ( Mulder, H; Schopman, W; van der Lely, AJ, 1987) |
| "Furosemide, a potent loop diuretic, is commonly used in the treatment of congestive heart failure (CHF)." | 3.67 | Steady state absorption kinetics and pharmacodynamics of furosemide in congestive heart failure. ( Chaturvedi, PR; Gwilt, PR; Nicholas, JM; O'Donnell, JP; Shoenthal, DR; Waters, DH, 1987) |
| "We have studied the efficiency of urea in the treatment of hyponatremia and hydrosaline retention in a 76-year-old man with chronic ischemic congestive heart failure." | 3.67 | Urea treatment for water retention in hyponatremic congestive heart failure. ( Cauchie, P; Decaux, G; Vincken, W, 1987) |
| "Twenty-three optimally digitalized patients with congestive heart failure completed a 4-week treatment period with a fixed-drug association of 20 mg furosemide plus 50 mg spironolactone." | 3.67 | A fixed-dose combination of furosemide and spironolactone in digitalized congestive heart failure patients. ( Collia, LF; Ledesma, GA; Tutera, A; Yasky, J, 1986) |
| "Seventeen non-digitalized congestive heart failure patients were treated with only the fixed-dose combinations of 20 mg furosemide and 50 mg spironolactone or 20 mg furosemide and 100 mg spironolactone, in a daily dose of 1 or 2 capsules, over a 4-week period." | 3.67 | The treatment of non-digitalized congestive heart failure patients with a fixed-dose combination of furosemide and spironolactone. ( Collia, LF; Ledesma, GA; Tutera, A; Yasky, J, 1986) |
| "The aims of this study were to investigate the influence of heart failure and dietary sodium content on the natriuretic effect of furosemide." | 3.67 | Influence of heart failure and sodium content in the diet on the natriuretic response to furosemide in hamsters. ( du Souich, P; Gutkowska, J; Lambert, C; Larose, P; Ong, H, 1985) |
| "We assessed whether patients with decompensated congestive heart failure had altered absorption of oral furosemide." | 3.67 | Furosemide absorption altered in decompensated congestive heart failure. ( Brater, DC; Cartwright, DB; Knochel, JP; Nixon, JV; Vasko, MR, 1985) |
| "Eight patients suffering from congestive heart failure (NYHA III-IV) and pretreated with digoxin received muzolimine over 14 days in an open clinical study." | 3.67 | Muzolimine therapy in patients with congestive heart failure in comparison with furosemide pretreatment. Effect on digoxin plasma concentration. ( Ertl, G; Kahles, H; Kochsiek, K; Liebau, G; Riegger, G, 1985) |
| "Excretion of VMA was measured in 10 healthy volunteers before and after intake of 40 mg furosemide and in 3 patients with congestive heart failure who were intermittently treated with 80 mg furosemide." | 3.67 | Effect of furosemide on urinary excretion of 4-hydroxy-3-methoxymandelic acid (VMA). ( Bursztyn, M; Gutman, A, 1985) |
| "High dose furosemide is commonly used in renal failure to induce diuresis but rarely employed in cardiac failure." | 3.67 | High dose furosemide in refractory cardiac failure. ( Kuchar, DL; O'Rourke, MF, 1985) |
| "To define the short-term haemodynamic, hormonal and electrolyte effects of enalapril in chronic heart failure, we administered it to nine patients." | 3.66 | Acute haemodynamic, hormonal and electrolyte effects and short-term clinical response to enalapril in heart failure. ( Espiner, EA; Fitzpatrick, D; Ikram, H; Nicholls, MG, 1983) |
| "Pharmacokinetic and haemodynamic studies with the alpha-1 adrenoceptor antagonist prazosin were made in 20 patients disabled by chronic ischaemic heart failure." | 3.66 | The pharmacokinetic, pharmacodynamic and haemodynamic effects of acute and chronic alpha-adrenoceptor blockade in chronic heart failure. ( Silke, B; Taylor, SH, 1981) |
| "Twenty patients with severe hypertension and chronic renal failure were given Captopril during a one year period." | 3.66 | [Long-term treatment with captopril in arterial hypertension complicated by renal failure]. ( Ader, JL; Bories, P; Durand, D; Emal, V; Girolami, JP; Suc, JM, 1982) |
| "The effects of long-term therapy with captopril (CPT) were studied in 11 patients with severe chronic congestive heart failure (CHF)." | 3.66 | Variable clinical response to long-term angiotensin inhibition in severe heart failure: demonstration of additive benefits of alpha-receptor blockade. ( Frishman, W; Kugler, J; LeJemtel, TH; Maskin, CS; Sonnenblick, EH, 1982) |
| " Since important interrelationships between haemodynamic and hormone indices are possible in cardiac failure, measurements of cardiac output, mean pulmonary artery pressure, plasma renin activity, angiotensin II and aldosterone were carried out before and during acute and chronic frusemide therapy in patients with oedematous heart failure who had been given digoxin." | 3.66 | Haemodynamic and hormone responses to acute and chronic frusemide therapy in congestive heart failure. ( Chan, W; Espiner, EA; Ikram, H; Nicholls, MG, 1980) |
| "A 4-year-old Quarter Horse gelding with atrial fibrillation, mitral regurgitation, and signs of bilateral congestive heart failure was initially treated IV with digoxin and furosemide." | 3.66 | Medical management of congestive heart failure in a horse. ( Brumbaugh, GW; Hodge, TG; Thomas, WP, 1982) |
| "Changes in response to furosemide and other diuretics in patients with congestive heart failure (CHF) could occur because of disease-induced changes in absorption of the drug or changes in disposition which affect its access to its site of action." | 3.66 | Absorption and disposition of furosemide in congestive heart failure. ( Anderson, S; Brater, DC; Burdette, A; Chennavasin, P; Dehmer, GJ; Seiwell, R, 1982) |
| "A wide interindividual variation in the degree of diuresis produced following treatment with furosemide has been observed in infants with congestive heart failure." | 3.66 | Determinants of the diuretic response to furosemide in infants with congestive heart failure. ( Green, TP; Mirkin, BL, 1982) |
| "The diuretic effect of furosemide was studied in 18 patients with congestive heart failure." | 3.66 | Effect of furosemide in congestive heart failure. ( Akimoto, T; Arita, T; Minami, M; Miyazaki, K; Nomura, A; Yasuda, H, 1981) |
| "Clinical and cardiovascular responses to drug therapy with furosemide were compared with those to furosemide plus digoxin in 15 heart patients with sinus rhythm admitted to the hospital for the management of congestive heart failure." | 3.66 | The role of furosemide alone and in combination with digoxin in the relief of symptoms of congestive heart failure. ( Hutcheon, D; Nemeth, E; Quinlan, D, 1980) |
| "We studied 10 patients with congestive heart failure to assess the dynamics of their response to 40 mg of furosemide." | 3.66 | Furosemide in patients with heart failure: shift in dose-response curves. ( Brater, DC; Chennavasin, P; Seiwell, R, 1980) |
| " This report describes 74 patients who had severe congestive heart failure treated with a combination of furosemide and spironolactone in whom this complication developed." | 3.66 | Treatment of refractory congestive heart failure and normokalemic hypochloremic alkalosis with acetazolamide and spironolactone. ( Khan, MI, 1980) |
| "Sudden withdrawal of oral therapy with hydralazine for reduction of afterload in a patient precipitated severe congestive heart failure." | 3.66 | Precipitation of heart failure following sudden withdrawal of hydralazine. ( Black, JR; Mehta, J, 1979) |
| "Four dogs with congestive heart failure associated with dirofilariasis and mitral valvular incompetence initially responded to treatment with digoxin or etamiphylline camsylate, and frusemide but became refractory to this therapy and were in cardiac decompensation." | 3.66 | The use of alpha blockade in the treatment of congestive heart failure associated with dirofilariasis and mitral valvular incompetence. ( Atwell, RB, 1979) |
| "An open trial was carried out on ten middle-aged and elderly patients in cardiac failure to assess the effect on plasma potassium levels of one or more tablets containing 40 mg frusemide and a controlled-release formulation containing 600 mg potassium chloride." | 3.66 | The effect on plasma potassium of a combined preparation of frusemide and slow-release potassium chloride (Diumide-K Continus tablets). ( Lewis, JG, 1979) |
| "Furosemide was administered intravenously to 11 patients with cardiac failure after acute myocardial infarction." | 3.66 | [Hemodynamic consequences of the furosemide treatment of cardiac insufficiency in recent myocardial infarct]. ( Baitsch, G; Bertel, O; Burkart, F; Ritz, R; Steiner, A; Vettiger, K, 1979) |
| "In two patients with severe hypertension and moderately severe renal insufficiency, metolazone and furosemide were used in combination with propranolol, methyldopa, and hydralazine to augment control of blood pressure." | 3.66 | Severe electrolyte disturbances associated with metolazone and furosemide. ( Black, WD; Roman, J; Shiner, PT, 1978) |
| "Severe tachycardia, ventricular ectopy, and sodium retention manifested by hemodynamic deterioration developed with hydralazine hydrochloride therapy in chronic coronary heart disease with congestive failure refractory to digitalis, diuretics, and nitrates." | 3.66 | Hydralazine-induced tachycardia and sodium retention in heart failure. Hemodynamic and symptomatic correction by prazosin therapy. ( Amsterdam, EA; DeMaria, AN; Laslett, LJ; Mason, DT, 1978) |
| " Symptomatic relief occurred as body weight was reduced, and after a 'dry' basal weight had been achieved, progressive-load exercise testing was done to examine any benefit that derived from adding oral digoxin to the diuretic." | 3.66 | The clinical value of digoxin in patients with heart failure and sinus rhythm. ( Guz, A; McHaffie, D; Mitchell-Heggs, P; Purcell, H, 1978) |
| "Dark red nodules that drained an opaque amber liquid developed on the extensor surfaces of both legs in a 69-year-old woman receiving furosemide and spironolactone for congestive heart failure." | 3.65 | Panniculitis of the legs with urate crystal deposition. ( Niemi, KM, 1977) |
| "The renin-angiotensin-aldosterone system and electrolyte levels in 11 patients with heart failure controlled on digoxin and frusemide were investigated after separate periods of Slow K, spironolactone, and amiloride therapy." | 3.65 | Effect of potassium-sparing diuretics on the renin-angiotensin-aldosterone system and potassium retention in heart failure. ( Espiner, EA; Hughes, H; Nicholls, MG; Rogers, T, 1976) |
| "Twenty-six patients were selected for treatment with minoxidil on the basis of hypertension which could not be controlled either because of (1) drug failures and/or (2) side effects of drugs." | 3.65 | Minoxidil in severe hypertension: value when conventional drugs have failed. ( Dormois, JC; Nies, AS; Young, JL, 1975) |
| "Six cases of edema, three due to the nephrotic syndrome, one to congestive heart failure and two to chronic renal failure, are reported in which furosemide was administered in oral doses higher than those usually prescribed (up to 720 mg." | 3.65 | Experiences with high doses of furosemide in renal disease and resistant edematous states. ( Baltzan, MA; Baltzan, RB; Silverberg, DS; Ulan, RA, 1970) |
| "31% of patients had type 2 diabetes mellitus (DM2)." | 3.30 | The use of Dapagliflozin in Acute Decompensated Heart Failure: Results of the Randomized Study. ( Andreev, DA; Charaya, KV; Dimchishina, AS; Kusova, ZR; Mesitskaya, DF; Nikiforova, TV; Novikova, NA; Schekochikhin, DIY; Shkliarov, AM; Soboleva, TV, 2023) |
| "31% of patients had type 2 diabetes mellitus (DM2)." | 3.30 | The use of Dapagliflozin in Acute Decompensated Heart Failure: Results of the Randomized Study. ( Andreev, DA; Charaya, KV; Dimchishina, AS; Kusova, ZR; Mesitskaya, DF; Nikiforova, TV; Novikova, NA; Schekochikhin, DY; Shkliarov, AM; Soboleva, TV, 2023) |
| "Although acute heart failure (AHF) with volume overload is treated with loop diuretics, their dosing and type of administration are mainly based upon expert opinion." | 3.01 | Rationale and Design of the Efficacy of a Standardized Diuretic Protocol in Acute Heart Failure Study. ( Al Balbissi, K; Alhaddad, IA; Barge-Caballero, G; Barker, D; Benkouar, R; Borbély, A; Bovolo, V; Bruckers, L; Cobo-Marcos, M; Dauw, J; de la Espriella, R; Doghmi, N; Fialho, I; Findeisen, H; Frea, S; George, V; Ghazi, AM; Klincheva, M; Knappe, D; Lekhakul, A; Lelonek, M; Martens, P; Miró, Ò; Mullens, W; Nasr, S; Paredes-Paucar, CP; Ross, NT; Shchekochikhin, D; Singh, JS; van den Heuvel, M; Zara, C; Zegri-Reiriz, I, 2021) |
| "Acute heart failure is a frequent cause of hospital admission in Portugal, and has an increasing tendency given the aging population." | 3.01 | Co-Administration of Albumin and Furosemide in Acute Heart Failure with Diuretics Resistance. ( Araújo, I; Bonifácio, D; Branco, P; Costa, R; Fernandes, J; Fonseca, C; Guerreiro, R; Henriques, C; Rodrigues, A, 2023) |
| " The lower Na and SBP in this instance should not lead to withholding or minimising diuretic dosage which should rather be dictated by volume status." | 2.94 | Higher Diuretic Requirements in Acute Heart Failure With Admission Hyponatraemia Versus Normonatraemia. ( Guglin, M; Omar, HR, 2020) |
| "CLOROTIC is the first large-scale trial to evaluate whether the addition of a thiazide diuretic (hydrochlorothiazide) to a loop diuretic (furosemide) is a safe and effective strategy for improving congestive symptoms resulting from HF." | 2.82 | Rationale and Design of the "Safety and Efficacy of the Combination of Loop with Thiazide-type Diuretics in Patients with Decompensated Heart Failure (CLOROTIC) Trial:" A Double-Blind, Randomized, Placebo-Controlled Study to Determine the Effect of Combin ( Casado, J; Formiga, F; Freitas Ramírez, A; Manzano, L; Morales-Rull, JL; Trullàs, JC, 2016) |
| "Loop diuretics used in the treatment of heart failure often induce renal impairment." | 2.82 | Early administration of tolvaptan preserves renal function in elderly patients with acute decompensated heart failure. ( Hasegawa, T; Ikeda, U; Izawa, A; Kimura, K; Misawa, T; Momose, T; Morita, T; Motoki, H, 2016) |
| "Intravenous loop diuretics are still the cornerstone of therapy in acute decompensated heart failure, however, the optimal dosage and administration strategies remain poorly defined particularly in patients with an associated renal dysfunction." | 2.80 | Short and long-term effects of continuous versus intermittent loop diuretics treatment in acute heart failure with renal dysfunction. ( Angelini, GD; Beltrami, M; Franci, B; Gonnelli, S; Nuti, R; Palazzuoli, A; Pellegrini, M; Ruocco, G, 2015) |
| " Further studies are necessary to evaluate potential pharmacodynamic differences between torasemide formulations and to assess its impact on clinical therapeutics." | 2.80 | Randomized, open-label, blinded-endpoint, crossover, single-dose study to compare the pharmacodynamics of torasemide-PR 10 mg, torasemide-IR 10 mg, and furosemide-IR 40 mg, in patients with chronic heart failure. ( Antonijoan, RM; Ballester, MR; Delgadillo, J; Gich, I; Puntes, M; Roig, E; Santos, B, 2015) |
| " No significant differences in adverse events were noted." | 2.79 | Efficacy and safety of high dose versus low dose furosemide with or without dopamine infusion: the Dopamine in Acute Decompensated Heart Failure II (DAD-HF II) trial. ( Antoniou, CK; Butler, J; Chrysohoou, C; Filippatos, G; Giamouzis, G; Giannakoulas, G; Kalogeropoulos, AP; Karayannis, G; Karvounis, H; Koutrakis, K; Mantziari, L; Nastas, J; Parisis, C; Parissis, J; Pitsavos, C; Rovithis, D; Skoularigis, J; Starling, RC; Stefanadis, C; Triposkiadis, FK; Tsaknakis, T; Wolski, K, 2014) |
| "Mean furosemide dose on day 0 was 5." | 2.77 | Effect of torsemide and furosemide on clinical, laboratory, radiographic and quality of life variables in dogs with heart failure secondary to mitral valve disease. ( Machen, MC; Oyama, MA; Peddle, GD; Reynolds, CA; Singletary, GE; Trafny, DJ, 2012) |
| "Results from the DOSE-AHF study suggest that an initial continuous infusion of loop diuretics is not superior to bolus dosing with regard to clinical endpoints in acute heart failure." | 2.77 | Effect of admission oral diuretic dose on response to continuous versus bolus intravenous diuretics in acute heart failure: an analysis from diuretic optimization strategies in acute heart failure. ( Braunwald, E; Felker, GM; Givertz, MM; McNulty, S; O'Connor, CM; Shah, RV, 2012) |
| "Furosemide was administered intravenously at 75% of the usual oral morning dose." | 2.76 | Activity with ambulation attenuates diuretic responsiveness in chronic heart failure. ( Chan, CT; Floras, JS; Galiwango, PJ; Ivanov, J; McReynolds, A, 2011) |
| " Although loop diuretics are used in nearly all patients with ADHF to relieve congestive symptoms, optimal dosing strategies remain poorly defined." | 2.75 | Continuous versus intermittent infusion of furosemide in acute decompensated heart failure. ( Dunn, SP; Hollis, IB; Nappi, JM; Rodgers, JE; Thomson, MR; Van Bakel, AB, 2010) |
| " However, the limited clinical data comparing dosing schemes are confounded." | 2.75 | Continuous versus bolus dosing of Furosemide for patients hospitalized for heart failure. ( Allen, LA; Cotter, G; Dewald, T; O'Connor, CM; Stough, WG; Turer, AT, 2010) |
| "Thiamine levels were determined using the erythrocyte transketolase activity." | 2.73 | Influence of spironolactone therapy on thiamine blood levels in patients with heart failure. ( Albanesi Filho, FM; de Albuquerque, DC; Rocha, RM; Silva, GV; Tura, BR, 2008) |
| "Weight loss was defined as the difference between baseline and last in-hospital weight." | 2.73 | Relation between dose of loop diuretics and outcomes in a heart failure population: results of the ESCAPE trial. ( Adams, KF; Califf, RM; Gattis Stough, W; Hasselblad, V; Lokhnygina, Y; O'Connor, CM; Shah, MR, 2007) |
| "The occurrence of renal failure is associated to an increased death risk." | 2.73 | Hypertonic saline solution for renal failure prevention in patients with decompensated heart failure. ( Azevedo, CH; Bacal, F; Bocchi, EA; Carneiro, RM; Chizzola, PR; Ferreira, SM; Issa, VS; Mangini, S, 2007) |
| "MDC of HF remains cost-beneficial when combined with optimal, medical care." | 2.71 | Is multidisciplinary care of heart failure cost-beneficial when combined with optimal medical care? ( Barry, M; Cahill, J; Ledwidge, M; Maurer, B; McDonald, K; Ryan, E; Ryder, M; Timmons, L; Travers, B, 2003) |
| "In patients with decompensated chronic congestive heart failure (CHF), intensive unloading therapy allows an acute decrease in ventricular filling pressures and improves long-term prognosis." | 2.71 | Hemodynamic response to intensive unloading therapy (furosemide and nitroprusside) in patients >70 years of age with left ventricular systolic dysfunction and decompensated chronic heart failure. ( Cioffi, G; Opasich, C; Stefenelli, C; Tarantini, L, 2003) |
| "Metolazone is a potent thiazide-like diuretic." | 2.71 | Combination therapy with metolazone and loop diuretics in outpatients with refractory heart failure: an observational study and review of the literature. ( Galatius, S; Gustafsson, F; Hildebrandt, PR; Rosenberg, J, 2005) |
| "Thirty-one patients with congestive heart failure who underwent only a single thoracentesis after diuretic therapy served as controls." | 2.70 | Influence of diuretics on the concentration of proteins and other components of pleural transudates in patients with heart failure. ( Fernández, C; Hernández, L; Martín, C; Romero-Candeira, S; Sánchez-Paya, J, 2001) |
| "In patients with congestive heart failure on standard therapy, including ACE inhibitors, BG9719 increased both urine output and GFR." | 2.70 | BG9719 (CVT-124), an A1 adenosine receptor antagonist, protects against the decline in renal function observed with diuretic therapy. ( Abraham, WT; Beckman, E; Bennett, D; Bourge, R; Brater, DC; Dyer, F; Goldman, S; Gomez, M; Gottlieb, SS; Havranek, E; Thomas, I; Ticho, B, 2002) |
| "The management of patients with congestive heart failure (CHF) can place a significant economic burden on managed care organizations, leading providers to seek treatments that are cost-effective." | 2.69 | A pharmacoeconomic assessment of torsemide and furosemide in the treatment of patients with congestive heart failure. ( Noe, LL; Pezzella, SM; Trotter, JP; Vreeland, MG, 1999) |
| "N-BNP-guided treatment of heart failure reduced total cardiovascular events, and delayed time to first event compared with intensive clinically guided treatment." | 2.69 | Treatment of heart failure guided by plasma aminoterminal brain natriuretic peptide (N-BNP) concentrations. ( Espiner, EA; Frampton, CM; Nicholls, MG; Richards, AM; Troughton, RW; Yandle, TG, 2000) |
| "Ventricular arrhythmias detected on 24 hour Holter monitoring didn't differ between the study groups." | 2.69 | [Comparison of the therapeutic efficacy of spironolactone and furosemide in patients with severe congestive heart failure]. ( Bednarz, B; Chamiec, T; Cybulski, J, 2000) |
| " On long term evaluation in an open design (Phase II), wherein Phase I participants continued Terminalia Arjuna in fixed dosage (500 mg 8-hourly) in addition to flexible diuretic, vasodilator and digitalis dosage for 20-28 months (mean 24 months) on outpatient basis, patients showed continued improvement in symptoms, signs, effort tolerance and NYHA Class, with improvement in quality of life." | 2.68 | Salutary effect of Terminalia Arjuna in patients with severe refractory heart failure. ( Bharani, A; Bhargava, KD; Ganguly, A, 1995) |
| " All patients received three dosing regimens administered in random order: (a) intravenous frusemide: 40 mg bolus then 40 mg h-1 for 3 h, (b) captopril: two 12." | 2.68 | The renin angiotensin aldosterone system and frusemide response in congestive heart failure. ( Cerimele, B; Greene, P; Reed, S; Ryan, T; Schwertschlag, U; Voelker, J; Weinberger, M, 1995) |
| "Peak reactive hyperemia (mL." | 2.68 | Nonselective beta-adrenergic blockade with carvedilol does not hinder the benefits of exercise training in patients with congestive heart failure. ( Bijou, R; Demopoulos, L; Gentilucci, M; Jones, M; Katz, SD; LeJemtel, TH; Mancini, D; Testa, M; Yeh, M, 1997) |
| "In moderate congestive heart failure pulmonary overhydration may be detected at chest X-ray even if therapy is optimized to keep the urinary output normal and to prevent weight gain and dependent edema formation." | 2.67 | [Body fluid withdrawal with isolated ultrafiltration effects persistent improvement of functional capacity in patients with chronic congestive heart failure. Furosemide does not produce the same result]. ( Agostoni, P; Guazzi, M; Lauri, G; Marenzi, G; Perego, GB; Sganzerla, P, 1994) |
| "Prazosin pre-treatment did not alter any of the renal responses to frusemide treatment (mean dose 85 +/- 14 mg)." | 2.67 | Renal effects of low dose prazosin in patients with congestive heart failure. ( Choy, AM; Lang, CC; Rahman, AR; Struthers, AD, 1993) |
| "Thus, patients with severe chronic congestive heart failure display metabolic derangement in muscle, which, in this study, was not corrected by treatment with enalapril." | 2.67 | Muscle energy metabolism in severe chronic congestive heart failure--effect of treatment with enalapril. ( Broqvist, M; Dahlström, U; Karlsson, E; Larsson, J, 1992) |
| " Oral medication and water intake were standardized; furosemide dosage was adjusted on a daly basis, allowing the study of this drug's requirements in each group." | 2.67 | [Diet with usual quantity of salt in hospital treatment of congestive heart insufficiency]. ( Alonso, RR; Barretto, AC; Bellotti, G; Ciscato, CM; Pileggi, F; Velloso, LG, 1991) |
| "Ibopamine is a novel oral dopamine analogue with positive inotropy and diuretic effects." | 2.67 | [Renal effects of ibopamine in comparison with furosemide in patients with mild heart failure]. ( Gerzer, R; Theisen, K; Wehling, M; Weil, J; Zimmermann, J, 1990) |
| "In 50 patients with chronic congestive heart failure (CCHF, III or IV class), aged 62." | 2.67 | [Effect of vasodilator agents on the character and incidence of cardiac arrhythmia in chronic heart failure]. ( Bechler-Lisińska, J; Cholewa, M; Górski, L; Markiewicz, K, 1990) |
| "Mild congestive cardiac failure symptoms (raised jugular venous pressure, oedema and dyspnoea at rest and on effort) were controlled in 9/10 patients receiving frusemide/amiloride but two patients receiving bumetanide/potassium chloride still had mild oedema after 8 weeks." | 2.67 | An open, randomized comparative study of a low-strength frusemide/amiloride combination and bumetanide/potassium chloride in the treatment of mild congestive cardiac failure. ( Allman, S; Dalton, K; Finnamore, VP; Latta, D, 1990) |
| "A total of 71 patients with cardiac failure requiring diuretic treatment were randomly allocated to receive either 20 mg frusemide/2." | 2.67 | An open, parallel group study comparing a frusemide/amiloride diuretic and a diuretic containing cyclopenthiazide with sustained release potassium in the treatment of congestive cardiac failure--a multicentre general practice study. ( Allman, S; Norris, RJ, 1990) |
| "Ibopamine does not produce undesirable renal side effects, but affects the neurohumoral status favourably." | 2.67 | Extracardial effects of oral ibopamine versus furosemide in patients with mild or moderate heart failure. A double-blind, randomized trial. ( Theisen, K; Wehling, M; Zimmermann, J, 1990) |
| "Diuretics are a cornerstone in treatment of heart failure (HF)." | 2.66 | Torasemide versus furosemide in treatment of heart failure: A systematic review and meta-analysis of randomized controlled trials. ( Al-Habbaa, A; Eid, PS; Elkady, AH; Elsayed, GG; Elshafay, A; Hirayama, K; Huy, NT; Kien, ND; Minh, LHN; Mohammed, AT; Morra, ME; Nghia, TLB; Sherif, NA; Thanh, LV; Turk, T; Y, MN, 2020) |
| "Heart failure is one of the most common disorders after malignant diseases." | 2.66 | [The Role of Pharmacists in Home Medical Care of Patients with Heart Failure]. ( Gyoda, Y; Kawauchi, J; Oikawa, Y; Sakuma, E; Watanabe, J, 2020) |
| " Frusemide in a dosage of 0." | 2.66 | A comparison of intravenous elantan and frusemide in patients with chronic cardiac failure. ( Hutton, I; Martin, W; McGhie, AI; Tweddel, AC, 1987) |
| "In the long-term therapy of congestive heart failure hydrochlorothiazide together with potassium-sparing amiloride is a pleasant and effective therapy for patients with normal renal function, but the risk of hypokalaemia must be kept in mind also when using this combination." | 2.65 | The effect of amiloride/hydrochlorothiazide combination vs furosemide plus potassium supplementation in the treatment of oedema of cardiac origin. ( Huikko, M; Varjoranta, K; Viherkoski, M, 1981) |
| "In a random crossover study in general practice, sixty patients with heart failure were given one week's maintenance treatment with the recommended dosage of Burinex K or Lasix+K." | 2.64 | Patient acceptability of two diuretic/potassium supplement preparations. ( Bennion-Pedley, J; Donald, JF; Gould, CH; Lomas, DM; Postlethwaite, DL; Rivlin, R, 1976) |
| "Advanced congestive heart failure (CHF) therapies include intravenous inotropic agents, change in class of diuretics, and venous ultrafiltration or hemodialysis." | 2.50 | Hypertonic saline with furosemide for the treatment of acute congestive heart failure: a systematic review and meta-analysis. ( Gandhi, S; Mosleh, W; Myers, RB, 2014) |
| "Although treatment of acute heart failure is based primarily on the administration of intravenous loop diuretics, evidence supporting this practice is still scarce and there is uncertainty about the optimal dose." | 2.50 | [Alternatives to conventional diuretic therapy in heart failure]. ( Formiga, F; Morales-Rull, JL; Trullàs, JC, 2014) |
| " Despite being available for decades, few randomized trials exist to guide dosing and administration of these drugs." | 2.48 | Diuretic dosing in acute decompensated heart failure: lessons from DOSE. ( Campbell, PT; Ryan, J, 2012) |
| " It is a high-ceiling diuretic that has a longer half-life, longer duration of action and higher bioavailability compared to furosemide." | 2.46 | [Update: prolonged-release torasemide]. ( Acuña, C, 2010) |
| " Torasemide has been developed as a newer type of loop diuretic with a longer half-life, longer duration of action, and higher bioavailability compared to the most commonly used loop diuretic, furosemide." | 2.44 | Torasemide for the treatment of heart failure. ( Ishido, H; Senzaki, H, 2008) |
| "Levosimendan has shown lower mortality compared to dobutamine in patients with acute congestive heart failure." | 2.43 | [Medical and ventilatory treatment of acute heart failure]. ( Atar, D; Hodt, A; Steine, K, 2006) |
| "The cardiorenal syndrome is not well understood, and a uniform definition is lacking." | 2.43 | Acute decompensated heart failure: the cardiorenal syndrome. ( Francis, G, 2006) |
| "Hyponatremia is common and associated with adverse outcomes in patients with congestive heart failure (CHF)." | 2.43 | Treating hyponatremia in heart failure. ( Goldsmith, SR, 2006) |
| " Torasemide also has a high bioavailability and is only slightly influenced by meals in humans." | 2.41 | [Torasemide (LUPRAC): a review of its pharmacological and clinical profile]. ( Kido, H; Ohtaki, Y, 2001) |
| "Most frequently, diuretic therapy in congestive heart failure has as its main objective ridding the lungs of water." | 2.38 | Loop diuretics versus others in the treatment of congestive heart failure after myocardial infarction. ( Reyes, AJ, 1993) |
| " A dose-response relationship has been established for the effect of amiloride in reducing fractional excretion of magnesium and potassium during frusemide diuresis in rats." | 2.37 | Effects of diuretics on the renal handling of magnesium. ( Counihan, TB; Devane, J; Ryan, MF; Ryan, MP, 1984) |
| "Lastly, in patients with congestive heart failure, with intravenous administration, resistance represents a pharmacodynamic phenomenon." | 2.37 | Resistance to loop diuretics. Why it happens and what to do about it. ( Brater, DC, 1985) |
| " In this study, we compared the effectiveness and safety of a continuous infusion with that of a bolus injection when an increased loop diuretic dosage is required in intensive care unit (ICU) patients." | 1.91 | Comparative effectiveness and safety of bolus vs. continuous infusion of loop diuretics: Results from the MIMIC-III Database. ( Chen, Q; Feng, P; He, C; Huo, Y; Jiang, J; Li, J; Li, Y; Nie, X; Sun, W; Weng, H; Zhang, Y; Zhao, F, 2023) |
| "We analyzed the prescription and dosage of essential pharmacotherapy in chronic heart failure (HF) at the time of discharge from the hospitalization for cardiac decompensation and how it may have influenced the prognosis of the patients." | 1.91 | Dosing of basic pharmacotherapy and its effect on the prognosis of patients hospitalized for heart failure. ( Bílková, S; Bruthans, J; Jirák, J; Krynský, T; Mayer, O, 2023) |
| "While rare, improvement in mitral regurgitation severity may occur without surgical intervention, allowing for reverse left-sided cardiac remodeling and discontinuation of furosemide." | 1.91 | Resolution of congestive heart failure and reverse remodeling in two Chihuahuas with flail mitral valve leaflets. ( Wesselowski, S, 2023) |
| "The role of taurine in the treatment of congestive heart failure (CHF) in dogs without systemic deficiency is unexplored." | 1.91 | The effect of taurine supplementation on the renin-angiotensin-aldosterone system of dogs with congestive heart failure. ( Adin, D; Brethel, S; Girens, R; Locker, S; Meurs, K; Rivera, P, 2023) |
| "On echocardiography, the left ventricular hypertrophy, identified earlier, shoed partial regression." | 1.91 | Heart failure in a cat due to hypertrophic cardiomyopathy phenotype caused by chronic uncontrolled hyperthyroidism. ( Chae, Y; Kang, BT; Kim, H; Koo, Y; Lee, D; Lee, H; Park, J; Yang, MP; Yun, T, 2023) |
| "There is substantial variability amongst physicians and between cardiologists and non-cardiologists in the management of patients with ADHF, with regard to clinical parameters used to tailor treatment, treatment goals, diuretic dosing and escalation strategies." | 1.91 | Decongestion strategies in patients presenting with acutely decompensated heart failure: A worldwide survey among physicians. ( Agaoglu, E; Chioncel, O; Coats, AJS; Filippatos, G; Kapelios, CJ; Lopatin, Y; Metra, M; Mullens, W; Rosano, G; Seferovic, P; Vazir, A, 2023) |
| " SCF was an effective and safe diuretic strategy for outpatient congestion management." | 1.72 | Efficacy and Safety of Subcutaneous Infusion of Non-formulated Furosemide in Patients with Worsening Heart Failure: a Real-World Study. ( Civera, J; Conesa, A; de la Espriella, R; Heredia, R; Martínez, A; Miñana, G; Mollar, A; Núñez, J; Santas, E; Sastre, C; Villaescusa, A, 2022) |
| "Spironolactone treatment demonstrated significant attenuation of cardiac fibrosis and apoptosis in left ventricular tissue compared to furosemide." | 1.72 | Mineralocorticoid Receptor Antagonists Mitigate Mitral Regurgitation-Induced Myocardial Dysfunction. ( Chang, WT; Chen, CY; Chen, ZC; Lin, YW; Liu, PY; Luo, CY; Shih, JY; Wu, CC, 2022) |
| "This study examined the combined effect of diuretic dosage and UNa concentration in chronic HF." | 1.62 | The ratio of furosemide dosage to urinary sodium concentration predicts mortality in patients with chronic stable heart failure. ( Amorim, M; Araújo, JP; Bettencourt, P; Elias, C; Lourenço, P; Oliveira, D; Soares-Carreira, M, 2021) |
| "Chronic heart failure is a condition associated with ageing, affecting 1-2% of the adult population, raising to 70% of the adult population over 70 years of age." | 1.62 | Intravenous diuretic administration in the home environment. ( Payne, D, 2021) |
| "Diabetes mellitus has been suggested as a determinant of diuretic resistance." | 1.56 | Diabetic patients need higher furosemide doses: a report on acute and chronic heart failure patients. ( Bettencourt, P; Cunha, FM; Lourenço, P; Marques, P; Pereira, J; Ribeiro, A, 2020) |
| "Pilsicainide (75 mg/day) was administered to reduce the LVOTO." | 1.56 | Development of Pulmonary Edema Despite Negative Fluid Balance with Diuretics in a Patient with Heart Failure and Sigmoid Septum. ( Kamono, M; Komatsu, R; Miyazaki, K; Onuma, Y, 2020) |
| " At initiation, median torasemide dosage was 0." | 1.56 | Tolerance of torasemide in cats with congestive heart failure: a retrospective study on 21 cases (2016-2019). ( Alvarado, MP; Barbarino, A; Chetboul, V; Delle Cave, J; Depré, B; Ghazal, S; Lefort, S; Marchal, CR; Passavin, P; Poissonnier, C; Saponaro, V; Tissier, R; Trehiou-Sechi, E; Vannucci, E; Verwaerde, P, 2020) |
| "Eight healthy dogs, 6 dogs with congestive heart failure (CHF)." | 1.56 | Prediction and measurement of diuretic responsiveness after oral administration of furosemide to healthy dogs and dogs with congestive heart failure. ( Huh, T; Larouche-Lebel, É; Loughran, KA; Oyama, MA; Rao, VS; Testani, JM, 2020) |
| "Furosemide was by far the most common diuretic given and the initial intravenous dose was only 20 mg in more than half of ICU admissions." | 1.51 | Patterns of diuretic use in the intensive care unit. ( Chang, TI; Chertow, GM; McCoy, IE, 2019) |
| " This study suggests that chronic administration of captopril, but not furosemide, could be beneficial in patients with HFpEF, particularly in those with comorbidities such as obesity, diabetes, and dyslipidemias." | 1.48 | Captopril Attenuates Cardiovascular and Renal Disease in a Rat Model of Heart Failure With Preserved Ejection Fraction. ( Bastacky, SI; Jackson, EK; Salah, EM; Tofovic, SP, 2018) |
| "Patients with diabetic nephropathy develop nephrotic syndrome and may show limited response to conventional therapy." | 1.48 | Tolvaptan alleviates excessive fluid retention of nephrotic diabetic renal failure unresponsive to furosemide. ( Hoshiyama, A; Kamata, Y; Masaki, T; Shichiri, M; Takada, T; Toki, T, 2018) |
| "Arterial hypertension was the leading indication for furosemide (38." | 1.48 | [Evaluation of the prescription of furosemide in persons aged 75years and older in a geriatric acute-care unit]. ( Asgassou, S; Buttard, M; d'Athis, P; Deïdda, M; Dipanda, M; Laborde, C; Mahmoudi, R; Manckoundia, P; Pioro, L; Putot, A; Putot, S, 2018) |
| "Hyponatremia is the most common electrolyte abnormality found in hospitalized patients with acute heart failure (AHF) and is related to poor prognosis." | 1.48 | Hyponatremia in Acute Heart Failure in Relation to Hematocrit Levels: Clinical Relevance and Prognostic Implication. ( Nuti, R; Palazzuoli, A; Ruocco, G; Verbrugge, FH, 2018) |
| "Furosemide was considered a long-term therapy for almost all patients (98." | 1.46 | Potentially inappropriate use of furosemide in a very elderly population: An observational study. ( Asgassou, S; d'Athis, P; Dipanda, M; Guepet, H; Manckoundia, P; Mazen, E; Menu, D; Perrin, S; Putot, A; Rodriguez-Cillero, C, 2017) |
| "Pharmacological treatment for heart failure involves different drugs as: angiotensin-converting enzyme inhibitors, B-adrenergic blockers, digitalis glycosides and diuretics." | 1.46 | [Analysis of the mitochondrial function and ultrastructure in healthy albino mice treated with heart failure medications] ( Baez, A; Bazán, C; Camino Willhuber, GO; Fretes, R; Guzman Mentesana, G; Lo Presti, S; Paglini-Oliva, PA; Rivarola, HW; Strauss, M, 2017) |
| "Extrinsic tricuspid valve stenosis was detected by transthoracic echocardiography." | 1.46 | [Heart failure provoked by a pacemaker lead-induced tricuspid stenosis]. ( Chaudesaygues, E; Ferrini, M; Ritz, B, 2017) |
| " Further efforts in this series led to the discovery of analogs with improved pharmacokinetic profiles." | 1.43 | Discovery of a potent and selective ROMK inhibitor with improved pharmacokinetic properties based on an octahydropyrazino[2,1-c][1,4]oxazine scaffold. ( Alonso-Galicia, M; Bailey, T; Brochu, RM; de Jesus, RK; Ding, FX; Ehrhart, J; Felix, JP; Garcia, ML; Gu, X; Ha, S; Hampton, C; Hernandez, M; Jiang, J; Kaczorowski, GJ; Owens, K; Pai, LY; Parmee, ER; Pasternak, A; Pio, B; Priest, BT; Roy, S; Shahripour, A; Sullivan, K; Swensen, AM; Tang, H; Teumelsan, N; Thomas-Fowlkes, B; Walsh, SP; Yang, L; Zhou, X; Zhu, Y, 2016) |
| " Diuretic dosing was derived from the maintenance oral loop diuretic dose with a standardized conversion algorithm." | 1.43 | Intravenous Diuretic Therapy for the Management of Heart Failure and Volume Overload in a Multidisciplinary Outpatient Unit. ( Belenkiy, RM; Buckley, LF; Burpee, LJ; Carter, DM; Cheng, JW; Desai, AS; Matta, L; Smallwood, JA; Stevens, C; Stevenson, LW; Weiffenbach, CS; Young, MA, 2016) |
| "Echocardiography showed 73% dilated cardiomyopathy; 83% showed moderate to severe LV systolic dysfunction (mean EF 36." | 1.43 | Clinical and echocardiographic characteristics and outcomes in congestive heart failure at the Hospital of The State University of Haiti. ( Malebranche, R; Morisset, PH; Raphael, NA; Tabou Moyo, C; Wilentz, JR, 2016) |
| "Treatment with furosemide initially reduced ascites, but the clinical condition worsened weeks later and enalapril, pimobendan, and sildenafil were added to the medical therapy." | 1.43 | Right Heart Failure in an African Penguin ( Spheniscus demersus ). ( Bossart, G; Camus, A; Clauss, T; Cusack, L; Field, C; McDermott, A; Pogue, B, 2016) |
| "Babies with SS presenting with cardiac failure are prone to develop exaggerated pulmonary vascular disease." | 1.42 | Scimitar syndrome with absent right pulmonary artery and severe pulmonary hypertension treated with coil occlusion of aortopulmonary collaterals in a term neonate. ( Masud, F; Parappil, H; Salama, H; ur Rahman, S, 2015) |
| "Congenital hepatic arteriovenous malformations are rarely seen in association with persistent neonatal pulmonary hypertension." | 1.42 | Regression of a large congenital hepatic arteriovenous malformation. ( Agha, HM; Hamza, H; Mostafa, FA; Zakaria, R, 2015) |
| "Large arteriovenous fistulas may result in decreased peripheral resistance and an increase in cardiac output with consequent cardiomegaly and high output heart failure." | 1.40 | Surgical correction of an arteriovenous fistula in a ring-tailed lemur (Lemur catta). ( Boedeker, NC; Guzzetta, P; Murray, S; Newman, K; Padilla, LR; Rosenthal, SL, 2014) |
| "Echocardiography detected left ventricular hypertrophy and diastolic dysfunction." | 1.39 | Pulmonary hypertension and refractory heart failure in a patient with Crow-Fukase (POEMS) syndrome. ( Hisa, S; Kanno, Y; Kobayashi, A; Mizukami, H; Nakazato, K; Noji, H; Ogawa, K; Ohkawara, H; Saitoh, S; Shichishima-Nakamura, A; Suzuki, H; Takahashi, H; Takeishi, Y; Yokokawa, T; Yoshihisa, A, 2013) |
| "In patients with congestive heart failure (CHF), use of loop diuretic therapy may result in acute kidney insufficiency (AKI)." | 1.39 | Predisposing factors for acute kidney injury in Hispanic patients treated with diuretics for decompensated heart failure. ( Cangiano, JL; López, JE; Marmorato, R; Pagán, P; Ramírez, T; Ricci, F; Soto-Salgado, M; Vega, J, 2013) |
| "furosemide dose or were switched furosemide to oral route (fast diuretic response, FDR)." | 1.39 | Tailoring diuretic therapy in acute heart failure: insight into early diuretic response predictors. ( Almeida, S; Bettencourt, P; Carvalho, H; Ferreira, JP; Marques, I; Santos, M, 2013) |
| "Acute myocardial infarction is a rare complication of dobutamine stress echocardiography." | 1.39 | [Acute myocardial infarction complicated by acute pulmonary oedema and cardiogenic collapse during dobutamine stress echocardiography]. ( Diack, B; Diagne-Sow, D; Dioum, M; Kagambega, LJ; Kane, A; Kane, M; Mbaye, A; Yameogo, NV, 2013) |
| "Nitrates were given most often in pulmonary oedema and hypertensive AHF." | 1.39 | Management of acute heart failure and the effect of systolic blood pressure on the use of intravenous therapies. ( Harjola, VP; Lassus, J; Nieminen, MS; Siirilä-Waris, K; Tarvasmäki, T; Tolonen, J, 2013) |
| " Subcutaneous dosing of furosemide has been explored as a potential alternative for management of CHF symptoms." | 1.39 | Intermittent subcutaneous furosemide: parenteral diuretic rescue for hospice patients with congestive heart failure resistant to oral diuretic. ( Bailey, FA; Farless, LB; Steil, N; Williams, BR, 2013) |
| "Pulmonary edema is usually bilateral, but unilateral lobar pulmonary edema can also be encountered in clinical practice." | 1.38 | Unilateral lobar pulmonary edema. ( Lim, TK; Mukhopadhyay, A; Pandya, GJ; Ping, CA, 2012) |
| "Enalapril was continued for 42 days." | 1.38 | Therapeutic challenges and management of heart failure during pregnancy (part I). ( Bilińska, ZT; Czajkowski, K; Dangel, J; Demkow, M; Dzielińska, Z; Konka, M; Kryczka, K; Przybylski, A; Różański, J; Szczudlik, J, 2012) |
| "In humans with congestive heart failure (CHF), better outcome is correlated with lower natriuretic peptide (NP) levels after starting treatment and greater percentage reduction of NP levels." | 1.38 | Lowered N-terminal pro-B-type natriuretic peptide levels in response to treatment predict survival in dogs with symptomatic mitral valve disease. ( Gerlach, N; Klima, A; Weber, K; Wess, G; Wolf, J, 2012) |
| " Dosing of diuretics is difficult in these patients." | 1.37 | Management of diuretic treatment: a challenge in the obese patient. ( Jespersen, B; Lassen, CK, 2011) |
| " Actually, a significant association with ARD was not present in any CHF patient with dilated left ventricle treated with high dosage of iv FUR, whereas a highly significant association with ARD was observed in HFNEF patients (OR: 72 95% CI: 6." | 1.37 | In chronic heart failure with marked fluid retention, the i.v. high doses of loop diuretic are a predictor of aggravated renal dysfunction, especially in the set of heart failure with normal or only mildly impaired left ventricular systolic function. ( Ariano, C; Cantatrione, S; Ciccarelli, A; Cioppa, C; De Vecchis, R; Giasi, A; Pucciarelli, A, 2011) |
| " A post-hoc analysis was performed to determine if there was an interaction between intravenous (iv) bolus diuretic dosing and outcomes." | 1.37 | Impact of diuretic dosing on mortality in acute heart failure using a propensity-matched analysis. ( Follath, F; Gayat, E; Laribi, S; Lassus, J; Mebazaa, A; Nikolaou, M; Parissis, J; Peacock, WF; Salem, R; Yilmaz, MB, 2011) |
| "Many observational studies in the general population have demonstrated an increased risk of adverse events associated with NSAIDs, including gastrointestinal bleeds, congestive heart failure, acute renal failure, hypertension and acute myocardial infarction." | 1.36 | Differential impact of NSAIDs on rate of adverse events that require hospitalization in high-risk and general veteran populations: a retrospective cohort study. ( Gilbert, AL; Pratt, N; Roughead, EE; Ryan, P, 2010) |
| "We describe a case of severe congestive heart failure and right ventricular overload associated with overt hyperthyroidism, completely reversed with antithyroid therapy in a few week." | 1.35 | Hyperthyroidism as a reversible cause of right ventricular overload and congestive heart failure. ( Di Giovambattista, R, 2008) |
| "Rural management of acute cardiogenic pulmonary edema should be based on avoidance of adverse outcomes such as in-hospital mortality, the need for intensive care unit care, and the need for intubation and mechanical ventilation." | 1.35 | Rural treatment of acute cardiogenic pulmonary edema: applying the evidence to achieve success with failure. ( Bosomworth, J, 2008) |
| "CHF was characterized by left ventricular remodeling and impaired systolic and diastolic function." | 1.35 | Effects of V2-receptor antagonist tolvaptan and the loop diuretic furosemide in rats with heart failure. ( Aizawa, Y; Kodama, M; Ma, M; Palaniyandi, SS; Veeraveedu, PT; Watanabe, K; Yamaguchi, K, 2008) |
| "Refractory congestive heart failure (CHF) with diuretic resistance is life-threatening and predicts a short life expectancy." | 1.34 | Potent diuretic effects of prednisone in heart failure patients with refractory diuretic resistance. ( Ji, Z; Liu, C; Liu, G; Liu, K; Zhen, Y; Zhou, C, 2007) |
| "Transcatheter closure of atrial septal defects (ASDs) is a safe and effective treatment." | 1.33 | Left ventricular conditioning in the elderly patient to prevent congestive heart failure after transcatheter closure of atrial septal defect. ( Abdul-Khaliq, H; Ewert, P; Lange, PE; Nagdyman, N; Peters, B; Schubert, S, 2005) |
| "Since blood pressure (BP) might be an important determinant of sodium excretion, we searched for an association between BP and diuretic dosage in severe CHF." | 1.33 | Hypotension is associated with diuretic resistance in severe chronic heart failure, independent of renal function. ( Arnolda, LF; De Pasquale, CG; Dunne, JS; Minson, RB, 2005) |
| "In patients with congestive heart failure (CHF), continuous diuretic therapy may result in acute renal insufficiency (ARI)." | 1.33 | Risk factors for acute renal insufficiency induced by diuretics in patients with congestive heart failure. ( Chou, SY; Reiser, IW; Sun, WY, 2006) |
| "Heart failure is a prominent problem of public health, requiring innovating methods of health services organization." | 1.33 | [Heart failure in Eastern Veneto: prevalence, hospitalization rate, adherence to guidelines and social costs]. ( Baccichetto, R; Barro, S; Calderan, A; Carbonieri, E; Chiatto, M; Chinellato, M; Corazza, F; D'Atri, M; D'Eri, A; Drigo, R; Fabris, S; Gelli, GF; Lo Giudice, A; Milani, L; Noventa, F; Pollon, A; Santin, P; Valle, R; Zanardi, F, 2006) |
| "Instrumental examinations revealed congestive heart failure and multiple focal lesions in the liver with typical features of hemangiomas." | 1.32 | Recombinant interferon alfa 2a in hepatic hemangiomatosis with congestive heart failure: a case report. ( Clerico, A; De Pasquale, MD; Di Salvo, S; Schiavetti, A; Ventriglia, F, 2003) |
| "Severe tricuspid regurgitation (TR), diagnosed with echocardiography, is not necessarily symptomatic." | 1.32 | Echocardiographic markers of severe tricuspid regurgitation associated with right-sided congestive heart failure. ( Matesko, R; Oron, A; Sagie, A; Shapira, Y; Vaknin-Assa, H; Vaturi, M, 2003) |
| "Heart failure is often treated with ACE inhibitors and diuretics although diuretic treatment could activate the renin-angiotensin system (RAS)." | 1.32 | Effects of diuretic treatment on cardiac and circulating RAS in chronic heart failure post-myocardial infarction in rats. ( Böhm, M; Itter, G; Jockenhövel, F; Kouchi, I; Linz, W; Seeland, U; Zolk, O, 2003) |
| "Chronic congestive heart failure (CHF) is a complex clinical syndrome characterized by marked neurohormonal activation which may lead to further decompensation of the circulatory system." | 1.32 | [Plasma levels of brain natriuretic peptide, cyclic 3'5'-guanosine monophosphate, endothelin 1, and noradrenaline in patients with chronic congestive heart failure]. ( Orda, A; Przewłocka-Kosmala, M; Salomon, P, 2003) |
| "Furthermore, congestive heart failure is associated with impaired creatinine clearance and increased urea and urate, and osteoporosis and hip fractures are characterized by low albumin and cholesterol." | 1.32 | Association of biochemical values with morbidity in the elderly: a population-based Swedish study of persons aged 82 or more years. ( Berg, S; Evrin, PE; Johansson, B; McClearn, G; Nilsson, SE; Takkinen, S; Tryding, N, 2003) |
| " Failed furosemide adherence (defined as < 10% of a dose excreted in 24 h urine where normal average excretion = 50% of an oral dose) during static prescribed dosing was infrequent relative to all days of therapy; yet was equally common across all outcome groups." | 1.32 | Furosemide responsiveness, non-adherence and resistance during the chronic treatment of heart failure: a longitudinal study. ( Brater, DC; Gorski, JC; MacFadyen, RJ; Struthers, AD, 2004) |
| "008) and furosemide dosage >/=80 mg (P=0." | 1.32 | Sex-related bedside clinical variables associated with survival of older inpatients with heart failure. ( Almoznino-Sarafian, D; Alon, I; Chachashvily, S; Cohen, N; Gorelik, O; Ilgiyaev, E; Modai, D; Shteinshnaider, M, 2004) |
| "Torasemide with its more complete and less variable bioavailability offers potential clinical and economic advantages over furosemide in the long-term treatment in patients with CHF." | 1.31 | [Long-term diuretic treatment in heart failure: are there differences between furosemide and torasemide?]. ( Falkenstein, P; Follath, F; Gutzwiller, F; Müller, K; Reitberger, U; Spannheimer, A, 2002) |
| "Anemia, hypertension and rheumatic fever were the causes of heart failure in these 3 patients, but they were not apparent when the initial diagnosis was made." | 1.31 | [Peripartum heart failure: the underestimated role of frequent diseases in the Sudan-Sahelian area]. ( Ba, SA; Dia, AA; Diop, IB; Diouf, SM; Kane, A; Sarr, M, 2000) |
| " The changes in the ETK (erythrocyte transketolase activity in whole blood) and a-ETK (ETK activity coefficient) during the hospital stay correlated with the cumulative dosage of furosemide adjusted for the duration of the therapy (r = 0." | 1.31 | Diuretic use: a risk for subclinical thiamine deficiency in elderly patients. ( Haller, J; Hany, A; Suter, PM; Vetter, W, 2000) |
| "Diuretics remain the mainstay in treating congestive heart failure." | 1.31 | [Unconventional treatment of severe heart failure in the elderly]. ( Fidelman, Z; Korshun, Z, 2000) |
| "Treatment with digoxin and furosemide alleviated clinical signs for approximately 10 months." | 1.31 | Congestive heart failure associated with myxomatous degeneration of the left atrioventricular valve in a parakeet. ( Lehmkuhl, L; Oglesbee, BL, 2001) |
| "Fifty-two consecutive patients with beta thalassemia and heart failure were followed in a prospective 5-year study." | 1.31 | Heart failure in beta thalassemia: a 5-year follow-up study. ( Karavolias, GK; Kattamis, CA; Kremastinos, DT; Ladis, VA; Tsetsos, GA; Tsiapras, DP, 2001) |
| "Treatment of congestive heart failure has changed dramatically during the past 20 years, but diuretic drugs remain an essential component." | 1.31 | Diuretic therapy and resistance in congestive heart failure. ( Ellison, DH, 2001) |
| "Both in CHF (congestive heart failure) and CRI (chronic renal insufficiency), blood pressure reduction is beneficial for preservation of cardiac and renal function." | 1.31 | Intensive blood pressure reduction is beneficial in patients with impaired cardiac function coexisting with chronic renal insufficiency. ( Ikeda, N; Kanno, Y; Moriwaki, K; Nakamoto, H; Okada, H; Sugahara, S; Suzuki, H, 2002) |
| "Patients with severe decompensated congestive heart failure (CHF) commonly exhibit acid-base and electrolyte disturbances mainly due to the activation of several neurohumoral mechanisms as well as to drugs regularly used in this population." | 1.31 | Hypomagnesemia and concurrent acid-base and electrolyte abnormalities in patients with congestive heart failure. ( Alexandrides, GE; Bairaktari, ET; Elisaf, MS; Goudevenos, J; Liberopoulos, EN; Milionis, HJ, 2002) |
| "Acute heart failure is a life-threatening medical emergency, most commonly occurring as an immediate or delayed complication of acute myocardial infarction (AMI), or resulting from severe hypertension or valvular defects (stenosis or incompetence)." | 1.31 | A case report of acute heart failure caused by a patient delaying taking his diuretic medication. ( Chapman, PJ, 2002) |
| "Since its introduction in cardiac failure in 1994, biventricular cardiac stimulation has been widely applied with many clinical trials and the development of new specific technology." | 1.31 | [Medium-term results of multisite biventricular stimulation in severe cardiac failure]. ( Alonso, C; Boulmier, D; Carré, F; Daubert, JC; de Place, C; Leclercq, C; Mabo, P; Pavin, D; Revault, dF, 2002) |
| "In a 63-year-old woman with longstanding type I diabetes mellitus, CAD and chronic heart failure, a subacute myocardial infarction developed, together with decompensation of cardiac function and diabetes and concurrent pneumonia." | 1.30 | [Heart failure after myocardial infarct in decompensated diabetes mellitus. Acute therapy with catecholamines--long-term therapy with ACE inhibitor-loop diuretic combination]. ( Brilla, CG, 1997) |
| "Heart failure was successfully treated with digitalis, diuretics and captopril." | 1.30 | [Pheochromocytoma and cardiac insufficiency]. ( Alvarez, J; de Mora, M; Malpartida, F; Mancha, I; Olveira, G; Soriguer, F; Vázquez, F; Vivancos, R, 1998) |
| "Oral furosemide or torsemide was administered before and after diuresis." | 1.30 | The effects of diuresis on the pharmacokinetics of the loop diuretics furosemide and torsemide in patients with heart failure. ( Fisher, ML; Gottlieb, SS; Khatta, M; Kramer, WG; Roffman, D; Wentworth, D, 1998) |
| "After the operation, her congestive heart failure and hyperglycemia dramatically improved." | 1.30 | Surgical successful treatment of Cushing's syndrome in a pregnant patient complicated with severe cardiac involvement. ( Hibino, T; Iwata, H; Jin-no, Y; Kajiura, S; Kamiya, Y; Kobayashi, S; Okada, M; Suzuki, Y; Watanabe, O; Yoneyama, A, 1998) |
| "Twelve patients had idiopathic dilated cardiomyopathy and two patients had a globally dilated heart with single vessel coronary artery disease." | 1.30 | Partial left ventriculectomy: preoperative risk factors for perioperative mortality. ( Bestetti, RB; Bombonato, R; Brasil, JC; Haddad, J; Moreira-Neto, F; Sgarbieri, RN, 1998) |
| "Furosemide was administered IV concurrently with IV administered digoxin every 12 hours." | 1.29 | Pharmacokinetics of digoxin administered to horses with congestive heart failure. ( Reef, VB; Reimer, JM; Sweeney, RW, 1993) |
| "Increased venous pressure caused by congestive heart failure and vomiting was implicated as the cause of bilateral uveal effusions." | 1.29 | Uveal effusion syndrome associated with primary pulmonary hypertension and vomiting. ( Akduman, L; Del Priore, LV; Kaplan, HJ; Meredith, T, 1996) |
| "Furosemide was added after the 3-week examination, and at 6 months, dogs had received furosemide for at least 4 months." | 1.29 | Effects of long-term treatment with enalapril or hydralazine on the renin-angiotensin-aldosterone system and fluid balance in dogs with naturally acquired mitral valve regurgitation. ( Häggström, J; Hansson, K; Karlberg, BE; Kvart, C; Madej, A; Olsson, K, 1996) |
| "Propranolol was preferred to diltiazem for treating feline hypertrophic cardiomyopathy." | 1.29 | Preferences of veterinarians for drugs to treat heart disease in dogs and cats. ( Church, DB; Watson, AD, 1995) |
| "Prehospital medications for congestive heart failure should affect hospital outcomes (survival and length of stay)." | 1.28 | Effects of prehospital medications on mortality and length of stay in congestive heart failure. ( Meador, SA; Wuerz, RC, 1992) |
| "Six patients with chronic congestive cardiac failure, who had never received any drug treatment, were studied before and after one month of therapy with frusemide alone at a dose of 40 mg a day." | 1.28 | Diuretics as initial and sole treatment in chronic cardiac failure. ( Anand, IS; De Giuli, F; Ferrari, R; Harris, P; Kalra, GS; Panzali, A; Poole-Wilson, PA, 1991) |
| "The patient's cardiac failure improved with conservative management using frusemide and digoxin." | 1.28 | Left atrial myxomas--a case report. ( Awotedu, AA; False, AO; Wilson, MM, 1991) |
| " Angiotensin-converting enzyme inhibitors cause an acute fall in creatinine clearance which may reduce the effects of loop diuretics and attention must be paid to diuretic dosage when initiating angiotensin-converting enzyme inhibitors for the treatment of cardiac failure." | 1.28 | Acute administration of captopril lowers the natriuretic and diuretic response to a loop diuretic in patients with chronic cardiac failure. ( Davies, E; Edwards, CR; Flapan, AD; Shaw, TR; Waugh, C; Williams, BC, 1991) |
| "In advanced heart failure, mitral regurgitation increases the burden of the failing ventricle and decreases effective stroke volume." | 1.28 | Afterload reduction with vasodilators and diuretics decreases mitral regurgitation during upright exercise in advanced heart failure. ( Belil, D; Brunken, RC; Grover-McKay, M; Schelbert, HR; Schwaiger, M; Stevenson, LW; Tillisch, JH, 1990) |
| "Seventeen patients with dilated cardiomyopathy (mean ejection fraction 22%) in the NYHA state III or IV were investigated." | 1.28 | Daily administration of furosemide in dilated cardiomyopathy--yes or no? ( Mihatov, S; Nikolić, VH; Omcikus, MP; Petrać, D; Rudar, M; Vukosavić, D, 1990) |
| "It is believed that the treatment of congestive heart failure may convert an associated transudative pleural effusion into a "pseudoexudate." | 1.28 | Treatment of congestive heart failure. Its effect on pleural fluid chemistry. ( Caldwell, SH; Chakko, SC; Sforza, PP, 1989) |
| "Documentation of the mechanism of sudden death is described in a patient with a prolonged QT interval." | 1.27 | Documented sudden cardiac death in prolonged QT syndrome. ( Brown, EJ; Cohn, PF; Mallis, GI; Vlay, SC, 1984) |
| "Furosemide was the most frequently used drug in both groups, but treatment with it was longer in patients with HF who presented a significantly higher frequency of adverse reactions to this diuretic (p less than 0." | 1.27 | Adverse drug reactions (ADRs) in patients with heart diseases. Comparison between patients without and with heart failure. ( Ortiz, M; Ruiz, I, 1984) |
| "Indirect signs of congestive heart failure tended to be less severe in patients given metoprolol within 12 hours of the onset of symptoms than in those given placebo." | 1.27 | Göteborg Metoprolol Trial: clinical observations. ( Hartford, M; Herlitz, J; Hjalmarson, A; Pennert, K; Waagstein, F; Waldenström, A; Wedel, H; Wilhelmsson, C, 1984) |
| "Eleven patients with acute congestive heart failure were studied during treatment with a loop diuretic." | 1.27 | The effect of treatment of congestive heart failure on plasma atrial natriuretic peptide concentration: a longitudinal study. ( Anderson, JV; Bloom, SR; Woodruff, PW, 1988) |
| "Because hyponatremia is frequently associated with preceding diuretic treatment and unrestricted fluid intake--conditions which have not been addressed sufficiently in published literature--we studied the pathophysiology and the clinical setting of such hyponatremia in a large group of internal medicine patients." | 1.27 | Role of diuretics, hormonal derangements, and clinical setting of hyponatremia in medical patients. ( Gross, P; Hackenthal, E; Hausmann, C; Ketteler, M; Rascher, W; Reinhard, C; Ritz, E; Schömig, A, 1988) |
| "Hyponatremia is a common complication of chronic advanced CHF unresponsive to the usual therapeutic measures." | 1.27 | A correctable complication of advanced congestive heart failure. ( Lemberg, L; Valle, GA, 1987) |
| " A transient decrease in total T4, elevation in the T3 resin uptake and consequent increase in the free T4 index (FT4I) were seen 2-5 h after ingestion of frusemide at a chronic morning dosage of 80, 120 or 250 mg." | 1.27 | Effect of oral frusemide on diagnostic indices of thyroid function. ( Hamblin, PS; Lim, CF; Long, F; Newnham, HH; Stockigt, JR; Topliss, DJ, 1987) |
| " Repeated oral dosing with frusemide 40 mg/day for 3 weeks produced an improvement in cardiac hemodynamics particularly during the first 2 weeks of treatment." | 1.27 | Echocardiographic determination of left ventricular haemodynamics following acute and chronic administration of frusemide (Lasix) to patients with heart failure. ( Maass, L; Stefan, G, 1986) |
| "Ten patients with severe congestive heart failure (6 women and 4 men, aged 67 +/- 4." | 1.27 | Combination of furosemide and metolazone in the treatment of severe congestive heart failure. ( Grosskopf, I; Rabinovitz, M; Rosenfeld, JB, 1986) |
| "Hemodynamic features of acute cardiac failure include decreases in cardiac output and mixed venous O2 saturation, together with increases in left ventricular filling pressure and systemic resistance." | 1.27 | Pathophysiology of cardiac failure. ( Janicki, JS; Maskin, CS; Weber, KT, 1985) |
| "Prazosin has proved to be beneficial in CHF resistant to digitalis and diuretics." | 1.26 | Haemodynamic effects of prazosin in CHF. ( Gale, EV; Kuan, P; Reuben, SR; Wilde, PM, 1981) |
| "Hyperaldosteronism is an important factor contributing to fluid and sodium retention in infants with heart failure." | 1.26 | The occurrence of hyperaldosteronism in infants with congestive heart failure. ( Baylen, BG; Johnson, G; Kaplan, S; Srivastava, L; Tsang, R, 1980) |
| " There was a preference for initiating treatment with a diuretic rather than digoxin and for commencing digoxin in daily maintenance dosage rather than with a loading dose." | 1.26 | Survey of cardiac failure therapy in Australian medical practice: dependence on digoxin level for diagnosis of toxicity. ( Read, TR; Schapel, GJ, 1980) |
| "Furosemide is an effective diuretic, the onset of pharmacologic action was within one hour, the peak action was sustained for three hours, and the duration of action was six hours." | 1.26 | The pharmacologic effects of furosemide therapy in the low-birth-weight infant. ( Oh, W; Pollak, A; Ross, BS, 1978) |
| " This article attempts to critically review these studies under seven different sections: furosemide pharmacokinetics in normal volunteers, furosemide pharmacokinetics in patients with decreased renal function, furosemide pharmacokinetics in patients with congestive heart failure, furosemide metabolism and assay methods, furosemide bioavailability, dose-response relationships, and the role of inhibitors and mediators on furosemide effects." | 1.26 | Pharmacokinetics/pharmacodynamics of furosemide in man: a review. ( Benet, LZ, 1979) |
| "The treatment of acute cardiogenic pulmonary edema is associated with the return of hypo-oncotic fluid from the interstitial compartment back into the intravascular compartment with expansion of plasma volume and reduction of colloid osmotic pressure and hemoglobin concentration." | 1.26 | Effect of afterload reduction on plasma volume during acute heart failure. ( Henning, RJ; Weil, MH, 1978) |
| "Furosemide (Lasix) was suspected primarily." | 1.26 | Occurrence of bullous pemphigoid after furosemide therapy. ( Fellner, MJ; Katz, JM, 1976) |
| " In the final phase, dosage was lowered to 20 mg per day and 24 of the 39 patients, (62%), were successfully controlled for four weeks, while 14, (36%), were controlled for eight weeks." | 1.25 | Dosage titration with furosemide in congestive heart failure patients. ( Exaire, JE; Figueroa, G; Hamdan, G; Villalpando, J, 1975) |
| "In 50 patients with congestive heart failure a compound diuretic drug aldactone--saltucine was used." | 1.25 | [Use of aldactone-saltucine for patients with chronic circulatory insufficiency]. ( Evsikov, EM; Kharchenko, VI; Savenkov, PM; Sidorenko, BA, 1975) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 430 (34.54) | 18.7374 |
| 1990's | 173 (13.90) | 18.2507 |
| 2000's | 191 (15.34) | 29.6817 |
| 2010's | 305 (24.50) | 24.3611 |
| 2020's | 146 (11.73) | 2.80 |
| Authors | Studies |
|---|---|
| Zhu, Y | 1 |
| de Jesus, RK | 1 |
| Tang, H | 1 |
| Walsh, SP | 1 |
| Jiang, J | 2 |
| Gu, X | 1 |
| Teumelsan, N | 1 |
| Shahripour, A | 1 |
| Pio, B | 1 |
| Ding, FX | 1 |
| Ha, S | 1 |
| Priest, BT | 1 |
| Swensen, AM | 1 |
| Alonso-Galicia, M | 1 |
| Felix, JP | 1 |
| Brochu, RM | 1 |
| Bailey, T | 1 |
| Thomas-Fowlkes, B | 1 |
| Zhou, X | 1 |
| Pai, LY | 1 |
| Hampton, C | 1 |
| Hernandez, M | 1 |
| Owens, K | 1 |
| Ehrhart, J | 1 |
| Roy, S | 1 |
| Kaczorowski, GJ | 1 |
| Yang, L | 1 |
| Parmee, ER | 1 |
| Sullivan, K | 1 |
| Garcia, ML | 1 |
| Pasternak, A | 1 |
| López-Vilella, R | 1 |
| Sánchez-Lázaro, I | 1 |
| Husillos Tamarit, I | 1 |
| Monte Boquet, E | 1 |
| Núñez Villota, J | 1 |
| Donoso Trenado, V | 1 |
| Martínez Dolz, L | 1 |
| Almenar Bonet, L | 1 |
| Elias, C | 1 |
| Oliveira, D | 1 |
| Soares-Carreira, M | 1 |
| Amorim, M | 1 |
| Araújo, JP | 2 |
| Bettencourt, P | 8 |
| Lourenço, P | 5 |
| Civera, J | 1 |
| de la Espriella, R | 3 |
| Heredia, R | 2 |
| Miñana, G | 3 |
| Santas, E | 2 |
| Conesa, A | 1 |
| Mollar, A | 1 |
| Sastre, C | 1 |
| Martínez, A | 1 |
| Villaescusa, A | 1 |
| Núñez, J | 4 |
| Wang, T | 2 |
| Han, Y | 1 |
| Song, Y | 1 |
| Khan, MS | 1 |
| Greene, SJ | 8 |
| Hellkamp, AS | 1 |
| DeVore, AD | 4 |
| Shen, X | 1 |
| Albert, NM | 1 |
| Patterson, JH | 3 |
| Spertus, JA | 2 |
| Thomas, LE | 1 |
| Williams, FB | 1 |
| Hernandez, AF | 9 |
| Fonarow, GC | 4 |
| Butler, J | 6 |
| Kleiner Shochat, M | 1 |
| Fudim, M | 3 |
| Kapustin, D | 1 |
| Kazatsker, M | 1 |
| Kleiner, I | 1 |
| Weinstein, JM | 1 |
| Panjrath, G | 1 |
| Rozen, G | 1 |
| Roguin, A | 2 |
| Meisel, SR | 1 |
| Dauw, J | 2 |
| Lelonek, M | 1 |
| Zegri-Reiriz, I | 1 |
| Paredes-Paucar, CP | 1 |
| Zara, C | 1 |
| George, V | 1 |
| Cobo-Marcos, M | 1 |
| Knappe, D | 1 |
| Shchekochikhin, D | 1 |
| Lekhakul, A | 1 |
| Klincheva, M | 1 |
| Frea, S | 4 |
| Miró, Ò | 4 |
| Barker, D | 1 |
| Borbély, A | 1 |
| Nasr, S | 1 |
| Doghmi, N | 1 |
| Singh, JS | 1 |
| Bovolo, V | 2 |
| Fialho, I | 1 |
| Ross, NT | 1 |
| van den Heuvel, M | 1 |
| Benkouar, R | 1 |
| Findeisen, H | 1 |
| Alhaddad, IA | 1 |
| Al Balbissi, K | 1 |
| Barge-Caballero, G | 1 |
| Ghazi, AM | 1 |
| Bruckers, L | 1 |
| Martens, P | 4 |
| Mullens, W | 7 |
| Blázquez-Bermejo, Z | 2 |
| Farré, N | 1 |
| Caravaca Perez, P | 3 |
| Llagostera, M | 1 |
| Morán-Fernández, L | 1 |
| Fort, A | 1 |
| de Juan Bagudá, J | 2 |
| García-Cosio, MD | 1 |
| Ruiz-Bustillo, S | 1 |
| Delgado, JF | 3 |
| Payne, D | 1 |
| Swolinsky, JS | 1 |
| Tuvshinbat, E | 1 |
| Leistner, DM | 1 |
| Edelmann, F | 1 |
| Knebel, F | 1 |
| Nerger, NP | 1 |
| Lemke, C | 1 |
| Roehle, R | 1 |
| Haase, M | 1 |
| Costanzo, MR | 2 |
| Rauch, G | 1 |
| Mitrovic, V | 2 |
| Gasanin, E | 1 |
| Meier, D | 1 |
| McCullough, PA | 3 |
| Eckardt, KU | 1 |
| Molitoris, BA | 1 |
| Schmidt-Ott, KM | 1 |
| Peters, AE | 1 |
| Mentz, RJ | 14 |
| DeWald, TA | 3 |
| Nuche, J | 2 |
| López-Azor, JC | 2 |
| Salguero-Bodes, R | 2 |
| Arribas Ynsaurriaga, F | 2 |
| Beldhuis, IE | 1 |
| Damman, K | 11 |
| Ter Maaten, JM | 7 |
| Cooper, LB | 1 |
| Bruce, S | 1 |
| Psotka, M | 1 |
| Mentz, R | 1 |
| Bell, R | 1 |
| Seliger, SL | 1 |
| O'Connor, C | 1 |
| deFilippi, C | 1 |
| Meena, J | 1 |
| Hari, P | 1 |
| Sinha, A | 1 |
| Bagga, A | 1 |
| Yoshioka, K | 4 |
| Maeda, D | 2 |
| Okumura, T | 6 |
| Kida, K | 10 |
| Oishi, S | 4 |
| Akiyama, E | 4 |
| Suzuki, S | 5 |
| Yamamoto, M | 5 |
| Mizukami, A | 2 |
| Kuroda, S | 3 |
| Kagiyama, N | 5 |
| Yamaguchi, T | 4 |
| Sasano, T | 1 |
| Matsumura, A | 3 |
| Kitai, T | 6 |
| Matsue, Y | 10 |
| Eisenstein, EL | 7 |
| Sapp, S | 3 |
| Harding, T | 3 |
| Harrington, A | 2 |
| Velazquez, EJ | 11 |
| Sachdev, V | 3 |
| Kim, DY | 4 |
| Anstrom, KJ | 11 |
| Kitajima, N | 1 |
| Yamada, H | 1 |
| Minami, T | 1 |
| Ohtsuru, S | 1 |
| Caiati, C | 1 |
| Argentiero, A | 1 |
| Favale, S | 1 |
| Lepera, ME | 1 |
| Komiya, S | 1 |
| Katsumata, M | 1 |
| Ozawa, M | 1 |
| Haze, T | 1 |
| Kawano, R | 1 |
| Ohki, Y | 1 |
| Kobayashi, Y | 1 |
| Fujiwara, A | 1 |
| Saka, S | 1 |
| Tamura, K | 1 |
| Hirawa, N | 1 |
| Cisowska, T | 1 |
| Pan, IZ | 1 |
| Biskupiak, J | 1 |
| Shah, KS | 1 |
| Fang, JC | 2 |
| Jacobs, JA | 1 |
| Imaeda, S | 1 |
| Shiraishi, Y | 1 |
| Kohsaka, S | 1 |
| Niimi, N | 1 |
| Goda, A | 1 |
| Nagatomo, Y | 1 |
| Takei, M | 2 |
| Saji, M | 1 |
| Nakano, S | 1 |
| Kohno, T | 1 |
| Fukuda, K | 2 |
| Yoshikawa, T | 1 |
| Choi, YA | 1 |
| Jung, JY | 1 |
| Park, JW | 1 |
| Lee, MS | 1 |
| Kim, TK | 1 |
| Lee, SGW | 1 |
| Lee, YH | 1 |
| Kim, KH | 1 |
| Nakatsukasa, T | 1 |
| Ishizu, T | 2 |
| Ouchi, M | 1 |
| Murakoshi, N | 1 |
| Sato, K | 1 |
| Kawanishi, K | 1 |
| Seo, Y | 1 |
| Ieda, M | 1 |
| Huang, Y | 1 |
| Guo, F | 1 |
| Chen, D | 1 |
| Lin, H | 1 |
| Huang, J | 1 |
| Wettersten, N | 1 |
| Duff, S | 1 |
| Murray, PT | 2 |
| Dotare, T | 1 |
| Sunayama, T | 1 |
| Mizuno, A | 3 |
| Inuzuka, Y | 3 |
| Minamino, T | 1 |
| Chang, WT | 1 |
| Lin, YW | 1 |
| Chen, CY | 1 |
| Chen, ZC | 1 |
| Shih, JY | 1 |
| Wu, CC | 1 |
| Luo, CY | 1 |
| Liu, PY | 1 |
| Chatur, S | 3 |
| Lakdawala, NK | 3 |
| Cunningham, JW | 1 |
| Claggett, BL | 1 |
| Vardeny, O | 3 |
| Jering, K | 1 |
| Desai, AS | 7 |
| Pfeffer, MA | 1 |
| Lefkowitz, M | 2 |
| McMurray, JJV | 5 |
| Solomon, SD | 3 |
| Vaduganathan, M | 4 |
| Li, Z | 1 |
| Wang, Z | 1 |
| Liu, N | 1 |
| Li, H | 1 |
| Ouwerkerk, W | 1 |
| Tromp, J | 3 |
| Cleland, JGF | 5 |
| Angermann, CE | 2 |
| Dahlstrom, U | 4 |
| Ertl, G | 2 |
| Hassanein, M | 1 |
| Perrone, SV | 1 |
| Ghadanfar, M | 1 |
| Schweizer, A | 1 |
| Obergfell, A | 1 |
| Dickstein, K | 4 |
| Filippatos, G | 5 |
| Collins, SP | 3 |
| Lam, CSP | 2 |
| Giorgi, ME | 1 |
| Mochel, JP | 1 |
| Yuan, L | 1 |
| Adin, DB | 1 |
| Ward, JL | 1 |
| Biegus, J | 3 |
| Voors, AA | 15 |
| Kosiborod, MN | 2 |
| Teerlink, JR | 6 |
| Ferreira, JP | 6 |
| Nassif, ME | 1 |
| Psotka, MA | 2 |
| Brueckmann, M | 1 |
| Salsali, A | 1 |
| Blatchford, JP | 1 |
| Ponikowski, P | 8 |
| Špinarová, M | 1 |
| Špinar, J | 1 |
| Špinarová, L | 1 |
| Krejčí, J | 1 |
| Goldbergová-Pávková, M | 1 |
| Pařenica, J | 1 |
| Ludka, O | 1 |
| Málek, F | 1 |
| Ošťádal, P | 1 |
| Benešová, K | 1 |
| Jarkovský, J | 1 |
| Lábr, K | 1 |
| Dias, J | 1 |
| Carballo, S | 1 |
| Meyer, P | 1 |
| Darbellay Farhoumand, P | 1 |
| Agoritsas, T | 1 |
| Goncalvesova, E | 1 |
| Dankova, M | 1 |
| Lesny, P | 1 |
| Luknar, M | 1 |
| Verbrugge, FH | 4 |
| Menon, V | 2 |
| Nuzzi, V | 3 |
| Cannatà, A | 3 |
| Pellicori, P | 3 |
| Manca, P | 3 |
| Stolfo, D | 3 |
| Gregorio, C | 3 |
| Barbati, G | 3 |
| Bromage, DI | 3 |
| McDonagh, T | 3 |
| Merlo, M | 3 |
| Sinagra, G | 3 |
| Oyama, MA | 7 |
| Adin, D | 4 |
| Trullàs, JC | 7 |
| Morales-Rull, JL | 7 |
| Casado, J | 5 |
| Carrera-Izquierdo, M | 3 |
| Sánchez-Marteles, M | 3 |
| Conde-Martel, A | 4 |
| Dávila-Ramos, MF | 3 |
| Llácer, P | 5 |
| Salamanca-Bautista, P | 3 |
| Pérez-Silvestre, J | 3 |
| Plasín, MÁ | 3 |
| Cerqueiro, JM | 3 |
| Gil, P | 3 |
| Formiga, F | 7 |
| Manzano, L | 6 |
| Horiuchi, Y | 3 |
| Nogi, K | 2 |
| Onitsuka, K | 2 |
| Hoshino, M | 2 |
| Shibata, T | 2 |
| Nitta, D | 2 |
| Yoshida, K | 7 |
| Sato, S | 2 |
| Patil, T | 2 |
| Halsey, E | 2 |
| Kaur, A | 2 |
| Minchak, J | 2 |
| Hobson, J | 2 |
| Eppes, D | 2 |
| Weng, H | 1 |
| Li, Y | 3 |
| Nie, X | 1 |
| He, C | 1 |
| Feng, P | 1 |
| Zhao, F | 1 |
| Chen, Q | 2 |
| Sun, W | 1 |
| Zhang, Y | 2 |
| Huo, Y | 1 |
| Li, J | 2 |
| Kawanami, S | 1 |
| Egami, Y | 1 |
| Sugae, H | 1 |
| Ukita, K | 1 |
| Kawamura, A | 1 |
| Nakamura, H | 1 |
| Matsuhiro, Y | 1 |
| Yasumoto, K | 1 |
| Tsuda, M | 1 |
| Okamoto, N | 1 |
| Matsunaga-Lee, Y | 1 |
| Yano, M | 1 |
| Nishino, M | 1 |
| Tanouchi, J | 1 |
| Kobayashi, M | 1 |
| Chikamori, T | 1 |
| Ito, S | 1 |
| Asakura, M | 2 |
| Yamashina, A | 2 |
| Kitakaze, M | 1 |
| Kinugawa, K | 2 |
| Matsukawa, M | 1 |
| Nakamura, Y | 2 |
| Aihara, M | 1 |
| Sano, H | 1 |
| Morgan, S | 2 |
| Testani, JM | 14 |
| Harrington, AH | 1 |
| Ketema, F | 3 |
| Desvigne-Nickens, P | 3 |
| Pitt, B | 6 |
| Ho, IW | 1 |
| Huang, CC | 1 |
| Au, HY | 1 |
| Chan, KY | 1 |
| Yap, DYH | 1 |
| Yip, T | 1 |
| Wong, CY | 1 |
| Marques, P | 2 |
| Brito, MT | 1 |
| Vasques-Nóvoa, F | 1 |
| Jardim, AL | 1 |
| Gouveia, R | 1 |
| Besteiro, B | 1 |
| Vieira, JT | 1 |
| Gomes, F | 1 |
| Leite-Moreira, A | 1 |
| Almeida, J | 1 |
| Friões, F | 2 |
| Takimura, H | 1 |
| Kurozumi, A | 1 |
| Taniguchi, R | 1 |
| Tsuzuki, I | 1 |
| Tajima, E | 1 |
| Yamaguchi, Y | 1 |
| Kawano, M | 1 |
| Takimura, Y | 1 |
| Nishio, S | 1 |
| Nakano, M | 2 |
| Tsukahara, R | 1 |
| Fernandes, J | 1 |
| Costa, R | 1 |
| Guerreiro, R | 1 |
| Bonifácio, D | 1 |
| Rodrigues, A | 1 |
| Henriques, C | 1 |
| Branco, P | 1 |
| Araújo, I | 1 |
| Fonseca, C | 1 |
| Setoguchi, N | 1 |
| Kawakami, T | 1 |
| Nakase, M | 1 |
| Watanabe, Y | 1 |
| Ishizawa, T | 1 |
| Sekiguchi, M | 1 |
| Nakajima, M | 1 |
| Nonaka, H | 1 |
| Asami, M | 1 |
| Yahagi, K | 1 |
| Komiyama, K | 1 |
| Yuzawa, H | 2 |
| Tanaka, J | 1 |
| Aoki, J | 1 |
| Tanabe, K | 1 |
| Liuzzo, G | 1 |
| Volpe, M | 1 |
| Zymliński, R | 2 |
| Testani, J | 2 |
| Cox, ZL | 6 |
| Guzik, M | 1 |
| Iwanek, G | 1 |
| Hurkacz, M | 1 |
| Raj, D | 1 |
| Marciniak, D | 1 |
| Ponikowska, B | 1 |
| Montgomery, RA | 1 |
| Mauch, J | 1 |
| Sankar, P | 1 |
| Martyn, T | 1 |
| Engelman, T | 1 |
| Faulkenberg, K | 1 |
| Estep, JD | 1 |
| Tang, WHW | 6 |
| Krynský, T | 1 |
| Mayer, O | 1 |
| Bruthans, J | 1 |
| Bílková, S | 1 |
| Jirák, J | 1 |
| Wolowich, WR | 1 |
| Yeoh, SE | 1 |
| Osmanska, J | 1 |
| Petrie, MC | 1 |
| Brooksbank, KJM | 1 |
| Clark, AL | 2 |
| Docherty, KF | 1 |
| Foley, PWX | 1 |
| Guha, K | 1 |
| Halliday, CA | 1 |
| Jhund, PS | 4 |
| Kalra, PR | 1 |
| McKinley, G | 1 |
| Lang, NN | 1 |
| Lee, MMY | 1 |
| McConnachie, A | 1 |
| McDermott, JJ | 1 |
| Platz, E | 1 |
| Sartipy, P | 1 |
| Seed, A | 1 |
| Stanley, B | 1 |
| Weir, RAP | 1 |
| Welsh, P | 1 |
| Campbell, RT | 1 |
| Clare, RM | 1 |
| Ambrosy, AP | 1 |
| Stevens, GR | 1 |
| Rommel, JJ | 1 |
| Alexy, T | 2 |
| Claggett, B | 2 |
| de Boer, RA | 1 |
| Shah, SJ | 1 |
| Martinez, F | 1 |
| Inzucchi, SE | 1 |
| Haddad, T | 1 |
| Mitter, SS | 1 |
| Miao, ZM | 1 |
| Petersson, M | 1 |
| Maria Langkilde, A | 1 |
| Aschenbrenner, DS | 1 |
| Wesselowski, S | 1 |
| Koprululu Kucuk, G | 1 |
| Guney, AI | 1 |
| Sunbul, M | 1 |
| Guctekin, T | 1 |
| Koç, G | 1 |
| Kirac, D | 1 |
| Tagaya, T | 1 |
| Hayashi, H | 1 |
| Ogata, S | 2 |
| Takahashi, K | 1 |
| Koide, S | 1 |
| Inaguma, D | 1 |
| Hasegawa, M | 1 |
| Yuzawa, Y | 1 |
| Tsuboi, N | 1 |
| Brethel, S | 1 |
| Locker, S | 1 |
| Girens, R | 1 |
| Rivera, P | 1 |
| Meurs, K | 1 |
| Kulkarni, NS | 1 |
| Lee, H | 1 |
| Lee, D | 1 |
| Park, J | 1 |
| Yun, T | 1 |
| Koo, Y | 1 |
| Chae, Y | 1 |
| Kang, BT | 1 |
| Yang, MP | 1 |
| Kim, H | 1 |
| Vazir, A | 1 |
| Kapelios, CJ | 2 |
| Agaoglu, E | 1 |
| Metra, M | 11 |
| Lopatin, Y | 1 |
| Seferovic, P | 2 |
| Rosano, G | 1 |
| Coats, AJS | 1 |
| Chioncel, O | 2 |
| Hughes, A | 1 |
| Guan, C | 1 |
| Li, C | 1 |
| Xu, L | 1 |
| Che, L | 1 |
| Wang, Y | 1 |
| Yang, C | 2 |
| Zhang, N | 1 |
| Liu, Z | 2 |
| Zhao, L | 1 |
| Zhou, B | 1 |
| Man, X | 1 |
| Luan, H | 1 |
| Xu, Y | 1 |
| Charaya, KV | 2 |
| Schekochikhin, DIY | 1 |
| Nikiforova, TV | 2 |
| Dimchishina, AS | 2 |
| Soboleva, TV | 2 |
| Shkliarov, AM | 2 |
| Kusova, ZR | 2 |
| Mesitskaya, DF | 2 |
| Novikova, NA | 2 |
| Andreev, DA | 2 |
| Schekochikhin, DY | 1 |
| Mazzoldi, C | 1 |
| Aspidi, F | 1 |
| Romito, G | 1 |
| Scholte, NT | 1 |
| Aydin, D | 1 |
| Linssen, GC | 2 |
| Koudstaal, S | 1 |
| Rademaker, PC | 2 |
| Geerlings, PR | 1 |
| van Gent, MW | 1 |
| Aksoy, I | 1 |
| Oosterom, L | 1 |
| Boersma, E | 1 |
| Brunner-La Rocca, HP | 3 |
| Brugts, JJ | 2 |
| Rohde, LE | 3 |
| Rover, MM | 1 |
| Figueiredo Neto, JA | 2 |
| Danzmann, LC | 2 |
| Bertoldi, EG | 2 |
| Simões, MV | 2 |
| Silvestre, OM | 1 |
| Ribeiro, ALP | 2 |
| Moura, LZ | 2 |
| Beck-da-Silva, L | 3 |
| Prado, D | 1 |
| Sant'Anna, RT | 2 |
| Bridi, LH | 1 |
| Zimerman, A | 1 |
| Raupp da Rosa, P | 1 |
| Biolo, A | 3 |
| Sherif, NA | 1 |
| Morra, ME | 1 |
| Thanh, LV | 1 |
| Elsayed, GG | 1 |
| Elkady, AH | 1 |
| Elshafay, A | 1 |
| Kien, ND | 1 |
| Al-Habbaa, A | 1 |
| Minh, LHN | 2 |
| Y, MN | 1 |
| Nghia, TLB | 1 |
| Mohammed, AT | 1 |
| Eid, PS | 2 |
| Turk, T | 1 |
| Hirayama, K | 2 |
| Huy, NT | 2 |
| Al-Ani, MA | 1 |
| Schwartz, C | 1 |
| Winchester, D | 1 |
| Barry, J | 1 |
| Cerda, M | 1 |
| Aranda, JM | 1 |
| Ahmed, MM | 1 |
| Pidello, S | 3 |
| Bergerone, S | 3 |
| D'Ascenzo, F | 2 |
| Shetty, AH | 1 |
| Shetty, HB | 1 |
| Cunha, FM | 2 |
| Pereira, J | 1 |
| Ribeiro, A | 1 |
| Chan, JSK | 2 |
| Kot, TKM | 1 |
| Ng, M | 1 |
| Harky, A | 2 |
| Hung, R | 1 |
| Lenihan, DJ | 2 |
| Salahudin, M | 1 |
| Shah, H | 1 |
| Jan, MU | 1 |
| Altaf, A | 1 |
| Buttà, C | 1 |
| Roberto, M | 1 |
| Tuttolomondo, A | 5 |
| Petrantoni, R | 2 |
| Miceli, G | 1 |
| Zappia, L | 1 |
| Pinto, A | 4 |
| McVeigh, T | 1 |
| Moore, C | 1 |
| Balsam, P | 3 |
| Ozierański, K | 3 |
| Marchel, M | 2 |
| Gawałko, M | 1 |
| Niedziela, Ł | 1 |
| Tymińska, A | 3 |
| Sieradzki, B | 2 |
| Sieradzki, M | 1 |
| Fojt, A | 2 |
| Bakuła, E | 2 |
| Główczyńska, R | 2 |
| Peller, M | 3 |
| Markulis, M | 2 |
| Bednarski, J | 1 |
| Kowalik, R | 3 |
| Cacko, A | 2 |
| Niewiński, G | 1 |
| Filipiak, KJ | 4 |
| Opolski, G | 4 |
| Grabowski, M | 3 |
| Patoulias, D | 1 |
| Papadopoulos, C | 1 |
| Zografou, I | 1 |
| Doumas, M | 1 |
| Monaghan, TF | 1 |
| Gong, F | 1 |
| Vaysblat, M | 1 |
| George, CD | 1 |
| Michelson, KP | 1 |
| Wu, ZD | 1 |
| Agudelo, CW | 1 |
| Bliwise, DL | 1 |
| Everaert, K | 1 |
| Weiss, JP | 1 |
| Sadovsky, R | 1 |
| Wein, AJ | 1 |
| Lazar, JM | 1 |
| Sury, K | 1 |
| Rao, VS | 4 |
| Ivey-Miranda, JB | 2 |
| Griffin, M | 2 |
| Mahoney, D | 3 |
| Gomez, N | 1 |
| Fleming, JH | 1 |
| Inker, LA | 1 |
| Coca, SG | 5 |
| Turner, J | 2 |
| Wilson, FP | 5 |
| Soufer, A | 1 |
| Goljo, E | 1 |
| Colna, M | 1 |
| Jeon, S | 1 |
| Raghavendra, P | 1 |
| D'Ambrosi, J | 1 |
| Riello, R | 1 |
| Jacoby, D | 1 |
| Ahmad, T | 4 |
| Chen, M | 2 |
| Baduashvili, A | 1 |
| Galluzzo, A | 2 |
| Boretto, P | 1 |
| Volpe, A | 2 |
| Canavosio, FG | 2 |
| Golzio, PG | 2 |
| De Ferrari, GM | 1 |
| Miyazaki, K | 3 |
| Onuma, Y | 1 |
| Komatsu, R | 1 |
| Kamono, M | 1 |
| Polito, MV | 1 |
| Silverio, A | 1 |
| Rispoli, A | 1 |
| Vitulano, G | 1 |
| Auria, F | 1 |
| De Angelis, E | 1 |
| Loria, F | 1 |
| Gigantino, A | 1 |
| Bonadies, D | 1 |
| Citro, R | 1 |
| Carrizzo, A | 1 |
| Galasso, G | 1 |
| Iaccarino, G | 1 |
| Vecchione, C | 1 |
| Ciccarelli, M | 1 |
| Juusela, A | 1 |
| Nazir, M | 1 |
| Gimovsky, M | 1 |
| Kin, H | 1 |
| Matsumura, K | 1 |
| Yamamoto, Y | 1 |
| Fujii, K | 1 |
| Otagaki, M | 1 |
| Takahashi, H | 3 |
| Park, H | 1 |
| Yokoi, M | 1 |
| Sugiura, T | 1 |
| Shiojima, I | 1 |
| Syed, MP | 1 |
| Doshi, A | 1 |
| Pandey, D | 1 |
| Kate, Y | 1 |
| Harizi, R | 1 |
| Wilczynski, JA | 1 |
| Decaro, MV | 1 |
| Marhefka, GD | 1 |
| Thoma, BN | 1 |
| Varghese, S | 1 |
| Tchantchaleishvili, V | 1 |
| Austin, M | 1 |
| Danelich, IM | 1 |
| Ng, TMH | 1 |
| Grazette, LP | 1 |
| Fong, MW | 1 |
| Yoon, AJ | 1 |
| Lou, M | 2 |
| Kuo, A | 1 |
| Upadhyay, RY | 1 |
| Han, EE | 1 |
| Mehra, A | 1 |
| Elkayam, U | 3 |
| Sakuma, E | 1 |
| Kawauchi, J | 1 |
| Gyoda, Y | 1 |
| Oikawa, Y | 1 |
| Watanabe, J | 1 |
| Lumpuy, D | 1 |
| Bell, RG | 1 |
| Siddique, M | 1 |
| Reddy, K | 1 |
| Oliveira, GH | 1 |
| Mitani, H | 1 |
| Funakubo, M | 1 |
| Sato, N | 8 |
| Murayama, H | 1 |
| Rached, RA | 1 |
| Matsui, N | 2 |
| Yoshida, S | 1 |
| Ishii, T | 1 |
| Oyama, N | 1 |
| Brown, A | 2 |
| Westley, K | 1 |
| Robson, J | 2 |
| Armstrong, L | 1 |
| Matthews, I | 1 |
| Runnett, C | 1 |
| Ripley, D | 1 |
| Thomas, H | 1 |
| Takagi, K | 1 |
| Ishihara, S | 1 |
| Iha, H | 1 |
| Kobayashi, N | 1 |
| Ito, Y | 1 |
| Nohara, T | 1 |
| Ohkuma, S | 1 |
| Mitsuishi, T | 1 |
| Ishizuka, A | 1 |
| Shigihara, S | 1 |
| Sone, M | 1 |
| Nakama, K | 1 |
| Tokuyama, H | 1 |
| Omote, T | 1 |
| Kikuchi, A | 1 |
| Nakamura, S | 2 |
| Yamamoto, E | 1 |
| Ishikawa, M | 1 |
| Amitani, K | 1 |
| Takahashi, N | 1 |
| Maruyama, Y | 1 |
| Imura, H | 1 |
| Shimizu, W | 2 |
| Velat, I | 1 |
| Bušić, Ž | 1 |
| Jurić Paić, M | 1 |
| Čulić, V | 1 |
| Stevenson, LW | 8 |
| Besche, B | 1 |
| Blondel, T | 1 |
| Guillot, E | 2 |
| Garelli-Paar, C | 2 |
| Ibrahim, DA | 1 |
| Zayan, AH | 1 |
| Elrahman, MMA | 1 |
| Shehata, MAA | 1 |
| Kandil, H | 1 |
| Abouibrahim, MA | 1 |
| Duy, LM | 1 |
| Shinkar, A | 1 |
| Elfaituri, MK | 1 |
| Fahmy, MM | 1 |
| Tam, DNH | 1 |
| Vuong, NL | 1 |
| Shah, J | 1 |
| Do, VBD | 1 |
| Piperata, A | 1 |
| Bottio, T | 1 |
| Gerosa, G | 1 |
| Bellino, MC | 1 |
| Massari, F | 1 |
| Albanese, M | 1 |
| Ursi, R | 1 |
| Angelini, G | 1 |
| Lisi, F | 1 |
| Amato, L | 1 |
| Scicchitano, P | 1 |
| Guida, P | 1 |
| Brunetti, ND | 1 |
| Di Serio, F | 1 |
| Ciccone, MM | 1 |
| Iacoviello, M | 1 |
| Poissonnier, C | 1 |
| Ghazal, S | 1 |
| Passavin, P | 1 |
| Alvarado, MP | 1 |
| Lefort, S | 1 |
| Trehiou-Sechi, E | 1 |
| Saponaro, V | 1 |
| Barbarino, A | 1 |
| Delle Cave, J | 1 |
| Marchal, CR | 1 |
| Depré, B | 1 |
| Vannucci, E | 1 |
| Tissier, R | 1 |
| Verwaerde, P | 1 |
| Chetboul, V | 2 |
| Wess, G | 2 |
| Kresken, JG | 1 |
| Wendt, R | 1 |
| Gaugele, J | 1 |
| Killich, M | 1 |
| Keller, L | 1 |
| Simak, J | 1 |
| Holler, P | 1 |
| Bauer, A | 1 |
| Küchenhof, H | 1 |
| Glaus, T | 1 |
| Loughran, KA | 1 |
| Larouche-Lebel, É | 1 |
| Huh, T | 1 |
| Freund, Y | 1 |
| Cachanado, M | 1 |
| Delannoy, Q | 1 |
| Laribi, S | 3 |
| Yordanov, Y | 1 |
| Gorlicki, J | 1 |
| Chouihed, T | 2 |
| Féral-Pierssens, AL | 1 |
| Truchot, J | 1 |
| Desmettre, T | 1 |
| Occelli, C | 1 |
| Bobbia, X | 1 |
| Khellaf, M | 1 |
| Ganansia, O | 1 |
| Bokobza, J | 1 |
| Balen, F | 1 |
| Beaune, S | 1 |
| Bloom, B | 1 |
| Simon, T | 1 |
| Mebazaa, A | 3 |
| Covic, A | 1 |
| Copur, S | 1 |
| Tapoi, L | 1 |
| Afsar, B | 1 |
| Ureche, C | 1 |
| Siriopol, D | 1 |
| Nistor, I | 1 |
| Kanbay, M | 1 |
| Simonavičius, J | 1 |
| Maeder, MT | 1 |
| Eurlings, CGMJ | 1 |
| Aizpurua, AB | 1 |
| Čelutkienė, J | 1 |
| Barysienė, J | 1 |
| Toggweiler, S | 1 |
| Kaufmann, BA | 1 |
| Chitsazan, M | 2 |
| Amin, A | 1 |
| Ziaie, N | 1 |
| Amri Maleh, P | 1 |
| Pouraliakbar, H | 1 |
| Von Haehling, S | 2 |
| Birch, F | 1 |
| Boam, E | 1 |
| Parsons, S | 2 |
| Ghosh, J | 1 |
| Johnson, MJ | 3 |
| Girerd, N | 2 |
| Aubry, M | 1 |
| Lantelme, P | 1 |
| Huttin, O | 1 |
| Rossignol, P | 2 |
| Gao, Y | 2 |
| Zhu, R | 1 |
| Tan, X | 1 |
| Harjola, P | 1 |
| Rossello, X | 1 |
| Gil, V | 2 |
| Jacob, J | 2 |
| Llorens, P | 3 |
| Martín-Sánchez, FJ | 2 |
| Herrero, P | 3 |
| Martínez-Nadal, G | 1 |
| Aguiló, S | 1 |
| López-Grima, ML | 1 |
| Fuentes, M | 1 |
| Álvarez Pérez, JM | 1 |
| Rodríguez-Adrada, E | 1 |
| Mir, M | 1 |
| Tost, J | 1 |
| Llauger, L | 1 |
| Ruschitzka, F | 1 |
| Harjola, VP | 2 |
| Masip, J | 1 |
| Peacock, WF | 3 |
| Müller, C | 1 |
| Li, L | 2 |
| Guo, Z | 1 |
| Zhang, S | 1 |
| Tersalvi, G | 1 |
| Schouteden, J | 1 |
| Deferm, S | 1 |
| Gruwez, H | 1 |
| De Moor, B | 1 |
| Nijst, P | 2 |
| Dupont, M | 3 |
| Zheng, Z | 1 |
| Jiang, X | 1 |
| Chen, J | 1 |
| He, D | 1 |
| Xie, X | 1 |
| Lu, Y | 1 |
| Nejadrahim, R | 1 |
| Khademolhosseini, S | 1 |
| Kavandi, H | 1 |
| Hajizadeh, R | 1 |
| Chen, S | 1 |
| Lin, Y | 1 |
| Zhou, M | 1 |
| Zhou, C | 2 |
| Orvin, NJ | 1 |
| Beavers, JC | 1 |
| Russell, SD | 4 |
| Coiro, S | 1 |
| Swedberg, K | 6 |
| van Veldhuisen, DJ | 8 |
| Lamiral, Z | 1 |
| Zannad, F | 5 |
| Spates, T | 1 |
| Sun, JL | 1 |
| Kittipibul, V | 1 |
| Starling, RC | 4 |
| Felker, GM | 7 |
| O'Connor, CM | 15 |
| Roche-Catholy, M | 1 |
| Van Cappellen, I | 1 |
| Locquet, L | 1 |
| Broeckx, BJG | 1 |
| Paepe, D | 1 |
| Smets, P | 1 |
| Morán Fernández, L | 1 |
| Lora, D | 1 |
| García-Cosío Carmena, MD | 1 |
| Escribano Subías, P | 1 |
| Mikami, T | 1 |
| Ishii, M | 1 |
| Yamamoto, N | 1 |
| Marume, K | 1 |
| Nakai, M | 1 |
| Kaichi, R | 1 |
| Ikebe, S | 1 |
| Mori, T | 1 |
| Komaki, S | 1 |
| Kusaka, H | 1 |
| Toida, R | 1 |
| Kurogi, K | 1 |
| Iwanaga, Y | 1 |
| Ogawa, H | 1 |
| Miyamoto, Y | 1 |
| Tsujita, K | 1 |
| Liu, C | 2 |
| Peng, Z | 1 |
| Gao, X | 2 |
| Gajic, O | 1 |
| Dong, Y | 1 |
| Prokop, LJ | 1 |
| Murad, MH | 1 |
| Kashani, KB | 1 |
| Domecq, JP | 1 |
| Maida, C | 1 |
| Casuccio, A | 1 |
| Di Raimondo, D | 2 |
| Fonte, R | 1 |
| Vassallo, V | 1 |
| Puleo, MG | 1 |
| Di Chiara, T | 1 |
| Mogavero, A | 1 |
| Del Cuore, A | 1 |
| Daidone, M | 1 |
| Ortello, A | 1 |
| Côté, JM | 1 |
| Bouchard, J | 1 |
| Beaubien-Souligny, W | 1 |
| Ekici, B | 1 |
| Yaman, M | 1 |
| Küçük, M | 1 |
| Dereli, S | 1 |
| Yenerçağ, M | 1 |
| Yiğit, Z | 1 |
| Baş, MM | 1 |
| Karavelioğlu, Y | 1 |
| Çakmak, HA | 1 |
| Kıvrak, T | 1 |
| Özkan, H | 1 |
| Altın, C | 1 |
| Şabanoğlu, C | 1 |
| Demirkan, B | 1 |
| Ataş, AE | 1 |
| Kılıçaslan, F | 1 |
| Altay, H | 1 |
| Tengiz, İ | 1 |
| Fahri Erkan, A | 1 |
| Kılıçaslan, B | 1 |
| Olgun, FE | 1 |
| Durakoğlugil, ME | 1 |
| Alhan, A | 1 |
| Zoghi, M | 1 |
| Ahmed, FZ | 1 |
| Taylor, JK | 1 |
| John, AV | 1 |
| Khan, MA | 1 |
| Zaidi, AM | 1 |
| Mamas, MA | 1 |
| Motwani, M | 1 |
| Cunnington, C | 1 |
| Piardi, DS | 1 |
| Butzke, M | 1 |
| Mazzuca, ACM | 1 |
| Gomes, BS | 1 |
| Alves, SG | 1 |
| Kotzian, BJ | 1 |
| Ghisleni, EC | 1 |
| Giaretta, V | 1 |
| Bellaver, P | 1 |
| Varaschin, GA | 1 |
| Garbin, AP | 1 |
| Maulion, C | 1 |
| Asher, JL | 1 |
| Moreno-Villagomez, J | 1 |
| Turner, JM | 1 |
| Wilcox, CS | 1 |
| Jefferies, JL | 2 |
| DeVita, M | 1 |
| García-Blas, S | 1 |
| Bonanad, C | 1 |
| Ventura, S | 2 |
| Núñez, JM | 1 |
| Sánchez, R | 1 |
| Chamorro, C | 1 |
| Fácila, L | 1 |
| Vaquer, JM | 1 |
| Cordero, A | 1 |
| Roqué, M | 1 |
| Ortiz, V | 1 |
| Racugno, P | 1 |
| Bodí, V | 3 |
| Valero, E | 1 |
| Moreno, MDC | 1 |
| Carratalá, A | 1 |
| Bondanza, L | 1 |
| Payá, A | 1 |
| Cardells, I | 1 |
| Pellicer, M | 1 |
| Valls, G | 1 |
| Palau, P | 2 |
| Bosch, MJ | 1 |
| Raso, R | 1 |
| Sánchez, A | 2 |
| Bertomeu-González, V | 2 |
| Bertomeu-Martínez, V | 1 |
| Montagud-Balaguer, V | 1 |
| Albiach-Montañana, C | 1 |
| Pendás-Meneau, J | 1 |
| Marcaida, G | 1 |
| Cervantes-García, S | 1 |
| San Antonio, R | 1 |
| de Mingo, E | 1 |
| Chorro, FJ | 2 |
| Sanchis, J | 3 |
| Laszczyńska, O | 1 |
| Severo, M | 1 |
| Silva, S | 1 |
| Lunet, N | 1 |
| Azevedo, A | 2 |
| Hanberg, JS | 3 |
| Brisco, MA | 3 |
| Lee, G | 1 |
| Pickstone, N | 1 |
| Facultad, J | 1 |
| Titchener, K | 1 |
| Momomura, SI | 1 |
| Ferrada, P | 1 |
| Carroll, C | 1 |
| Hassanin, A | 1 |
| Carlson, S | 1 |
| Duber, HC | 1 |
| Achan, J | 1 |
| Ikilezi, G | 1 |
| Mokdad, AH | 1 |
| Stergachis, A | 1 |
| Wollum, A | 1 |
| Bukhman, G | 1 |
| Roth, GA | 1 |
| Huang, WL | 1 |
| Yang, Y | 1 |
| Yang, J | 3 |
| Wang, HB | 1 |
| Xiong, XL | 1 |
| Zhang, YF | 1 |
| Ames, MK | 1 |
| Atkins, CE | 1 |
| Eriksson, A | 1 |
| Hess, AM | 1 |
| Rodriguez-Cillero, C | 1 |
| Menu, D | 1 |
| d'Athis, P | 2 |
| Perrin, S | 1 |
| Dipanda, M | 2 |
| Asgassou, S | 2 |
| Guepet, H | 1 |
| Mazen, E | 1 |
| Manckoundia, P | 2 |
| Putot, A | 2 |
| Matsukawa, R | 2 |
| Kato, K | 2 |
| Naruke, T | 2 |
| Miyoshi, T | 2 |
| Baba, Y | 2 |
| Murai, K | 3 |
| Mizutani, K | 2 |
| Januzzi, JL | 1 |
| Yan, S | 1 |
| Yu, J | 1 |
| Xia, Z | 1 |
| Zhu, B | 1 |
| Hu, J | 1 |
| Wan, Y | 1 |
| Niu, H | 1 |
| Ma, X | 1 |
| Yuan, C | 1 |
| Mu, G | 1 |
| Zhang, J | 2 |
| Sud, M | 1 |
| Yu, B | 1 |
| Wijeysundera, HC | 1 |
| Austin, PC | 2 |
| Ko, DT | 1 |
| Braga, J | 1 |
| Cram, P | 1 |
| Domanski, M | 1 |
| Lee, DS | 2 |
| Inomata, T | 4 |
| Ikeda, Y | 3 |
| Shibagaki, Y | 6 |
| Kumagai, Y | 1 |
| Shinagawa, H | 1 |
| Ako, J | 2 |
| Izumi, T | 6 |
| Ng, KT | 1 |
| Yap, JLL | 1 |
| Imiela, T | 1 |
| Budaj, A | 1 |
| Boonen, L | 1 |
| Verhaert, D | 1 |
| Noyens, P | 1 |
| De Vusser, P | 1 |
| Pouchelon, JL | 1 |
| Menard, J | 1 |
| Blanc, J | 1 |
| Desquilbet, L | 1 |
| Petit, A | 1 |
| Rougier, S | 1 |
| Lucats, L | 1 |
| Woehrle, F | 1 |
| Palazzuoli, A | 5 |
| Ruocco, G | 5 |
| Vescovo, G | 1 |
| Valle, R | 3 |
| Di Somma, S | 1 |
| Nuti, R | 5 |
| Pages, C | 1 |
| Schambach, S | 1 |
| Noblet, D | 1 |
| Thompson, MA | 1 |
| Sirvain, S | 1 |
| Fraisse, T | 1 |
| Tan, VS | 1 |
| Nash, DM | 1 |
| McArthur, E | 1 |
| Jain, AK | 1 |
| Garg, AX | 1 |
| Juurlink, DN | 1 |
| Weir, MA | 1 |
| Tominaga, N | 4 |
| Akashi, YJ | 4 |
| da Rosa, PR | 1 |
| Doebber, M | 1 |
| Prado, DP | 1 |
| Kohler, I | 1 |
| Rover, M | 1 |
| Gilotra, NA | 2 |
| Princewill, O | 1 |
| Marino, B | 1 |
| Okwuosa, IS | 1 |
| Chasler, J | 1 |
| Almansa, J | 1 |
| Cummings, A | 1 |
| Rhodes, P | 1 |
| Chambers, J | 1 |
| Cuomo, K | 1 |
| Francis, GS | 3 |
| Omar, HR | 2 |
| Guglin, M | 2 |
| James, R | 1 |
| Huxley, J | 1 |
| Grassi, V | 1 |
| Cobb, M | 1 |
| Brinkley, DM | 1 |
| Burpee, LJ | 2 |
| Chaudhry, SP | 1 |
| Smallwood, JA | 2 |
| Lindenfeld, J | 2 |
| Kiernan, MS | 1 |
| Stevens, SR | 2 |
| Birati, EY | 1 |
| Grodin, JL | 2 |
| Gupta, D | 1 |
| Margulies, KB | 1 |
| LaRue, S | 1 |
| Dávila-Román, VG | 1 |
| de Las Fuentes, L | 1 |
| Rangaswami, J | 1 |
| Ando, T | 4 |
| Okuhara, Y | 4 |
| Orihara, Y | 3 |
| Nishimura, K | 3 |
| Yamamoto, K | 5 |
| Masuyama, T | 7 |
| Hirotani, S | 5 |
| De Vecchis, R | 6 |
| Rigopoulos, A | 1 |
| Bigalke, B | 1 |
| Manginas, A | 1 |
| Tschöpe, C | 2 |
| Noutsias, M | 1 |
| Salah, EM | 1 |
| Bastacky, SI | 1 |
| Jackson, EK | 1 |
| Tofovic, SP | 1 |
| Beaumier, A | 1 |
| Rush, JE | 2 |
| Yang, VK | 1 |
| Freeman, LM | 2 |
| Takada, T | 1 |
| Masaki, T | 1 |
| Hoshiyama, A | 1 |
| Toki, T | 1 |
| Kamata, Y | 1 |
| Shichiri, M | 1 |
| Buttard, M | 1 |
| Pioro, L | 1 |
| Putot, S | 1 |
| Deïdda, M | 1 |
| Laborde, C | 1 |
| Mahmoudi, R | 1 |
| Yao, Y | 2 |
| Zhang, R | 1 |
| Camino Willhuber, GO | 1 |
| Guzman Mentesana, G | 1 |
| Baez, A | 1 |
| Lo Presti, S | 1 |
| Bazán, C | 1 |
| Strauss, M | 1 |
| Fretes, R | 1 |
| Paglini-Oliva, PA | 1 |
| Rivarola, HW | 1 |
| Lozano Bahamonde, A | 2 |
| Escolar Pérez, V | 2 |
| Laskibar Asua, A | 1 |
| Rodríguez Rodríguez, M | 1 |
| Murga Eizagaechevarria, N | 1 |
| Luk, A | 1 |
| Groarke, JD | 1 |
| Mahmood, SS | 1 |
| Gopal, DM | 1 |
| Joyce, E | 1 |
| Shah, SP | 1 |
| Stevenson, L | 1 |
| Azuma, K | 1 |
| Kondo, H | 1 |
| Naito, Y | 3 |
| Kashiwase, K | 1 |
| Ishihara, M | 1 |
| Grzeskowiak, MZ | 1 |
| Ahmed, N | 1 |
| Echebarria Chousa, A | 1 |
| Azcona Lucio, A | 1 |
| Alfambra Vicente, S | 1 |
| Rodríguez Rodríguez, B | 1 |
| Ward, MJ | 1 |
| Liu, D | 1 |
| Froehle, CM | 1 |
| Kuriyama, A | 1 |
| Urushidani, S | 1 |
| Wussler, D | 1 |
| Walter, J | 1 |
| du Fay de Lavallaz, J | 1 |
| Strebel, I | 1 |
| Mueller, C | 1 |
| Park, JJ | 1 |
| Choi, DJ | 1 |
| Sharma, K | 1 |
| Vaishnav, J | 1 |
| Kalathiya, R | 1 |
| Hu, JR | 1 |
| Miller, J | 1 |
| Shah, N | 1 |
| Hill, T | 1 |
| Sharp, M | 1 |
| Tsao, A | 1 |
| Alexander, KM | 1 |
| Gupta, R | 1 |
| Montemayor, K | 1 |
| Kovell, L | 2 |
| Chasler, JE | 1 |
| Lee, YJ | 1 |
| Fine, DM | 1 |
| Kass, DA | 1 |
| Weiss, RG | 1 |
| Thiemann, DR | 1 |
| Ndumele, CE | 1 |
| Schulman, SP | 1 |
| Ohad, DG | 1 |
| Segev, Y | 1 |
| Kelmer, E | 1 |
| Aroch, I | 1 |
| Bdolah-Abram, T | 1 |
| Segev, G | 1 |
| Klainbart, S | 1 |
| Feola, M | 2 |
| Testa, M | 2 |
| Ferreri, C | 1 |
| Cardone, M | 1 |
| Sola, M | 1 |
| Ariotti, S | 1 |
| Rosso, GL | 1 |
| Shah, P | 1 |
| Patel, H | 2 |
| Mithawala, P | 1 |
| Doshi, R | 1 |
| Pizzarossa, AC | 1 |
| Rebella, M | 1 |
| Boulestreau, R | 1 |
| Lalanne, P | 1 |
| Durieux, W | 1 |
| Delarche, N | 1 |
| Mordi, I | 1 |
| Gregson, J | 1 |
| Anker, SD | 4 |
| Hillege, HL | 6 |
| Ng, LL | 2 |
| Lang, CC | 4 |
| Erolu, E | 1 |
| Akalın, F | 1 |
| Saylan Çevik, B | 1 |
| Yücelten, D | 1 |
| Kondo, T | 1 |
| Shiraishi, A | 2 |
| Murohara, T | 1 |
| Bonanomi, C | 1 |
| Gherbesi, E | 1 |
| Colli, AM | 1 |
| Malanchini, G | 1 |
| Lombardi, F | 1 |
| Smeele, FJ | 1 |
| van Drimmelen, AA | 1 |
| Schaafsma, HJ | 1 |
| Westendorp, PH | 1 |
| van de Kamp, HJ | 1 |
| Hoes, AW | 2 |
| Quirós, R | 1 |
| Epelde, F | 1 |
| González-Franco, Á | 1 |
| Montero-Pérez-Barquero, M | 1 |
| Afari, ME | 1 |
| Aoun, J | 1 |
| Khare, S | 1 |
| Tsao, L | 1 |
| Kapłon-Cieślicka, A | 1 |
| Wancerz, A | 1 |
| Crespo-Leiro, MG | 1 |
| Maggioni, AP | 3 |
| Drożdż, J | 2 |
| Yata, M | 1 |
| Kooistra, HS | 1 |
| Beijerink, NJ | 1 |
| Prather, K | 1 |
| Gabriel, D | 1 |
| Jones, I | 1 |
| Kachadourian, J | 1 |
| Packer, M | 1 |
| Rouleau, J | 1 |
| Zile, MR | 2 |
| Shi, V | 1 |
| Dos Reis, D | 1 |
| Fraticelli, L | 1 |
| Bassand, A | 1 |
| Manzo-Silberman, S | 1 |
| Peschanski, N | 1 |
| Charpentier, S | 1 |
| Elbaz, M | 1 |
| Savary, D | 1 |
| Bonnefoy-Cudraz, E | 1 |
| Henry, P | 1 |
| Guerraoui, A | 1 |
| Tazarourte, K | 1 |
| El Khoury, C | 1 |
| Onitsuka, H | 1 |
| Koyama, S | 1 |
| Ideguchi, T | 1 |
| Ishikawa, T | 2 |
| Kitamura, K | 1 |
| Nagamachi, S | 1 |
| Täger, T | 1 |
| Fröhlich, H | 1 |
| Grundtvig, M | 2 |
| Seiz, M | 1 |
| Schellberg, D | 1 |
| Goode, K | 1 |
| Kazmi, S | 1 |
| Hole, T | 2 |
| Katus, HA | 1 |
| Atar, D | 2 |
| Agewall, S | 1 |
| Frankenstein, L | 1 |
| Miles, JA | 1 |
| Hanumanthu, BK | 1 |
| Patel, K | 1 |
| Siegel, RM | 2 |
| Kokkinidis, DG | 1 |
| Ellison, DH | 2 |
| Siwolowski, P | 1 |
| Szachniewicz, J | 1 |
| Tycińska, A | 1 |
| Banasiak, W | 1 |
| Halpert, A | 1 |
| Levin, H | 1 |
| Rahhal, A | 1 |
| Saad, MO | 1 |
| Tawengi, K | 1 |
| Assi, AAR | 1 |
| Habra, M | 1 |
| Ahmed, D | 1 |
| McCoy, IE | 1 |
| Chertow, GM | 1 |
| Chang, TI | 1 |
| Toyoda, S | 1 |
| Arikawa, T | 1 |
| Inami, S | 1 |
| Nishikawa, R | 1 |
| Saito, F | 1 |
| Watanabe, R | 1 |
| Sakuma, M | 1 |
| Kanaya, T | 1 |
| Abe, S | 1 |
| Inoue, T | 2 |
| Xiong, L | 1 |
| Chinaeke, EE | 1 |
| Lu, K | 1 |
| Merritt, TE | 1 |
| Camarda, A | 1 |
| Rinaldi, M | 1 |
| Gaita, F | 1 |
| Soucy-Giguere, MC | 1 |
| Charbonneau, É | 1 |
| Cinq Mars, A | 1 |
| Dubois, M | 1 |
| Sénéchal, M | 1 |
| Kolkhof, P | 1 |
| Pook, E | 1 |
| Pavkovic, M | 1 |
| Kretschmer, A | 1 |
| Buchmüller, A | 1 |
| Tinel, H | 1 |
| Delbeck, M | 1 |
| Mondritzki, T | 1 |
| Wasnaire, P | 1 |
| Dinh, W | 1 |
| Truebel, H | 1 |
| Hüser, J | 1 |
| Schmeck, C | 1 |
| Bikdeli, B | 1 |
| Strait, KM | 1 |
| Dharmarajan, K | 1 |
| Partovian, C | 1 |
| Kim, N | 1 |
| Li, SX | 1 |
| Khan, U | 1 |
| Krumholz, HM | 1 |
| Kajimoto, K | 1 |
| Keida, T | 1 |
| Mizuno, M | 1 |
| Minami, Y | 1 |
| Yumino, D | 1 |
| Asai, K | 1 |
| Muanakata, R | 1 |
| Aokage, T | 1 |
| Sakata, Y | 2 |
| Mizuno, K | 2 |
| Takano, T | 1 |
| Ng, TM | 2 |
| Konopka, E | 1 |
| Hyderi, AF | 1 |
| Hshieh, S | 2 |
| Tsuji, Y | 1 |
| Kim, BJ | 1 |
| Han, SY | 1 |
| Phan, DH | 1 |
| Jeng, AI | 1 |
| Pandya, GJ | 1 |
| Mukhopadhyay, A | 1 |
| Ping, CA | 1 |
| Lim, TK | 1 |
| Legrand, M | 1 |
| Payen, D | 1 |
| Solymosi, EA | 1 |
| Kaestle-Gembardt, SM | 1 |
| Vadász, I | 1 |
| Wang, L | 1 |
| Neye, N | 1 |
| Chupin, CJ | 1 |
| Rozowsky, S | 1 |
| Ruehl, R | 1 |
| Tabuchi, A | 1 |
| Schulz, H | 1 |
| Kapus, A | 1 |
| Morty, RE | 1 |
| Kuebler, WM | 1 |
| Yokokawa, T | 1 |
| Nakazato, K | 1 |
| Kanno, Y | 2 |
| Mizukami, H | 1 |
| Kobayashi, A | 1 |
| Yoshihisa, A | 1 |
| Shichishima-Nakamura, A | 1 |
| Ohkawara, H | 1 |
| Noji, H | 1 |
| Suzuki, H | 4 |
| Saitoh, S | 1 |
| Ogawa, K | 1 |
| Hisa, S | 1 |
| Takeishi, Y | 1 |
| Wu, Y | 1 |
| Chen, B | 1 |
| Hong, K | 1 |
| Hu, W | 1 |
| Peng, Q | 1 |
| Cheng, X | 1 |
| Su, H | 1 |
| Bartone, C | 1 |
| Menon, S | 1 |
| Egnaczyk, GF | 1 |
| O'Brien, TM | 1 |
| Chung, ES | 1 |
| Dini, FL | 1 |
| Ghio, S | 1 |
| Klersy, C | 1 |
| Rossi, A | 1 |
| Simioniuc, A | 1 |
| Scelsi, L | 1 |
| Genta, FT | 1 |
| Cicoira, M | 1 |
| Tavazzi, L | 2 |
| Temporelli, PL | 1 |
| Ricci, F | 1 |
| Ramírez, T | 1 |
| Marmorato, R | 1 |
| Vega, J | 1 |
| Pagán, P | 1 |
| López, JE | 1 |
| Soto-Salgado, M | 1 |
| Cangiano, JL | 1 |
| Valero, A | 1 |
| Alonso, H | 1 |
| Pérez-Durá, MJ | 1 |
| Noval, A | 1 |
| Gil-Román, JJ | 1 |
| Zapater, P | 1 |
| Llanos, L | 1 |
| Perelló, R | 1 |
| Pitsiou, G | 1 |
| Paspala, A | 1 |
| Bagalas, V | 1 |
| Boutou, AK | 1 |
| Stanopoulos, I | 1 |
| Santos, M | 2 |
| Almeida, S | 2 |
| Marques, I | 2 |
| Carvalho, H | 2 |
| Yamazaki, T | 1 |
| Shiota, M | 1 |
| Osada-Oka, M | 1 |
| Fujiki, H | 2 |
| Hanatani, A | 1 |
| Shimada, K | 1 |
| Miura, K | 1 |
| Yoshiyama, M | 1 |
| Iwao, H | 1 |
| Izumi, Y | 1 |
| Suzuki, M | 3 |
| Nagahori, W | 2 |
| Onishi, Y | 1 |
| Satoh, Y | 1 |
| Ono, Y | 1 |
| Nishioka, T | 1 |
| Noda, M | 1 |
| Sugi, K | 1 |
| Torii, S | 1 |
| Tejima, T | 1 |
| Sakurada, H | 1 |
| Yamaguchi, S | 1 |
| Okishige, K | 1 |
| Fujii, H | 2 |
| Takahashi, A | 1 |
| Van Wart, SA | 1 |
| Shoaf, SE | 1 |
| Mallikaarjun, S | 1 |
| Mager, DE | 1 |
| Yameogo, NV | 1 |
| Mbaye, A | 1 |
| Kagambega, LJ | 1 |
| Dioum, M | 1 |
| Diagne-Sow, D | 1 |
| Kane, M | 1 |
| Diack, B | 1 |
| Kane, A | 2 |
| Tarvasmäki, T | 1 |
| Tolonen, J | 1 |
| Siirilä-Waris, K | 1 |
| Nieminen, MS | 1 |
| Lassus, J | 2 |
| Ege, MR | 1 |
| Yilmaz, MB | 2 |
| Marenzi, G | 5 |
| Muratori, M | 1 |
| Cosentino, ER | 1 |
| Rinaldi, ER | 1 |
| Donghi, V | 1 |
| Milazzo, V | 1 |
| Ferramosca, E | 1 |
| Borghi, C | 1 |
| Santoro, A | 1 |
| Agostoni, P | 4 |
| Wu, MY | 1 |
| Chang, NC | 1 |
| Su, CL | 1 |
| Hsu, YH | 1 |
| Chen, TW | 1 |
| Lin, YF | 1 |
| Wu, CH | 1 |
| Tam, KW | 1 |
| Ogino, K | 1 |
| Kinugasa, Y | 1 |
| Kato, M | 1 |
| Hisatome, I | 1 |
| Doehner, W | 2 |
| Nakabo, A | 1 |
| Iwasaku, T | 1 |
| Eguchi, A | 1 |
| Morisawa, D | 1 |
| Sawada, H | 1 |
| Manabe, E | 1 |
| Austin, J | 1 |
| Hockey, D | 1 |
| Williams, WR | 1 |
| Hutchison, S | 1 |
| Triposkiadis, FK | 1 |
| Karayannis, G | 2 |
| Wolski, K | 1 |
| Parissis, J | 2 |
| Parisis, C | 2 |
| Rovithis, D | 2 |
| Koutrakis, K | 1 |
| Skoularigis, J | 2 |
| Antoniou, CK | 1 |
| Chrysohoou, C | 1 |
| Pitsavos, C | 1 |
| Stefanadis, C | 1 |
| Nastas, J | 2 |
| Tsaknakis, T | 2 |
| Mantziari, L | 1 |
| Giannakoulas, G | 1 |
| Karvounis, H | 1 |
| Kalogeropoulos, AP | 1 |
| Giamouzis, G | 2 |
| Igarashi, K | 1 |
| Kawahara, M | 1 |
| Fernando, J | 1 |
| Percy, J | 1 |
| Davidson, L | 1 |
| Allan, S | 1 |
| Sica, DA | 1 |
| Shah, KB | 1 |
| Valente, MA | 4 |
| Massie, BM | 3 |
| Cotter, G | 8 |
| Davison, B | 3 |
| Cleland, JG | 8 |
| Givertz, MM | 8 |
| Bloomfield, DM | 3 |
| Fiuzat, M | 3 |
| Dittrich, HC | 4 |
| Nazmi, A | 1 |
| Weatherall, M | 1 |
| Wilkins, B | 1 |
| Robinson, GM | 1 |
| Galindo-Ocaña, J | 1 |
| Romero-Mena, J | 1 |
| Castillo-Ferrando, JR | 1 |
| Aguilera-González, C | 1 |
| Bernabeu-Wittel, M | 1 |
| Ollero-Baturone, M | 1 |
| Beattie, JM | 2 |
| Satchithananda, D | 1 |
| Ingram, A | 1 |
| Hookey, C | 1 |
| Boedeker, NC | 1 |
| Guzzetta, P | 1 |
| Rosenthal, SL | 1 |
| Padilla, LR | 1 |
| Murray, S | 1 |
| Newman, K | 1 |
| Gandhi, S | 2 |
| Mosleh, W | 2 |
| Myers, RB | 2 |
| Esposito, C | 2 |
| Ariano, C | 3 |
| Cantatrione, S | 3 |
| Singh, D | 1 |
| Shrestha, K | 1 |
| Tang, WH | 5 |
| Pan, A | 1 |
| Stiell, IG | 1 |
| Dionne, R | 1 |
| Maloney, J | 1 |
| Núñez, E | 3 |
| Bayés-Genís, A | 2 |
| Dalzell, JR | 2 |
| Connolly, EC | 1 |
| Zatarain-Nicolás, E | 2 |
| López-Díaz, J | 1 |
| de la Fuente-Galán, L | 2 |
| García-Pardo, H | 1 |
| Recio-Platero, A | 1 |
| San Román-Calvar, JA | 2 |
| Sancho-Zamora, MA | 1 |
| Tchernodrinski, S | 1 |
| Lucas, BP | 1 |
| Athavale, A | 1 |
| Candotti, C | 1 |
| Margeta, B | 1 |
| Katz, A | 1 |
| Kumapley, R | 1 |
| Selman, A | 1 |
| Molyneux, E | 1 |
| Kennedy, N | 1 |
| Wu, ZL | 1 |
| Ren, H | 1 |
| Lai, WY | 1 |
| Lin, S | 1 |
| Jiang, RY | 1 |
| Ye, TC | 1 |
| Shen, QB | 1 |
| Zeng, QC | 1 |
| Xu, DL | 1 |
| Pellegrini, M | 3 |
| Martini, G | 1 |
| Franci, B | 2 |
| Campagna, MS | 1 |
| Gilleman, M | 1 |
| Ronco, C | 2 |
| Kissling, KT | 1 |
| Pickworth, KK | 1 |
| Niu, X | 1 |
| Beltrami, M | 1 |
| Gonnelli, S | 1 |
| Angelini, GD | 1 |
| Davison, BA | 1 |
| Greenberg, BH | 1 |
| Pang, PS | 2 |
| Levin, B | 1 |
| Hua, TA | 1 |
| Severin, T | 1 |
| Kaldara, E | 1 |
| Ntalianis, A | 1 |
| Nana, E | 1 |
| Pantsios, C | 1 |
| Repasos, E | 1 |
| Margari, Z | 1 |
| Sousonis, V | 1 |
| Malliaras, K | 1 |
| Nanas, JN | 3 |
| Matsumoto, N | 2 |
| Miyake, F | 2 |
| Kimura, K | 3 |
| Ennezat, PV | 2 |
| Stewart, M | 1 |
| Samson, R | 1 |
| Bouabdallaoui, N | 1 |
| Maréchaux, S | 1 |
| Banfi, C | 1 |
| Bouvaist, H | 1 |
| Le Jemtel, TH | 1 |
| Baldi, C | 1 |
| Di Biase, G | 1 |
| Lala, A | 1 |
| Vader, JM | 1 |
| AbouEzzeddine, OF | 1 |
| Khazanie, P | 1 |
| Redfield, MM | 4 |
| Goldsmith, SR | 7 |
| Bart, BA | 2 |
| Braunwald, E | 4 |
| Füeßl, HS | 1 |
| Makadia, S | 1 |
| Simmons, T | 1 |
| Augustine, S | 1 |
| Harris, C | 1 |
| Chibungu, A | 1 |
| Parakh, K | 1 |
| Nieves, LC | 1 |
| Mehrtens, GM | 1 |
| Pores, N | 1 |
| Pickrell, C | 1 |
| Tanis, J | 1 |
| Satty, T | 1 |
| Chuang, M | 1 |
| Young, TC | 1 |
| Merlin, MA | 1 |
| McNaughton, A | 1 |
| Frasca, S | 1 |
| Mishra, N | 1 |
| Tuttle, AD | 1 |
| de Grooth, HJ | 1 |
| Girbes, AR | 1 |
| Tuinman, PR | 1 |
| Parappil, H | 1 |
| Masud, F | 1 |
| Salama, H | 1 |
| ur Rahman, S | 1 |
| Buggey, J | 2 |
| Kamiya, M | 1 |
| Nozaki, A | 1 |
| Akiya, M | 1 |
| Okazaki, H | 1 |
| Takahashi, Y | 1 |
| Chen, HY | 1 |
| Chou, KJ | 1 |
| Fang, HC | 1 |
| Chen, CL | 1 |
| Hsu, CY | 1 |
| Huang, WC | 1 |
| Huang, CW | 1 |
| Huang, CK | 1 |
| Lee, PT | 1 |
| Owen, DR | 1 |
| MacAllister, R | 1 |
| Sofat, R | 1 |
| Mamcarz, A | 1 |
| Nessler, J | 1 |
| Tykarski, A | 1 |
| Niemczyk, M | 1 |
| Wożakowska-Kapłon, B | 1 |
| Soyler, C | 1 |
| Tanriover, MD | 1 |
| Ascioglu, S | 1 |
| Aksu, NM | 1 |
| Arici, M | 1 |
| Agha, HM | 1 |
| Zakaria, R | 1 |
| Mostafa, FA | 1 |
| Hamza, H | 1 |
| Tamura, Y | 1 |
| Kimura, M | 2 |
| Ono, T | 1 |
| Kuwana, M | 1 |
| Satoh, T | 1 |
| Humbert, M | 1 |
| Ersbøll, MK | 1 |
| Schulte, PJ | 3 |
| OʼConnor, CM | 1 |
| Yayla, Ç | 1 |
| Akyel, A | 1 |
| Canpolat, U | 1 |
| Gayretli Yayla, K | 1 |
| Eyiol, A | 1 |
| Akboğa, MK | 1 |
| Türkoğlu, S | 1 |
| Tavil, Y | 1 |
| Boyacı, B | 1 |
| Çengel, A | 1 |
| Roughead, EE | 2 |
| Chan, EW | 1 |
| Choi, NK | 1 |
| Kimura, T | 1 |
| Kubota, K | 1 |
| Lai, EC | 1 |
| Man, KK | 1 |
| Nguyen, TA | 1 |
| Ooba, N | 1 |
| Park, BJ | 1 |
| Sato, T | 1 |
| Shin, JY | 1 |
| Griffiths, J | 1 |
| Wong, IC | 1 |
| Yang, YH | 1 |
| Pratt, NL | 1 |
| Ballester, MR | 1 |
| Roig, E | 1 |
| Gich, I | 1 |
| Puntes, M | 1 |
| Delgadillo, J | 1 |
| Santos, B | 1 |
| Antonijoan, RM | 1 |
| Bruno, N | 1 |
| Dunning, AM | 1 |
| Ezekowitz, JA | 2 |
| Califf, RM | 2 |
| van der Meer, P | 2 |
| Zepeda, P | 1 |
| Rain, C | 1 |
| Sepúlveda, P | 1 |
| Kumar, V | 1 |
| McKendry, C | 1 |
| Chiswell, K | 1 |
| Paterna, S | 12 |
| Di Gaudio, F | 2 |
| La Rocca, V | 1 |
| Balistreri, F | 1 |
| Greco, M | 1 |
| Torres, D | 6 |
| Lupo, U | 2 |
| Rizzo, G | 1 |
| di Pasquale, P | 12 |
| Indelicato, S | 1 |
| Cuttitta, F | 1 |
| Parrinello, G | 12 |
| Imamura, T | 1 |
| Fabiano, V | 1 |
| Carnovale, C | 1 |
| Gentili, M | 1 |
| Radice, S | 1 |
| Zuccotti, GV | 1 |
| Clementi, E | 1 |
| Perrotta, C | 1 |
| Mameli, C | 1 |
| Freitas Ramírez, A | 1 |
| Buckley, LF | 1 |
| Carter, DM | 1 |
| Matta, L | 1 |
| Cheng, JW | 1 |
| Stevens, C | 1 |
| Belenkiy, RM | 1 |
| Young, MA | 1 |
| Weiffenbach, CS | 1 |
| Momose, T | 1 |
| Hasegawa, T | 1 |
| Morita, T | 1 |
| Misawa, T | 1 |
| Motoki, H | 1 |
| Izawa, A | 1 |
| Ikeda, U | 1 |
| Kjekshus, J | 2 |
| Wikstrand, J | 1 |
| Komajda, M | 1 |
| Wedel, H | 3 |
| Waagstein, F | 4 |
| McMurray, JJ | 4 |
| Hasselblad, V | 2 |
| Armstrong, PW | 1 |
| Wu, W | 1 |
| Zhang, L | 1 |
| Chen, W | 1 |
| Kume, T | 1 |
| Okura, H | 1 |
| Hashimoto, Y | 2 |
| Katta, N | 1 |
| Balla, S | 1 |
| Alpert, MA | 1 |
| Teigen, LM | 1 |
| Twernbold, DD | 1 |
| Miller, WL | 2 |
| de Denus, S | 1 |
| Rouleau, JL | 2 |
| Mann, DL | 1 |
| Huggins, GS | 1 |
| Cappola, TP | 1 |
| Shah, SH | 1 |
| Keleti, J | 1 |
| Zada, YF | 1 |
| Provost, S | 1 |
| Bardhadi, A | 1 |
| Phillips, MS | 1 |
| Normand, V | 1 |
| Mongrain, I | 1 |
| Dubé, MP | 1 |
| AlFaleh, H | 1 |
| Elasfar, AA | 1 |
| Ullah, A | 1 |
| AlHabib, KF | 1 |
| Hersi, A | 1 |
| Mimish, L | 1 |
| Almasood, A | 1 |
| Al Ghamdi, S | 1 |
| Ghabashi, A | 1 |
| Malik, A | 1 |
| Hussein, GA | 1 |
| Al-Murayeh, M | 1 |
| Abuosa, A | 1 |
| Al Habeeb, W | 1 |
| Kashour, T | 1 |
| Ödek, Ç | 1 |
| Kendirli, T | 1 |
| Kocaay, P | 1 |
| Azapağası, E | 1 |
| Uçar, T | 1 |
| Şıklar, Z | 1 |
| Berberoğlu, M | 1 |
| Shiraishi, M | 1 |
| Murakami, T | 1 |
| Nawa, T | 1 |
| Kobayashi, H | 1 |
| Nagamine, H | 1 |
| Shiraga, K | 1 |
| Higashi, K | 1 |
| Nakajima, H | 1 |
| van der Harst, P | 1 |
| Ng, L | 1 |
| Samani, NJ | 1 |
| Zwinderman, AH | 1 |
| Subacius, H | 1 |
| Gheorghiade, M | 5 |
| Parikh, CR | 2 |
| Komamura, K | 1 |
| Mano, T | 2 |
| Malebranche, R | 1 |
| Tabou Moyo, C | 1 |
| Morisset, PH | 1 |
| Raphael, NA | 1 |
| Wilentz, JR | 1 |
| Rao, V | 1 |
| Laur, O | 1 |
| Perry Wilson, F | 1 |
| Assefa, M | 1 |
| Samuel Broughton, J | 1 |
| Planavsky, NJ | 1 |
| Bellumkonda, L | 1 |
| Ekmekçi, A | 1 |
| Keskin, M | 1 |
| Güvenç, TS | 1 |
| Uluganyan, M | 1 |
| Karaca, G | 1 |
| Hayıroğlu, Mİ | 1 |
| Ağustos, SŞ | 1 |
| Eren, M | 1 |
| Watanabe, K | 4 |
| Sreedhar, R | 1 |
| Thandavarayan, RA | 2 |
| Karuppagounder, V | 1 |
| Giridharan, VV | 1 |
| Antony, S | 1 |
| Harima, M | 2 |
| Nakamura, M | 1 |
| Suzuki, K | 4 |
| Sone, H | 1 |
| Arumugam, S | 1 |
| Cusack, L | 1 |
| Field, C | 1 |
| McDermott, A | 1 |
| Pogue, B | 1 |
| Clauss, T | 1 |
| Bossart, G | 1 |
| Camus, A | 1 |
| Wen, S | 1 |
| Ning, J | 1 |
| Collins, S | 1 |
| Berry, D | 1 |
| Newhard, D | 1 |
| Jung, S | 1 |
| Luo, J | 1 |
| Chen, X | 1 |
| Luo, C | 1 |
| Lu, G | 1 |
| Peng, L | 1 |
| Zuo, Z | 1 |
| Fukui, M | 1 |
| Tsujino, T | 2 |
| Ito, H | 2 |
| Akasaka, T | 2 |
| Hirano, Y | 2 |
| Ohte, N | 2 |
| Daimon, T | 2 |
| Nakatani, S | 2 |
| Kawabata, M | 1 |
| Huczek, Z | 1 |
| Pacho, C | 1 |
| Domingo, M | 1 |
| Núñez, R | 1 |
| Lupón, J | 1 |
| Moliner, P | 1 |
| de Antonio, M | 1 |
| González, B | 1 |
| Santesmases, J | 1 |
| Vela, E | 1 |
| Tor, J | 1 |
| Jalaba, S | 1 |
| Palermo, J | 1 |
| Budavari, AI | 1 |
| Chaudesaygues, E | 1 |
| Ferrini, M | 1 |
| Ritz, B | 1 |
| Mielniczuk, LM | 1 |
| Tsang, SW | 1 |
| Nohria, A | 1 |
| Lewis, EF | 1 |
| Baughman, KL | 1 |
| Rocha, RM | 1 |
| Silva, GV | 1 |
| de Albuquerque, DC | 1 |
| Tura, BR | 1 |
| Albanesi Filho, FM | 1 |
| Ishido, H | 1 |
| Senzaki, H | 1 |
| Di Giovambattista, R | 1 |
| Ahmad, K | 1 |
| Gandhi, MS | 1 |
| Smith, WC | 1 |
| Weber, KT | 5 |
| Licata, G | 9 |
| Goebel, JA | 1 |
| Van Bakel, AB | 2 |
| Gottlieb, SS | 6 |
| Bosomworth, J | 1 |
| De Marco, T | 1 |
| Lopatin, M | 1 |
| Wynne, J | 1 |
| Mills, RM | 2 |
| Emerman, CL | 1 |
| Mattu, A | 1 |
| Lawner, B | 1 |
| López, B | 3 |
| Querejeta, R | 3 |
| González, A | 3 |
| Beaumont, J | 2 |
| Larman, M | 3 |
| Díez, J | 5 |
| Sheikhi, A | 1 |
| Jaberi, Y | 1 |
| Esmaeilzadeh, A | 1 |
| Khani, M | 1 |
| Moosaeefard, M | 1 |
| Shafaqatian, M | 1 |
| Anguita, M | 2 |
| Toledano, F | 1 |
| León, C | 1 |
| Castillo, JC | 1 |
| Snopek, G | 1 |
| Kotlarska, J | 1 |
| Daniewska, D | 1 |
| Zelek, T | 1 |
| Drewniak, W | 1 |
| Król-Jaskulska, A | 1 |
| Dabrowski, M | 1 |
| Szmit, S | 1 |
| Nurzyński, P | 1 |
| Szaluś, N | 1 |
| Szczylik, C | 1 |
| McKinney, J | 1 |
| Brywczynski, J | 1 |
| Slovis, CM | 1 |
| Rasmussen, ZZ | 1 |
| Barfod, T | 1 |
| Klit, J | 1 |
| Lobo-Vielma, L | 1 |
| Colmenarez-Mendoza, H | 1 |
| Donis, JH | 1 |
| Sanchez, F | 1 |
| Perez, A | 1 |
| Villarroel, V | 1 |
| Dávila, DF | 1 |
| Nicklas, J | 1 |
| Tanaka, H | 1 |
| Thanikachalam, PV | 1 |
| Yamaguchi, K | 3 |
| Tachikawa, H | 1 |
| Kodama, M | 4 |
| Aizawa, Y | 4 |
| Coca, A | 1 |
| de Teresa, E | 1 |
| Castro-Beiras, A | 1 |
| Conthe, P | 1 |
| Cobo, E | 1 |
| Fernández, E | 1 |
| Jolobe, OM | 2 |
| Wargo, KA | 1 |
| Banta, WM | 1 |
| Hasegawa-Moriyama, M | 1 |
| Fujimoto, A | 1 |
| Aoyama, K | 1 |
| Imai, M | 1 |
| Kikutani, T | 1 |
| Oshima, M | 1 |
| Sonoda, S | 1 |
| Inada, E | 1 |
| Haass, M | 1 |
| Mehta, S | 1 |
| Vijayakumar, M | 1 |
| Dodic, S | 1 |
| Krotin, M | 1 |
| Neskovic, A | 1 |
| de Voogd, H | 1 |
| Böcker, C | 1 |
| Ziegler, D | 1 |
| Godes, M | 1 |
| Nakov, R | 1 |
| Essers, H | 1 |
| Verboom, C | 1 |
| Hocher, B | 2 |
| Rademaker, MT | 3 |
| Charles, CJ | 3 |
| Nicholls, MG | 8 |
| Richards, AM | 4 |
| Stiefelhagen, P | 1 |
| Pratt, N | 1 |
| Ryan, P | 1 |
| Gilbert, AL | 1 |
| Nakayama, M | 2 |
| Nakano, H | 2 |
| Tabak'ian, EA | 1 |
| Zaruba, AIu | 1 |
| Miasnikov, RP | 1 |
| Ataullakhanova, DM | 2 |
| Kukharchuk, VV | 1 |
| Tsuda, E | 1 |
| Matsuo, M | 1 |
| Sakaguchi, H | 1 |
| Hayashi, T | 3 |
| Hosoda, K | 1 |
| Miyazaki, A | 1 |
| Berger, R | 2 |
| Moertl, D | 1 |
| Peter, S | 1 |
| Ahmadi, R | 1 |
| Huelsmann, M | 1 |
| Yamuti, S | 1 |
| Wagner, B | 1 |
| Pacher, R | 3 |
| Thomson, MR | 1 |
| Nappi, JM | 1 |
| Dunn, SP | 1 |
| Hollis, IB | 1 |
| Rodgers, JE | 1 |
| Corrao, S | 1 |
| Di Sciacca, R | 1 |
| Scaglione, R | 1 |
| Caruso, C | 1 |
| Feagans, JM | 1 |
| Jahann, DA | 1 |
| Barkin, JS | 1 |
| Westheim, A | 1 |
| Flønaes, B | 1 |
| Gullestad, L | 2 |
| Allen, LA | 1 |
| Turer, AT | 1 |
| Dewald, T | 1 |
| Stough, WG | 1 |
| Sica, D | 1 |
| Oren, RM | 1 |
| Gottwald, MD | 1 |
| Eshar, D | 1 |
| Peddle, GD | 3 |
| Briscoe, JA | 1 |
| Goutal, CM | 1 |
| Keir, I | 1 |
| Kenney, S | 1 |
| Lopukhova, VV | 1 |
| Sapel'nikov, OV | 1 |
| Grishin, IR | 1 |
| Erastova, NV | 1 |
| Latypov, RS | 1 |
| Mareev, IuV | 1 |
| Chernova, NA | 1 |
| Saidova, MA | 1 |
| Akchurin, RS | 1 |
| Karpov, IuA | 1 |
| Abdel-Qadir, HM | 1 |
| Tu, JV | 1 |
| Yun, L | 1 |
| Newton, GE | 1 |
| Acuña, C | 1 |
| Xu, J | 1 |
| Qiao, R | 1 |
| Towers, KA | 1 |
| Bardsley, KA | 1 |
| Macdonald, PS | 1 |
| Economou, D | 1 |
| Savvatis, K | 1 |
| Kirlidis, T | 1 |
| Westermann, D | 1 |
| Triposkiadis, F | 1 |
| Giglioli, C | 1 |
| Landi, D | 1 |
| Cecchi, E | 1 |
| Chiostri, M | 1 |
| Gensini, GF | 1 |
| Valente, S | 1 |
| Ciaccheri, M | 1 |
| Castelli, G | 1 |
| Romano, SM | 1 |
| Izgi, C | 1 |
| Feray, H | 1 |
| Cevik, C | 1 |
| Saltan, Y | 1 |
| Mansuroglu, D | 1 |
| Nugent, K | 1 |
| Lassen, CK | 1 |
| Jespersen, B | 1 |
| Ciccarelli, A | 3 |
| Cioppa, C | 3 |
| Giasi, A | 2 |
| Pucciarelli, A | 1 |
| Martins, J | 1 |
| Mascarenhas, J | 1 |
| Lopes, R | 1 |
| Bugatti, S | 2 |
| Bettari, L | 1 |
| Carubelli, V | 1 |
| Danesi, R | 2 |
| Lazzarini, V | 1 |
| Lombardi, C | 3 |
| Cas, LD | 1 |
| Lombardo, E | 1 |
| Taglieri, C | 1 |
| Vallauri, P | 1 |
| Piccolo, S | 1 |
| Lee, KL | 2 |
| Bull, DA | 1 |
| LeWinter, MM | 1 |
| Deswal, A | 1 |
| Ofili, EO | 1 |
| McNulty, SE | 2 |
| Kfoury, AG | 1 |
| Chen, HH | 4 |
| Semigran, MJ | 1 |
| Mascette, AM | 1 |
| Kelder, JC | 1 |
| Cramer, MJ | 1 |
| Rutten, FH | 1 |
| Plokker, HW | 1 |
| Grobbee, DE | 1 |
| Zacharias, H | 1 |
| Raw, J | 1 |
| Nunn, A | 1 |
| Johnson, M | 1 |
| Mezzero, M | 1 |
| Cardillo, M | 3 |
| Fasullo, S | 5 |
| La Rocca, G | 1 |
| Aziz, EF | 1 |
| Kukin, M | 1 |
| Javed, F | 1 |
| Pratap, B | 1 |
| Sabharwal, MS | 1 |
| Tormey, D | 1 |
| Frankenberger, O | 1 |
| Herzog, E | 1 |
| Rokutan, H | 1 |
| Suckow, C | 1 |
| Strassburg, S | 1 |
| Bockmeyer, B | 1 |
| Waller, C | 1 |
| Bauersachs, J | 1 |
| von Websky, K | 1 |
| Springer, J | 1 |
| Trapanese, C | 1 |
| Bellanca, M | 1 |
| Hisatake, S | 1 |
| Nanjo, S | 1 |
| Fujimoto, S | 1 |
| Yamashina, S | 1 |
| Namiki, A | 1 |
| Yamazaki, J | 1 |
| Escobar, C | 1 |
| Sánchez-Zamorano, MA | 1 |
| Mohan, A | 1 |
| Mohan, CP | 1 |
| Jenkins, PG | 1 |
| Ng Kam Chuen, MJ | 1 |
| MacFadyen, RJ | 4 |
| Lip, GY | 1 |
| Gaze, D | 1 |
| Collinson, PO | 1 |
| van Oeveren, W | 1 |
| Costello-Boerrigter, LC | 4 |
| Burnett, JC | 10 |
| Wada, Y | 1 |
| Kobayashi, D | 1 |
| Murakami, S | 1 |
| Oda, M | 1 |
| Hanawa, H | 1 |
| Kuroda, T | 1 |
| Narita, I | 1 |
| Cannizzaro, S | 1 |
| Basile, I | 1 |
| Vitrano, G | 1 |
| Terrazzino, G | 1 |
| Maringhini, G | 1 |
| Ganci, F | 1 |
| Scalzo, S | 1 |
| Sarullo, FM | 3 |
| Cice, G | 1 |
| Celik, T | 1 |
| Yuksel, UC | 1 |
| Turagam, MK | 1 |
| Velagapudi, P | 1 |
| Kalra, AS | 1 |
| Ramalingam, VS | 1 |
| Sinnakirouchenan, R | 1 |
| Holley, JL | 1 |
| Badawy, SS | 1 |
| Fahmy, A | 1 |
| Siniorakis, E | 1 |
| Arvanitakis, S | 1 |
| Pantelis, N | 1 |
| Galiwango, PJ | 1 |
| McReynolds, A | 1 |
| Ivanov, J | 1 |
| Chan, CT | 1 |
| Floras, JS | 1 |
| Sobotka, PA | 1 |
| Freda, BJ | 1 |
| Slawsky, M | 1 |
| Mallidi, J | 1 |
| Braden, GL | 1 |
| Gayat, E | 1 |
| Salem, R | 1 |
| Nikolaou, M | 1 |
| Follath, F | 2 |
| Reynolds, CA | 2 |
| Singletary, GE | 2 |
| Matsuzaki, M | 1 |
| Hori, M | 2 |
| Asanoi, H | 1 |
| Tsutamoto, T | 3 |
| Onogawa, T | 1 |
| Sakamoto, Y | 1 |
| Nakayama, S | 1 |
| Yamamura, Y | 1 |
| Gilbertson, DT | 1 |
| Mackedanz, SA | 1 |
| Swan, SK | 2 |
| Amer, M | 1 |
| Adomaityte, J | 1 |
| Qayyum, R | 1 |
| Barsuk, JH | 1 |
| Paparello, J | 1 |
| Cotts, W | 1 |
| Trafny, DJ | 1 |
| Machen, MC | 1 |
| Miyata, M | 1 |
| Sasaki, T | 3 |
| Shinsato, T | 1 |
| Kubozono, T | 1 |
| Furusho, Y | 1 |
| Kusumoto, A | 1 |
| Hamasaki, S | 1 |
| Tei, C | 1 |
| Origasa, H | 1 |
| Besancon, A | 1 |
| Schmitt, C | 1 |
| Glaizal, M | 1 |
| Tichadou, L | 1 |
| Klouche, K | 1 |
| Hayek-Lanthois, M | 1 |
| de Haro, L | 1 |
| Natale, E | 1 |
| Newton, PJ | 1 |
| Davidson, PM | 1 |
| Krum, H | 1 |
| Ollerton, R | 1 |
| Macdonald, P | 1 |
| Kryczka, K | 1 |
| Dzielińska, Z | 1 |
| Przybylski, A | 1 |
| Szczudlik, J | 1 |
| Dangel, J | 1 |
| Konka, M | 1 |
| Czajkowski, K | 1 |
| Różański, J | 1 |
| Bilińska, ZT | 1 |
| Demkow, M | 1 |
| de Madron, E | 1 |
| King, JN | 1 |
| Strehlau, G | 1 |
| White, RV | 1 |
| Fusco, A | 1 |
| Banerjee, P | 1 |
| Tanner, G | 1 |
| Williams, L | 1 |
| Chan, CY | 1 |
| Shoji, T | 1 |
| Takatori, E | 1 |
| Oyama, R | 1 |
| Kumagai, S | 1 |
| Fukushima, A | 1 |
| Yoshizaki, A | 1 |
| Sugiyama, T | 1 |
| Konstam, MA | 2 |
| Grinfeld, L | 2 |
| Krasa, HB | 1 |
| Zimmer, C | 2 |
| Blair, J | 1 |
| Ouyang, J | 4 |
| Patel, CB | 1 |
| Milano, CA | 1 |
| Rogers, JG | 1 |
| Campbell, PT | 1 |
| Ryan, J | 1 |
| Merlos, P | 1 |
| Grayson, S | 1 |
| Gandy, WE | 1 |
| Wolf, J | 1 |
| Gerlach, N | 1 |
| Weber, K | 1 |
| Klima, A | 1 |
| Caivano, D | 1 |
| Birettoni, F | 1 |
| Fruganti, A | 1 |
| Rishniw, M | 2 |
| Knafelz, P | 1 |
| Moïse, NS | 1 |
| Porciello, F | 1 |
| Boerrigter, G | 3 |
| Soergel, DG | 1 |
| Violin, JD | 1 |
| Lark, MW | 1 |
| Malfatto, G | 1 |
| Della Rosa, F | 1 |
| Villani, A | 1 |
| Rella, V | 1 |
| Branzi, G | 1 |
| Facchini, M | 1 |
| Parati, G | 1 |
| Schimmenti, C | 1 |
| Iatrino, R | 1 |
| Montaina, C | 1 |
| Giambanco, S | 1 |
| Farless, LB | 1 |
| Steil, N | 1 |
| Williams, BR | 1 |
| Bailey, FA | 1 |
| Seya, M | 1 |
| Iwatsuka, R | 1 |
| Ohno, M | 1 |
| Shah, RV | 1 |
| McNulty, S | 1 |
| Kociol, RD | 1 |
| Tracy, RP | 1 |
| Sawant, RD | 1 |
| Freeman, LJ | 1 |
| Stanley, KP | 1 |
| McKelvey, A | 1 |
| Koslow, M | 1 |
| Raskin, S | 1 |
| Sidi, Y | 1 |
| Ben-Dov, I | 1 |
| Segel, MJ | 1 |
| Cosín, J | 1 |
| Mehagnoul-Schipper, DJ | 1 |
| Colier, WN | 1 |
| Hoefnagels, WH | 5 |
| Verheugt, FW | 2 |
| Jansen, RW | 5 |
| Spannheimer, A | 2 |
| Müller, K | 2 |
| Falkenstein, P | 1 |
| Reitberger, U | 1 |
| Gutzwiller, F | 1 |
| Simon, HB | 1 |
| Lauri, G | 3 |
| Assanelli, E | 1 |
| Grazi, M | 1 |
| Campodonico, J | 1 |
| Famoso, G | 1 |
| Tomiyama, H | 2 |
| Watanabe, G | 2 |
| Yoshida, H | 2 |
| Doba, N | 2 |
| Schiavetti, A | 1 |
| De Pasquale, MD | 1 |
| Di Salvo, S | 1 |
| Ventriglia, F | 1 |
| Clerico, A | 1 |
| van Kraaij, DJ | 4 |
| Sweep, FC | 1 |
| Güler, N | 1 |
| Demirbag, R | 1 |
| Eryonucu, B | 1 |
| Gül, A | 1 |
| Earl, G | 1 |
| Davenport, J | 1 |
| Narula, J | 1 |
| Cohen, N | 6 |
| Almoznino-Sarafian, D | 4 |
| Zaidenstein, R | 5 |
| Alon, I | 4 |
| Gorelik, O | 4 |
| Shteinshnaider, M | 3 |
| Chachashvily, S | 3 |
| Averbukh, Z | 2 |
| Golik, A | 6 |
| Chen-Levy, Z | 1 |
| Modai, D | 5 |
| Jourdain, P | 1 |
| Funck, F | 1 |
| Bellorini, M | 1 |
| Guillard, N | 1 |
| Loiret, J | 1 |
| Thebault, B | 1 |
| Desnos, M | 1 |
| Duboc, D | 1 |
| Wright, SP | 1 |
| Verouhis, D | 1 |
| Gamble, G | 1 |
| Sharpe, N | 1 |
| Doughty, RN | 1 |
| Drazner, MH | 1 |
| Palmer, BF | 1 |
| Cardinale, A | 2 |
| Scandurra, A | 1 |
| Follone, G | 2 |
| Argano, C | 1 |
| Nordstrom, LJ | 1 |
| Cataliotti, A | 3 |
| Gouin, S | 1 |
| Ali, S | 1 |
| Vaturi, M | 1 |
| Shapira, Y | 1 |
| Vaknin-Assa, H | 1 |
| Oron, A | 1 |
| Matesko, R | 1 |
| Sagie, A | 1 |
| Yamato, M | 1 |
| Honda, K | 1 |
| Fukuda, M | 1 |
| Akutagawa, O | 1 |
| Okamoto, M | 1 |
| Niazi, I | 1 |
| Czerwiec, F | 1 |
| Kambayashi, J | 1 |
| Zampino, M | 1 |
| Orlandi, C | 3 |
| Seeland, U | 2 |
| Kouchi, I | 2 |
| Zolk, O | 2 |
| Jockenhövel, F | 1 |
| Itter, G | 2 |
| Linz, W | 2 |
| Böhm, M | 2 |
| Sparrow, N | 1 |
| Adlam, D | 1 |
| Cowley, A | 1 |
| Hampton, JR | 3 |
| Ledwidge, M | 1 |
| Barry, M | 1 |
| Cahill, J | 1 |
| Ryan, E | 1 |
| Maurer, B | 1 |
| Ryder, M | 1 |
| Travers, B | 1 |
| Timmons, L | 1 |
| McDonald, K | 1 |
| Salomon, P | 1 |
| Przewłocka-Kosmala, M | 1 |
| Orda, A | 1 |
| LARIZZA, P | 2 |
| BRUNETTI, P | 2 |
| NENCI, G | 2 |
| COLI, L | 2 |
| BERGSTROEM, J | 1 |
| HULTMAN, E | 1 |
| JOSEPHSON, B | 1 |
| STOKES, W | 1 |
| ROBSON, AO | 1 |
| KERR, DN | 1 |
| ASHCROFT, R | 1 |
| TEASDALE, G | 1 |
| VEREL, D | 1 |
| STENTIFORD, NH | 1 |
| RAHMAN, F | 1 |
| SAYNOR, R | 1 |
| BERMAN, LB | 1 |
| EBRAHIMI, A | 1 |
| LEDERBOGEN, K | 1 |
| HUEDEPOHL, M | 1 |
| HUTCHEON, DE | 1 |
| MEHTA, D | 1 |
| ROMANO, A | 1 |
| KIESSLING, J | 1 |
| MARELLI, G | 1 |
| PELTOLA, P | 3 |
| RINALDI, A | 2 |
| MALIZIA, E | 1 |
| BERTOLINI, G | 1 |
| CHIAVARELLI, S | 1 |
| BARACCHI, G | 1 |
| CAPPAI, G | 1 |
| GIACOMASSO, P | 1 |
| McGrotty, YL | 1 |
| Cioffi, G | 3 |
| Stefenelli, C | 3 |
| Tarantini, L | 3 |
| Opasich, C | 2 |
| Hirooka, K | 3 |
| Koretsune, Y | 1 |
| Yoshimoto, S | 1 |
| Irino, H | 1 |
| Abe, H | 1 |
| Yasuoka, Y | 1 |
| Yamamoto, H | 1 |
| Hashimoto, K | 1 |
| Chin, W | 1 |
| Kusuoka, H | 1 |
| Kobayakawa, N | 1 |
| Sawaki, D | 1 |
| Otani, Y | 1 |
| Sekita, G | 1 |
| Fukushima, K | 1 |
| Takeuchi, H | 1 |
| Aoyagi, T | 1 |
| Gamba, G | 1 |
| Jaquet, F | 1 |
| Hess, B | 1 |
| Zenuk, C | 1 |
| Healey, J | 1 |
| Donnelly, J | 1 |
| Vaillancourt, R | 1 |
| Almalki, Y | 1 |
| Smith, S | 1 |
| Alexopoulos, GP | 1 |
| Anastasiou-Nana, MI | 2 |
| Rapti, ACh | 1 |
| Margari, ZJ | 1 |
| Terrovitis, JV | 2 |
| Mitsibounas, D | 1 |
| Makri, S | 1 |
| Paul, RV | 1 |
| Nilsson, SE | 1 |
| Takkinen, S | 1 |
| Tryding, N | 1 |
| Evrin, PE | 1 |
| Berg, S | 1 |
| McClearn, G | 1 |
| Johansson, B | 1 |
| Schirger, JA | 1 |
| Tsuruda, T | 1 |
| Heublein, DM | 1 |
| Malatino, LS | 1 |
| Gorski, JC | 1 |
| Brater, DC | 13 |
| Struthers, AD | 5 |
| White, SE | 1 |
| Sánchez, E | 2 |
| Kasama, S | 2 |
| Toyama, T | 2 |
| Kumakura, H | 2 |
| Takayama, Y | 2 |
| Ichikawa, S | 2 |
| Suzuki, T | 2 |
| Kurabayashi, M | 2 |
| Graham, CA | 1 |
| Velickovic, IA | 1 |
| Leicht, CH | 1 |
| Goenaga, MA | 1 |
| Millet, M | 1 |
| Garde, C | 1 |
| Carrera, JA | 1 |
| Arzellus, E | 1 |
| McCurley, JM | 1 |
| Hanlon, SU | 1 |
| Wei, SK | 1 |
| Wedam, EF | 1 |
| Michalski, M | 1 |
| Haigney, MC | 1 |
| Chappuis, B | 1 |
| Cottier, C | 1 |
| Papazoglou, PP | 1 |
| Kanakakis, J | 1 |
| Dalianis, A | 1 |
| Tsolakis, E | 1 |
| Tsagalou, EP | 1 |
| Agrios, N | 1 |
| Christodoulou, K | 1 |
| Ilgiyaev, E | 1 |
| Sakai, H | 1 |
| Wada, A | 1 |
| Ishikawa, C | 1 |
| Ohno, K | 1 |
| Fujii, M | 1 |
| Yamamoto, T | 1 |
| Takayama, T | 1 |
| Dohke, T | 1 |
| Horie, M | 1 |
| Maheshwari, M | 1 |
| Mittal, SR | 1 |
| Cowburn, PJ | 1 |
| Jolliffe, RE | 1 |
| Wald, RW | 1 |
| Parker, JD | 1 |
| Cheong, HI | 1 |
| Lee, JW | 1 |
| Zheng, SH | 1 |
| Lee, JH | 1 |
| Kang, JH | 1 |
| Kang, HG | 1 |
| Ha, IS | 1 |
| Lee, SJ | 1 |
| Choi, Y | 1 |
| Crivellari, M | 1 |
| Bove, T | 1 |
| Landoni, G | 1 |
| Zangrillo, A | 1 |
| Schubert, S | 1 |
| Peters, B | 1 |
| Abdul-Khaliq, H | 1 |
| Nagdyman, N | 1 |
| Lange, PE | 1 |
| Ewert, P | 1 |
| Dia, AA | 1 |
| Diop, IB | 1 |
| Sarr, M | 1 |
| Ba, SA | 1 |
| Diouf, SM | 1 |
| Tzur, I | 1 |
| Kobayashi, C | 1 |
| Sasaki, H | 1 |
| Kosuge, K | 1 |
| Miyakita, Y | 1 |
| Hayakawa, M | 1 |
| Suzuki, A | 1 |
| Abe, E | 1 |
| Singh, A | 1 |
| Blackwell, J | 1 |
| Neher, J | 1 |
| Tabidze, G | 1 |
| Iakobashvili, M | 1 |
| Kobaladze, N | 1 |
| Bagaturia, D | 1 |
| Tsibadze, T | 1 |
| De Pasquale, CG | 1 |
| Dunne, JS | 1 |
| Minson, RB | 1 |
| Arnolda, LF | 1 |
| Govindarajan, G | 1 |
| Bashir, Q | 1 |
| Kuppuswamy, S | 1 |
| Brooks, C | 1 |
| Fornaciari, E | 1 |
| Giammanco, M | 1 |
| Rinaldi, S | 1 |
| Yoshida, J | 1 |
| Nishio, M | 1 |
| Ohtani, T | 1 |
| Miwa, T | 1 |
| Mougenot, N | 1 |
| Bos, R | 1 |
| Médiani, O | 1 |
| Lechat, P | 1 |
| Ennezat, CA | 1 |
| Vijayaraman, P | 1 |
| Lachmann, J | 1 |
| Asseman, P | 1 |
| Cohen-Solal, A | 1 |
| Sonnenblick, EH | 2 |
| LeJemtel, TH | 3 |
| Smith, WB | 2 |
| Zimmer, CA | 1 |
| Rosenberg, J | 1 |
| Gustafsson, F | 1 |
| Galatius, S | 2 |
| Hildebrandt, PR | 1 |
| Saito, M | 2 |
| Takada, M | 2 |
| Isobe, F | 1 |
| Yasumura, Y | 2 |
| Libetta, C | 2 |
| Sepe, V | 2 |
| Zucchi, M | 2 |
| Campana, C | 2 |
| Dal Canton, A | 2 |
| Uemura, K | 1 |
| Kamiya, A | 1 |
| Hidaka, I | 1 |
| Kawada, T | 1 |
| Shimizu, S | 1 |
| Shishido, T | 1 |
| Yoshizawa, M | 1 |
| Sugimachi, M | 1 |
| Sunagawa, K | 1 |
| Tran, HA | 1 |
| Khouzam, RN | 2 |
| Dishmon, DA | 1 |
| Farah, V | 1 |
| Flax, SD | 1 |
| Carbone, LD | 1 |
| Starklint, J | 1 |
| Bech, JN | 1 |
| Nyvad, O | 1 |
| Jensen, P | 1 |
| Pedersen, EB | 1 |
| Hodt, A | 1 |
| Steine, K | 1 |
| Hatori, T | 1 |
| Sumino, H | 1 |
| Sun, WY | 1 |
| Reiser, IW | 1 |
| Chou, SY | 1 |
| Eshaghian, S | 1 |
| Horwich, TB | 1 |
| Francis, G | 2 |
| Ochoa, PG | 1 |
| Arribas, MT | 1 |
| Mena, JM | 1 |
| Pérez, MG | 1 |
| Nelson, MD | 1 |
| Klemis, JE | 1 |
| Wall, BM | 1 |
| Mangold, TA | 1 |
| Di Sessa, TG | 1 |
| Howard, SC | 1 |
| Salim, MA | 1 |
| Azzetti, G | 1 |
| Marco, R | 1 |
| Carlucci, S | 1 |
| Furlanello, F | 2 |
| Baccichetto, R | 1 |
| Barro, S | 1 |
| Calderan, A | 1 |
| Carbonieri, E | 1 |
| Chinellato, M | 1 |
| Chiatto, M | 1 |
| D'Eri, A | 1 |
| Corazza, F | 1 |
| D'Atri, M | 1 |
| Drigo, R | 1 |
| Fabris, S | 1 |
| Gelli, GF | 1 |
| Lo Giudice, A | 1 |
| Noventa, F | 1 |
| Pollon, A | 1 |
| Santin, P | 1 |
| Zanardi, F | 1 |
| Milani, L | 1 |
| Chuen, MJ | 1 |
| Kurien, S | 1 |
| Warfield, KT | 1 |
| Wood, CM | 1 |
| Nakayama, D | 1 |
| Ferasin, L | 1 |
| Marcora, S | 1 |
| Pisacco, P | 1 |
| Cosmai, L | 1 |
| Meloni, F | 1 |
| Rampino, T | 1 |
| Monti, C | 1 |
| Udelson, JE | 1 |
| Cook, T | 1 |
| Pulignano, G | 1 |
| Del Sindaco, D | 1 |
| De Feo, S | 1 |
| Dilenarda, A | 1 |
| Smithline, HA | 1 |
| Brunckhorst, CB | 1 |
| Sohn, IS | 1 |
| Jin, ES | 1 |
| Cho, JM | 1 |
| Kim, CJ | 1 |
| Bae, JH | 1 |
| Moon, JY | 1 |
| Lee, SH | 1 |
| Kim, MJ | 1 |
| Gaspare, P | 1 |
| Bucca, CB | 1 |
| Brussino, L | 1 |
| Battisti, A | 1 |
| Mutani, R | 1 |
| Rolla, G | 1 |
| Mangiardi, L | 1 |
| Cicolin, A | 1 |
| Christou, L | 1 |
| Economou, M | 1 |
| Economou, G | 1 |
| Kolettis, TM | 1 |
| Tsianos, EV | 1 |
| Gattis Stough, W | 1 |
| Shah, MR | 1 |
| Lokhnygina, Y | 1 |
| Adams, KF | 2 |
| Liu, G | 1 |
| Ji, Z | 1 |
| Zhen, Y | 1 |
| Liu, K | 1 |
| Fields, TK | 1 |
| Pearson, LL | 1 |
| Issa, VS | 1 |
| Bacal, F | 1 |
| Mangini, S | 1 |
| Carneiro, RM | 1 |
| Azevedo, CH | 1 |
| Chizzola, PR | 1 |
| Ferreira, SM | 1 |
| Bocchi, EA | 1 |
| Veeraveedu, PT | 2 |
| Ma, M | 2 |
| Palaniyandi, SS | 2 |
| Rogers, HL | 1 |
| Marshall, J | 2 |
| Bock, J | 1 |
| Dowling, TC | 1 |
| Feller, E | 1 |
| Robinson, S | 1 |
| Ghali, JK | 1 |
| Vaitkevicius, P | 1 |
| Nodari, S | 1 |
| Bordonali, T | 1 |
| Fontanella, B | 1 |
| Milani, P | 1 |
| Verzura, G | 1 |
| Dittrich, H | 1 |
| Dei Cas, L | 1 |
| Mehta, RL | 1 |
| Cantarovich, F | 1 |
| Shaw, A | 1 |
| Hoste, E | 1 |
| Murray, P | 1 |
| Martin, FL | 1 |
| Pupita, F | 1 |
| Bartoli, E | 1 |
| Molaschi, M | 1 |
| Schneider, KW | 1 |
| Vorburger, C | 1 |
| Cottier, P | 1 |
| Schnitzler, R | 1 |
| Fritz, KW | 1 |
| Wertheimer, L | 1 |
| Almondhiry, H | 1 |
| Khero, B | 1 |
| Magidson, O | 1 |
| Soffe, AM | 1 |
| King, JC | 1 |
| Majeron, PL | 1 |
| Martinoli, E | 1 |
| Stinco, G | 1 |
| Roguski, J | 1 |
| Hasik, J | 1 |
| Hryniewiecki, L | 1 |
| Roguska, J | 1 |
| Grala, T | 1 |
| Makowska, K | 1 |
| Davidov, M | 3 |
| Kakaviatos, N | 2 |
| Finnerty, FA | 4 |
| Lantz, P | 1 |
| Enghoff, E | 1 |
| Hedlund, A | 1 |
| Hägg, A | 1 |
| Fitzpatrick, D | 1 |
| Ikram, H | 5 |
| Espiner, EA | 7 |
| Romano, E | 1 |
| Gullo, A | 1 |
| Fischer, E | 1 |
| Siegenthaler, W | 1 |
| Taylor, SH | 7 |
| Silke, B | 7 |
| Durand, D | 1 |
| Ader, JL | 1 |
| Emal, V | 1 |
| Bories, P | 1 |
| Girolami, JP | 1 |
| Suc, JM | 1 |
| Kugler, J | 1 |
| Maskin, CS | 2 |
| Frishman, W | 1 |
| Karlsson, E | 3 |
| Nelson, GI | 5 |
| Ahuja, RC | 4 |
| Hussain, M | 4 |
| Herlitz, J | 5 |
| Waldenström, J | 1 |
| Hjalmarson, A | 5 |
| Walker, C | 1 |
| Forsyth, DR | 2 |
| Verma, SP | 2 |
| Kupper, W | 1 |
| Hamm, CW | 1 |
| Bleifeld, W | 2 |
| Lütz, G | 1 |
| Pape, K | 1 |
| Bart, BIa | 1 |
| Pashkova, TL | 1 |
| Stepanov, NG | 1 |
| Orlova, TV | 1 |
| Kalmanova, EN | 1 |
| Rumeau, M | 1 |
| Pourrat, J | 1 |
| Chambeu, Y | 1 |
| Artman, M | 1 |
| Parrish, MD | 1 |
| Graham, TP | 1 |
| Kremer, D | 1 |
| Dzau, VJ | 2 |
| Hollenberg, NK | 1 |
| Holmberg, S | 1 |
| Vedin, A | 1 |
| Waldenström, A | 2 |
| Wilhelmsen, L | 1 |
| Wilhelmsson, C | 2 |
| Barre, J | 1 |
| Houin, G | 1 |
| Brunner, F | 1 |
| Bree, F | 1 |
| Tillement, JP | 1 |
| Ryan, MP | 1 |
| Devane, J | 1 |
| Ryan, MF | 1 |
| Counihan, TB | 1 |
| Sagar, S | 1 |
| Sharma, BK | 1 |
| Sharma, PL | 1 |
| Wahi, PL | 1 |
| Pearse, DM | 1 |
| Kaude, JV | 1 |
| Williams, JL | 1 |
| Bush, D | 1 |
| Wright, PG | 1 |
| Wiernikowski, A | 1 |
| Michajlik, A | 1 |
| Wysznacka-Aleksandrow, W | 1 |
| Hamdy, RC | 3 |
| Vinson, ME | 1 |
| Robbins, AD | 1 |
| Struthers, LP | 1 |
| Chapman, SF | 1 |
| Norris, RJ | 3 |
| Shaw, HL | 1 |
| Townsend, HA | 1 |
| Waddy, AL | 1 |
| Eason, CT | 1 |
| Richards, HH | 3 |
| Spitzer, W | 1 |
| Sörgel, F | 1 |
| Krakau, I | 1 |
| Tang, D | 1 |
| Benet, LZ | 3 |
| Lang, E | 1 |
| Vlay, SC | 1 |
| Mallis, GI | 1 |
| Brown, EJ | 1 |
| Cohn, PF | 1 |
| Cronin, JW | 1 |
| Kroop, SF | 1 |
| Diamond, J | 1 |
| Rolla, AR | 1 |
| Howell, DM | 1 |
| Gumbiner, CH | 1 |
| Martin, GE | 1 |
| Potter, JM | 1 |
| Blake, GM | 1 |
| Cox, JR | 1 |
| Cocco, G | 1 |
| Strozzi, C | 1 |
| Padula, A | 1 |
| Al Yassini, K | 1 |
| Bulgarelli, R | 1 |
| Sfrisi, C | 1 |
| Zaniol, P | 1 |
| Burkhardt, H | 1 |
| Graul, EH | 1 |
| Pfab, R | 1 |
| Schuster, O | 1 |
| Loew, D | 1 |
| Chennavasin, P | 3 |
| Dehmer, GJ | 2 |
| Ruiz, I | 1 |
| Ortiz, M | 1 |
| Nishijima, H | 2 |
| Yasuda, H | 4 |
| Ito, K | 1 |
| Murakami, R | 1 |
| Hayashi, K | 1 |
| Yamazaki, M | 1 |
| Hattori, T | 1 |
| Day, B | 1 |
| Burdette, A | 2 |
| Anderson, S | 2 |
| O'Rourke, MF | 2 |
| Sammel, NL | 1 |
| Kuchar, D | 1 |
| Ge, H | 1 |
| Schäfer, GE | 1 |
| Sievert, H | 2 |
| Okoli, RC | 1 |
| Pan, HY | 1 |
| Wang, RY | 1 |
| Chan, TK | 1 |
| Schuster, CJ | 1 |
| Weil, MH | 2 |
| Besso, J | 1 |
| Carpio, M | 1 |
| Henning, RJ | 2 |
| Hill, R | 1 |
| Wang, NS | 1 |
| Berry, G | 1 |
| Hartford, M | 1 |
| Pennert, K | 1 |
| Rao, CR | 1 |
| Stroobandt, R | 1 |
| Dodion, L | 1 |
| Kesteloot, H | 1 |
| Franciosa, JA | 3 |
| Magrini, F | 1 |
| Niarchos, AP | 1 |
| Laiwah, AC | 1 |
| Mactier, RA | 1 |
| Krapf, R | 1 |
| Thalmann, H | 1 |
| Bachour, G | 3 |
| Poe, TE | 1 |
| Scott, RB | 1 |
| Keith, JF | 1 |
| Swedeberg, K | 1 |
| Wallentin, I | 1 |
| Minami, M | 2 |
| Yamazaki, N | 2 |
| Kojima, S | 1 |
| Matsumura, N | 1 |
| Togashi, H | 1 |
| Koike, Y | 1 |
| Saito, H | 1 |
| Reuben, SR | 1 |
| Kuan, P | 1 |
| Gale, EV | 1 |
| Wilde, PM | 1 |
| Kidner, PH | 1 |
| Baylen, BG | 2 |
| Johnson, G | 1 |
| Tsang, R | 1 |
| Srivastava, L | 1 |
| Kaplan, S | 2 |
| Gross, P | 2 |
| Handelman, W | 1 |
| Schrier, RW | 1 |
| Chan, W | 1 |
| Viherkoski, M | 1 |
| Huikko, M | 1 |
| Varjoranta, K | 1 |
| Gabriel, R | 1 |
| Baylor, P | 1 |
| Lewy, JE | 2 |
| Meyer, J | 1 |
| Merx, W | 2 |
| Von Essen, R | 1 |
| Erbel, R | 1 |
| Rupprecht, J | 1 |
| Püllen, C | 1 |
| Effert, S | 1 |
| Silverstein, SR | 1 |
| Calvert, CA | 1 |
| Thrall, DE | 1 |
| Brumbaugh, GW | 1 |
| Thomas, WP | 1 |
| Hodge, TG | 1 |
| Kerremans, AL | 2 |
| Tan, Y | 3 |
| Van Ginneken, CA | 2 |
| Gribnau, FW | 4 |
| Nomura, A | 3 |
| Katoh, K | 1 |
| Akimoto, T | 2 |
| Arita, T | 2 |
| Hufnagle, KG | 1 |
| Khan, SN | 1 |
| Penn, D | 1 |
| Cacciarelli, A | 1 |
| Williams, P | 1 |
| Lawson, DH | 3 |
| O'Connor, PC | 1 |
| Jick, H | 1 |
| Holzgreve, H | 1 |
| Seiwell, R | 2 |
| Mukharliamov, NM | 2 |
| Sazonova, LN | 2 |
| Green, TP | 1 |
| Mirkin, BL | 1 |
| Moodie, DS | 1 |
| de Torrenté, A | 1 |
| Mauro, G | 1 |
| Cantino, G | 1 |
| Vigiani, L | 1 |
| Hutcheon, D | 1 |
| Nemeth, E | 1 |
| Quinlan, D | 1 |
| Carabello, BA | 1 |
| Green, LH | 1 |
| Grossman, W | 1 |
| Cohn, LH | 1 |
| Koster, JK | 1 |
| Collins, JJ | 1 |
| Forssell, G | 1 |
| Nordlander, R | 1 |
| Orinius, E | 1 |
| Schapel, GJ | 1 |
| Read, TR | 1 |
| Silverman, KJ | 1 |
| Hutchins, GM | 1 |
| López, M | 1 |
| da Silva, OA | 1 |
| Amaral, CF | 1 |
| Lopes, JA | 1 |
| da Silveira, JC | 1 |
| Fonseca, JG | 1 |
| de Oliveira, JS | 1 |
| Cardini, JF | 1 |
| Khan, MI | 1 |
| Franchi, F | 1 |
| Michelucci, A | 1 |
| Morace, G | 1 |
| Porciani, MC | 1 |
| Fantini, F | 1 |
| Whiting, RB | 1 |
| Ataullakhanov, DM | 1 |
| Mareev, VIu | 1 |
| Heitmann, M | 1 |
| Rasmussen, K | 1 |
| Nielsen, JI | 1 |
| Møgelvang, JC | 1 |
| Langes, K | 1 |
| Siebels, J | 1 |
| Carnarius, H | 1 |
| Weiss, C | 1 |
| Kuck, KH | 1 |
| Nienaber, CA | 1 |
| Brouwer, J | 1 |
| Man in 't Veld, AJ | 1 |
| Dunselman, PH | 1 |
| Boomsma, F | 1 |
| Haaksma, J | 1 |
| Lie, KI | 1 |
| Guignard, JP | 1 |
| Dubourg, L | 1 |
| Gouyon, JB | 1 |
| Mouallem, M | 1 |
| Brif, I | 1 |
| Mayan, H | 1 |
| Farfel, Z | 1 |
| Waterer, G | 1 |
| Donaldson, M | 1 |
| Blose, JS | 1 |
| Bharani, A | 1 |
| Ganguly, A | 1 |
| Bhargava, KD | 1 |
| Navarro González, JF | 1 |
| García Pérez, JJ | 1 |
| Brady, JA | 1 |
| Rock, CL | 1 |
| Horneffer, MR | 1 |
| Frey, B | 2 |
| Wutte, M | 1 |
| Ioannides, C | 1 |
| Hülsmann, M | 1 |
| Stanek, B | 2 |
| Shimon, I | 1 |
| Almog, S | 3 |
| Vered, Z | 2 |
| Seligmann, H | 3 |
| Shefi, M | 1 |
| Peleg, E | 1 |
| Rosenthal, T | 1 |
| Motro, M | 2 |
| Halkin, H | 4 |
| Ezra, D | 4 |
| Guazzi, M | 1 |
| Perego, GB | 1 |
| Sganzerla, P | 2 |
| Clegg, HW | 1 |
| Riopel, DA | 1 |
| Smal, J | 1 |
| Haapala, O | 1 |
| Marvola, M | 1 |
| Kuusela, S | 1 |
| Happonen, I | 1 |
| Reed, S | 1 |
| Greene, P | 1 |
| Ryan, T | 1 |
| Cerimele, B | 1 |
| Schwertschlag, U | 1 |
| Weinberger, M | 1 |
| Voelker, J | 1 |
| Vargo, DL | 2 |
| Kramer, WG | 2 |
| Black, PK | 1 |
| Serpas, T | 1 |
| Lees, KR | 1 |
| Reid, JL | 1 |
| Banapurmath, CR | 1 |
| Muganagowda, P | 1 |
| Kumar, CS | 1 |
| Prakash, V | 1 |
| Somashekhar, KS | 1 |
| Subratty, AH | 1 |
| Manraj, M | 1 |
| Baligadoo, S | 1 |
| Mattioli, AV | 1 |
| Castellani, ET | 1 |
| Casali, E | 1 |
| Mattioli, G | 1 |
| Reyes, AJ | 1 |
| Alon, US | 1 |
| Scagliotti, D | 1 |
| Garola, RE | 1 |
| Good, JM | 1 |
| Brady, AJ | 1 |
| Noormohamed, FH | 2 |
| Oakley, CM | 2 |
| Hariman, RJ | 1 |
| Bremner, S | 1 |
| Louie, EK | 1 |
| Rogers, WJ | 1 |
| Kostis, JB | 1 |
| Nocero, MA | 1 |
| Jones, JP | 1 |
| Ramadwar, RH | 1 |
| Deshmukh, SS | 1 |
| Oak, SN | 1 |
| Karmarkar, SJ | 1 |
| Saitoh, Y | 1 |
| Sasaki, F | 2 |
| Sakai, T | 2 |
| Ishizaki, T | 2 |
| Nakai, T | 2 |
| Miyabo, S | 2 |
| Kanamori, K | 1 |
| Mifune, J | 2 |
| Krahwinkel, W | 1 |
| Kober, R | 1 |
| Horstkotte, D | 1 |
| Borchard, F | 1 |
| Winter, J | 1 |
| Strauer, BE | 1 |
| Königshausen, T | 1 |
| van Meyel, JJ | 3 |
| Smits, P | 3 |
| Dormans, T | 1 |
| Gerlag, PG | 6 |
| Russel, FG | 3 |
| Perego, G | 1 |
| Schianni, M | 1 |
| Guazzi, MD | 2 |
| McLay, JS | 1 |
| Bridges, AB | 1 |
| Fraser, CG | 1 |
| Choy, AM | 1 |
| Rahman, AR | 1 |
| Parker, JO | 1 |
| Faggiano, P | 1 |
| Sorgato, A | 1 |
| Ghizzoni, G | 1 |
| Spedini, C | 1 |
| Rusconi, C | 1 |
| Connelly, TP | 1 |
| Williams, KJ | 1 |
| Beltran, AM | 1 |
| Cohn, JN | 5 |
| Sweeney, RW | 1 |
| Reef, VB | 1 |
| Reimer, JM | 1 |
| Fett, DL | 1 |
| Cavero, PG | 1 |
| Aronow, WS | 1 |
| Kronzon, I | 1 |
| Hidaka, T | 2 |
| Aisaka, K | 1 |
| Ohno, T | 1 |
| Ishihara, T | 1 |
| Coodley, EL | 1 |
| Segal, JL | 1 |
| Smith, DH | 1 |
| Neutel, JM | 1 |
| Northridge, D | 1 |
| Akduman, L | 1 |
| Del Priore, LV | 1 |
| Kaplan, HJ | 1 |
| Meredith, T | 1 |
| Clarke, KW | 1 |
| Gray, D | 1 |
| Leslie, D | 1 |
| Carlton, LD | 1 |
| Mattson, CN | 1 |
| Schmith, VD | 1 |
| Dormans, TP | 3 |
| Huige, RM | 1 |
| Bissoli, F | 1 |
| Gini, G | 1 |
| Bosio, M | 1 |
| Ceriani, R | 1 |
| Levine, TB | 2 |
| Levine, AB | 1 |
| Goldberg, D | 1 |
| Narins, B | 1 |
| Goldstein, S | 1 |
| Lesch, M | 1 |
| Riley, JA | 1 |
| Brown, AR | 1 |
| Walker, BE | 1 |
| Dishi, V | 1 |
| Weissgarten, J | 3 |
| Rudy, DW | 1 |
| Banerjee, AK | 1 |
| Campbell, RW | 1 |
| Fitzpatrick, MA | 3 |
| Sybertz, E | 2 |
| Häggström, J | 1 |
| Hansson, K | 1 |
| Karlberg, BE | 2 |
| Kvart, C | 1 |
| Madej, A | 1 |
| Olsson, K | 1 |
| Saunderson, EM | 1 |
| Sanderson, EM | 1 |
| Watson, AD | 1 |
| Church, DB | 1 |
| Bellido Casado, J | 1 |
| Fernando de Frutos Arribas, J | 1 |
| del Río Fernández, MC | 1 |
| Mena Martín, J | 1 |
| Howard, PA | 2 |
| Dunn, MI | 2 |
| Garty, BZ | 1 |
| Flapan, AD | 4 |
| Goodfield, NE | 1 |
| Wright, RA | 1 |
| Francis, CM | 1 |
| Neilson, JM | 1 |
| Demopoulos, L | 1 |
| Yeh, M | 1 |
| Gentilucci, M | 1 |
| Bijou, R | 1 |
| Katz, SD | 1 |
| Mancini, D | 1 |
| Jones, M | 1 |
| Knauf, H | 1 |
| Mutschler, E | 1 |
| Andrews, R | 1 |
| Charlesworth, A | 1 |
| Evans, A | 1 |
| Cowley, AJ | 2 |
| Aaser, E | 1 |
| Tølløfsrud, S | 1 |
| Lundberg, J | 1 |
| Hall, C | 1 |
| Djøseland, O | 1 |
| Forfang, K | 1 |
| Metzkor, E | 2 |
| Moshkovitz, Y | 2 |
| Litinski, I | 1 |
| Tavori, U | 1 |
| Perry, C | 1 |
| Chomsky, DB | 1 |
| Rayos, G | 1 |
| Wilson, JR | 1 |
| de Luis, DA | 1 |
| Liaño, F | 1 |
| Pascual, J | 1 |
| Ortuño, J | 1 |
| Müller, FO | 1 |
| Middle, MV | 1 |
| Schall, R | 1 |
| Terblanché, J | 1 |
| Hundt, HK | 1 |
| Groenewoud, G | 1 |
| Miyamoto, T | 1 |
| Kubo, T | 1 |
| Matsuo, H | 1 |
| Miyatake, K | 1 |
| Brilla, CG | 1 |
| Yue, QY | 1 |
| Beermann, B | 3 |
| Lindström, B | 1 |
| Nyquist, O | 1 |
| Kaluski, E | 1 |
| Faigenberg, Z | 1 |
| Miller, R | 2 |
| Simovitz, A | 1 |
| Shaham, O | 1 |
| Marghitay, D | 1 |
| Koren, M | 1 |
| Blatt, A | 1 |
| Otani, S | 1 |
| Kurasaka, N | 1 |
| Tanaka, T | 1 |
| Kousogabe, Y | 1 |
| Tokioka, H | 1 |
| Alvarez, J | 1 |
| Mancha, I | 1 |
| Vivancos, R | 1 |
| Vázquez, F | 1 |
| Olveira, G | 1 |
| de Mora, M | 1 |
| Soriguer, F | 1 |
| Malpartida, F | 1 |
| Koller-Strametz, J | 1 |
| Kos, T | 1 |
| Woloszczuk, W | 1 |
| Campbell, N | 1 |
| Brant, R | 1 |
| Stalts, H | 1 |
| Stone, J | 1 |
| Mahallati, H | 1 |
| Khatta, M | 1 |
| Wentworth, D | 1 |
| Roffman, D | 1 |
| Fisher, ML | 2 |
| Pivac, N | 1 |
| Rumboldt, Z | 1 |
| Sardelić, S | 1 |
| Bagatin, J | 1 |
| Polić, S | 1 |
| Ljutić, D | 1 |
| Naranca, M | 1 |
| Capkun, V | 1 |
| Ettinger, SJ | 1 |
| Benitz, AM | 1 |
| Ericsson, GF | 1 |
| Cifelli, S | 1 |
| Jernigan, AD | 1 |
| Longhofer, SL | 1 |
| Trimboli, W | 1 |
| Hanson, PD | 1 |
| Missouris, CG | 1 |
| Grouzmann, E | 1 |
| Buckley, MG | 1 |
| Barron, J | 1 |
| MacGregor, GA | 1 |
| Singer, DR | 1 |
| Li, S | 1 |
| Ikeda, J | 1 |
| Takita, T | 1 |
| Sekiguchi, Y | 1 |
| Demachi, J | 1 |
| Chikama, H | 1 |
| Goto, A | 1 |
| Shirato, K | 1 |
| Kamiya, Y | 1 |
| Okada, M | 1 |
| Yoneyama, A | 1 |
| Jin-no, Y | 1 |
| Hibino, T | 1 |
| Watanabe, O | 1 |
| Kajiura, S | 1 |
| Suzuki, Y | 1 |
| Iwata, H | 1 |
| Kobayashi, S | 1 |
| Bestetti, RB | 1 |
| Moreira-Neto, F | 1 |
| Brasil, JC | 1 |
| Bombonato, R | 1 |
| Sgarbieri, RN | 1 |
| Haddad, J | 1 |
| Nakayama, T | 1 |
| Shiojima, K | 1 |
| Sakuma, Y | 1 |
| Yamamoto, A | 1 |
| Imai, Y | 1 |
| Wroblewski, H | 1 |
| Sørensen, VB | 1 |
| Bie, P | 1 |
| Parving, HH | 1 |
| Kastrup, J | 1 |
| Mettauer, B | 1 |
| Lampert, E | 1 |
| Charloux, A | 1 |
| Zhao, QM | 1 |
| Epailly, E | 1 |
| Oswald, M | 1 |
| Frans, A | 1 |
| Piquard, F | 1 |
| Lonsdorfer, J | 1 |
| Heaton, AH | 1 |
| Bryant, J | 1 |
| Berman, BN | 1 |
| Trotter, JP | 2 |
| Bischof, RO | 1 |
| Loh, E | 1 |
| Smith, RL | 1 |
| Gradinac, S | 1 |
| Jovanović, I | 1 |
| Dukić, M | 1 |
| Hercog, D | 1 |
| Jovović, L | 1 |
| Kokai, G | 1 |
| Stajević, M | 1 |
| Simeunović, S | 1 |
| Ben-Ami, H | 1 |
| Krivoy, N | 1 |
| Nagachandran, P | 1 |
| Edoute, Y | 1 |
| Liguori, A | 1 |
| Casini, A | 1 |
| Di Loreto, M | 1 |
| Andreini, I | 1 |
| Napoli, C | 1 |
| McLean, J | 1 |
| Manchip, S | 1 |
| Rutgers, SR | 1 |
| Schweitzer, M | 1 |
| Lewis, BS | 1 |
| Rabinowitz, B | 1 |
| Schlesinger, Z | 1 |
| Caspi, A | 1 |
| Markiewicz, W | 1 |
| Rosenfeld, T | 1 |
| Sclarovsky, S | 1 |
| Ermer, W | 1 |
| Noe, LL | 1 |
| Vreeland, MG | 1 |
| Pezzella, SM | 1 |
| Bouwels, LH | 3 |
| Saarela, T | 1 |
| Lanning, P | 1 |
| Koivisto, M | 1 |
| Paavilainen, T | 1 |
| Rieck, J | 1 |
| Seligman, H | 1 |
| Lubetsky, A | 2 |
| Olchovsky, D | 2 |
| Winaver, J | 1 |
| Werdan, K | 1 |
| Carmel, BP | 1 |
| Go, RI | 1 |
| Northridge, DB | 1 |
| Newby, DE | 1 |
| Rooney, E | 1 |
| Norrie, J | 1 |
| Dargie, HJ | 2 |
| Westheim, AS | 1 |
| Bostrøm, P | 1 |
| Christensen, CC | 1 |
| Parikka, H | 1 |
| Rykke, EO | 1 |
| Toivonen, L | 1 |
| MacFadyen, R | 1 |
| Fraser, C | 1 |
| Morton, JJ | 2 |
| Junot, C | 1 |
| Ezan, E | 1 |
| Goertz, A | 1 |
| Dreckmann-Behrendt, B | 1 |
| Parissis, JT | 1 |
| Venetsanou, KF | 1 |
| Mentzikof, DG | 1 |
| Ziras, NG | 1 |
| Kefalas, CG | 1 |
| Karas, SM | 1 |
| Skettino, SL | 1 |
| Wolff, A | 1 |
| Beckman, E | 2 |
| Freudenberger, R | 1 |
| Gladwell, T | 1 |
| Cines, M | 1 |
| Bennett, D | 2 |
| Liittschwager, EB | 1 |
| Harjai, KJ | 1 |
| Dinshaw, HK | 1 |
| Shah, M | 1 |
| Thompson, H | 1 |
| Turgut, T | 1 |
| Ventura, HO | 1 |
| Fernandez, HM | 1 |
| Leipzig, RM | 1 |
| Puschett, JB | 1 |
| Rietzschel, E | 1 |
| Duprez, DA | 1 |
| De Buyzere, ML | 1 |
| Clement, DL | 1 |
| Turner, CJ | 1 |
| Parfrey, P | 1 |
| Ryan, K | 1 |
| Troughton, RW | 1 |
| Frampton, CM | 1 |
| Yandle, TG | 2 |
| Härdig, L | 1 |
| Daae, C | 1 |
| Dellborg, M | 1 |
| Kontny, F | 1 |
| Bohmer, T | 1 |
| Roberge, RJ | 1 |
| Sorensen, T | 1 |
| Gardtman, M | 1 |
| Waagstein, L | 1 |
| Karlsson, T | 1 |
| Suter, PM | 1 |
| Haller, J | 1 |
| Hany, A | 1 |
| Vetter, W | 1 |
| Berman, S | 1 |
| Fidelman, Z | 1 |
| Korshun, Z | 1 |
| Davie, AP | 2 |
| Amato, P | 1 |
| Giubilato, A | 1 |
| Stroupe, KT | 1 |
| Forthofer, MM | 1 |
| Murray, MD | 2 |
| Duell, T | 1 |
| Mittermüller, J | 1 |
| Hiddemann, W | 1 |
| Bednarz, B | 1 |
| Cybulski, J | 1 |
| Chamiec, T | 1 |
| Shinohara, T | 1 |
| Yanai, H | 1 |
| Ohsuzu, F | 1 |
| Oglesbee, BL | 1 |
| Lehmkuhl, L | 1 |
| Johnson, A | 1 |
| Mackway-Jones, K | 1 |
| Adigun, AQ | 2 |
| Ajayi, AA | 2 |
| Romero-Candeira, S | 1 |
| Fernández, C | 1 |
| Martín, C | 1 |
| Sánchez-Paya, J | 1 |
| Hernández, L | 1 |
| Suehiro, K | 1 |
| Shimizu, J | 1 |
| Yi, GH | 1 |
| Gu, A | 1 |
| Wang, J | 1 |
| Keren, G | 1 |
| Burkhoff, D | 1 |
| Levy, AR | 1 |
| Briggs, AH | 1 |
| Demers, C | 1 |
| O'Brien, BJ | 1 |
| Kido, H | 1 |
| Ohtaki, Y | 1 |
| Kremastinos, DT | 1 |
| Tsetsos, GA | 1 |
| Tsiapras, DP | 1 |
| Karavolias, GK | 1 |
| Ladis, VA | 1 |
| Kattamis, CA | 1 |
| Herholz, C | 1 |
| Deer, MM | 1 |
| Ferguson, JA | 1 |
| Dexter, PR | 1 |
| Bennett, SJ | 1 |
| Perkins, SM | 1 |
| Smith, FE | 1 |
| Lane, KA | 1 |
| Adams, LD | 1 |
| Tierney, WM | 1 |
| Asiyanbola, B | 1 |
| Tsutsui, T | 1 |
| Maeda, K | 1 |
| Kinoshita, M | 1 |
| Thomas, I | 1 |
| Havranek, E | 1 |
| Bourge, R | 1 |
| Goldman, S | 2 |
| Dyer, F | 1 |
| Gomez, M | 1 |
| Ticho, B | 1 |
| Abraham, WT | 1 |
| Ikeda, N | 1 |
| Moriwaki, K | 1 |
| Sugahara, S | 1 |
| Okada, H | 1 |
| Nakamoto, H | 1 |
| Milionis, HJ | 1 |
| Alexandrides, GE | 1 |
| Liberopoulos, EN | 1 |
| Bairaktari, ET | 1 |
| Goudevenos, J | 1 |
| Elisaf, MS | 1 |
| Furian, T | 1 |
| Campos, C | 1 |
| Rabelo, E | 1 |
| Foppa, M | 1 |
| Clausell, N | 1 |
| Song, J | 1 |
| Kalus, JS | 1 |
| Caron, MF | 1 |
| Kluger, J | 1 |
| White, CM | 1 |
| Webb, AR | 1 |
| Chapman, PJ | 1 |
| Leclercq, C | 1 |
| Alonso, C | 1 |
| Revault, dF | 1 |
| Boulmier, D | 1 |
| de Place, C | 1 |
| Carré, F | 1 |
| Pavin, D | 1 |
| Mabo, P | 1 |
| Daubert, JC | 1 |
| Ross, BS | 1 |
| Pollak, A | 1 |
| Oh, W | 1 |
| McHaffie, D | 2 |
| Guz, A | 3 |
| Freude, J | 1 |
| Enenkel, W | 1 |
| Dittel, M | 1 |
| Kiss, E | 1 |
| Nobis, H | 1 |
| Prachar, H | 1 |
| Spiel, R | 1 |
| Falase, AO | 1 |
| Blot, P | 1 |
| Swartz, C | 3 |
| Kim, KE | 2 |
| Tilley, LP | 1 |
| Weitz, J | 1 |
| Levy, B | 1 |
| Shteĭngardt, IuN | 1 |
| Inzel', TN | 1 |
| Bussmann, WD | 2 |
| Black, JR | 1 |
| Mehta, J | 1 |
| Atwell, RB | 1 |
| Biamino, G | 2 |
| Kopp, H | 1 |
| Rudroff, W | 1 |
| Schneider, B | 1 |
| Heims, F | 1 |
| Lewis, JG | 1 |
| Greither, A | 1 |
| Edelen, JS | 1 |
| Cohn, K | 1 |
| Martynov, AA | 1 |
| Petrovskiĭ, VI | 1 |
| Baitsch, G | 1 |
| Bertel, O | 1 |
| Burkart, F | 1 |
| Steiner, A | 1 |
| Vettiger, K | 1 |
| Ritz, R | 1 |
| Scandiffo, T | 1 |
| Veglia, L | 1 |
| Guerricchio, G | 1 |
| Kossmann, CE | 1 |
| Khaleeli, AA | 1 |
| Wyman, AL | 1 |
| Cotton, RB | 1 |
| Stahlman, MT | 1 |
| Kovar, I | 1 |
| Catterton, WZ | 1 |
| Black, WD | 1 |
| Shiner, PT | 1 |
| Roman, J | 1 |
| Heinemann, HO | 1 |
| Laslett, LJ | 1 |
| DeMaria, AN | 1 |
| Amsterdam, EA | 3 |
| Mason, DT | 3 |
| Gray, JM | 2 |
| Henry, DA | 1 |
| Tillstone, WJ | 1 |
| Datey, KK | 1 |
| Bhagat, SJ | 1 |
| Barat, AK | 1 |
| Surana, MC | 1 |
| Davidson, C | 1 |
| Burkinshaw, L | 1 |
| Morgan, DB | 1 |
| Serwer, GA | 1 |
| Edwards, SB | 1 |
| Benson, DW | 1 |
| Anderson, PA | 1 |
| Spach, M | 1 |
| Majorano, G | 1 |
| Fillastre, JP | 1 |
| Apoil, E | 1 |
| Godin, N | 1 |
| Temperville, B | 1 |
| Ponomareva, AG | 1 |
| Gusarev, AF | 1 |
| Vorob'ev, VB | 1 |
| Purcell, H | 1 |
| Mitchell-Heggs, P | 1 |
| Biddle, TL | 1 |
| Yu, PN | 1 |
| Hall, WD | 1 |
| Mahabir, RN | 2 |
| Bacchus, R | 1 |
| Michalsen, H | 1 |
| Stokkeland, M | 1 |
| Ditlefsen, EM | 1 |
| Sangvik, K | 1 |
| Bennion-Pedley, J | 1 |
| Donald, JF | 1 |
| Gould, CH | 1 |
| Lomas, DM | 1 |
| Postlethwaite, DL | 1 |
| Rivlin, R | 1 |
| Frohlich, ED | 1 |
| Urbaszek, W | 1 |
| Löwe, HR | 1 |
| Rentsch, W | 1 |
| Pankau, H | 1 |
| Günther, K | 1 |
| Oh, TE | 1 |
| Miller, RR | 1 |
| Williams, DO | 1 |
| Niemi, KM | 1 |
| Werning, C | 1 |
| Andreasen, F | 1 |
| Mikkelsen, E | 1 |
| Florkiewicz, H | 1 |
| Rymar, B | 1 |
| Rumiński, W | 1 |
| Staśkiewicz, J | 1 |
| Kharchenko, VI | 3 |
| Evsikov, EM | 2 |
| Boddy, K | 1 |
| Mahaffey, M | 1 |
| Mills, E | 1 |
| Coltorti, M | 1 |
| Radaeli, E | 1 |
| Ciaccio, S | 1 |
| Corsini, R | 1 |
| Trebbi, R | 1 |
| Hall, GS | 1 |
| Helmsworth, JA | 1 |
| Schreiber, JT | 1 |
| Rosenkrantz, JG | 1 |
| Martin, LW | 1 |
| Hughes, H | 1 |
| Rogers, T | 1 |
| Daskalov, T | 1 |
| Popnikolov, S | 1 |
| Panikian, G | 1 |
| Korochkin, IM | 1 |
| Matveeva, IV | 1 |
| Miller, RA | 1 |
| Exaire, JE | 1 |
| Villalpando, J | 1 |
| Hamdan, G | 1 |
| Figueroa, G | 1 |
| Rahimtoola, SH | 1 |
| Gunnar, RM | 1 |
| Johansson, BW | 1 |
| Fellner, MJ | 1 |
| Katz, JM | 1 |
| Rand, RJ | 1 |
| Jenkins, DM | 1 |
| Scott, DG | 1 |
| Borrello, G | 2 |
| Rowe, WS | 1 |
| Sidorenko, BA | 4 |
| Savenkov, PM | 1 |
| Avissar, R | 1 |
| Menaché, R | 1 |
| Mandel, EM | 1 |
| Rubinstein, I | 1 |
| Djaldetti, M | 1 |
| Dormois, JC | 1 |
| Young, JL | 1 |
| Nies, AS | 1 |
| Castile, RG | 1 |
| Kleinberg, F | 1 |
| Ianhez, LE | 1 |
| André, M | 1 |
| Normand, J | 1 |
| Bozio, A | 1 |
| Sassolas, F | 1 |
| Jocteur-Monrozier, D | 1 |
| Ferreira Filho, SR | 1 |
| Hatab, SA | 1 |
| Benchimol, C | 1 |
| Nascimento, LO | 1 |
| Saragoça, MA | 2 |
| Portaluppi, F | 1 |
| Montanari, L | 1 |
| Ferlini, M | 1 |
| Vergnani, L | 1 |
| Bagni, B | 1 |
| Degli Uberti, EC | 1 |
| Broqvist, M | 2 |
| Larsson, J | 1 |
| Fujita, T | 1 |
| Tsuda, T | 1 |
| Nonaka, R | 1 |
| Miyajima, T | 1 |
| Tanaka, Y | 1 |
| Shibata, A | 1 |
| Hifumi, S | 1 |
| Fujimura, M | 1 |
| Markiewicz, K | 5 |
| Cholewa, M | 5 |
| Górski, L | 4 |
| Gawor, Z | 4 |
| Kuś, W | 1 |
| Kaczkowska-Marusik, E | 2 |
| Dryjański, T | 4 |
| Good, J | 1 |
| Frost, G | 1 |
| Pomini, G | 1 |
| Rugna, A | 1 |
| Lupia, M | 1 |
| Opocher, G | 1 |
| Gribaldo, R | 1 |
| Sakai, Y | 1 |
| Morooka, S | 1 |
| Takayanagi, K | 1 |
| Takabatake, Y | 1 |
| Lahav, M | 1 |
| Regev, A | 1 |
| Ra'anani, P | 1 |
| Theodor, E | 1 |
| Brown, G | 1 |
| O'Leary, M | 1 |
| Douglas, I | 1 |
| Herkes, R | 1 |
| Geller, JC | 1 |
| Barkow, UH | 1 |
| Becher, H | 1 |
| Zhou, H | 1 |
| Vetter, H | 1 |
| Glänzer, K | 1 |
| Zawada, ET | 1 |
| Garrido, MC | 1 |
| Davies, JE | 1 |
| Brochwicz-Lewinski, MJ | 1 |
| Tan, LB | 1 |
| Wuerz, RC | 1 |
| Meador, SA | 1 |
| Schwinger, RH | 1 |
| Antoni, DH | 1 |
| O'Keeffe, S | 1 |
| Grimes, H | 1 |
| Finn, J | 1 |
| McMurrough, P | 1 |
| Daly, K | 1 |
| Motwani, JG | 1 |
| Fenwick, MK | 1 |
| Davies, E | 3 |
| Williams, BC | 3 |
| Shaw, TR | 3 |
| Edwards, CR | 3 |
| Domingo, E | 1 |
| Gilabert, MR | 1 |
| Alio, J | 1 |
| Angel, J | 1 |
| Soler-Soler, J | 1 |
| Anand, IS | 1 |
| Kalra, GS | 1 |
| Harris, P | 1 |
| Poole-Wilson, PA | 2 |
| Panzali, A | 1 |
| De Giuli, F | 1 |
| Ferrari, R | 1 |
| Waugh, C | 2 |
| Monova, D | 1 |
| Belovezhdov, N | 1 |
| Wilson, MM | 1 |
| Awotedu, AA | 1 |
| False, AO | 1 |
| Velloso, LG | 1 |
| Alonso, RR | 1 |
| Ciscato, CM | 1 |
| Barretto, AC | 1 |
| Bellotti, G | 1 |
| Pileggi, F | 1 |
| Ferrari, E | 1 |
| Taillan, B | 1 |
| Dricci, M | 1 |
| Peuchot, N | 1 |
| Proton, A | 1 |
| Leonetti, J | 1 |
| Baur, LH | 1 |
| Schipperheyn, JJ | 1 |
| Bann, J | 1 |
| van der Laarse, A | 1 |
| van der Wall, EE | 1 |
| van Dijk, AD | 1 |
| Buis, B | 1 |
| Manger Cats, V | 1 |
| Bruschke, AV | 1 |
| Keller, N | 1 |
| Sykulski, R | 1 |
| Larsen, J | 1 |
| Rauchfleisch, S | 1 |
| Kaufmann, N | 1 |
| Hue, DP | 1 |
| Culank, LS | 1 |
| Toase, PD | 1 |
| Maguire, GA | 1 |
| Kröger, N | 1 |
| Szuba, J | 1 |
| Frenzel, H | 1 |
| Varriale, P | 2 |
| David, WJ | 1 |
| Chryssos, BE | 1 |
| Cachofeiro, V | 1 |
| Schiffrin, EL | 1 |
| Cantin, M | 1 |
| Garcia, R | 1 |
| Channer, KS | 1 |
| Richardson, M | 1 |
| Crook, R | 1 |
| Jones, JV | 1 |
| Matsuhashi, H | 1 |
| Onodera, S | 1 |
| Hasebe, N | 1 |
| Maruyama, J | 1 |
| Honda, H | 1 |
| Yamashita, H | 1 |
| Tobise, K | 1 |
| Kochmański, M | 1 |
| Zochowski, RJ | 1 |
| Tugarinov, SA | 1 |
| Chaus, NI | 1 |
| Krivitskiĭ, NM | 1 |
| Kislukhin, VV | 1 |
| Khandiukov, SB | 1 |
| Rasche, K | 1 |
| Strunk, M | 1 |
| Höltmann, BJ | 1 |
| Marek, W | 1 |
| Ulmer, WT | 1 |
| Bourgain, C | 1 |
| Bienvenu, T | 1 |
| Crémieux, AC | 1 |
| Delage, A | 1 |
| Carbon, C | 1 |
| Wehling, M | 2 |
| Zimmermann, J | 2 |
| Weil, J | 1 |
| Gerzer, R | 1 |
| Theisen, K | 2 |
| Ponto, LL | 1 |
| Schoenwald, RD | 1 |
| Bechler-Lisińska, J | 2 |
| Krátký, V | 1 |
| Bartonová, J | 1 |
| Hrdina, R | 1 |
| Latta, D | 1 |
| Finnamore, VP | 1 |
| Dalton, K | 1 |
| Allman, S | 5 |
| Marangoni, E | 1 |
| Oddone, A | 1 |
| Surian, M | 1 |
| Panciroli, C | 1 |
| Galloni, G | 1 |
| Masa, A | 1 |
| Caizzi, V | 1 |
| Belletti, S | 1 |
| Cominesi, WR | 1 |
| Orlandi, M | 1 |
| Orynchak, MA | 4 |
| Bubiński, R | 1 |
| Brunken, RC | 1 |
| Belil, D | 1 |
| Grover-McKay, M | 1 |
| Schwaiger, M | 1 |
| Schelbert, HR | 1 |
| Tillisch, JH | 2 |
| Straand, J | 1 |
| Sletvold, O | 1 |
| Balaguer Santamaría, JA | 1 |
| García Conesa, JA | 1 |
| Goñi Oyaren, C | 1 |
| Escribano Subías, J | 1 |
| Castelló Girona, F | 1 |
| Gallart Catalá, A | 1 |
| Nikolić, VH | 1 |
| Omcikus, MP | 1 |
| Mihatov, S | 1 |
| Rudar, M | 1 |
| Vukosavić, D | 1 |
| Petrać, D | 1 |
| Guédon, J | 1 |
| Morrison, DA | 1 |
| Gay, RG | 1 |
| Feldshon, D | 1 |
| Sampliner, RE | 1 |
| Zwaveling, JH | 1 |
| Gans, SJ | 1 |
| Crozier, IG | 1 |
| Hattersley, AT | 1 |
| Langley, S | 1 |
| Thompson, JR | 1 |
| Blackwood, RA | 1 |
| Salmon, AP | 1 |
| Finkel, Y | 1 |
| Silove, ED | 1 |
| Evans, JA | 1 |
| De Giovanni, JV | 1 |
| Wright, JG | 1 |
| Booth, IW | 1 |
| Marklund, T | 1 |
| Loureiro, PA | 1 |
| Correia, JM | 1 |
| Dracup, KA | 1 |
| Broks-Bratkowska, B | 1 |
| Gillen, G | 1 |
| Olivari, MT | 1 |
| Stainer, K | 1 |
| Wynne, RD | 1 |
| Rowley, JM | 1 |
| Boccanelli, A | 2 |
| Liberatore, SM | 2 |
| Prati, PL | 2 |
| Muller, J | 1 |
| Richardson, A | 1 |
| Bayliss, J | 2 |
| Scriven, AJ | 1 |
| Parameshwar, J | 1 |
| Sutton, GC | 1 |
| Chakko, SC | 1 |
| Caldwell, SH | 1 |
| Sforza, PP | 1 |
| Anderson, JV | 1 |
| Woodruff, PW | 1 |
| Bloom, SR | 1 |
| Webster, MW | 1 |
| Wells, JE | 1 |
| Funck-Brentano, C | 1 |
| Chatellier, G | 1 |
| Alexandre, JM | 1 |
| Ketteler, M | 1 |
| Hausmann, C | 1 |
| Reinhard, C | 1 |
| Schömig, A | 1 |
| Hackenthal, E | 1 |
| Ritz, E | 1 |
| Rascher, W | 1 |
| Jardim, PC | 1 |
| Branco, RF | 1 |
| Silva, EG | 1 |
| Agarwala, BN | 2 |
| McNabb, WR | 1 |
| Lant, AF | 1 |
| Kitchen, SP | 2 |
| Crawford, RJ | 3 |
| Vitolo, E | 1 |
| Segalini, G | 1 |
| Carini, L | 1 |
| Castini, D | 1 |
| Moreo, A | 1 |
| Mazzola, C | 1 |
| Segagni, S | 1 |
| Villa, G | 1 |
| Salvadeo, A | 1 |
| Heseltine, D | 1 |
| Bramble, MG | 1 |
| Car, N | 1 |
| Skrabalo, Z | 1 |
| Verho, M | 1 |
| Riancho, JA | 1 |
| Hazas, J | 1 |
| Sanroma, P | 1 |
| González Macías, J | 1 |
| Chaudhuri, ML | 1 |
| Catania, J | 1 |
| Larsen, FF | 1 |
| Kahles, H | 2 |
| Riegger, AJ | 1 |
| Eriksson, LO | 2 |
| Kallner, M | 2 |
| Tartagni, F | 1 |
| Ortolani, P | 1 |
| Degli Esposti, D | 1 |
| Cervi, V | 1 |
| Magnani, B | 1 |
| Daniels, AR | 1 |
| Ferreira, SR | 1 |
| Homsi, E | 1 |
| Ajzen, H | 1 |
| Draibe, SA | 1 |
| Ribeiro, AB | 1 |
| Ramos, OL | 1 |
| van Meijel, JJ | 1 |
| Offermann, T | 1 |
| Hopf, R | 1 |
| Kaltenbach, M | 1 |
| Kerr, HD | 1 |
| Ramsay, F | 1 |
| Bailey, R | 1 |
| Martin, A | 1 |
| Aranda, JV | 1 |
| Chemtob, S | 1 |
| Laudignon, N | 1 |
| Sasyniuk, BI | 1 |
| Zachara, E | 1 |
| Carboni, GP | 1 |
| Norell, M | 1 |
| Canepa-Anson, R | 1 |
| Sutton, G | 1 |
| Poole-Wilson, P | 1 |
| Valle, GA | 1 |
| Lemberg, L | 1 |
| Mulder, H | 1 |
| Schopman, W | 2 |
| van der Lely, AJ | 1 |
| Chaturvedi, PR | 1 |
| O'Donnell, JP | 1 |
| Nicholas, JM | 1 |
| Shoenthal, DR | 1 |
| Waters, DH | 1 |
| Gwilt, PR | 1 |
| Hutton, I | 2 |
| McGhie, AI | 1 |
| Martin, W | 1 |
| Tweddel, AC | 1 |
| Ryan, AM | 1 |
| Newnham, HH | 1 |
| Hamblin, PS | 1 |
| Long, F | 1 |
| Lim, CF | 1 |
| Topliss, DJ | 1 |
| Stockigt, JR | 1 |
| Cauchie, P | 1 |
| Vincken, W | 1 |
| Decaux, G | 1 |
| Rimondini, A | 1 |
| Cipolla, CM | 1 |
| Della Bella, P | 1 |
| Grazi, S | 1 |
| Sisillo, E | 1 |
| Susini, G | 1 |
| Tondo, C | 1 |
| Yasky, J | 2 |
| Ledesma, GA | 2 |
| Tutera, A | 2 |
| Collia, LF | 2 |
| Darlington, LG | 1 |
| Grigor'iants, RA | 1 |
| Gerasimova, VV | 1 |
| Stefan, G | 2 |
| Maass, L | 1 |
| Scheen, AJ | 1 |
| Vancrombreucq, JC | 1 |
| Delarge, J | 1 |
| Luyckx, AS | 1 |
| Grosskopf, I | 1 |
| Rabinovitz, M | 1 |
| Rosenfeld, JB | 1 |
| Slutsky, RA | 1 |
| Olson, LK | 1 |
| Pehrsson, SK | 1 |
| Lambert, C | 1 |
| Larose, P | 1 |
| Ong, H | 1 |
| Gutkowska, J | 1 |
| du Souich, P | 1 |
| Talcott, J | 1 |
| Simpson, IA | 1 |
| Rae, AP | 1 |
| Simpson, K | 1 |
| Gribben, J | 1 |
| Boulton Jones, JM | 1 |
| Allison, ME | 1 |
| Vasko, MR | 1 |
| Cartwright, DB | 1 |
| Knochel, JP | 1 |
| Nixon, JV | 1 |
| Riegger, G | 1 |
| Liebau, G | 1 |
| Kochsiek, K | 1 |
| Salerno, M | 1 |
| Di Salvo, M | 1 |
| Furnari, R | 1 |
| Vaccaro, F | 1 |
| Licciardi, S | 1 |
| Finocchiaro, S | 1 |
| Mauersberger, H | 1 |
| Rangoonwala, B | 1 |
| Ehrlich, E | 1 |
| Janicki, JS | 1 |
| Niazov, R | 1 |
| Bar-Yochai, J | 1 |
| Alcalay, J | 1 |
| Alkalay, L | 1 |
| Wordsworth, BP | 1 |
| Mowat, AG | 1 |
| Bursztyn, M | 1 |
| Gutman, A | 1 |
| Kuchar, DL | 1 |
| Dyckner, T | 1 |
| Wester, PO | 1 |
| Harrold, BP | 1 |
| Noble, MI | 1 |
| Trenchard, D | 1 |
| Roux, M | 1 |
| Herne, N | 1 |
| Gilly, R | 1 |
| Michaud, J | 1 |
| Le Gall, F | 1 |
| Schweiser, W | 1 |
| Aryanpur, I | 1 |
| Farhoudi, A | 1 |
| Zangeneh, F | 1 |
| Whight, C | 1 |
| Morgan, T | 1 |
| Carney, S | 1 |
| Wilson, M | 1 |
| Budow, J | 1 |
| Natarajan, P | 1 |
| Kroop, IG | 1 |
| Zinganell, K | 1 |
| Hilmes, H | 1 |
| Macmillan, AL | 1 |
| Arnold, K | 1 |
| Nouaille, J | 1 |
| Vandongen, R | 1 |
| Gordon, RD | 1 |
| Lahovaara, S | 1 |
| Paasonen, MK | 1 |
| Krause, DK | 1 |
| Rosskamp, E | 1 |
| Meurer, KA | 1 |
| Kaufmann, W | 1 |
| Ito, T | 1 |
| Hidaka, H | 1 |
| Kato, T | 1 |
| Yoshitoski, Y | 1 |
| Lvoff, R | 1 |
| Wilcken, DE | 1 |
| Sharefkin, JB | 1 |
| Silen, W | 1 |
| Glauser, FL | 1 |
| Wessel, HJ | 1 |
| Schüren, KP | 1 |
| Ramdohr, B | 1 |
| Nöring, J | 1 |
| Schröder, R | 1 |
| Mathew, KJ | 1 |
| Snow, JA | 1 |
| Hochrein, H | 1 |
| Wolf, R | 1 |
| Beck, OA | 1 |
| Helwing, HP | 1 |
| Tojo, S | 1 |
| Hubert, C | 1 |
| Sevens-Rocmans, C | 1 |
| Demanet, JC | 1 |
| Cannon, PJ | 2 |
| Kilcoyne, MM | 1 |
| Schmidt, DH | 1 |
| Ronan, JA | 1 |
| Koch-Weser, J | 1 |
| Burger, P | 1 |
| Anderson, IF | 1 |
| Viles, PH | 1 |
| Manning, JA | 1 |
| Lazarus, JM | 1 |
| Hampers, C | 1 |
| Merrill, JP | 1 |
| Szachowski, J | 1 |
| Pawliszewska, J | 1 |
| Puchalska-Krotki, H | 1 |
| Agrawal, BV | 1 |
| Singh, RB | 1 |
| Vaish, SK | 1 |
| Edin, H | 1 |
| Ch'en, CL | 1 |
| Shiikai, T | 1 |
| Ideura, T | 1 |
| Koshikawa, S | 1 |
| Runeberg, L | 1 |
| Pasternack, A | 1 |
| Borgmästars, H | 1 |
| von Bonsdorff, M | 1 |
| Hastings, SG | 1 |
| Johnston, DJ | 1 |
| Blouin, LT | 1 |
| Speranskaia, NV | 1 |
| Kuz'mina, AE | 1 |
| Sidhu, AK | 1 |
| Bhakoo, ON | 1 |
| Jolly, JG | 1 |
| Walia, BN | 1 |
| Hannemann, HR | 1 |
| King, JF | 1 |
| Salel, AF | 1 |
| Massumi, RA | 1 |
| Zelis, R | 1 |
| Dikshit, K | 1 |
| Vyden, JK | 1 |
| Forrester, JS | 1 |
| Chatterjee, K | 1 |
| Prakash, R | 1 |
| Swan, HJ | 1 |
| Stock, E | 2 |
| Sigurd, B | 2 |
| Leth, A | 1 |
| Steiness, E | 1 |
| Fulop, M | 1 |
| Horowitz, M | 1 |
| Aberman, A | 1 |
| Jaffe, ER | 1 |
| Lüllmann, H | 1 |
| Schaefer, J | 1 |
| Lieberman, E | 1 |
| Lindy, S | 1 |
| Tarssanen, L | 1 |
| Nitter-Hauge, S | 1 |
| Brodwall, EK | 1 |
| Rootwelt, K | 1 |
| Kounis, NG | 1 |
| Cesari, L | 1 |
| Vattimo, A | 1 |
| Nardi, P | 1 |
| Hanrath, P | 1 |
| Mathey, D | 1 |
| Hurtig, HI | 1 |
| Dyson, WL | 1 |
| Lavender, S | 1 |
| McGill, RJ | 1 |
| Tattersfield, AE | 2 |
| McNicol, MW | 1 |
| Sillett, RW | 1 |
| Adrogue, HJ | 1 |
| Roehr, EE | 1 |
| Roncoroni, AJ | 1 |
| Fialk, MA | 1 |
| Romankiewicz, J | 1 |
| Perrone, F | 1 |
| Sherman, RL | 1 |
| Chaudhury, RR | 2 |
| Chugh, KS | 2 |
| Gupta, GS | 1 |
| Sodhi, P | 1 |
| Gupta, KK | 2 |
| McFarland, MD | 1 |
| Kirkendall, WM | 1 |
| Stein, JH | 1 |
| Brest, AN | 1 |
| Seller, R | 1 |
| Onesti, G | 2 |
| Ramirez, O | 1 |
| Moyer, JH | 2 |
| Szám, I | 1 |
| Sólyom, I | 1 |
| Fischer, J | 1 |
| Juul, J | 1 |
| Leiter, L | 1 |
| Radó, JP | 2 |
| Marosi, J | 2 |
| Takó, J | 2 |
| Anderton, JL | 1 |
| Kincaid-Smith, P | 1 |
| Olesen, KH | 4 |
| Reubi, FC | 1 |
| Dévényi, I | 1 |
| Ebringer, A | 1 |
| Adam, WR | 1 |
| Parkin, JD | 1 |
| Baglin, A | 1 |
| Safar, M | 1 |
| Milliez, P | 1 |
| Repetto, HA | 1 |
| Braudo, JL | 1 |
| Metcoff, J | 1 |
| Gazes, PC | 1 |
| Hamlin, RL | 1 |
| Pipers, FS | 1 |
| Carter, KL | 1 |
| McElligott, M | 1 |
| Benaim, R | 1 |
| Chapelle, M | 1 |
| Haiat, R | 1 |
| Meilhac, B | 1 |
| Chiche, P | 1 |
| Azzi, E | 1 |
| Perraro, F | 1 |
| Tolstykh, AN | 1 |
| Mel'nichenko, GA | 1 |
| Merzon, AK | 1 |
| Konopko, TF | 1 |
| Sabbaga, E | 1 |
| Koperstych, S | 1 |
| de Faria, CV | 1 |
| Garcia, EM | 1 |
| Prata DJ da, C | 1 |
| de Carvalho, LV | 1 |
| Riggio, G | 1 |
| Kuhlbäck, B | 1 |
| Shanoff, HM | 1 |
| Vinogradov, AV | 2 |
| Tsibekmakher, TD | 1 |
| Matveev, LN | 2 |
| Mroczek, WJ | 1 |
| Gavrilovich, L | 1 |
| Malo, RA | 1 |
| Silverberg, DS | 1 |
| Ulan, RA | 1 |
| Baltzan, MA | 1 |
| Baltzan, RB | 1 |
| Fischer, R | 1 |
| Lenhartz, A | 1 |
| Tang, JV | 1 |
| Villanueva, F | 1 |
| Gibson, TP | 1 |
| Blue, P | 1 |
| Poliantseva, LP | 1 |
| Moiseev, VS | 2 |
| Ermolenko, VM | 2 |
| Ferrante, P | 1 |
| Beffagnotti, A | 1 |
| Palva, IP | 1 |
| Salokannel, SJ | 1 |
| Takkunen, JT | 1 |
| Van der Horst, RL | 1 |
| Lovisato, L | 1 |
| Maieron, PL | 1 |
| Gentili, G | 1 |
| Liberti, R | 1 |
| Richardson, H | 1 |
| Bucur, V | 1 |
| Bunghez, G | 1 |
| Trilla-Sánchez, E | 1 |
| Fort De Ribot, R | 1 |
| Salazar-Badias, M | 1 |
| Torner-Soler, M | 1 |
| Drozdova, ES | 1 |
| Khodzhamirova, VS | 1 |
| Gel'fond, MB | 1 |
| Samosiuk, IM | 1 |
| Poliantseva, LR | 1 |
| Rensch, H | 1 |
| Kitayama, S | 1 |
| Bull, MB | 1 |
| Laragh, JH | 2 |
| Keyes, MH | 1 |
| Belle, MS | 1 |
| Jahrmärker, H | 1 |
| Avenhaus, H | 1 |
| Grohmann, H | 1 |
| Koczorek, KR | 1 |
| Herrmann, GR | 1 |
| Ghiselli, RG | 1 |
| Yamane, Y | 1 |
| Veltkamp, U | 1 |
| Muysers, K | 1 |
| Smidt, U | 1 |
| Pickering, D | 1 |
| Krishnankutti, PK | 1 |
| Quellhorst, E | 1 |
| Scheler, F | 1 |
| Laufer, ST | 1 |
| Denis, B | 1 |
| Rival, M | 1 |
| Singh, BN | 1 |
| Hurley, PJ | 1 |
| North, JD | 1 |
| Haywood, LJ | 1 |
| Pijoán de Beristáin, C | 1 |
| Casares Potau, R | 1 |
| Périz Sagué, A | 1 |
| Nay, RM | 1 |
| Awamura, M | 1 |
| Branciari, C | 1 |
| Lauro, G | 1 |
| Menghini, G | 1 |
| Stewart, JH | 1 |
| Edwards, KD | 1 |
| Soulié, P | 1 |
| Gaudeau, S | 1 |
| Gourgon, R | 1 |
| Atkins, LL | 1 |
| Proto, C | 1 |
| Rapaport, S | 1 |
| Nijensohn, C | 1 |
| Bronstein, A | 1 |
| Regatky, E | 1 |
| Berconsky, I | 1 |
| Mikolajczyk, W | 1 |
| Kuzmanic, A | 1 |
| Faivovich, A | 1 |
| Del Rio, R | 1 |
| Jaruffe, F | 1 |
| Vera, Y | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| [NCT01315223] | Phase 3 | 300 participants (Anticipated) | Interventional | 2011-03-31 | Recruiting | ||
| TRANSFORM-HF: ToRsemide compArisoN With furoSemide FORManagement of Heart Failure[NCT03296813] | Phase 3 | 2,859 participants (Actual) | Interventional | 2018-07-11 | Completed | ||
| Safety and Tolerability of Diuretics Withdrawal in Heart Failure With Reduced Ejection Fraction. REDICAE Trial.[NCT05964738] | Phase 2 | 90 participants (Anticipated) | Interventional | 2022-12-19 | Recruiting | ||
| Effect of Furosemide Withdraw in Stable Chronic Heart Failure Outpatients With Left Ventricular Dysfunction - the Brazilian Research Network on Heart Failure[NCT02689180] | Phase 3 | 230 participants (Anticipated) | Interventional | 2015-05-31 | Recruiting | ||
| Comparison of Oral Thiazides vs Intravenous Thiazides vs Tolvaptan in Combination With Loop Diuretics for Diuretic Resistant Decompensated Heart Failure[NCT02606253] | Phase 4 | 60 participants (Actual) | Interventional | 2016-02-29 | Completed | ||
| Early and Comprehensive Care Bundle in Elderly for Acute Heart Failure: a Stepped Wedge Cluster Randomized Trial[NCT03683212] | 503 participants (Actual) | Interventional | 2018-12-10 | Completed | |||
| Effect of Short-Term Prednisone Therapy on C-reactive Protein Change in Emergency Department Patients With Acute Heart Failure and Elevated Inflammatory Markers[NCT05916586] | 120 participants (Anticipated) | Interventional | 2023-08-11 | Recruiting | |||
| Outgoing Lung Team - a Cross-sectorial and Preventive Intervention in Patients at Risk of Hospitalisation Due to Exacerbation of COPD[NCT04119856] | 144 participants (Actual) | Interventional | 2017-09-25 | Completed | |||
| Diuretic Efficiency in Patients With Stable Heart Failure: Ion Excretion Capacity of the Kidneys (DIPSTICK) Study[NCT02288819] | 50 participants (Actual) | Interventional | 2014-09-30 | Terminated (stopped due to Slow recruitment and a lack of funding to complete further follow-up) | |||
| Continuous Versus Bolus Intermittent Loop Diuretic Infusion in Acutely Decompensated Heart Failure: Evaluation of Renal Function, Congestion Signs, BNP and Outcome[NCT02638142] | 116 participants (Actual) | Observational | 2015-12-31 | Active, not recruiting | |||
| Prospective, Randomized, Parallel-Group Pilot Study Comparing IV Furosemide to Subcutaneous Furosemide in Acute Decompensated Heart Failure Patients[NCT02579057] | Phase 2/Phase 3 | 40 participants (Actual) | Interventional | 2016-02-29 | Completed | ||
| Randomized Evaluation of Heart Failure With Preserved Ejection Fraction (HFpEF) Patients With Acute Heart Failure and Dopamine (ROPA-DOP) Trial[NCT01901809] | Phase 4 | 90 participants (Actual) | Interventional | 2013-08-31 | Completed | ||
| Safety and Efficacy of the Combination of Loop Diuretics With Thiazide-type Diuretics in Patients With Decompensated Heart Failure: a Double-blind, Randomized, Placebo-controlled Trial (CLOROTIC Trial).[NCT01647932] | Phase 3 | 232 participants (Actual) | Interventional | 2014-10-31 | Completed | ||
| Reverse Remodeling is Associated With Hemodynamic Improvement and Stabilization in Outpatients With Heart Failure With Reduced Ejection Fraction Treated With Sacubitril/Valsartan: an Echocardiographic Study[NCT04397302] | 652 participants (Actual) | Observational [Patient Registry] | 2019-01-13 | Completed | |||
| Diuretic Treatment in High Risk Decompensated Advanced Heart Failure. Bolus Intermittent Versus Continuous Infusion of Furosemide: a Randomized Controlled Trial.[NCT03592836] | Phase 3 | 80 participants (Actual) | Interventional | 2013-05-01 | Completed | ||
| Impact of Renin-Angiotensin System Inhibitors Continuation on Outcome After Major Surgery : a Multicenter, Prospective, Randomized and Controlled Trial[NCT03374449] | 2,222 participants (Actual) | Interventional | 2018-02-06 | Active, not recruiting | |||
| Ultrafiltration for the Chronic Treatment of Severe Congestive Heart Failure[NCT00360958] | Phase 4 | 60 participants (Actual) | Interventional | 2006-08-31 | Completed | ||
| Effects of Adding Hypertonic Saline Solutions and/or Etilefrine to Standard Diuretics Therapy in Egyptian Cirrhotic Patients With Ascites[NCT04785755] | Phase 2 | 90 participants (Actual) | Interventional | 2017-11-30 | Completed | ||
| Oral Sodium to Preserve Renal EfficiencY in Acute Heart Failure (OSPREY-AHF)[NCT04334668] | 70 participants (Actual) | Interventional | 2020-05-20 | Active, not recruiting | |||
| Comparison of High-dose Furosemide, Low-dose Furosemide, and the Combination of Low-dose Furosemide and Low-dose Dopamine in Patients With Acute Decompensated Heart Failure[NCT01060293] | Phase 4 | 161 participants (Actual) | Interventional | 2009-07-31 | Terminated (stopped due to Safety issues in the LDFD-group (higher heart rate with dopamine)) | ||
| A Randomized, Open-label Study of Dapagliflozin in Patients With or Without Type 2 Diabetes Admitted With Acute Heart Failure[NCT04298229] | Phase 3 | 240 participants (Actual) | Interventional | 2020-04-01 | Completed | ||
| Monitoring Patients With Acute Dyspnea With Serial Focused Ultrasound of the Heart and the Lungs[NCT04091334] | 206 participants (Actual) | Interventional | 2019-10-09 | Completed | |||
| Continuous Versus Intermittent Loop Diuretics Infusion Dosing in Acute Heart Failure: Effects on Renal Function, Outcome and BNP Levels[NCT01441245] | Phase 4 | 57 participants (Actual) | Interventional | 2010-04-30 | Completed | ||
| A Phase II/III, Multicenter, Randomized, Double-blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Relaxin in Subjects With Acute Heart Failure[NCT00520806] | Phase 2/Phase 3 | 1,161 participants (Actual) | Interventional | 2007-10-31 | Completed | ||
| CARdiorenal REScue Study in Acute Decompensated Heart Failure: CARRESS[NCT00608491] | Phase 3 | 188 participants (Actual) | Interventional | 2008-03-31 | Completed | ||
| Diuretic Optimal Strategy Evaluation in Acute Heart Failure (The DOSE-AHF Study)[NCT00577135] | Phase 3 | 308 participants (Actual) | Interventional | 2008-02-29 | Completed | ||
| Pathophysiologic and Outcomes Impact of the Relation of Intravascular Volume Expansion to Neuroendocrine-Renal Function Profiles in Chronic Heart Failure - Pathway to More Individualized Therapy[NCT04156854] | 15 participants (Actual) | Interventional | 2020-01-30 | Completed | |||
| Randomized, Open-Label, Blinded-Endpoint, Crossover, Single Dose Study to Compare the Pharmacodynamics of Torasemide-PR 10 mg,Torasemide-IR 10 mg and Furosemide-IR 40 mg, in Patients With Compensated Heart Failure (CHF).[NCT01549158] | Phase 4 | 8 participants (Actual) | Interventional | 2012-02-29 | Terminated (stopped due to Slow recruitment) | ||
| Impact of Sodium-glucose Cotransporter Type 2 Inhibitors on the Course of Cardiorenal Syndrome in Acute Decompensation of Chronic Heart Failure[NCT04778787] | Phase 4 | 370 participants (Actual) | Interventional | 2021-01-01 | Completed | ||
| Effect of Thiamin Supplementation on Thiamin Status in Children With Heart Disease Receiving Diuretic Drugs: Randomized Controlled Trial[NCT03989700] | Phase 3 | 60 participants (Anticipated) | Interventional | 2019-07-01 | Not yet recruiting | ||
| Renal Optimization Strategies Evaluation in Acute Heart Failure and Reliable Evaluation of Dyspnea in the Heart Failure Network ROSE Study[NCT01132846] | Phase 2 | 360 participants (Actual) | Interventional | 2010-08-31 | Completed | ||
| Protocol 156-03-236: Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Long Term Efficacy and Safety of Oral Tolvaptan Tablets in Subjects Hospitalized With Worsening Congestive Heart Failure[NCT00071331] | Phase 3 | 3,600 participants | Interventional | 2003-09-30 | Completed | ||
| A Multicenter, Randomized, Double-blind, Placebo-controlled Study of the Effects of KW-3902 Injectable Emulsion on Heart Failure Signs and Symptoms and Renal Function in Subjects With Acute Heart Failure Syndrome and Renal Impairment Who Are Hospitalized [NCT00354458] | Phase 3 | 1,102 participants (Actual) | Interventional | 2006-10-31 | Completed | ||
| "Prospective Pre-post Pilot Study on the Effects of Dietary Chloride Supplementation on Neurohormonal and Diuretic Function in Patients With Heart Failure"[NCT02031354] | 11 participants (Actual) | Interventional | 2014-01-31 | Completed | |||
| The Impact of TORasemide oN hemodynAmic and Neurohormonal Stress, and carDiac remOdeling in Heart Failure - Prospective, Randomized, Open, Blinded Endpoint Trial[NCT01942109] | Phase 4 | 100 participants (Anticipated) | Interventional | 2013-09-30 | Recruiting | ||
| Efficacy and Tolerability of Combination Intravenous Diuretic Therapy Versus Intravenous Loop Diuretic Therapy Alone for the Treatment of Acute Decompensated Heart Failure[NCT05840536] | Phase 4 | 0 participants (Actual) | Interventional | 2014-05-31 | Withdrawn | ||
| High-Dose Aldactone for Treatment of Diuretic Resistant Heart Failure[NCT02429388] | Phase 4 | 0 participants (Actual) | Interventional | 2014-05-31 | Withdrawn (stopped due to Principal Investigator left institution prior to subjects being enrolled) | ||
| Prospective, Randomised, Open, Blinded-endpoint Study of Torasemide Prolonged Release vs Furosemide to Evaluate the Efficacy on Myocardial Fibrosis in Patients With Heart Failure[NCT00409942] | Phase 4 | 142 participants (Actual) | Interventional | 2007-03-31 | Completed | ||
| A Randomized, Placebo-Controlled, Double-Blind, Multi-Center, Parallel Group, Single Dose Study to Evaluate Cardiac Hemodynamics and Safety During Right Heart Catheterization of Three IV Doses of SLV320 in Subjects With Congestive Heart Failure Requiring [NCT00160134] | Phase 2 | 0 participants | Interventional | 2005-01-31 | Completed | ||
| NT-BNP Guided Care in Addition to Multidisciplinary Care in Patients With Chronic Heart Failure A Three-Arm, Prospective, Randomised Study[NCT00355017] | 0 participants | Interventional | 2003-09-30 | Terminated | |||
| Immune-inflammatory and Metabolic Effects of High Dose Furosemide Plus Hypertonic Saline Solution (HSS) Treatment in Cirrhotic Subjects With Refractory Ascite[NCT02821377] | Phase 2 | 40 participants (Actual) | Interventional | 2013-12-31 | Completed | ||
| NATriuretic Response to Expansion and dIUretics in huMans With Heart Failure[NCT04235062] | 229 participants (Actual) | Interventional | 2020-04-01 | Completed | |||
| Comparison of High-dose Furosemide Versus the Combination of Low-dose Furosemide and Low-dose Dopamine in Patients With Acute Decompensated Heart Failure[NCT00937092] | Phase 4 | 300 participants (Anticipated) | Interventional | 2009-01-31 | Recruiting | ||
| Effects of High Furosemide Doses Alone or With Hypertonic Saline on Troponin I Myocardial Release in Acute Decompensated Heart Failure: a Double Blind Study.[NCT01419132] | Phase 4 | 60 participants (Anticipated) | Interventional | 2011-08-31 | Completed | ||
| Comparative Effects of Conivaptan and Loop Diuretics on Plasma Neurohormones and Systemic and Renal Hemodynamics in Subjects With Chronic Congestive Heart Failure[NCT00924014] | 8 participants (Anticipated) | Interventional | 2009-07-31 | Not yet recruiting | |||
| Japanese Multicenter Evaluation of Long- Versus Short-acting Diuretics in Congestive Heart Failure[NCT00355667] | Phase 4 | 320 participants (Actual) | Interventional | 2006-06-30 | Completed | ||
| Remote Dielectric Sensing (ReDS) for a SAFE Discharge in Patients With Acutely Decompensated Heart Failure: The ReDS-SAFE HF Study[NCT04305717] | 240 participants (Anticipated) | Interventional | 2020-08-14 | Recruiting | |||
| ESTIA: TorasEmide Induced Effect on Quality of Life and Clinical parameterS in paTients With chronIc heArt Failure Receiving Eplerenone. Multicenter, Non-interventional, Prospective, Observational Clinical Study.[NCT06117722] | 210 participants (Anticipated) | Observational | 2024-01-01 | Not yet recruiting | |||
| Hypertonic Saline Solution in Decompensated Heart Failure[NCT00555685] | Phase 2 | 34 participants (Actual) | Interventional | 2008-02-29 | Completed | ||
| Hypertonic Saline With Furosemide and a Normosodic Diet for the Treatment of Decompensated Congestive Heart Failure With Prerenal Physiology[NCT00575484] | Phase 2 | 11 participants (Actual) | Interventional | 2007-11-30 | Terminated | ||
| Assessing the Renal Consequences and Functional Efficacy of Low Dose Hypertonic Saline Solution and Furosemide for the Treatment of Congestive Heart Failure in a Randomized, Double Blind, Prospective Study[NCT01028170] | Phase 3 | 50 participants (Actual) | Interventional | 2009-11-30 | Completed | ||
| HSS (Hypertonic Saline Solution) Plus High Dose Furosemide vs High Dose Furosemide in Nephrotic Syndrome - a Randomized Trial[NCT03750136] | 30 participants (Anticipated) | Interventional | 2018-12-15 | Recruiting | |||
| The Role of Vasopressin Antagonism on Renal Sodium Handling[NCT03910231] | Phase 1 | 30 participants (Actual) | Interventional | 2012-02-01 | Completed | ||
| Tolvaptan Treatment to Reverse Worsening Outpatient Heart Failure: Possible Role of Copeptin In Identifying Responders (TROUPER)[NCT02476409] | Phase 4 | 40 participants (Actual) | Interventional | 2015-07-31 | Completed | ||
| Strategies for Assessment of Fluid Overload in Acute Decompensated Heart Failure[NCT04901039] | 150 participants (Anticipated) | Observational | 2022-04-14 | Recruiting | |||
| A Normal Sodium Diet Preserves Serum Sodium Levels During Treatment of Acute Decompensated Heart Failure[NCT03722069] | 44 participants (Actual) | Interventional | 2014-07-20 | Completed | |||
| Long-term Prednisone Use in Patients With Advanced Heart Failure (ACCF/AHA Stage D) and Hyperuricemia[NCT02282683] | Phase 2/Phase 3 | 90 participants (Anticipated) | Interventional | 2013-12-31 | Recruiting | ||
| The Effect of Aminophylline on Preventing Acute Kidney Injury in Pediatric Patients Undergoing Open Heart Surgery[NCT03897335] | Phase 3 | 80 participants (Anticipated) | Interventional | 2019-02-07 | Recruiting | ||
| The Effects of Levosimendan on Renal Function in Patients With Low Ejection Fraction Undergoing Mitral Valve Surgery.[NCT01969071] | Phase 4 | 140 participants (Actual) | Interventional | 2009-07-31 | Completed | ||
| Single Dose of Furosemide to Improve Respiratory Distress in Moderate to Severe Bronchiolitis[NCT02469597] | Phase 2 | 46 participants (Actual) | Interventional | 2013-10-31 | Completed | ||
| Efficacy of Aquapheresis in Patients Treated as Outpatients With Decompensated Heart Failure at a Veterans Hospital[NCT04572867] | 0 participants (Actual) | Interventional | 2021-06-08 | Withdrawn (stopped due to Due to low enrollment, COVID-19 pandemic causing suspension of most outpatient elective procedures, and no protected research time, Dr. Gelzer Bell is unable to continue this study.) | |||
| Resistant Hypertension On Treatment - Sequential Nephron Blockade Compared to Dual Blockade of the Renin-angiotensin-aldosterone System Plus Bisoprolol in the Treatment of Resistant Arterial Hypertension: A Randomized Trial (ResHypOT)[NCT02832973] | Phase 4 | 72 participants (Actual) | Interventional | 2015-09-30 | Completed | ||
| HF Assessment With BNP in the Home: Part II[NCT02351063] | 1 participants (Actual) | Interventional | 2014-04-30 | Terminated (stopped due to Sponsor's discretion to terminate study prematurely for further evaluation.) | |||
| Tunneled Pleural Catheters for Refractory Effusions Attributed to Congestive Heart Failure (TREAT-CHF) Trial[NCT03696524] | 0 participants (Actual) | Interventional | 2020-10-01 | Withdrawn (stopped due to Lack of enrollment) | |||
| Randomized,Open Label,Balanced,Two Treatment, Four Period, Two Sequence, Single Oral Dose, Crossover, Replicate Study Under Fasting Conditions to Test Within Subject Variability of 20mg ER Torsemide and Demadex Tablets in Healthy Adults[NCT03214874] | Phase 1 | 24 participants (Actual) | Interventional | 2017-06-19 | Completed | ||
| Thiamine Supplementation in High Risk Cardiac Surgery Patients[NCT03306732] | Phase 4 | 40 participants (Actual) | Interventional | 2017-10-19 | Completed | ||
| Bioequivalence Study of Furosemide in Indonesian Healthy Volunteers[NCT04982874] | 24 participants (Actual) | Interventional | 2019-12-13 | Completed | |||
| Double Blind Randomized Placebo Controlled Trial of Natrecor in Patients Hospitalized for Decompensated Heart Failure in the Presence of a Normal Left Ventricular Ejection Fraction[NCT00505791] | Phase 4 | 0 participants (Actual) | Interventional | 2007-08-31 | Withdrawn (stopped due to Unable to enroll patients) | ||
| Congestive Heart Failure Atrial Arrhythmia Monitoring and Pacing (CHAMP)[NCT00156728] | Phase 4 | 172 participants | Interventional | 2003-10-31 | Completed | ||
| Diuretic Effect of Metolazone Pre-dosing Versus Concurrent Dosing With Furosemide: a Pilot Study[NCT03746002] | Phase 4 | 3 participants (Actual) | Interventional | 2019-01-01 | Terminated (stopped due to Insufficient rate of patient enrollment/accrual.) | ||
| A Retrospective Chart Review Evaluating the Impact of Steroid, Diuretic, and Fluid Use Practice Trends in Extreme Premature Infants at Risk for Bronchopulmonary Dysplasia (BPD) at a Single Center Neonatal Intensive Care Unit[NCT04971694] | 175 participants (Anticipated) | Observational | 2021-09-08 | Recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
Change in estimated glomerular filtration rate (ml/min/m2) from baseline to 48 hours (NCT02606253)
Timeframe: 48 hours
| Intervention | ml/min/m2 (Mean) |
|---|---|
| Metolazone | -6 |
| Chlorothiazide | -9 |
| Tolvaptan | 2 |
"Participants will score their congestion on a 10cm scale ranging from Best (10cm) to Worst (0cm). Change in score (units in centimeters) from baseline to 48 hours." (NCT02606253)
Timeframe: 48 hours
| Intervention | cm of dyspena analog scale (Median) |
|---|---|
| Metolazone | 4.0 |
| Chlorothiazide | 3.0 |
| Tolvaptan | 3.0 |
Change in serum chloride (mEq/L) from baseline to 48 hrs (NCT02606253)
Timeframe: 48 hours
| Intervention | mEq/L (Mean) |
|---|---|
| Metolazone | -7 |
| Chlorothiazide | -7 |
| Tolvaptan | 2 |
Diuretic Efficiency is calculated as 48hr urine output/ 48hr Furosemide equivalents in milligrams (NCT02606253)
Timeframe: 48 hours
| Intervention | UOP / 40mg IV furosemide (Mean) |
|---|---|
| Metolazone | 217 |
| Chlorothiazide | 294 |
| Tolvaptan | 326 |
Mean change in glomerular filtration rate from enrollment to end of study at hospital discharge, an average of 5 days (NCT02606253)
Timeframe: hospital discharge an average of 5 days
| Intervention | ml/min/m2 (Mean) |
|---|---|
| Metolazone | -2 |
| Chlorothiazide | -2 |
| Tolvaptan | -6 |
Mean change in serum creatinine (mg/dl) from enrollment to end of study at 48 hours (NCT02606253)
Timeframe: 48 hours
| Intervention | mg/dl (Mean) |
|---|---|
| Metolazone | 0.3 |
| Chlorothiazide | 0.5 |
| Tolvaptan | 0.03 |
Mean change in serum potassium (mEq/L) from enrollment to end of study at 48 hours (NCT02606253)
Timeframe: 48 hours
| Intervention | mEq/L (Mean) |
|---|---|
| Metolazone | -0.1 |
| Chlorothiazide | -0.2 |
| Tolvaptan | 0.1 |
Mean change in serum sodium (mEq/L) from enrollment to end of study at 48 hours (NCT02606253)
Timeframe: 48 hours
| Intervention | mEq/L (Mean) |
|---|---|
| Metolazone | -1 |
| Chlorothiazide | -1 |
| Tolvaptan | 4 |
Net urine output from enrollment to the end of study at 48 hours measured in liters (NCT02606253)
Timeframe: 48 hours
| Intervention | liters (Median) |
|---|---|
| Metolazone | -7.8 |
| Chlorothiazide | -8.8 |
| Tolvaptan | -9.8 |
Incidence of new atrial or ventricular arrhythmias from enrollment to end of study at 48 hours (NCT02606253)
Timeframe: 48 hours
| Intervention | Participants (Count of Participants) |
|---|---|
| Metolazone | 0 |
| Chlorothiazide | 0 |
| Tolvaptan | 0 |
Provider escalation of loop diuretic dosage at 24 hours for urine output less than 3 L at 24 hours (NCT02606253)
Timeframe: 24 hours
| Intervention | Participants (Count of Participants) |
|---|---|
| Metolazone | 4 |
| Chlorothiazide | 4 |
| Tolvaptan | 2 |
Incidence of hypokalemia (serum potassium less than 3.5mEq/L ) from enrollment to end of study (NCT02606253)
Timeframe: 48 hours
| Intervention | Participants (Count of Participants) |
|---|---|
| Metolazone | 3 |
| Chlorothiazide | 2 |
| Tolvaptan | 2 |
Incidence of death from study enrollment to hospital discharge, an average of 5 days (NCT02606253)
Timeframe: Enrollment to hospital discharge an average of 5 days
| Intervention | Participants (Count of Participants) |
|---|---|
| Metolazone | 0 |
| Chlorothiazide | 0 |
| Tolvaptan | 0 |
Incidence of new initiation of dopamine, dobutamine, or milrinone from enrollment to end of study at 48 hours (NCT02606253)
Timeframe: 48 hours
| Intervention | Participants (Count of Participants) |
|---|---|
| Metolazone | 1 |
| Chlorothiazide | 0 |
| Tolvaptan | 2 |
Incidence of Renal replacement therapy utilization (hemodialysis, ultrafiltration) from enrollment to hospital discharge, an average of 5 days (NCT02606253)
Timeframe: enrollment to hospital discharge an average of 5 days
| Intervention | Participants (Count of Participants) |
|---|---|
| Metolazone | 0 |
| Chlorothiazide | 0 |
| Tolvaptan | 0 |
SBP < 85 mmHg plus medical intervention for symptomatic hypotension (NCT02606253)
Timeframe: 48 hours
| Intervention | Participants (Count of Participants) |
|---|---|
| Metolazone | 2 |
| Chlorothiazide | 0 |
| Tolvaptan | 2 |
Cumulative dose of potassium supplementation (mEq) administered from enrollment to end of study at 48 hours (NCT02606253)
Timeframe: 48 hours
| Intervention | mEq (Mean) |
|---|---|
| Metolazone | 103 |
| Chlorothiazide | 63 |
| Tolvaptan | 58 |
The primary outcome will be 48-hour standing scale weight change (kg) from enrollment among the metolazone, intravenous chlorothiazide, and tolvaptan arms, using metolazone group as the comparator group for all other groups. (NCT02606253)
Timeframe: 48 hours
| Intervention | kg (Mean) |
|---|---|
| Metolazone | -4.6 |
| Chlorothiazide | -5.8 |
| Tolvaptan | -4.1 |
(NCT02288819)
Timeframe: 30 days after baseline
| Intervention | Participants (Count of Participants) |
|---|---|
| Loop Diuretic Downtitration | 1 |
"NYHA class is a semi-quantitative measurement of functional capacity on a scale from 1 to 4:~No limitation of physical activity. Ordinary physical activity does not cause undue fatigue, palpitation, dyspnea (shortness of breath).~Slight limitation of physical activity. Comfortable at rest. Ordinary physical activity results in fatigue, palpitation, dyspnea (shortness of breath).~Marked limitation of physical activity. Comfortable at rest. Less than ordinary activity causes fatigue, palpitation, or dyspnea.~Unable to carry on any physical activity without discomfort. Symptoms of heart failure at rest. If any physical activity is undertaken, discomfort increases.~For the purpose of this outcome parameter, the patient is contacted by phone 30 days after baseline and NYHA functional class is assessed by a study investigator." (NCT02288819)
Timeframe: 30 days after baseline
| Intervention | units on a scale from 1 to 4 (Mean) |
|---|---|
| Loop Diuretic Downtitration | 1.41 |
Unplanned hospital admission for symptoms of congestion and/or low output heart failure requiring either intravenous therapy and/or increase of oral diuretics. (NCT02288819)
Timeframe: 30 days after baseline
| Intervention | Participants (Count of Participants) |
|---|---|
| Loop Diuretic Downtitration | 1 |
Dose increase of oral maintenance therapy with loop diuretics compared to the final dose achieved in the study 7 days after baseline. (NCT02288819)
Timeframe: 30 days after baseline
| Intervention | Participants (Count of Participants) |
|---|---|
| Loop Diuretic Downtitration | 1 |
After baseline evaluation, loop diuretics are temporarily downtitrated or stopped for 7 consecutive days. The patient is instructed to measure his/her weight in the morning of these days, immediately after waking up, on the same balance. In case of weight increase >1,5 kg, the original dose of diuretics is restored. To check this, patients are contacted by phone after 3 and 7 days. If the patient has not gained >1,5 kg of weight after 7 days, loop diuretics are considered to be successfully downtitrated. (NCT02288819)
Timeframe: 7 days after baseline
| Intervention | Participants (Count of Participants) |
|---|---|
| Loop Diuretic Downtitration | 37 |
The patient is contacted by phone 30 days after baseline and asked for self-reported presence of lower leg edema. (NCT02288819)
Timeframe: 30 days after baseline
| Intervention | Participants (Count of Participants) |
|---|---|
| Loop Diuretic Downtitration | 1 |
The patient is contacted by phone 30 days after baseline and asked for self-reported orthopnea. (NCT02288819)
Timeframe: 30 days after baseline
| Intervention | Participants (Count of Participants) |
|---|---|
| Loop Diuretic Downtitration | 5 |
Weight change [kg] 30 days after baseline compared to weight 7 days after baseline (after achieving the final dose of loop diuretics). (NCT02288819)
Timeframe: 30 days after baseline
| Intervention | kg (Mean) |
|---|---|
| Loop Diuretic Downtitration | -0.261 |
Weight change [kg] 7 days after baseline compared to baseline weight. (NCT02288819)
Timeframe: 7 days after baseline
| Intervention | kg (Mean) |
|---|---|
| Loop Diuretic Downtitration | 0.502 |
The volume of urine produced in milliliters over the 6 hours after drug delivery will be measured. (NCT02579057)
Timeframe: 6-hour period
| Intervention | mL (Mean) |
|---|---|
| Furosemide IV | 1636 |
| Furosemide SC | 1515 |
Total urinary sodium produced during the 6 hour urine collection (NCT02579057)
Timeframe: 6-hour period
| Intervention | mEq/L (Mean) |
|---|---|
| Furosemide IV | 7.3 |
| Furosemide SC | 32.8 |
Cumulative total of pain, local skin reactions (including hematoma and induration) and electrolyte abnormalities. (NCT02579057)
Timeframe: Up to 6 hours
| Intervention | Participants (Count of Participants) | ||
|---|---|---|---|
| Hypokalemia | Skin irritation | Infusion site pain | |
| Furosemide IV | 0 | 0 | 0 |
| Furosemide SC | 1 | 0 | 0 |
Percent change in serum creatinine from randomization to 72 hrs from treatment protocol initiation by diuretic strategy (NCT01901809)
Timeframe: 72 hours
| Intervention | percent change in serum creatinine (Mean) |
|---|---|
| Bolus Furosemide | 4.6 |
| Continuous Infusion Furosemide | 16 |
Percent change in serum creatinine from randomization to 72 hrs from treatment protocol initiation by dopamine strategy (NCT01901809)
Timeframe: 72 hours
| Intervention | percent change in serum creatinine (Mean) |
|---|---|
| Dopamine | 8.0 |
| No Dopamine | 12.8 |
Percent change in serum creatinine from randomization to 72 hrs from treatment protocol initiation. (NCT01901809)
Timeframe: 72 hours
| Intervention | percent change in serum creatinine (Mean) |
|---|---|
| Bolus Furosemide and no Dopamine | 4 |
| Continuous Infusion Furosemide and no Dopamine | 11 |
| Bolus Furosemide Plus Dopamine | 5 |
| Continuous Furosemide Plus Dopamine | 20 |
(NCT01441245)
Timeframe: participants were followed for the duration of hospital stay, an average of 13 days
| Intervention | pg/mL (Mean) |
|---|---|
| BNP Change in cIV | -525 |
| BNP Change in iIV | -148 |
(NCT01441245)
Timeframe: in-hospital
| Intervention | percentage of partecipants (Number) |
|---|---|
| Dopamine Infusion in cIV | 50 |
| Dopamine Infusion in iIV | 26 |
(NCT01441245)
Timeframe: from admission to discharge, an average of 12 days
| Intervention | pg/ml (Mean) |
|---|---|
| BNP Levels at Discharge in cIV Group | 679 |
| BNP Levels at Discharge in iIV Group | 949 |
this study aimed to evaluate the effects of continuous infusion of furosemide in comparison to twice daily regimens at similar doses with respect to changes in renal function in terms of creatinine levels and GFR, urine output and BNP levels from admission to discharge (NCT01441245)
Timeframe: time period ranging from 72 h to 120 h.
| Intervention | mL (Mean) |
|---|---|
| Urine Output in cIV | 2505 |
| Urine Output in iIV | 2140 |
evaluation of renal function in terms of changes in creatinine levels during hospitalization in the two arms. (NCT01441245)
Timeframe: participants were followed for the duration of hospital stay, an average of 13 days
| Intervention | mg/dL (Mean) |
|---|---|
| Changes in Creatinine in cIV Group | -0.10 |
| Changes in Creatinine in iIV Group | -0.50 |
(NCT01441245)
Timeframe: from admission to discharge, an average of 12 days
| Intervention | (ml/min·1.73 m2) (Mean) |
|---|---|
| GFR Change in cIV | -3.18 |
| GFR Change in iIV | -1.93 |
(NCT01441245)
Timeframe: from admission to discharge, an average of 12 days
| Intervention | mg/dL (Mean) |
|---|---|
| Creatinine at Discharge in cIV | 1.78 |
| Creatinine at Discharge in iIV | 1.51 |
(NCT01441245)
Timeframe: from admission to discharge, an average of 12 days
| Intervention | (ml/min·1.73 m2) (Mean) |
|---|---|
| GFR at Discharge in cIV | 44.8 |
| GFR at Discharge in iIV | 46.7 |
percentage of participants with hospital stay > 10 days (NCT01441245)
Timeframe: in-hospital
| Intervention | percentage of partecipants (Number) |
|---|---|
| Lenght of Hospitalization in cIV | 80 |
| Lenght of Hospitalization in iIV | 44 |
Core laboratory when available. If not available, local laboratory results were used. (NCT00608491)
Timeframe: Baseline to Day 60
| Intervention | mL/min (Mean) |
|---|---|
| Stepped Pharmacologic Care | 8.86 |
| Ultrafiltration | 5.63 |
Core laboratory when available. If not available, local laboratory results were used. (NCT00608491)
Timeframe: Baseline to Day 60
| Intervention | mg/dL (Mean) |
|---|---|
| Stepped Pharmacologic Care | -0.28 |
| Ultrafiltration | -0.12 |
(NCT00608491)
Timeframe: Baseline to Day 4
| Intervention | pg/mL (Mean) |
|---|---|
| Stepped Pharmacologic Care | -109.13 |
| Ultrafiltration | -3.07 |
(NCT00608491)
Timeframe: Baseline to Day 60
| Intervention | pg/mL (Mean) |
|---|---|
| Stepped Pharmacologic Care | -6.91 |
| Ultrafiltration | 40.35 |
(NCT00608491)
Timeframe: Baseline to Day 7/Discharge
| Intervention | pg/mL (Mean) |
|---|---|
| Stepped Pharmacologic Care | -74.26 |
| Ultrafiltration | 68.13 |
(NCT00608491)
Timeframe: Baseline to Day 4
| Intervention | mEq/L (Mean) |
|---|---|
| Stepped Pharmacologic Care | 3.29 |
| Ultrafiltration | -1.01 |
(NCT00608491)
Timeframe: Baseline to Day 7/Discharge
| Intervention | mEq/L (Mean) |
|---|---|
| Stepped Pharmacologic Care | 3.07 |
| Ultrafiltration | -0.70 |
(NCT00608491)
Timeframe: Baseline to Day 4
| Intervention | ug/L (Mean) |
|---|---|
| Stepped Pharmacologic Care | 7.63 |
| Ultrafiltration | 9.07 |
(NCT00608491)
Timeframe: Baseline to Day 60
| Intervention | ug/L (Mean) |
|---|---|
| Stepped Pharmacologic Care | 2.24 |
| Ultrafiltration | 4.57 |
(NCT00608491)
Timeframe: Baseline to Day 7/Discharge
| Intervention | ug/L (Mean) |
|---|---|
| Stepped Pharmacologic Care | 10.21 |
| Ultrafiltration | 10.54 |
(NCT00608491)
Timeframe: Baseline to Day 4
| Intervention | mg/L (Mean) |
|---|---|
| Stepped Pharmacologic Care | 0.14 |
| Ultrafiltration | 0.22 |
(NCT00608491)
Timeframe: Baseline to Day 60
| Intervention | mg/L (Mean) |
|---|---|
| Stepped Pharmacologic Care | -0.18 |
| Ultrafiltration | -0.03 |
(NCT00608491)
Timeframe: Baseline to Day 7/Discharge
| Intervention | mg/L (Mean) |
|---|---|
| Stepped Pharmacologic Care | 0.12 |
| Ultrafiltration | 0.09 |
(NCT00608491)
Timeframe: Baseline to Day 4
| Intervention | pg/mL (Mean) |
|---|---|
| Stepped Pharmacologic Care | -0.76 |
| Ultrafiltration | -1.13 |
(NCT00608491)
Timeframe: Baseline to Day 60
| Intervention | pg/mL (Mean) |
|---|---|
| Stepped Pharmacologic Care | -0.82 |
| Ultrafiltration | -1.32 |
(NCT00608491)
Timeframe: Baseline to Day 7/Discharge
| Intervention | pg/mL (Mean) |
|---|---|
| Stepped Pharmacologic Care | -0.69 |
| Ultrafiltration | -1.24 |
(NCT00608491)
Timeframe: Baseline to Day 4
| Intervention | g/dL (Mean) |
|---|---|
| Stepped Pharmacologic Care | 0.38 |
| Ultrafiltration | -0.01 |
(NCT00608491)
Timeframe: Baseline to Day 7/Discharge
| Intervention | g/dL (Mean) |
|---|---|
| Stepped Pharmacologic Care | 0.35 |
| Ultrafiltration | -0.02 |
(NCT00608491)
Timeframe: Baseline to Day 4
| Intervention | mg/L (Mean) |
|---|---|
| Stepped Pharmacologic Care | -1.71 |
| Ultrafiltration | 1.89 |
(NCT00608491)
Timeframe: Baseline to Day 60
| Intervention | mg/L (Mean) |
|---|---|
| Stepped Pharmacologic Care | -13.62 |
| Ultrafiltration | 1.99 |
(NCT00608491)
Timeframe: Baseline to Day 7/Discharge
| Intervention | mg/L (Mean) |
|---|---|
| Stepped Pharmacologic Care | -6.39 |
| Ultrafiltration | 2.18 |
(NCT00608491)
Timeframe: Baseline to Day 4
| Intervention | pg/mL (Mean) |
|---|---|
| Stepped Pharmacologic Care | 47.38 |
| Ultrafiltration | -38.95 |
(NCT00608491)
Timeframe: Baseline to Day 60
| Intervention | pg/mL (Mean) |
|---|---|
| Stepped Pharmacologic Care | -17.48 |
| Ultrafiltration | -73.58 |
(NCT00608491)
Timeframe: Baseline to Day 7/Discharge
| Intervention | pg/mL (Mean) |
|---|---|
| Stepped Pharmacologic Care | 37.28 |
| Ultrafiltration | -37.16 |
(NCT00608491)
Timeframe: Baseline to Day 60
| Intervention | pg/mL (Mean) |
|---|---|
| Stepped Pharmacologic Care | -490.56 |
| Ultrafiltration | -937.69 |
(NCT00608491)
Timeframe: Baseline to Day 7/Discharge
| Intervention | pg/mL (Mean) |
|---|---|
| Stepped Pharmacologic Care | -1071.88 |
| Ultrafiltration | -740.82 |
(NCT00608491)
Timeframe: Baseline to Day 4
| Intervention | pg/mL (Mean) |
|---|---|
| Stepped Pharmacologic Care | -978.61 |
| Ultrafiltration | -814.45 |
(NCT00608491)
Timeframe: Baseline to Day 4
| Intervention | mEq/L (Mean) |
|---|---|
| Stepped Pharmacologic Care | -0.23 |
| Ultrafiltration | 0.26 |
(NCT00608491)
Timeframe: Baseline to Day 7/Discharge
| Intervention | mEq/L (Mean) |
|---|---|
| Stepped Pharmacologic Care | -0.14 |
| Ultrafiltration | 0.27 |
(NCT00608491)
Timeframe: Baseline to Day 4
| Intervention | ug/L (Mean) |
|---|---|
| Stepped Pharmacologic Care | 0.22 |
| Ultrafiltration | -0.64 |
(NCT00608491)
Timeframe: Baseline to Day 60
| Intervention | ug/L (Mean) |
|---|---|
| Stepped Pharmacologic Care | 0.75 |
| Ultrafiltration | 0.58 |
(NCT00608491)
Timeframe: Baseline to Day 7/Discharge
| Intervention | ug/L (Mean) |
|---|---|
| Stepped Pharmacologic Care | -0.07 |
| Ultrafiltration | -0.93 |
(NCT00608491)
Timeframe: Baseline to Day 4
| Intervention | mEq/L (Mean) |
|---|---|
| Stepped Pharmacologic Care | 0.00 |
| Ultrafiltration | -2.3 |
(NCT00608491)
Timeframe: Baseline to Day 7/Discharge
| Intervention | mEq/L (Mean) |
|---|---|
| Stepped Pharmacologic Care | -0.49 |
| Ultrafiltration | -2.02 |
(NCT00608491)
Timeframe: Baseline to Day 4
| Intervention | mg/dL (Mean) |
|---|---|
| Stepped Pharmacologic Care | 5.68 |
| Ultrafiltration | 12.54 |
(NCT00608491)
Timeframe: Baseline to Day 7/Discharge
| Intervention | mg/dL (Mean) |
|---|---|
| Stepped Pharmacologic Care | 7.23 |
| Ultrafiltration | 13.81 |
(NCT00608491)
Timeframe: Baseline to Day 60
| Intervention | mg/dL (Mean) |
|---|---|
| Stepped Pharmacologic Care | -0.31 |
| Ultrafiltration | -0.54 |
(NCT00608491)
Timeframe: Baseline to Day 7/Discharge
| Intervention | mg/dL (Mean) |
|---|---|
| Stepped Pharmacologic Care | 1.10 |
| Ultrafiltration | -0.15 |
"Scale range: -100 , +100~-100=worse, +100=better" (NCT00608491)
Timeframe: Baseline to Day 7/Discharge
| Intervention | units on a scale (Mean) |
|---|---|
| Stepped Pharmacologic Care | 22.8 |
| Ultrafiltration | 19.4 |
Furosemide-Equivalent Dose is the dose bumetanide or torsemide converted to furosemide equivalent (Torsemide dose x 2,Bumetanide dose x 40) (NCT00608491)
Timeframe: Baseline to Day 30
| Intervention | mg (Mean) |
|---|---|
| Stepped Pharmacologic Care | 9.8 |
| Ultrafiltration | 27.3 |
Furosemide-Equivalent Dose is the dose bumetanide or torsemide converted to furosemide equivalent (Torsemide dose x 2,Bumetanide dose x 40) (NCT00608491)
Timeframe: Baseline to Day 60
| Intervention | mg (Mean) |
|---|---|
| Stepped Pharmacologic Care | -12.4 |
| Ultrafiltration | 8.8 |
Furosemide-Equivalent Dose is the dose bumetanide or torsemide converted to furosemide equivalent (Torsemide dose x 2,Bumetanide dose x 40) (NCT00608491)
Timeframe: Baseline to Day 7/Discharge
| Intervention | mg (Mean) |
|---|---|
| Stepped Pharmacologic Care | 2.2 |
| Ultrafiltration | -20.6 |
"Scale range: -100 , +100~-100=worse, +100=better Participants asked to mark their global well being on a 10 cm vertical line, with the top labeled best you have ever felt and the bottom labeled worst you have ever felt." (NCT00608491)
Timeframe: Baseline to Day 7/Discharge
| Intervention | units on a scale (Mean) |
|---|---|
| Stepped Pharmacologic Care | 25.8 |
| Ultrafiltration | 16.9 |
"Scale range: -100 , +100~-100=worse, +100=better Participants asked to mark their global well being on a 10 cm vertical line, with the top labeled best you have ever felt and the bottom labeled worst you have ever felt." (NCT00608491)
Timeframe: Change from Baseline to Day 4
| Intervention | units on a scale (Mean) |
|---|---|
| Stepped Pharmacologic Care | 22.8 |
| Ultrafiltration | 13.7 |
(NCT00608491)
Timeframe: Change from Baseline to Day 4
| Intervention | mL/min (Mean) |
|---|---|
| Stepped Pharmacologic Care | 1.67 |
| Ultrafiltration | 0.93 |
(NCT00608491)
Timeframe: Change from Baseline to Day 7
| Intervention | mL/min (Mean) |
|---|---|
| Stepped Pharmacologic Care | 2.06 |
| Ultrafiltration | 1.82 |
(NCT00608491)
Timeframe: Baseline to Day 4
| Intervention | ng/mL/hr (Mean) |
|---|---|
| Stepped Pharmacologic Care | 5.78 |
| Ultrafiltration | 12.67 |
(NCT00608491)
Timeframe: Baseline to Day 60
| Intervention | ng/mL/hr (Mean) |
|---|---|
| Stepped Pharmacologic Care | -2.18 |
| Ultrafiltration | 0.54 |
(NCT00608491)
Timeframe: Baseline to Day 7/Discharge
| Intervention | ng/mL/hr (Mean) |
|---|---|
| Stepped Pharmacologic Care | 2.58 |
| Ultrafiltration | 11.40 |
(NCT00608491)
Timeframe: Change from Baseline to Day 4
| Intervention | mg/dL (Mean) |
|---|---|
| Stepped Pharmacologic Care | -0.04 |
| Ultrafiltration | 0.23 |
(NCT00608491)
Timeframe: Change from Baseline to Day 7
| Intervention | mg/dL (Mean) |
|---|---|
| Stepped Pharmacologic Care | -0.00 |
| Ultrafiltration | 0.11 |
(NCT00608491)
Timeframe: Baseline to Day 4
| Intervention | mg/dL (Mean) |
|---|---|
| Stepped Pharmacologic Care | 1.06 |
| Ultrafiltration | -0.23 |
(NCT00608491)
Timeframe: Change from Baseline to Day 3
| Intervention | lbs (Mean) |
|---|---|
| Stepped Pharmacologic Care | -10.8 |
| Ultrafiltration | -11.7 |
(NCT00608491)
Timeframe: Change from Baseline to Day 4
| Intervention | lbs (Mean) |
|---|---|
| Stepped Pharmacologic Care | -12.1 |
| Ultrafiltration | -12.6 |
(NCT00608491)
Timeframe: Change from Baseline to Day 6
| Intervention | lbs (Mean) |
|---|---|
| Stepped Pharmacologic Care | -16.5 |
| Ultrafiltration | -15.7 |
(NCT00608491)
Timeframe: Change from Baseline to Day 1
| Intervention | lbs (Mean) |
|---|---|
| Stepped Pharmacologic Care | -3.4 |
| Ultrafiltration | -4.4 |
(NCT00608491)
Timeframe: Change from Baseline to Day 2
| Intervention | lbs (Mean) |
|---|---|
| Stepped Pharmacologic Care | -7.4 |
| Ultrafiltration | -8.8 |
(NCT00608491)
Timeframe: Change from Baseline to Day 5
| Intervention | lbs (Mean) |
|---|---|
| Stepped Pharmacologic Care | -15.6 |
| Ultrafiltration | -14.3 |
(NCT00608491)
Timeframe: Baseline to Day 30
| Intervention | mg/dL (Mean) |
|---|---|
| Stepped Pharmacologic Care | -0.25 |
| Ultrafiltration | -0.12 |
(NCT00608491)
Timeframe: Randomization through Day 1
| Intervention | mL (Mean) |
|---|---|
| Stepped Pharmacologic Care | 1714.1 |
| Ultrafiltration | 2193.6 |
(NCT00608491)
Timeframe: Randomization through Day 2
| Intervention | mL (Mean) |
|---|---|
| Stepped Pharmacologic Care | 3814.2 |
| Ultrafiltration | 4705.8 |
(NCT00608491)
Timeframe: Randomization through Day 3
| Intervention | mL (Mean) |
|---|---|
| Stepped Pharmacologic Care | 5706.8 |
| Ultrafiltration | 6257.1 |
(NCT00608491)
Timeframe: Randomization through Day 4
| Intervention | mL (Mean) |
|---|---|
| Stepped Pharmacologic Care | 7081.5 |
| Ultrafiltration | 7443.0 |
(NCT00608491)
Timeframe: Randomization through Day 5
| Intervention | mL (Mean) |
|---|---|
| Stepped Pharmacologic Care | 8358.8 |
| Ultrafiltration | 8308.4 |
(NCT00608491)
Timeframe: Randomization through Day 6
| Intervention | mL (Mean) |
|---|---|
| Stepped Pharmacologic Care | 9700.7 |
| Ultrafiltration | 9822.1 |
(NCT00608491)
Timeframe: Randomization through Day 7
| Intervention | mL (Mean) |
|---|---|
| Stepped Pharmacologic Care | 11659.6 |
| Ultrafiltration | 10595.1 |
"Scale range: -100 , +100~-100=worse, +100=better" (NCT00608491)
Timeframe: Change from Baseline to Day 4
| Intervention | units on a scale (Mean) |
|---|---|
| Stepped Pharmacologic Care | 20.5 |
| Ultrafiltration | 16.5 |
(NCT00608491)
Timeframe: Baseline to Day 30
| Intervention | mL/min (Mean) |
|---|---|
| Stepped Pharmacologic Care | 7.95 |
| Ultrafiltration | 6.07 |
(NCT00608491)
Timeframe: Baseline to Day 30
| Intervention | lbs (Mean) |
|---|---|
| Stepped Pharmacologic Care | -15.9 |
| Ultrafiltration | -13.4 |
(NCT00608491)
Timeframe: Baseline to Day 60
| Intervention | lbs (Mean) |
|---|---|
| Stepped Pharmacologic Care | -17.2 |
| Ultrafiltration | -15.4 |
Change in NTproBNP (NCT00577135)
Timeframe: baseline and 72 hours
| Intervention | pg/mL (Mean) |
|---|---|
| Q 12 Hour Bolus | -1316.2 |
| Continuous Infusion | -1773.2 |
| Low Intensification | -1193.8 |
| High Intensification | -1881.6 |
(NCT00577135)
Timeframe: baseline and 72 hours
| Intervention | mg/L (Mean) |
|---|---|
| Q 12 Hour Bolus | 0.11 |
| Continuous Infusion | 0.17 |
| Low Intensification | 0.12 |
| High Intensification | 0.17 |
(NCT00577135)
Timeframe: baseline and day 60
| Intervention | mg/L (Mean) |
|---|---|
| Q 12 Hour Bolus | 0.20 |
| Continuous Infusion | 0.16 |
| Low Intensification | 0.18 |
| High Intensification | 0.18 |
(NCT00577135)
Timeframe: baseline and day 7
| Intervention | mg/L (Mean) |
|---|---|
| Q 12 Hour Bolus | 0.21 |
| Continuous Infusion | 0.16 |
| Low Intensification | 0.16 |
| High Intensification | 0.21 |
(NCT00577135)
Timeframe: baseline and Day 60
| Intervention | pg/mL (Mean) |
|---|---|
| Q 12 Hour Bolus | -1449.3 |
| Continuous Infusion | -1035.1 |
| Low Intensification | -1445.6 |
| High Intensification | -1038.5 |
(NCT00577135)
Timeframe: baseline and Day 7
| Intervention | pg/mL (Mean) |
|---|---|
| Q 12 Hour Bolus | -1133.3 |
| Continuous Infusion | -1552.0 |
| Low Intensification | -1037.2 |
| High Intensification | -1629.7 |
(NCT00577135)
Timeframe: baseline and 24 hours
| Intervention | mg/dL (Mean) |
|---|---|
| Q 12 Hour Bolus | 0.00 |
| Continuous Infusion | 0.01 |
| Low Intensification | -0.01 |
| High Intensification | 0.02 |
(NCT00577135)
Timeframe: baseline and 48 hours
| Intervention | mg/dL (Mean) |
|---|---|
| Q 12 Hour Bolus | 0.02 |
| Continuous Infusion | 0.05 |
| Low Intensification | 0.01 |
| High Intensification | 0.06 |
(NCT00577135)
Timeframe: baseline and 96 hours
| Intervention | mg/dL (Mean) |
|---|---|
| Q 12 Hour Bolus | 0.06 |
| Continuous Infusion | 0.05 |
| Low Intensification | 0.05 |
| High Intensification | 0.07 |
(NCT00577135)
Timeframe: baseline and day 60
| Intervention | mg/dL (Mean) |
|---|---|
| Q 12 Hour Bolus | 0.09 |
| Continuous Infusion | 0.07 |
| Low Intensification | 0.09 |
| High Intensification | 0.07 |
(NCT00577135)
Timeframe: baseline and day 7
| Intervention | mg/dL (Mean) |
|---|---|
| Q 12 Hour Bolus | 0.10 |
| Continuous Infusion | 0.04 |
| Low Intensification | 0.07 |
| High Intensification | 0.08 |
(NCT00577135)
Timeframe: Measured at baseline and 72 hours
| Intervention | mg/dL (Mean) |
|---|---|
| Q 12 Hour Bolus | 0.05 |
| Continuous Infusion | 0.07 |
| Low Intensification | 0.04 |
| High Intensification | 0.08 |
(NCT00577135)
Timeframe: baseline and 72 hours
| Intervention | mg/dL (Mean) |
|---|---|
| Q 12 Hour Bolus | 0.30 |
| Continuous Infusion | 0.44 |
| Low Intensification | 0.11 |
| High Intensification | 0.61 |
(NCT00577135)
Timeframe: baseline and Day 60
| Intervention | mg/dL (Mean) |
|---|---|
| Q 12 Hour Bolus | -0.09 |
| Continuous Infusion | -0.71 |
| Low Intensification | -0.13 |
| High Intensification | -0.67 |
(NCT00577135)
Timeframe: baseline and day 7
| Intervention | mg/dL (Mean) |
|---|---|
| Q 12 Hour Bolus | 0.40 |
| Continuous Infusion | 0.09 |
| Low Intensification | 0.07 |
| High Intensification | 0.42 |
(NCT00577135)
Timeframe: baseline and 96 hours
| Intervention | lbs (Mean) |
|---|---|
| Q 12 Hour Bolus | -8.0 |
| Continuous Infusion | -9.1 |
| Low Intensification | -7.4 |
| High Intensification | -9.6 |
Dyspnea Visual Analog Scale Scale Range 0-4800; higher score is better (NCT00577135)
Timeframe: 48 hours
| Intervention | units on a scale (Mean) |
|---|---|
| Q 12 Hour Bolus | 2876.6 |
| Continuous Infusion | 3033.1 |
| Low Intensification | 2924.9 |
| High Intensification | 2981.3 |
Dyspnea Visual Analog Scale Scale Range 0-7200; higher score is better (NCT00577135)
Timeframe: 72 hours
| Intervention | units on a scale (Mean) |
|---|---|
| Q 12 Hour Bolus | 4455.6 |
| Continuous Infusion | 4699.1 |
| Low Intensification | 4477.9 |
| High Intensification | 4668.3 |
Global Visual Analog Scale Scale Range 0-2400; higher score is better (NCT00577135)
Timeframe: Measured at 24 hours
| Intervention | units on a scale (Mean) |
|---|---|
| Q 12 Hour Bolus | 1370.8 |
| Continuous Infusion | 1453.8 |
| Low Intensification | 1426.0 |
| High Intensification | 1398.2 |
(NCT00577135)
Timeframe: Through 24 hours
| Intervention | mL (Mean) |
|---|---|
| Q 12 Hour Bolus | 1595.7 |
| Continuous Infusion | 1796.4 |
| Low Intensification | 1209.7 |
| High Intensification | 2149.6 |
(NCT00577135)
Timeframe: Through 48 hours
| Intervention | mL (Mean) |
|---|---|
| Q 12 Hour Bolus | 2996.7 |
| Continuous Infusion | 3120.6 |
| Low Intensification | 2334.8 |
| High Intensification | 3747.4 |
(NCT00577135)
Timeframe: Through 72 hours
| Intervention | mL (Mean) |
|---|---|
| Q 12 Hour Bolus | 4236.7 |
| Continuous Infusion | 4249.2 |
| Low Intensification | 3575.2 |
| High Intensification | 4898.9 |
Global Visual Analog Scale Scale Range 0-2400; higher score is better (NCT00577135)
Timeframe: Measured at 24 hours
| Intervention | units on a scale (Mean) |
|---|---|
| Q 12 Hour Bolus | 1280.8 |
| Continuous Infusion | 1303.0 |
| Low Intensification | 1288.6 |
| High Intensification | 1294.8 |
Global Visual Analog Scale Scale Range 0-4800; higher score is better (NCT00577135)
Timeframe: 48 hours
| Intervention | units on a scale (Mean) |
|---|---|
| Q 12 Hour Bolus | 2722.6 |
| Continuous Infusion | 2792.6 |
| Low Intensification | 2706.5 |
| High Intensification | 2805.2 |
Global Visual Analog Scale Scale Range 0-7200; higher score is better (NCT00577135)
Timeframe: Measured at 72 hours
| Intervention | units on a scale (Mean) |
|---|---|
| Q 12 Hour Bolus | 4236 |
| Continuous Infusion | 4372.7 |
| Low Intensification | 4170.8 |
| High Intensification | 4429.6 |
(NCT00577135)
Timeframe: Within 72 hours
| Intervention | percentage of participants (Number) |
|---|---|
| Q 12 Hour Bolus | 17.4 |
| Continuous Infusion | 19.2 |
| Low Intensification | 13.6 |
| High Intensification | 22.7 |
(NCT00577135)
Timeframe: Measured at 72 hours
| Intervention | percentage of participants (Number) |
|---|---|
| Q 12 Hour Bolus | 14.4 |
| Continuous Infusion | 15.3 |
| Low Intensification | 11.2 |
| High Intensification | 18.2 |
Treatment failure is defined as the patient met cardiorenal syndrome endpoint, worsening or persistent heart failure endpoint, patient died, or there was clinical evidence of overdiuresis requiring intervention within first 72 hours after randomization (NCT00577135)
Timeframe: Within 72 hours
| Intervention | percentage of participants (Number) |
|---|---|
| Q 12 Hour Bolus | 38.1 |
| Continuous Infusion | 38.8 |
| Low Intensification | 36.7 |
| High Intensification | 40.0 |
"BUN measured in mg/dL Cystatin C measured in mg/L~No units were used in calculated the ratio" (NCT01132846)
Timeframe: Randomization to 72 hours
| Intervention | ratio (Mean) |
|---|---|
| Low Dose Dopamine | -2.34 |
| Placebo | 0.23 |
| Low Dose Nesiritide | 0.74 |
Change in clinical stability as assessed by 60 day death, re-hospitalization or unscheduled outpatient visit (NCT01132846)
Timeframe: Baseline to 60 days
| Intervention | participants (Number) |
|---|---|
| Low Dose Dopamine | 30 |
| Placebo | 34 |
| Low Dose Nesiritide | 27 |
The primary Safety endpoint is change in serum cystatin C from randomization to 72 hours. (NCT01132846)
Timeframe: Randomization to 72 hours
| Intervention | mg/L (Mean) |
|---|---|
| Low Dose Dopamine | .12 |
| Placebo | .11 |
| Low Dose Nesiritide | .07 |
"To determine whether the pDSS is a more sensitive index of variability in dyspnea status than the dyspnea VAS assessed without standardization of conditions at assessment as assessed by change in Dyspnea VAS.~Dyspnea VAS range -100 to + 100 Larger number is better" (NCT01132846)
Timeframe: Baseline to 72 hours
| Intervention | units on a scale (Mean) |
|---|---|
| Low Dose Dopamine | 16.1 |
| Placebo | 16.2 |
| Low Dose Nesiritide | 16.8 |
Persistent or worsening heart failure defined as need for rescue therapy. (NCT01132846)
Timeframe: randomization to 72 hours
| Intervention | participants (Number) |
|---|---|
| Low Dose Dopamine | 11 |
| Placebo | 5 |
| Low Dose Nesiritide | 6 |
(NCT01132846)
Timeframe: randomization to 72 hours
| Intervention | mg/dL (Mean) |
|---|---|
| Low Dose Dopamine | 0.00 |
| Placebo | 0.02 |
| Low Dose Nesiritide | 0.02 |
"Treatment failure including any of the following:~development of cardio-renal syndrome~worsening/persistent heart failure~significant hypotension requiring discontinuation of study drug~significant tachycardia requiring discontinuation of study drug death" (NCT01132846)
Timeframe: randomization to 72 hours
| Intervention | participants (Number) |
|---|---|
| Low Dose Dopamine | 35 |
| Placebo | 32 |
| Low Dose Nesiritide | 48 |
Change in weight from randomization to 72 hours. Secondary Endpoint (NCT01132846)
Timeframe: randomization to 72 hours
| Intervention | lbs (Mean) |
|---|---|
| Low Dose Dopamine | -7.40 |
| Placebo | -7.73 |
| Low Dose Nesiritide | -7.15 |
(NCT01132846)
Timeframe: Randomization to 72 hours
| Intervention | mmol (Mean) |
|---|---|
| Low Dose Dopamine | 527.0 |
| Placebo | 539.8 |
| Low Dose Nesiritide | 515.2 |
The primary efficacy endpoint is cumulative urinary volume (UV; +/- indwelling urinary catheter) at 72 hours (NCT01132846)
Timeframe: Randomization to 72 hours
| Intervention | mL (Mean) |
|---|---|
| Low Dose Dopamine | 8524 |
| Placebo | 8296 |
| Low Dose Nesiritide | 8574 |
"To determine whether changes in pDSS or dyspnea VAS are related to the response to decongestive therapy as evidenced by fluid volume loss~Fluid volume loss is defined as cumulative urinary output minus fluid intake during the first 72 hours post randomization." (NCT01132846)
Timeframe: Baseline to 72 hours
| Intervention | mL (Mean) |
|---|---|
| Low Dose Dopamine | 4526.0 |
| Placebo | 4659.9 |
| Low Dose Nesiritide | 5177.2 |
(NCT01132846)
Timeframe: Randomization to 72 hours
| Intervention | participants (Number) |
|---|---|
| Low Dose Dopamine | 23 |
| Placebo | 24 |
| Low Dose Nesiritide | 28 |
Range 0 to 7200 Higher is better (NCT01132846)
Timeframe: randomization to 72 hours
| Intervention | units on a scale * hours (Mean) |
|---|---|
| Low Dose Dopamine | 4935.8 |
| Placebo | 4997.6 |
| Low Dose Nesiritide | 4831.4 |
Range 0 to 7200 Higher is better/improved (NCT01132846)
Timeframe: Randomization to 72 hours
| Intervention | units on a scale * hours (Mean) |
|---|---|
| Low Dose Dopamine | 4553.4 |
| Placebo | 4703.6 |
| Low Dose Nesiritide | 4498.3 |
"To determine whether changes in worst reported symptom (WRS) (dyspnea, body swelling or fatigue) VAS (WRS-VAS) are related to the response to decongestive therapy as assessed by change in WRS VAS.~WRS range -100 to + 100 Higher number is better (improved)" (NCT01132846)
Timeframe: Change from Baseline to 72 hours
| Intervention | units on a scale (Mean) |
|---|---|
| Low Dose Dopamine | 20.9 |
| Placebo | 19.6 |
| Low Dose Nesiritide | 25.6 |
The primary endpoint for the study will be change in body weight between patients randomized to tolvaptan versus placebo from baseline to 48 hours (NCT02476409)
Timeframe: Baseline, Day 3 (48 hours)
| Intervention | pounds (Mean) |
|---|---|
| Tolvaptan | -3.3 |
| Placebo | -0.8 |
The primary endpoint for the study will be change in body weight between patients randomized to tolvaptan versus placebo from baseline to 48 hours with stratification for baseline copeptin level (NCT02476409)
Timeframe: Baseline, Day 3 (48 hours)
| Intervention | pounds (Mean) |
|---|---|
| High Copeptin - Tolvaptan | -2.9 |
| High Copeptin - Placebo | 0.3 |
| Low Copeptin - Tolvaptan | -3.8 |
| Low Copeptin - Placebo | -2.4 |
Change in body weight at 8 days will be analyzed in a similar fashion to the change in body weight at 48 hours (NCT02476409)
Timeframe: Baseline, 8 days
| Intervention | pounds (Mean) |
|---|---|
| Tolvaptan | -1.8 |
| Placebo | -2.8 |
Change in loop diuretic dose at 48 hours where doses of loop diuretic are expressed as furosemide milligram equivalents based on standard conversions of bumetanide and torsemide doses to milligram equivalents of furosemide. The formula for the conversion of doses of loop diuretics were standardized to milligram equivalents of furosemide based on 40 milligrams of furosemide for each 1 milligram of bumetanide and 2 milligrams of furosemide for each 1 milligram of torsemide. (NCT02476409)
Timeframe: Day 3 (48 hours)
| Intervention | furosemide milligram equivalents (Mean) |
|---|---|
| Tolvaptan | -57 |
| Placebo | -11 |
Change in loop diuretic score defined by change in loop diuretic use at Visit 2. The change in loop diuretic score endpoint was calculated as follows: patients having an increase in loop diuretic use at Visit 2 were given a score of 2, patients with no change a score of 0, and patients with a decrease in loop use at Visit 2 were given a score of -1. Increases in loop diuretic use were given a higher weighting to account for their reflection of treatment failure. (NCT02476409)
Timeframe: Day 3 (48 hours)
| Intervention | units on a scale (Mean) |
|---|---|
| Tolvaptan | -0.47 |
| Placebo | 0 |
"Changes in patient reported dyspnea scale from baseline to 48 hours based on the visual analog scale.~Visual Analog Scale (VAS) - Patient Dyspnea has a minimum value of 0 and a maximum value of 100. Higher scores mean a better outcome." (NCT02476409)
Timeframe: Baseline, Day 3 (48 hours)
| Intervention | score on a scale (Mean) |
|---|---|
| Tolvaptan | 21 |
| Placebo | 15 |
Number of participants with a decrease in loop diuretic diuretic dosing at 48 hours in the Tolvaptan group and the Placebo group. (NCT02476409)
Timeframe: Day 3 (48 hours)
| Intervention | Participants (Count of Participants) |
|---|---|
| Tolvaptan | 9 |
| Placebo | 4 |
(NCT02469597)
Timeframe: Participants will be followed for the duration of hospital stay up to 1 week
| Intervention | Days (Least Squares Mean) |
|---|---|
| Single Dose of Furosemide | 3.1 |
| Placebo | 3.0 |
(NCT02469597)
Timeframe: 2 hours after medication adminstration
| Intervention | Percentage change in oxygen saturation (Least Squares Mean) |
|---|---|
| Single Dose of Furosemide | -0.14 |
| Placebo | 0.2 |
(NCT02469597)
Timeframe: 4 hours after medication adminstration
| Intervention | Percentage change in oxygen saturation (Least Squares Mean) |
|---|---|
| Single Dose of Furosemide | -0.19 |
| Placebo | 0.29 |
(NCT02469597)
Timeframe: Within 72 hours of medication administration
| Intervention | participants (Number) |
|---|---|
| Single Dose of Furosemide | 0 |
| Placebo | 0 |
(NCT02469597)
Timeframe: 2 hours after medication adminstration
| Intervention | Percentage change in respiratory rate (Least Squares Mean) |
|---|---|
| Single Dose of Furosemide | -3.7 |
| Placebo | -1.7 |
(NCT02469597)
Timeframe: 4 hours after medication adminstration
| Intervention | Percentage change in respiratory rate (Least Squares Mean) |
|---|---|
| Single Dose of Furosemide | -2.8 |
| Placebo | -5.4 |
The ratio between test drug and reference drug (NCT04982874)
Timeframe: before dosing (0 h) and at 0.25, 0.5, 1, 1.5, 2, 2.5, 3, 4, 5, 6, 8, 10, 12, 16 and 24 hours after drug administration
| Intervention | percentage (Geometric Mean) |
|---|---|
| Furosemide 40 mg Tablet | 101.79 |
The ratio between test drug and reference drug (NCT04982874)
Timeframe: before dosing (0 h) and at 0.25, 0.5, 1, 1.5, 2, 2.5, 3, 4, 5, 6, 8, 10, 12, 16 and 24 hours after drug administration
| Intervention | percentage (Geometric Mean) |
|---|---|
| Furosemide 40 mg Tablet | 104.51 |
Area Under Curve from 0 to 24 hours (NCT04982874)
Timeframe: before dosing (0 h) and at 0.25, 0.5, 1, 1.5, 2, 2.5, 3, 4, 5, 6, 8, 10, 12, 16 and 24 hours after drug administration
| Intervention | ng*h/mL (Mean) |
|---|---|
| Furosemide 40 mg Tablet | 4938.79 |
| Lasix® 40 mg Tablet | 4921.94 |
Maximum plasma concentration (NCT04982874)
Timeframe: before dosing (0 h) and at 0.25, 0.5, 1, 1.5, 2, 2.5, 3, 4, 5, 6, 8, 10, 12, 16 and 24 hours after drug administration
| Intervention | ng/mL (Mean) |
|---|---|
| Furosemide 40 mg Tablet | 1893.09 |
| Lasix® 40 mg Tablet | 1907.32 |
Total measured urine output in milliliters produced after metolazone dose is given (NCT03746002)
Timeframe: 24 hours
| Intervention | mL (Mean) |
|---|---|
| Metolazone Concurrent Dosing | 2030 |
| Metolazone Pre-dosing | 5650 |
Portion of patients with increase in serum creatinine by ≥ 0.3 mg/dL or ≥ 50% from baseline (NCT03746002)
Timeframe: Baseline and at 12 to 23 hours after metolazone dose
| Intervention | Participants (Count of Participants) |
|---|---|
| Metolazone Concurrent Dosing | 1 |
| Metolazone Pre-dosing | 1 |
Change in serum creatinine from baseline value collected prior to metolazone dose to value collected after metolazone dose (NCT03746002)
Timeframe: Baseline and at 12 to 23 hours after metolazone dose
| Intervention | mg/dL (Mean) |
|---|---|
| Metolazone Concurrent Dosing | 0.45 |
| Metolazone Pre-dosing | 0.38 |
Change in total body weight from baseline value measured prior to metolazone dose to value collected after metolazone dose (NCT03746002)
Timeframe: Baseline and at 12 to 23 hours after metolazone dose
| Intervention | kg (Mean) |
|---|---|
| Metolazone Concurrent Dosing | -.6 |
| Metolazone Pre-dosing | -8.5 |
Proportion of patients with potassium level less than 4.0 mEq/L measured after metolazone dose is given (NCT03746002)
Timeframe: Baseline and at 12 to 23 hours after metolazone dose
| Intervention | Participants (Count of Participants) |
|---|---|
| Metolazone Concurrent Dosing | 0 |
| Metolazone Pre-dosing | 1 |
Proportion of patients with magnesium level less than 2.0 mg/dL measured after metolazone dose is given (NCT03746002)
Timeframe: Baseline and at 12 to 23 hours after metolazone dose
| Intervention | Participants (Count of Participants) |
|---|---|
| Metolazone Concurrent Dosing | 0 |
| Metolazone Pre-dosing | 1 |
Proportion of patients with serum sodium level less than 135 mg/dL measured after metolazone dose is given (NCT03746002)
Timeframe: Baseline and at 12 to 23 hours after metolazone dose
| Intervention | Participants (Count of Participants) |
|---|---|
| Metolazone Concurrent Dosing | 0 |
| Metolazone Pre-dosing | 0 |
99 reviews available for furosemide and Heart Failure
| Article | Year |
|---|---|
An evaluation of torsemide in patients with heart failure and renal disease.
Topics: Diuretics; Furosemide; Heart Failure; Humans; Multicenter Studies as Topic; Sodium Potassium Chlorid | 2022 |
An evaluation of torsemide in patients with heart failure and renal disease.
Topics: Diuretics; Furosemide; Heart Failure; Humans; Multicenter Studies as Topic; Sodium Potassium Chlorid | 2022 |
Comparison of Different Furosemide Regimens in the Treatment of Acute Heart Failure: A Meta-Analysis.
Topics: Furosemide; Heart Failure; Humans; Infusions, Intravenous; Length of Stay; Weight Loss | 2022 |
Comparison of Different Furosemide Regimens in the Treatment of Acute Heart Failure: A Meta-Analysis.
Topics: Furosemide; Heart Failure; Humans; Infusions, Intravenous; Length of Stay; Weight Loss | 2022 |
Effect of Hypertonic Saline Solution Combined with Furosemide on Acute Heart Failure: A Meta-Analysis.
Topics: Creatinine; Diuretics; Furosemide; Heart Failure; Humans; Saline Solution, Hypertonic; Weight Loss | 2022 |
Effect of Hypertonic Saline Solution Combined with Furosemide on Acute Heart Failure: A Meta-Analysis.
Topics: Creatinine; Diuretics; Furosemide; Heart Failure; Humans; Saline Solution, Hypertonic; Weight Loss | 2022 |
Toward quantification of loop diuretic responsiveness for congestive heart failure.
Topics: Animals; Diuretics; Dog Diseases; Dogs; Furosemide; Heart Failure; Humans; Sodium; Sodium Potassium | 2023 |
Toward quantification of loop diuretic responsiveness for congestive heart failure.
Topics: Animals; Diuretics; Dog Diseases; Dogs; Furosemide; Heart Failure; Humans; Sodium; Sodium Potassium | 2023 |
Toward quantification of loop diuretic responsiveness for congestive heart failure.
Topics: Animals; Diuretics; Dog Diseases; Dogs; Furosemide; Heart Failure; Humans; Sodium; Sodium Potassium | 2023 |
Toward quantification of loop diuretic responsiveness for congestive heart failure.
Topics: Animals; Diuretics; Dog Diseases; Dogs; Furosemide; Heart Failure; Humans; Sodium; Sodium Potassium | 2023 |
Toward quantification of loop diuretic responsiveness for congestive heart failure.
Topics: Animals; Diuretics; Dog Diseases; Dogs; Furosemide; Heart Failure; Humans; Sodium; Sodium Potassium | 2023 |
Toward quantification of loop diuretic responsiveness for congestive heart failure.
Topics: Animals; Diuretics; Dog Diseases; Dogs; Furosemide; Heart Failure; Humans; Sodium; Sodium Potassium | 2023 |
Toward quantification of loop diuretic responsiveness for congestive heart failure.
Topics: Animals; Diuretics; Dog Diseases; Dogs; Furosemide; Heart Failure; Humans; Sodium; Sodium Potassium | 2023 |
Toward quantification of loop diuretic responsiveness for congestive heart failure.
Topics: Animals; Diuretics; Dog Diseases; Dogs; Furosemide; Heart Failure; Humans; Sodium; Sodium Potassium | 2023 |
Toward quantification of loop diuretic responsiveness for congestive heart failure.
Topics: Animals; Diuretics; Dog Diseases; Dogs; Furosemide; Heart Failure; Humans; Sodium; Sodium Potassium | 2023 |
Toward quantification of loop diuretic responsiveness for congestive heart failure.
Topics: Animals; Diuretics; Dog Diseases; Dogs; Furosemide; Heart Failure; Humans; Sodium; Sodium Potassium | 2023 |
Toward quantification of loop diuretic responsiveness for congestive heart failure.
Topics: Animals; Diuretics; Dog Diseases; Dogs; Furosemide; Heart Failure; Humans; Sodium; Sodium Potassium | 2023 |
Toward quantification of loop diuretic responsiveness for congestive heart failure.
Topics: Animals; Diuretics; Dog Diseases; Dogs; Furosemide; Heart Failure; Humans; Sodium; Sodium Potassium | 2023 |
Toward quantification of loop diuretic responsiveness for congestive heart failure.
Topics: Animals; Diuretics; Dog Diseases; Dogs; Furosemide; Heart Failure; Humans; Sodium; Sodium Potassium | 2023 |
Toward quantification of loop diuretic responsiveness for congestive heart failure.
Topics: Animals; Diuretics; Dog Diseases; Dogs; Furosemide; Heart Failure; Humans; Sodium; Sodium Potassium | 2023 |
Toward quantification of loop diuretic responsiveness for congestive heart failure.
Topics: Animals; Diuretics; Dog Diseases; Dogs; Furosemide; Heart Failure; Humans; Sodium; Sodium Potassium | 2023 |
Toward quantification of loop diuretic responsiveness for congestive heart failure.
Topics: Animals; Diuretics; Dog Diseases; Dogs; Furosemide; Heart Failure; Humans; Sodium; Sodium Potassium | 2023 |
Toward quantification of loop diuretic responsiveness for congestive heart failure.
Topics: Animals; Diuretics; Dog Diseases; Dogs; Furosemide; Heart Failure; Humans; Sodium; Sodium Potassium | 2023 |
Toward quantification of loop diuretic responsiveness for congestive heart failure.
Topics: Animals; Diuretics; Dog Diseases; Dogs; Furosemide; Heart Failure; Humans; Sodium; Sodium Potassium | 2023 |
Effect of eplerenone on clinical stability of Japanese patients with acute heart failure.
Topics: Aged; Aged, 80 and over; Diuretics; East Asian People; Eplerenone; Female; Furosemide; Heart Failure | 2023 |
Effect of eplerenone on clinical stability of Japanese patients with acute heart failure.
Topics: Aged; Aged, 80 and over; Diuretics; East Asian People; Eplerenone; Female; Furosemide; Heart Failure | 2023 |
Co-Administration of Albumin and Furosemide in Acute Heart Failure with Diuretics Resistance.
Topics: Albumins; Diuretics; Furosemide; Heart Failure; Humans; Sodium Potassium Chloride Symporter Inhibito | 2023 |
Co-Administration of Albumin and Furosemide in Acute Heart Failure with Diuretics Resistance.
Topics: Albumins; Diuretics; Furosemide; Heart Failure; Humans; Sodium Potassium Chloride Symporter Inhibito | 2023 |
The blunted loop diuretic response in acute heart failure is driven by reduced tubular responsiveness rather than insufficient tubular delivery. The role of furosemide urine excretion on diuretic and natriuretic response in acute heart failure.
Topics: Diuretics; Furosemide; Heart Failure; Humans; Observational Studies as Topic; Prospective Studies; S | 2023 |
The blunted loop diuretic response in acute heart failure is driven by reduced tubular responsiveness rather than insufficient tubular delivery. The role of furosemide urine excretion on diuretic and natriuretic response in acute heart failure.
Topics: Diuretics; Furosemide; Heart Failure; Humans; Observational Studies as Topic; Prospective Studies; S | 2023 |
Torasemide versus furosemide in treatment of heart failure: A systematic review and meta-analysis of randomized controlled trials.
Topics: Furosemide; Heart Failure; Humans; Randomized Controlled Trials as Topic; Torsemide; Treatment Outco | 2020 |
Torasemide versus furosemide in treatment of heart failure: A systematic review and meta-analysis of randomized controlled trials.
Topics: Furosemide; Heart Failure; Humans; Randomized Controlled Trials as Topic; Torsemide; Treatment Outco | 2020 |
Continuous Infusion Versus Intermittent Boluses of Furosemide in Acute Heart Failure: A Systematic Review and Meta-Analysis.
Topics: Creatinine; Diuretics; Furosemide; Heart Failure; Humans; Infusions, Intravenous; Injections, Intrav | 2020 |
Continuous Infusion Versus Intermittent Boluses of Furosemide in Acute Heart Failure: A Systematic Review and Meta-Analysis.
Topics: Creatinine; Diuretics; Furosemide; Heart Failure; Humans; Infusions, Intravenous; Injections, Intrav | 2020 |
[The Role of Pharmacists in Home Medical Care of Patients with Heart Failure].
Topics: Catecholamines; Chronic Disease; Dobutamine; Furosemide; Heart Failure; Home Care Services; Humans; | 2020 |
[The Role of Pharmacists in Home Medical Care of Patients with Heart Failure].
Topics: Catecholamines; Chronic Disease; Dobutamine; Furosemide; Heart Failure; Home Care Services; Humans; | 2020 |
Comparative effects of furosemide and other diuretics in the treatment of heart failure: a systematic review and combined meta-analysis of randomized controlled trials.
Topics: Diuretics; Furosemide; Heart Failure; Humans; Randomized Controlled Trials as Topic; Torsemide | 2021 |
Comparative effects of furosemide and other diuretics in the treatment of heart failure: a systematic review and combined meta-analysis of randomized controlled trials.
Topics: Diuretics; Furosemide; Heart Failure; Humans; Randomized Controlled Trials as Topic; Torsemide | 2021 |
Efficiency of Hypertonic Saline in the Management of Decompensated Heart Failure: A Systematic Review and Meta-Analysis of Clinical Studies.
Topics: Body Weight; Diuresis; Diuretics; Drug Therapy, Combination; Furosemide; Heart Failure; Humans; Kidn | 2021 |
Efficiency of Hypertonic Saline in the Management of Decompensated Heart Failure: A Systematic Review and Meta-Analysis of Clinical Studies.
Topics: Body Weight; Diuresis; Diuretics; Drug Therapy, Combination; Furosemide; Heart Failure; Humans; Kidn | 2021 |
Pragmatic Design of Randomized Clinical Trials for Heart Failure: Rationale and Design of the TRANSFORM-HF Trial.
Topics: Diuretics; Furosemide; Heart Failure; Humans; Prospective Studies; Randomized Controlled Trials as T | 2021 |
Pragmatic Design of Randomized Clinical Trials for Heart Failure: Rationale and Design of the TRANSFORM-HF Trial.
Topics: Diuretics; Furosemide; Heart Failure; Humans; Prospective Studies; Randomized Controlled Trials as T | 2021 |
Simultaneous Use of Hypertonic Saline and IV Furosemide for Fluid Overload: A Systematic Review and Meta-Analysis.
Topics: Diuretics; Dose-Response Relationship, Drug; Drug Administration Schedule; Furosemide; Heart Failure | 2021 |
Simultaneous Use of Hypertonic Saline and IV Furosemide for Fluid Overload: A Systematic Review and Meta-Analysis.
Topics: Diuretics; Dose-Response Relationship, Drug; Drug Administration Schedule; Furosemide; Heart Failure | 2021 |
Use of tolvaptan vs. furosemide in older patients with heart failure : Meta-analysis of randomized controlled trials.
Topics: Aged; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Diuretics; Furosemide; Heart Failure; | 2018 |
Use of tolvaptan vs. furosemide in older patients with heart failure : Meta-analysis of randomized controlled trials.
Topics: Aged; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Diuretics; Furosemide; Heart Failure; | 2018 |
Continuous infusion vs. intermittent bolus injection of furosemide in acute decompensated heart failure: systematic review and meta-analysis of randomised controlled trials.
Topics: Acute Disease; Diuretics; Furosemide; Heart Failure; Humans; Infusions, Intravenous; Injections, Int | 2018 |
Continuous infusion vs. intermittent bolus injection of furosemide in acute decompensated heart failure: systematic review and meta-analysis of randomised controlled trials.
Topics: Acute Disease; Diuretics; Furosemide; Heart Failure; Humans; Infusions, Intravenous; Injections, Int | 2018 |
Continuous versus intermittent administration of furosemide in acute decompensated heart failure: a systematic review and meta-analysis.
Topics: Acute Disease; Aged; Aged, 80 and over; Female; Furosemide; Heart Failure; Humans; Male; Middle Aged | 2019 |
Continuous versus intermittent administration of furosemide in acute decompensated heart failure: a systematic review and meta-analysis.
Topics: Acute Disease; Aged; Aged, 80 and over; Female; Furosemide; Heart Failure; Humans; Male; Middle Aged | 2019 |
Torsemide versus furosemide in heart failure patients: A meta-analysis of randomized controlled trials.
Topics: Furosemide; Heart Failure; Humans; Patient Readmission; Randomized Controlled Trials as Topic; Time | 2018 |
Torsemide versus furosemide in heart failure patients: A meta-analysis of randomized controlled trials.
Topics: Furosemide; Heart Failure; Humans; Patient Readmission; Randomized Controlled Trials as Topic; Time | 2018 |
Subcutaneous furosemide for the treatment of heart failure: a state-of-the art review.
Topics: Acute Disease; Animals; Diuretics; Dogs; Furosemide; Heart Failure; Hospice Care; Humans; Infusions, | 2019 |
Subcutaneous furosemide for the treatment of heart failure: a state-of-the art review.
Topics: Acute Disease; Animals; Diuretics; Dogs; Furosemide; Heart Failure; Hospice Care; Humans; Infusions, | 2019 |
Torsemide versus furosemide and intermediate-term outcomes in patients with heart failure: an updated meta-analysis.
Topics: Furosemide; Heart Failure; Humans; Observational Studies as Topic; Patient Readmission; Randomized C | 2019 |
Torsemide versus furosemide and intermediate-term outcomes in patients with heart failure: an updated meta-analysis.
Topics: Furosemide; Heart Failure; Humans; Observational Studies as Topic; Patient Readmission; Randomized C | 2019 |
Population-based meta-analysis of furosemide pharmacokinetics.
Topics: Adult; Diuretics; Female; Furosemide; Heart Failure; Humans; Liver Cirrhosis; Male; Middle Aged; Mod | 2014 |
Population-based meta-analysis of furosemide pharmacokinetics.
Topics: Adult; Diuretics; Female; Furosemide; Heart Failure; Humans; Liver Cirrhosis; Male; Middle Aged; Mod | 2014 |
Loop diuretic strategies in patients with acute decompensated heart failure: a meta-analysis of randomized controlled trials.
Topics: Acute Disease; Critical Care; Furosemide; Heart Failure; Hospital Mortality; Humans; Infusions, Intr | 2014 |
Loop diuretic strategies in patients with acute decompensated heart failure: a meta-analysis of randomized controlled trials.
Topics: Acute Disease; Critical Care; Furosemide; Heart Failure; Hospital Mortality; Humans; Infusions, Intr | 2014 |
The challenge of providing palliative care to a rural population with cardiovascular disease.
Topics: Caregivers; Communication; Cooperative Behavior; Furosemide; Health Services Accessibility; Heart Fa | 2014 |
The challenge of providing palliative care to a rural population with cardiovascular disease.
Topics: Caregivers; Communication; Cooperative Behavior; Furosemide; Health Services Accessibility; Heart Fa | 2014 |
Hypertonic saline with furosemide for the treatment of acute congestive heart failure: a systematic review and meta-analysis.
Topics: Acute Disease; Diuretics; Furosemide; Heart Failure; Humans; Randomized Controlled Trials as Topic; | 2014 |
Hypertonic saline with furosemide for the treatment of acute congestive heart failure: a systematic review and meta-analysis.
Topics: Acute Disease; Diuretics; Furosemide; Heart Failure; Humans; Randomized Controlled Trials as Topic; | 2014 |
Hypertonic saline plus i.v. furosemide improve renal safety profile and clinical outcomes in acute decompensated heart failure: A meta-analysis of the literature.
Topics: Comorbidity; Diuretics; Drug Therapy, Combination; Female; Furosemide; Heart Failure; Hospital Morta | 2015 |
Hypertonic saline plus i.v. furosemide improve renal safety profile and clinical outcomes in acute decompensated heart failure: A meta-analysis of the literature.
Topics: Comorbidity; Diuretics; Drug Therapy, Combination; Female; Furosemide; Heart Failure; Hospital Morta | 2015 |
[Diuretic therapy in acute heart failure].
Topics: Acute Disease; Adsorption; Diuretics; Drug Synergism; Drug Therapy, Combination; Furosemide; Heart F | 2014 |
[Diuretic therapy in acute heart failure].
Topics: Acute Disease; Adsorption; Diuretics; Drug Synergism; Drug Therapy, Combination; Furosemide; Heart F | 2014 |
[Alternatives to conventional diuretic therapy in heart failure].
Topics: Acute Disease; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Cardio-Renal Syndrome; Clini | 2014 |
[Alternatives to conventional diuretic therapy in heart failure].
Topics: Acute Disease; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Cardio-Renal Syndrome; Clini | 2014 |
Editor's Choice-Recent therapeutic trials on fluid removal and vasodilation in acute heart failure.
Topics: Diuretics; Furosemide; Heart Failure; Humans; Randomized Controlled Trials as Topic; Recombinant Pro | 2016 |
Editor's Choice-Recent therapeutic trials on fluid removal and vasodilation in acute heart failure.
Topics: Diuretics; Furosemide; Heart Failure; Humans; Randomized Controlled Trials as Topic; Recombinant Pro | 2016 |
A reappraisal of loop diuretic choice in heart failure patients.
Topics: Choice Behavior; Fibrosis; Furosemide; Heart; Heart Failure; Humans; Myocardium; Practice Patterns, | 2015 |
A reappraisal of loop diuretic choice in heart failure patients.
Topics: Choice Behavior; Fibrosis; Furosemide; Heart; Heart Failure; Humans; Myocardium; Practice Patterns, | 2015 |
Effect of ultrafiltration versus intravenous furosemide for decompensated heart failure in cardiorenal syndrome: a systematic review with meta-analysis of randomized controlled trials.
Topics: Cardio-Renal Syndrome; Diuretics; Furosemide; Heart Failure; Humans; Randomized Controlled Trials as | 2015 |
Effect of ultrafiltration versus intravenous furosemide for decompensated heart failure in cardiorenal syndrome: a systematic review with meta-analysis of randomized controlled trials.
Topics: Cardio-Renal Syndrome; Diuretics; Furosemide; Heart Failure; Humans; Randomized Controlled Trials as | 2015 |
Intravenous Furosemide for Acute Decompensated Congestive Heart Failure: What Is the Evidence?
Topics: Administration, Intravenous; Administration, Oral; Diuretics; Evidence-Based Medicine; Furosemide; H | 2015 |
Intravenous Furosemide for Acute Decompensated Congestive Heart Failure: What Is the Evidence?
Topics: Administration, Intravenous; Administration, Oral; Diuretics; Evidence-Based Medicine; Furosemide; H | 2015 |
What are the effects of hypertonic saline plus furosemide in acute heart failure?
Topics: Acute Disease; Diuretics; Furosemide; Heart Failure; Humans; Length of Stay; Patient Readmission; Ra | 2015 |
What are the effects of hypertonic saline plus furosemide in acute heart failure?
Topics: Acute Disease; Diuretics; Furosemide; Heart Failure; Humans; Length of Stay; Patient Readmission; Ra | 2015 |
Does Long-Term Furosemide Therapy Cause Thiamine Deficiency in Patients with Heart Failure? A Focused Review.
Topics: Dietary Supplements; Furosemide; Heart Failure; Humans; Sodium Potassium Chloride Symporter Inhibito | 2016 |
Does Long-Term Furosemide Therapy Cause Thiamine Deficiency in Patients with Heart Failure? A Focused Review.
Topics: Dietary Supplements; Furosemide; Heart Failure; Humans; Sodium Potassium Chloride Symporter Inhibito | 2016 |
A pharmacogenetic investigation of intravenous furosemide in decompensated heart failure: a meta-analysis of three clinical trials.
Topics: Administration, Intravenous; Aged; Aged, 80 and over; Apolipoprotein L1; Apolipoproteins; Clinical T | 2017 |
A pharmacogenetic investigation of intravenous furosemide in decompensated heart failure: a meta-analysis of three clinical trials.
Topics: Administration, Intravenous; Aged; Aged, 80 and over; Apolipoprotein L1; Apolipoproteins; Clinical T | 2017 |
A pharmacogenetic investigation of intravenous furosemide in decompensated heart failure: a meta-analysis of three clinical trials.
Topics: Administration, Intravenous; Aged; Aged, 80 and over; Apolipoprotein L1; Apolipoproteins; Clinical T | 2017 |
A pharmacogenetic investigation of intravenous furosemide in decompensated heart failure: a meta-analysis of three clinical trials.
Topics: Administration, Intravenous; Aged; Aged, 80 and over; Apolipoprotein L1; Apolipoproteins; Clinical T | 2017 |
A pharmacogenetic investigation of intravenous furosemide in decompensated heart failure: a meta-analysis of three clinical trials.
Topics: Administration, Intravenous; Aged; Aged, 80 and over; Apolipoprotein L1; Apolipoproteins; Clinical T | 2017 |
A pharmacogenetic investigation of intravenous furosemide in decompensated heart failure: a meta-analysis of three clinical trials.
Topics: Administration, Intravenous; Aged; Aged, 80 and over; Apolipoprotein L1; Apolipoproteins; Clinical T | 2017 |
A pharmacogenetic investigation of intravenous furosemide in decompensated heart failure: a meta-analysis of three clinical trials.
Topics: Administration, Intravenous; Aged; Aged, 80 and over; Apolipoprotein L1; Apolipoproteins; Clinical T | 2017 |
A pharmacogenetic investigation of intravenous furosemide in decompensated heart failure: a meta-analysis of three clinical trials.
Topics: Administration, Intravenous; Aged; Aged, 80 and over; Apolipoprotein L1; Apolipoproteins; Clinical T | 2017 |
A pharmacogenetic investigation of intravenous furosemide in decompensated heart failure: a meta-analysis of three clinical trials.
Topics: Administration, Intravenous; Aged; Aged, 80 and over; Apolipoprotein L1; Apolipoproteins; Clinical T | 2017 |
A pharmacogenetic investigation of intravenous furosemide in decompensated heart failure: a meta-analysis of three clinical trials.
Topics: Administration, Intravenous; Aged; Aged, 80 and over; Apolipoprotein L1; Apolipoproteins; Clinical T | 2017 |
A pharmacogenetic investigation of intravenous furosemide in decompensated heart failure: a meta-analysis of three clinical trials.
Topics: Administration, Intravenous; Aged; Aged, 80 and over; Apolipoprotein L1; Apolipoproteins; Clinical T | 2017 |
A pharmacogenetic investigation of intravenous furosemide in decompensated heart failure: a meta-analysis of three clinical trials.
Topics: Administration, Intravenous; Aged; Aged, 80 and over; Apolipoprotein L1; Apolipoproteins; Clinical T | 2017 |
A pharmacogenetic investigation of intravenous furosemide in decompensated heart failure: a meta-analysis of three clinical trials.
Topics: Administration, Intravenous; Aged; Aged, 80 and over; Apolipoprotein L1; Apolipoproteins; Clinical T | 2017 |
A pharmacogenetic investigation of intravenous furosemide in decompensated heart failure: a meta-analysis of three clinical trials.
Topics: Administration, Intravenous; Aged; Aged, 80 and over; Apolipoprotein L1; Apolipoproteins; Clinical T | 2017 |
A pharmacogenetic investigation of intravenous furosemide in decompensated heart failure: a meta-analysis of three clinical trials.
Topics: Administration, Intravenous; Aged; Aged, 80 and over; Apolipoprotein L1; Apolipoproteins; Clinical T | 2017 |
A pharmacogenetic investigation of intravenous furosemide in decompensated heart failure: a meta-analysis of three clinical trials.
Topics: Administration, Intravenous; Aged; Aged, 80 and over; Apolipoprotein L1; Apolipoproteins; Clinical T | 2017 |
A pharmacogenetic investigation of intravenous furosemide in decompensated heart failure: a meta-analysis of three clinical trials.
Topics: Administration, Intravenous; Aged; Aged, 80 and over; Apolipoprotein L1; Apolipoproteins; Clinical T | 2017 |
A pharmacogenetic investigation of intravenous furosemide in decompensated heart failure: a meta-analysis of three clinical trials.
Topics: Administration, Intravenous; Aged; Aged, 80 and over; Apolipoprotein L1; Apolipoproteins; Clinical T | 2017 |
Which dosing of furosemide is better in acute decompensated heart failure?
Topics: Acute Disease; Diuretics; Furosemide; Heart Failure; Humans | 2017 |
Which dosing of furosemide is better in acute decompensated heart failure?
Topics: Acute Disease; Diuretics; Furosemide; Heart Failure; Humans | 2017 |
Torasemide for the treatment of heart failure.
Topics: Animals; Clinical Trials as Topic; Diuretics; Furosemide; Heart Failure; Humans; Quality of Life; Su | 2008 |
Torasemide for the treatment of heart failure.
Topics: Animals; Clinical Trials as Topic; Diuretics; Furosemide; Heart Failure; Humans; Quality of Life; Su | 2008 |
Rational use of diuretics in acute decompensated heart failure.
Topics: Acute Disease; Antidiuretic Hormone Receptor Antagonists; Diuretics; Drug Resistance; Drug Therapy, | 2008 |
Rational use of diuretics in acute decompensated heart failure.
Topics: Acute Disease; Antidiuretic Hormone Receptor Antagonists; Diuretics; Drug Resistance; Drug Therapy, | 2008 |
Adenosine A1 antagonists and the cardiorenal syndrome.
Topics: Adenosine A1 Receptor Antagonists; Animals; Disease Models, Animal; Dose-Response Relationship, Drug | 2008 |
Adenosine A1 antagonists and the cardiorenal syndrome.
Topics: Adenosine A1 Receptor Antagonists; Animals; Disease Models, Animal; Dose-Response Relationship, Drug | 2008 |
Prehospital management of congestive heart failure.
Topics: Advanced Cardiac Life Support; Angiotensin-Converting Enzyme Inhibitors; Bronchodilator Agents; Clin | 2009 |
Prehospital management of congestive heart failure.
Topics: Advanced Cardiac Life Support; Angiotensin-Converting Enzyme Inhibitors; Bronchodilator Agents; Clin | 2009 |
[Hypertension, hypertensive heart disease and heart failure. Role of loop diuretics].
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive | 2008 |
[Hypertension, hypertensive heart disease and heart failure. Role of loop diuretics].
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive | 2008 |
A comprehensive review of the loop diuretics: should furosemide be first line?
Topics: Furosemide; Heart Failure; Humans; Kidney Failure, Chronic; Liver Cirrhosis; Sodium Potassium Chlori | 2009 |
A comprehensive review of the loop diuretics: should furosemide be first line?
Topics: Furosemide; Heart Failure; Humans; Kidney Failure, Chronic; Liver Cirrhosis; Sodium Potassium Chlori | 2009 |
[Vasopressin receptor antagonists and heart failure].
Topics: Administration, Oral; Aged; Antidiuretic Hormone Receptor Antagonists; Azepines; Benzamides; Benzaze | 2009 |
[Vasopressin receptor antagonists and heart failure].
Topics: Administration, Oral; Aged; Antidiuretic Hormone Receptor Antagonists; Azepines; Benzamides; Benzaze | 2009 |
[Update: prolonged-release torasemide].
Topics: Animals; Chronic Disease; Delayed-Action Preparations; Diuretics; Furosemide; Heart Failure; Humans; | 2010 |
[Update: prolonged-release torasemide].
Topics: Animals; Chronic Disease; Delayed-Action Preparations; Diuretics; Furosemide; Heart Failure; Humans; | 2010 |
Can we improve the treatment of congestion in heart failure?
Topics: Animals; Diuretics; Dyspnea; Edema; Furosemide; Heart Failure; Humans; Lung | 2011 |
Can we improve the treatment of congestion in heart failure?
Topics: Animals; Diuretics; Dyspnea; Edema; Furosemide; Heart Failure; Humans; Lung | 2011 |
Is there a role for subcutaneous furosemide in the community and hospice management of end-stage heart failure?
Topics: Adult; Chronic Disease; Disease Management; Diuretics; Female; Furosemide; Heart Failure; Hospice Ca | 2011 |
Is there a role for subcutaneous furosemide in the community and hospice management of end-stage heart failure?
Topics: Adult; Chronic Disease; Disease Management; Diuretics; Female; Furosemide; Heart Failure; Hospice Ca | 2011 |
Acute heart failure with dyspnoea: initial treatment. Furosemide and trinitrine, despite the lack of a proven survival benefit.
Topics: Acute Disease; Blood Pressure; Diuretics; Dyspnea; Furosemide; Heart Failure; Nitroglycerin; Vasodil | 2011 |
Acute heart failure with dyspnoea: initial treatment. Furosemide and trinitrine, despite the lack of a proven survival benefit.
Topics: Acute Disease; Blood Pressure; Diuretics; Dyspnea; Furosemide; Heart Failure; Nitroglycerin; Vasodil | 2011 |
Decongestive treatment of acute decompensated heart failure: cardiorenal implications of ultrafiltration and diuretics.
Topics: Arteriovenous Shunt, Surgical; Cardio-Renal Syndrome; Creatinine; Diuretics; Furosemide; Glomerular | 2011 |
Decongestive treatment of acute decompensated heart failure: cardiorenal implications of ultrafiltration and diuretics.
Topics: Arteriovenous Shunt, Surgical; Cardio-Renal Syndrome; Creatinine; Diuretics; Furosemide; Glomerular | 2011 |
Intravenous high-dose furosemide and hypertonic saline solutions for refractory heart failure and ascites.
Topics: Ascites; Cardio-Renal Syndrome; Diuretics; Furosemide; Heart Failure; Humans; Infusions, Intravenous | 2011 |
Intravenous high-dose furosemide and hypertonic saline solutions for refractory heart failure and ascites.
Topics: Ascites; Cardio-Renal Syndrome; Diuretics; Furosemide; Heart Failure; Humans; Infusions, Intravenous | 2011 |
Continuous infusion versus intermittent bolus furosemide in ADHF: an updated meta-analysis of randomized control trials.
Topics: Acute Disease; Aged; Female; Furosemide; Heart Failure; Humans; Infusions, Intravenous; Male; Middle | 2012 |
Continuous infusion versus intermittent bolus furosemide in ADHF: an updated meta-analysis of randomized control trials.
Topics: Acute Disease; Aged; Female; Furosemide; Heart Failure; Humans; Infusions, Intravenous; Male; Middle | 2012 |
Diuretic dosing in acute decompensated heart failure: lessons from DOSE.
Topics: Acute Disease; Aged; Creatinine; Dose-Response Relationship, Drug; Drug Administration Schedule; Fem | 2012 |
Diuretic dosing in acute decompensated heart failure: lessons from DOSE.
Topics: Acute Disease; Aged; Creatinine; Dose-Response Relationship, Drug; Drug Administration Schedule; Fem | 2012 |
Rational diuretic management in congestive heart failure: a case-based review.
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Diuretics; Drug Interactions; Drug Monitoring; Drug R | 2003 |
Rational diuretic management in congestive heart failure: a case-based review.
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Diuretics; Drug Interactions; Drug Monitoring; Drug R | 2003 |
Pharmacological therapy of acute cardiogenic pulmonary oedema in the emergency department.
Topics: Acute Disease; Analgesics, Opioid; Angiotensin-Converting Enzyme Inhibitors; Cardiotonic Agents; Cri | 2004 |
Pharmacological therapy of acute cardiogenic pulmonary oedema in the emergency department.
Topics: Acute Disease; Analgesics, Opioid; Angiotensin-Converting Enzyme Inhibitors; Cardiotonic Agents; Cri | 2004 |
Clinical inquiries. Does furosemide decrease morbidity or mortality for patients with diastolic or systolic dysfunction?
Topics: Diuretics; Exercise Tolerance; Furosemide; Heart Failure; Humans; Patient Readmission; Treatment Out | 2005 |
Clinical inquiries. Does furosemide decrease morbidity or mortality for patients with diastolic or systolic dysfunction?
Topics: Diuretics; Exercise Tolerance; Furosemide; Heart Failure; Humans; Patient Readmission; Treatment Out | 2005 |
Sweet syndrome associated with furosemide.
Topics: Diuretics; Drug Eruptions; Female; Furosemide; Heart Failure; Humans; Middle Aged; Sweet Syndrome | 2005 |
Sweet syndrome associated with furosemide.
Topics: Diuretics; Drug Eruptions; Female; Furosemide; Heart Failure; Humans; Middle Aged; Sweet Syndrome | 2005 |
[Medical and ventilatory treatment of acute heart failure].
Topics: Acute Disease; Adrenergic beta-Agonists; Cardiotonic Agents; Continuous Positive Airway Pressure; Di | 2006 |
[Medical and ventilatory treatment of acute heart failure].
Topics: Acute Disease; Adrenergic beta-Agonists; Cardiotonic Agents; Continuous Positive Airway Pressure; Di | 2006 |
Acute decompensated heart failure: the cardiorenal syndrome.
Topics: Acute Disease; Disease Progression; Diuretics; Furosemide; Glomerular Filtration Rate; Heart Failure | 2006 |
Acute decompensated heart failure: the cardiorenal syndrome.
Topics: Acute Disease; Disease Progression; Diuretics; Furosemide; Glomerular Filtration Rate; Heart Failure | 2006 |
Zinc balance and medications commonly used in the management of heart failure.
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Furosemi | 2006 |
Zinc balance and medications commonly used in the management of heart failure.
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Furosemi | 2006 |
Treating hyponatremia in heart failure.
Topics: Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Diuretics; Furosemide; Heart Failur | 2006 |
Treating hyponatremia in heart failure.
Topics: Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Diuretics; Furosemide; Heart Failur | 2006 |
Targeting the kidney in acute decompensated heart failure: conventional diuretics and renal-acting vasodilators.
Topics: Acute Disease; Cyclic GMP; Diuretics; Furosemide; Glomerular Filtration Rate; Heart Failure; Humans; | 2008 |
Targeting the kidney in acute decompensated heart failure: conventional diuretics and renal-acting vasodilators.
Topics: Acute Disease; Cyclic GMP; Diuretics; Furosemide; Glomerular Filtration Rate; Heart Failure; Humans; | 2008 |
Congestive heart failure in childhood and adolescence: recognition and management.
Topics: Adolescent; Captopril; Cardiomyopathies; Child; Digoxin; Dobutamine; Dopamine; Echocardiography; Ele | 1983 |
Congestive heart failure in childhood and adolescence: recognition and management.
Topics: Adolescent; Captopril; Cardiomyopathies; Child; Digoxin; Dobutamine; Dopamine; Echocardiography; Ele | 1983 |
Disease-induced modifications of drug pharmacokinetics.
Topics: Acute Kidney Injury; Blood Proteins; Disease; Furosemide; Glomerular Filtration Rate; Heart Failure; | 1983 |
Disease-induced modifications of drug pharmacokinetics.
Topics: Acute Kidney Injury; Blood Proteins; Disease; Furosemide; Glomerular Filtration Rate; Heart Failure; | 1983 |
Effects of diuretics on the renal handling of magnesium.
Topics: Amiloride; Animals; Diuretics; Drug Interactions; Electrolytes; Furosemide; Glomerular Filtration Ra | 1984 |
Effects of diuretics on the renal handling of magnesium.
Topics: Amiloride; Animals; Diuretics; Drug Interactions; Electrolytes; Furosemide; Glomerular Filtration Ra | 1984 |
[Evaluation and treatment of hyponatremia (author's transl)].
Topics: Furosemide; Heart Failure; Humans; Hypertonic Solutions; Hyponatremia; Inappropriate ADH Syndrome; I | 1980 |
[Evaluation and treatment of hyponatremia (author's transl)].
Topics: Furosemide; Heart Failure; Humans; Hypertonic Solutions; Hyponatremia; Inappropriate ADH Syndrome; I | 1980 |
Diuretics in infancy.
Topics: Acute Disease; Benzothiadiazines; Diet, Sodium-Restricted; Diuretics; Diuretics, Osmotic; Edema; Eth | 1981 |
Diuretics in infancy.
Topics: Acute Disease; Benzothiadiazines; Diet, Sodium-Restricted; Diuretics; Diuretics, Osmotic; Edema; Eth | 1981 |
[Diuretics in the neonatal period].
Topics: Benzothiadiazines; Bronchopulmonary Dysplasia; Diuretics; Furosemide; Heart Failure; Humans; Infant, | 1995 |
[Diuretics in the neonatal period].
Topics: Benzothiadiazines; Bronchopulmonary Dysplasia; Diuretics; Furosemide; Heart Failure; Humans; Infant, | 1995 |
Torsemide: a pyridine-sulfonylurea loop diuretic.
Topics: Clinical Trials as Topic; Diuretics; Drug Interactions; Furosemide; Heart Failure; Humans; Liver Cir | 1995 |
Torsemide: a pyridine-sulfonylurea loop diuretic.
Topics: Clinical Trials as Topic; Diuretics; Drug Interactions; Furosemide; Heart Failure; Humans; Liver Cir | 1995 |
Loop diuretics versus others in the treatment of congestive heart failure after myocardial infarction.
Topics: Diuretics; Furosemide; Heart Failure; Humans; Myocardial Infarction | 1993 |
Loop diuretics versus others in the treatment of congestive heart failure after myocardial infarction.
Topics: Diuretics; Furosemide; Heart Failure; Humans; Myocardial Infarction | 1993 |
Central hemodynamic effects of diuretic therapy in chronic heart failure.
Topics: Bumetanide; Cardiac Output; Diuresis; Diuretics; Furosemide; Heart Failure; Hemodynamics; Humans; Mu | 1993 |
Central hemodynamic effects of diuretic therapy in chronic heart failure.
Topics: Bumetanide; Cardiac Output; Diuresis; Diuretics; Furosemide; Heart Failure; Hemodynamics; Humans; Mu | 1993 |
Is there a role for thiamine supplementation in the management of heart failure?
Topics: Diuretics; Furosemide; Heart Failure; Humans; Thiamine; Thiamine Deficiency | 1996 |
Is there a role for thiamine supplementation in the management of heart failure?
Topics: Diuretics; Furosemide; Heart Failure; Humans; Thiamine; Thiamine Deficiency | 1996 |
[Emergency treatment of acute heart failure].
Topics: Acute Disease; Adrenergic beta-Antagonists; Aged; Analgesics, Opioid; Angioplasty, Balloon, Coronary | 1999 |
[Emergency treatment of acute heart failure].
Topics: Acute Disease; Adrenergic beta-Antagonists; Aged; Analgesics, Opioid; Angioplasty, Balloon, Coronary | 1999 |
Diuretics and the therapy of hypertension.
Topics: Antihypertensive Agents; Blood Pressure; Chlorothiazide; Diuretics; Edema; Furosemide; Guidelines as | 2000 |
Diuretics and the therapy of hypertension.
Topics: Antihypertensive Agents; Blood Pressure; Chlorothiazide; Diuretics; Edema; Furosemide; Guidelines as | 2000 |
The acute vascular effects of frusemide in heart failure.
Topics: Arteries; Diuretics; Furosemide; Heart Failure; Humans; Veins | 2000 |
The acute vascular effects of frusemide in heart failure.
Topics: Arteries; Diuretics; Furosemide; Heart Failure; Humans; Veins | 2000 |
[Torasemide (LUPRAC): a review of its pharmacological and clinical profile].
Topics: Animals; Clinical Trials as Topic; Diuretics; Edema, Cardiac; Furosemide; Heart Failure; Humans; Hyp | 2001 |
[Torasemide (LUPRAC): a review of its pharmacological and clinical profile].
Topics: Animals; Clinical Trials as Topic; Diuretics; Edema, Cardiac; Furosemide; Heart Failure; Humans; Hyp | 2001 |
Management of acute heart failure.
Topics: Acute Disease; Anti-Arrhythmia Agents; Diuretics; First Aid; Furosemide; Heart Failure; Humans; Shoc | 2002 |
Management of acute heart failure.
Topics: Acute Disease; Anti-Arrhythmia Agents; Diuretics; First Aid; Furosemide; Heart Failure; Humans; Shoc | 2002 |
[The efficacy of the intra-aortic balloon pump for patients with heart failure complicating acute myocardial infarction (author's transl)].
Topics: Adult; Aged; Aortic Valve Insufficiency; Assisted Circulation; Dopamine; Furosemide; Heart Failure; | 1979 |
[The efficacy of the intra-aortic balloon pump for patients with heart failure complicating acute myocardial infarction (author's transl)].
Topics: Adult; Aged; Aortic Valve Insufficiency; Assisted Circulation; Dopamine; Furosemide; Heart Failure; | 1979 |
Pharmacologic and other forms of medical therapy in feline cardiac disease.
Topics: Animals; Cardiomyopathies; Cat Diseases; Cats; Diet, Sodium-Restricted; Digoxin; Electrocardiography | 1977 |
Pharmacologic and other forms of medical therapy in feline cardiac disease.
Topics: Animals; Cardiomyopathies; Cat Diseases; Cats; Diet, Sodium-Restricted; Digoxin; Electrocardiography | 1977 |
Digitalis in acute myocardial infarction: help or hazard?
Topics: Acute Disease; Animals; Arrhythmias, Cardiac; Blood Pressure; Cardiac Output; Depression, Chemical; | 1975 |
Digitalis in acute myocardial infarction: help or hazard?
Topics: Acute Disease; Animals; Arrhythmias, Cardiac; Blood Pressure; Cardiac Output; Depression, Chemical; | 1975 |
[The place of new therapies in the treatment of congestive heart failure. The combination of digitalis and diuretics is always in good place].
Topics: Age Factors; Angiotensin-Converting Enzyme Inhibitors; Captopril; Child; Child, Preschool; Digoxin; | 1992 |
[The place of new therapies in the treatment of congestive heart failure. The combination of digitalis and diuretics is always in good place].
Topics: Age Factors; Angiotensin-Converting Enzyme Inhibitors; Captopril; Child; Child, Preschool; Digoxin; | 1992 |
Furosemide (frusemide). A pharmacokinetic/pharmacodynamic review (Part I).
Topics: Acute Kidney Injury; Furosemide; Heart Failure; Humans; Hypertension; Liver Diseases | 1990 |
Furosemide (frusemide). A pharmacokinetic/pharmacodynamic review (Part I).
Topics: Acute Kidney Injury; Furosemide; Heart Failure; Humans; Hypertension; Liver Diseases | 1990 |
The effects of frusemide and angiotensin-converting enzyme inhibitors and their combination on cardiac and renal haemodynamics in heart failure.
Topics: Administration, Oral; Angiotensin-Converting Enzyme Inhibitors; Clinical Trials as Topic; Drug Admin | 1988 |
The effects of frusemide and angiotensin-converting enzyme inhibitors and their combination on cardiac and renal haemodynamics in heart failure.
Topics: Administration, Oral; Angiotensin-Converting Enzyme Inhibitors; Clinical Trials as Topic; Drug Admin | 1988 |
Haemodynamic effects of high or low doses of furosemide in acute myocardial infarction.
Topics: Aged; Blood Pressure; Cardiac Output; Clinical Trials as Topic; Female; Furosemide; Heart Arrest; He | 1988 |
Haemodynamic effects of high or low doses of furosemide in acute myocardial infarction.
Topics: Aged; Blood Pressure; Cardiac Output; Clinical Trials as Topic; Female; Furosemide; Heart Arrest; He | 1988 |
Disposition and response to bumetanide and furosemide.
Topics: Adult; Aged; Biological Availability; Bumetanide; Diuretics; Furosemide; Heart Failure; Humans; Kidn | 1986 |
Disposition and response to bumetanide and furosemide.
Topics: Adult; Aged; Biological Availability; Bumetanide; Diuretics; Furosemide; Heart Failure; Humans; Kidn | 1986 |
Furosemide and vitamin E. Two problem drugs in neonatology.
Topics: Acid-Base Imbalance; Anemia; Bronchopulmonary Dysplasia; Cerebral Hemorrhage; Diuresis; Ductus Arter | 1986 |
Furosemide and vitamin E. Two problem drugs in neonatology.
Topics: Acid-Base Imbalance; Anemia; Bronchopulmonary Dysplasia; Cerebral Hemorrhage; Diuresis; Ductus Arter | 1986 |
Resistance to loop diuretics. Why it happens and what to do about it.
Topics: Anti-Inflammatory Agents; Diet, Sodium-Restricted; Diuretics; Drug Interactions; Drug Resistance; Fu | 1985 |
Resistance to loop diuretics. Why it happens and what to do about it.
Topics: Anti-Inflammatory Agents; Diet, Sodium-Restricted; Diuretics; Drug Interactions; Drug Resistance; Fu | 1985 |
[Congestive heart failure].
Topics: Acetazolamide; Aldosterone; Angiotensin II; Benzothiadiazines; Catecholamines; Diuretics; Ethacrynic | 1974 |
[Congestive heart failure].
Topics: Acetazolamide; Aldosterone; Angiotensin II; Benzothiadiazines; Catecholamines; Diuretics; Ethacrynic | 1974 |
Diuretics in edema: how they work; how to pick the best one.
Topics: Carbonic Anhydrase Inhibitors; Chlorothiazide; Diuretics; Edema; Ethacrynic Acid; Furosemide; Heart | 1972 |
Diuretics in edema: how they work; how to pick the best one.
Topics: Carbonic Anhydrase Inhibitors; Chlorothiazide; Diuretics; Edema; Ethacrynic Acid; Furosemide; Heart | 1972 |
Correlation of pathophysiology and pharmacotherapy in primary hypertension.
Topics: Blood Pressure; Cardiac Output; Cardiac Volume; Diuretics; Furosemide; Guanethidine; Heart Failure; | 1973 |
Correlation of pathophysiology and pharmacotherapy in primary hypertension.
Topics: Blood Pressure; Cardiac Output; Cardiac Volume; Diuretics; Furosemide; Guanethidine; Heart Failure; | 1973 |
Recent advances in the treatment of congenital heart disease.
Topics: Age Factors; Arrhythmias, Cardiac; Child; Child, Preschool; Chlorothiazide; Diet, Sodium-Restricted; | 1974 |
Recent advances in the treatment of congenital heart disease.
Topics: Age Factors; Arrhythmias, Cardiac; Child; Child, Preschool; Chlorothiazide; Diet, Sodium-Restricted; | 1974 |
Hypertension in chronic renal failure. Treatment with hemodialysis and nephrectomy.
Topics: Antihypertensive Agents; Brain Diseases; Cardiac Output; Extracellular Space; Furosemide; Heart Fail | 1974 |
Hypertension in chronic renal failure. Treatment with hemodialysis and nephrectomy.
Topics: Antihypertensive Agents; Brain Diseases; Cardiac Output; Extracellular Space; Furosemide; Heart Fail | 1974 |
[Diuretics in refractory circulatory failure].
Topics: Dehydration; Diuretics; Edema; Ethacrynic Acid; Furosemide; Heart Failure; Hemodynamics; Humans; Hyp | 1974 |
[Diuretics in refractory circulatory failure].
Topics: Dehydration; Diuretics; Edema; Ethacrynic Acid; Furosemide; Heart Failure; Hemodynamics; Humans; Hyp | 1974 |
[Clinical use of diuretics].
Topics: Acid-Base Equilibrium; Benzothiadiazines; Diuretics; Ethacrynic Acid; Furosemide; Hearing Disorders; | 1974 |
[Clinical use of diuretics].
Topics: Acid-Base Equilibrium; Benzothiadiazines; Diuretics; Ethacrynic Acid; Furosemide; Hearing Disorders; | 1974 |
[Diuretic-resistant edema].
Topics: Adult; Aged; Animals; Body Fluids; Cats; Diet, Sodium-Restricted; Diuretics; Drug Resistance; Edema; | 1974 |
[Diuretic-resistant edema].
Topics: Adult; Aged; Animals; Body Fluids; Cats; Diet, Sodium-Restricted; Diuretics; Drug Resistance; Edema; | 1974 |
Clinical pharmacology of furosemide and ethacrynic acid.
Topics: Anuria; Diabetes Insipidus; Edema; Ethacrynic Acid; Furosemide; Heart Failure; Hemodynamics; Humans; | 1968 |
Clinical pharmacology of furosemide and ethacrynic acid.
Topics: Anuria; Diabetes Insipidus; Edema; Ethacrynic Acid; Furosemide; Heart Failure; Hemodynamics; Humans; | 1968 |
Clinical selection of diuretic drugs in the management of cardiac edema.
Topics: Adult; Diuretics; Ethacrynic Acid; Furosemide; Heart Failure; Humans; Kidney; Male; Middle Aged; Org | 1968 |
Clinical selection of diuretic drugs in the management of cardiac edema.
Topics: Adult; Diuretics; Ethacrynic Acid; Furosemide; Heart Failure; Humans; Kidney; Male; Middle Aged; Org | 1968 |
[Depletion therapy of chronic congestive heart failure].
Topics: Bloodletting; Carbonic Anhydrase Inhibitors; Chlorides; Diet, Sodium-Restricted; Digitalis Glycoside | 1968 |
[Depletion therapy of chronic congestive heart failure].
Topics: Bloodletting; Carbonic Anhydrase Inhibitors; Chlorides; Diet, Sodium-Restricted; Digitalis Glycoside | 1968 |
Combinations of diuretics in the treatment of edema.
Topics: Acetazolamide; Benzothiadiazines; Chlorthalidone; Diuretics; Edema; Ethacrynic Acid; Furosemide; Glu | 1970 |
Combinations of diuretics in the treatment of edema.
Topics: Acetazolamide; Benzothiadiazines; Chlorthalidone; Diuretics; Edema; Ethacrynic Acid; Furosemide; Glu | 1970 |
Ethacrynic acid and furosemide. Diuretic and hemodynamic effects and clinical uses.
Topics: Animals; Anuria; Blood Pressure; Cardiac Output; Central Venous Pressure; Chlorides; Diuresis; Dogs; | 1971 |
Ethacrynic acid and furosemide. Diuretic and hemodynamic effects and clinical uses.
Topics: Animals; Anuria; Blood Pressure; Cardiac Output; Central Venous Pressure; Chlorides; Diuresis; Dogs; | 1971 |
Diuretics. II. Clinical considerations.
Topics: Administration, Oral; Aminophylline; Ascites; Calcium; Carbohydrate Metabolism; Carbonic Anhydrase I | 1971 |
Diuretics. II. Clinical considerations.
Topics: Administration, Oral; Aminophylline; Ascites; Calcium; Carbohydrate Metabolism; Carbonic Anhydrase I | 1971 |
Combination diuretic drug therapy.
Topics: Amiloride; Benzothiadiazines; Diet; Diuretics; Drug Therapy, Combination; Ethacrynic Acid; Furosemid | 1971 |
Combination diuretic drug therapy.
Topics: Amiloride; Benzothiadiazines; Diet; Diuretics; Drug Therapy, Combination; Ethacrynic Acid; Furosemid | 1971 |
282 trials available for furosemide and Heart Failure
| Article | Year |
|---|---|
Early Impedance-Guided Intervention Improves Long-Term Outcome in Patients With Heart Failure.
Topics: Diuretics; Electric Impedance; Furosemide; Heart Failure; Humans; Lung; Lung Diseases; Outpatients; | 2021 |
Early Impedance-Guided Intervention Improves Long-Term Outcome in Patients With Heart Failure.
Topics: Diuretics; Electric Impedance; Furosemide; Heart Failure; Humans; Lung; Lung Diseases; Outpatients; | 2021 |
Rationale and Design of the Efficacy of a Standardized Diuretic Protocol in Acute Heart Failure Study.
Topics: Diuretics; Furosemide; Heart Failure; Humans; Infusions, Intravenous; Sodium Potassium Chloride Symp | 2021 |
Rationale and Design of the Efficacy of a Standardized Diuretic Protocol in Acute Heart Failure Study.
Topics: Diuretics; Furosemide; Heart Failure; Humans; Infusions, Intravenous; Sodium Potassium Chloride Symp | 2021 |
Ascertaining Death Events in a Pragmatic Clinical Trial: Insights From the TRANSFORM-HF Trial.
Topics: Furosemide; Heart Failure; Humans; Reproducibility of Results; Torsemide; United States | 2022 |
Ascertaining Death Events in a Pragmatic Clinical Trial: Insights From the TRANSFORM-HF Trial.
Topics: Furosemide; Heart Failure; Humans; Reproducibility of Results; Torsemide; United States | 2022 |
Efficacy of tolvaptan on advanced chronic kidney disease with heart failure: a randomized controlled trial.
Topics: Antidiuretic Hormone Receptor Antagonists; Benzazepines; Diuretics; Furosemide; Heart Failure; Human | 2022 |
Efficacy of tolvaptan on advanced chronic kidney disease with heart failure: a randomized controlled trial.
Topics: Antidiuretic Hormone Receptor Antagonists; Benzazepines; Diuretics; Furosemide; Heart Failure; Human | 2022 |
Sacubitril/valsartan and loop diuretic requirement in heart failure with preserved ejection fraction in the PARAGON-HF trial.
Topics: Aminobutyrates; Angiotensin Receptor Antagonists; Biphenyl Compounds; Diuretics; Drug Combinations; | 2023 |
Sacubitril/valsartan and loop diuretic requirement in heart failure with preserved ejection fraction in the PARAGON-HF trial.
Topics: Aminobutyrates; Angiotensin Receptor Antagonists; Biphenyl Compounds; Diuretics; Drug Combinations; | 2023 |
Association of time-to-intravenous furosemide with mortality in acute heart failure: data from REPORT-HF.
Topics: Aftercare; Diuretics; Female; Furosemide; Heart Failure; Humans; Patient Discharge; Stroke Volume; V | 2023 |
Association of time-to-intravenous furosemide with mortality in acute heart failure: data from REPORT-HF.
Topics: Aftercare; Diuretics; Female; Furosemide; Heart Failure; Humans; Patient Discharge; Stroke Volume; V | 2023 |
Impact of empagliflozin on decongestion in acute heart failure: the EMPULSE trial.
Topics: Benzhydryl Compounds; Furosemide; Glucosides; Heart Failure; Humans | 2023 |
Impact of empagliflozin on decongestion in acute heart failure: the EMPULSE trial.
Topics: Benzhydryl Compounds; Furosemide; Glucosides; Heart Failure; Humans | 2023 |
Combining loop with thiazide diuretics for decompensated heart failure: the CLOROTIC trial.
Topics: Diuretics; Dyspnea; Female; Furosemide; Heart Failure; Humans; Hydrochlorothiazide; Hypokalemia; Pro | 2023 |
Combining loop with thiazide diuretics for decompensated heart failure: the CLOROTIC trial.
Topics: Diuretics; Dyspnea; Female; Furosemide; Heart Failure; Humans; Hydrochlorothiazide; Hypokalemia; Pro | 2023 |
Combining loop with thiazide diuretics for decompensated heart failure: the CLOROTIC trial.
Topics: Diuretics; Dyspnea; Female; Furosemide; Heart Failure; Humans; Hydrochlorothiazide; Hypokalemia; Pro | 2023 |
Combining loop with thiazide diuretics for decompensated heart failure: the CLOROTIC trial.
Topics: Diuretics; Dyspnea; Female; Furosemide; Heart Failure; Humans; Hydrochlorothiazide; Hypokalemia; Pro | 2023 |
Combining loop with thiazide diuretics for decompensated heart failure: the CLOROTIC trial.
Topics: Diuretics; Dyspnea; Female; Furosemide; Heart Failure; Humans; Hydrochlorothiazide; Hypokalemia; Pro | 2023 |
Combining loop with thiazide diuretics for decompensated heart failure: the CLOROTIC trial.
Topics: Diuretics; Dyspnea; Female; Furosemide; Heart Failure; Humans; Hydrochlorothiazide; Hypokalemia; Pro | 2023 |
Combining loop with thiazide diuretics for decompensated heart failure: the CLOROTIC trial.
Topics: Diuretics; Dyspnea; Female; Furosemide; Heart Failure; Humans; Hydrochlorothiazide; Hypokalemia; Pro | 2023 |
Combining loop with thiazide diuretics for decompensated heart failure: the CLOROTIC trial.
Topics: Diuretics; Dyspnea; Female; Furosemide; Heart Failure; Humans; Hydrochlorothiazide; Hypokalemia; Pro | 2023 |
Combining loop with thiazide diuretics for decompensated heart failure: the CLOROTIC trial.
Topics: Diuretics; Dyspnea; Female; Furosemide; Heart Failure; Humans; Hydrochlorothiazide; Hypokalemia; Pro | 2023 |
Combining loop with thiazide diuretics for decompensated heart failure: the CLOROTIC trial.
Topics: Diuretics; Dyspnea; Female; Furosemide; Heart Failure; Humans; Hydrochlorothiazide; Hypokalemia; Pro | 2023 |
Combining loop with thiazide diuretics for decompensated heart failure: the CLOROTIC trial.
Topics: Diuretics; Dyspnea; Female; Furosemide; Heart Failure; Humans; Hydrochlorothiazide; Hypokalemia; Pro | 2023 |
Combining loop with thiazide diuretics for decompensated heart failure: the CLOROTIC trial.
Topics: Diuretics; Dyspnea; Female; Furosemide; Heart Failure; Humans; Hydrochlorothiazide; Hypokalemia; Pro | 2023 |
Combining loop with thiazide diuretics for decompensated heart failure: the CLOROTIC trial.
Topics: Diuretics; Dyspnea; Female; Furosemide; Heart Failure; Humans; Hydrochlorothiazide; Hypokalemia; Pro | 2023 |
Combining loop with thiazide diuretics for decompensated heart failure: the CLOROTIC trial.
Topics: Diuretics; Dyspnea; Female; Furosemide; Heart Failure; Humans; Hydrochlorothiazide; Hypokalemia; Pro | 2023 |
Combining loop with thiazide diuretics for decompensated heart failure: the CLOROTIC trial.
Topics: Diuretics; Dyspnea; Female; Furosemide; Heart Failure; Humans; Hydrochlorothiazide; Hypokalemia; Pro | 2023 |
Combining loop with thiazide diuretics for decompensated heart failure: the CLOROTIC trial.
Topics: Diuretics; Dyspnea; Female; Furosemide; Heart Failure; Humans; Hydrochlorothiazide; Hypokalemia; Pro | 2023 |
Combining loop with thiazide diuretics for decompensated heart failure: the CLOROTIC trial.
Topics: Diuretics; Dyspnea; Female; Furosemide; Heart Failure; Humans; Hydrochlorothiazide; Hypokalemia; Pro | 2023 |
Combining loop with thiazide diuretics for decompensated heart failure: the CLOROTIC trial.
Topics: Diuretics; Dyspnea; Female; Furosemide; Heart Failure; Humans; Hydrochlorothiazide; Hypokalemia; Pro | 2023 |
Early treatment with a sodium-glucose co-transporter 2 inhibitor in high-risk patients with acute heart failure: Rationale for and design of the EMPA-AHF trial.
Topics: Diabetes Mellitus, Type 2; Double-Blind Method; Furosemide; Glucose; Heart Failure; Humans; Sodium; | 2023 |
Early treatment with a sodium-glucose co-transporter 2 inhibitor in high-risk patients with acute heart failure: Rationale for and design of the EMPA-AHF trial.
Topics: Diabetes Mellitus, Type 2; Double-Blind Method; Furosemide; Glucose; Heart Failure; Humans; Sodium; | 2023 |
Early treatment with a sodium-glucose co-transporter 2 inhibitor in high-risk patients with acute heart failure: Rationale for and design of the EMPA-AHF trial.
Topics: Diabetes Mellitus, Type 2; Double-Blind Method; Furosemide; Glucose; Heart Failure; Humans; Sodium; | 2023 |
Early treatment with a sodium-glucose co-transporter 2 inhibitor in high-risk patients with acute heart failure: Rationale for and design of the EMPA-AHF trial.
Topics: Diabetes Mellitus, Type 2; Double-Blind Method; Furosemide; Glucose; Heart Failure; Humans; Sodium; | 2023 |
Early treatment with a sodium-glucose co-transporter 2 inhibitor in high-risk patients with acute heart failure: Rationale for and design of the EMPA-AHF trial.
Topics: Diabetes Mellitus, Type 2; Double-Blind Method; Furosemide; Glucose; Heart Failure; Humans; Sodium; | 2023 |
Early treatment with a sodium-glucose co-transporter 2 inhibitor in high-risk patients with acute heart failure: Rationale for and design of the EMPA-AHF trial.
Topics: Diabetes Mellitus, Type 2; Double-Blind Method; Furosemide; Glucose; Heart Failure; Humans; Sodium; | 2023 |
Early treatment with a sodium-glucose co-transporter 2 inhibitor in high-risk patients with acute heart failure: Rationale for and design of the EMPA-AHF trial.
Topics: Diabetes Mellitus, Type 2; Double-Blind Method; Furosemide; Glucose; Heart Failure; Humans; Sodium; | 2023 |
Early treatment with a sodium-glucose co-transporter 2 inhibitor in high-risk patients with acute heart failure: Rationale for and design of the EMPA-AHF trial.
Topics: Diabetes Mellitus, Type 2; Double-Blind Method; Furosemide; Glucose; Heart Failure; Humans; Sodium; | 2023 |
Effect of Torsemide vs Furosemide After Discharge on All-Cause Mortality in Patients Hospitalized With Heart Failure: The TRANSFORM-HF Randomized Clinical Trial.
Topics: Aged; Female; Furosemide; Heart Failure; Hospitalization; Humans; Male; Middle Aged; Patient Dischar | 2023 |
Effect of Torsemide vs Furosemide After Discharge on All-Cause Mortality in Patients Hospitalized With Heart Failure: The TRANSFORM-HF Randomized Clinical Trial.
Topics: Aged; Female; Furosemide; Heart Failure; Hospitalization; Humans; Male; Middle Aged; Patient Dischar | 2023 |
Oral Sodium to Preserve Renal Efficiency in Acute Heart Failure: A Randomized, Placebo-Controlled, Double-Blind Study.
Topics: Diuretics; Double-Blind Method; Furosemide; Heart Failure; Humans; Kidney; Sodium; Sodium Chloride; | 2023 |
Oral Sodium to Preserve Renal Efficiency in Acute Heart Failure: A Randomized, Placebo-Controlled, Double-Blind Study.
Topics: Diuretics; Double-Blind Method; Furosemide; Heart Failure; Humans; Kidney; Sodium; Sodium Chloride; | 2023 |
Dapagliflozin vs. metolazone in heart failure resistant to loop diuretics.
Topics: Diuretics; Furosemide; Heart Failure; Humans; Metolazone; Sodium; Sodium Potassium Chloride Symporte | 2023 |
Dapagliflozin vs. metolazone in heart failure resistant to loop diuretics.
Topics: Diuretics; Furosemide; Heart Failure; Humans; Metolazone; Sodium; Sodium Potassium Chloride Symporte | 2023 |
Effect of Torsemide Versus Furosemide on Symptoms and Quality of Life Among Patients Hospitalized for Heart Failure: The TRANSFORM-HF Randomized Clinical Trial.
Topics: Furosemide; Heart Failure; Humans; Quality of Life; Sodium Potassium Chloride Symporter Inhibitors; | 2023 |
Effect of Torsemide Versus Furosemide on Symptoms and Quality of Life Among Patients Hospitalized for Heart Failure: The TRANSFORM-HF Randomized Clinical Trial.
Topics: Furosemide; Heart Failure; Humans; Quality of Life; Sodium Potassium Chloride Symporter Inhibitors; | 2023 |
The use of Dapagliflozin in Acute Decompensated Heart Failure: Results of the Randomized Study.
Topics: Acute Kidney Injury; Aged; Aged, 80 and over; Diabetes Mellitus, Type 2; Female; Furosemide; Heart F | 2023 |
The use of Dapagliflozin in Acute Decompensated Heart Failure: Results of the Randomized Study.
Topics: Acute Kidney Injury; Aged; Aged, 80 and over; Diabetes Mellitus, Type 2; Female; Furosemide; Heart F | 2023 |
The use of Dapagliflozin in Acute Decompensated Heart Failure: Results of the Randomized Study.
Topics: Acute Kidney Injury; Aged; Aged, 80 and over; Diabetes Mellitus, Type 2; Female; Furosemide; Heart F | 2023 |
The use of Dapagliflozin in Acute Decompensated Heart Failure: Results of the Randomized Study.
Topics: Acute Kidney Injury; Aged; Aged, 80 and over; Diabetes Mellitus, Type 2; Female; Furosemide; Heart F | 2023 |
Short-term diuretic withdrawal in stable outpatients with mild heart failure and no fluid retention receiving optimal therapy: a double-blind, multicentre, randomized trial.
Topics: Aged; Body Fluids; Brazil; Case-Control Studies; Double-Blind Method; Dyspnea; Female; Follow-Up Stu | 2019 |
Short-term diuretic withdrawal in stable outpatients with mild heart failure and no fluid retention receiving optimal therapy: a double-blind, multicentre, randomized trial.
Topics: Aged; Body Fluids; Brazil; Case-Control Studies; Double-Blind Method; Dyspnea; Female; Follow-Up Stu | 2019 |
Short-term diuretic withdrawal in stable outpatients with mild heart failure and no fluid retention receiving optimal therapy: a double-blind, multicentre, randomized trial.
Topics: Aged; Body Fluids; Brazil; Case-Control Studies; Double-Blind Method; Dyspnea; Female; Follow-Up Stu | 2019 |
Short-term diuretic withdrawal in stable outpatients with mild heart failure and no fluid retention receiving optimal therapy: a double-blind, multicentre, randomized trial.
Topics: Aged; Body Fluids; Brazil; Case-Control Studies; Double-Blind Method; Dyspnea; Female; Follow-Up Stu | 2019 |
Short-term diuretic withdrawal in stable outpatients with mild heart failure and no fluid retention receiving optimal therapy: a double-blind, multicentre, randomized trial.
Topics: Aged; Body Fluids; Brazil; Case-Control Studies; Double-Blind Method; Dyspnea; Female; Follow-Up Stu | 2019 |
Short-term diuretic withdrawal in stable outpatients with mild heart failure and no fluid retention receiving optimal therapy: a double-blind, multicentre, randomized trial.
Topics: Aged; Body Fluids; Brazil; Case-Control Studies; Double-Blind Method; Dyspnea; Female; Follow-Up Stu | 2019 |
Short-term diuretic withdrawal in stable outpatients with mild heart failure and no fluid retention receiving optimal therapy: a double-blind, multicentre, randomized trial.
Topics: Aged; Body Fluids; Brazil; Case-Control Studies; Double-Blind Method; Dyspnea; Female; Follow-Up Stu | 2019 |
Short-term diuretic withdrawal in stable outpatients with mild heart failure and no fluid retention receiving optimal therapy: a double-blind, multicentre, randomized trial.
Topics: Aged; Body Fluids; Brazil; Case-Control Studies; Double-Blind Method; Dyspnea; Female; Follow-Up Stu | 2019 |
Diuretic Strategies for Loop Diuretic Resistance in Acute Heart Failure: The 3T Trial.
Topics: Administration, Oral; Aged; Chlorothiazide; Diuretics; Dose-Response Relationship, Drug; Double-Blin | 2020 |
Diuretic Strategies for Loop Diuretic Resistance in Acute Heart Failure: The 3T Trial.
Topics: Administration, Oral; Aged; Chlorothiazide; Diuretics; Dose-Response Relationship, Drug; Double-Blin | 2020 |
Comparing the sodium excreting efficacy of furosemide and indapamide combination against furosemide and metolazone combination in congestive heart failure patients: A randomized control trial.
Topics: Administration, Intravenous; Administration, Oral; Aged; Body Weight; Diuretics; Drug Therapy, Combi | 2019 |
Comparing the sodium excreting efficacy of furosemide and indapamide combination against furosemide and metolazone combination in congestive heart failure patients: A randomized control trial.
Topics: Administration, Intravenous; Administration, Oral; Aged; Body Weight; Diuretics; Drug Therapy, Combi | 2019 |
Comparative effectiveness of torasemide versus furosemide in symptomatic therapy in heart failure patients: Preliminary results from the randomized TORNADO trial.
Topics: Aged; Comparative Effectiveness Research; Exercise Tolerance; Female; Furosemide; Heart Failure; Hum | 2019 |
Comparative effectiveness of torasemide versus furosemide in symptomatic therapy in heart failure patients: Preliminary results from the randomized TORNADO trial.
Topics: Aged; Comparative Effectiveness Research; Exercise Tolerance; Female; Furosemide; Heart Failure; Hum | 2019 |
Spot urinary sodium in acute decompensation of advanced heart failure and dilutional hyponatremia: insights from DRAIN trial.
Topics: Administration, Intravenous; Aged; Biomarkers; Diuretics; Double-Blind Method; Drug Resistance; Fema | 2020 |
Spot urinary sodium in acute decompensation of advanced heart failure and dilutional hyponatremia: insights from DRAIN trial.
Topics: Administration, Intravenous; Aged; Biomarkers; Diuretics; Double-Blind Method; Drug Resistance; Fema | 2020 |
Tolvaptan vs. furosemide-based diuretic regimens in patients hospitalized for heart failure with hyponatremia (AQUA-AHF).
Topics: Antidiuretic Hormone Receptor Antagonists; Benzazepines; Diuretics; Furosemide; Heart Failure; Human | 2020 |
Tolvaptan vs. furosemide-based diuretic regimens in patients hospitalized for heart failure with hyponatremia (AQUA-AHF).
Topics: Antidiuretic Hormone Receptor Antagonists; Benzazepines; Diuretics; Furosemide; Heart Failure; Human | 2020 |
Differences in pharmacological property between combined therapy of the vasopressin V2-receptor antagonist tolvaptan plus furosemide and monotherapy of furosemide in patients with hospitalized heart failure.
Topics: Aged; Aged, 80 and over; Antidiuretic Agents; Antidiuretic Hormone Receptor Antagonists; Blood Press | 2020 |
Differences in pharmacological property between combined therapy of the vasopressin V2-receptor antagonist tolvaptan plus furosemide and monotherapy of furosemide in patients with hospitalized heart failure.
Topics: Aged; Aged, 80 and over; Antidiuretic Agents; Antidiuretic Hormone Receptor Antagonists; Blood Press | 2020 |
Efficacy of oral torasemide in dogs with degenerative mitral valve disease and new onset congestive heart failure: The CARPODIEM study.
Topics: Animals; Diuretics; Dog Diseases; Dogs; Furosemide; Heart Failure; Male; Mitral Valve; Sulfonamides; | 2020 |
Efficacy of oral torasemide in dogs with degenerative mitral valve disease and new onset congestive heart failure: The CARPODIEM study.
Topics: Animals; Diuretics; Dog Diseases; Dogs; Furosemide; Heart Failure; Male; Mitral Valve; Sulfonamides; | 2020 |
Efficacy of adding ramipril (VAsotop) to the combination of furosemide (Lasix) and pimobendan (VEtmedin) in dogs with mitral valve degeneration: The VALVE trial.
Topics: Animals; Dog Diseases; Dogs; Furosemide; Heart Failure; Mitral Valve; Prospective Studies; Pyridazin | 2020 |
Efficacy of adding ramipril (VAsotop) to the combination of furosemide (Lasix) and pimobendan (VEtmedin) in dogs with mitral valve degeneration: The VALVE trial.
Topics: Animals; Dog Diseases; Dogs; Furosemide; Heart Failure; Mitral Valve; Prospective Studies; Pyridazin | 2020 |
Effect of an Emergency Department Care Bundle on 30-Day Hospital Discharge and Survival Among Elderly Patients With Acute Heart Failure: The ELISABETH Randomized Clinical Trial.
Topics: Acute Disease; Aged; Aged, 80 and over; Diuretics; Emergency Service, Hospital; Female; France; Furo | 2020 |
Effect of an Emergency Department Care Bundle on 30-Day Hospital Discharge and Survival Among Elderly Patients With Acute Heart Failure: The ELISABETH Randomized Clinical Trial.
Topics: Acute Disease; Aged; Aged, 80 and over; Diuretics; Emergency Service, Hospital; Female; France; Furo | 2020 |
Effect of an Emergency Department Care Bundle on 30-Day Hospital Discharge and Survival Among Elderly Patients With Acute Heart Failure: The ELISABETH Randomized Clinical Trial.
Topics: Acute Disease; Aged; Aged, 80 and over; Diuretics; Emergency Service, Hospital; Female; France; Furo | 2020 |
Effect of an Emergency Department Care Bundle on 30-Day Hospital Discharge and Survival Among Elderly Patients With Acute Heart Failure: The ELISABETH Randomized Clinical Trial.
Topics: Acute Disease; Aged; Aged, 80 and over; Diuretics; Emergency Service, Hospital; Female; France; Furo | 2020 |
Effect of an Emergency Department Care Bundle on 30-Day Hospital Discharge and Survival Among Elderly Patients With Acute Heart Failure: The ELISABETH Randomized Clinical Trial.
Topics: Acute Disease; Aged; Aged, 80 and over; Diuretics; Emergency Service, Hospital; Female; France; Furo | 2020 |
Effect of an Emergency Department Care Bundle on 30-Day Hospital Discharge and Survival Among Elderly Patients With Acute Heart Failure: The ELISABETH Randomized Clinical Trial.
Topics: Acute Disease; Aged; Aged, 80 and over; Diuretics; Emergency Service, Hospital; Female; France; Furo | 2020 |
Effect of an Emergency Department Care Bundle on 30-Day Hospital Discharge and Survival Among Elderly Patients With Acute Heart Failure: The ELISABETH Randomized Clinical Trial.
Topics: Acute Disease; Aged; Aged, 80 and over; Diuretics; Emergency Service, Hospital; Female; France; Furo | 2020 |
Effect of an Emergency Department Care Bundle on 30-Day Hospital Discharge and Survival Among Elderly Patients With Acute Heart Failure: The ELISABETH Randomized Clinical Trial.
Topics: Acute Disease; Aged; Aged, 80 and over; Diuretics; Emergency Service, Hospital; Female; France; Furo | 2020 |
Shenfu injection combined with furosemide in the treatment of chronic heart failure in patients with coronary heart disease: A protocol of randomized controlled trial.
Topics: Chronic Disease; Coronary Disease; Diuretics; Drug Therapy, Combination; Drugs, Chinese Herbal; Furo | 2021 |
Shenfu injection combined with furosemide in the treatment of chronic heart failure in patients with coronary heart disease: A protocol of randomized controlled trial.
Topics: Chronic Disease; Coronary Disease; Diuretics; Drug Therapy, Combination; Drugs, Chinese Herbal; Furo | 2021 |
Comparative effectiveness of furosemide vs torasemide in symptomatic therapy in heart failure patients: A randomized controlled study protocol.
Topics: Diuretics; Furosemide; Heart Failure; Humans; Randomized Controlled Trials as Topic; Torsemide | 2021 |
Comparative effectiveness of furosemide vs torasemide in symptomatic therapy in heart failure patients: A randomized controlled study protocol.
Topics: Diuretics; Furosemide; Heart Failure; Humans; Randomized Controlled Trials as Topic; Torsemide | 2021 |
Diuretic therapy as prognostic enrichment factor for clinical trials in patients with heart failure with reduced ejection fraction.
Topics: Aged; Double-Blind Method; Female; Furosemide; Heart Failure; Hospitalization; Humans; Male; Prognos | 2021 |
Diuretic therapy as prognostic enrichment factor for clinical trials in patients with heart failure with reduced ejection fraction.
Topics: Aged; Double-Blind Method; Female; Furosemide; Heart Failure; Hospitalization; Humans; Male; Prognos | 2021 |
Early diuretic strategies and the association with In-hospital and Post-discharge outcomes in acute heart failure.
Topics: Creatinine; Diuretics; Drug Monitoring; Female; Furosemide; Heart Failure; Hospitalization; Humans; | 2021 |
Early diuretic strategies and the association with In-hospital and Post-discharge outcomes in acute heart failure.
Topics: Creatinine; Diuretics; Drug Monitoring; Female; Furosemide; Heart Failure; Hospitalization; Humans; | 2021 |
Effects of intravenous furosemide plus small-volume hypertonic saline solutions on markers of heart failure.
Topics: Biomarkers; Diuretics; Furosemide; Heart Failure; Humans; Saline Solution, Hypertonic | 2021 |
Effects of intravenous furosemide plus small-volume hypertonic saline solutions on markers of heart failure.
Topics: Biomarkers; Diuretics; Furosemide; Heart Failure; Humans; Saline Solution, Hypertonic | 2021 |
Effect of adding hydrochlorothiazide to usual treatment of patients with acute decompensated heart failure: a randomized clinical trial.
Topics: Creatinine; Diuretics; Double-Blind Method; Female; Furosemide; Heart Failure; Humans; Hydrochloroth | 2021 |
Effect of adding hydrochlorothiazide to usual treatment of patients with acute decompensated heart failure: a randomized clinical trial.
Topics: Creatinine; Diuretics; Double-Blind Method; Female; Furosemide; Heart Failure; Humans; Hydrochloroth | 2021 |
Diuretic Strategies in Acute Heart Failure and Renal Dysfunction: Conventional vs Carbohydrate Antigen 125-guided Strategy. Clinical Trial Design.
Topics: Acetazolamide; Acute Disease; CA-125 Antigen; Cardio-Renal Syndrome; Chlorthalidone; Creatinine; Diu | 2017 |
Diuretic Strategies in Acute Heart Failure and Renal Dysfunction: Conventional vs Carbohydrate Antigen 125-guided Strategy. Clinical Trial Design.
Topics: Acetazolamide; Acute Disease; CA-125 Antigen; Cardio-Renal Syndrome; Chlorthalidone; Creatinine; Diu | 2017 |
An exploratory analysis of the competing effects of aggressive decongestion and high-dose loop diuretic therapy in the DOSE trial.
Topics: Aged; Aged, 80 and over; Dose-Response Relationship, Drug; Double-Blind Method; Female; Follow-Up St | 2017 |
An exploratory analysis of the competing effects of aggressive decongestion and high-dose loop diuretic therapy in the DOSE trial.
Topics: Aged; Aged, 80 and over; Dose-Response Relationship, Drug; Double-Blind Method; Female; Follow-Up St | 2017 |
Impact of Compound Hypertonic Saline Solution on Decompensated Heart Failure.
Topics: China; Diuretics; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Follow-Up Stu | 2017 |
Impact of Compound Hypertonic Saline Solution on Decompensated Heart Failure.
Topics: China; Diuretics; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Follow-Up Stu | 2017 |
Effects of Additive Tolvaptan vs. Increased Furosemide on Heart Failure With Diuretic Resistance and Renal Impairment - Results From the K-STAR Study.
Topics: Aged; Aged, 80 and over; Antidiuretic Hormone Receptor Antagonists; Diuretics; Dose-Response Relatio | 2017 |
Effects of Additive Tolvaptan vs. Increased Furosemide on Heart Failure With Diuretic Resistance and Renal Impairment - Results From the K-STAR Study.
Topics: Aged; Aged, 80 and over; Antidiuretic Hormone Receptor Antagonists; Diuretics; Dose-Response Relatio | 2017 |
Acetazolamide as Add-on Diuretic Therapy in Exacerbations of Chronic Heart Failure: a Pilot Study.
Topics: Acetazolamide; Administration, Intravenous; Aged; Aged, 80 and over; Chronic Disease; Diuretics; Dos | 2017 |
Acetazolamide as Add-on Diuretic Therapy in Exacerbations of Chronic Heart Failure: a Pilot Study.
Topics: Acetazolamide; Administration, Intravenous; Aged; Aged, 80 and over; Chronic Disease; Diuretics; Dos | 2017 |
Short-Term Efficacy and Safety of Torasemide and Furosemide in 366 Dogs with Degenerative Mitral Valve Disease: The TEST Study.
Topics: Animals; Diuretics; Dogs; Female; Furosemide; Heart Failure; Heart Valve Diseases; Male; Mitral Valv | 2017 |
Short-Term Efficacy and Safety of Torasemide and Furosemide in 366 Dogs with Degenerative Mitral Valve Disease: The TEST Study.
Topics: Animals; Diuretics; Dogs; Female; Furosemide; Heart Failure; Heart Valve Diseases; Male; Mitral Valv | 2017 |
Rationale and study design of intravenous loop diuretic administration in acute heart failure: DIUR-AHF.
Topics: Acute Disease; Dose-Response Relationship, Drug; Follow-Up Studies; Furosemide; Heart Failure; Human | 2017 |
Rationale and study design of intravenous loop diuretic administration in acute heart failure: DIUR-AHF.
Topics: Acute Disease; Dose-Response Relationship, Drug; Follow-Up Studies; Furosemide; Heart Failure; Human | 2017 |
Effects of Tolvaptan Addition to Furosemide in Normo- and Hyponatremia Patients with Heart Failure and Chronic Kidney Disease Stages G3b-5: A Subanalysis of the K-STAR Study.
Topics: Administration, Oral; Aged; Aged, 80 and over; Antidiuretic Hormone Receptor Antagonists; Benzazepin | 2017 |
Effects of Tolvaptan Addition to Furosemide in Normo- and Hyponatremia Patients with Heart Failure and Chronic Kidney Disease Stages G3b-5: A Subanalysis of the K-STAR Study.
Topics: Administration, Oral; Aged; Aged, 80 and over; Antidiuretic Hormone Receptor Antagonists; Benzazepin | 2017 |
Rational and design of a randomized, double-blind, multicenter trial to evaluate the safety and tolerability of furosemide withdrawal in stable chronic outpatients with heart failure: The ReBIC-1 trial.
Topics: Aged; Biomarkers; Clinical Deterioration; Diuretics; Dose-Response Relationship, Drug; Double-Blind | 2017 |
Rational and design of a randomized, double-blind, multicenter trial to evaluate the safety and tolerability of furosemide withdrawal in stable chronic outpatients with heart failure: The ReBIC-1 trial.
Topics: Aged; Biomarkers; Clinical Deterioration; Diuretics; Dose-Response Relationship, Drug; Double-Blind | 2017 |
Efficacy of Intravenous Furosemide Versus a Novel, pH-Neutral Furosemide Formulation Administered Subcutaneously in Outpatients With Worsening Heart Failure.
Topics: Acute Disease; Diuretics; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Furosemide; H | 2018 |
Efficacy of Intravenous Furosemide Versus a Novel, pH-Neutral Furosemide Formulation Administered Subcutaneously in Outpatients With Worsening Heart Failure.
Topics: Acute Disease; Diuretics; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Furosemide; H | 2018 |
The SEISICAT study: a pilot study assessing efficacy and safety of spironolactone in cats with congestive heart failure secondary to cardiomyopathy.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Cardiomyopathies; Cat Diseases; Cats; Diuretics; | 2018 |
The SEISICAT study: a pilot study assessing efficacy and safety of spironolactone in cats with congestive heart failure secondary to cardiomyopathy.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Cardiomyopathies; Cat Diseases; Cats; Diuretics; | 2018 |
Determinants of Diuretic Responsiveness and Associated Outcomes During Acute Heart Failure Hospitalization: An Analysis From the NHLBI Heart Failure Network Clinical Trials.
Topics: Acute Disease; Aged; Aged, 80 and over; Biomarkers; Cystatin C; Dose-Response Relationship, Drug; Fe | 2018 |
Determinants of Diuretic Responsiveness and Associated Outcomes During Acute Heart Failure Hospitalization: An Analysis From the NHLBI Heart Failure Network Clinical Trials.
Topics: Acute Disease; Aged; Aged, 80 and over; Biomarkers; Cystatin C; Dose-Response Relationship, Drug; Fe | 2018 |
Comparison of the effects of tolvaptan and furosemide on renal water and sodium excretion in patients with heart failure and advanced chronic kidney disease: a subanalysis of the K-STAR study.
Topics: Aged; Aged, 80 and over; Antidiuretic Hormone Receptor Antagonists; Diuretics; Female; Furosemide; H | 2018 |
Comparison of the effects of tolvaptan and furosemide on renal water and sodium excretion in patients with heart failure and advanced chronic kidney disease: a subanalysis of the K-STAR study.
Topics: Aged; Aged, 80 and over; Antidiuretic Hormone Receptor Antagonists; Diuretics; Female; Furosemide; H | 2018 |
Randomized Evaluation of Heart Failure With Preserved Ejection Fraction Patients With Acute Heart Failure and Dopamine: The ROPA-DOP Trial.
Topics: Acute Disease; Aged; Creatinine; Diuretics; Dopamine; Drug Therapy, Combination; Female; Furosemide; | 2018 |
Randomized Evaluation of Heart Failure With Preserved Ejection Fraction Patients With Acute Heart Failure and Dopamine: The ROPA-DOP Trial.
Topics: Acute Disease; Aged; Creatinine; Diuretics; Dopamine; Drug Therapy, Combination; Female; Furosemide; | 2018 |
Different diuretic properties between tolvaptan and furosemide in congestive heart failure patients with diuretic resistance and renal impairment: a subanalysis of the K-STAR.
Topics: Aged; Aged, 80 and over; Antidiuretic Hormone Receptor Antagonists; Biomarkers; Creatinine; Drug Res | 2019 |
Different diuretic properties between tolvaptan and furosemide in congestive heart failure patients with diuretic resistance and renal impairment: a subanalysis of the K-STAR.
Topics: Aged; Aged, 80 and over; Antidiuretic Hormone Receptor Antagonists; Biomarkers; Creatinine; Drug Res | 2019 |
Specialty-Related Differences in the Acute-Phase Treatment and Prognosis in Patients With Acute Heart Failure - Insights From REALITY-AHF.
Topics: Acute Disease; Aged; Aged, 80 and over; Cardiologists; Disease-Free Survival; Emergency Service, Hos | 2018 |
Specialty-Related Differences in the Acute-Phase Treatment and Prognosis in Patients With Acute Heart Failure - Insights From REALITY-AHF.
Topics: Acute Disease; Aged; Aged, 80 and over; Cardiologists; Disease-Free Survival; Emergency Service, Hos | 2018 |
Reduced loop diuretic use in patients taking sacubitril/valsartan compared with enalapril: the PARADIGM-HF trial.
Topics: Aged; Aminobutyrates; Angiotensin Receptor Antagonists; Biological Availability; Biphenyl Compounds; | 2019 |
Reduced loop diuretic use in patients taking sacubitril/valsartan compared with enalapril: the PARADIGM-HF trial.
Topics: Aged; Aminobutyrates; Angiotensin Receptor Antagonists; Biological Availability; Biphenyl Compounds; | 2019 |
Reduced loop diuretic use in patients taking sacubitril/valsartan compared with enalapril: the PARADIGM-HF trial.
Topics: Aged; Aminobutyrates; Angiotensin Receptor Antagonists; Biological Availability; Biphenyl Compounds; | 2019 |
Reduced loop diuretic use in patients taking sacubitril/valsartan compared with enalapril: the PARADIGM-HF trial.
Topics: Aged; Aminobutyrates; Angiotensin Receptor Antagonists; Biological Availability; Biphenyl Compounds; | 2019 |
Reduced loop diuretic use in patients taking sacubitril/valsartan compared with enalapril: the PARADIGM-HF trial.
Topics: Aged; Aminobutyrates; Angiotensin Receptor Antagonists; Biological Availability; Biphenyl Compounds; | 2019 |
Reduced loop diuretic use in patients taking sacubitril/valsartan compared with enalapril: the PARADIGM-HF trial.
Topics: Aged; Aminobutyrates; Angiotensin Receptor Antagonists; Biological Availability; Biphenyl Compounds; | 2019 |
Reduced loop diuretic use in patients taking sacubitril/valsartan compared with enalapril: the PARADIGM-HF trial.
Topics: Aged; Aminobutyrates; Angiotensin Receptor Antagonists; Biological Availability; Biphenyl Compounds; | 2019 |
Reduced loop diuretic use in patients taking sacubitril/valsartan compared with enalapril: the PARADIGM-HF trial.
Topics: Aged; Aminobutyrates; Angiotensin Receptor Antagonists; Biological Availability; Biphenyl Compounds; | 2019 |
Higher Diuretic Requirements in Acute Heart Failure With Admission Hyponatraemia Versus Normonatraemia.
Topics: Acute Disease; Adult; Aged; Diuretics; Female; Furosemide; Heart Failure; Humans; Hyponatremia; Male | 2020 |
Higher Diuretic Requirements in Acute Heart Failure With Admission Hyponatraemia Versus Normonatraemia.
Topics: Acute Disease; Adult; Aged; Diuretics; Female; Furosemide; Heart Failure; Humans; Hyponatremia; Male | 2020 |
Controlled decongestion by Reprieve therapy in acute heart failure: results of the TARGET-1 and TARGET-2 studies.
Topics: Acute Disease; Aged; Central Venous Pressure; Creatinine; Diuretics; Edema, Cardiac; Equipment and S | 2019 |
Controlled decongestion by Reprieve therapy in acute heart failure: results of the TARGET-1 and TARGET-2 studies.
Topics: Acute Disease; Aged; Central Venous Pressure; Creatinine; Diuretics; Edema, Cardiac; Equipment and S | 2019 |
Diuretic treatment in high-risk acute decompensation of advanced chronic heart failure-bolus intermittent vs. continuous infusion of furosemide: a randomized controlled trial.
Topics: Aged; Central Venous Pressure; Chronic Disease; Double-Blind Method; Drug Administration Schedule; D | 2020 |
Diuretic treatment in high-risk acute decompensation of advanced chronic heart failure-bolus intermittent vs. continuous infusion of furosemide: a randomized controlled trial.
Topics: Aged; Central Venous Pressure; Chronic Disease; Double-Blind Method; Drug Administration Schedule; D | 2020 |
Clinical features and outcome in hospitalized heart failure in Japan (from the ATTEND Registry).
Topics: Aged; Aged, 80 and over; Angiotensin Receptor Antagonists; Atrial Natriuretic Factor; Diabetes Compl | 2013 |
Clinical features and outcome in hospitalized heart failure in Japan (from the ATTEND Registry).
Topics: Aged; Aged, 80 and over; Angiotensin Receptor Antagonists; Atrial Natriuretic Factor; Diabetes Compl | 2013 |
Clinical effects and safety of different strategies for administering intravenous diuretics in acutely decompensated heart failure: a randomised clinical trial.
Topics: Acute Disease; Aged; Aged, 80 and over; Biomarkers; Creatinine; Diuretics; Female; Furosemide; Heart | 2014 |
Clinical effects and safety of different strategies for administering intravenous diuretics in acutely decompensated heart failure: a randomised clinical trial.
Topics: Acute Disease; Aged; Aged, 80 and over; Biomarkers; Creatinine; Diuretics; Female; Furosemide; Heart | 2014 |
Clinical effectiveness of tolvaptan in patients with acute decompensated heart failure and renal failure: design and rationale of the AQUAMARINE study.
Topics: Acute Disease; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Diuretics; Drug Therapy, Com | 2014 |
Clinical effectiveness of tolvaptan in patients with acute decompensated heart failure and renal failure: design and rationale of the AQUAMARINE study.
Topics: Acute Disease; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Diuretics; Drug Therapy, Com | 2014 |
Mineralocorticoid receptor antagonism in acutely decompensated chronic heart failure.
Topics: Acute Disease; Aged; Aged, 80 and over; Chronic Disease; Disease Progression; Diuretics; Edema; Fema | 2014 |
Mineralocorticoid receptor antagonism in acutely decompensated chronic heart failure.
Topics: Acute Disease; Aged; Aged, 80 and over; Chronic Disease; Disease Progression; Diuretics; Edema; Fema | 2014 |
Continuous ultrafiltration for congestive heart failure: the CUORE trial.
Topics: Aged; Aged, 80 and over; Body Weight; Cardiovascular Agents; Confidence Intervals; Diuretics; Dose-R | 2014 |
Continuous ultrafiltration for congestive heart failure: the CUORE trial.
Topics: Aged; Aged, 80 and over; Body Weight; Cardiovascular Agents; Confidence Intervals; Diuretics; Dose-R | 2014 |
Spironolactone, not furosemide, improved insulin resistance in patients with chronic heart failure.
Topics: Aged; Blood Glucose; Chronic Disease; Cross-Over Studies; Double-Blind Method; Female; Furosemide; H | 2014 |
Spironolactone, not furosemide, improved insulin resistance in patients with chronic heart failure.
Topics: Aged; Blood Glucose; Chronic Disease; Cross-Over Studies; Double-Blind Method; Female; Furosemide; H | 2014 |
Intravenous salt supplementation with low-dose furosemide for treatment of acute decompensated heart failure.
Topics: Acute Disease; Aged; Aged, 80 and over; Drug Therapy, Combination; Female; Furosemide; Glomerular Fi | 2014 |
Intravenous salt supplementation with low-dose furosemide for treatment of acute decompensated heart failure.
Topics: Acute Disease; Aged; Aged, 80 and over; Drug Therapy, Combination; Female; Furosemide; Glomerular Fi | 2014 |
Intravenous salt supplementation with low-dose furosemide for treatment of acute decompensated heart failure.
Topics: Acute Disease; Aged; Aged, 80 and over; Drug Therapy, Combination; Female; Furosemide; Glomerular Fi | 2014 |
Intravenous salt supplementation with low-dose furosemide for treatment of acute decompensated heart failure.
Topics: Acute Disease; Aged; Aged, 80 and over; Drug Therapy, Combination; Female; Furosemide; Glomerular Fi | 2014 |
Intravenous salt supplementation with low-dose furosemide for treatment of acute decompensated heart failure.
Topics: Acute Disease; Aged; Aged, 80 and over; Drug Therapy, Combination; Female; Furosemide; Glomerular Fi | 2014 |
Intravenous salt supplementation with low-dose furosemide for treatment of acute decompensated heart failure.
Topics: Acute Disease; Aged; Aged, 80 and over; Drug Therapy, Combination; Female; Furosemide; Glomerular Fi | 2014 |
Intravenous salt supplementation with low-dose furosemide for treatment of acute decompensated heart failure.
Topics: Acute Disease; Aged; Aged, 80 and over; Drug Therapy, Combination; Female; Furosemide; Glomerular Fi | 2014 |
Intravenous salt supplementation with low-dose furosemide for treatment of acute decompensated heart failure.
Topics: Acute Disease; Aged; Aged, 80 and over; Drug Therapy, Combination; Female; Furosemide; Glomerular Fi | 2014 |
Assessing parenteral diuretic treatment of decompensated heart failure in the community.
Topics: Aged; Aged, 80 and over; Diuretics; Female; Furosemide; Heart Failure; Home Care Services; Humans; I | 2013 |
Assessing parenteral diuretic treatment of decompensated heart failure in the community.
Topics: Aged; Aged, 80 and over; Diuretics; Female; Furosemide; Heart Failure; Home Care Services; Humans; I | 2013 |
Efficacy and safety of high dose versus low dose furosemide with or without dopamine infusion: the Dopamine in Acute Decompensated Heart Failure II (DAD-HF II) trial.
Topics: Aged; Aged, 80 and over; Blood Pressure; Cardiotonic Agents; Diuretics; Dopamine; Dose-Response Rela | 2014 |
Efficacy and safety of high dose versus low dose furosemide with or without dopamine infusion: the Dopamine in Acute Decompensated Heart Failure II (DAD-HF II) trial.
Topics: Aged; Aged, 80 and over; Blood Pressure; Cardiotonic Agents; Diuretics; Dopamine; Dose-Response Rela | 2014 |
Diuretic response in acute heart failure: clinical characteristics and prognostic significance.
Topics: Acute Disease; Aged; Analysis of Variance; Atherosclerosis; Bumetanide; Diabetes Complications; Diur | 2014 |
Diuretic response in acute heart failure: clinical characteristics and prognostic significance.
Topics: Acute Disease; Aged; Analysis of Variance; Atherosclerosis; Bumetanide; Diabetes Complications; Diur | 2014 |
Continuous versus bolus intermittent loop diuretic infusion in acutely decompensated heart failure: a prospective randomized trial.
Topics: Acute Kidney Injury; Aged; Aged, 80 and over; Creatinine; Diuretics; Double-Blind Method; Female; Fu | 2014 |
Continuous versus bolus intermittent loop diuretic infusion in acutely decompensated heart failure: a prospective randomized trial.
Topics: Acute Kidney Injury; Aged; Aged, 80 and over; Creatinine; Diuretics; Double-Blind Method; Female; Fu | 2014 |
Continuous versus bolus intermittent loop diuretic infusion in acutely decompensated heart failure: a prospective randomized trial.
Topics: Acute Kidney Injury; Aged; Aged, 80 and over; Creatinine; Diuretics; Double-Blind Method; Female; Fu | 2014 |
Continuous versus bolus intermittent loop diuretic infusion in acutely decompensated heart failure: a prospective randomized trial.
Topics: Acute Kidney Injury; Aged; Aged, 80 and over; Creatinine; Diuretics; Double-Blind Method; Female; Fu | 2014 |
Continuous versus bolus intermittent loop diuretic infusion in acutely decompensated heart failure: a prospective randomized trial.
Topics: Acute Kidney Injury; Aged; Aged, 80 and over; Creatinine; Diuretics; Double-Blind Method; Female; Fu | 2014 |
Continuous versus bolus intermittent loop diuretic infusion in acutely decompensated heart failure: a prospective randomized trial.
Topics: Acute Kidney Injury; Aged; Aged, 80 and over; Creatinine; Diuretics; Double-Blind Method; Female; Fu | 2014 |
Continuous versus bolus intermittent loop diuretic infusion in acutely decompensated heart failure: a prospective randomized trial.
Topics: Acute Kidney Injury; Aged; Aged, 80 and over; Creatinine; Diuretics; Double-Blind Method; Female; Fu | 2014 |
Continuous versus bolus intermittent loop diuretic infusion in acutely decompensated heart failure: a prospective randomized trial.
Topics: Acute Kidney Injury; Aged; Aged, 80 and over; Creatinine; Diuretics; Double-Blind Method; Female; Fu | 2014 |
Short and long-term effects of continuous versus intermittent loop diuretics treatment in acute heart failure with renal dysfunction.
Topics: Acute Disease; Administration, Intravenous; Aged; Diuretics; Female; Furosemide; Heart Failure; Huma | 2015 |
Short and long-term effects of continuous versus intermittent loop diuretics treatment in acute heart failure with renal dysfunction.
Topics: Acute Disease; Administration, Intravenous; Aged; Diuretics; Female; Furosemide; Heart Failure; Huma | 2015 |
Diuretic response in patients with acute decompensated heart failure: characteristics and clinical outcome--an analysis from RELAX-AHF.
Topics: Acute Disease; Aged; Diuretics; Double-Blind Method; Female; Furosemide; Heart Failure; Humans; Leng | 2014 |
Diuretic response in patients with acute decompensated heart failure: characteristics and clinical outcome--an analysis from RELAX-AHF.
Topics: Acute Disease; Aged; Diuretics; Double-Blind Method; Female; Furosemide; Heart Failure; Humans; Leng | 2014 |
Diuretic response in patients with acute decompensated heart failure: characteristics and clinical outcome--an analysis from RELAX-AHF.
Topics: Acute Disease; Aged; Diuretics; Double-Blind Method; Female; Furosemide; Heart Failure; Humans; Leng | 2014 |
Diuretic response in patients with acute decompensated heart failure: characteristics and clinical outcome--an analysis from RELAX-AHF.
Topics: Acute Disease; Aged; Diuretics; Double-Blind Method; Female; Furosemide; Heart Failure; Humans; Leng | 2014 |
Diuretic response in patients with acute decompensated heart failure: characteristics and clinical outcome--an analysis from RELAX-AHF.
Topics: Acute Disease; Aged; Diuretics; Double-Blind Method; Female; Furosemide; Heart Failure; Humans; Leng | 2014 |
Diuretic response in patients with acute decompensated heart failure: characteristics and clinical outcome--an analysis from RELAX-AHF.
Topics: Acute Disease; Aged; Diuretics; Double-Blind Method; Female; Furosemide; Heart Failure; Humans; Leng | 2014 |
Diuretic response in patients with acute decompensated heart failure: characteristics and clinical outcome--an analysis from RELAX-AHF.
Topics: Acute Disease; Aged; Diuretics; Double-Blind Method; Female; Furosemide; Heart Failure; Humans; Leng | 2014 |
Diuretic response in patients with acute decompensated heart failure: characteristics and clinical outcome--an analysis from RELAX-AHF.
Topics: Acute Disease; Aged; Diuretics; Double-Blind Method; Female; Furosemide; Heart Failure; Humans; Leng | 2014 |
Diuretic response in patients with acute decompensated heart failure: characteristics and clinical outcome--an analysis from RELAX-AHF.
Topics: Acute Disease; Aged; Diuretics; Double-Blind Method; Female; Furosemide; Heart Failure; Humans; Leng | 2014 |
Diuretic response in patients with acute decompensated heart failure: characteristics and clinical outcome--an analysis from RELAX-AHF.
Topics: Acute Disease; Aged; Diuretics; Double-Blind Method; Female; Furosemide; Heart Failure; Humans; Leng | 2014 |
Diuretic response in patients with acute decompensated heart failure: characteristics and clinical outcome--an analysis from RELAX-AHF.
Topics: Acute Disease; Aged; Diuretics; Double-Blind Method; Female; Furosemide; Heart Failure; Humans; Leng | 2014 |
Diuretic response in patients with acute decompensated heart failure: characteristics and clinical outcome--an analysis from RELAX-AHF.
Topics: Acute Disease; Aged; Diuretics; Double-Blind Method; Female; Furosemide; Heart Failure; Humans; Leng | 2014 |
Diuretic response in patients with acute decompensated heart failure: characteristics and clinical outcome--an analysis from RELAX-AHF.
Topics: Acute Disease; Aged; Diuretics; Double-Blind Method; Female; Furosemide; Heart Failure; Humans; Leng | 2014 |
Diuretic response in patients with acute decompensated heart failure: characteristics and clinical outcome--an analysis from RELAX-AHF.
Topics: Acute Disease; Aged; Diuretics; Double-Blind Method; Female; Furosemide; Heart Failure; Humans; Leng | 2014 |
Diuretic response in patients with acute decompensated heart failure: characteristics and clinical outcome--an analysis from RELAX-AHF.
Topics: Acute Disease; Aged; Diuretics; Double-Blind Method; Female; Furosemide; Heart Failure; Humans; Leng | 2014 |
Diuretic response in patients with acute decompensated heart failure: characteristics and clinical outcome--an analysis from RELAX-AHF.
Topics: Acute Disease; Aged; Diuretics; Double-Blind Method; Female; Furosemide; Heart Failure; Humans; Leng | 2014 |
Diuretic response in patients with acute decompensated heart failure: characteristics and clinical outcome--an analysis from RELAX-AHF.
Topics: Acute Disease; Aged; Diuretics; Double-Blind Method; Female; Furosemide; Heart Failure; Humans; Leng | 2014 |
Diuretic response in patients with acute decompensated heart failure: characteristics and clinical outcome--an analysis from RELAX-AHF.
Topics: Acute Disease; Aged; Diuretics; Double-Blind Method; Female; Furosemide; Heart Failure; Humans; Leng | 2014 |
Lowering furosemide dose in stable chronic heart failure patients with reduced ejection fraction is not accompanied by decompensation: a randomized study.
Topics: Adult; Aged; Diuretics; Dose-Response Relationship, Drug; Female; Furosemide; Heart Failure; Humans; | 2014 |
Lowering furosemide dose in stable chronic heart failure patients with reduced ejection fraction is not accompanied by decompensation: a randomized study.
Topics: Adult; Aged; Diuretics; Dose-Response Relationship, Drug; Female; Furosemide; Heart Failure; Humans; | 2014 |
Efficacy of tolvaptan added to furosemide in heart failure patients with advanced kidney dysfunction: a pharmacokinetic and pharmacodynamic study.
Topics: Adult; Aged; Aged, 80 and over; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Diuretics; | 2015 |
Efficacy of tolvaptan added to furosemide in heart failure patients with advanced kidney dysfunction: a pharmacokinetic and pharmacodynamic study.
Topics: Adult; Aged; Aged, 80 and over; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Diuretics; | 2015 |
Decongestion strategies and renin-angiotensin-aldosterone system activation in acute heart failure.
Topics: Aged; Aldosterone; Biomarkers; Blood Pressure; Blood Urea Nitrogen; Diuretics; Dose-Response Relatio | 2015 |
Decongestion strategies and renin-angiotensin-aldosterone system activation in acute heart failure.
Topics: Aged; Aldosterone; Biomarkers; Blood Pressure; Blood Urea Nitrogen; Diuretics; Dose-Response Relatio | 2015 |
Decongestion strategies and renin-angiotensin-aldosterone system activation in acute heart failure.
Topics: Aged; Aldosterone; Biomarkers; Blood Pressure; Blood Urea Nitrogen; Diuretics; Dose-Response Relatio | 2015 |
Decongestion strategies and renin-angiotensin-aldosterone system activation in acute heart failure.
Topics: Aged; Aldosterone; Biomarkers; Blood Pressure; Blood Urea Nitrogen; Diuretics; Dose-Response Relatio | 2015 |
Decongestion strategies and renin-angiotensin-aldosterone system activation in acute heart failure.
Topics: Aged; Aldosterone; Biomarkers; Blood Pressure; Blood Urea Nitrogen; Diuretics; Dose-Response Relatio | 2015 |
Decongestion strategies and renin-angiotensin-aldosterone system activation in acute heart failure.
Topics: Aged; Aldosterone; Biomarkers; Blood Pressure; Blood Urea Nitrogen; Diuretics; Dose-Response Relatio | 2015 |
Decongestion strategies and renin-angiotensin-aldosterone system activation in acute heart failure.
Topics: Aged; Aldosterone; Biomarkers; Blood Pressure; Blood Urea Nitrogen; Diuretics; Dose-Response Relatio | 2015 |
Decongestion strategies and renin-angiotensin-aldosterone system activation in acute heart failure.
Topics: Aged; Aldosterone; Biomarkers; Blood Pressure; Blood Urea Nitrogen; Diuretics; Dose-Response Relatio | 2015 |
Decongestion strategies and renin-angiotensin-aldosterone system activation in acute heart failure.
Topics: Aged; Aldosterone; Biomarkers; Blood Pressure; Blood Urea Nitrogen; Diuretics; Dose-Response Relatio | 2015 |
Decongestion strategies and renin-angiotensin-aldosterone system activation in acute heart failure.
Topics: Aged; Aldosterone; Biomarkers; Blood Pressure; Blood Urea Nitrogen; Diuretics; Dose-Response Relatio | 2015 |
Decongestion strategies and renin-angiotensin-aldosterone system activation in acute heart failure.
Topics: Aged; Aldosterone; Biomarkers; Blood Pressure; Blood Urea Nitrogen; Diuretics; Dose-Response Relatio | 2015 |
Decongestion strategies and renin-angiotensin-aldosterone system activation in acute heart failure.
Topics: Aged; Aldosterone; Biomarkers; Blood Pressure; Blood Urea Nitrogen; Diuretics; Dose-Response Relatio | 2015 |
Decongestion strategies and renin-angiotensin-aldosterone system activation in acute heart failure.
Topics: Aged; Aldosterone; Biomarkers; Blood Pressure; Blood Urea Nitrogen; Diuretics; Dose-Response Relatio | 2015 |
Decongestion strategies and renin-angiotensin-aldosterone system activation in acute heart failure.
Topics: Aged; Aldosterone; Biomarkers; Blood Pressure; Blood Urea Nitrogen; Diuretics; Dose-Response Relatio | 2015 |
Decongestion strategies and renin-angiotensin-aldosterone system activation in acute heart failure.
Topics: Aged; Aldosterone; Biomarkers; Blood Pressure; Blood Urea Nitrogen; Diuretics; Dose-Response Relatio | 2015 |
Decongestion strategies and renin-angiotensin-aldosterone system activation in acute heart failure.
Topics: Aged; Aldosterone; Biomarkers; Blood Pressure; Blood Urea Nitrogen; Diuretics; Dose-Response Relatio | 2015 |
Decongestion strategies and renin-angiotensin-aldosterone system activation in acute heart failure.
Topics: Aged; Aldosterone; Biomarkers; Blood Pressure; Blood Urea Nitrogen; Diuretics; Dose-Response Relatio | 2015 |
Decongestion strategies and renin-angiotensin-aldosterone system activation in acute heart failure.
Topics: Aged; Aldosterone; Biomarkers; Blood Pressure; Blood Urea Nitrogen; Diuretics; Dose-Response Relatio | 2015 |
Renal effects of added low-dose dopamine in acute heart failure patients with diuretic resistance to natriuretic peptide.
Topics: Aged; Aged, 80 and over; Atrial Natriuretic Factor; Biomarkers; Creatinine; Diuresis; Diuretics; Dop | 2015 |
Renal effects of added low-dose dopamine in acute heart failure patients with diuretic resistance to natriuretic peptide.
Topics: Aged; Aged, 80 and over; Atrial Natriuretic Factor; Biomarkers; Creatinine; Diuresis; Diuretics; Dop | 2015 |
Safety of add-on tolvaptan in patients with furosemide-resistant congestive heart failure complicated by advanced chronic kidney disease: a sub-analysis of a pharmacokinetics/ pharmacodynamics study.
Topics: Adult; Aged; Aged, 80 and over; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Blood Press | 2015 |
Safety of add-on tolvaptan in patients with furosemide-resistant congestive heart failure complicated by advanced chronic kidney disease: a sub-analysis of a pharmacokinetics/ pharmacodynamics study.
Topics: Adult; Aged; Aged, 80 and over; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Blood Press | 2015 |
Comparison of three diuretic treatment strategies for patients with acute decompensated heart failure.
Topics: Acute Disease; Administration, Oral; Adrenergic beta-Antagonists; Aged; Angiotensin-Converting Enzym | 2015 |
Comparison of three diuretic treatment strategies for patients with acute decompensated heart failure.
Topics: Acute Disease; Administration, Oral; Adrenergic beta-Antagonists; Aged; Angiotensin-Converting Enzym | 2015 |
Randomized, open-label, blinded-endpoint, crossover, single-dose study to compare the pharmacodynamics of torasemide-PR 10 mg, torasemide-IR 10 mg, and furosemide-IR 40 mg, in patients with chronic heart failure.
Topics: Aged; Aged, 80 and over; Chemistry, Pharmaceutical; Chronic Disease; Cross-Over Studies; Delayed-Act | 2015 |
Randomized, open-label, blinded-endpoint, crossover, single-dose study to compare the pharmacodynamics of torasemide-PR 10 mg, torasemide-IR 10 mg, and furosemide-IR 40 mg, in patients with chronic heart failure.
Topics: Aged; Aged, 80 and over; Chemistry, Pharmaceutical; Chronic Disease; Cross-Over Studies; Delayed-Act | 2015 |
Diuretic response in acute heart failure-an analysis from ASCEND-HF.
Topics: Acute Disease; Aged; Disease Progression; Diuretics; Dose-Response Relationship, Drug; Double-Blind | 2015 |
Diuretic response in acute heart failure-an analysis from ASCEND-HF.
Topics: Acute Disease; Aged; Disease Progression; Diuretics; Dose-Response Relationship, Drug; Double-Blind | 2015 |
Diuretic response in acute heart failure-an analysis from ASCEND-HF.
Topics: Acute Disease; Aged; Disease Progression; Diuretics; Dose-Response Relationship, Drug; Double-Blind | 2015 |
Diuretic response in acute heart failure-an analysis from ASCEND-HF.
Topics: Acute Disease; Aged; Disease Progression; Diuretics; Dose-Response Relationship, Drug; Double-Blind | 2015 |
Diuretic response in acute heart failure-an analysis from ASCEND-HF.
Topics: Acute Disease; Aged; Disease Progression; Diuretics; Dose-Response Relationship, Drug; Double-Blind | 2015 |
Diuretic response in acute heart failure-an analysis from ASCEND-HF.
Topics: Acute Disease; Aged; Disease Progression; Diuretics; Dose-Response Relationship, Drug; Double-Blind | 2015 |
Diuretic response in acute heart failure-an analysis from ASCEND-HF.
Topics: Acute Disease; Aged; Disease Progression; Diuretics; Dose-Response Relationship, Drug; Double-Blind | 2015 |
Diuretic response in acute heart failure-an analysis from ASCEND-HF.
Topics: Acute Disease; Aged; Disease Progression; Diuretics; Dose-Response Relationship, Drug; Double-Blind | 2015 |
Comparative effectiveness of torsemide versus furosemide in heart failure patients: insights from the PROTECT trial.
Topics: Aged; Disease Progression; Diuretics; Dose-Response Relationship, Drug; Europe; Female; Follow-Up St | 2015 |
Comparative effectiveness of torsemide versus furosemide in heart failure patients: insights from the PROTECT trial.
Topics: Aged; Disease Progression; Diuretics; Dose-Response Relationship, Drug; Europe; Female; Follow-Up St | 2015 |
Hypertonic Saline in Conjunction with High-Dose Furosemide Improves Dose-Response Curves in Worsening Refractory Congestive Heart Failure.
Topics: Aged; Aged, 80 and over; Chronic Disease; Diuretics; Dose-Response Relationship, Drug; Drug Therapy, | 2015 |
Hypertonic Saline in Conjunction with High-Dose Furosemide Improves Dose-Response Curves in Worsening Refractory Congestive Heart Failure.
Topics: Aged; Aged, 80 and over; Chronic Disease; Diuretics; Dose-Response Relationship, Drug; Drug Therapy, | 2015 |
Rationale and Design of the "Safety and Efficacy of the Combination of Loop with Thiazide-type Diuretics in Patients with Decompensated Heart Failure (CLOROTIC) Trial:" A Double-Blind, Randomized, Placebo-Controlled Study to Determine the Effect of Combin
Topics: Chronic Disease; Diuretics; Double-Blind Method; Drug Therapy, Combination; Drug Tolerance; Furosemi | 2016 |
Rationale and Design of the "Safety and Efficacy of the Combination of Loop with Thiazide-type Diuretics in Patients with Decompensated Heart Failure (CLOROTIC) Trial:" A Double-Blind, Randomized, Placebo-Controlled Study to Determine the Effect of Combin
Topics: Chronic Disease; Diuretics; Double-Blind Method; Drug Therapy, Combination; Drug Tolerance; Furosemi | 2016 |
Early administration of tolvaptan preserves renal function in elderly patients with acute decompensated heart failure.
Topics: Acute Disease; Aged, 80 and over; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Diuretics | 2016 |
Early administration of tolvaptan preserves renal function in elderly patients with acute decompensated heart failure.
Topics: Acute Disease; Aged, 80 and over; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Diuretics | 2016 |
Torsemide Versus Furosemide in Patients With Acute Heart Failure (from the ASCEND-HF Trial).
Topics: Acute Disease; Aged; Cause of Death; Dose-Response Relationship, Drug; Double-Blind Method; Female; | 2016 |
Torsemide Versus Furosemide in Patients With Acute Heart Failure (from the ASCEND-HF Trial).
Topics: Acute Disease; Aged; Cause of Death; Dose-Response Relationship, Drug; Double-Blind Method; Female; | 2016 |
Combining Diuretic Response and Hemoconcentration to Predict Rehospitalization After Admission for Acute Heart Failure.
Topics: Acute Disease; Aged; Aged, 80 and over; Benzazepines; Biomarkers; Decision Support Techniques; Diure | 2016 |
Combining Diuretic Response and Hemoconcentration to Predict Rehospitalization After Admission for Acute Heart Failure.
Topics: Acute Disease; Aged; Aged, 80 and over; Benzazepines; Biomarkers; Decision Support Techniques; Diure | 2016 |
Combining Diuretic Response and Hemoconcentration to Predict Rehospitalization After Admission for Acute Heart Failure.
Topics: Acute Disease; Aged; Aged, 80 and over; Benzazepines; Biomarkers; Decision Support Techniques; Diure | 2016 |
Combining Diuretic Response and Hemoconcentration to Predict Rehospitalization After Admission for Acute Heart Failure.
Topics: Acute Disease; Aged; Aged, 80 and over; Benzazepines; Biomarkers; Decision Support Techniques; Diure | 2016 |
Combining Diuretic Response and Hemoconcentration to Predict Rehospitalization After Admission for Acute Heart Failure.
Topics: Acute Disease; Aged; Aged, 80 and over; Benzazepines; Biomarkers; Decision Support Techniques; Diure | 2016 |
Combining Diuretic Response and Hemoconcentration to Predict Rehospitalization After Admission for Acute Heart Failure.
Topics: Acute Disease; Aged; Aged, 80 and over; Benzazepines; Biomarkers; Decision Support Techniques; Diure | 2016 |
Combining Diuretic Response and Hemoconcentration to Predict Rehospitalization After Admission for Acute Heart Failure.
Topics: Acute Disease; Aged; Aged, 80 and over; Benzazepines; Biomarkers; Decision Support Techniques; Diure | 2016 |
Combining Diuretic Response and Hemoconcentration to Predict Rehospitalization After Admission for Acute Heart Failure.
Topics: Acute Disease; Aged; Aged, 80 and over; Benzazepines; Biomarkers; Decision Support Techniques; Diure | 2016 |
Combining Diuretic Response and Hemoconcentration to Predict Rehospitalization After Admission for Acute Heart Failure.
Topics: Acute Disease; Aged; Aged, 80 and over; Benzazepines; Biomarkers; Decision Support Techniques; Diure | 2016 |
Combining Diuretic Response and Hemoconcentration to Predict Rehospitalization After Admission for Acute Heart Failure.
Topics: Acute Disease; Aged; Aged, 80 and over; Benzazepines; Biomarkers; Decision Support Techniques; Diure | 2016 |
Combining Diuretic Response and Hemoconcentration to Predict Rehospitalization After Admission for Acute Heart Failure.
Topics: Acute Disease; Aged; Aged, 80 and over; Benzazepines; Biomarkers; Decision Support Techniques; Diure | 2016 |
Combining Diuretic Response and Hemoconcentration to Predict Rehospitalization After Admission for Acute Heart Failure.
Topics: Acute Disease; Aged; Aged, 80 and over; Benzazepines; Biomarkers; Decision Support Techniques; Diure | 2016 |
Combining Diuretic Response and Hemoconcentration to Predict Rehospitalization After Admission for Acute Heart Failure.
Topics: Acute Disease; Aged; Aged, 80 and over; Benzazepines; Biomarkers; Decision Support Techniques; Diure | 2016 |
Combining Diuretic Response and Hemoconcentration to Predict Rehospitalization After Admission for Acute Heart Failure.
Topics: Acute Disease; Aged; Aged, 80 and over; Benzazepines; Biomarkers; Decision Support Techniques; Diure | 2016 |
Combining Diuretic Response and Hemoconcentration to Predict Rehospitalization After Admission for Acute Heart Failure.
Topics: Acute Disease; Aged; Aged, 80 and over; Benzazepines; Biomarkers; Decision Support Techniques; Diure | 2016 |
Combining Diuretic Response and Hemoconcentration to Predict Rehospitalization After Admission for Acute Heart Failure.
Topics: Acute Disease; Aged; Aged, 80 and over; Benzazepines; Biomarkers; Decision Support Techniques; Diure | 2016 |
Combining Diuretic Response and Hemoconcentration to Predict Rehospitalization After Admission for Acute Heart Failure.
Topics: Acute Disease; Aged; Aged, 80 and over; Benzazepines; Biomarkers; Decision Support Techniques; Diure | 2016 |
Combining Diuretic Response and Hemoconcentration to Predict Rehospitalization After Admission for Acute Heart Failure.
Topics: Acute Disease; Aged; Aged, 80 and over; Benzazepines; Biomarkers; Decision Support Techniques; Diure | 2016 |
Relevance of Changes in Serum Creatinine During a Heart Failure Trial of Decongestive Strategies: Insights From the DOSE Trial.
Topics: Aged; Biomarkers; Cause of Death; Creatinine; Disease Progression; Disease-Free Survival; Diuretics; | 2016 |
Relevance of Changes in Serum Creatinine During a Heart Failure Trial of Decongestive Strategies: Insights From the DOSE Trial.
Topics: Aged; Biomarkers; Cause of Death; Creatinine; Disease Progression; Disease-Free Survival; Diuretics; | 2016 |
Hypochloremia and Diuretic Resistance in Heart Failure: Mechanistic Insights.
Topics: Aged; Aged, 80 and over; Biomarkers; Chlorides; Connecticut; Cross-Sectional Studies; Down-Regulatio | 2016 |
Hypochloremia and Diuretic Resistance in Heart Failure: Mechanistic Insights.
Topics: Aged; Aged, 80 and over; Biomarkers; Chlorides; Connecticut; Cross-Sectional Studies; Down-Regulatio | 2016 |
Different diuretic dose and response in acute decompensated heart failure: Clinical characteristics and prognostic significance.
Topics: Acute Disease; Administration, Intravenous; Aged; Aged, 80 and over; Diuretics; Dose-Response Relati | 2016 |
Different diuretic dose and response in acute decompensated heart failure: Clinical characteristics and prognostic significance.
Topics: Acute Disease; Administration, Intravenous; Aged; Aged, 80 and over; Diuretics; Dose-Response Relati | 2016 |
A response-adaptive design of initial therapy for emergency department patients with heart failure.
Topics: Acute Disease; Bayes Theorem; Blood Pressure; Diuretics; Dyspnea; Emergency Service, Hospital; Furos | 2017 |
A response-adaptive design of initial therapy for emergency department patients with heart failure.
Topics: Acute Disease; Bayes Theorem; Blood Pressure; Diuretics; Dyspnea; Emergency Service, Hospital; Furos | 2017 |
Changes in brain natriuretic peptide in chronic heart failure patients treated with long-acting versus short-acting loop diuretics: J-MELODIC subanalysis.
Topics: Aged; Aged, 80 and over; Biomarkers; Chronic Disease; Echocardiography; Female; Furosemide; Heart Fa | 2017 |
Changes in brain natriuretic peptide in chronic heart failure patients treated with long-acting versus short-acting loop diuretics: J-MELODIC subanalysis.
Topics: Aged; Aged, 80 and over; Biomarkers; Chronic Disease; Echocardiography; Female; Furosemide; Heart Fa | 2017 |
The impact of torasemide on haemodynamic and neurohormonal stress, and cardiac remodelling in heart failure - TORNADO: a study protocol for a randomized controlled trial.
Topics: Biomarkers; Chronic Disease; Clinical Protocols; Echocardiography; Electrocardiography, Ambulatory; | 2017 |
The impact of torasemide on haemodynamic and neurohormonal stress, and cardiac remodelling in heart failure - TORNADO: a study protocol for a randomized controlled trial.
Topics: Biomarkers; Chronic Disease; Clinical Protocols; Echocardiography; Electrocardiography, Ambulatory; | 2017 |
Influence of spironolactone therapy on thiamine blood levels in patients with heart failure.
Topics: Aged; Aged, 80 and over; Chi-Square Distribution; Chronic Disease; Cross-Sectional Studies; Diuretic | 2008 |
Influence of spironolactone therapy on thiamine blood levels in patients with heart failure.
Topics: Aged; Aged, 80 and over; Chi-Square Distribution; Chronic Disease; Cross-Sectional Studies; Diuretic | 2008 |
Impact of treatment on myocardial lysyl oxidase expression and collagen cross-linking in patients with heart failure.
Topics: Aged; Collagen; Diuretics; Dose-Response Relationship, Drug; Female; Furosemide; Heart Failure; Hear | 2009 |
Impact of treatment on myocardial lysyl oxidase expression and collagen cross-linking in patients with heart failure.
Topics: Aged; Collagen; Diuretics; Dose-Response Relationship, Drug; Female; Furosemide; Heart Failure; Hear | 2009 |
TORAFIC study protocol: torasemide prolonged release versus furosemide in patients with chronic heart failure.
Topics: Chronic Disease; Collagen Type I; Delayed-Action Preparations; Diuretics; Female; Fibrosis; Furosemi | 2009 |
TORAFIC study protocol: torasemide prolonged release versus furosemide in patients with chronic heart failure.
Topics: Chronic Disease; Collagen Type I; Delayed-Action Preparations; Diuretics; Female; Fibrosis; Furosemi | 2009 |
Cardio-renal effects of the A1 adenosine receptor antagonist SLV320 in patients with heart failure.
Topics: Adenosine A1 Receptor Antagonists; Cardiovascular Agents; Cyclohexanes; Diuresis; Diuretics; Dose-Re | 2009 |
Cardio-renal effects of the A1 adenosine receptor antagonist SLV320 in patients with heart failure.
Topics: Adenosine A1 Receptor Antagonists; Cardiovascular Agents; Cyclohexanes; Diuresis; Diuretics; Dose-Re | 2009 |
[Application of methods of renal replacement therapy for abolishment of hyperhydration in patients with decompensated chronic heart failure].
Topics: Adult; Aged; Aged, 80 and over; Diuretics; Edema, Cardiac; Female; Furosemide; Heart Failure; Hemofi | 2010 |
[Application of methods of renal replacement therapy for abolishment of hyperhydration in patients with decompensated chronic heart failure].
Topics: Adult; Aged; Aged, 80 and over; Diuretics; Edema, Cardiac; Female; Furosemide; Heart Failure; Hemofi | 2010 |
N-terminal pro-B-type natriuretic peptide-guided, intensive patient management in addition to multidisciplinary care in chronic heart failure a 3-arm, prospective, randomized pilot study.
Topics: Adrenergic beta-Antagonists; Aged; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting E | 2010 |
N-terminal pro-B-type natriuretic peptide-guided, intensive patient management in addition to multidisciplinary care in chronic heart failure a 3-arm, prospective, randomized pilot study.
Topics: Adrenergic beta-Antagonists; Aged; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting E | 2010 |
Continuous versus intermittent infusion of furosemide in acute decompensated heart failure.
Topics: Acute Disease; Adolescent; Adult; Aged; Aged, 80 and over; Chi-Square Distribution; Dose-Response Re | 2010 |
Continuous versus intermittent infusion of furosemide in acute decompensated heart failure.
Topics: Acute Disease; Adolescent; Adult; Aged; Aged, 80 and over; Chi-Square Distribution; Dose-Response Re | 2010 |
Continuous versus bolus dosing of Furosemide for patients hospitalized for heart failure.
Topics: Aged; Creatinine; Diuretics; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; | 2010 |
Continuous versus bolus dosing of Furosemide for patients hospitalized for heart failure.
Topics: Aged; Creatinine; Diuretics; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; | 2010 |
Natriuretic and neurohormonal responses to nesiritide, furosemide, and combined nesiritide and furosemide in patients with stable systolic dysfunction.
Topics: Adult; Aged; Aldosterone; Biomarkers; Cross-Over Studies; Drug Resistance; Drug Therapy, Combination | 2010 |
Natriuretic and neurohormonal responses to nesiritide, furosemide, and combined nesiritide and furosemide in patients with stable systolic dysfunction.
Topics: Adult; Aged; Aldosterone; Biomarkers; Cross-Over Studies; Drug Resistance; Drug Therapy, Combination | 2010 |
Impact of dopamine infusion on renal function in hospitalized heart failure patients: results of the Dopamine in Acute Decompensated Heart Failure (DAD-HF) Trial.
Topics: Acute Disease; Aged; Aged, 80 and over; Dopamine; Double-Blind Method; Female; Furosemide; Heart Fai | 2010 |
Impact of dopamine infusion on renal function in hospitalized heart failure patients: results of the Dopamine in Acute Decompensated Heart Failure (DAD-HF) Trial.
Topics: Acute Disease; Aged; Aged, 80 and over; Dopamine; Double-Blind Method; Female; Furosemide; Heart Fai | 2010 |
Effects of ULTRAfiltration vs. DIureticS on clinical, biohumoral and haemodynamic variables in patients with deCOmpensated heart failure: the ULTRADISCO study.
Topics: Analysis of Variance; Creatinine; Diuretics; Drug Therapy, Combination; Female; Furosemide; Heart Fa | 2011 |
Effects of ULTRAfiltration vs. DIureticS on clinical, biohumoral and haemodynamic variables in patients with deCOmpensated heart failure: the ULTRADISCO study.
Topics: Analysis of Variance; Creatinine; Diuretics; Drug Therapy, Combination; Female; Furosemide; Heart Fa | 2011 |
Effects of levosimendan/furosemide infusion on plasma brain natriuretic peptide, echocardiographic parameters and cardiac output in end-stage heart failure patients.
Topics: Aged; Cardiac Output; Case-Control Studies; Echocardiography; Female; Follow-Up Studies; Furosemide; | 2011 |
Effects of levosimendan/furosemide infusion on plasma brain natriuretic peptide, echocardiographic parameters and cardiac output in end-stage heart failure patients.
Topics: Aged; Cardiac Output; Case-Control Studies; Echocardiography; Female; Follow-Up Studies; Furosemide; | 2011 |
Diuretic strategies in patients with acute decompensated heart failure.
Topics: Acute Disease; Aged; Area Under Curve; Creatinine; Diuretics; Double-Blind Method; Drug Administrati | 2011 |
Diuretic strategies in patients with acute decompensated heart failure.
Topics: Acute Disease; Aged; Area Under Curve; Creatinine; Diuretics; Double-Blind Method; Drug Administrati | 2011 |
Diuretic strategies in patients with acute decompensated heart failure.
Topics: Acute Disease; Aged; Area Under Curve; Creatinine; Diuretics; Double-Blind Method; Drug Administrati | 2011 |
Diuretic strategies in patients with acute decompensated heart failure.
Topics: Acute Disease; Aged; Area Under Curve; Creatinine; Diuretics; Double-Blind Method; Drug Administrati | 2011 |
Diuretic strategies in patients with acute decompensated heart failure.
Topics: Acute Disease; Aged; Area Under Curve; Creatinine; Diuretics; Double-Blind Method; Drug Administrati | 2011 |
Diuretic strategies in patients with acute decompensated heart failure.
Topics: Acute Disease; Aged; Area Under Curve; Creatinine; Diuretics; Double-Blind Method; Drug Administrati | 2011 |
Diuretic strategies in patients with acute decompensated heart failure.
Topics: Acute Disease; Aged; Area Under Curve; Creatinine; Diuretics; Double-Blind Method; Drug Administrati | 2011 |
Diuretic strategies in patients with acute decompensated heart failure.
Topics: Acute Disease; Aged; Area Under Curve; Creatinine; Diuretics; Double-Blind Method; Drug Administrati | 2011 |
Diuretic strategies in patients with acute decompensated heart failure.
Topics: Acute Disease; Aged; Area Under Curve; Creatinine; Diuretics; Double-Blind Method; Drug Administrati | 2011 |
Diuretic strategies in patients with acute decompensated heart failure.
Topics: Acute Disease; Aged; Area Under Curve; Creatinine; Diuretics; Double-Blind Method; Drug Administrati | 2011 |
Diuretic strategies in patients with acute decompensated heart failure.
Topics: Acute Disease; Aged; Area Under Curve; Creatinine; Diuretics; Double-Blind Method; Drug Administrati | 2011 |
Diuretic strategies in patients with acute decompensated heart failure.
Topics: Acute Disease; Aged; Area Under Curve; Creatinine; Diuretics; Double-Blind Method; Drug Administrati | 2011 |
Diuretic strategies in patients with acute decompensated heart failure.
Topics: Acute Disease; Aged; Area Under Curve; Creatinine; Diuretics; Double-Blind Method; Drug Administrati | 2011 |
Diuretic strategies in patients with acute decompensated heart failure.
Topics: Acute Disease; Aged; Area Under Curve; Creatinine; Diuretics; Double-Blind Method; Drug Administrati | 2011 |
Diuretic strategies in patients with acute decompensated heart failure.
Topics: Acute Disease; Aged; Area Under Curve; Creatinine; Diuretics; Double-Blind Method; Drug Administrati | 2011 |
Diuretic strategies in patients with acute decompensated heart failure.
Topics: Acute Disease; Aged; Area Under Curve; Creatinine; Diuretics; Double-Blind Method; Drug Administrati | 2011 |
Diuretic strategies in patients with acute decompensated heart failure.
Topics: Acute Disease; Aged; Area Under Curve; Creatinine; Diuretics; Double-Blind Method; Drug Administrati | 2011 |
Diuretic strategies in patients with acute decompensated heart failure.
Topics: Acute Disease; Aged; Area Under Curve; Creatinine; Diuretics; Double-Blind Method; Drug Administrati | 2011 |
Diuretic strategies in patients with acute decompensated heart failure.
Topics: Acute Disease; Aged; Area Under Curve; Creatinine; Diuretics; Double-Blind Method; Drug Administrati | 2011 |
Diuretic strategies in patients with acute decompensated heart failure.
Topics: Acute Disease; Aged; Area Under Curve; Creatinine; Diuretics; Double-Blind Method; Drug Administrati | 2011 |
Diuretic strategies in patients with acute decompensated heart failure.
Topics: Acute Disease; Aged; Area Under Curve; Creatinine; Diuretics; Double-Blind Method; Drug Administrati | 2011 |
Diuretic strategies in patients with acute decompensated heart failure.
Topics: Acute Disease; Aged; Area Under Curve; Creatinine; Diuretics; Double-Blind Method; Drug Administrati | 2011 |
Diuretic strategies in patients with acute decompensated heart failure.
Topics: Acute Disease; Aged; Area Under Curve; Creatinine; Diuretics; Double-Blind Method; Drug Administrati | 2011 |
Diuretic strategies in patients with acute decompensated heart failure.
Topics: Acute Disease; Aged; Area Under Curve; Creatinine; Diuretics; Double-Blind Method; Drug Administrati | 2011 |
Diuretic strategies in patients with acute decompensated heart failure.
Topics: Acute Disease; Aged; Area Under Curve; Creatinine; Diuretics; Double-Blind Method; Drug Administrati | 2011 |
Diuretic strategies in patients with acute decompensated heart failure.
Topics: Acute Disease; Aged; Area Under Curve; Creatinine; Diuretics; Double-Blind Method; Drug Administrati | 2011 |
Diuretic strategies in patients with acute decompensated heart failure.
Topics: Acute Disease; Aged; Area Under Curve; Creatinine; Diuretics; Double-Blind Method; Drug Administrati | 2011 |
Diuretic strategies in patients with acute decompensated heart failure.
Topics: Acute Disease; Aged; Area Under Curve; Creatinine; Diuretics; Double-Blind Method; Drug Administrati | 2011 |
Diuretic strategies in patients with acute decompensated heart failure.
Topics: Acute Disease; Aged; Area Under Curve; Creatinine; Diuretics; Double-Blind Method; Drug Administrati | 2011 |
Diuretic strategies in patients with acute decompensated heart failure.
Topics: Acute Disease; Aged; Area Under Curve; Creatinine; Diuretics; Double-Blind Method; Drug Administrati | 2011 |
Diuretic strategies in patients with acute decompensated heart failure.
Topics: Acute Disease; Aged; Area Under Curve; Creatinine; Diuretics; Double-Blind Method; Drug Administrati | 2011 |
Diuretic strategies in patients with acute decompensated heart failure.
Topics: Acute Disease; Aged; Area Under Curve; Creatinine; Diuretics; Double-Blind Method; Drug Administrati | 2011 |
Diuretic strategies in patients with acute decompensated heart failure.
Topics: Acute Disease; Aged; Area Under Curve; Creatinine; Diuretics; Double-Blind Method; Drug Administrati | 2011 |
Diuretic strategies in patients with acute decompensated heart failure.
Topics: Acute Disease; Aged; Area Under Curve; Creatinine; Diuretics; Double-Blind Method; Drug Administrati | 2011 |
Diuretic strategies in patients with acute decompensated heart failure.
Topics: Acute Disease; Aged; Area Under Curve; Creatinine; Diuretics; Double-Blind Method; Drug Administrati | 2011 |
Diuretic strategies in patients with acute decompensated heart failure.
Topics: Acute Disease; Aged; Area Under Curve; Creatinine; Diuretics; Double-Blind Method; Drug Administrati | 2011 |
Diuretic strategies in patients with acute decompensated heart failure.
Topics: Acute Disease; Aged; Area Under Curve; Creatinine; Diuretics; Double-Blind Method; Drug Administrati | 2011 |
Diuretic strategies in patients with acute decompensated heart failure.
Topics: Acute Disease; Aged; Area Under Curve; Creatinine; Diuretics; Double-Blind Method; Drug Administrati | 2011 |
Diuretic strategies in patients with acute decompensated heart failure.
Topics: Acute Disease; Aged; Area Under Curve; Creatinine; Diuretics; Double-Blind Method; Drug Administrati | 2011 |
Diuretic strategies in patients with acute decompensated heart failure.
Topics: Acute Disease; Aged; Area Under Curve; Creatinine; Diuretics; Double-Blind Method; Drug Administrati | 2011 |
Diuretic strategies in patients with acute decompensated heart failure.
Topics: Acute Disease; Aged; Area Under Curve; Creatinine; Diuretics; Double-Blind Method; Drug Administrati | 2011 |
Diuretic strategies in patients with acute decompensated heart failure.
Topics: Acute Disease; Aged; Area Under Curve; Creatinine; Diuretics; Double-Blind Method; Drug Administrati | 2011 |
Diuretic strategies in patients with acute decompensated heart failure.
Topics: Acute Disease; Aged; Area Under Curve; Creatinine; Diuretics; Double-Blind Method; Drug Administrati | 2011 |
Diuretic strategies in patients with acute decompensated heart failure.
Topics: Acute Disease; Aged; Area Under Curve; Creatinine; Diuretics; Double-Blind Method; Drug Administrati | 2011 |
Diuretic strategies in patients with acute decompensated heart failure.
Topics: Acute Disease; Aged; Area Under Curve; Creatinine; Diuretics; Double-Blind Method; Drug Administrati | 2011 |
Diuretic strategies in patients with acute decompensated heart failure.
Topics: Acute Disease; Aged; Area Under Curve; Creatinine; Diuretics; Double-Blind Method; Drug Administrati | 2011 |
Diuretic strategies in patients with acute decompensated heart failure.
Topics: Acute Disease; Aged; Area Under Curve; Creatinine; Diuretics; Double-Blind Method; Drug Administrati | 2011 |
Diuretic strategies in patients with acute decompensated heart failure.
Topics: Acute Disease; Aged; Area Under Curve; Creatinine; Diuretics; Double-Blind Method; Drug Administrati | 2011 |
Diuretic strategies in patients with acute decompensated heart failure.
Topics: Acute Disease; Aged; Area Under Curve; Creatinine; Diuretics; Double-Blind Method; Drug Administrati | 2011 |
Diuretic strategies in patients with acute decompensated heart failure.
Topics: Acute Disease; Aged; Area Under Curve; Creatinine; Diuretics; Double-Blind Method; Drug Administrati | 2011 |
Changes in estimating echocardiography pulmonary capillary wedge pressure after hypersaline plus furosemide versus furosemide alone in decompensated heart failure.
Topics: Aged; Aged, 80 and over; Diuretics; Double-Blind Method; Echocardiography; Female; Furosemide; Heart | 2011 |
Changes in estimating echocardiography pulmonary capillary wedge pressure after hypersaline plus furosemide versus furosemide alone in decompensated heart failure.
Topics: Aged; Aged, 80 and over; Diuretics; Double-Blind Method; Echocardiography; Female; Furosemide; Heart | 2011 |
Early and personalized ambulatory follow-up to tailor furosemide and fluid intake according to congestion in post-discharge heart failure.
Topics: Aged; Ambulatory Care; Diuretics; Female; Fluid Therapy; Follow-Up Studies; Furosemide; Heart Failur | 2013 |
Early and personalized ambulatory follow-up to tailor furosemide and fluid intake according to congestion in post-discharge heart failure.
Topics: Aged; Ambulatory Care; Diuretics; Female; Fluid Therapy; Follow-Up Studies; Furosemide; Heart Failur | 2013 |
Comparative analysis of the therapeutic effects of long-acting and short-acting loop diuretics in the treatment of chronic heart failure using (123)I-metaiodobenzylguanidine scintigraphy.
Topics: 3-Iodobenzylguanidine; Adult; Aged; Aged, 80 and over; Chronic Disease; Cross-Over Studies; Female; | 2011 |
Comparative analysis of the therapeutic effects of long-acting and short-acting loop diuretics in the treatment of chronic heart failure using (123)I-metaiodobenzylguanidine scintigraphy.
Topics: 3-Iodobenzylguanidine; Adult; Aged; Aged, 80 and over; Chronic Disease; Cross-Over Studies; Female; | 2011 |
Short-term effects of hypertonic saline solution in acute heart failure and long-term effects of a moderate sodium restriction in patients with compensated heart failure with New York Heart Association class III (Class C) (SMAC-HF Study).
Topics: Aged; Aged, 80 and over; Diet, Sodium-Restricted; Diuresis; Female; Furosemide; Heart Failure; Hospi | 2011 |
Short-term effects of hypertonic saline solution in acute heart failure and long-term effects of a moderate sodium restriction in patients with compensated heart failure with New York Heart Association class III (Class C) (SMAC-HF Study).
Topics: Aged; Aged, 80 and over; Diet, Sodium-Restricted; Diuresis; Female; Furosemide; Heart Failure; Hospi | 2011 |
Efficacy and cardiovascular tolerability of continuous veno-venous hemodiafiltration in acute decompensated heart failure: a randomized comparative study.
Topics: Aged; Diuretics; Female; Furosemide; Heart Failure; Hemodiafiltration; Humans; Infusions, Intravenou | 2012 |
Efficacy and cardiovascular tolerability of continuous veno-venous hemodiafiltration in acute decompensated heart failure: a randomized comparative study.
Topics: Aged; Diuretics; Female; Furosemide; Heart Failure; Hemodiafiltration; Humans; Infusions, Intravenou | 2012 |
Effects of prolonged-release torasemide versus furosemide on myocardial fibrosis in hypertensive patients with chronic heart failure: a randomized, blinded-end point, active-controlled study.
Topics: Aged; Biomarkers; Chronic Disease; Delayed-Action Preparations; Diuretics; Endpoint Determination; F | 2011 |
Effects of prolonged-release torasemide versus furosemide on myocardial fibrosis in hypertensive patients with chronic heart failure: a randomized, blinded-end point, active-controlled study.
Topics: Aged; Biomarkers; Chronic Disease; Delayed-Action Preparations; Diuretics; Endpoint Determination; F | 2011 |
Activity with ambulation attenuates diuretic responsiveness in chronic heart failure.
Topics: Angiotensin-Converting Enzyme Inhibitors; Diuretics; Female; Furosemide; Heart Failure; Humans; Midd | 2011 |
Activity with ambulation attenuates diuretic responsiveness in chronic heart failure.
Topics: Angiotensin-Converting Enzyme Inhibitors; Diuretics; Female; Furosemide; Heart Failure; Humans; Midd | 2011 |
Effects of tolvaptan on volume overload in Japanese patients with heart failure: results of a phase II, multicenter, randomized, double-blind, placebo-controlled, parallel-group study.
Topics: Adult; Aged; Antidiuretic Hormone Receptor Antagonists; Asian People; Benzazepines; Body Weight; Diu | 2011 |
Effects of tolvaptan on volume overload in Japanese patients with heart failure: results of a phase II, multicenter, randomized, double-blind, placebo-controlled, parallel-group study.
Topics: Adult; Aged; Antidiuretic Hormone Receptor Antagonists; Asian People; Benzazepines; Body Weight; Diu | 2011 |
Renal effects of conivaptan, furosemide, and the combination in patients with chronic heart failure.
Topics: Antidiuretic Hormone Receptor Antagonists; Benzazepines; Blood Pressure; Cross-Over Studies; Drug Th | 2011 |
Renal effects of conivaptan, furosemide, and the combination in patients with chronic heart failure.
Topics: Antidiuretic Hormone Receptor Antagonists; Benzazepines; Blood Pressure; Cross-Over Studies; Drug Th | 2011 |
Effect of torsemide and furosemide on clinical, laboratory, radiographic and quality of life variables in dogs with heart failure secondary to mitral valve disease.
Topics: Animals; Cross-Over Studies; Diuretics; Dog Diseases; Dogs; Furosemide; Heart Failure; Mitral Valve | 2012 |
Effect of torsemide and furosemide on clinical, laboratory, radiographic and quality of life variables in dogs with heart failure secondary to mitral valve disease.
Topics: Animals; Cross-Over Studies; Diuretics; Dog Diseases; Dogs; Furosemide; Heart Failure; Mitral Valve | 2012 |
Comparative study of therapeutic effects of short- and long-acting loop diuretics in outpatients with chronic heart failure (COLD-CHF).
Topics: Aged; Atrial Natriuretic Factor; Biomarkers; Chronic Disease; Delayed-Action Preparations; Echocardi | 2012 |
Comparative study of therapeutic effects of short- and long-acting loop diuretics in outpatients with chronic heart failure (COLD-CHF).
Topics: Aged; Atrial Natriuretic Factor; Biomarkers; Chronic Disease; Delayed-Action Preparations; Echocardi | 2012 |
Superiority of long-acting to short-acting loop diuretics in the treatment of congestive heart failure.
Topics: Aged; Aged, 80 and over; Chi-Square Distribution; Chronic Disease; Disease-Free Survival; Female; Fu | 2012 |
Superiority of long-acting to short-acting loop diuretics in the treatment of congestive heart failure.
Topics: Aged; Aged, 80 and over; Chi-Square Distribution; Chronic Disease; Disease-Free Survival; Female; Fu | 2012 |
[The DOSE study].
Topics: Biomarkers; Creatinine; Furosemide; Heart Failure; Humans; Italy; Sicily; Treatment Outcome | 2012 |
[The DOSE study].
Topics: Biomarkers; Creatinine; Furosemide; Heart Failure; Humans; Italy; Sicily; Treatment Outcome | 2012 |
The acute haemodynamic effect of nebulised frusemide in stable, advanced heart failure.
Topics: Acute Disease; Cardiac Catheterization; Diuretics; Double-Blind Method; Female; Furosemide; Heart Fa | 2012 |
The acute haemodynamic effect of nebulised frusemide in stable, advanced heart failure.
Topics: Acute Disease; Cardiac Catheterization; Diuretics; Double-Blind Method; Female; Furosemide; Heart Fa | 2012 |
Efficacy of oral tolvaptan in acute heart failure patients with hypotension and renal impairment.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Antidiuretic Hormone Receptor Antagonists; Ben | 2012 |
Efficacy of oral tolvaptan in acute heart failure patients with hypotension and renal impairment.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Antidiuretic Hormone Receptor Antagonists; Ben | 2012 |
Intermittent levosimendan infusions in advanced heart failure: favourable effects on left ventricular function, neurohormonal balance, and one-year survival.
Topics: Aged; Calcium; Chronic Disease; Data Interpretation, Statistical; Diuretics; Drug Administration Sch | 2012 |
Intermittent levosimendan infusions in advanced heart failure: favourable effects on left ventricular function, neurohormonal balance, and one-year survival.
Topics: Aged; Calcium; Chronic Disease; Data Interpretation, Statistical; Diuretics; Drug Administration Sch | 2012 |
Troponin I release after intravenous treatment with high furosemide doses plus hypertonic saline solution in decompensated heart failure trial (Tra-HSS-Fur).
Topics: Administration, Intravenous; Aged; Aged, 80 and over; Diuretics; Double-Blind Method; Drug Therapy, | 2012 |
Troponin I release after intravenous treatment with high furosemide doses plus hypertonic saline solution in decompensated heart failure trial (Tra-HSS-Fur).
Topics: Administration, Intravenous; Aged; Aged, 80 and over; Diuretics; Double-Blind Method; Drug Therapy, | 2012 |
Effect of admission oral diuretic dose on response to continuous versus bolus intravenous diuretics in acute heart failure: an analysis from diuretic optimization strategies in acute heart failure.
Topics: Acute Disease; Administration, Oral; Aged; Aged, 80 and over; Creatinine; Cystatin C; Diuretics; Dos | 2012 |
Effect of admission oral diuretic dose on response to continuous versus bolus intravenous diuretics in acute heart failure: an analysis from diuretic optimization strategies in acute heart failure.
Topics: Acute Disease; Administration, Oral; Aged; Aged, 80 and over; Creatinine; Cystatin C; Diuretics; Dos | 2012 |
Effects of furosemide versus captopril on postprandial and orthostatic blood pressure and on cerebral oxygenation in patients > or = 70 years of age with heart failure.
Topics: Aged; Aged, 80 and over; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Captopril; Cerebr | 2002 |
Effects of furosemide versus captopril on postprandial and orthostatic blood pressure and on cerebral oxygenation in patients > or = 70 years of age with heart failure.
Topics: Aged; Aged, 80 and over; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Captopril; Cerebr | 2002 |
Reduction of oxidative stress augments natriuretic effect of furosemide in moderate heart failure.
Topics: Angiotensin-Converting Enzyme Inhibitors; Ascorbic Acid; Cross-Over Studies; Cyclic GMP; Drug Therap | 2003 |
Reduction of oxidative stress augments natriuretic effect of furosemide in moderate heart failure.
Topics: Angiotensin-Converting Enzyme Inhibitors; Ascorbic Acid; Cross-Over Studies; Cyclic GMP; Drug Therap | 2003 |
Neurohormonal effects of furosemide withdrawal in elderly heart failure patients with normal systolic function.
Topics: Aged; Aldosterone; Angiotensin-Converting Enzyme Inhibitors; Atrial Natriuretic Factor; Blood Pressu | 2003 |
Neurohormonal effects of furosemide withdrawal in elderly heart failure patients with normal systolic function.
Topics: Aged; Aldosterone; Angiotensin-Converting Enzyme Inhibitors; Atrial Natriuretic Factor; Blood Pressu | 2003 |
Hypertonic saline: a novel therapy for advanced heart failure?
Topics: Aged; Aged, 80 and over; Diuresis; Diuretics; Furosemide; Heart Failure; Hemodynamics; Humans; Infus | 2003 |
Hypertonic saline: a novel therapy for advanced heart failure?
Topics: Aged; Aged, 80 and over; Diuresis; Diuretics; Furosemide; Heart Failure; Hemodynamics; Humans; Infus | 2003 |
Effects of high-dose furosemide and small-volume hypertonic saline solution infusion in comparison with a high dose of furosemide as bolus in refractory congestive heart failure: long-term effects.
Topics: Administration, Oral; Aged; Aged, 80 and over; Diuretics; Dose-Response Relationship, Drug; Drug Adm | 2003 |
Effects of high-dose furosemide and small-volume hypertonic saline solution infusion in comparison with a high dose of furosemide as bolus in refractory congestive heart failure: long-term effects.
Topics: Administration, Oral; Aged; Aged, 80 and over; Diuretics; Dose-Response Relationship, Drug; Drug Adm | 2003 |
Effects of high-dose furosemide and small-volume hypertonic saline solution infusion in comparison with a high dose of furosemide as bolus in refractory congestive heart failure: long-term effects.
Topics: Administration, Oral; Aged; Aged, 80 and over; Diuretics; Dose-Response Relationship, Drug; Drug Adm | 2003 |
Effects of high-dose furosemide and small-volume hypertonic saline solution infusion in comparison with a high dose of furosemide as bolus in refractory congestive heart failure: long-term effects.
Topics: Administration, Oral; Aged; Aged, 80 and over; Diuretics; Dose-Response Relationship, Drug; Drug Adm | 2003 |
Effects of high-dose furosemide and small-volume hypertonic saline solution infusion in comparison with a high dose of furosemide as bolus in refractory congestive heart failure: long-term effects.
Topics: Administration, Oral; Aged; Aged, 80 and over; Diuretics; Dose-Response Relationship, Drug; Drug Adm | 2003 |
Effects of high-dose furosemide and small-volume hypertonic saline solution infusion in comparison with a high dose of furosemide as bolus in refractory congestive heart failure: long-term effects.
Topics: Administration, Oral; Aged; Aged, 80 and over; Diuretics; Dose-Response Relationship, Drug; Drug Adm | 2003 |
Effects of high-dose furosemide and small-volume hypertonic saline solution infusion in comparison with a high dose of furosemide as bolus in refractory congestive heart failure: long-term effects.
Topics: Administration, Oral; Aged; Aged, 80 and over; Diuretics; Dose-Response Relationship, Drug; Drug Adm | 2003 |
Effects of high-dose furosemide and small-volume hypertonic saline solution infusion in comparison with a high dose of furosemide as bolus in refractory congestive heart failure: long-term effects.
Topics: Administration, Oral; Aged; Aged, 80 and over; Diuretics; Dose-Response Relationship, Drug; Drug Adm | 2003 |
Effects of high-dose furosemide and small-volume hypertonic saline solution infusion in comparison with a high dose of furosemide as bolus in refractory congestive heart failure: long-term effects.
Topics: Administration, Oral; Aged; Aged, 80 and over; Diuretics; Dose-Response Relationship, Drug; Drug Adm | 2003 |
Effects of high-dose furosemide and small-volume hypertonic saline solution infusion in comparison with a high dose of furosemide as bolus in refractory congestive heart failure: long-term effects.
Topics: Administration, Oral; Aged; Aged, 80 and over; Diuretics; Dose-Response Relationship, Drug; Drug Adm | 2003 |
Effects of high-dose furosemide and small-volume hypertonic saline solution infusion in comparison with a high dose of furosemide as bolus in refractory congestive heart failure: long-term effects.
Topics: Administration, Oral; Aged; Aged, 80 and over; Diuretics; Dose-Response Relationship, Drug; Drug Adm | 2003 |
Effects of high-dose furosemide and small-volume hypertonic saline solution infusion in comparison with a high dose of furosemide as bolus in refractory congestive heart failure: long-term effects.
Topics: Administration, Oral; Aged; Aged, 80 and over; Diuretics; Dose-Response Relationship, Drug; Drug Adm | 2003 |
Effects of high-dose furosemide and small-volume hypertonic saline solution infusion in comparison with a high dose of furosemide as bolus in refractory congestive heart failure: long-term effects.
Topics: Administration, Oral; Aged; Aged, 80 and over; Diuretics; Dose-Response Relationship, Drug; Drug Adm | 2003 |
Effects of high-dose furosemide and small-volume hypertonic saline solution infusion in comparison with a high dose of furosemide as bolus in refractory congestive heart failure: long-term effects.
Topics: Administration, Oral; Aged; Aged, 80 and over; Diuretics; Dose-Response Relationship, Drug; Drug Adm | 2003 |
Effects of high-dose furosemide and small-volume hypertonic saline solution infusion in comparison with a high dose of furosemide as bolus in refractory congestive heart failure: long-term effects.
Topics: Administration, Oral; Aged; Aged, 80 and over; Diuretics; Dose-Response Relationship, Drug; Drug Adm | 2003 |
Effects of high-dose furosemide and small-volume hypertonic saline solution infusion in comparison with a high dose of furosemide as bolus in refractory congestive heart failure: long-term effects.
Topics: Administration, Oral; Aged; Aged, 80 and over; Diuretics; Dose-Response Relationship, Drug; Drug Adm | 2003 |
Effects of high-dose furosemide and small-volume hypertonic saline solution infusion in comparison with a high dose of furosemide as bolus in refractory congestive heart failure: long-term effects.
Topics: Administration, Oral; Aged; Aged, 80 and over; Diuretics; Dose-Response Relationship, Drug; Drug Adm | 2003 |
Effects of high-dose furosemide and small-volume hypertonic saline solution infusion in comparison with a high dose of furosemide as bolus in refractory congestive heart failure: long-term effects.
Topics: Administration, Oral; Aged; Aged, 80 and over; Diuretics; Dose-Response Relationship, Drug; Drug Adm | 2003 |
Effects of high-dose furosemide and small-volume hypertonic saline solution infusion in comparison with a high dose of furosemide as bolus in refractory congestive heart failure: long-term effects.
Topics: Administration, Oral; Aged; Aged, 80 and over; Diuretics; Dose-Response Relationship, Drug; Drug Adm | 2003 |
Effects of high-dose furosemide and small-volume hypertonic saline solution infusion in comparison with a high dose of furosemide as bolus in refractory congestive heart failure: long-term effects.
Topics: Administration, Oral; Aged; Aged, 80 and over; Diuretics; Dose-Response Relationship, Drug; Drug Adm | 2003 |
Effects of high-dose furosemide and small-volume hypertonic saline solution infusion in comparison with a high dose of furosemide as bolus in refractory congestive heart failure: long-term effects.
Topics: Administration, Oral; Aged; Aged, 80 and over; Diuretics; Dose-Response Relationship, Drug; Drug Adm | 2003 |
Effects of high-dose furosemide and small-volume hypertonic saline solution infusion in comparison with a high dose of furosemide as bolus in refractory congestive heart failure: long-term effects.
Topics: Administration, Oral; Aged; Aged, 80 and over; Diuretics; Dose-Response Relationship, Drug; Drug Adm | 2003 |
Effects of high-dose furosemide and small-volume hypertonic saline solution infusion in comparison with a high dose of furosemide as bolus in refractory congestive heart failure: long-term effects.
Topics: Administration, Oral; Aged; Aged, 80 and over; Diuretics; Dose-Response Relationship, Drug; Drug Adm | 2003 |
Effects of high-dose furosemide and small-volume hypertonic saline solution infusion in comparison with a high dose of furosemide as bolus in refractory congestive heart failure: long-term effects.
Topics: Administration, Oral; Aged; Aged, 80 and over; Diuretics; Dose-Response Relationship, Drug; Drug Adm | 2003 |
Effects of high-dose furosemide and small-volume hypertonic saline solution infusion in comparison with a high dose of furosemide as bolus in refractory congestive heart failure: long-term effects.
Topics: Administration, Oral; Aged; Aged, 80 and over; Diuretics; Dose-Response Relationship, Drug; Drug Adm | 2003 |
Effects of high-dose furosemide and small-volume hypertonic saline solution infusion in comparison with a high dose of furosemide as bolus in refractory congestive heart failure: long-term effects.
Topics: Administration, Oral; Aged; Aged, 80 and over; Diuretics; Dose-Response Relationship, Drug; Drug Adm | 2003 |
Effects of high-dose furosemide and small-volume hypertonic saline solution infusion in comparison with a high dose of furosemide as bolus in refractory congestive heart failure: long-term effects.
Topics: Administration, Oral; Aged; Aged, 80 and over; Diuretics; Dose-Response Relationship, Drug; Drug Adm | 2003 |
Effects of high-dose furosemide and small-volume hypertonic saline solution infusion in comparison with a high dose of furosemide as bolus in refractory congestive heart failure: long-term effects.
Topics: Administration, Oral; Aged; Aged, 80 and over; Diuretics; Dose-Response Relationship, Drug; Drug Adm | 2003 |
Effects of high-dose furosemide and small-volume hypertonic saline solution infusion in comparison with a high dose of furosemide as bolus in refractory congestive heart failure: long-term effects.
Topics: Administration, Oral; Aged; Aged, 80 and over; Diuretics; Dose-Response Relationship, Drug; Drug Adm | 2003 |
Effects of high-dose furosemide and small-volume hypertonic saline solution infusion in comparison with a high dose of furosemide as bolus in refractory congestive heart failure: long-term effects.
Topics: Administration, Oral; Aged; Aged, 80 and over; Diuretics; Dose-Response Relationship, Drug; Drug Adm | 2003 |
Effects of high-dose furosemide and small-volume hypertonic saline solution infusion in comparison with a high dose of furosemide as bolus in refractory congestive heart failure: long-term effects.
Topics: Administration, Oral; Aged; Aged, 80 and over; Diuretics; Dose-Response Relationship, Drug; Drug Adm | 2003 |
Effects of high-dose furosemide and small-volume hypertonic saline solution infusion in comparison with a high dose of furosemide as bolus in refractory congestive heart failure: long-term effects.
Topics: Administration, Oral; Aged; Aged, 80 and over; Diuretics; Dose-Response Relationship, Drug; Drug Adm | 2003 |
Effects of high-dose furosemide and small-volume hypertonic saline solution infusion in comparison with a high dose of furosemide as bolus in refractory congestive heart failure: long-term effects.
Topics: Administration, Oral; Aged; Aged, 80 and over; Diuretics; Dose-Response Relationship, Drug; Drug Adm | 2003 |
Effects of high-dose furosemide and small-volume hypertonic saline solution infusion in comparison with a high dose of furosemide as bolus in refractory congestive heart failure: long-term effects.
Topics: Administration, Oral; Aged; Aged, 80 and over; Diuretics; Dose-Response Relationship, Drug; Drug Adm | 2003 |
Effects of high-dose furosemide and small-volume hypertonic saline solution infusion in comparison with a high dose of furosemide as bolus in refractory congestive heart failure: long-term effects.
Topics: Administration, Oral; Aged; Aged, 80 and over; Diuretics; Dose-Response Relationship, Drug; Drug Adm | 2003 |
Effects of high-dose furosemide and small-volume hypertonic saline solution infusion in comparison with a high dose of furosemide as bolus in refractory congestive heart failure: long-term effects.
Topics: Administration, Oral; Aged; Aged, 80 and over; Diuretics; Dose-Response Relationship, Drug; Drug Adm | 2003 |
Effects of high-dose furosemide and small-volume hypertonic saline solution infusion in comparison with a high dose of furosemide as bolus in refractory congestive heart failure: long-term effects.
Topics: Administration, Oral; Aged; Aged, 80 and over; Diuretics; Dose-Response Relationship, Drug; Drug Adm | 2003 |
Effects of high-dose furosemide and small-volume hypertonic saline solution infusion in comparison with a high dose of furosemide as bolus in refractory congestive heart failure: long-term effects.
Topics: Administration, Oral; Aged; Aged, 80 and over; Diuretics; Dose-Response Relationship, Drug; Drug Adm | 2003 |
Effects of high-dose furosemide and small-volume hypertonic saline solution infusion in comparison with a high dose of furosemide as bolus in refractory congestive heart failure: long-term effects.
Topics: Administration, Oral; Aged; Aged, 80 and over; Diuretics; Dose-Response Relationship, Drug; Drug Adm | 2003 |
Effects of high-dose furosemide and small-volume hypertonic saline solution infusion in comparison with a high dose of furosemide as bolus in refractory congestive heart failure: long-term effects.
Topics: Administration, Oral; Aged; Aged, 80 and over; Diuretics; Dose-Response Relationship, Drug; Drug Adm | 2003 |
Effects of high-dose furosemide and small-volume hypertonic saline solution infusion in comparison with a high dose of furosemide as bolus in refractory congestive heart failure: long-term effects.
Topics: Administration, Oral; Aged; Aged, 80 and over; Diuretics; Dose-Response Relationship, Drug; Drug Adm | 2003 |
Effects of high-dose furosemide and small-volume hypertonic saline solution infusion in comparison with a high dose of furosemide as bolus in refractory congestive heart failure: long-term effects.
Topics: Administration, Oral; Aged; Aged, 80 and over; Diuretics; Dose-Response Relationship, Drug; Drug Adm | 2003 |
Effects of high-dose furosemide and small-volume hypertonic saline solution infusion in comparison with a high dose of furosemide as bolus in refractory congestive heart failure: long-term effects.
Topics: Administration, Oral; Aged; Aged, 80 and over; Diuretics; Dose-Response Relationship, Drug; Drug Adm | 2003 |
Effects of high-dose furosemide and small-volume hypertonic saline solution infusion in comparison with a high dose of furosemide as bolus in refractory congestive heart failure: long-term effects.
Topics: Administration, Oral; Aged; Aged, 80 and over; Diuretics; Dose-Response Relationship, Drug; Drug Adm | 2003 |
Effects of high-dose furosemide and small-volume hypertonic saline solution infusion in comparison with a high dose of furosemide as bolus in refractory congestive heart failure: long-term effects.
Topics: Administration, Oral; Aged; Aged, 80 and over; Diuretics; Dose-Response Relationship, Drug; Drug Adm | 2003 |
Effects of high-dose furosemide and small-volume hypertonic saline solution infusion in comparison with a high dose of furosemide as bolus in refractory congestive heart failure: long-term effects.
Topics: Administration, Oral; Aged; Aged, 80 and over; Diuretics; Dose-Response Relationship, Drug; Drug Adm | 2003 |
Effects of high-dose furosemide and small-volume hypertonic saline solution infusion in comparison with a high dose of furosemide as bolus in refractory congestive heart failure: long-term effects.
Topics: Administration, Oral; Aged; Aged, 80 and over; Diuretics; Dose-Response Relationship, Drug; Drug Adm | 2003 |
Effects of high-dose furosemide and small-volume hypertonic saline solution infusion in comparison with a high dose of furosemide as bolus in refractory congestive heart failure: long-term effects.
Topics: Administration, Oral; Aged; Aged, 80 and over; Diuretics; Dose-Response Relationship, Drug; Drug Adm | 2003 |
Effects of high-dose furosemide and small-volume hypertonic saline solution infusion in comparison with a high dose of furosemide as bolus in refractory congestive heart failure: long-term effects.
Topics: Administration, Oral; Aged; Aged, 80 and over; Diuretics; Dose-Response Relationship, Drug; Drug Adm | 2003 |
Effects of high-dose furosemide and small-volume hypertonic saline solution infusion in comparison with a high dose of furosemide as bolus in refractory congestive heart failure: long-term effects.
Topics: Administration, Oral; Aged; Aged, 80 and over; Diuretics; Dose-Response Relationship, Drug; Drug Adm | 2003 |
Angiotensin II AT1 receptor antagonism prevents detrimental renal actions of acute diuretic therapy in human heart failure.
Topics: Aldosterone; Angiotensin II; Angiotensin Receptor Antagonists; Cross-Over Studies; Diuretics; Double | 2003 |
Angiotensin II AT1 receptor antagonism prevents detrimental renal actions of acute diuretic therapy in human heart failure.
Topics: Aldosterone; Angiotensin II; Angiotensin Receptor Antagonists; Cross-Over Studies; Diuretics; Double | 2003 |
Effects of torasemide on left ventricular function and neurohumoral factors in patients with chronic heart failure.
Topics: Aged; Aldosterone; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Echocardiograp | 2003 |
Effects of torasemide on left ventricular function and neurohumoral factors in patients with chronic heart failure.
Topics: Aged; Aldosterone; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Echocardiograp | 2003 |
Vasopressin V2-receptor blockade with tolvaptan in patients with chronic heart failure: results from a double-blind, randomized trial.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Antidiuretic Hormone Receptor Antagonists; Arg | 2003 |
Vasopressin V2-receptor blockade with tolvaptan in patients with chronic heart failure: results from a double-blind, randomized trial.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Antidiuretic Hormone Receptor Antagonists; Arg | 2003 |
Is multidisciplinary care of heart failure cost-beneficial when combined with optimal medical care?
Topics: Aged; Aged, 80 and over; Angiotensin-Converting Enzyme Inhibitors; Cost-Benefit Analysis; Decision M | 2003 |
Is multidisciplinary care of heart failure cost-beneficial when combined with optimal medical care?
Topics: Aged; Aged, 80 and over; Angiotensin-Converting Enzyme Inhibitors; Cost-Benefit Analysis; Decision M | 2003 |
Hemodynamic response to intensive unloading therapy (furosemide and nitroprusside) in patients >70 years of age with left ventricular systolic dysfunction and decompensated chronic heart failure.
Topics: Age Factors; Aged; Aged, 80 and over; Female; Furosemide; Heart Failure; Hemodynamics; Humans; Male; | 2003 |
Hemodynamic response to intensive unloading therapy (furosemide and nitroprusside) in patients >70 years of age with left ventricular systolic dysfunction and decompensated chronic heart failure.
Topics: Age Factors; Aged; Aged, 80 and over; Female; Furosemide; Heart Failure; Hemodynamics; Humans; Male; | 2003 |
Twice-daily administration of a long-acting angiotensin-converting enzyme inhibitor has greater effects on neurohumoral factors than a once-daily regimen in patients with chronic congestive heart failure.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Diuretics; Drug Administration Sched | 2004 |
Twice-daily administration of a long-acting angiotensin-converting enzyme inhibitor has greater effects on neurohumoral factors than a once-daily regimen in patients with chronic congestive heart failure.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Diuretics; Drug Administration Sched | 2004 |
Torasemide vs. furosemide in primary care patients with chronic heart failure NYHA II to IV--efficacy and quality of life.
Topics: Aged; Aged, 80 and over; Analysis of Variance; Chronic Disease; Diuretics; Female; Follow-Up Studies | 2003 |
Torasemide vs. furosemide in primary care patients with chronic heart failure NYHA II to IV--efficacy and quality of life.
Topics: Aged; Aged, 80 and over; Analysis of Variance; Chronic Disease; Diuretics; Female; Follow-Up Studies | 2003 |
Effects of loop diuretics on myocardial fibrosis and collagen type I turnover in chronic heart failure.
Topics: Collagen Type I; Diuretics; Echocardiography; Endomyocardial Fibrosis; Female; Furosemide; Heart Fai | 2004 |
Effects of loop diuretics on myocardial fibrosis and collagen type I turnover in chronic heart failure.
Topics: Collagen Type I; Diuretics; Echocardiography; Endomyocardial Fibrosis; Female; Furosemide; Heart Fai | 2004 |
Effects of intravenous atrial natriuretic peptide on cardiac sympathetic nerve activity in patients with decompensated congestive heart failure.
Topics: 3-Iodobenzylguanidine; Aged; Atrial Natriuretic Factor; Cardiotonic Agents; Dopamine; Drug Combinati | 2004 |
Effects of intravenous atrial natriuretic peptide on cardiac sympathetic nerve activity in patients with decompensated congestive heart failure.
Topics: 3-Iodobenzylguanidine; Aged; Atrial Natriuretic Factor; Cardiotonic Agents; Dopamine; Drug Combinati | 2004 |
Hemodynamic effects of levosimendan added to dobutamine in patients with decompensated advanced heart failure refractory to dobutamine alone.
Topics: Administration, Oral; Cardiac Output; Cardiotonic Agents; Diuretics; Dobutamine; Drug Therapy, Combi | 2004 |
Hemodynamic effects of levosimendan added to dobutamine in patients with decompensated advanced heart failure refractory to dobutamine alone.
Topics: Administration, Oral; Cardiac Output; Cardiotonic Agents; Diuretics; Dobutamine; Drug Therapy, Combi | 2004 |
Torasemide inhibits transcardiac extraction of aldosterone in patients with congestive heart failure.
Topics: Aldosterone; Diuretics; Female; Furosemide; Heart; Heart Failure; Humans; Male; Middle Aged; Mineral | 2004 |
Torasemide inhibits transcardiac extraction of aldosterone in patients with congestive heart failure.
Topics: Aldosterone; Diuretics; Female; Furosemide; Heart; Heart Failure; Humans; Male; Middle Aged; Mineral | 2004 |
Changes in brain natriuretic peptide levels and bioelectrical impedance measurements after treatment with high-dose furosemide and hypertonic saline solution versus high-dose furosemide alone in refractory congestive heart failure: a double-blind study.
Topics: Aged; Aged, 80 and over; Diuretics; Dose-Response Relationship, Drug; Double-Blind Method; Drug Ther | 2005 |
Changes in brain natriuretic peptide levels and bioelectrical impedance measurements after treatment with high-dose furosemide and hypertonic saline solution versus high-dose furosemide alone in refractory congestive heart failure: a double-blind study.
Topics: Aged; Aged, 80 and over; Diuretics; Dose-Response Relationship, Drug; Double-Blind Method; Drug Ther | 2005 |
Changes in brain natriuretic peptide levels and bioelectrical impedance measurements after treatment with high-dose furosemide and hypertonic saline solution versus high-dose furosemide alone in refractory congestive heart failure: a double-blind study.
Topics: Aged; Aged, 80 and over; Diuretics; Dose-Response Relationship, Drug; Double-Blind Method; Drug Ther | 2005 |
Changes in brain natriuretic peptide levels and bioelectrical impedance measurements after treatment with high-dose furosemide and hypertonic saline solution versus high-dose furosemide alone in refractory congestive heart failure: a double-blind study.
Topics: Aged; Aged, 80 and over; Diuretics; Dose-Response Relationship, Drug; Double-Blind Method; Drug Ther | 2005 |
Changes in brain natriuretic peptide levels and bioelectrical impedance measurements after treatment with high-dose furosemide and hypertonic saline solution versus high-dose furosemide alone in refractory congestive heart failure: a double-blind study.
Topics: Aged; Aged, 80 and over; Diuretics; Dose-Response Relationship, Drug; Double-Blind Method; Drug Ther | 2005 |
Changes in brain natriuretic peptide levels and bioelectrical impedance measurements after treatment with high-dose furosemide and hypertonic saline solution versus high-dose furosemide alone in refractory congestive heart failure: a double-blind study.
Topics: Aged; Aged, 80 and over; Diuretics; Dose-Response Relationship, Drug; Double-Blind Method; Drug Ther | 2005 |
Changes in brain natriuretic peptide levels and bioelectrical impedance measurements after treatment with high-dose furosemide and hypertonic saline solution versus high-dose furosemide alone in refractory congestive heart failure: a double-blind study.
Topics: Aged; Aged, 80 and over; Diuretics; Dose-Response Relationship, Drug; Double-Blind Method; Drug Ther | 2005 |
Changes in brain natriuretic peptide levels and bioelectrical impedance measurements after treatment with high-dose furosemide and hypertonic saline solution versus high-dose furosemide alone in refractory congestive heart failure: a double-blind study.
Topics: Aged; Aged, 80 and over; Diuretics; Dose-Response Relationship, Drug; Double-Blind Method; Drug Ther | 2005 |
Vasopressin-2-receptor antagonism augments water excretion without changes in renal hemodynamics or sodium and potassium excretion in human heart failure.
Topics: Antidiuretic Hormone Receptor Antagonists; Benzazepines; Cross-Over Studies; Diuretics; Female; Furo | 2006 |
Vasopressin-2-receptor antagonism augments water excretion without changes in renal hemodynamics or sodium and potassium excretion in human heart failure.
Topics: Antidiuretic Hormone Receptor Antagonists; Benzazepines; Cross-Over Studies; Diuretics; Female; Furo | 2006 |
Combination therapy with metolazone and loop diuretics in outpatients with refractory heart failure: an observational study and review of the literature.
Topics: Aged; Aged, 80 and over; Blood Pressure; Body Weight; Bumetanide; Diuretics; Drug Therapy, Combinati | 2005 |
Combination therapy with metolazone and loop diuretics in outpatients with refractory heart failure: an observational study and review of the literature.
Topics: Aged; Aged, 80 and over; Blood Pressure; Body Weight; Bumetanide; Diuretics; Drug Therapy, Combinati | 2005 |
Serum concentration of potassium in chronic heart failure patients administered spironolactone plus furosemide and either enalapril maleate, losartan potassium or candesartan cilexetil.
Topics: Adult; Aged; Aged, 80 and over; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzy | 2005 |
Serum concentration of potassium in chronic heart failure patients administered spironolactone plus furosemide and either enalapril maleate, losartan potassium or candesartan cilexetil.
Topics: Adult; Aged; Aged, 80 and over; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzy | 2005 |
Standard hemodiafiltration improves diuretic responsiveness in advanced congestive heart failure.
Topics: Adult; Aged; Diuretics; Furosemide; Heart Failure; Hemodiafiltration; Humans; Middle Aged; Prospecti | 2006 |
Standard hemodiafiltration improves diuretic responsiveness in advanced congestive heart failure.
Topics: Adult; Aged; Diuretics; Furosemide; Heart Failure; Hemodiafiltration; Humans; Middle Aged; Prospecti | 2006 |
Increased urinary aquaporin-2 excretion in response to furosemide in patients with chronic heart failure.
Topics: Adult; Aged; Aged, 80 and over; Angiotensin II; Aquaporin 2; Arginine Vasopressin; Atrial Natriureti | 2006 |
Increased urinary aquaporin-2 excretion in response to furosemide in patients with chronic heart failure.
Topics: Adult; Aged; Aged, 80 and over; Angiotensin II; Aquaporin 2; Arginine Vasopressin; Atrial Natriureti | 2006 |
Effects of torasemide on cardiac sympathetic nerve activity and left ventricular remodelling in patients with congestive heart failure.
Topics: Aged; Autonomic Nervous System Diseases; Diuretics; Female; Furosemide; Heart Failure; Humans; Male; | 2006 |
Effects of torasemide on cardiac sympathetic nerve activity and left ventricular remodelling in patients with congestive heart failure.
Topics: Aged; Autonomic Nervous System Diseases; Diuretics; Female; Furosemide; Heart Failure; Humans; Male; | 2006 |
Effect of timed semirecumbency and furosemide dosing on urinary sodium excretion in patients with compensated heart failure.
Topics: Adult; Aged; Bed Rest; Diuretics; Female; Furosemide; Heart Failure; Humans; Male; Middle Aged; Moto | 2006 |
Effect of timed semirecumbency and furosemide dosing on urinary sodium excretion in patients with compensated heart failure.
Topics: Adult; Aged; Bed Rest; Diuretics; Female; Furosemide; Heart Failure; Humans; Male; Middle Aged; Moto | 2006 |
Short-term clinical effects of tolvaptan, an oral vasopressin antagonist, in patients hospitalized for heart failure: the EVEREST Clinical Status Trials.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Antidiuretic Hormone Receptor Antagonists; Ben | 2007 |
Short-term clinical effects of tolvaptan, an oral vasopressin antagonist, in patients hospitalized for heart failure: the EVEREST Clinical Status Trials.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Antidiuretic Hormone Receptor Antagonists; Ben | 2007 |
Short-term clinical effects of tolvaptan, an oral vasopressin antagonist, in patients hospitalized for heart failure: the EVEREST Clinical Status Trials.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Antidiuretic Hormone Receptor Antagonists; Ben | 2007 |
Short-term clinical effects of tolvaptan, an oral vasopressin antagonist, in patients hospitalized for heart failure: the EVEREST Clinical Status Trials.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Antidiuretic Hormone Receptor Antagonists; Ben | 2007 |
Short-term clinical effects of tolvaptan, an oral vasopressin antagonist, in patients hospitalized for heart failure: the EVEREST Clinical Status Trials.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Antidiuretic Hormone Receptor Antagonists; Ben | 2007 |
Short-term clinical effects of tolvaptan, an oral vasopressin antagonist, in patients hospitalized for heart failure: the EVEREST Clinical Status Trials.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Antidiuretic Hormone Receptor Antagonists; Ben | 2007 |
Short-term clinical effects of tolvaptan, an oral vasopressin antagonist, in patients hospitalized for heart failure: the EVEREST Clinical Status Trials.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Antidiuretic Hormone Receptor Antagonists; Ben | 2007 |
Short-term clinical effects of tolvaptan, an oral vasopressin antagonist, in patients hospitalized for heart failure: the EVEREST Clinical Status Trials.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Antidiuretic Hormone Receptor Antagonists; Ben | 2007 |
Short-term clinical effects of tolvaptan, an oral vasopressin antagonist, in patients hospitalized for heart failure: the EVEREST Clinical Status Trials.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Antidiuretic Hormone Receptor Antagonists; Ben | 2007 |
Short-term clinical effects of tolvaptan, an oral vasopressin antagonist, in patients hospitalized for heart failure: the EVEREST Clinical Status Trials.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Antidiuretic Hormone Receptor Antagonists; Ben | 2007 |
Short-term clinical effects of tolvaptan, an oral vasopressin antagonist, in patients hospitalized for heart failure: the EVEREST Clinical Status Trials.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Antidiuretic Hormone Receptor Antagonists; Ben | 2007 |
Short-term clinical effects of tolvaptan, an oral vasopressin antagonist, in patients hospitalized for heart failure: the EVEREST Clinical Status Trials.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Antidiuretic Hormone Receptor Antagonists; Ben | 2007 |
Short-term clinical effects of tolvaptan, an oral vasopressin antagonist, in patients hospitalized for heart failure: the EVEREST Clinical Status Trials.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Antidiuretic Hormone Receptor Antagonists; Ben | 2007 |
Short-term clinical effects of tolvaptan, an oral vasopressin antagonist, in patients hospitalized for heart failure: the EVEREST Clinical Status Trials.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Antidiuretic Hormone Receptor Antagonists; Ben | 2007 |
Short-term clinical effects of tolvaptan, an oral vasopressin antagonist, in patients hospitalized for heart failure: the EVEREST Clinical Status Trials.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Antidiuretic Hormone Receptor Antagonists; Ben | 2007 |
Short-term clinical effects of tolvaptan, an oral vasopressin antagonist, in patients hospitalized for heart failure: the EVEREST Clinical Status Trials.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Antidiuretic Hormone Receptor Antagonists; Ben | 2007 |
Short-term clinical effects of tolvaptan, an oral vasopressin antagonist, in patients hospitalized for heart failure: the EVEREST Clinical Status Trials.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Antidiuretic Hormone Receptor Antagonists; Ben | 2007 |
Short-term clinical effects of tolvaptan, an oral vasopressin antagonist, in patients hospitalized for heart failure: the EVEREST Clinical Status Trials.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Antidiuretic Hormone Receptor Antagonists; Ben | 2007 |
Rationale and design of a randomized trial to assess the effects of diuretics in heart failure: Japanese Multicenter Evaluation of Long- vs Short-Acting Diuretics in Congestive Heart Failure (J-MELODIC).
Topics: Adult; Aged; Aged, 80 and over; Delayed-Action Preparations; Diuretics; Furosemide; Heart Failure; H | 2007 |
Rationale and design of a randomized trial to assess the effects of diuretics in heart failure: Japanese Multicenter Evaluation of Long- vs Short-Acting Diuretics in Congestive Heart Failure (J-MELODIC).
Topics: Adult; Aged; Aged, 80 and over; Delayed-Action Preparations; Diuretics; Furosemide; Heart Failure; H | 2007 |
Normal-sodium diet compared with low-sodium diet in compensated congestive heart failure: is sodium an old enemy or a new friend?
Topics: Aged; Aged, 80 and over; Aldosterone; Combined Modality Therapy; Diet, Sodium-Restricted; Diuretics; | 2008 |
Normal-sodium diet compared with low-sodium diet in compensated congestive heart failure: is sodium an old enemy or a new friend?
Topics: Aged; Aged, 80 and over; Aldosterone; Combined Modality Therapy; Diet, Sodium-Restricted; Diuretics; | 2008 |
Relation between dose of loop diuretics and outcomes in a heart failure population: results of the ESCAPE trial.
Topics: Aged; Cardiotonic Agents; Databases as Topic; Female; Furosemide; Heart Failure; Hospitalization; Hu | 2007 |
Relation between dose of loop diuretics and outcomes in a heart failure population: results of the ESCAPE trial.
Topics: Aged; Cardiotonic Agents; Databases as Topic; Female; Furosemide; Heart Failure; Hospitalization; Hu | 2007 |
Identification of a potential cardiac antifibrotic mechanism of torasemide in patients with chronic heart failure.
Topics: Adult; Aged; Antihypertensive Agents; Blotting, Western; Endocardium; Extracellular Matrix; Female; | 2007 |
Identification of a potential cardiac antifibrotic mechanism of torasemide in patients with chronic heart failure.
Topics: Adult; Aged; Antihypertensive Agents; Blotting, Western; Endocardium; Extracellular Matrix; Female; | 2007 |
The effects of KW-3902, an adenosine A1-receptor antagonist,on diuresis and renal function in patients with acute decompensated heart failure and renal impairment or diuretic resistance.
Topics: Aged; Creatinine; Diuresis; Diuretics; Dose-Response Relationship, Drug; Double-Blind Method; Drug R | 2007 |
The effects of KW-3902, an adenosine A1-receptor antagonist,on diuresis and renal function in patients with acute decompensated heart failure and renal impairment or diuretic resistance.
Topics: Aged; Creatinine; Diuresis; Diuretics; Dose-Response Relationship, Drug; Double-Blind Method; Drug R | 2007 |
Hypertonic saline solution for renal failure prevention in patients with decompensated heart failure.
Topics: Biomarkers; Cardiotonic Agents; Creatinine; Diuretics; Dobutamine; Female; Furosemide; Heart Failure | 2007 |
Hypertonic saline solution for renal failure prevention in patients with decompensated heart failure.
Topics: Biomarkers; Cardiotonic Agents; Creatinine; Diuretics; Dobutamine; Female; Furosemide; Heart Failure | 2007 |
A randomized, controlled trial of the renal effects of ultrafiltration as compared to furosemide in patients with acute decompensated heart failure.
Topics: Acute Disease; Adult; Aged; Dose-Response Relationship, Drug; Drug Administration Schedule; Edema; E | 2008 |
A randomized, controlled trial of the renal effects of ultrafiltration as compared to furosemide in patients with acute decompensated heart failure.
Topics: Acute Disease; Adult; Aged; Dose-Response Relationship, Drug; Drug Administration Schedule; Edema; E | 2008 |
Prenalterol in the treatment of congestive heart failure developing during beta-blocking therapy. A comparison with frusemide in patients with acute myocardial infarction.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Blood Pressure; Dose-Response Relationship, D | 1982 |
Prenalterol in the treatment of congestive heart failure developing during beta-blocking therapy. A comparison with frusemide in patients with acute myocardial infarction.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Blood Pressure; Dose-Response Relationship, D | 1982 |
Haemodynamic advantages of isosorbide dinitrate over frusemide in acute heart-failure following myocardial infarction.
Topics: Acute Disease; Adult; Aged; Clinical Trials as Topic; Furosemide; Heart Failure; Hemodynamics; Human | 1983 |
Haemodynamic advantages of isosorbide dinitrate over frusemide in acute heart-failure following myocardial infarction.
Topics: Acute Disease; Adult; Aged; Clinical Trials as Topic; Furosemide; Heart Failure; Hemodynamics; Human | 1983 |
Frusemide or isosorbide dinitrate for acute heart failure?
Topics: Acute Disease; Clinical Trials as Topic; Furosemide; Heart Failure; Hemodynamics; Humans; Infusions, | 1983 |
Frusemide or isosorbide dinitrate for acute heart failure?
Topics: Acute Disease; Clinical Trials as Topic; Furosemide; Heart Failure; Hemodynamics; Humans; Infusions, | 1983 |
Hemodynamic trial of sequential treatment with diuretic, vasodilator, and positive inotropic drugs in left ventricular failure following acute myocardial infarction.
Topics: Adrenergic beta-Agonists; Adult; Cardiotonic Agents; Drug Therapy, Combination; Furosemide; Heart Fa | 1984 |
Hemodynamic trial of sequential treatment with diuretic, vasodilator, and positive inotropic drugs in left ventricular failure following acute myocardial infarction.
Topics: Adrenergic beta-Agonists; Adult; Cardiotonic Agents; Drug Therapy, Combination; Furosemide; Heart Fa | 1984 |
[Treatment of cardiac failure with diuretics. A double-blind study comparing a fixed combination of hydrochlorothiazide/amiloride and furosemide plus potassium substitution].
Topics: Adult; Aged; Amiloride; Clinical Trials as Topic; Double-Blind Method; Drug Therapy, Combination; Fu | 1983 |
[Treatment of cardiac failure with diuretics. A double-blind study comparing a fixed combination of hydrochlorothiazide/amiloride and furosemide plus potassium substitution].
Topics: Adult; Aged; Amiloride; Clinical Trials as Topic; Double-Blind Method; Drug Therapy, Combination; Fu | 1983 |
Renal response to captopril in severe heart failure: role of furosemide in natriuresis and reversal of hyponatremia.
Topics: Adult; Aged; Blood Pressure; Captopril; Drug Therapy, Combination; Female; Furosemide; Glomerular Fi | 1984 |
Renal response to captopril in severe heart failure: role of furosemide in natriuresis and reversal of hyponatremia.
Topics: Adult; Aged; Blood Pressure; Captopril; Drug Therapy, Combination; Female; Furosemide; Glomerular Fi | 1984 |
Development of congestive heart failure after treatment with metoprolol in acute myocardial infarction.
Topics: Adult; Aged; Clinical Trials as Topic; Double-Blind Method; Furosemide; Heart Failure; Humans; Metop | 1984 |
Development of congestive heart failure after treatment with metoprolol in acute myocardial infarction.
Topics: Adult; Aged; Clinical Trials as Topic; Double-Blind Method; Furosemide; Heart Failure; Humans; Metop | 1984 |
A comparative randomized double-blind clinical trial of bumetanide and furosemide in congestive cardiac failure and other edema states.
Topics: Administration, Oral; Adolescent; Adult; Aged; Bumetanide; Clinical Trials as Topic; Diuretics; Doub | 1984 |
A comparative randomized double-blind clinical trial of bumetanide and furosemide in congestive cardiac failure and other edema states.
Topics: Administration, Oral; Adolescent; Adult; Aged; Bumetanide; Clinical Trials as Topic; Diuretics; Doub | 1984 |
Urinary electrolyte excretion after frusemide, amiloride and a combination of these drugs: an open, crossover study.
Topics: Aged; Amiloride; Clinical Trials as Topic; Drug Combinations; Electrolytes; Female; Furosemide; Hear | 1984 |
Urinary electrolyte excretion after frusemide, amiloride and a combination of these drugs: an open, crossover study.
Topics: Aged; Amiloride; Clinical Trials as Topic; Drug Combinations; Electrolytes; Female; Furosemide; Hear | 1984 |
Frusemide/amiloride combination ('Frumil') in heart failure: an open, multi-centre study in general practice.
Topics: Aged; Amiloride; Body Weight; Clinical Trials as Topic; Drug Combinations; Edema; Female; Furosemide | 1984 |
Frusemide/amiloride combination ('Frumil') in heart failure: an open, multi-centre study in general practice.
Topics: Aged; Amiloride; Body Weight; Clinical Trials as Topic; Drug Combinations; Edema; Female; Furosemide | 1984 |
Potassium supplements and total body potassium in elderly patients.
Topics: Aged; Furosemide; Heart Failure; Humans; Potassium; Potassium Deficiency | 1984 |
Potassium supplements and total body potassium in elderly patients.
Topics: Aged; Furosemide; Heart Failure; Humans; Potassium; Potassium Deficiency | 1984 |
Bumetanide and furosemide in heart failure.
Topics: Absorption; Adult; Aged; Bumetanide; Diuretics; Dose-Response Relationship, Drug; Female; Furosemide | 1984 |
Bumetanide and furosemide in heart failure.
Topics: Absorption; Adult; Aged; Bumetanide; Diuretics; Dose-Response Relationship, Drug; Female; Furosemide | 1984 |
Hemodynamic comparison of primary venous or arteriolar dilatation and the subsequent effect of furosemide in left ventricular failure after acute myocardial infarction.
Topics: Adult; Blood Pressure; Cardiac Output; Drug Therapy, Combination; Furosemide; Heart Failure; Heart R | 1983 |
Hemodynamic comparison of primary venous or arteriolar dilatation and the subsequent effect of furosemide in left ventricular failure after acute myocardial infarction.
Topics: Adult; Blood Pressure; Cardiac Output; Drug Therapy, Combination; Furosemide; Heart Failure; Heart R | 1983 |
Management of acute heart failure following myocardial infarction: hemodynamic advantages of isosorbide dinitrate over frusemide.
Topics: Adult; Aged; Furosemide; Heart Failure; Hemodynamics; Humans; Isosorbide Dinitrate; Male; Middle Age | 1983 |
Management of acute heart failure following myocardial infarction: hemodynamic advantages of isosorbide dinitrate over frusemide.
Topics: Adult; Aged; Furosemide; Heart Failure; Hemodynamics; Humans; Isosorbide Dinitrate; Male; Middle Age | 1983 |
A comparison of the effect of combined frusemide and controlled-release potassium tablets (Diumide-K continus tablets) and frusemide and slow-K tablets in elderly patients with cardiac failure.
Topics: Aged; Body Weight; Clinical Trials as Topic; Delayed-Action Preparations; Drug Combinations; Drug Th | 1982 |
A comparison of the effect of combined frusemide and controlled-release potassium tablets (Diumide-K continus tablets) and frusemide and slow-K tablets in elderly patients with cardiac failure.
Topics: Aged; Body Weight; Clinical Trials as Topic; Delayed-Action Preparations; Drug Combinations; Drug Th | 1982 |
Clinical efficacy of torasemide, a new diuretic agent, in patients with acute heart failure: a double blind comparison with furosemide.
Topics: Adult; Aged; Blood Pressure; Clinical Trials as Topic; Diuretics; Double-Blind Method; Electrolytes; | 1982 |
Clinical efficacy of torasemide, a new diuretic agent, in patients with acute heart failure: a double blind comparison with furosemide.
Topics: Adult; Aged; Blood Pressure; Clinical Trials as Topic; Diuretics; Double-Blind Method; Electrolytes; | 1982 |
Non-steroidal anti-inflammatory drugs and frusemide-induced diuresis.
Topics: Aged; Anti-Inflammatory Agents; Clinical Trials as Topic; Diuresis; Furosemide; Heart Failure; Human | 1981 |
Non-steroidal anti-inflammatory drugs and frusemide-induced diuresis.
Topics: Aged; Anti-Inflammatory Agents; Clinical Trials as Topic; Diuresis; Furosemide; Heart Failure; Human | 1981 |
The effect of amiloride/hydrochlorothiazide combination vs furosemide plus potassium supplementation in the treatment of oedema of cardiac origin.
Topics: Adult; Aged; Amiloride; Clinical Trials as Topic; Double-Blind Method; Drug Combinations; Edema, Car | 1981 |
The effect of amiloride/hydrochlorothiazide combination vs furosemide plus potassium supplementation in the treatment of oedema of cardiac origin.
Topics: Adult; Aged; Amiloride; Clinical Trials as Topic; Double-Blind Method; Drug Combinations; Edema, Car | 1981 |
Comparison of the chronic effects of bendrofluazide, bumetanide and frusemide on plasma biochemical variables.
Topics: Aged; Analysis of Variance; Bendroflumethiazide; Blood Chemical Analysis; Bumetanide; Clinical Trial | 1981 |
Comparison of the chronic effects of bendrofluazide, bumetanide and frusemide on plasma biochemical variables.
Topics: Aged; Analysis of Variance; Bendroflumethiazide; Blood Chemical Analysis; Bumetanide; Clinical Trial | 1981 |
Heart rate variability in patients with mild to moderate heart failure: effects of neurohormonal modulation by digoxin and ibopamine. The Dutch Ibopamine Multicenter Trial (DIMT) Study Group.
Topics: Aldosterone; Cardiotonic Agents; Deoxyepinephrine; Digoxin; Diuretics; Dopamine Agonists; Double-Bli | 1995 |
Heart rate variability in patients with mild to moderate heart failure: effects of neurohormonal modulation by digoxin and ibopamine. The Dutch Ibopamine Multicenter Trial (DIMT) Study Group.
Topics: Aldosterone; Cardiotonic Agents; Deoxyepinephrine; Digoxin; Diuretics; Dopamine Agonists; Double-Bli | 1995 |
Salutary effect of Terminalia Arjuna in patients with severe refractory heart failure.
Topics: Adult; Aged; Cardiomyopathy, Dilated; Chemotherapy, Adjuvant; Chronic Disease; Coronary Disease; Cro | 1995 |
Salutary effect of Terminalia Arjuna in patients with severe refractory heart failure.
Topics: Adult; Aged; Cardiomyopathy, Dilated; Chemotherapy, Adjuvant; Chronic Disease; Coronary Disease; Cro | 1995 |
Sudden death and staged therapy for hemodynamic stabilization in patients enrolled in a heart transplantation program.
Topics: Alprostadil; Angiotensin-Converting Enzyme Inhibitors; Death, Sudden, Cardiac; Digoxin; Dobutamine; | 1995 |
Sudden death and staged therapy for hemodynamic stabilization in patients enrolled in a heart transplantation program.
Topics: Alprostadil; Angiotensin-Converting Enzyme Inhibitors; Death, Sudden, Cardiac; Digoxin; Dobutamine; | 1995 |
Improved left ventricular function after thiamine supplementation in patients with congestive heart failure receiving long-term furosemide therapy.
Topics: Aged; Aged, 80 and over; Diuresis; Double-Blind Method; Echocardiography; Erythrocytes; Female; Furo | 1995 |
Improved left ventricular function after thiamine supplementation in patients with congestive heart failure receiving long-term furosemide therapy.
Topics: Aged; Aged, 80 and over; Diuresis; Double-Blind Method; Echocardiography; Erythrocytes; Female; Furo | 1995 |
[Body fluid withdrawal with isolated ultrafiltration effects persistent improvement of functional capacity in patients with chronic congestive heart failure. Furosemide does not produce the same result].
Topics: Aged; Female; Follow-Up Studies; Furosemide; Heart Failure; Heart Function Tests; Hemofiltration; Hu | 1994 |
[Body fluid withdrawal with isolated ultrafiltration effects persistent improvement of functional capacity in patients with chronic congestive heart failure. Furosemide does not produce the same result].
Topics: Aged; Female; Follow-Up Studies; Furosemide; Heart Failure; Heart Function Tests; Hemofiltration; Hu | 1994 |
The renin angiotensin aldosterone system and frusemide response in congestive heart failure.
Topics: Administration, Oral; Aged; Aldosterone; Captopril; Cross-Over Studies; Drug Therapy, Combination; F | 1995 |
The renin angiotensin aldosterone system and frusemide response in congestive heart failure.
Topics: Administration, Oral; Aged; Aldosterone; Captopril; Cross-Over Studies; Drug Therapy, Combination; F | 1995 |
Bioavailability, pharmacokinetics, and pharmacodynamics of torsemide and furosemide in patients with congestive heart failure.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Analysis of Variance; Biological Availability; | 1995 |
Bioavailability, pharmacokinetics, and pharmacodynamics of torsemide and furosemide in patients with congestive heart failure.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Analysis of Variance; Biological Availability; | 1995 |
Responses to low dose intravenous perindoprilat infusion in salt deplete/salt replete normotensive volunteers.
Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Cross-Over Studies; Diet, Sodium-Re | 1994 |
Responses to low dose intravenous perindoprilat infusion in salt deplete/salt replete normotensive volunteers.
Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Cross-Over Studies; Diet, Sodium-Re | 1994 |
Symptomatic achievements with diuretics in congestive heart failure.
Topics: Diuretics; Exercise Test; Female; Furosemide; Heart Failure; Humans; Jugular Veins; Male; Middle Age | 1994 |
Symptomatic achievements with diuretics in congestive heart failure.
Topics: Diuretics; Exercise Test; Female; Furosemide; Heart Failure; Humans; Jugular Veins; Male; Middle Age | 1994 |
Effect of intense angiotensin II suppression on the diuretic response to furosemide during chronic ACE inhibition.
Topics: Aged; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Captopril; Diuresis; Drug Synergism; | 1994 |
Effect of intense angiotensin II suppression on the diuretic response to furosemide during chronic ACE inhibition.
Topics: Aged; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Captopril; Diuresis; Drug Synergism; | 1994 |
Dose-response study of intravenous torsemide in congestive heart failure.
Topics: Adult; Aged; Chlorides; Diuretics; Dose-Response Relationship, Drug; Double-Blind Method; Female; Fu | 1994 |
Dose-response study of intravenous torsemide in congestive heart failure.
Topics: Adult; Aged; Chlorides; Diuretics; Dose-Response Relationship, Drug; Double-Blind Method; Female; Fu | 1994 |
Continuous infusion of furosemide in the treatment of patients with congestive heart failure and diuretic resistance.
Topics: Aged; Aged, 80 and over; Diuretics; Drug Administration Schedule; Drug Resistance; Female; Furosemid | 1994 |
Continuous infusion of furosemide in the treatment of patients with congestive heart failure and diuretic resistance.
Topics: Aged; Aged, 80 and over; Diuretics; Drug Administration Schedule; Drug Resistance; Female; Furosemid | 1994 |
Sustained improvement in functional capacity after removal of body fluid with isolated ultrafiltration in chronic cardiac insufficiency: failure of furosemide to provide the same result.
Topics: Aged; Chronic Disease; Exercise Test; Female; Furosemide; Heart Failure; Hemodynamics; Humans; Injec | 1994 |
Sustained improvement in functional capacity after removal of body fluid with isolated ultrafiltration in chronic cardiac insufficiency: failure of furosemide to provide the same result.
Topics: Aged; Chronic Disease; Exercise Test; Female; Furosemide; Heart Failure; Hemodynamics; Humans; Injec | 1994 |
Acute effects of captopril on the renal actions of furosemide in patients with chronic heart failure.
Topics: Administration, Oral; Aged; Blood Pressure; Captopril; Chronic Disease; Diuresis; Double-Blind Metho | 1993 |
Acute effects of captopril on the renal actions of furosemide in patients with chronic heart failure.
Topics: Administration, Oral; Aged; Blood Pressure; Captopril; Chronic Disease; Diuresis; Double-Blind Metho | 1993 |
Renal effects of low dose prazosin in patients with congestive heart failure.
Topics: Aged; Female; Furosemide; Glomerular Filtration Rate; Heart Failure; Hemodynamics; Humans; Kidney; M | 1993 |
Renal effects of low dose prazosin in patients with congestive heart failure.
Topics: Aged; Female; Furosemide; Glomerular Filtration Rate; Heart Failure; Hemodynamics; Humans; Kidney; M | 1993 |
The effects of oral ibopamine in patients with mild heart failure--a double blind placebo controlled comparison to furosemide. The Ibopamine Study Group.
Topics: Administration, Oral; Adolescent; Adult; Aged; Cardiac Output; Cardiotonic Agents; Child; Deoxyepine | 1993 |
The effects of oral ibopamine in patients with mild heart failure--a double blind placebo controlled comparison to furosemide. The Ibopamine Study Group.
Topics: Administration, Oral; Adolescent; Adult; Aged; Cardiac Output; Cardiotonic Agents; Child; Deoxyepine | 1993 |
Interaction of intravenous atrial natriuretic factor with furosemide in patients with heart failure.
Topics: Aged; Atrial Natriuretic Factor; Blood Pressure; Cardiac Output; Double-Blind Method; Drug Interacti | 1994 |
Interaction of intravenous atrial natriuretic factor with furosemide in patients with heart failure.
Topics: Aged; Atrial Natriuretic Factor; Blood Pressure; Cardiac Output; Double-Blind Method; Drug Interacti | 1994 |
The effects of epoprostenol on drug disposition. II: A pilot study of the pharmacokinetics of furosemide with and without epoprostenol in patients with congestive heart failure.
Topics: Diuretics; Epoprostenol; Furosemide; Heart Failure; Humans; Metabolic Clearance Rate; Middle Aged; N | 1996 |
The effects of epoprostenol on drug disposition. II: A pilot study of the pharmacokinetics of furosemide with and without epoprostenol in patients with congestive heart failure.
Topics: Diuretics; Epoprostenol; Furosemide; Heart Failure; Humans; Metabolic Clearance Rate; Middle Aged; N | 1996 |
Chronic intermittent haemofiltration and haemodialysis in end stage chronic heart failure with oedema refractory to high dose frusemide.
Topics: Aged; Chronic Disease; Edema; Female; Furosemide; Heart Failure; Hemofiltration; Humans; Male; Middl | 1996 |
Chronic intermittent haemofiltration and haemodialysis in end stage chronic heart failure with oedema refractory to high dose frusemide.
Topics: Aged; Chronic Disease; Edema; Female; Furosemide; Heart Failure; Hemofiltration; Humans; Male; Middl | 1996 |
Diuretic efficacy of high dose furosemide in severe heart failure: bolus injection versus continuous infusion.
Topics: Aged; Cross-Over Studies; Diuretics; Dose-Response Relationship, Drug; Female; Furosemide; Hearing D | 1996 |
Diuretic efficacy of high dose furosemide in severe heart failure: bolus injection versus continuous infusion.
Topics: Aged; Cross-Over Studies; Diuretics; Dose-Response Relationship, Drug; Female; Furosemide; Hearing D | 1996 |
Dopamine does not enhance furosemide-induced natriuresis in patients with congestive heart failure.
Topics: Aged; Diuretics; Dopamine; Drug Interactions; Female; Furosemide; Glomerular Filtration Rate; Heart | 1996 |
Dopamine does not enhance furosemide-induced natriuresis in patients with congestive heart failure.
Topics: Aged; Diuretics; Dopamine; Drug Interactions; Female; Furosemide; Glomerular Filtration Rate; Heart | 1996 |
Effectiveness of spironolactone added to an angiotensin-converting enzyme inhibitor and a loop diuretic for severe chronic congestive heart failure (the Randomized Aldactone Evaluation Study [RALES]).
Topics: Adult; Aged; Aged, 80 and over; Angiotensin-Converting Enzyme Inhibitors; Digitalis Glycosides; Diur | 1996 |
Effectiveness of spironolactone added to an angiotensin-converting enzyme inhibitor and a loop diuretic for severe chronic congestive heart failure (the Randomized Aldactone Evaluation Study [RALES]).
Topics: Adult; Aged; Aged, 80 and over; Angiotensin-Converting Enzyme Inhibitors; Digitalis Glycosides; Diur | 1996 |
Combination of high-dose furosemide and hydrochlorothiazide in the treatment of refractory congestive heart failure.
Topics: Adult; Aged; Aged, 80 and over; Chronic Disease; Diuretics; Dose-Response Relationship, Drug; Drug S | 1996 |
Combination of high-dose furosemide and hydrochlorothiazide in the treatment of refractory congestive heart failure.
Topics: Adult; Aged; Aged, 80 and over; Chronic Disease; Diuretics; Dose-Response Relationship, Drug; Drug S | 1996 |
Nonselective beta-adrenergic blockade with carvedilol does not hinder the benefits of exercise training in patients with congestive heart failure.
Topics: Adaptation, Physiological; Adrenergic beta-Antagonists; Aerobiosis; Aged; Angiotensin-Converting Enz | 1997 |
Nonselective beta-adrenergic blockade with carvedilol does not hinder the benefits of exercise training in patients with congestive heart failure.
Topics: Adaptation, Physiological; Adrenergic beta-Antagonists; Aerobiosis; Aged; Angiotensin-Converting Enz | 1997 |
A double-blind, cross-over comparison of the effects of a loop diuretic and a dopamine receptor agonist as first line therapy in patients with mild congestive heart failure.
Topics: Adult; Cross-Over Studies; Deoxyepinephrine; Diuretics; Dopamine Agonists; Double-Blind Method; Exer | 1997 |
A double-blind, cross-over comparison of the effects of a loop diuretic and a dopamine receptor agonist as first line therapy in patients with mild congestive heart failure.
Topics: Adult; Cross-Over Studies; Deoxyepinephrine; Diuretics; Dopamine Agonists; Double-Blind Method; Exer | 1997 |
Effect of bolus injection versus continuous infusion of furosemide on diuresis and neurohormonal activation in patients with severe congestive heart failure.
Topics: Atrial Natriuretic Factor; Blood Pressure; Brain; Catecholamines; Cross-Over Studies; Diuresis; Diur | 1997 |
Effect of bolus injection versus continuous infusion of furosemide on diuresis and neurohormonal activation in patients with severe congestive heart failure.
Topics: Atrial Natriuretic Factor; Blood Pressure; Brain; Catecholamines; Cross-Over Studies; Diuresis; Diur | 1997 |
Increased toxicity of high-dose furosemide versus low-dose dopamine in the treatment of refractory congestive heart failure.
Topics: Acute Kidney Injury; Administration, Oral; Aged; Blood Pressure; Diuretics; Dopamine; Drug Therapy, | 1997 |
Increased toxicity of high-dose furosemide versus low-dose dopamine in the treatment of refractory congestive heart failure.
Topics: Acute Kidney Injury; Administration, Oral; Aged; Blood Pressure; Diuretics; Dopamine; Drug Therapy, | 1997 |
An evaluation of the interaction of meloxicam with frusemide in patients with compensated chronic cardiac failure.
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Area Under Curve; Cross-Over Studies; Diuretics; Doub | 1997 |
An evaluation of the interaction of meloxicam with frusemide in patients with compensated chronic cardiac failure.
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Area Under Curve; Cross-Over Studies; Diuretics; Doub | 1997 |
Randomised trial of high-dose isosorbide dinitrate plus low-dose furosemide versus high-dose furosemide plus low-dose isosorbide dinitrate in severe pulmonary oedema.
Topics: Acute Disease; Aged; Diuretics; Drug Therapy, Combination; Female; Furosemide; Heart Failure; Humans | 1998 |
Randomised trial of high-dose isosorbide dinitrate plus low-dose furosemide versus high-dose furosemide plus low-dose isosorbide dinitrate in severe pulmonary oedema.
Topics: Acute Disease; Aged; Diuretics; Drug Therapy, Combination; Female; Furosemide; Heart Failure; Humans | 1998 |
Fluctuations in blood lipid levels during furosemide therapy: a randomized, double-blind, placebo-controlled crossover study.
Topics: Aged; Apolipoproteins; Cholesterol; Chronic Disease; Cross-Over Studies; Diuretics; Double-Blind Met | 1998 |
Fluctuations in blood lipid levels during furosemide therapy: a randomized, double-blind, placebo-controlled crossover study.
Topics: Aged; Apolipoproteins; Cholesterol; Chronic Disease; Cross-Over Studies; Diuretics; Double-Blind Met | 1998 |
Diuretic effects of furosemide infusion versus bolus injection in congestive heart failure.
Topics: Adult; Aged; Analysis of Variance; Chlorides; Colorimetry; Cross-Over Studies; Diuretics; Female; Fu | 1998 |
Diuretic effects of furosemide infusion versus bolus injection in congestive heart failure.
Topics: Adult; Aged; Analysis of Variance; Chlorides; Colorimetry; Cross-Over Studies; Diuretics; Female; Fu | 1998 |
Effects of enalapril maleate on survival of dogs with naturally acquired heart failure. The Long-Term Investigation of Veterinary Enalapril (LIVE) Study Group.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Cardiomyopathy, Dilated; Cardiotonic Agents; Deat | 1998 |
Effects of enalapril maleate on survival of dogs with naturally acquired heart failure. The Long-Term Investigation of Veterinary Enalapril (LIVE) Study Group.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Cardiomyopathy, Dilated; Cardiotonic Agents; Deat | 1998 |
Effects of short-acting and long-acting loop diuretics on heart rate variability in patients with chronic compensated congestive heart failure.
Topics: Blood Pressure; Cardiac Output; Chronic Disease; Cross-Over Studies; Diuretics; Echocardiography, Do | 1999 |
Effects of short-acting and long-acting loop diuretics on heart rate variability in patients with chronic compensated congestive heart failure.
Topics: Blood Pressure; Cardiac Output; Chronic Disease; Cross-Over Studies; Diuretics; Echocardiography, Do | 1999 |
Effect of isosorbide-5-mononitrate on exercise performance and clinical status in patients with congestive heart failure. Results of the Nitrates in Congestive Heart Failure (NICE) Study.
Topics: Administration, Oral; Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Captopril; Diuretics; D | 1999 |
Effect of isosorbide-5-mononitrate on exercise performance and clinical status in patients with congestive heart failure. Results of the Nitrates in Congestive Heart Failure (NICE) Study.
Topics: Administration, Oral; Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Captopril; Diuretics; D | 1999 |
A pharmacoeconomic assessment of torsemide and furosemide in the treatment of patients with congestive heart failure.
Topics: Aged; Diuretics; Female; Furosemide; Heart Failure; Humans; Male; Managed Care Programs; Quality of | 1999 |
A pharmacoeconomic assessment of torsemide and furosemide in the treatment of patients with congestive heart failure.
Topics: Aged; Diuretics; Female; Furosemide; Heart Failure; Humans; Male; Managed Care Programs; Quality of | 1999 |
Furosemide withdrawal improves postprandial hypotension in elderly patients with heart failure and preserved left ventricular systolic function.
Topics: Aged; Blood Pressure; Diuretics; Echocardiography, Doppler; Female; Furosemide; Heart Failure; Human | 1999 |
Furosemide withdrawal improves postprandial hypotension in elderly patients with heart failure and preserved left ventricular systolic function.
Topics: Aged; Blood Pressure; Diuretics; Echocardiography, Doppler; Female; Furosemide; Heart Failure; Human | 1999 |
Use of Valsalva's maneuver to detect early recurrence of congestive heart failure in a randomized trial of furosemide withdrawal in older patients.
Topics: Aged; Blood Pressure; Cardiac Output; Confidence Intervals; Diuretics; Edema; Follow-Up Studies; Fur | 1999 |
Use of Valsalva's maneuver to detect early recurrence of congestive heart failure in a randomized trial of furosemide withdrawal in older patients.
Topics: Aged; Blood Pressure; Cardiac Output; Confidence Intervals; Diuretics; Edema; Follow-Up Studies; Fur | 1999 |
Comparison of the short-term effects of candoxatril, an orally active neutral endopeptidase inhibitor, and frusemide in the treatment of patients with chronic heart failure.
Topics: Atrial Natriuretic Factor; Chronic Disease; Diuretics; Double-Blind Method; Exercise Test; Furosemid | 1999 |
Comparison of the short-term effects of candoxatril, an orally active neutral endopeptidase inhibitor, and frusemide in the treatment of patients with chronic heart failure.
Topics: Atrial Natriuretic Factor; Chronic Disease; Diuretics; Double-Blind Method; Exercise Test; Furosemid | 1999 |
Hemodynamic and neuroendocrine effects for candoxatril and frusemide in mild stable chronic heart failure.
Topics: Adolescent; Adult; Aged; Aldosterone; Antihypertensive Agents; Chronic Disease; Diuretics; Double-Bl | 1999 |
Hemodynamic and neuroendocrine effects for candoxatril and frusemide in mild stable chronic heart failure.
Topics: Adolescent; Adult; Aged; Aldosterone; Antihypertensive Agents; Chronic Disease; Diuretics; Double-Bl | 1999 |
Nonadherence with angiotensin-converting enzyme inhibitor therapy: a comparison of different ways of measuring it in patients with chronic heart failure.
Topics: Aged; Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Biomarkers; Chronic D | 1999 |
Nonadherence with angiotensin-converting enzyme inhibitor therapy: a comparison of different ways of measuring it in patients with chronic heart failure.
Topics: Aged; Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Biomarkers; Chronic D | 1999 |
Effects of BG9719 (CVT-124), an A1-adenosine receptor antagonist, and furosemide on glomerular filtration rate and natriuresis in patients with congestive heart failure.
Topics: Adult; Aged; Diuretics; Double-Blind Method; Female; Furosemide; Glomerular Filtration Rate; Heart F | 2000 |
Effects of BG9719 (CVT-124), an A1-adenosine receptor antagonist, and furosemide on glomerular filtration rate and natriuresis in patients with congestive heart failure.
Topics: Adult; Aged; Diuretics; Double-Blind Method; Female; Furosemide; Glomerular Filtration Rate; Heart F | 2000 |
The prognostic implications of outpatient diuretic dose in heart failure.
Topics: Aged; Diuretics; Dose-Response Relationship, Drug; Female; Furosemide; Heart Failure; Humans; Male; | 1999 |
The prognostic implications of outpatient diuretic dose in heart failure.
Topics: Aged; Diuretics; Dose-Response Relationship, Drug; Female; Furosemide; Heart Failure; Humans; Male; | 1999 |
Community pharmacist outreach program directed at physicians treating congestive heart failure.
Topics: Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Cardiotonic Agents; Comm | 2000 |
Community pharmacist outreach program directed at physicians treating congestive heart failure.
Topics: Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Cardiotonic Agents; Comm | 2000 |
Treatment of heart failure guided by plasma aminoterminal brain natriuretic peptide (N-BNP) concentrations.
Topics: Adult; Aged; Aged, 80 and over; Angiotensin-Converting Enzyme Inhibitors; Biomarkers; Digoxin; Diure | 2000 |
Treatment of heart failure guided by plasma aminoterminal brain natriuretic peptide (N-BNP) concentrations.
Topics: Adult; Aged; Aged, 80 and over; Angiotensin-Converting Enzyme Inhibitors; Biomarkers; Digoxin; Diure | 2000 |
Effects of high-dose furosemide and small-volume hypertonic saline solution infusion in comparison with a high dose of furosemide as a bolus, in refractory congestive heart failure.
Topics: Aged; Aged, 80 and over; Blood Pressure; Body Weight; Creatinine; Diuresis; Diuretics; Drug Therapy, | 2000 |
Effects of high-dose furosemide and small-volume hypertonic saline solution infusion in comparison with a high dose of furosemide as a bolus, in refractory congestive heart failure.
Topics: Aged; Aged, 80 and over; Blood Pressure; Body Weight; Creatinine; Diuresis; Diuretics; Drug Therapy, | 2000 |
Effects of high-dose furosemide and small-volume hypertonic saline solution infusion in comparison with a high dose of furosemide as a bolus, in refractory congestive heart failure.
Topics: Aged; Aged, 80 and over; Blood Pressure; Body Weight; Creatinine; Diuresis; Diuretics; Drug Therapy, | 2000 |
Effects of high-dose furosemide and small-volume hypertonic saline solution infusion in comparison with a high dose of furosemide as a bolus, in refractory congestive heart failure.
Topics: Aged; Aged, 80 and over; Blood Pressure; Body Weight; Creatinine; Diuresis; Diuretics; Drug Therapy, | 2000 |
Effects of high-dose furosemide and small-volume hypertonic saline solution infusion in comparison with a high dose of furosemide as a bolus, in refractory congestive heart failure.
Topics: Aged; Aged, 80 and over; Blood Pressure; Body Weight; Creatinine; Diuresis; Diuretics; Drug Therapy, | 2000 |
Effects of high-dose furosemide and small-volume hypertonic saline solution infusion in comparison with a high dose of furosemide as a bolus, in refractory congestive heart failure.
Topics: Aged; Aged, 80 and over; Blood Pressure; Body Weight; Creatinine; Diuresis; Diuretics; Drug Therapy, | 2000 |
Effects of high-dose furosemide and small-volume hypertonic saline solution infusion in comparison with a high dose of furosemide as a bolus, in refractory congestive heart failure.
Topics: Aged; Aged, 80 and over; Blood Pressure; Body Weight; Creatinine; Diuresis; Diuretics; Drug Therapy, | 2000 |
Effects of high-dose furosemide and small-volume hypertonic saline solution infusion in comparison with a high dose of furosemide as a bolus, in refractory congestive heart failure.
Topics: Aged; Aged, 80 and over; Blood Pressure; Body Weight; Creatinine; Diuresis; Diuretics; Drug Therapy, | 2000 |
Healthcare costs of patients with heart failure treated with torasemide or furosemide.
Topics: Adult; Aged; Diuretics; Drug Costs; Female; Furosemide; Health Care Costs; Heart Failure; Humans; Ma | 2000 |
Healthcare costs of patients with heart failure treated with torasemide or furosemide.
Topics: Adult; Aged; Diuretics; Drug Costs; Female; Furosemide; Health Care Costs; Heart Failure; Humans; Ma | 2000 |
[Comparison of the therapeutic efficacy of spironolactone and furosemide in patients with severe congestive heart failure].
Topics: Aged; Arrhythmias, Cardiac; Diuretics; Electrocardiography, Ambulatory; Female; Furosemide; Heart Fa | 2000 |
[Comparison of the therapeutic efficacy of spironolactone and furosemide in patients with severe congestive heart failure].
Topics: Aged; Arrhythmias, Cardiac; Diuretics; Electrocardiography, Ambulatory; Female; Furosemide; Heart Fa | 2000 |
Aspirin inhibits the acute venodilator response to furosemide in patients with chronic heart failure.
Topics: Aged; Aspirin; Chronic Disease; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind M | 2001 |
Aspirin inhibits the acute venodilator response to furosemide in patients with chronic heart failure.
Topics: Aged; Aspirin; Chronic Disease; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind M | 2001 |
Influence of diuretics on the concentration of proteins and other components of pleural transudates in patients with heart failure.
Topics: Aged; Albumins; Amiloride; Benzothiadiazines; Cholesterol; Cholinesterases; Diuresis; Diuretics; Exu | 2001 |
Influence of diuretics on the concentration of proteins and other components of pleural transudates in patients with heart failure.
Topics: Aged; Albumins; Amiloride; Benzothiadiazines; Cholesterol; Cholinesterases; Diuresis; Diuretics; Exu | 2001 |
Open-label randomized trial of torsemide compared with furosemide therapy for patients with heart failure.
Topics: Aged; Biological Availability; Diuretics; Female; Furosemide; Heart Failure; Hospitalization; Humans | 2001 |
Open-label randomized trial of torsemide compared with furosemide therapy for patients with heart failure.
Topics: Aged; Biological Availability; Diuretics; Female; Furosemide; Heart Failure; Hospitalization; Humans | 2001 |
BG9719 (CVT-124), an A1 adenosine receptor antagonist, protects against the decline in renal function observed with diuretic therapy.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Creatinine; Cross-Over Studies; Diur | 2002 |
BG9719 (CVT-124), an A1 adenosine receptor antagonist, protects against the decline in renal function observed with diuretic therapy.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Creatinine; Cross-Over Studies; Diur | 2002 |
Effect of diuresis on P-wave duration and dispersion.
Topics: Aged; Diuresis; Diuretics; Electrocardiography; Electrophysiology; Female; Furosemide; Heart Failure | 2002 |
Effect of diuresis on P-wave duration and dispersion.
Topics: Aged; Diuresis; Diuretics; Electrocardiography; Electrophysiology; Female; Furosemide; Heart Failure | 2002 |
The efficacy and safety of furosemide and a combination of spironolactone and hydrochlorothiazide in congestive heart failure.
Topics: Adult; Aged; Clinical Trials as Topic; Double-Blind Method; Drug Combinations; Drug Evaluation; Elec | 1977 |
The efficacy and safety of furosemide and a combination of spironolactone and hydrochlorothiazide in congestive heart failure.
Topics: Adult; Aged; Clinical Trials as Topic; Double-Blind Method; Drug Combinations; Drug Evaluation; Elec | 1977 |
[Dynamics of the amount of fluid in the chest cavity and lower extremities in cardiac insufficiency under the influence of strophanthin and lasix].
Topics: Clinical Trials as Topic; Drug Evaluation; Edema; Furosemide; Heart Failure; Humans; Leg; Pulmonary | 1978 |
[Dynamics of the amount of fluid in the chest cavity and lower extremities in cardiac insufficiency under the influence of strophanthin and lasix].
Topics: Clinical Trials as Topic; Drug Evaluation; Edema; Furosemide; Heart Failure; Humans; Leg; Pulmonary | 1978 |
[Studies on the diuretic effects of etozolin (Elkapin) in heart failure - a comparison with the loop diuretic agent furosemide (author's transl)].
Topics: Blood Cell Count; Blood Pressure; Body Weight; Diuretics; Electrolytes; Furosemide; Heart Failure; H | 1979 |
[Studies on the diuretic effects of etozolin (Elkapin) in heart failure - a comparison with the loop diuretic agent furosemide (author's transl)].
Topics: Blood Cell Count; Blood Pressure; Body Weight; Diuretics; Electrolytes; Furosemide; Heart Failure; H | 1979 |
Pharmacokinetics of furosemide in patients with congestive heart failure.
Topics: Absorption; Administration, Oral; Aged; Biological Availability; Diuresis; Female; Furosemide; Heart | 1979 |
Pharmacokinetics of furosemide in patients with congestive heart failure.
Topics: Absorption; Administration, Oral; Aged; Biological Availability; Diuresis; Female; Furosemide; Heart | 1979 |
The effects of potassium supplements, spironolactone of amiloride on the potassium status of patients with heart failure.
Topics: Adult; Aged; Amiloride; Female; Furosemide; Heart Failure; Humans; Male; Middle Aged; Potassium; Pot | 1978 |
The effects of potassium supplements, spironolactone of amiloride on the potassium status of patients with heart failure.
Topics: Adult; Aged; Amiloride; Female; Furosemide; Heart Failure; Humans; Male; Middle Aged; Potassium; Pot | 1978 |
Diuretic and clinical effects of low-dose furosemide in congestive heart failure patients.
Topics: Adult; Aged; Clinical Trials as Topic; Diuresis; Female; Furosemide; Heart Failure; Humans; Male; Mi | 1976 |
Diuretic and clinical effects of low-dose furosemide in congestive heart failure patients.
Topics: Adult; Aged; Clinical Trials as Topic; Diuresis; Female; Furosemide; Heart Failure; Humans; Male; Mi | 1976 |
[Bumetanide (Burinex) --furosemide (Lasix). A comparative study in congestive heart failure].
Topics: Bumetanide; Clinical Trials as Topic; Diuretics; Drug Evaluation; Furosemide; Heart Failure; Humans | 1976 |
[Bumetanide (Burinex) --furosemide (Lasix). A comparative study in congestive heart failure].
Topics: Bumetanide; Clinical Trials as Topic; Diuretics; Drug Evaluation; Furosemide; Heart Failure; Humans | 1976 |
Patient acceptability of two diuretic/potassium supplement preparations.
Topics: Aged; Bumetanide; Clinical Trials as Topic; Deglutition; Delayed-Action Preparations; Diuretics; Dru | 1976 |
Patient acceptability of two diuretic/potassium supplement preparations.
Topics: Aged; Bumetanide; Clinical Trials as Topic; Deglutition; Delayed-Action Preparations; Diuretics; Dru | 1976 |
[Bumetanide--a new potent diuretic for oral and intravenous use].
Topics: Bumetanide; Clinical Trials as Topic; Diuretics; Drug Evaluation; Furosemide; Heart Failure; Humans; | 1975 |
[Bumetanide--a new potent diuretic for oral and intravenous use].
Topics: Bumetanide; Clinical Trials as Topic; Diuretics; Drug Evaluation; Furosemide; Heart Failure; Humans; | 1975 |
[Captopril in the treatment of patients with congestive heart failure. Its bicycle ergometry evaluation].
Topics: Analysis of Variance; Captopril; Chronic Disease; Digitoxin; Double-Blind Method; Drug Therapy, Comb | 1992 |
[Captopril in the treatment of patients with congestive heart failure. Its bicycle ergometry evaluation].
Topics: Analysis of Variance; Captopril; Chronic Disease; Digitoxin; Double-Blind Method; Drug Therapy, Comb | 1992 |
Muscle energy metabolism in severe chronic congestive heart failure--effect of treatment with enalapril.
Topics: Adenosine Triphosphate; Aged; Aged, 80 and over; Biopsy; Double-Blind Method; Drug Therapy, Combinat | 1992 |
Muscle energy metabolism in severe chronic congestive heart failure--effect of treatment with enalapril.
Topics: Adenosine Triphosphate; Aged; Aged, 80 and over; Biopsy; Double-Blind Method; Drug Therapy, Combinat | 1992 |
[Results of conventional treatment of severe congestive heart failure with vasodilators].
Topics: Adult; Aged; Captopril; Digoxin; Drug Administration Schedule; Drug Therapy, Combination; Female; Fu | 1992 |
[Results of conventional treatment of severe congestive heart failure with vasodilators].
Topics: Adult; Aged; Captopril; Digoxin; Drug Administration Schedule; Drug Therapy, Combination; Female; Fu | 1992 |
The renal effects of dopamine and dobutamine in stable chronic heart failure.
Topics: Aged; Chronic Disease; Diuresis; Dobutamine; Dopamine; Drug Interactions; Drug Therapy, Combination; | 1992 |
The renal effects of dopamine and dobutamine in stable chronic heart failure.
Topics: Aged; Chronic Disease; Diuresis; Dobutamine; Dopamine; Drug Interactions; Drug Therapy, Combination; | 1992 |
Intermittent administration of furosemide vs continuous infusion preceded by a loading dose for congestive heart failure.
Topics: Aged; Diuresis; Female; Furosemide; Heart Failure; Humans; Infusions, Intravenous; Injections, Intra | 1992 |
Intermittent administration of furosemide vs continuous infusion preceded by a loading dose for congestive heart failure.
Topics: Aged; Diuresis; Female; Furosemide; Heart Failure; Humans; Infusions, Intravenous; Injections, Intra | 1992 |
Triamterene may preserve lymphocyte magnesium and potassium in patients with congestive heart failure.
Topics: Aged; Aged, 80 and over; Digoxin; Double-Blind Method; Drug Therapy, Combination; Erythrocytes; Furo | 1992 |
Triamterene may preserve lymphocyte magnesium and potassium in patients with congestive heart failure.
Topics: Aged; Aged, 80 and over; Digoxin; Double-Blind Method; Drug Therapy, Combination; Erythrocytes; Furo | 1992 |
Furosemide-induced natriuresis is augmented by ultra-low-dose captopril but not by standard doses of captopril in chronic heart failure.
Topics: Aged; Angiotensin II; Captopril; Double-Blind Method; Female; Furosemide; Glomerular Filtration Rate | 1992 |
Furosemide-induced natriuresis is augmented by ultra-low-dose captopril but not by standard doses of captopril in chronic heart failure.
Topics: Aged; Angiotensin II; Captopril; Double-Blind Method; Female; Furosemide; Glomerular Filtration Rate | 1992 |
Posture determines the nature of the interaction between angiotensin converting enzyme inhibitors and loop diuretics in patients with chronic cardiac failure.
Topics: Aged; Captopril; Chronic Disease; Creatinine; Drug Interactions; Drug Therapy, Combination; Furosemi | 1991 |
Posture determines the nature of the interaction between angiotensin converting enzyme inhibitors and loop diuretics in patients with chronic cardiac failure.
Topics: Aged; Captopril; Chronic Disease; Creatinine; Drug Interactions; Drug Therapy, Combination; Furosemi | 1991 |
[Diet with usual quantity of salt in hospital treatment of congestive heart insufficiency].
Topics: Adult; Aged; Aged, 80 and over; Diuresis; Female; Furosemide; Heart Failure; Hospitalization; Humans | 1991 |
[Diet with usual quantity of salt in hospital treatment of congestive heart insufficiency].
Topics: Adult; Aged; Aged, 80 and over; Diuresis; Female; Furosemide; Heart Failure; Hospitalization; Humans | 1991 |
Hemodynamic resistance to intravenous nitroglycerin in severe congestive heart failure and restored response after diuresis.
Topics: Aged; Catheterization, Swan-Ganz; Diuresis; Drug Resistance; Female; Furosemide; Heart Failure; Hemo | 1991 |
Hemodynamic resistance to intravenous nitroglycerin in severe congestive heart failure and restored response after diuresis.
Topics: Aged; Catheterization, Swan-Ganz; Diuresis; Drug Resistance; Female; Furosemide; Heart Failure; Hemo | 1991 |
[Renal effects of ibopamine in comparison with furosemide in patients with mild heart failure].
Topics: Atrial Natriuretic Factor; Blood Pressure; Cardiomyopathy, Dilated; Coronary Disease; Cyclic GMP; De | 1990 |
[Renal effects of ibopamine in comparison with furosemide in patients with mild heart failure].
Topics: Atrial Natriuretic Factor; Blood Pressure; Cardiomyopathy, Dilated; Coronary Disease; Cyclic GMP; De | 1990 |
[Effect of vasodilator agents on the character and incidence of cardiac arrhythmia in chronic heart failure].
Topics: Adult; Aged; Aged, 80 and over; Arrhythmias, Cardiac; Atrial Fibrillation; Captopril; Cardiac Output | 1990 |
[Effect of vasodilator agents on the character and incidence of cardiac arrhythmia in chronic heart failure].
Topics: Adult; Aged; Aged, 80 and over; Arrhythmias, Cardiac; Atrial Fibrillation; Captopril; Cardiac Output | 1990 |
An open, randomized comparative study of a low-strength frusemide/amiloride combination and bumetanide/potassium chloride in the treatment of mild congestive cardiac failure.
Topics: Adult; Amiloride; Blood Pressure; Bumetanide; Diuretics; Drug Combinations; Female; Furosemide; Hear | 1990 |
An open, randomized comparative study of a low-strength frusemide/amiloride combination and bumetanide/potassium chloride in the treatment of mild congestive cardiac failure.
Topics: Adult; Amiloride; Blood Pressure; Bumetanide; Diuretics; Drug Combinations; Female; Furosemide; Hear | 1990 |
An open, parallel group study comparing a frusemide/amiloride diuretic and a diuretic containing cyclopenthiazide with sustained release potassium in the treatment of congestive cardiac failure--a multicentre general practice study.
Topics: Aged; Amiloride; Clinical Trials as Topic; Cyclopenthiazide; Delayed-Action Preparations; Diuretics; | 1990 |
An open, parallel group study comparing a frusemide/amiloride diuretic and a diuretic containing cyclopenthiazide with sustained release potassium in the treatment of congestive cardiac failure--a multicentre general practice study.
Topics: Aged; Amiloride; Clinical Trials as Topic; Cyclopenthiazide; Delayed-Action Preparations; Diuretics; | 1990 |
Effect of high-dose furosemide in refractory congestive heart failure.
Topics: Administration, Oral; Adult; Aged; Drug Administration Schedule; Female; Follow-Up Studies; Furosemi | 1990 |
Effect of high-dose furosemide in refractory congestive heart failure.
Topics: Administration, Oral; Adult; Aged; Drug Administration Schedule; Female; Follow-Up Studies; Furosemi | 1990 |
Extracardial effects of oral ibopamine versus furosemide in patients with mild or moderate heart failure. A double-blind, randomized trial.
Topics: Administration, Oral; Adult; Cardiotonic Agents; Deoxyepinephrine; Double-Blind Method; Female; Furo | 1990 |
Extracardial effects of oral ibopamine versus furosemide in patients with mild or moderate heart failure. A double-blind, randomized trial.
Topics: Administration, Oral; Adult; Cardiotonic Agents; Deoxyepinephrine; Double-Blind Method; Female; Furo | 1990 |
[Evaluation of the effect of nifedipine in patients with chronic congestive heart failure].
Topics: Adult; Aged; Chronic Disease; Clinical Trials as Topic; Digoxin; Diuresis; Female; Furosemide; Heart | 1989 |
[Evaluation of the effect of nifedipine in patients with chronic congestive heart failure].
Topics: Adult; Aged; Chronic Disease; Clinical Trials as Topic; Digoxin; Diuresis; Female; Furosemide; Heart | 1989 |
The effects of frusemide and angiotensin-converting enzyme inhibitors and their combination on cardiac and renal haemodynamics in heart failure.
Topics: Administration, Oral; Angiotensin-Converting Enzyme Inhibitors; Clinical Trials as Topic; Drug Admin | 1988 |
The effects of frusemide and angiotensin-converting enzyme inhibitors and their combination on cardiac and renal haemodynamics in heart failure.
Topics: Administration, Oral; Angiotensin-Converting Enzyme Inhibitors; Clinical Trials as Topic; Drug Admin | 1988 |
Symptomatic assessment of patients with heart failure: double-blind comparison of increasing doses of diuretics and captopril in moderate heart failure.
Topics: Aged; Captopril; Clinical Trials as Topic; Double-Blind Method; Drug Therapy, Combination; Exercise | 1986 |
Symptomatic assessment of patients with heart failure: double-blind comparison of increasing doses of diuretics and captopril in moderate heart failure.
Topics: Aged; Captopril; Clinical Trials as Topic; Double-Blind Method; Drug Therapy, Combination; Exercise | 1986 |
Captopril versus frusemide in moderate heart failure.
Topics: Captopril; Furosemide; Heart Failure; Humans | 1986 |
Captopril versus frusemide in moderate heart failure.
Topics: Captopril; Furosemide; Heart Failure; Humans | 1986 |
Double-blind comparison of captopril alone against frusemide plus amiloride in mild heart failure.
Topics: Amiloride; Captopril; Chronic Disease; Clinical Trials as Topic; Diuretics; Double-Blind Method; Dru | 1987 |
Double-blind comparison of captopril alone against frusemide plus amiloride in mild heart failure.
Topics: Amiloride; Captopril; Chronic Disease; Clinical Trials as Topic; Diuretics; Double-Blind Method; Dru | 1987 |
Effect of enalapril on ventricular arrhythmias in congestive heart failure.
Topics: Adult; Aged; Arrhythmias, Cardiac; Blood Pressure; Digoxin; Dipeptides; Electrocardiography; Enalapr | 1985 |
Effect of enalapril on ventricular arrhythmias in congestive heart failure.
Topics: Adult; Aged; Arrhythmias, Cardiac; Blood Pressure; Digoxin; Dipeptides; Electrocardiography; Enalapr | 1985 |
[Evaluation of the need for potassium supplementation in patients subjected to furosemide therapy].
Topics: Adult; Aged; Clinical Trials as Topic; Female; Furosemide; Heart Failure; Humans; Hypertension; Male | 1988 |
[Evaluation of the need for potassium supplementation in patients subjected to furosemide therapy].
Topics: Adult; Aged; Clinical Trials as Topic; Female; Furosemide; Heart Failure; Humans; Hypertension; Male | 1988 |
Effects of ibopamine in combination with furosemide on renal function in patients with chronic congestive heart failure.
Topics: Aged; Blood Glucose; Chlorides; Creatinine; Deoxyepinephrine; Dopamine; Drug Therapy, Combination; E | 1988 |
Effects of ibopamine in combination with furosemide on renal function in patients with chronic congestive heart failure.
Topics: Aged; Blood Glucose; Chlorides; Creatinine; Deoxyepinephrine; Dopamine; Drug Therapy, Combination; E | 1988 |
The effects of piretanide in patients with congestive heart failure and diabetes mellitus: a double-blind comparison with furosemide.
Topics: Adult; Aged; Blood Chemical Analysis; Blood Glucose; Diabetes Complications; Diabetes Mellitus; Diur | 1988 |
The effects of piretanide in patients with congestive heart failure and diabetes mellitus: a double-blind comparison with furosemide.
Topics: Adult; Aged; Blood Chemical Analysis; Blood Glucose; Diabetes Complications; Diabetes Mellitus; Diur | 1988 |
A comparison of the effects of bumetanide (Burinex) and frusemide on carbohydrate metabolism in the elderly.
Topics: Aged; Aged, 80 and over; Blood Glucose; Bumetanide; Diuretics; Female; Furosemide; Glucose Tolerance | 1988 |
A comparison of the effects of bumetanide (Burinex) and frusemide on carbohydrate metabolism in the elderly.
Topics: Aged; Aged, 80 and over; Blood Glucose; Bumetanide; Diuretics; Female; Furosemide; Glucose Tolerance | 1988 |
Haemodynamic effects of high or low doses of furosemide in acute myocardial infarction.
Topics: Aged; Blood Pressure; Cardiac Output; Clinical Trials as Topic; Female; Furosemide; Heart Arrest; He | 1988 |
Haemodynamic effects of high or low doses of furosemide in acute myocardial infarction.
Topics: Aged; Blood Pressure; Cardiac Output; Clinical Trials as Topic; Female; Furosemide; Heart Arrest; He | 1988 |
[Indomethacin and furosemide in patients with cardiac insufficiency. Kidney function, the renin-angiotensin system and renal prostaglandins].
Topics: Clinical Trials as Topic; Drug Therapy, Combination; Furosemide; Heart Failure; Humans; Indomethacin | 1987 |
[Indomethacin and furosemide in patients with cardiac insufficiency. Kidney function, the renin-angiotensin system and renal prostaglandins].
Topics: Clinical Trials as Topic; Drug Therapy, Combination; Furosemide; Heart Failure; Humans; Indomethacin | 1987 |
Renal function and tubular transport effects of sulindac and naproxen in chronic heart failure.
Topics: Aged; Biological Transport; Body Water; Chronic Disease; Electrolytes; Female; Furosemide; Glomerula | 1987 |
Renal function and tubular transport effects of sulindac and naproxen in chronic heart failure.
Topics: Aged; Biological Transport; Body Water; Chronic Disease; Electrolytes; Female; Furosemide; Glomerula | 1987 |
[Effects of sequentially administered or combined muzolimine and furosemide on water and solute excretion: quantitative and qualitative aspects].
Topics: Aged; Clinical Trials as Topic; Diuresis; Drug Therapy, Combination; Electrolytes; Female; Furosemid | 1987 |
[Effects of sequentially administered or combined muzolimine and furosemide on water and solute excretion: quantitative and qualitative aspects].
Topics: Aged; Clinical Trials as Topic; Diuresis; Drug Therapy, Combination; Electrolytes; Female; Furosemid | 1987 |
An open comparative study of two diuretic combinations, frusemide/amiloride ('Frumil') and bumetanide/potassium chloride ('Burinex' K), in the treatment of congestive cardiac failure in hospital out-patients.
Topics: Aged; Aged, 80 and over; Ambulatory Care; Amiloride; Bumetanide; Diuretics; Drug Combinations; Femal | 1988 |
An open comparative study of two diuretic combinations, frusemide/amiloride ('Frumil') and bumetanide/potassium chloride ('Burinex' K), in the treatment of congestive cardiac failure in hospital out-patients.
Topics: Aged; Aged, 80 and over; Ambulatory Care; Amiloride; Bumetanide; Diuretics; Drug Combinations; Femal | 1988 |
Addition of captopril versus increasing diuretics in moderate but deteriorating heart failure: a double-blind comparative trial.
Topics: Aged; Captopril; Clinical Trials as Topic; Digoxin; Double-Blind Method; Drug Therapy, Combination; | 1986 |
Addition of captopril versus increasing diuretics in moderate but deteriorating heart failure: a double-blind comparative trial.
Topics: Aged; Captopril; Clinical Trials as Topic; Digoxin; Double-Blind Method; Drug Therapy, Combination; | 1986 |
A comparison of intravenous elantan and frusemide in patients with chronic cardiac failure.
Topics: Blood Pressure; Cardiac Output; Chronic Disease; Coronary Circulation; Furosemide; Heart Failure; Hu | 1987 |
A comparison of intravenous elantan and frusemide in patients with chronic cardiac failure.
Topics: Blood Pressure; Cardiac Output; Chronic Disease; Coronary Circulation; Furosemide; Heart Failure; Hu | 1987 |
Diuretic activity of torasemide and furosemide in chronic heart failure: a comparative double blind cross-over study.
Topics: Aged; Calcium; Chronic Disease; Creatinine; Diuretics; Double-Blind Method; Drug Evaluation; Electro | 1986 |
Diuretic activity of torasemide and furosemide in chronic heart failure: a comparative double blind cross-over study.
Topics: Aged; Calcium; Chronic Disease; Creatinine; Diuretics; Double-Blind Method; Drug Evaluation; Electro | 1986 |
Multicentre comparison between slow-release furosemide and bendroflumethiazide in congestive heart failure.
Topics: Adult; Aged; Bendroflumethiazide; Clinical Trials as Topic; Delayed-Action Preparations; Female; Fur | 1985 |
Multicentre comparison between slow-release furosemide and bendroflumethiazide in congestive heart failure.
Topics: Adult; Aged; Bendroflumethiazide; Clinical Trials as Topic; Delayed-Action Preparations; Female; Fur | 1985 |
Comparison of muzolimine and furosemide in heart failure.
Topics: Aged; Electrolytes; Female; Furosemide; Heart Failure; Humans; Kidney; Male; Middle Aged; Muzolimine | 1985 |
Comparison of muzolimine and furosemide in heart failure.
Topics: Aged; Electrolytes; Female; Furosemide; Heart Failure; Humans; Kidney; Male; Middle Aged; Muzolimine | 1985 |
[Comparative study of 2 diuretic-containing combination preparations in patients with edematous heart failure].
Topics: Aged; Diuretics; Drug Combinations; Edema, Cardiac; Female; Furosemide; Heart Failure; Humans; Hydro | 1985 |
[Comparative study of 2 diuretic-containing combination preparations in patients with edematous heart failure].
Topics: Aged; Diuretics; Drug Combinations; Edema, Cardiac; Female; Furosemide; Heart Failure; Humans; Hydro | 1985 |
Furosemide (Lasix).
Topics: Abnormalities, Drug-Induced; Administration, Oral; Antihypertensive Agents; Clinical Trials as Topic | 1972 |
Furosemide (Lasix).
Topics: Abnormalities, Drug-Induced; Administration, Oral; Antihypertensive Agents; Clinical Trials as Topic | 1972 |
Clinical trial of a new diuretic--metindamide.
Topics: Adult; Aged; Benzamides; Blood Pressure; Chlorides; Clinical Trials as Topic; Depression, Chemical; | 1974 |
Clinical trial of a new diuretic--metindamide.
Topics: Adult; Aged; Benzamides; Blood Pressure; Chlorides; Clinical Trials as Topic; Depression, Chemical; | 1974 |
Clinical trial of a new diuretic, bumetanide, in seriously ill patients.
Topics: Acute Kidney Injury; Adolescent; Adult; Aged; Benzoates; Butylamines; Clinical Trials as Topic; Diur | 1974 |
Clinical trial of a new diuretic, bumetanide, in seriously ill patients.
Topics: Acute Kidney Injury; Adolescent; Adult; Aged; Benzoates; Butylamines; Clinical Trials as Topic; Diur | 1974 |
[Bumetanide. A comparison between the diuretic effect of bumetanide and furosemide in patients with chronic congestive heart failure].
Topics: Adult; Benzoates; Butylamines; Diuretics; Furosemide; Heart Failure; Humans; Kidney Tubules; Phenols | 1973 |
[Bumetanide. A comparison between the diuretic effect of bumetanide and furosemide in patients with chronic congestive heart failure].
Topics: Adult; Benzoates; Butylamines; Diuretics; Furosemide; Heart Failure; Humans; Kidney Tubules; Phenols | 1973 |
A controlled clinical trial comparing the diuretic furosemide and hydrochlorothiazide.
Topics: Clinical Trials as Topic; Furosemide; Heart Failure; Humans; Hydrochlorothiazide; Liver Cirrhosis; N | 1968 |
A controlled clinical trial comparing the diuretic furosemide and hydrochlorothiazide.
Topics: Clinical Trials as Topic; Furosemide; Heart Failure; Humans; Hydrochlorothiazide; Liver Cirrhosis; N | 1968 |
A clinical trial of furosemide in patients with congestive heart failure.
Topics: Adult; Aged; Clinical Trials as Topic; Female; Furosemide; Heart Failure; Humans; Male; Middle Aged | 1968 |
A clinical trial of furosemide in patients with congestive heart failure.
Topics: Adult; Aged; Clinical Trials as Topic; Female; Furosemide; Heart Failure; Humans; Male; Middle Aged | 1968 |
A controlled clinical trial comparing the diuretic ethacrynic acid and furosemide in patients with congestive heart failure.
Topics: Chlorides; Clinical Trials as Topic; Ethacrynic Acid; Furosemide; Heart Failure; Humans; Photometry; | 1969 |
A controlled clinical trial comparing the diuretic ethacrynic acid and furosemide in patients with congestive heart failure.
Topics: Chlorides; Clinical Trials as Topic; Ethacrynic Acid; Furosemide; Heart Failure; Humans; Photometry; | 1969 |
[Biometric assay of the saluretic synergism of clopamide and furosemide].
Topics: Adult; Aged; Amides; Aortic Valve Insufficiency; Biometry; Clinical Trials as Topic; Clopamide; Diur | 1969 |
[Biometric assay of the saluretic synergism of clopamide and furosemide].
Topics: Adult; Aged; Amides; Aortic Valve Insufficiency; Biometry; Clinical Trials as Topic; Clopamide; Diur | 1969 |
[Amiloride. A clinical study of a potassium-retaining diuretic].
Topics: Adult; Aged; Bendroflumethiazide; Bicarbonates; Clinical Trials as Topic; Diuresis; Diuretics; Femal | 1969 |
[Amiloride. A clinical study of a potassium-retaining diuretic].
Topics: Adult; Aged; Bendroflumethiazide; Bicarbonates; Clinical Trials as Topic; Diuresis; Diuretics; Femal | 1969 |
High doses of spironolactone (Aldactone, SC-14266, Verospirone) alone and in combination with triamterene and-or diuretics in the treatment of refractory edema associated with secondary hyperaldosteronism.
Topics: Adult; Aged; Body Weight; Chlorides; Clinical Trials as Topic; Clopamide; Creatinine; Diet, Sodium-R | 1970 |
High doses of spironolactone (Aldactone, SC-14266, Verospirone) alone and in combination with triamterene and-or diuretics in the treatment of refractory edema associated with secondary hyperaldosteronism.
Topics: Adult; Aged; Body Weight; Chlorides; Clinical Trials as Topic; Clopamide; Creatinine; Diet, Sodium-R | 1970 |
The natriuretic effect addition of quinethazone and furosemide in congestive heart failure. A permutation trial test.
Topics: Adult; Clinical Trials as Topic; Diuresis; Drug Synergism; Furosemide; Heart Failure; Humans; Kidney | 1971 |
The natriuretic effect addition of quinethazone and furosemide in congestive heart failure. A permutation trial test.
Topics: Adult; Clinical Trials as Topic; Diuresis; Drug Synergism; Furosemide; Heart Failure; Humans; Kidney | 1971 |
The supra-additive natriuretic effect addition of quinethazone or bendroflumethiazide during long-term treatment with furosemide and spironolactone. Permutation trial tests in patients with congestive heart failure.
Topics: Adult; Bendroflumethiazide; Clinical Trials as Topic; Diuresis; Drug Synergism; Furosemide; Heart Fa | 1971 |
The supra-additive natriuretic effect addition of quinethazone or bendroflumethiazide during long-term treatment with furosemide and spironolactone. Permutation trial tests in patients with congestive heart failure.
Topics: Adult; Bendroflumethiazide; Clinical Trials as Topic; Diuresis; Drug Synergism; Furosemide; Heart Fa | 1971 |
[Controlled clinical trial of the association of furosemide and triamterene].
Topics: Ascites; Diuresis; Edema; Electrolytes; Furosemide; Heart Failure; Humans; Liver Cirrhosis; Triamter | 1971 |
[Controlled clinical trial of the association of furosemide and triamterene].
Topics: Ascites; Diuresis; Edema; Electrolytes; Furosemide; Heart Failure; Humans; Liver Cirrhosis; Triamter | 1971 |
[Clinical evaluation of a new diuretic].
Topics: Clinical Trials as Topic; Diuretics; Furosemide; Heart Failure; Humans; Hypertension; Liver Cirrhosi | 1965 |
[Clinical evaluation of a new diuretic].
Topics: Clinical Trials as Topic; Diuretics; Furosemide; Heart Failure; Humans; Hypertension; Liver Cirrhosi | 1965 |
[The effect of a new diuretic (furosemide) on the uric acid metabolism].
Topics: Clinical Trials as Topic; Furosemide; Heart Failure; Humans; Uric Acid | 1965 |
[The effect of a new diuretic (furosemide) on the uric acid metabolism].
Topics: Clinical Trials as Topic; Furosemide; Heart Failure; Humans; Uric Acid | 1965 |
[Experience with a new diuretic].
Topics: Adolescent; Adult; Aged; Anilides; Diuresis; Diuretics; Edema; Female; Furosemide; Heart Failure; Hu | 1970 |
[Experience with a new diuretic].
Topics: Adolescent; Adult; Aged; Anilides; Diuresis; Diuretics; Edema; Female; Furosemide; Heart Failure; Hu | 1970 |
A comparison of the diuretic action of mercaptomerin, ethacrynic acid and furosemide in congestive heart failure.
Topics: Adult; Alkalosis; Ethacrynic Acid; Furosemide; Heart Failure; Humans; Organomercury Compounds; Potas | 1970 |
A comparison of the diuretic action of mercaptomerin, ethacrynic acid and furosemide in congestive heart failure.
Topics: Adult; Alkalosis; Ethacrynic Acid; Furosemide; Heart Failure; Humans; Organomercury Compounds; Potas | 1970 |
Clinical comparison of frusemide with bendrofluazide, mersalyl, and ethacrynic acid.
Topics: Adult; Aged; Bendroflumethiazide; Diuretics; Edema; Ethacrynic Acid; Female; Furosemide; Heart Failu | 1965 |
Clinical comparison of frusemide with bendrofluazide, mersalyl, and ethacrynic acid.
Topics: Adult; Aged; Bendroflumethiazide; Diuretics; Edema; Ethacrynic Acid; Female; Furosemide; Heart Failu | 1965 |
866 other studies available for furosemide and Heart Failure
| Article | Year |
|---|---|
Discovery of a potent and selective ROMK inhibitor with improved pharmacokinetic properties based on an octahydropyrazino[2,1-c][1,4]oxazine scaffold.
Topics: Animals; Diuresis; Dogs; Heart Failure; Humans; Hypertension; Macaca mulatta; Oxazines; Potassium Ch | 2016 |
Discovery of a potent and selective ROMK inhibitor with improved pharmacokinetic properties based on an octahydropyrazino[2,1-c][1,4]oxazine scaffold.
Topics: Animals; Diuresis; Dogs; Heart Failure; Humans; Hypertension; Macaca mulatta; Oxazines; Potassium Ch | 2016 |
Administration of Subcutaneous Furosemide in Elastomeric Pump vs. Oral Solution for the Treatment of Diuretic Refractory Congestion.
Topics: Administration, Oral; Diuretics; Furosemide; Heart Failure; Humans; Infusion Pumps; Infusions, Subcu | 2021 |
Administration of Subcutaneous Furosemide in Elastomeric Pump vs. Oral Solution for the Treatment of Diuretic Refractory Congestion.
Topics: Administration, Oral; Diuretics; Furosemide; Heart Failure; Humans; Infusion Pumps; Infusions, Subcu | 2021 |
The ratio of furosemide dosage to urinary sodium concentration predicts mortality in patients with chronic stable heart failure.
Topics: Aged; Diuretics; Female; Furosemide; Heart Failure; Humans; Male; Retrospective Studies; Sodium | 2021 |
The ratio of furosemide dosage to urinary sodium concentration predicts mortality in patients with chronic stable heart failure.
Topics: Aged; Diuretics; Female; Furosemide; Heart Failure; Humans; Male; Retrospective Studies; Sodium | 2021 |
Efficacy and Safety of Subcutaneous Infusion of Non-formulated Furosemide in Patients with Worsening Heart Failure: a Real-World Study.
Topics: Diuretics; Furosemide; Heart Failure; Humans; Infusions, Subcutaneous; Treatment Outcome | 2022 |
Efficacy and Safety of Subcutaneous Infusion of Non-formulated Furosemide in Patients with Worsening Heart Failure: a Real-World Study.
Topics: Diuretics; Furosemide; Heart Failure; Humans; Infusions, Subcutaneous; Treatment Outcome | 2022 |
Comparison of continuous infusion and intermittent boluses of furosemide in acute heart failure: A protocol for systematic review and meta-analysis.
Topics: Clinical Protocols; Diuretics; Furosemide; Heart Failure; Humans; Infusion Pumps; Meta-Analysis as T | 2021 |
Comparison of continuous infusion and intermittent boluses of furosemide in acute heart failure: A protocol for systematic review and meta-analysis.
Topics: Clinical Protocols; Diuretics; Furosemide; Heart Failure; Humans; Infusion Pumps; Meta-Analysis as T | 2021 |
Diuretic Changes, Health Care Resource Utilization, and Clinical Outcomes for Heart Failure With Reduced Ejection Fraction: From the Change the Management of Patients With Heart Failure Registry.
Topics: Aged; Angiotensin Receptor Antagonists; Carbonic Anhydrase Inhibitors; Delivery of Health Care; Diur | 2021 |
Diuretic Changes, Health Care Resource Utilization, and Clinical Outcomes for Heart Failure With Reduced Ejection Fraction: From the Change the Management of Patients With Heart Failure Registry.
Topics: Aged; Angiotensin Receptor Antagonists; Carbonic Anhydrase Inhibitors; Delivery of Health Care; Diur | 2021 |
Dose of furosemide before admission predicts diuretic efficiency and long-term prognosis in acute heart failure.
Topics: Aged; Aged, 80 and over; Diuretics; Furosemide; Heart Failure; Hospitalization; Humans; Male; Middle | 2022 |
Dose of furosemide before admission predicts diuretic efficiency and long-term prognosis in acute heart failure.
Topics: Aged; Aged, 80 and over; Diuretics; Furosemide; Heart Failure; Hospitalization; Humans; Male; Middle | 2022 |
Intravenous diuretic administration in the home environment.
Topics: Adult; Aged; Aged, 80 and over; Diuretics; Furosemide; Heart Failure; Home Environment; Humans; Pilo | 2021 |
Intravenous diuretic administration in the home environment.
Topics: Adult; Aged; Aged, 80 and over; Diuretics; Furosemide; Heart Failure; Home Environment; Humans; Pilo | 2021 |
Discordance between estimated and measured changes in plasma volume among patients with acute heart failure.
Topics: Diuretics; Furosemide; Heart Failure; Humans; Plasma Volume | 2022 |
Discordance between estimated and measured changes in plasma volume among patients with acute heart failure.
Topics: Diuretics; Furosemide; Heart Failure; Humans; Plasma Volume | 2022 |
Response by Caravaca Pérez et al to Letter Regarding Article, "Potential Role of Natriuretic Response to Furosemide Stress Test During Acute Heart Failure".
Topics: Diuretics; Exercise Test; Furosemide; Heart Failure; Humans | 2022 |
Response by Caravaca Pérez et al to Letter Regarding Article, "Potential Role of Natriuretic Response to Furosemide Stress Test During Acute Heart Failure".
Topics: Diuretics; Exercise Test; Furosemide; Heart Failure; Humans | 2022 |
Letter by Beldhuis et al Regarding Article, "Potential Role of Natriuretic Response to Furosemide Stress Test During Acute Heart Failure".
Topics: Diuretics; Exercise Test; Furosemide; Heart Failure; Humans | 2022 |
Letter by Beldhuis et al Regarding Article, "Potential Role of Natriuretic Response to Furosemide Stress Test During Acute Heart Failure".
Topics: Diuretics; Exercise Test; Furosemide; Heart Failure; Humans | 2022 |
Proteomic differences among patients with heart failure taking furosemide or torsemide.
Topics: Diuretics; Female; Furosemide; Heart Failure; Humans; Proteomics; Torsemide | 2022 |
Proteomic differences among patients with heart failure taking furosemide or torsemide.
Topics: Diuretics; Female; Furosemide; Heart Failure; Humans; Proteomics; Torsemide | 2022 |
Efficacy and Safety of Combination Therapy with Tolvaptan and Furosemide in Children with Nephrotic Syndrome and Refractory Edema: A Prospective Interventional Study.
Topics: Child; Child, Preschool; Diuretics; Drug Therapy, Combination; Edema; Furosemide; Heart Failure; Hum | 2022 |
Efficacy and Safety of Combination Therapy with Tolvaptan and Furosemide in Children with Nephrotic Syndrome and Refractory Edema: A Prospective Interventional Study.
Topics: Child; Child, Preschool; Diuretics; Drug Therapy, Combination; Edema; Furosemide; Heart Failure; Hum | 2022 |
Clinical implication of initial intravenous diuretic dose for acute decompensated heart failure.
Topics: Administration, Intravenous; Aged; Aged, 80 and over; Diuretics; Female; Furosemide; Heart Failure; | 2022 |
Clinical implication of initial intravenous diuretic dose for acute decompensated heart failure.
Topics: Administration, Intravenous; Aged; Aged, 80 and over; Diuretics; Female; Furosemide; Heart Failure; | 2022 |
Optimal Evidence Grading of Simultaneous Use of Hypertonic Saline and Furosemide for Fluid Overload.
Topics: Diuretics; Furosemide; Heart Failure; Humans; Saline Solution, Hypertonic; Water-Electrolyte Imbalan | 2022 |
Optimal Evidence Grading of Simultaneous Use of Hypertonic Saline and Furosemide for Fluid Overload.
Topics: Diuretics; Furosemide; Heart Failure; Humans; Saline Solution, Hypertonic; Water-Electrolyte Imbalan | 2022 |
Cardiorenal Syndrome Triggered by Slowly Progressive Drugs Toxicity-Induced Renal Failure along with Minimal Mitral Disease: A Case Report.
Topics: Aged, 80 and over; Cardio-Renal Syndrome; Female; Furosemide; Heart Failure; Humans; Mitral Valve; M | 2022 |
Cardiorenal Syndrome Triggered by Slowly Progressive Drugs Toxicity-Induced Renal Failure along with Minimal Mitral Disease: A Case Report.
Topics: Aged, 80 and over; Cardio-Renal Syndrome; Female; Furosemide; Heart Failure; Humans; Mitral Valve; M | 2022 |
Metolazone Versus Intravenous Chlorothiazide for Decompensated Heart Failure Sequential Nephron Blockade: A Retrospective Cohort Study.
Topics: Chlorothiazide; Diuretics; Furosemide; Heart Failure; Humans; Metolazone; Nephrons; Retrospective St | 2022 |
Metolazone Versus Intravenous Chlorothiazide for Decompensated Heart Failure Sequential Nephron Blockade: A Retrospective Cohort Study.
Topics: Chlorothiazide; Diuretics; Furosemide; Heart Failure; Humans; Metolazone; Nephrons; Retrospective St | 2022 |
Use of short-acting vs. long-acting loop diuretics after heart failure hospitalization.
Topics: Aged; Female; Furosemide; Heart Failure; Hospitalization; Humans; Male; Sodium Potassium Chloride Sy | 2022 |
Use of short-acting vs. long-acting loop diuretics after heart failure hospitalization.
Topics: Aged; Female; Furosemide; Heart Failure; Hospitalization; Humans; Male; Sodium Potassium Chloride Sy | 2022 |
Association between focused cardiac ultrasound and time to furosemide administration in acute heart failure.
Topics: Diuretics; Emergency Service, Hospital; Furosemide; Heart Failure; Humans; Retrospective Studies; Tr | 2022 |
Association between focused cardiac ultrasound and time to furosemide administration in acute heart failure.
Topics: Diuretics; Emergency Service, Hospital; Furosemide; Heart Failure; Humans; Retrospective Studies; Tr | 2022 |
Sodium Glucose Co-Transporter 2 Inhibitors Improve Renal Congestion and Left Ventricular Fibrosis in Rats With Hypertensive Heart Failure.
Topics: Animals; Canagliflozin; Fibrosis; Furosemide; Heart Failure; Heart Ventricles; Hypertension; Kidney; | 2022 |
Sodium Glucose Co-Transporter 2 Inhibitors Improve Renal Congestion and Left Ventricular Fibrosis in Rats With Hypertensive Heart Failure.
Topics: Animals; Canagliflozin; Fibrosis; Furosemide; Heart Failure; Heart Ventricles; Hypertension; Kidney; | 2022 |
Diuretic Resistance-A Key to Identifying Clinically Significant Worsening Renal Function in Heart Failure?
Topics: Diuretics; Furosemide; Heart Failure; Humans; Kidney | 2022 |
Diuretic Resistance-A Key to Identifying Clinically Significant Worsening Renal Function in Heart Failure?
Topics: Diuretics; Furosemide; Heart Failure; Humans; Kidney | 2022 |
Early drop in systolic blood pressure is associated with poor diuretic response and prognosis in patients with acute heart failure.
Topics: Acute Disease; Blood Pressure; Diuretics; Furosemide; Heart Failure; Humans; Prognosis | 2022 |
Early drop in systolic blood pressure is associated with poor diuretic response and prognosis in patients with acute heart failure.
Topics: Acute Disease; Blood Pressure; Diuretics; Furosemide; Heart Failure; Humans; Prognosis | 2022 |
Mineralocorticoid Receptor Antagonists Mitigate Mitral Regurgitation-Induced Myocardial Dysfunction.
Topics: Animals; Fibrosis; Furosemide; Heart Failure; Mineralocorticoid Receptor Antagonists; Mitral Valve I | 2022 |
Mineralocorticoid Receptor Antagonists Mitigate Mitral Regurgitation-Induced Myocardial Dysfunction.
Topics: Animals; Fibrosis; Furosemide; Heart Failure; Mineralocorticoid Receptor Antagonists; Mitral Valve I | 2022 |
Random admission urinary sodium for diuretic response: promise in pragmatism?
Topics: Diuretics; Furosemide; Heart Failure; Humans; Sodium; Sodium Potassium Chloride Symporter Inhibitors | 2022 |
Random admission urinary sodium for diuretic response: promise in pragmatism?
Topics: Diuretics; Furosemide; Heart Failure; Humans; Sodium; Sodium Potassium Chloride Symporter Inhibitors | 2022 |
Retrospective evaluation of risk factors for development of kidney injury after parenteral furosemide treatment of left-sided congestive heart failure in dogs.
Topics: Acute Kidney Injury; Animals; Diuretics; Dog Diseases; Dogs; Furosemide; Heart Failure; Kidney; Retr | 2022 |
Retrospective evaluation of risk factors for development of kidney injury after parenteral furosemide treatment of left-sided congestive heart failure in dogs.
Topics: Acute Kidney Injury; Animals; Diuretics; Dog Diseases; Dogs; Furosemide; Heart Failure; Kidney; Retr | 2022 |
Relation between Mid-Regional Pro-Adrenomedullin in Patients with Chronic Heart Failure and the Dose of Diuretics in 2-Year Follow-Up-Data from FAR NHL Registry.
Topics: Adrenomedullin; Aged; Biomarkers; Diuretics; Female; Follow-Up Studies; Furosemide; Heart Failure; H | 2022 |
Relation between Mid-Regional Pro-Adrenomedullin in Patients with Chronic Heart Failure and the Dose of Diuretics in 2-Year Follow-Up-Data from FAR NHL Registry.
Topics: Adrenomedullin; Aged; Biomarkers; Diuretics; Female; Follow-Up Studies; Furosemide; Heart Failure; H | 2022 |
[Intravenous furosemide for acute heart failure : continuous infusion or intermittent bolus ?]
Topics: Diuretics; Furosemide; Heart Failure; Humans; Infusions, Intravenous; Injections, Intravenous; Sodiu | 2022 |
[Intravenous furosemide for acute heart failure : continuous infusion or intermittent bolus ?]
Topics: Diuretics; Furosemide; Heart Failure; Humans; Infusions, Intravenous; Injections, Intravenous; Sodiu | 2022 |
Impact of prehospital IV furosemide or nitrate application on hospital outcome in acute heart failure patients.
Topics: Acute Disease; Aged; Aged, 80 and over; Diuretics; Emergency Medical Services; Furosemide; Heart Fai | 2022 |
Impact of prehospital IV furosemide or nitrate application on hospital outcome in acute heart failure patients.
Topics: Acute Disease; Aged; Aged, 80 and over; Diuretics; Emergency Medical Services; Furosemide; Heart Fai | 2022 |
Torsemide comparison with furosemide for management of heart failure (TRANSFORM-HF) trial.
Topics: Diuretics; Furosemide; Heart Failure; Humans; Torsemide; Treatment Outcome | 2022 |
Torsemide comparison with furosemide for management of heart failure (TRANSFORM-HF) trial.
Topics: Diuretics; Furosemide; Heart Failure; Humans; Torsemide; Treatment Outcome | 2022 |
Diuretic dose trajectories in dilated cardiomyopathy: prognostic implications.
Topics: Cardiomyopathy, Dilated; Diuretics; Furosemide; Heart Failure; Humans; Prognosis; Sodium Potassium C | 2023 |
Diuretic dose trajectories in dilated cardiomyopathy: prognostic implications.
Topics: Cardiomyopathy, Dilated; Diuretics; Furosemide; Heart Failure; Humans; Prognosis; Sodium Potassium C | 2023 |
Diuretic dose trajectories in dilated cardiomyopathy: prognostic implications.
Topics: Cardiomyopathy, Dilated; Diuretics; Furosemide; Heart Failure; Humans; Prognosis; Sodium Potassium C | 2023 |
Diuretic dose trajectories in dilated cardiomyopathy: prognostic implications.
Topics: Cardiomyopathy, Dilated; Diuretics; Furosemide; Heart Failure; Humans; Prognosis; Sodium Potassium C | 2023 |
Diuretic dose trajectories in dilated cardiomyopathy: prognostic implications.
Topics: Cardiomyopathy, Dilated; Diuretics; Furosemide; Heart Failure; Humans; Prognosis; Sodium Potassium C | 2023 |
Diuretic dose trajectories in dilated cardiomyopathy: prognostic implications.
Topics: Cardiomyopathy, Dilated; Diuretics; Furosemide; Heart Failure; Humans; Prognosis; Sodium Potassium C | 2023 |
Diuretic dose trajectories in dilated cardiomyopathy: prognostic implications.
Topics: Cardiomyopathy, Dilated; Diuretics; Furosemide; Heart Failure; Humans; Prognosis; Sodium Potassium C | 2023 |
Diuretic dose trajectories in dilated cardiomyopathy: prognostic implications.
Topics: Cardiomyopathy, Dilated; Diuretics; Furosemide; Heart Failure; Humans; Prognosis; Sodium Potassium C | 2023 |
Diuretic dose trajectories in dilated cardiomyopathy: prognostic implications.
Topics: Cardiomyopathy, Dilated; Diuretics; Furosemide; Heart Failure; Humans; Prognosis; Sodium Potassium C | 2023 |
Diuretic dose trajectories in dilated cardiomyopathy: prognostic implications.
Topics: Cardiomyopathy, Dilated; Diuretics; Furosemide; Heart Failure; Humans; Prognosis; Sodium Potassium C | 2023 |
Diuretic dose trajectories in dilated cardiomyopathy: prognostic implications.
Topics: Cardiomyopathy, Dilated; Diuretics; Furosemide; Heart Failure; Humans; Prognosis; Sodium Potassium C | 2023 |
Diuretic dose trajectories in dilated cardiomyopathy: prognostic implications.
Topics: Cardiomyopathy, Dilated; Diuretics; Furosemide; Heart Failure; Humans; Prognosis; Sodium Potassium C | 2023 |
Diuretic dose trajectories in dilated cardiomyopathy: prognostic implications.
Topics: Cardiomyopathy, Dilated; Diuretics; Furosemide; Heart Failure; Humans; Prognosis; Sodium Potassium C | 2023 |
Diuretic dose trajectories in dilated cardiomyopathy: prognostic implications.
Topics: Cardiomyopathy, Dilated; Diuretics; Furosemide; Heart Failure; Humans; Prognosis; Sodium Potassium C | 2023 |
Diuretic dose trajectories in dilated cardiomyopathy: prognostic implications.
Topics: Cardiomyopathy, Dilated; Diuretics; Furosemide; Heart Failure; Humans; Prognosis; Sodium Potassium C | 2023 |
Diuretic dose trajectories in dilated cardiomyopathy: prognostic implications.
Topics: Cardiomyopathy, Dilated; Diuretics; Furosemide; Heart Failure; Humans; Prognosis; Sodium Potassium C | 2023 |
Diuretic dose trajectories in dilated cardiomyopathy: prognostic implications.
Topics: Cardiomyopathy, Dilated; Diuretics; Furosemide; Heart Failure; Humans; Prognosis; Sodium Potassium C | 2023 |
Diuretic dose trajectories in dilated cardiomyopathy: prognostic implications.
Topics: Cardiomyopathy, Dilated; Diuretics; Furosemide; Heart Failure; Humans; Prognosis; Sodium Potassium C | 2023 |
CHAnges in Diuretic Medication Prescribing and Surrogate Laboratory Parameters After Initiating EmpagliflOziN in Veterans (CHAMPION Cohort Study).
Topics: Benzhydryl Compounds; Cohort Studies; Diabetes Mellitus, Type 2; Diuretics; Furosemide; Glucose; Gly | 2023 |
CHAnges in Diuretic Medication Prescribing and Surrogate Laboratory Parameters After Initiating EmpagliflOziN in Veterans (CHAMPION Cohort Study).
Topics: Benzhydryl Compounds; Cohort Studies; Diabetes Mellitus, Type 2; Diuretics; Furosemide; Glucose; Gly | 2023 |
CHAnges in Diuretic Medication Prescribing and Surrogate Laboratory Parameters After Initiating EmpagliflOziN in Veterans (CHAMPION Cohort Study).
Topics: Benzhydryl Compounds; Cohort Studies; Diabetes Mellitus, Type 2; Diuretics; Furosemide; Glucose; Gly | 2023 |
CHAnges in Diuretic Medication Prescribing and Surrogate Laboratory Parameters After Initiating EmpagliflOziN in Veterans (CHAMPION Cohort Study).
Topics: Benzhydryl Compounds; Cohort Studies; Diabetes Mellitus, Type 2; Diuretics; Furosemide; Glucose; Gly | 2023 |
CHAnges in Diuretic Medication Prescribing and Surrogate Laboratory Parameters After Initiating EmpagliflOziN in Veterans (CHAMPION Cohort Study).
Topics: Benzhydryl Compounds; Cohort Studies; Diabetes Mellitus, Type 2; Diuretics; Furosemide; Glucose; Gly | 2023 |
CHAnges in Diuretic Medication Prescribing and Surrogate Laboratory Parameters After Initiating EmpagliflOziN in Veterans (CHAMPION Cohort Study).
Topics: Benzhydryl Compounds; Cohort Studies; Diabetes Mellitus, Type 2; Diuretics; Furosemide; Glucose; Gly | 2023 |
CHAnges in Diuretic Medication Prescribing and Surrogate Laboratory Parameters After Initiating EmpagliflOziN in Veterans (CHAMPION Cohort Study).
Topics: Benzhydryl Compounds; Cohort Studies; Diabetes Mellitus, Type 2; Diuretics; Furosemide; Glucose; Gly | 2023 |
CHAnges in Diuretic Medication Prescribing and Surrogate Laboratory Parameters After Initiating EmpagliflOziN in Veterans (CHAMPION Cohort Study).
Topics: Benzhydryl Compounds; Cohort Studies; Diabetes Mellitus, Type 2; Diuretics; Furosemide; Glucose; Gly | 2023 |
Comparative effectiveness and safety of bolus vs. continuous infusion of loop diuretics: Results from the MIMIC-III Database.
Topics: Acute Kidney Injury; Diuretics; Furosemide; Heart Failure; Humans; Infusions, Intravenous; Sodium Po | 2023 |
Comparative effectiveness and safety of bolus vs. continuous infusion of loop diuretics: Results from the MIMIC-III Database.
Topics: Acute Kidney Injury; Diuretics; Furosemide; Heart Failure; Humans; Infusions, Intravenous; Sodium Po | 2023 |
Predictors of bleeding events in acute decompensated heart failure patients with antithrombotic therapy: AURORA study.
Topics: Aged; Aged, 80 and over; Anticoagulants; Fibrinolytic Agents; Furosemide; Heart Failure; Hemorrhage; | 2023 |
Predictors of bleeding events in acute decompensated heart failure patients with antithrombotic therapy: AURORA study.
Topics: Aged; Aged, 80 and over; Anticoagulants; Fibrinolytic Agents; Furosemide; Heart Failure; Hemorrhage; | 2023 |
Impact of tolvaptan add-on treatment on patients with heart failure requiring long-term congestion management: A retrospective cohort study using a medical claim database in Japan.
Topics: Antidiuretic Hormone Receptor Antagonists; Benzazepines; Furosemide; Heart Failure; Hospital Mortali | 2023 |
Impact of tolvaptan add-on treatment on patients with heart failure requiring long-term congestion management: A retrospective cohort study using a medical claim database in Japan.
Topics: Antidiuretic Hormone Receptor Antagonists; Benzazepines; Furosemide; Heart Failure; Hospital Mortali | 2023 |
In brief: Furoscix - a subcutaneous furosemide infusor for heart failure.
Topics: Furosemide; Heart Failure; Humans; Sulfonamides | 2023 |
In brief: Furoscix - a subcutaneous furosemide infusor for heart failure.
Topics: Furosemide; Heart Failure; Humans; Sulfonamides | 2023 |
Furosemide-induced haemolytic anaemia in an extreme elderly patient.
Topics: Aged; Aged, 80 and over; Anemia, Hemolytic; Furosemide; Heart Failure; Hemolysis; Humans; Male | 2023 |
Furosemide-induced haemolytic anaemia in an extreme elderly patient.
Topics: Aged; Aged, 80 and over; Anemia, Hemolytic; Furosemide; Heart Failure; Hemolysis; Humans; Male | 2023 |
Topics: Conservative Treatment; Furosemide; Heart Failure; Humans; Kidney Failure, Chronic; Metolazone | 2023 |
Topics: Conservative Treatment; Furosemide; Heart Failure; Humans; Kidney Failure, Chronic; Metolazone | 2023 |
Door-to-furosemide time and clinical outcomes in acute heart failure.
Topics: Acute Disease; Diuretics; Furosemide; Heart Failure; Humans; Prospective Studies | 2023 |
Door-to-furosemide time and clinical outcomes in acute heart failure.
Topics: Acute Disease; Diuretics; Furosemide; Heart Failure; Humans; Prospective Studies | 2023 |
Predictors of Poor Very Early Diuretic Response and Effectiveness of Early Tolvaptan in Symptomatic Acute Heart Failure.
Topics: Diuretics; Furosemide; Heart Failure; Humans; Retrospective Studies; Sodium Potassium Chloride Sympo | 2023 |
Predictors of Poor Very Early Diuretic Response and Effectiveness of Early Tolvaptan in Symptomatic Acute Heart Failure.
Topics: Diuretics; Furosemide; Heart Failure; Humans; Retrospective Studies; Sodium Potassium Chloride Sympo | 2023 |
Diuretic and renal effects of angiotensin receptor-neprilysin inhibitor in patients hospitalized for acute heart failure.
Topics: Antihypertensive Agents; Diuretics; Drug Combinations; Furosemide; Heart Failure; Humans; Kidney; Ne | 2023 |
Diuretic and renal effects of angiotensin receptor-neprilysin inhibitor in patients hospitalized for acute heart failure.
Topics: Antihypertensive Agents; Diuretics; Drug Combinations; Furosemide; Heart Failure; Humans; Kidney; Ne | 2023 |
TRANSFORM-HF closes the loop on diuretic therapy in heart failure.
Topics: Diuretics; Furosemide; Heart Failure; Humans; Sodium Potassium Chloride Symporter Inhibitors | 2023 |
TRANSFORM-HF closes the loop on diuretic therapy in heart failure.
Topics: Diuretics; Furosemide; Heart Failure; Humans; Sodium Potassium Chloride Symporter Inhibitors | 2023 |
Dosing of basic pharmacotherapy and its effect on the prognosis of patients hospitalized for heart failure.
Topics: Adrenergic beta-Antagonists; Angiotensin Receptor Antagonists; Female; Furosemide; Heart Failure; Hu | 2023 |
Dosing of basic pharmacotherapy and its effect on the prognosis of patients hospitalized for heart failure.
Topics: Adrenergic beta-Antagonists; Angiotensin Receptor Antagonists; Female; Furosemide; Heart Failure; Hu | 2023 |
Torsemide vs Furosemide After Discharge and All-Cause Mortality in Patients With Heart Failure-Reply.
Topics: Diuretics; Furosemide; Heart Failure; Humans; Patient Discharge; Sulfonamides; Torsemide | 2023 |
Torsemide vs Furosemide After Discharge and All-Cause Mortality in Patients With Heart Failure-Reply.
Topics: Diuretics; Furosemide; Heart Failure; Humans; Patient Discharge; Sulfonamides; Torsemide | 2023 |
Torsemide vs Furosemide After Discharge and All-Cause Mortality in Patients With Heart Failure.
Topics: Diuretics; Furosemide; Heart Failure; Humans; Patient Discharge; Sulfonamides; Torsemide | 2023 |
Torsemide vs Furosemide After Discharge and All-Cause Mortality in Patients With Heart Failure.
Topics: Diuretics; Furosemide; Heart Failure; Humans; Patient Discharge; Sulfonamides; Torsemide | 2023 |
Dapagliflozin and diuretic utilization in heart failure with mildly reduced or preserved ejection fraction: the DELIVER trial.
Topics: Benzhydryl Compounds; Diuretics; Furosemide; Heart Failure; Humans; Sodium Potassium Chloride Sympor | 2023 |
Dapagliflozin and diuretic utilization in heart failure with mildly reduced or preserved ejection fraction: the DELIVER trial.
Topics: Benzhydryl Compounds; Diuretics; Furosemide; Heart Failure; Humans; Sodium Potassium Chloride Sympor | 2023 |
New Delivery Route for Furosemide in Heart Failure.
Topics: Adult; Diuretics; Furosemide; Heart Failure; Humans; Water-Electrolyte Imbalance | 2023 |
New Delivery Route for Furosemide in Heart Failure.
Topics: Adult; Diuretics; Furosemide; Heart Failure; Humans; Water-Electrolyte Imbalance | 2023 |
Resolution of congestive heart failure and reverse remodeling in two Chihuahuas with flail mitral valve leaflets.
Topics: Animals; Dog Diseases; Dogs; Furosemide; Heart Failure; Heart Valve Diseases; Male; Mitral Valve; Mi | 2023 |
Resolution of congestive heart failure and reverse remodeling in two Chihuahuas with flail mitral valve leaflets.
Topics: Animals; Dog Diseases; Dogs; Furosemide; Heart Failure; Heart Valve Diseases; Male; Mitral Valve; Mi | 2023 |
Il-6 and UGT1A1 variations may related to furosemide resistance in heart failure patients.
Topics: Diuretics; Furosemide; Glucuronosyltransferase; Heart Failure; Humans; Interleukin-6 | 2023 |
Il-6 and UGT1A1 variations may related to furosemide resistance in heart failure patients.
Topics: Diuretics; Furosemide; Glucuronosyltransferase; Heart Failure; Humans; Interleukin-6 | 2023 |
Tolvaptan's Association with Low Risk of Acute Kidney Injury in Patients with Advanced Chronic Kidney Disease and Acute Decompensated Heart Failure.
Topics: Acute Disease; Acute Kidney Injury; Aged; Antidiuretic Hormone Receptor Antagonists; Benzazepines; F | 2023 |
Tolvaptan's Association with Low Risk of Acute Kidney Injury in Patients with Advanced Chronic Kidney Disease and Acute Decompensated Heart Failure.
Topics: Acute Disease; Acute Kidney Injury; Aged; Antidiuretic Hormone Receptor Antagonists; Benzazepines; F | 2023 |
The effect of taurine supplementation on the renin-angiotensin-aldosterone system of dogs with congestive heart failure.
Topics: Aldosterone; Animals; Dietary Supplements; Dogs; Furosemide; Heart Failure; Renin-Angiotensin System | 2023 |
The effect of taurine supplementation on the renin-angiotensin-aldosterone system of dogs with congestive heart failure.
Topics: Aldosterone; Animals; Dietary Supplements; Dogs; Furosemide; Heart Failure; Renin-Angiotensin System | 2023 |
No Benefit With Torsemide Over Furosemide for Posthospitalization Treatment of Heart Failure.
Topics: Diuretics; Furosemide; Heart Failure; Humans; Sulfonamides; Torsemide | 2023 |
No Benefit With Torsemide Over Furosemide for Posthospitalization Treatment of Heart Failure.
Topics: Diuretics; Furosemide; Heart Failure; Humans; Sulfonamides; Torsemide | 2023 |
Heart failure in a cat due to hypertrophic cardiomyopathy phenotype caused by chronic uncontrolled hyperthyroidism.
Topics: Animals; Cardiomegaly; Cardiomyopathy, Hypertrophic; Cat Diseases; Cats; Furosemide; Heart Failure; | 2023 |
Heart failure in a cat due to hypertrophic cardiomyopathy phenotype caused by chronic uncontrolled hyperthyroidism.
Topics: Animals; Cardiomegaly; Cardiomyopathy, Hypertrophic; Cat Diseases; Cats; Furosemide; Heart Failure; | 2023 |
Decongestion strategies in patients presenting with acutely decompensated heart failure: A worldwide survey among physicians.
Topics: Acute Disease; Diuretics; Furosemide; Heart Failure; Humans; Physicians; Surveys and Questionnaires; | 2023 |
Decongestion strategies in patients presenting with acutely decompensated heart failure: A worldwide survey among physicians.
Topics: Acute Disease; Diuretics; Furosemide; Heart Failure; Humans; Physicians; Surveys and Questionnaires; | 2023 |
Topics: Diuretics; Furosemide; Heart Failure; Humans; Palliative Care; Randomized Controlled Trials as Topic | 2023 |
Topics: Diuretics; Furosemide; Heart Failure; Humans; Palliative Care; Randomized Controlled Trials as Topic | 2023 |
Hospitalized patients received furosemide undergoing acute kidney injury: the risk and prediction tool.
Topics: Acute Kidney Injury; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Ant | 2023 |
Hospitalized patients received furosemide undergoing acute kidney injury: the risk and prediction tool.
Topics: Acute Kidney Injury; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Ant | 2023 |
Dermatologic adverse effect of subcutaneous furosemide administration in a cat.
Topics: Animals; Cat Diseases; Cats; Dog Diseases; Dogs; Edema; Furosemide; Heart Failure; Humans | 2023 |
Dermatologic adverse effect of subcutaneous furosemide administration in a cat.
Topics: Animals; Cat Diseases; Cats; Dog Diseases; Dogs; Edema; Furosemide; Heart Failure; Humans | 2023 |
Use of loop diuretics in patients with chronic heart failure: an observational overview.
Topics: Diabetes Mellitus; Diuretics; Furosemide; Heart Failure; Humans; Prognosis; Sodium Potassium Chlorid | 2023 |
Use of loop diuretics in patients with chronic heart failure: an observational overview.
Topics: Diabetes Mellitus; Diuretics; Furosemide; Heart Failure; Humans; Prognosis; Sodium Potassium Chlorid | 2023 |
Outpatient Intravenous Diuretic Therapy for Acute Heart Failure: A Simplified Solution to a Formidable Problem.
Topics: Acute Disease; Diuretics; Furosemide; Heart Failure; Humans; Outpatients; Sodium Potassium Chloride | 2020 |
Outpatient Intravenous Diuretic Therapy for Acute Heart Failure: A Simplified Solution to a Formidable Problem.
Topics: Acute Disease; Diuretics; Furosemide; Heart Failure; Humans; Outpatients; Sodium Potassium Chloride | 2020 |
Response letter to Shetty and Shetty's reply about DRAIN trial.
Topics: Chronic Disease; Diuretics; Drainage; Furosemide; Heart Failure; Humans | 2020 |
Response letter to Shetty and Shetty's reply about DRAIN trial.
Topics: Chronic Disease; Diuretics; Drainage; Furosemide; Heart Failure; Humans | 2020 |
A reply to "Diuretic treatment in high-risk acute decompensation of advanced chronic heart failure-bolus intermittent vs. continuous infusion of furosemide: a randomized controlled trial".
Topics: Diuretics; Furosemide; Heart Failure; Humans | 2020 |
A reply to "Diuretic treatment in high-risk acute decompensation of advanced chronic heart failure-bolus intermittent vs. continuous infusion of furosemide: a randomized controlled trial".
Topics: Diuretics; Furosemide; Heart Failure; Humans | 2020 |
Diabetic patients need higher furosemide doses: a report on acute and chronic heart failure patients.
Topics: Acute Disease; Aged; Aged, 80 and over; Chronic Disease; Diabetes Mellitus; Drug Resistance; Female; | 2020 |
Diabetic patients need higher furosemide doses: a report on acute and chronic heart failure patients.
Topics: Acute Disease; Aged; Aged, 80 and over; Chronic Disease; Diabetes Mellitus; Drug Resistance; Female; | 2020 |
Old and New Drugs for Treatment of Advanced Heart Failure.
Topics: Diuretics; Furosemide; Heart Failure; Humans; Prognosis; Simendan | 2020 |
Old and New Drugs for Treatment of Advanced Heart Failure.
Topics: Diuretics; Furosemide; Heart Failure; Humans; Prognosis; Simendan | 2020 |
What is causing this patient's recurrent cough and dyspnea?
Topics: Adrenergic beta-Antagonists; Adult; Bundle-Branch Block; Cough; Diagnosis, Differential; Dyspnea; Ec | 2020 |
What is causing this patient's recurrent cough and dyspnea?
Topics: Adrenergic beta-Antagonists; Adult; Bundle-Branch Block; Cough; Diagnosis, Differential; Dyspnea; Ec | 2020 |
Acute heart failure, type 2 diabetes and loop diuretic use: any adjunct role for sodium-glucose cotransporter-2 inhibitors?
Topics: Diabetes Mellitus, Type 2; Furosemide; Heart Failure; Humans; Sodium Potassium Chloride Symporter In | 2020 |
Acute heart failure, type 2 diabetes and loop diuretic use: any adjunct role for sodium-glucose cotransporter-2 inhibitors?
Topics: Diabetes Mellitus, Type 2; Furosemide; Heart Failure; Humans; Sodium Potassium Chloride Symporter In | 2020 |
Nocturia: a marker of furosemide treatment response? An exploratory study.
Topics: Aged; Diuretics; Female; Furosemide; Heart Failure; Humans; Incidence; Male; Middle Aged; Nocturia; | 2020 |
Nocturia: a marker of furosemide treatment response? An exploratory study.
Topics: Aged; Diuretics; Female; Furosemide; Heart Failure; Humans; Incidence; Male; Middle Aged; Nocturia; | 2020 |
Effect of Loop Diuretics on the Fractional Excretion of Urea in Decompensated Heart Failure.
Topics: Diuretics; Furosemide; Heart Failure; Humans; Prospective Studies; Sodium; Sodium Potassium Chloride | 2020 |
Effect of Loop Diuretics on the Fractional Excretion of Urea in Decompensated Heart Failure.
Topics: Diuretics; Furosemide; Heart Failure; Humans; Prospective Studies; Sodium; Sodium Potassium Chloride | 2020 |
Real World Use of Hypertonic Saline in Refractory Acute Decompensated Heart Failure: A U.S. Center's Experience.
Topics: Acute Disease; Diuretics; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Furosemide; H | 2020 |
Real World Use of Hypertonic Saline in Refractory Acute Decompensated Heart Failure: A U.S. Center's Experience.
Topics: Acute Disease; Diuretics; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Furosemide; H | 2020 |
Simpson's Paradox: Meta-Analysis Comparing Torsemide Versus Furosemide in Patients With Heart Failure.
Topics: Furosemide; Heart Failure; Humans; Sodium Potassium Chloride Symporter Inhibitors; Torsemide | 2020 |
Simpson's Paradox: Meta-Analysis Comparing Torsemide Versus Furosemide in Patients With Heart Failure.
Topics: Furosemide; Heart Failure; Humans; Sodium Potassium Chloride Symporter Inhibitors; Torsemide | 2020 |
Response to letter: 'Acute heart failure, type 2 diabetes and loop diuretic use: any adjunct role for SGLT-2 inhibitors?'
Topics: Diabetes Mellitus, Type 2; Furosemide; Heart Failure; Humans; Sodium Potassium Chloride Symporter In | 2020 |
Response to letter: 'Acute heart failure, type 2 diabetes and loop diuretic use: any adjunct role for SGLT-2 inhibitors?'
Topics: Diabetes Mellitus, Type 2; Furosemide; Heart Failure; Humans; Sodium Potassium Chloride Symporter In | 2020 |
Development of Pulmonary Edema Despite Negative Fluid Balance with Diuretics in a Patient with Heart Failure and Sigmoid Septum.
Topics: Aged, 80 and over; Diuretics; Furosemide; Heart Failure; Humans; Lidocaine; Male; Pulmonary Edema; V | 2020 |
Development of Pulmonary Edema Despite Negative Fluid Balance with Diuretics in a Patient with Heart Failure and Sigmoid Septum.
Topics: Aged, 80 and over; Diuretics; Furosemide; Heart Failure; Humans; Lidocaine; Male; Pulmonary Edema; V | 2020 |
Clinical and echocardiographic benefit of Sacubitril/Valsartan in a real-world population with HF with reduced ejection fraction.
Topics: Aged; Aminobutyrates; Angiotensin Receptor Antagonists; Arterial Pressure; Biphenyl Compounds; Cardi | 2020 |
Clinical and echocardiographic benefit of Sacubitril/Valsartan in a real-world population with HF with reduced ejection fraction.
Topics: Aged; Aminobutyrates; Angiotensin Receptor Antagonists; Arterial Pressure; Biphenyl Compounds; Cardi | 2020 |
Two cases of coronavirus 2019-related cardiomyopathy in pregnancy.
Topics: Adult; Anti-Arrhythmia Agents; Antibodies, Monoclonal, Humanized; Anticonvulsants; Blood Gas Analysi | 2020 |
Two cases of coronavirus 2019-related cardiomyopathy in pregnancy.
Topics: Adult; Anti-Arrhythmia Agents; Antibodies, Monoclonal, Humanized; Anticonvulsants; Blood Gas Analysi | 2020 |
Renoprotective effect of tolvaptan in patients with new-onset acute heart failure.
Topics: Diuretics; Furosemide; Heart Failure; Humans; Retrospective Studies; Tolvaptan | 2020 |
Renoprotective effect of tolvaptan in patients with new-onset acute heart failure.
Topics: Diuretics; Furosemide; Heart Failure; Humans; Retrospective Studies; Tolvaptan | 2020 |
A rare case of biventricular non-compaction.
Topics: Cardiomyopathies; Carvedilol; Coronary Artery Disease; Dyspnea; Furosemide; Heart Failure; Heart Ven | 2020 |
A rare case of biventricular non-compaction.
Topics: Cardiomyopathies; Carvedilol; Coronary Artery Disease; Dyspnea; Furosemide; Heart Failure; Heart Ven | 2020 |
Simpson's Paradox in Meta-Analysis - Choice of Studies and Summary Statistics.
Topics: Data Interpretation, Statistical; Furosemide; Heart Failure; Humans; Torsemide | 2020 |
Simpson's Paradox in Meta-Analysis - Choice of Studies and Summary Statistics.
Topics: Data Interpretation, Statistical; Furosemide; Heart Failure; Humans; Torsemide | 2020 |
Very High-Dose Furosemide Continuous Infusions: A Case Series.
Topics: Diuretics; Furosemide; Heart Failure; Humans; Infusions, Intravenous; Retrospective Studies | 2020 |
Very High-Dose Furosemide Continuous Infusions: A Case Series.
Topics: Diuretics; Furosemide; Heart Failure; Humans; Infusions, Intravenous; Retrospective Studies | 2020 |
Diuretic Resistance in Acutely Decompensated Heart Failure: The Solution May Just Be Hypertonic.
Topics: Diuretics; Furosemide; Heart Failure; Humans; Saline Solution, Hypertonic | 2020 |
Diuretic Resistance in Acutely Decompensated Heart Failure: The Solution May Just Be Hypertonic.
Topics: Diuretics; Furosemide; Heart Failure; Humans; Saline Solution, Hypertonic | 2020 |
In-hospital resource utilization, worsening heart failure, and factors associated with length of hospital stay in patients with hospitalized heart failure: A Japanese database cohort study.
Topics: Aged; Aged, 80 and over; Cohort Studies; Databases, Factual; Disease Progression; Female; Furosemide | 2020 |
In-hospital resource utilization, worsening heart failure, and factors associated with length of hospital stay in patients with hospitalized heart failure: A Japanese database cohort study.
Topics: Aged; Aged, 80 and over; Cohort Studies; Databases, Factual; Disease Progression; Female; Furosemide | 2020 |
Furosemide in end-stage heart failure: community subcutaneous infusions.
Topics: Aged; Diuretics; Furosemide; Heart Failure; Humans; Infusions, Subcutaneous; Retrospective Studies; | 2022 |
Furosemide in end-stage heart failure: community subcutaneous infusions.
Topics: Aged; Diuretics; Furosemide; Heart Failure; Humans; Infusions, Subcutaneous; Retrospective Studies; | 2022 |
Furosemide and spironolactone doses and hyponatremia in patients with heart failure.
Topics: Aged; Aged, 80 and over; Diuretics; Female; Furosemide; Heart Failure; Hospitalization; Humans; Hydr | 2020 |
Furosemide and spironolactone doses and hyponatremia in patients with heart failure.
Topics: Aged; Aged, 80 and over; Diuretics; Female; Furosemide; Heart Failure; Hospitalization; Humans; Hydr | 2020 |
The Weight of Evidence for Diuretics and Parachutes.
Topics: Aged; Diuretics; Furosemide; Heart Failure; Humans; Prescriptions; Sodium Potassium Chloride Symport | 2020 |
The Weight of Evidence for Diuretics and Parachutes.
Topics: Aged; Diuretics; Furosemide; Heart Failure; Humans; Prescriptions; Sodium Potassium Chloride Symport | 2020 |
COVID-19 infection in left ventricular assist device patients.
Topics: Aged; Cardiotonic Agents; COVID-19; Dobutamine; Furosemide; Heart Failure; Heart-Assist Devices; Hum | 2020 |
COVID-19 infection in left ventricular assist device patients.
Topics: Aged; Cardiotonic Agents; COVID-19; Dobutamine; Furosemide; Heart Failure; Heart-Assist Devices; Hum | 2020 |
Baseline and incident hypochloremia in chronic heart failure outpatients: Clinical correlates and prognostic role.
Topics: Furosemide; Heart Failure; Humans; Outpatients; Prognosis; Water-Electrolyte Imbalance | 2021 |
Baseline and incident hypochloremia in chronic heart failure outpatients: Clinical correlates and prognostic role.
Topics: Furosemide; Heart Failure; Humans; Outpatients; Prognosis; Water-Electrolyte Imbalance | 2021 |
Tolerance of torasemide in cats with congestive heart failure: a retrospective study on 21 cases (2016-2019).
Topics: Animals; Cat Diseases; Cats; Diuretics; Female; Furosemide; Heart Failure; Male; Retrospective Studi | 2020 |
Tolerance of torasemide in cats with congestive heart failure: a retrospective study on 21 cases (2016-2019).
Topics: Animals; Cat Diseases; Cats; Diuretics; Female; Furosemide; Heart Failure; Male; Retrospective Studi | 2020 |
Prediction and measurement of diuretic responsiveness after oral administration of furosemide to healthy dogs and dogs with congestive heart failure.
Topics: Administration, Oral; Animals; Diuretics; Dog Diseases; Dogs; Furosemide; Heart Failure; Humans; Pro | 2020 |
Prediction and measurement of diuretic responsiveness after oral administration of furosemide to healthy dogs and dogs with congestive heart failure.
Topics: Administration, Oral; Animals; Diuretics; Dog Diseases; Dogs; Furosemide; Heart Failure; Humans; Pro | 2020 |
Intensification of pharmacological decongestion but not the actual daily loop diuretic dose predicts worse chronic heart failure outcome: insights from TIME-CHF.
Topics: Aged; Aged, 80 and over; Chronic Disease; Disease Progression; Female; Furosemide; Germany; Heart Fa | 2021 |
Intensification of pharmacological decongestion but not the actual daily loop diuretic dose predicts worse chronic heart failure outcome: insights from TIME-CHF.
Topics: Aged; Aged, 80 and over; Chronic Disease; Disease Progression; Female; Furosemide; Germany; Heart Fa | 2021 |
Heart failure with preserved ejection fraction in coronavirus disease 2019 patients: the promising role of diuretic therapy in critically ill patients.
Topics: COVID-19; Diuretics; Furosemide; Heart Failure; Humans; Male; Middle Aged; Stroke Volume | 2021 |
Heart failure with preserved ejection fraction in coronavirus disease 2019 patients: the promising role of diuretic therapy in critically ill patients.
Topics: COVID-19; Diuretics; Furosemide; Heart Failure; Humans; Male; Middle Aged; Stroke Volume | 2021 |
Subcutaneous furosemide in advanced heart failure: service improvement project.
Topics: Aged; Diuretics; Furosemide; Heart Failure; Hospice Care; Hospices; Humans; Male; Palliative Care; T | 2023 |
Subcutaneous furosemide in advanced heart failure: service improvement project.
Topics: Aged; Diuretics; Furosemide; Heart Failure; Hospice Care; Hospices; Humans; Male; Palliative Care; T | 2023 |
Intravenous Mineralocorticoid Receptor Antagonist Use in Acutely Decompensated Heart Failure with Diuretic Resistance.
Topics: Administration, Intravenous; Aged; Aged, 80 and over; Bumetanide; Canrenoic Acid; Creatinine; Diures | 2021 |
Intravenous Mineralocorticoid Receptor Antagonist Use in Acutely Decompensated Heart Failure with Diuretic Resistance.
Topics: Administration, Intravenous; Aged; Aged, 80 and over; Bumetanide; Canrenoic Acid; Creatinine; Diures | 2021 |
The FAST-FURO study: effect of very early administration of intravenous furosemide in the prehospital setting to patients with acute heart failure attending the emergency department.
Topics: Acute Disease; Diuretics; Emergency Medical Services; Emergency Service, Hospital; Furosemide; Heart | 2021 |
The FAST-FURO study: effect of very early administration of intravenous furosemide in the prehospital setting to patients with acute heart failure attending the emergency department.
Topics: Acute Disease; Diuretics; Emergency Medical Services; Emergency Service, Hospital; Furosemide; Heart | 2021 |
Diuretic response and effects of diuretic omission in ambulatory heart failure patients on chronic low-dose loop diuretic therapy.
Topics: Diuretics; Furosemide; Heart Failure; Humans; Natriuresis; Sodium Potassium Chloride Symporter Inhib | 2021 |
Diuretic response and effects of diuretic omission in ambulatory heart failure patients on chronic low-dose loop diuretic therapy.
Topics: Diuretics; Furosemide; Heart Failure; Humans; Natriuresis; Sodium Potassium Chloride Symporter Inhib | 2021 |
Continuous versus intermittent use of furosemide in patients with heart failure and moderate chronic renal dysfunction.
Topics: Acute Kidney Injury; Diuretics; Furosemide; Heart Failure; Humans; Sodium Potassium Chloride Symport | 2021 |
Continuous versus intermittent use of furosemide in patients with heart failure and moderate chronic renal dysfunction.
Topics: Acute Kidney Injury; Diuretics; Furosemide; Heart Failure; Humans; Sodium Potassium Chloride Symport | 2021 |
Severe acute respiratory syndrome coronavirus-2- or pregnancy-related cardiomyopathy, a differential to be considered in the current pandemic: a case report.
Topics: Adult; Anti-Bacterial Agents; Antiviral Agents; Azithromycin; Cardiomyopathies; Cesarean Section; Co | 2021 |
Severe acute respiratory syndrome coronavirus-2- or pregnancy-related cardiomyopathy, a differential to be considered in the current pandemic: a case report.
Topics: Adult; Anti-Bacterial Agents; Antiviral Agents; Azithromycin; Cardiomyopathies; Cesarean Section; Co | 2021 |
Efficacy and safety of intermittent vs continuous furosemide for heart failure concomitant renal dysfunction: A protocol for systematic review and meta-analysis.
Topics: Drug Administration Schedule; Furosemide; Heart Failure; Humans; Meta-Analysis as Topic; Randomized | 2021 |
Efficacy and safety of intermittent vs continuous furosemide for heart failure concomitant renal dysfunction: A protocol for systematic review and meta-analysis.
Topics: Drug Administration Schedule; Furosemide; Heart Failure; Humans; Meta-Analysis as Topic; Randomized | 2021 |
Acute Diuretic-Sparing Effects of Sacubitril-Valsartan: Staying in the Loop.
Topics: Aminobutyrates; Angiotensin Receptor Antagonists; Diuretics; Drug Combinations; Furosemide; Heart Fa | 2022 |
Acute Diuretic-Sparing Effects of Sacubitril-Valsartan: Staying in the Loop.
Topics: Aminobutyrates; Angiotensin Receptor Antagonists; Diuretics; Drug Combinations; Furosemide; Heart Fa | 2022 |
Clinical relevance of serum electrolytes in dogs and cats with acute heart failure: A retrospective study.
Topics: Animals; Cat Diseases; Cats; Diuretics; Dog Diseases; Dogs; Electrolytes; Furosemide; Heart Failure; | 2021 |
Clinical relevance of serum electrolytes in dogs and cats with acute heart failure: A retrospective study.
Topics: Animals; Cat Diseases; Cats; Diuretics; Dog Diseases; Dogs; Electrolytes; Furosemide; Heart Failure; | 2021 |
Potential Role of Natriuretic Response to Furosemide Stress Test During Acute Heart Failure.
Topics: Aged; Biomarkers; Diuretics; Exercise Test; Female; Furosemide; Heart Failure; Humans; Male; Middle | 2021 |
Potential Role of Natriuretic Response to Furosemide Stress Test During Acute Heart Failure.
Topics: Aged; Biomarkers; Diuretics; Exercise Test; Female; Furosemide; Heart Failure; Humans; Male; Middle | 2021 |
Association of early administration of furosemide with improved oxygenation in patients with acute heart failure.
Topics: Acute Disease; Diuretics; Furosemide; Heart Failure; Hospital Mortality; Humans | 2021 |
Association of early administration of furosemide with improved oxygenation in patients with acute heart failure.
Topics: Acute Disease; Diuretics; Furosemide; Heart Failure; Hospital Mortality; Humans | 2021 |
Diuretic strategies in patients with resistance to loop-diuretics in the intensive care unit: A retrospective study from the MIMIC-III database.
Topics: Adult; Diuretics; Furosemide; Heart Failure; Humans; Intensive Care Units; Retrospective Studies; So | 2021 |
Diuretic strategies in patients with resistance to loop-diuretics in the intensive care unit: A retrospective study from the MIMIC-III database.
Topics: Adult; Diuretics; Furosemide; Heart Failure; Humans; Intensive Care Units; Retrospective Studies; So | 2021 |
Angiotensin receptor neprilysin inhibitor for patients with heart failure and reduced ejection fraction: Real-world experience from Turkey (ARNi-TR).
Topics: Aged; Aminobutyrates; Angiotensin Receptor Antagonists; Biphenyl Compounds; Diuretics; Drug Combinat | 2021 |
Angiotensin receptor neprilysin inhibitor for patients with heart failure and reduced ejection fraction: Real-world experience from Turkey (ARNi-TR).
Topics: Aged; Aminobutyrates; Angiotensin Receptor Antagonists; Biphenyl Compounds; Diuretics; Drug Combinat | 2021 |
Ambulatory intravenous furosemide for decompensated heart failure: safe, feasible, and effective.
Topics: COVID-19; Furosemide; Heart Failure; Humans; Retrospective Studies; SARS-CoV-2; Treatment Outcome | 2021 |
Ambulatory intravenous furosemide for decompensated heart failure: safe, feasible, and effective.
Topics: COVID-19; Furosemide; Heart Failure; Humans; Retrospective Studies; SARS-CoV-2; Treatment Outcome | 2021 |
Renal negative pressure treatment as a novel therapy for heart failure-induced renal dysfunction.
Topics: Animals; Cardio-Renal Syndrome; Disease Models, Animal; Diuresis; Female; Fluid Therapy; Furosemide; | 2021 |
Renal negative pressure treatment as a novel therapy for heart failure-induced renal dysfunction.
Topics: Animals; Cardio-Renal Syndrome; Disease Models, Animal; Diuresis; Female; Fluid Therapy; Furosemide; | 2021 |
Diuresis-Related Weight Loss Reflects Interstitial Compartment Decongestion With Minimal Impact on Intravascular Volume Expansion or Outcomes in Post-Acute Heart Failure.
Topics: Diuresis; Furosemide; Heart Failure; Humans; Weight Loss | 2022 |
Diuresis-Related Weight Loss Reflects Interstitial Compartment Decongestion With Minimal Impact on Intravascular Volume Expansion or Outcomes in Post-Acute Heart Failure.
Topics: Diuresis; Furosemide; Heart Failure; Humans; Weight Loss | 2022 |
Prognostic Effect of the Dose of Loop Diuretic Over 5 Years in Chronic Heart Failure.
Topics: Aged; Chronic Disease; Cohort Studies; Diuretics; Dose-Response Relationship, Drug; Female; Furosemi | 2017 |
Prognostic Effect of the Dose of Loop Diuretic Over 5 Years in Chronic Heart Failure.
Topics: Aged; Chronic Disease; Cohort Studies; Diuretics; Dose-Response Relationship, Drug; Female; Furosemi | 2017 |
The future of community nursing: Hospital in the Home.
Topics: Acute Disease; Aged; Anti-Bacterial Agents; Bronchodilator Agents; Clergy; Community Health Nursing; | 2017 |
The future of community nursing: Hospital in the Home.
Topics: Acute Disease; Aged; Anti-Bacterial Agents; Bronchodilator Agents; Clergy; Community Health Nursing; | 2017 |
Tolvaptan, Is It a Trump to Worsening Renal Function?
Topics: Antidiuretic Hormone Receptor Antagonists; Benzazepines; Diuretics; Furosemide; Heart Failure; Human | 2017 |
Tolvaptan, Is It a Trump to Worsening Renal Function?
Topics: Antidiuretic Hormone Receptor Antagonists; Benzazepines; Diuretics; Furosemide; Heart Failure; Human | 2017 |
Limited transthoracic echocardiogram: "This is how I do it".
Topics: Adult; Aged; Crystalloid Solutions; Diuretics; Echocardiography; Furosemide; Heart Failure; Humans; | 2017 |
Limited transthoracic echocardiogram: "This is how I do it".
Topics: Adult; Aged; Crystalloid Solutions; Diuretics; Echocardiography; Furosemide; Heart Failure; Humans; | 2017 |
Polypharmacy in the Elderly-When Good Drugs Lead to Bad Outcomes: A Teachable Moment.
Topics: Aged, 80 and over; Anti-Arrhythmia Agents; Antihypertensive Agents; Atorvastatin; Atrial Fibrillatio | 2017 |
Polypharmacy in the Elderly-When Good Drugs Lead to Bad Outcomes: A Teachable Moment.
Topics: Aged, 80 and over; Anti-Arrhythmia Agents; Antihypertensive Agents; Atorvastatin; Atrial Fibrillatio | 2017 |
Capacity for diagnosis and treatment of heart failure in sub-Saharan Africa.
Topics: Adrenergic beta-Antagonists; Ambulatory Care; Angiotensin-Converting Enzyme Inhibitors; Cardiac Imag | 2017 |
Capacity for diagnosis and treatment of heart failure in sub-Saharan Africa.
Topics: Adrenergic beta-Antagonists; Ambulatory Care; Angiotensin-Converting Enzyme Inhibitors; Cardiac Imag | 2017 |
Aldosterone breakthrough in dogs with naturally occurring myxomatous mitral valve disease.
Topics: Aldosterone; Angiotensin-Converting Enzyme Inhibitors; Animals; Creatinine; Dog Diseases; Dogs; Fema | 2017 |
Aldosterone breakthrough in dogs with naturally occurring myxomatous mitral valve disease.
Topics: Aldosterone; Angiotensin-Converting Enzyme Inhibitors; Animals; Creatinine; Dog Diseases; Dogs; Fema | 2017 |
Potentially inappropriate use of furosemide in a very elderly population: An observational study.
Topics: Adrenergic beta-Antagonists; Age Factors; Aged, 80 and over; Angiotensin-Converting Enzyme Inhibitor | 2017 |
Potentially inappropriate use of furosemide in a very elderly population: An observational study.
Topics: Adrenergic beta-Antagonists; Age Factors; Aged, 80 and over; Angiotensin-Converting Enzyme Inhibitor | 2017 |
Time-to-Furosemide Treatment and Mortality in Patients Hospitalized With Acute Heart Failure.
Topics: Acute Disease; Aged; Diuretics; Female; Follow-Up Studies; Furosemide; Heart Failure; Hospital Morta | 2017 |
Time-to-Furosemide Treatment and Mortality in Patients Hospitalized With Acute Heart Failure.
Topics: Acute Disease; Aged; Diuretics; Female; Follow-Up Studies; Furosemide; Heart Failure; Hospital Morta | 2017 |
Door-to-Furosemide Therapy in the ED: New Quality Metric or Just a Piece of the Puzzle?
Topics: Diuretics; Furosemide; Heart Failure; Humans; Time-to-Treatment | 2017 |
Door-to-Furosemide Therapy in the ED: New Quality Metric or Just a Piece of the Puzzle?
Topics: Diuretics; Furosemide; Heart Failure; Humans; Time-to-Treatment | 2017 |
A rare form of extremely wide QRS complex due to reversed homologous electrical ventricular separation of acute heart failure.
Topics: Acute Disease; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhythmia Agents; Benzaze | 2018 |
A rare form of extremely wide QRS complex due to reversed homologous electrical ventricular separation of acute heart failure.
Topics: Acute Disease; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhythmia Agents; Benzaze | 2018 |
Reply: Readmissions and Diuretic Dosing.
Topics: Diuretics; Furosemide; Heart Failure; Humans; Patient Readmission; Sodium Potassium Chloride Symport | 2017 |
Reply: Readmissions and Diuretic Dosing.
Topics: Diuretics; Furosemide; Heart Failure; Humans; Patient Readmission; Sodium Potassium Chloride Symport | 2017 |
Loop diuretic down-titration in stable chronic heart failure is often achievable, especially when urinary chloride concentration is low.
Topics: Aged; Biomarkers; Chlorates; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Furosemide | 2018 |
Loop diuretic down-titration in stable chronic heart failure is often achievable, especially when urinary chloride concentration is low.
Topics: Aged; Biomarkers; Chlorates; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Furosemide | 2018 |
Potential advantages of torsemide in patients with heart failure: more than just a 'water pill'?
Topics: Furosemide; Heart Failure; Humans; Sulfonamides; Torsemide; Water | 2018 |
Potential advantages of torsemide in patients with heart failure: more than just a 'water pill'?
Topics: Furosemide; Heart Failure; Humans; Sulfonamides; Torsemide; Water | 2018 |
[Furosemide induced agranulocytosis in heart failure, what else?]
Topics: Aged, 80 and over; Agranulocytosis; Furosemide; Heart Failure; Humans; Male | 2017 |
[Furosemide induced agranulocytosis in heart failure, what else?]
Topics: Aged, 80 and over; Agranulocytosis; Furosemide; Heart Failure; Humans; Male | 2017 |
Impact of Injectable Furosemide Hospital Shortage on Congestive Heart Failure Outcomes: A Time Series Analysis.
Topics: Diuretics; Female; Furosemide; Heart Failure; Hospital Mortality; Humans; Length of Stay; Male; Onta | 2017 |
Impact of Injectable Furosemide Hospital Shortage on Congestive Heart Failure Outcomes: A Time Series Analysis.
Topics: Diuretics; Female; Furosemide; Heart Failure; Hospital Mortality; Humans; Length of Stay; Male; Onta | 2017 |
Furosemide Reimagined: Novel Subcutaneous Formulation for a 50-Year-Old Loop Diuretic Agent for the Treatment of Acute Decompensated Heart Failure.
Topics: Diuretics; Furosemide; Heart Failure; Humans; Hydrogen-Ion Concentration; Middle Aged; Outpatients; | 2018 |
Furosemide Reimagined: Novel Subcutaneous Formulation for a 50-Year-Old Loop Diuretic Agent for the Treatment of Acute Decompensated Heart Failure.
Topics: Diuretics; Furosemide; Heart Failure; Humans; Hydrogen-Ion Concentration; Middle Aged; Outpatients; | 2018 |
Etiology of discharge hyponatremia in decompensated heart failure and normal admission Na
Topics: Diuretics; Female; Furosemide; Heart Failure; Hemodynamics; Humans; Hyponatremia; Male; Middle Aged; | 2018 |
Etiology of discharge hyponatremia in decompensated heart failure and normal admission Na
Topics: Diuretics; Female; Furosemide; Heart Failure; Hemodynamics; Humans; Hyponatremia; Male; Middle Aged; | 2018 |
Spot Urine Sodium as Triage for Effective Diuretic Infusion in an Ambulatory Heart Failure Unit.
Topics: Aged; Aged, 80 and over; Ambulatory Care Facilities; Biomarkers; Diuretics; Dose-Response Relationsh | 2018 |
Spot Urine Sodium as Triage for Effective Diuretic Infusion in an Ambulatory Heart Failure Unit.
Topics: Aged; Aged, 80 and over; Ambulatory Care Facilities; Biomarkers; Diuretics; Dose-Response Relationsh | 2018 |
Efficacy of Subcutaneous Versus Intravenous Administration of Furosemide in Patients With Worsening Heart Failure: The Devil Is in the Details.
Topics: Administration, Intravenous; Diuretics; Furosemide; Heart Failure; Humans; Hydrogen-Ion Concentratio | 2018 |
Efficacy of Subcutaneous Versus Intravenous Administration of Furosemide in Patients With Worsening Heart Failure: The Devil Is in the Details.
Topics: Administration, Intravenous; Diuretics; Furosemide; Heart Failure; Humans; Hydrogen-Ion Concentratio | 2018 |
Reply: Efficacy of Subcutaneous vs. Intravenous Administration of Furosemide in Patients With Worsening Heart Failure: The Devil Is in the Details.
Topics: Administration, Intravenous; Diuretics; Furosemide; Heart Failure; Humans; Hydrogen-Ion Concentratio | 2018 |
Reply: Efficacy of Subcutaneous vs. Intravenous Administration of Furosemide in Patients With Worsening Heart Failure: The Devil Is in the Details.
Topics: Administration, Intravenous; Diuretics; Furosemide; Heart Failure; Humans; Hydrogen-Ion Concentratio | 2018 |
Urinary composition predicts diuretic efficiency of hypertonic saline solution with furosemide therapy and heart failure prognosis.
Topics: Aged; Aged, 80 and over; Blood Pressure; Diuretics; Drug Therapy, Combination; Female; Follow-Up Stu | 2018 |
Urinary composition predicts diuretic efficiency of hypertonic saline solution with furosemide therapy and heart failure prognosis.
Topics: Aged; Aged, 80 and over; Blood Pressure; Diuretics; Drug Therapy, Combination; Female; Follow-Up Stu | 2018 |
Diuretic dosing in heart failure: more data are needed.
Topics: Diuretics; Furosemide; Heart Failure; Humans | 2018 |
Diuretic dosing in heart failure: more data are needed.
Topics: Diuretics; Furosemide; Heart Failure; Humans | 2018 |
Captopril Attenuates Cardiovascular and Renal Disease in a Rat Model of Heart Failure With Preserved Ejection Fraction.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Captopril; Comorbidity; Disease M | 2018 |
Captopril Attenuates Cardiovascular and Renal Disease in a Rat Model of Heart Failure With Preserved Ejection Fraction.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Captopril; Comorbidity; Disease M | 2018 |
Clinical findings and survival time in dogs with advanced heart failure.
Topics: Animals; Cardiotonic Agents; Dog Diseases; Dogs; Female; Furosemide; Heart Failure; Male; Mitral Val | 2018 |
Clinical findings and survival time in dogs with advanced heart failure.
Topics: Animals; Cardiotonic Agents; Dog Diseases; Dogs; Female; Furosemide; Heart Failure; Male; Mitral Val | 2018 |
Tolvaptan alleviates excessive fluid retention of nephrotic diabetic renal failure unresponsive to furosemide.
Topics: Aged; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Diabetic Nephropathies; Drug Resistan | 2018 |
Tolvaptan alleviates excessive fluid retention of nephrotic diabetic renal failure unresponsive to furosemide.
Topics: Aged; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Diabetic Nephropathies; Drug Resistan | 2018 |
What Is Your Diagnosis?
Topics: Animals; Atherosclerosis; Bird Diseases; Cardiotonic Agents; Diagnosis, Differential; Diuretics; Ech | 2018 |
What Is Your Diagnosis?
Topics: Animals; Atherosclerosis; Bird Diseases; Cardiotonic Agents; Diagnosis, Differential; Diuretics; Ech | 2018 |
[Evaluation of the prescription of furosemide in persons aged 75years and older in a geriatric acute-care unit].
Topics: Aged; Aged, 80 and over; Diuretics; Drug Prescriptions; Female; France; Furosemide; Guideline Adhere | 2018 |
[Evaluation of the prescription of furosemide in persons aged 75years and older in a geriatric acute-care unit].
Topics: Aged; Aged, 80 and over; Diuretics; Drug Prescriptions; Female; France; Furosemide; Guideline Adhere | 2018 |
Can Torsemide and Combination of Loop Diuretics Improve Mortality in Patients with Chronic Heart Failure After Discharge?
Topics: Aged; China; Diuretics; Drug Therapy, Combination; Female; Furosemide; Heart Failure; Humans; Male; | 2018 |
Can Torsemide and Combination of Loop Diuretics Improve Mortality in Patients with Chronic Heart Failure After Discharge?
Topics: Aged; China; Diuretics; Drug Therapy, Combination; Female; Furosemide; Heart Failure; Humans; Male; | 2018 |
[Analysis of the mitochondrial function and ultrastructure in healthy albino mice treated with heart failure medications]
Topics: Animals; Antihypertensive Agents; Atenolol; Cardiotonic Agents; Digoxin; Disease Models, Animal; Diu | 2017 |
[Analysis of the mitochondrial function and ultrastructure in healthy albino mice treated with heart failure medications]
Topics: Animals; Antihypertensive Agents; Atenolol; Cardiotonic Agents; Digoxin; Disease Models, Animal; Diu | 2017 |
Subcutaneous furosemide in patients with refractory heart failure.
Topics: Aged; Aged, 80 and over; Diuretics; Female; Follow-Up Studies; Furosemide; Heart Failure; Humans; In | 2018 |
Subcutaneous furosemide in patients with refractory heart failure.
Topics: Aged; Aged, 80 and over; Diuretics; Female; Follow-Up Studies; Furosemide; Heart Failure; Humans; In | 2018 |
First spot urine sodium after initial diuretic identifies patients at high risk for adverse outcome after heart failure hospitalization.
Topics: Aged; Biomarkers; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Furosemide; Heart Fai | 2018 |
First spot urine sodium after initial diuretic identifies patients at high risk for adverse outcome after heart failure hospitalization.
Topics: Aged; Biomarkers; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Furosemide; Heart Fai | 2018 |
Effects of early diuretic response to carperitide in acute decompensated heart failure treatment: A single-center retrospective study.
Topics: Aged; Atrial Natriuretic Factor; Blood Urea Nitrogen; Body Mass Index; Diuretics; Female; Furosemide | 2018 |
Effects of early diuretic response to carperitide in acute decompensated heart failure treatment: A single-center retrospective study.
Topics: Aged; Atrial Natriuretic Factor; Blood Urea Nitrogen; Body Mass Index; Diuretics; Female; Furosemide | 2018 |
Case of giant left atrium from congestive heart failure.
Topics: Aged; Atrial Fibrillation; Cardiac Output, Low; Cardiomegaly; Echocardiography; Female; Furosemide; | 2018 |
Case of giant left atrium from congestive heart failure.
Topics: Aged; Atrial Fibrillation; Cardiac Output, Low; Cardiomegaly; Echocardiography; Female; Furosemide; | 2018 |
Subcutaneous Furosemide in Patients With Refractory Heart Failure.
Topics: Aged; Aged, 80 and over; Cardiac Output; Diuretics; Dose-Response Relationship, Drug; Furosemide; He | 2019 |
Subcutaneous Furosemide in Patients With Refractory Heart Failure.
Topics: Aged; Aged, 80 and over; Cardiac Output; Diuretics; Dose-Response Relationship, Drug; Furosemide; He | 2019 |
Preventable delays to intravenous furosemide administration in the emergency department prolong hospitalization for patients with acute heart failure.
Topics: Acute Disease; Administration, Intravenous; Aged; Diuretics; Emergency Service, Hospital; Female; Fu | 2018 |
Preventable delays to intravenous furosemide administration in the emergency department prolong hospitalization for patients with acute heart failure.
Topics: Acute Disease; Administration, Intravenous; Aged; Diuretics; Emergency Service, Hospital; Female; Fu | 2018 |
Hyponatremia in Acute Heart Failure in Relation to Hematocrit Levels: Clinical Relevance and Prognostic Implication.
Topics: Acute Disease; Administration, Intravenous; Aged; Aged, 80 and over; Diuretics; Female; Furosemide; | 2018 |
Hyponatremia in Acute Heart Failure in Relation to Hematocrit Levels: Clinical Relevance and Prognostic Implication.
Topics: Acute Disease; Administration, Intravenous; Aged; Aged, 80 and over; Diuretics; Female; Furosemide; | 2018 |
Time to Diuretic in Acute Heart Failure.
Topics: Diuretics; Furosemide; Heart Failure; Humans; Sodium Potassium Chloride Symporter Inhibitors | 2018 |
Time to Diuretic in Acute Heart Failure.
Topics: Diuretics; Furosemide; Heart Failure; Humans; Sodium Potassium Chloride Symporter Inhibitors | 2018 |
Reply: Time to Diuretic in Acute Heart Failure.
Topics: Diuretics; Furosemide; Heart Failure; Humans; Sodium Potassium Chloride Symporter Inhibitors | 2018 |
Reply: Time to Diuretic in Acute Heart Failure.
Topics: Diuretics; Furosemide; Heart Failure; Humans; Sodium Potassium Chloride Symporter Inhibitors | 2018 |
Constant rate infusion vs. intermittent bolus administration of IV furosemide in 100 pets with acute left-sided congestive heart failure: A retrospective study.
Topics: Animals; Cat Diseases; Cats; Diuretics; Dog Diseases; Dogs; Female; Furosemide; Heart Failure; Infus | 2018 |
Constant rate infusion vs. intermittent bolus administration of IV furosemide in 100 pets with acute left-sided congestive heart failure: A retrospective study.
Topics: Animals; Cat Diseases; Cats; Diuretics; Dog Diseases; Dogs; Female; Furosemide; Heart Failure; Infus | 2018 |
Role of Response-to-Diuretic in Predicting Prognosis in Discharged Heart Failure Patients After an Acute Decompensation.
Topics: Aged; Biomarkers; Blood Proteins; Diuretics; Echocardiography; Female; Furosemide; Galectin 3; Galec | 2018 |
Role of Response-to-Diuretic in Predicting Prognosis in Discharged Heart Failure Patients After an Acute Decompensation.
Topics: Aged; Biomarkers; Blood Proteins; Diuretics; Echocardiography; Female; Furosemide; Galectin 3; Galec | 2018 |
Hypoxic hepatitis and furosemide.
Topics: Chemical and Drug Induced Liver Injury; Dehydration; Diagnosis, Differential; Diuretics; Echocardiog | 2018 |
Hypoxic hepatitis and furosemide.
Topics: Chemical and Drug Induced Liver Injury; Dehydration; Diagnosis, Differential; Diuretics; Echocardiog | 2018 |
[Prescription of furosemide in general medicine in Aquitaine: Prospective practice survey among universities general practitioners].
Topics: Aged, 80 and over; Diuretics; Drug Prescriptions; Female; France; Furosemide; General Practitioners; | 2018 |
[Prescription of furosemide in general medicine in Aquitaine: Prospective practice survey among universities general practitioners].
Topics: Aged, 80 and over; Diuretics; Drug Prescriptions; Female; France; Furosemide; General Practitioners; | 2018 |
Heart failure in the outpatient versus inpatient setting: findings from the BIOSTAT-CHF study.
Topics: Aged; Disease Progression; Diuretics; Europe; Female; Furosemide; Heart Failure; Hospitalization; Hu | 2019 |
Heart failure in the outpatient versus inpatient setting: findings from the BIOSTAT-CHF study.
Topics: Aged; Disease Progression; Diuretics; Europe; Female; Furosemide; Heart Failure; Hospitalization; Hu | 2019 |
Arrhythmogenic right ventricular dysplasia, cutaneous manifestations and desmoplakin mutation: Carvajal syndrome.
Topics: Adrenergic beta-1 Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Arrhythmogenic Rig | 2018 |
Arrhythmogenic right ventricular dysplasia, cutaneous manifestations and desmoplakin mutation: Carvajal syndrome.
Topics: Adrenergic beta-1 Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Arrhythmogenic Rig | 2018 |
Never trust first impressions when assessing the heart of a pregnant woman.
Topics: Adult; Crisscross Heart; Diuretics; Echocardiography; Female; Fluid Therapy; Furosemide; Heart; Hear | 2019 |
Never trust first impressions when assessing the heart of a pregnant woman.
Topics: Adult; Crisscross Heart; Diuretics; Echocardiography; Female; Fluid Therapy; Furosemide; Heart; Hear | 2019 |
Contemporary Drug Treatment of Chronic Heart Failure With Reduced Ejection Fraction: The CHECK-HF Registry.
Topics: Age Factors; Aged; Aged, 80 and over; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzym | 2019 |
Contemporary Drug Treatment of Chronic Heart Failure With Reduced Ejection Fraction: The CHECK-HF Registry.
Topics: Age Factors; Aged; Aged, 80 and over; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzym | 2019 |
Prevalence and outcome of diuretic resistance in heart failure.
Topics: Aged; Analysis of Variance; Chi-Square Distribution; Drug Resistance; Female; Furosemide; Heart Fail | 2019 |
Prevalence and outcome of diuretic resistance in heart failure.
Topics: Aged; Analysis of Variance; Chi-Square Distribution; Drug Resistance; Female; Furosemide; Heart Fail | 2019 |
Comparative Analysis of Long-Term Outcomes of Torasemide and Furosemide in Heart Failure Patients in Heart Failure Registries of the European Society of Cardiology.
Topics: Aged; Disease Progression; Female; Furosemide; Heart Failure; Humans; Male; Middle Aged; Poland; Rec | 2019 |
Comparative Analysis of Long-Term Outcomes of Torasemide and Furosemide in Heart Failure Patients in Heart Failure Registries of the European Society of Cardiology.
Topics: Aged; Disease Progression; Female; Furosemide; Heart Failure; Humans; Male; Middle Aged; Poland; Rec | 2019 |
Cardiorenal and endocrine effects of synthetic canine BNP1-32 in dogs with compensated congestive heart failure caused by myxomatous mitral valve disease.
Topics: Aldosterone; Animals; Cross-Over Studies; Dog Diseases; Dogs; Furosemide; Heart Failure; Heart Valve | 2019 |
Cardiorenal and endocrine effects of synthetic canine BNP1-32 in dogs with compensated congestive heart failure caused by myxomatous mitral valve disease.
Topics: Aldosterone; Animals; Cross-Over Studies; Dog Diseases; Dogs; Furosemide; Heart Failure; Heart Valve | 2019 |
Death: The Simple Clinical Trial Endpoint.
Topics: Clinical Trials as Topic; Data Collection; Diuretics; Endpoint Determination; Furosemide; Heart Fail | 2019 |
Death: The Simple Clinical Trial Endpoint.
Topics: Clinical Trials as Topic; Data Collection; Diuretics; Endpoint Determination; Furosemide; Heart Fail | 2019 |
Impact of renal dysfunction on the management and outcome of acute heart failure: results from the French prospective, multicentre, DeFSSICA survey.
Topics: Acute Disease; Aged; Aged, 80 and over; Cardio-Renal Syndrome; Comorbidity; Defibrillators; Disease | 2019 |
Impact of renal dysfunction on the management and outcome of acute heart failure: results from the French prospective, multicentre, DeFSSICA survey.
Topics: Acute Disease; Aged; Aged, 80 and over; Cardio-Renal Syndrome; Comorbidity; Defibrillators; Disease | 2019 |
Impact of short-acting loop diuretic doses and cardiac sympathetic nerve abnormalities on outcomes of patients with reduced left ventricular function.
Topics: 3-Iodobenzylguanidine; Aged; Biological Availability; Dose-Response Relationship, Drug; Female; Furo | 2019 |
Impact of short-acting loop diuretic doses and cardiac sympathetic nerve abnormalities on outcomes of patients with reduced left ventricular function.
Topics: 3-Iodobenzylguanidine; Aged; Biological Availability; Dose-Response Relationship, Drug; Female; Furo | 2019 |
Comparative effectiveness of loop diuretics on mortality in the treatment of patients with chronic heart failure - A multicenter propensity score matched analysis.
Topics: Aged; Blood Pressure; Bumetanide; Cause of Death; Europe; Female; Follow-Up Studies; Furosemide; Hea | 2019 |
Comparative effectiveness of loop diuretics on mortality in the treatment of patients with chronic heart failure - A multicenter propensity score matched analysis.
Topics: Aged; Blood Pressure; Bumetanide; Cause of Death; Europe; Female; Follow-Up Studies; Furosemide; Hea | 2019 |
Mechanistic Insights into Loop Diuretic Responsiveness in Heart Failure.
Topics: Albumins; Furosemide; Heart Failure; Humans; Sodium Potassium Chloride Symporter Inhibitors; Urinaly | 2019 |
Mechanistic Insights into Loop Diuretic Responsiveness in Heart Failure.
Topics: Albumins; Furosemide; Heart Failure; Humans; Sodium Potassium Chloride Symporter Inhibitors; Urinaly | 2019 |
Torsemide versus furosemide after acute decompensated heart failure: a retrospective observational study.
Topics: Aged; Drug Substitution; Female; Furosemide; Heart Failure; Humans; Male; Middle Aged; Patient Readm | 2019 |
Torsemide versus furosemide after acute decompensated heart failure: a retrospective observational study.
Topics: Aged; Drug Substitution; Female; Furosemide; Heart Failure; Humans; Male; Middle Aged; Patient Readm | 2019 |
Patterns of diuretic use in the intensive care unit.
Topics: Aged; Diuretics; Dose-Response Relationship, Drug; Female; Furosemide; Heart Failure; Hospital Admin | 2019 |
Patterns of diuretic use in the intensive care unit.
Topics: Aged; Diuretics; Dose-Response Relationship, Drug; Female; Furosemide; Heart Failure; Hospital Admin | 2019 |
Patients With CONgestive Heart Failure Benefit From Long-Term Treatment Effects With Novel Treatment Using Azosemide Compared With Furosemide Derived From Existing Retrospective Study Data: CONTENTED.
Topics: Aged; Aged, 80 and over; Disease Progression; Female; Furosemide; Glomerular Filtration Rate; Heart | 2019 |
Patients With CONgestive Heart Failure Benefit From Long-Term Treatment Effects With Novel Treatment Using Azosemide Compared With Furosemide Derived From Existing Retrospective Study Data: CONTENTED.
Topics: Aged; Aged, 80 and over; Disease Progression; Female; Furosemide; Glomerular Filtration Rate; Heart | 2019 |
Evaluation of Severe Myalgia Induced by Continuous-Infusion Bumetanide in Patients with Acute Heart Failure.
Topics: Bumetanide; Diuretics; Electronic Health Records; Female; Furosemide; Heart Failure; Humans; Inciden | 2019 |
Evaluation of Severe Myalgia Induced by Continuous-Infusion Bumetanide in Patients with Acute Heart Failure.
Topics: Bumetanide; Diuretics; Electronic Health Records; Female; Furosemide; Heart Failure; Humans; Inciden | 2019 |
Temporary left ventricular assist device for complete recovery from reversible acute heart failure due to tumor necrosis factor-α inhibitor.
Topics: Adult; Arthritis; Cardiomyopathy, Dilated; Cardiotonic Agents; Crohn Disease; Etanercept; Female; Fu | 2019 |
Temporary left ventricular assist device for complete recovery from reversible acute heart failure due to tumor necrosis factor-α inhibitor.
Topics: Adult; Arthritis; Cardiomyopathy, Dilated; Cardiotonic Agents; Crohn Disease; Etanercept; Female; Fu | 2019 |
Vascular Protection and Decongestion Without Renin-Angiotensin-Aldosterone System Stimulation Mediated by a Novel Dual-Acting Vasopressin V1a/V2 Receptor Antagonist.
Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Aorta; Arterial Pressure; CHO Cells; Cricetulus; | 2019 |
Vascular Protection and Decongestion Without Renin-Angiotensin-Aldosterone System Stimulation Mediated by a Novel Dual-Acting Vasopressin V1a/V2 Receptor Antagonist.
Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Aorta; Arterial Pressure; CHO Cells; Cricetulus; | 2019 |
Dominance of furosemide for loop diuretic therapy in heart failure: time to revisit the alternatives?
Topics: Databases, Factual; Female; Follow-Up Studies; Furosemide; Heart Failure; Humans; Male; Randomized C | 2013 |
Dominance of furosemide for loop diuretic therapy in heart failure: time to revisit the alternatives?
Topics: Databases, Factual; Female; Follow-Up Studies; Furosemide; Heart Failure; Humans; Male; Randomized C | 2013 |
Comparison of bumetanide- and metolazone-based diuretic regimens to furosemide in acute heart failure.
Topics: Acute Disease; Adult; Aged; Blood Urea Nitrogen; Bumetanide; Cohort Studies; Diuretics; Drug Therapy | 2013 |
Comparison of bumetanide- and metolazone-based diuretic regimens to furosemide in acute heart failure.
Topics: Acute Disease; Adult; Aged; Blood Urea Nitrogen; Bumetanide; Cohort Studies; Diuretics; Drug Therapy | 2013 |
Unilateral lobar pulmonary edema.
Topics: Aged; Anti-Bacterial Agents; Cardiomyopathy, Alcoholic; Ceftriaxone; Clarithromycin; Diagnosis, Diff | 2012 |
Unilateral lobar pulmonary edema.
Topics: Aged; Anti-Bacterial Agents; Cardiomyopathy, Alcoholic; Ceftriaxone; Clarithromycin; Diagnosis, Diff | 2012 |
Case scenario: Hemodynamic management of postoperative acute kidney injury.
Topics: Acute Kidney Injury; Adrenergic alpha-Agonists; Cardiac Output; Central Venous Pressure; Diuretics; | 2013 |
Case scenario: Hemodynamic management of postoperative acute kidney injury.
Topics: Acute Kidney Injury; Adrenergic alpha-Agonists; Cardiac Output; Central Venous Pressure; Diuretics; | 2013 |
Chloride transport-driven alveolar fluid secretion is a major contributor to cardiogenic lung edema.
Topics: Amiloride; Animals; Body Fluids; Chlorides; Cystic Fibrosis Transmembrane Conductance Regulator; Diu | 2013 |
Chloride transport-driven alveolar fluid secretion is a major contributor to cardiogenic lung edema.
Topics: Amiloride; Animals; Body Fluids; Chlorides; Cystic Fibrosis Transmembrane Conductance Regulator; Diu | 2013 |
Pulmonary hypertension and refractory heart failure in a patient with Crow-Fukase (POEMS) syndrome.
Topics: Aged; Dexamethasone; Diuretics; Drug Resistance; Edema; Furosemide; Heart Failure; Humans; Hypertens | 2013 |
Pulmonary hypertension and refractory heart failure in a patient with Crow-Fukase (POEMS) syndrome.
Topics: Aged; Dexamethasone; Diuretics; Drug Resistance; Edema; Furosemide; Heart Failure; Humans; Hypertens | 2013 |
Passive leg movement enhances diuresis and decline of plasma NT-proBNP level in patients with decompensated heart failure treated with furosemide.
Topics: Biomarkers; Diuresis; Diuretics; Furosemide; Heart Failure; Humans; Leg; Motion Therapy, Continuous | 2013 |
Passive leg movement enhances diuresis and decline of plasma NT-proBNP level in patients with decompensated heart failure treated with furosemide.
Topics: Biomarkers; Diuresis; Diuretics; Furosemide; Heart Failure; Humans; Leg; Motion Therapy, Continuous | 2013 |
Ultrafiltration in heart failure with preserved ejection fraction: comparison with systolic heart failure patients.
Topics: Aged; Body Weight; Diuretics; Female; Furosemide; Heart Failure; Humans; Length of Stay; Male; Middl | 2013 |
Ultrafiltration in heart failure with preserved ejection fraction: comparison with systolic heart failure patients.
Topics: Aged; Body Weight; Diuretics; Female; Furosemide; Heart Failure; Humans; Length of Stay; Male; Middl | 2013 |
Effects on survival of loop diuretic dosing in ambulatory patients with chronic heart failure using a propensity score analysis.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Chronic Disease; Dose-Response Relationship, D | 2013 |
Effects on survival of loop diuretic dosing in ambulatory patients with chronic heart failure using a propensity score analysis.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Chronic Disease; Dose-Response Relationship, D | 2013 |
Predisposing factors for acute kidney injury in Hispanic patients treated with diuretics for decompensated heart failure.
Topics: Acute Kidney Injury; Adult; Aged; Blood Urea Nitrogen; Creatinine; Diabetes Mellitus; Drug Utilizati | 2013 |
Predisposing factors for acute kidney injury in Hispanic patients treated with diuretics for decompensated heart failure.
Topics: Acute Kidney Injury; Adult; Aged; Blood Urea Nitrogen; Creatinine; Diabetes Mellitus; Drug Utilizati | 2013 |
Inhaled iloprost plus levosimendan to decompensate right heart failure due to chronic thromboembolic pulmonary hypertension.
Topics: Administration, Inhalation; Critical Care; Diuretics; Furosemide; Heart Failure; Humans; Hydrazones; | 2013 |
Inhaled iloprost plus levosimendan to decompensate right heart failure due to chronic thromboembolic pulmonary hypertension.
Topics: Administration, Inhalation; Critical Care; Diuretics; Furosemide; Heart Failure; Humans; Hydrazones; | 2013 |
Tailoring diuretic therapy in acute heart failure: insight into early diuretic response predictors.
Topics: Acute Disease; Administration, Intravenous; Administration, Oral; Aged; Aged, 80 and over; Diuretics | 2013 |
Tailoring diuretic therapy in acute heart failure: insight into early diuretic response predictors.
Topics: Acute Disease; Administration, Intravenous; Administration, Oral; Aged; Aged, 80 and over; Diuretics | 2013 |
Tolvaptan attenuates left ventricular fibrosis after acute myocardial infarction in rats.
Topics: Acute-Phase Reaction; Animals; Benzazepines; Disease Models, Animal; Drug Therapy, Combination; Fibr | 2013 |
Tolvaptan attenuates left ventricular fibrosis after acute myocardial infarction in rats.
Topics: Acute-Phase Reaction; Animals; Benzazepines; Disease Models, Animal; Drug Therapy, Combination; Fibr | 2013 |
[Acute myocardial infarction complicated by acute pulmonary oedema and cardiogenic collapse during dobutamine stress echocardiography].
Topics: Diabetes Mellitus, Type 2; Diuretics; Echocardiography, Stress; Furosemide; Heart Failure; Humans; M | 2013 |
[Acute myocardial infarction complicated by acute pulmonary oedema and cardiogenic collapse during dobutamine stress echocardiography].
Topics: Diabetes Mellitus, Type 2; Diuretics; Echocardiography, Stress; Furosemide; Heart Failure; Humans; M | 2013 |
Management of acute heart failure and the effect of systolic blood pressure on the use of intravenous therapies.
Topics: Acute Disease; Aged; Analgesics, Opioid; Blood Pressure; Cardiotonic Agents; Chronic Disease; Diseas | 2013 |
Management of acute heart failure and the effect of systolic blood pressure on the use of intravenous therapies.
Topics: Acute Disease; Aged; Analgesics, Opioid; Blood Pressure; Cardiotonic Agents; Chronic Disease; Diseas | 2013 |
Heart failure and diuretic treatment.
Topics: Creatinine; Diuretics; Furosemide; Heart Failure; Humans; Kidney Diseases; Sodium Potassium Chloride | 2013 |
Heart failure and diuretic treatment.
Topics: Creatinine; Diuretics; Furosemide; Heart Failure; Humans; Kidney Diseases; Sodium Potassium Chloride | 2013 |
[Examination of the cause of changing solution color by mixing aminophylline and dopamine, the compatibility of which was indicated by the supplier].
Topics: Aged; Aminophylline; Color; Dopamine; Drug Combinations; Drug Interactions; Furosemide; Heart Failur | 2014 |
[Examination of the cause of changing solution color by mixing aminophylline and dopamine, the compatibility of which was indicated by the supplier].
Topics: Aged; Aminophylline; Color; Dopamine; Drug Combinations; Drug Interactions; Furosemide; Heart Failur | 2014 |
More salt is better: a novel management approach to acute decompensated heart failure.
Topics: Female; Furosemide; Heart Failure; Humans; Male; Sodium Chloride | 2014 |
More salt is better: a novel management approach to acute decompensated heart failure.
Topics: Female; Furosemide; Heart Failure; Humans; Male; Sodium Chloride | 2014 |
Thiamin concentration in geriatric hospitalized patients using frusemide.
Topics: Aged; Aged, 80 and over; Aging; Diuretics; Female; Furosemide; Glomerular Filtration Rate; Heart Fai | 2014 |
Thiamin concentration in geriatric hospitalized patients using frusemide.
Topics: Aged; Aged, 80 and over; Aging; Diuretics; Female; Furosemide; Glomerular Filtration Rate; Heart Fai | 2014 |
Subcutaneous furosemide as palliative treatment in patients with advanced and terminal-phase heart failure.
Topics: Evidence-Based Medicine; Furosemide; Heart Failure; Humans; Palliative Care | 2013 |
Subcutaneous furosemide as palliative treatment in patients with advanced and terminal-phase heart failure.
Topics: Evidence-Based Medicine; Furosemide; Heart Failure; Humans; Palliative Care | 2013 |
Subcutaneous furosemide in advanced heart failure: has clinical practice run ahead of the evidence base?
Topics: Evidence-Based Medicine; Furosemide; Heart Failure; Hospice Care; Humans; Infusions, Subcutaneous; O | 2012 |
Subcutaneous furosemide in advanced heart failure: has clinical practice run ahead of the evidence base?
Topics: Evidence-Based Medicine; Furosemide; Heart Failure; Hospice Care; Humans; Infusions, Subcutaneous; O | 2012 |
Left ventricular systolic dysfunction is where the robust evidence base for heart failure therapy has evolved.
Topics: Evidence-Based Medicine; Furosemide; Heart Failure; Humans; Palliative Care | 2012 |
Left ventricular systolic dysfunction is where the robust evidence base for heart failure therapy has evolved.
Topics: Evidence-Based Medicine; Furosemide; Heart Failure; Humans; Palliative Care | 2012 |
Response to editorial on subcutaneous diuretics.
Topics: Evidence-Based Medicine; Furosemide; Heart Failure; Humans; Palliative Care | 2012 |
Response to editorial on subcutaneous diuretics.
Topics: Evidence-Based Medicine; Furosemide; Heart Failure; Humans; Palliative Care | 2012 |
Surgical correction of an arteriovenous fistula in a ring-tailed lemur (Lemur catta).
Topics: Animals; Arteriovenous Fistula; Diuretics; Female; Femoral Artery; Femoral Vein; Furosemide; Heart F | 2014 |
Surgical correction of an arteriovenous fistula in a ring-tailed lemur (Lemur catta).
Topics: Animals; Arteriovenous Fistula; Diuretics; Female; Femoral Artery; Femoral Vein; Furosemide; Heart F | 2014 |
Insufficient natriuretic response to continuous intravenous furosemide is associated with poor long-term outcomes in acute decompensated heart failure.
Topics: Acute Disease; Adult; Aged; Biomarkers; Cohort Studies; Female; Furosemide; Heart Failure; Humans; I | 2014 |
Insufficient natriuretic response to continuous intravenous furosemide is associated with poor long-term outcomes in acute decompensated heart failure.
Topics: Acute Disease; Adult; Aged; Biomarkers; Cohort Studies; Female; Furosemide; Heart Failure; Humans; I | 2014 |
Prehospital use of furosemide for the treatment of heart failure.
Topics: Adult; Aged; Diuretics; Emergency Medical Services; Female; Furosemide; Heart Failure; Humans; Middl | 2015 |
Prehospital use of furosemide for the treatment of heart failure.
Topics: Adult; Aged; Diuretics; Emergency Medical Services; Female; Furosemide; Heart Failure; Humans; Middl | 2015 |
Optimal decongestive therapy in acute decompensated heart failure syndromes: far from being solved.
Topics: Cardiotonic Agents; Diuretics; Dopamine; Female; Furosemide; Heart Failure; Humans; Male | 2014 |
Optimal decongestive therapy in acute decompensated heart failure syndromes: far from being solved.
Topics: Cardiotonic Agents; Diuretics; Dopamine; Female; Furosemide; Heart Failure; Humans; Male | 2014 |
Dopamine in acute decompensated heart failure: does left ventricular ejection fraction matter?
Topics: Cardiotonic Agents; Diuretics; Dopamine; Female; Furosemide; Heart Failure; Humans; Male | 2014 |
Dopamine in acute decompensated heart failure: does left ventricular ejection fraction matter?
Topics: Cardiotonic Agents; Diuretics; Dopamine; Female; Furosemide; Heart Failure; Humans; Male | 2014 |
Subcutaneous infusion of furosemide administered by elastomeric pumps for decompensated heart failure treatment: initial experience.
Topics: Aged; Aged, 80 and over; Cohort Studies; Diuretics; Dose-Response Relationship, Drug; Drug Administr | 2013 |
Subcutaneous infusion of furosemide administered by elastomeric pumps for decompensated heart failure treatment: initial experience.
Topics: Aged; Aged, 80 and over; Cohort Studies; Diuretics; Dose-Response Relationship, Drug; Drug Administr | 2013 |
Home subcutaneous infusion of furosemide in advanced decompensated heart failure.
Topics: Diuretics; Female; Furosemide; Heart Failure; Humans; Infusions, Subcutaneous; Male | 2014 |
Home subcutaneous infusion of furosemide in advanced decompensated heart failure.
Topics: Diuretics; Female; Furosemide; Heart Failure; Humans; Infusions, Subcutaneous; Male | 2014 |
Home subcutaneous infusion of furosemide in advanced decompensated heart failure. Response.
Topics: Diuretics; Female; Furosemide; Heart Failure; Humans; Infusions, Subcutaneous; Male | 2014 |
Home subcutaneous infusion of furosemide in advanced decompensated heart failure. Response.
Topics: Diuretics; Female; Furosemide; Heart Failure; Humans; Infusions, Subcutaneous; Male | 2014 |
Inferior vena cava diameter change after intravenous furosemide in patients diagnosed with acute decompensated heart failure.
Topics: Acute Disease; Adult; Aged; Aged, 80 and over; Cohort Studies; Diuretics; Female; Furosemide; Heart | 2015 |
Inferior vena cava diameter change after intravenous furosemide in patients diagnosed with acute decompensated heart failure.
Topics: Acute Disease; Adult; Aged; Aged, 80 and over; Cohort Studies; Diuretics; Female; Furosemide; Heart | 2015 |
A 6 year-old boy was referred from a district hospital with congestive cardiac failure.
Topics: Antihypertensive Agents; Diuretics; Echocardiography; Edema; Enalapril; Furosemide; Heart Failure; H | 2013 |
A 6 year-old boy was referred from a district hospital with congestive cardiac failure.
Topics: Antihypertensive Agents; Diuretics; Echocardiography; Edema; Enalapril; Furosemide; Heart Failure; H | 2013 |
Sclederma of Poria cocos exerts its diuretic effect via suppression of renal aquaporin-2 expression in rats with chronic heart failure.
Topics: Administration, Oral; Animals; Aquaporin 2; Arginine Vasopressin; Chronic Disease; Disease Models, A | 2014 |
Sclederma of Poria cocos exerts its diuretic effect via suppression of renal aquaporin-2 expression in rats with chronic heart failure.
Topics: Administration, Oral; Animals; Aquaporin 2; Arginine Vasopressin; Chronic Disease; Disease Models, A | 2014 |
Comparison of the effects of combination diuretic therapy with oral hydrochlorothiazide or intravenous chlorothiazide in patients receiving intravenous furosemide therapy for the treatment of heart failure.
Topics: Administration, Intravenous; Administration, Oral; Aged; Chlorothiazide; Diuretics; Drug Therapy, Co | 2014 |
Comparison of the effects of combination diuretic therapy with oral hydrochlorothiazide or intravenous chlorothiazide in patients receiving intravenous furosemide therapy for the treatment of heart failure.
Topics: Administration, Intravenous; Administration, Oral; Aged; Chlorothiazide; Diuretics; Drug Therapy, Co | 2014 |
Comments on hypertonic saline with furosemide for the treatment of acute congestive heart failure: a systematic review and meta-analysis.
Topics: Diuretics; Furosemide; Heart Failure; Humans; Saline Solution, Hypertonic | 2014 |
Comments on hypertonic saline with furosemide for the treatment of acute congestive heart failure: a systematic review and meta-analysis.
Topics: Diuretics; Furosemide; Heart Failure; Humans; Saline Solution, Hypertonic | 2014 |
Reply: Comments on hypertonic saline with furosemide for the treatment of acute congestive heart failure: a systematic review and meta-analysis.
Topics: Diuretics; Furosemide; Heart Failure; Humans; Saline Solution, Hypertonic | 2014 |
Reply: Comments on hypertonic saline with furosemide for the treatment of acute congestive heart failure: a systematic review and meta-analysis.
Topics: Diuretics; Furosemide; Heart Failure; Humans; Saline Solution, Hypertonic | 2014 |
Poor concordance between different definitions of worsening renal function in patients with acute exacerbation of chronic heart failure: a retrospective study.
Topics: Acute Disease; Administration, Intravenous; Aged; Aged, 80 and over; Chronic Disease; Creatinine; Di | 2016 |
Poor concordance between different definitions of worsening renal function in patients with acute exacerbation of chronic heart failure: a retrospective study.
Topics: Acute Disease; Administration, Intravenous; Aged; Aged, 80 and over; Chronic Disease; Creatinine; Di | 2016 |
[Furosemide bolus in acute heart failure].
Topics: Diuretics; Female; Furosemide; Heart Failure; Humans; Male; Renal Insufficiency | 2014 |
[Furosemide bolus in acute heart failure].
Topics: Diuretics; Female; Furosemide; Heart Failure; Humans; Male; Renal Insufficiency | 2014 |
The diuresis clinic: a new paradigm for the treatment of mild decompensated heart failure.
Topics: Aged; Cost of Illness; Cost-Benefit Analysis; Diuretics; Female; Furosemide; Heart Failure; Hospital | 2015 |
The diuresis clinic: a new paradigm for the treatment of mild decompensated heart failure.
Topics: Aged; Cost of Illness; Cost-Benefit Analysis; Diuretics; Female; Furosemide; Heart Failure; Hospital | 2015 |
The Effect of Furosemide Dose Administered in the Out-of-hospital Setting on Renal Function Among Patients with Suspected Acute Decompensated Heart Failure.
Topics: Aged; Biomarkers; Blood Urea Nitrogen; Comorbidity; Creatinine; Diuretics; Dose-Response Relationshi | 2015 |
The Effect of Furosemide Dose Administered in the Out-of-hospital Setting on Renal Function Among Patients with Suspected Acute Decompensated Heart Failure.
Topics: Aged; Biomarkers; Blood Urea Nitrogen; Comorbidity; Creatinine; Diuretics; Dose-Response Relationshi | 2015 |
Valvular dysplasia and congestive heart failure in a juvenile African penguin (Spheniscus demersus).
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Animals, Zoo; Bird Diseases; Cardiotonic Agents; | 2014 |
Valvular dysplasia and congestive heart failure in a juvenile African penguin (Spheniscus demersus).
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Animals, Zoo; Bird Diseases; Cardiotonic Agents; | 2014 |
Intravenous furosemide in decompensated heart failure: do not protocolize dosing but the desired effect!
Topics: Diuretics; Female; Furosemide; Heart Failure; Humans; Male | 2014 |
Intravenous furosemide in decompensated heart failure: do not protocolize dosing but the desired effect!
Topics: Diuretics; Female; Furosemide; Heart Failure; Humans; Male | 2014 |
Scimitar syndrome with absent right pulmonary artery and severe pulmonary hypertension treated with coil occlusion of aortopulmonary collaterals in a term neonate.
Topics: Cardiac Catheterization; Collateral Circulation; Coronary Angiography; Diuretics; Echocardiography; | 2015 |
Scimitar syndrome with absent right pulmonary artery and severe pulmonary hypertension treated with coil occlusion of aortopulmonary collaterals in a term neonate.
Topics: Cardiac Catheterization; Collateral Circulation; Coronary Angiography; Diuretics; Echocardiography; | 2015 |
[Loop diuretics: old and new ones--which one to choose in clinical practice? Experts' Group Consensus endorsed by the Polish Cardiac Society Working Group on Cardiovascular Pharmacotherapy and Working Group on Heart Failure].
Topics: Cardiology; Furosemide; Heart Failure; Humans; Poland; Societies, Medical; Sodium Potassium Chloride | 2015 |
[Loop diuretics: old and new ones--which one to choose in clinical practice? Experts' Group Consensus endorsed by the Polish Cardiac Society Working Group on Cardiovascular Pharmacotherapy and Working Group on Heart Failure].
Topics: Cardiology; Furosemide; Heart Failure; Humans; Poland; Societies, Medical; Sodium Potassium Chloride | 2015 |
Urine neutrophil gelatinase-associated lipocalin levels predict acute kidney injury in acute decompensated heart failure patients.
Topics: Acute Kidney Injury; Acute-Phase Proteins; Aged; Aged, 80 and over; Biomarkers; Female; Furosemide; | 2015 |
Urine neutrophil gelatinase-associated lipocalin levels predict acute kidney injury in acute decompensated heart failure patients.
Topics: Acute Kidney Injury; Acute-Phase Proteins; Aged; Aged, 80 and over; Biomarkers; Female; Furosemide; | 2015 |
Regression of a large congenital hepatic arteriovenous malformation.
Topics: Arteriovenous Malformations; Captopril; Diuretics; Female; Furosemide; Heart Failure; Hepatic Veins; | 2015 |
Regression of a large congenital hepatic arteriovenous malformation.
Topics: Arteriovenous Malformations; Captopril; Diuretics; Female; Furosemide; Heart Failure; Hepatic Veins; | 2015 |
Oral vasopressin receptor antagonist tolvaptan in right heart failure due to pulmonary hypertension.
Topics: Administration, Oral; Adult; Aged; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Drug Adm | 2015 |
Oral vasopressin receptor antagonist tolvaptan in right heart failure due to pulmonary hypertension.
Topics: Administration, Oral; Adult; Aged; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Drug Adm | 2015 |
Torsemide versus furosemide in heart failure patients: insights from Duke University Hospital.
Topics: Academic Medical Centers; Aged; Comorbidity; Databases, Factual; Female; Furosemide; Heart Failure; | 2015 |
Torsemide versus furosemide in heart failure patients: insights from Duke University Hospital.
Topics: Academic Medical Centers; Aged; Comorbidity; Databases, Factual; Female; Furosemide; Heart Failure; | 2015 |
Variation in Association Between Thiazolidinediones and Heart Failure Across Ethnic Groups: Retrospective analysis of Large Healthcare Claims Databases in Six Countries.
Topics: Databases, Factual; Edema; Ethnicity; Furosemide; Heart Failure; Hospitalization; Humans; Pioglitazo | 2015 |
Variation in Association Between Thiazolidinediones and Heart Failure Across Ethnic Groups: Retrospective analysis of Large Healthcare Claims Databases in Six Countries.
Topics: Databases, Factual; Edema; Ethnicity; Furosemide; Heart Failure; Hospitalization; Humans; Pioglitazo | 2015 |
A combined clinical and biomarker approach to predict diuretic response in acute heart failure.
Topics: Acute Disease; Atherosclerosis; Biomarkers; Clinical Trials, Phase III as Topic; Diuretics; Electrol | 2016 |
A combined clinical and biomarker approach to predict diuretic response in acute heart failure.
Topics: Acute Disease; Atherosclerosis; Biomarkers; Clinical Trials, Phase III as Topic; Diuretics; Electrol | 2016 |
Unsolved challenges in diuretic therapy for acute heart failure: a focus on diuretic response.
Topics: Acute Disease; Atherosclerosis; Diuretics; Dose-Response Relationship, Drug; Furosemide; Heart Failu | 2015 |
Unsolved challenges in diuretic therapy for acute heart failure: a focus on diuretic response.
Topics: Acute Disease; Atherosclerosis; Diuretics; Dose-Response Relationship, Drug; Furosemide; Heart Failu | 2015 |
Mid-Term Administration of Tolvaptan Improves Renal Function Accompanied by Dose-Reduction in Furosemide in Aquaporin-Defined Responders.
Topics: Antidiuretic Hormone Receptor Antagonists; Aquaporins; Arginine Vasopressin; Benzazepines; Diuretics | 2015 |
Mid-Term Administration of Tolvaptan Improves Renal Function Accompanied by Dose-Reduction in Furosemide in Aquaporin-Defined Responders.
Topics: Antidiuretic Hormone Receptor Antagonists; Aquaporins; Arginine Vasopressin; Benzazepines; Diuretics | 2015 |
Enalapril Associated with Furosemide Induced Acute Kidney Injury in an Infant with Heart Failure. A Case Report, a Revision of the Literature and a Pharmacovigilance Database Analysis.
Topics: Acute Kidney Injury; Angiotensin-Converting Enzyme Inhibitors; Diuretics; Drug Interactions; Drug Th | 2016 |
Enalapril Associated with Furosemide Induced Acute Kidney Injury in an Infant with Heart Failure. A Case Report, a Revision of the Literature and a Pharmacovigilance Database Analysis.
Topics: Acute Kidney Injury; Angiotensin-Converting Enzyme Inhibitors; Diuretics; Drug Interactions; Drug Th | 2016 |
Intravenous Diuretic Therapy for the Management of Heart Failure and Volume Overload in a Multidisciplinary Outpatient Unit.
Topics: Aged; Aged, 80 and over; Ambulatory Care; Cardiac Volume; Dose-Response Relationship, Drug; Female; | 2016 |
Intravenous Diuretic Therapy for the Management of Heart Failure and Volume Overload in a Multidisciplinary Outpatient Unit.
Topics: Aged; Aged, 80 and over; Ambulatory Care; Cardiac Volume; Dose-Response Relationship, Drug; Female; | 2016 |
Loop diuretics, renal function and clinical outcome in patients with heart failure and reduced ejection fraction.
Topics: Aged; Aged, 80 and over; Chronic Disease; Dose-Response Relationship, Drug; Female; Furosemide; Glom | 2016 |
Loop diuretics, renal function and clinical outcome in patients with heart failure and reduced ejection fraction.
Topics: Aged; Aged, 80 and over; Chronic Disease; Dose-Response Relationship, Drug; Female; Furosemide; Glom | 2016 |
Epidural anesthesia for cesarean section for pregnant women with rheumatic heart disease and mitral stenosis.
Topics: Adult; Anesthesia, Epidural; Anesthesia, Obstetrical; Anti-Arrhythmia Agents; Cesarean Section; Chin | 2016 |
Epidural anesthesia for cesarean section for pregnant women with rheumatic heart disease and mitral stenosis.
Topics: Adult; Anesthesia, Epidural; Anesthesia, Obstetrical; Anti-Arrhythmia Agents; Cesarean Section; Chin | 2016 |
Renal function on admission modifies prognostic impact of diuretics in acute heart failure: a propensity score matched and interaction analysis.
Topics: Acute Disease; Administration, Intravenous; Aged; Aged, 80 and over; Chi-Square Distribution; Diuret | 2016 |
Renal function on admission modifies prognostic impact of diuretics in acute heart failure: a propensity score matched and interaction analysis.
Topics: Acute Disease; Administration, Intravenous; Aged; Aged, 80 and over; Chi-Square Distribution; Diuret | 2016 |
Prevalence of thiamine deficiency in a stable heart failure outpatient cohort on standard loop diuretic therapy.
Topics: Aged; Cross-Sectional Studies; Diuretics; Female; Furosemide; Heart Failure; Humans; Male; Outpatien | 2016 |
Prevalence of thiamine deficiency in a stable heart failure outpatient cohort on standard loop diuretic therapy.
Topics: Aged; Cross-Sectional Studies; Diuretics; Female; Furosemide; Heart Failure; Humans; Male; Outpatien | 2016 |
Worsening heart failure in 'real-world' clinical practice: predictors and prognostic impact.
Topics: Acute Disease; Adrenergic beta-Antagonists; Cardiotonic Agents; Disease Progression; Diuretics; Drug | 2017 |
Worsening heart failure in 'real-world' clinical practice: predictors and prognostic impact.
Topics: Acute Disease; Adrenergic beta-Antagonists; Cardiotonic Agents; Disease Progression; Diuretics; Drug | 2017 |
Acute reversible cardiomyopathy and heart failure in a child with acute adrenal crisis.
Topics: Adrenal Insufficiency; Autoimmune Diseases; Cardiomyopathies; Child; Female; Furosemide; Heart Failu | 2017 |
Acute reversible cardiomyopathy and heart failure in a child with acute adrenal crisis.
Topics: Adrenal Insufficiency; Autoimmune Diseases; Cardiomyopathies; Child; Female; Furosemide; Heart Failu | 2017 |
Hypertonic saline with furosemide for diuretic resistant congestive heart failure in an infant.
Topics: Diuretics; Drug Therapy, Combination; Female; Furosemide; Heart Failure; Humans; Infant; Pregnancy; | 2016 |
Hypertonic saline with furosemide for diuretic resistant congestive heart failure in an infant.
Topics: Diuretics; Drug Therapy, Combination; Female; Furosemide; Heart Failure; Humans; Infant; Pregnancy; | 2016 |
A systems BIOlogy Study to TAilored Treatment in Chronic Heart Failure: rationale, design, and baseline characteristics of BIOSTAT-CHF.
Topics: Adrenergic beta-Antagonists; Aged; Aged, 80 and over; Angiotensin Receptor Antagonists; Angiotensin- | 2016 |
A systems BIOlogy Study to TAilored Treatment in Chronic Heart Failure: rationale, design, and baseline characteristics of BIOSTAT-CHF.
Topics: Adrenergic beta-Antagonists; Aged; Aged, 80 and over; Angiotensin Receptor Antagonists; Angiotensin- | 2016 |
Comparison of salt with low-dose furosemide and carperitide for treating acute decompensated heart failure: a single-center retrospective cohort study.
Topics: Acute Disease; Aged; Aged, 80 and over; Atrial Natriuretic Factor; Costs and Cost Analysis; Diuretic | 2017 |
Comparison of salt with low-dose furosemide and carperitide for treating acute decompensated heart failure: a single-center retrospective cohort study.
Topics: Acute Disease; Aged; Aged, 80 and over; Atrial Natriuretic Factor; Costs and Cost Analysis; Diuretic | 2017 |
Clinical and echocardiographic characteristics and outcomes in congestive heart failure at the Hospital of The State University of Haiti.
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Age Distribution; Aged; Aged, 80 and over; Angiotens | 2016 |
Clinical and echocardiographic characteristics and outcomes in congestive heart failure at the Hospital of The State University of Haiti.
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Age Distribution; Aged; Aged, 80 and over; Angiotens | 2016 |
Usefulness of the thrombolysis in myocardial infarction risk index in acute heart failure: a pilot study.
Topics: Acute Disease; Adult; Age Factors; Blood Pressure; Blood Urea Nitrogen; C-Reactive Protein; Diuretic | 2016 |
Usefulness of the thrombolysis in myocardial infarction risk index in acute heart failure: a pilot study.
Topics: Acute Disease; Adult; Age Factors; Blood Pressure; Blood Urea Nitrogen; C-Reactive Protein; Diuretic | 2016 |
Comparative effects of torasemide and furosemide on gap junction proteins and cardiac fibrosis in a rat model of dilated cardiomyopathy.
Topics: Animals; Cadherins; Cardiac Myosins; Cardiomyopathy, Dilated; Connexin 43; Connexins; Disease Models | 2017 |
Comparative effects of torasemide and furosemide on gap junction proteins and cardiac fibrosis in a rat model of dilated cardiomyopathy.
Topics: Animals; Cadherins; Cardiac Myosins; Cardiomyopathy, Dilated; Connexin 43; Connexins; Disease Models | 2017 |
Right Heart Failure in an African Penguin ( Spheniscus demersus ).
Topics: Animals; Bird Diseases; Cardiovascular Agents; Diuretics; Fatal Outcome; Furosemide; Heart Failure; | 2016 |
Right Heart Failure in an African Penguin ( Spheniscus demersus ).
Topics: Animals; Bird Diseases; Cardiovascular Agents; Diuretics; Fatal Outcome; Furosemide; Heart Failure; | 2016 |
What Is Your Diagnosis?
Topics: Animals; Aortic Dissection; Cat Diseases; Cats; Echocardiography; Enalapril; Furosemide; Heart Failu | 2017 |
What Is Your Diagnosis?
Topics: Animals; Aortic Dissection; Cat Diseases; Cats; Echocardiography; Enalapril; Furosemide; Heart Failu | 2017 |
Hydrochlorothiazide modulates ischemic heart failure-induced cardiac remodeling via inhibiting angiotensin II type 1 receptor pathway in rats.
Topics: Aldosterone; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Animals, Newborn; Cel | 2017 |
Hydrochlorothiazide modulates ischemic heart failure-induced cardiac remodeling via inhibiting angiotensin II type 1 receptor pathway in rats.
Topics: Aldosterone; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Animals, Newborn; Cel | 2017 |
Early Postdischarge STOP-HF-Clinic Reduces 30-day Readmissions in Old and Frail Patients With Heart Failure.
Topics: Aged; Aged, 80 and over; Ambulatory Care; Cardiotonic Agents; Diuretics; Erythrocyte Transfusion; Fe | 2017 |
Early Postdischarge STOP-HF-Clinic Reduces 30-day Readmissions in Old and Frail Patients With Heart Failure.
Topics: Aged; Aged, 80 and over; Ambulatory Care; Cardiotonic Agents; Diuretics; Erythrocyte Transfusion; Fe | 2017 |
[Heart failure provoked by a pacemaker lead-induced tricuspid stenosis].
Topics: Aged; Angiography; Diuretics; Echocardiography; Furosemide; Heart Failure; Humans; Male; Pacemaker, | 2017 |
[Heart failure provoked by a pacemaker lead-induced tricuspid stenosis].
Topics: Aged; Angiography; Diuretics; Echocardiography; Furosemide; Heart Failure; Humans; Male; Pacemaker, | 2017 |
The association between high-dose diuretics and clinical stability in ambulatory chronic heart failure patients.
Topics: Ambulatory Care; Ambulatory Care Facilities; Antihypertensive Agents; Bumetanide; Comorbidity; Diure | 2008 |
The association between high-dose diuretics and clinical stability in ambulatory chronic heart failure patients.
Topics: Ambulatory Care; Ambulatory Care Facilities; Antihypertensive Agents; Bumetanide; Comorbidity; Diure | 2008 |
The association between high-dose diuretics and clinical stability in ambulatory chronic heart failure patients.
Topics: Ambulatory Care; Ambulatory Care Facilities; Antihypertensive Agents; Bumetanide; Comorbidity; Diure | 2008 |
The association between high-dose diuretics and clinical stability in ambulatory chronic heart failure patients.
Topics: Ambulatory Care; Ambulatory Care Facilities; Antihypertensive Agents; Bumetanide; Comorbidity; Diure | 2008 |
The association between high-dose diuretics and clinical stability in ambulatory chronic heart failure patients.
Topics: Ambulatory Care; Ambulatory Care Facilities; Antihypertensive Agents; Bumetanide; Comorbidity; Diure | 2008 |
The association between high-dose diuretics and clinical stability in ambulatory chronic heart failure patients.
Topics: Ambulatory Care; Ambulatory Care Facilities; Antihypertensive Agents; Bumetanide; Comorbidity; Diure | 2008 |
The association between high-dose diuretics and clinical stability in ambulatory chronic heart failure patients.
Topics: Ambulatory Care; Ambulatory Care Facilities; Antihypertensive Agents; Bumetanide; Comorbidity; Diure | 2008 |
The association between high-dose diuretics and clinical stability in ambulatory chronic heart failure patients.
Topics: Ambulatory Care; Ambulatory Care Facilities; Antihypertensive Agents; Bumetanide; Comorbidity; Diure | 2008 |
Hyperthyroidism as a reversible cause of right ventricular overload and congestive heart failure.
Topics: Adrenergic beta-Antagonists; Drug Therapy, Combination; Dyspnea; Echocardiography, Transesophageal; | 2008 |
Hyperthyroidism as a reversible cause of right ventricular overload and congestive heart failure.
Topics: Adrenergic beta-Antagonists; Drug Therapy, Combination; Dyspnea; Echocardiography, Transesophageal; | 2008 |
Bilateral pleural effusions in congestive heart failure.
Topics: Cardiomyopathy, Dilated; Diuretics; Furosemide; Heart Failure; Humans; Hydrothorax; Male; Middle Age | 2008 |
Bilateral pleural effusions in congestive heart failure.
Topics: Cardiomyopathy, Dilated; Diuretics; Furosemide; Heart Failure; Humans; Hydrothorax; Male; Middle Age | 2008 |
The pathophysiology of acute heart failure: the key role of fluid accumulation.
Topics: Acute Disease; Diuretics; Edema, Cardiac; Furosemide; Heart Failure; Hemodynamics; Humans | 2008 |
The pathophysiology of acute heart failure: the key role of fluid accumulation.
Topics: Acute Disease; Diuretics; Edema, Cardiac; Furosemide; Heart Failure; Hemodynamics; Humans | 2008 |
Rural treatment of acute cardiogenic pulmonary edema: applying the evidence to achieve success with failure.
Topics: Acute Disease; Angiotensin-Converting Enzyme Inhibitors; Benzodiazepines; Captopril; Continuous Posi | 2008 |
Rural treatment of acute cardiogenic pulmonary edema: applying the evidence to achieve success with failure.
Topics: Acute Disease; Angiotensin-Converting Enzyme Inhibitors; Benzodiazepines; Captopril; Continuous Posi | 2008 |
Impact of intravenous loop diuretics on outcomes of patients hospitalized with acute decompensated heart failure: insights from the ADHERE registry.
Topics: Aged; Aged, 80 and over; Female; Furosemide; Heart Failure; Humans; Infusions, Intravenous; Kidney; | 2009 |
Impact of intravenous loop diuretics on outcomes of patients hospitalized with acute decompensated heart failure: insights from the ADHERE registry.
Topics: Aged; Aged, 80 and over; Female; Furosemide; Heart Failure; Humans; Infusions, Intravenous; Kidney; | 2009 |
Impact of intravenous loop diuretics on outcomes of patients hospitalized with acute decompensated heart failure: insights from the ADHERE registry.
Topics: Aged; Aged, 80 and over; Female; Furosemide; Heart Failure; Humans; Infusions, Intravenous; Kidney; | 2009 |
Impact of intravenous loop diuretics on outcomes of patients hospitalized with acute decompensated heart failure: insights from the ADHERE registry.
Topics: Aged; Aged, 80 and over; Female; Furosemide; Heart Failure; Humans; Infusions, Intravenous; Kidney; | 2009 |
Impact of intravenous loop diuretics on outcomes of patients hospitalized with acute decompensated heart failure: insights from the ADHERE registry.
Topics: Aged; Aged, 80 and over; Female; Furosemide; Heart Failure; Humans; Infusions, Intravenous; Kidney; | 2009 |
Impact of intravenous loop diuretics on outcomes of patients hospitalized with acute decompensated heart failure: insights from the ADHERE registry.
Topics: Aged; Aged, 80 and over; Female; Furosemide; Heart Failure; Humans; Infusions, Intravenous; Kidney; | 2009 |
Impact of intravenous loop diuretics on outcomes of patients hospitalized with acute decompensated heart failure: insights from the ADHERE registry.
Topics: Aged; Aged, 80 and over; Female; Furosemide; Heart Failure; Humans; Infusions, Intravenous; Kidney; | 2009 |
Impact of intravenous loop diuretics on outcomes of patients hospitalized with acute decompensated heart failure: insights from the ADHERE registry.
Topics: Aged; Aged, 80 and over; Female; Furosemide; Heart Failure; Humans; Infusions, Intravenous; Kidney; | 2009 |
The effect of cardiovascular drugs on pro-inflammatory cytokine secretion and natural killer activity of peripheral blood mononuclear cells of patients with chronic heart failure in vitro.
Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Cytokines; Diuretics; Female; Furosemide; Heart | 2007 |
The effect of cardiovascular drugs on pro-inflammatory cytokine secretion and natural killer activity of peripheral blood mononuclear cells of patients with chronic heart failure in vitro.
Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Cytokines; Diuretics; Female; Furosemide; Heart | 2007 |
[Use of intermittent ultrafiltration in decompensated, diuretic-resistant heart failure--six case reports].
Topics: Aged; Diuretics; Drug Resistance; Female; Furosemide; Heart Failure; Hemofiltration; Humans; Male; M | 2008 |
[Use of intermittent ultrafiltration in decompensated, diuretic-resistant heart failure--six case reports].
Topics: Aged; Diuretics; Drug Resistance; Female; Furosemide; Heart Failure; Hemofiltration; Humans; Male; M | 2008 |
Reversible myocardial dysfunction in a young woman with metastatic renal cell carcinoma treated with sunitinib.
Topics: Adrenergic beta-Antagonists; Adult; Antineoplastic Agents; Blood Pressure; Carcinoma, Renal Cell; Di | 2009 |
Reversible myocardial dysfunction in a young woman with metastatic renal cell carcinoma treated with sunitinib.
Topics: Adrenergic beta-Antagonists; Adult; Antineoplastic Agents; Blood Pressure; Carcinoma, Renal Cell; Di | 2009 |
Med under scrutiny: the declining roles of furosemide, morphine & beta blockers in prehospital care.
Topics: Adrenergic beta-Antagonists; Analgesics, Opioid; Diuretics; Emergency Medical Services; Furosemide; | 2009 |
Med under scrutiny: the declining roles of furosemide, morphine & beta blockers in prehospital care.
Topics: Adrenergic beta-Antagonists; Analgesics, Opioid; Diuretics; Emergency Medical Services; Furosemide; | 2009 |
[Renal effect of treatment for heart failure].
Topics: Angiotensin-Converting Enzyme Inhibitors; Cardiomyopathies; Diuretics; Furosemide; Heart Failure; Hu | 2009 |
[Renal effect of treatment for heart failure].
Topics: Angiotensin-Converting Enzyme Inhibitors; Cardiomyopathies; Diuretics; Furosemide; Heart Failure; Hu | 2009 |
Acutely decompensated systolic heart failure: effects of frequent doses of furosemide vs a single dose plus carvedilol on clinical status, neurohormonal activation and ventricular arrhythmias.
Topics: Acute Disease; Adrenergic beta-Antagonists; Carbazoles; Carvedilol; Diuretics; Drug Administration S | 2010 |
Acutely decompensated systolic heart failure: effects of frequent doses of furosemide vs a single dose plus carvedilol on clinical status, neurohormonal activation and ventricular arrhythmias.
Topics: Acute Disease; Adrenergic beta-Antagonists; Carbazoles; Carvedilol; Diuretics; Drug Administration S | 2010 |
Loop diuretics in patients with heart failure: time to change to torsemide?
Topics: Diuretics; Furosemide; Heart Failure; Humans; Sodium Potassium Chloride Symporter Inhibitors; Sulfon | 2009 |
Loop diuretics in patients with heart failure: time to change to torsemide?
Topics: Diuretics; Furosemide; Heart Failure; Humans; Sodium Potassium Chloride Symporter Inhibitors; Sulfon | 2009 |
[Effects of various diuretics on cardiac function in rats with heart failure].
Topics: Animals; Cytochrome P-450 CYP11B2; Disease Models, Animal; Diuretics; Furosemide; Heart Failure; Hem | 2009 |
[Effects of various diuretics on cardiac function in rats with heart failure].
Topics: Animals; Cytochrome P-450 CYP11B2; Disease Models, Animal; Diuretics; Furosemide; Heart Failure; Hem | 2009 |
Triple therapy can achieve striking reductions in frusemide dosage.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Diuretics; Drug Therapy, Combination; Female; Furose | 2009 |
Triple therapy can achieve striking reductions in frusemide dosage.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Diuretics; Drug Therapy, Combination; Female; Furose | 2009 |
[Suspected case of peripartum cardiomyopathy developed during elective cesarean section].
Topics: Adult; Anesthesia, Epidural; Anesthesia, Obstetrical; Anesthesia, Spinal; Cardiomyopathies; Cesarean | 2009 |
[Suspected case of peripartum cardiomyopathy developed during elective cesarean section].
Topics: Adult; Anesthesia, Epidural; Anesthesia, Obstetrical; Anesthesia, Spinal; Cardiomyopathies; Cesarean | 2009 |
Complications during enalapril and diuretic therapy for congestive cardiac failure.
Topics: Angiotensin-Converting Enzyme Inhibitors; Cardiotonic Agents; Digoxin; Diuretics; Drug Therapy, Comb | 2009 |
Complications during enalapril and diuretic therapy for congestive cardiac failure.
Topics: Angiotensin-Converting Enzyme Inhibitors; Cardiotonic Agents; Digoxin; Diuretics; Drug Therapy, Comb | 2009 |
Urocortin 2 inhibits furosemide-induced activation of renin and enhances renal function and diuretic responsiveness in experimental heart failure.
Topics: Aldosterone; Animals; Biomarkers; Cardiac Pacing, Artificial; Cardiovascular Agents; Corticotropin-R | 2009 |
Urocortin 2 inhibits furosemide-induced activation of renin and enhances renal function and diuretic responsiveness in experimental heart failure.
Topics: Aldosterone; Animals; Biomarkers; Cardiac Pacing, Artificial; Cardiovascular Agents; Corticotropin-R | 2009 |
[First decompensated heart failure. Then suddenly blisters develop on the whole body].
Topics: Adrenal Cortex Hormones; Age Factors; Aged, 80 and over; Angiotensin-Converting Enzyme Inhibitors; A | 2009 |
[First decompensated heart failure. Then suddenly blisters develop on the whole body].
Topics: Adrenal Cortex Hormones; Age Factors; Aged, 80 and over; Angiotensin-Converting Enzyme Inhibitors; A | 2009 |
Differential impact of NSAIDs on rate of adverse events that require hospitalization in high-risk and general veteran populations: a retrospective cohort study.
Topics: Aged; Aged, 80 and over; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhi | 2010 |
Differential impact of NSAIDs on rate of adverse events that require hospitalization in high-risk and general veteran populations: a retrospective cohort study.
Topics: Aged; Aged, 80 and over; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhi | 2010 |
Novel therapeutic option for refractory heart failure in elderly patients with chronic kidney disease by incremental peritoneal dialysis.
Topics: Aged; Aged, 80 and over; Aldosterone; Diuretics; Female; Furosemide; Heart Failure; Hemofiltration; | 2010 |
Novel therapeutic option for refractory heart failure in elderly patients with chronic kidney disease by incremental peritoneal dialysis.
Topics: Aged; Aged, 80 and over; Aldosterone; Diuretics; Female; Furosemide; Heart Failure; Hemofiltration; | 2010 |
Combined amiodarone and low-dose carvedilol treatment for severe heart failure in childhood.
Topics: Adolescent; Amiodarone; Anti-Arrhythmia Agents; Carbazoles; Cardiomyopathy, Dilated; Carvedilol; Dos | 2010 |
Combined amiodarone and low-dose carvedilol treatment for severe heart failure in childhood.
Topics: Adolescent; Amiodarone; Anti-Arrhythmia Agents; Carbazoles; Cardiomyopathy, Dilated; Carvedilol; Dos | 2010 |
Changes in natriuretic peptide and cytokine plasma levels in patients with heart failure, after treatment with high dose of furosemide plus hypertonic saline solution (HSS) and after a saline loading.
Topics: Aged; Aged, 80 and over; Case-Control Studies; Cytokines; Female; Furosemide; Heart Failure; Humans; | 2011 |
Changes in natriuretic peptide and cytokine plasma levels in patients with heart failure, after treatment with high dose of furosemide plus hypertonic saline solution (HSS) and after a saline loading.
Topics: Aged; Aged, 80 and over; Case-Control Studies; Cytokines; Female; Furosemide; Heart Failure; Humans; | 2011 |
Changes in natriuretic peptide and cytokine plasma levels in patients with heart failure, after treatment with high dose of furosemide plus hypertonic saline solution (HSS) and after a saline loading.
Topics: Aged; Aged, 80 and over; Case-Control Studies; Cytokines; Female; Furosemide; Heart Failure; Humans; | 2011 |
Changes in natriuretic peptide and cytokine plasma levels in patients with heart failure, after treatment with high dose of furosemide plus hypertonic saline solution (HSS) and after a saline loading.
Topics: Aged; Aged, 80 and over; Case-Control Studies; Cytokines; Female; Furosemide; Heart Failure; Humans; | 2011 |
Changes in natriuretic peptide and cytokine plasma levels in patients with heart failure, after treatment with high dose of furosemide plus hypertonic saline solution (HSS) and after a saline loading.
Topics: Aged; Aged, 80 and over; Case-Control Studies; Cytokines; Female; Furosemide; Heart Failure; Humans; | 2011 |
Changes in natriuretic peptide and cytokine plasma levels in patients with heart failure, after treatment with high dose of furosemide plus hypertonic saline solution (HSS) and after a saline loading.
Topics: Aged; Aged, 80 and over; Case-Control Studies; Cytokines; Female; Furosemide; Heart Failure; Humans; | 2011 |
Changes in natriuretic peptide and cytokine plasma levels in patients with heart failure, after treatment with high dose of furosemide plus hypertonic saline solution (HSS) and after a saline loading.
Topics: Aged; Aged, 80 and over; Case-Control Studies; Cytokines; Female; Furosemide; Heart Failure; Humans; | 2011 |
Changes in natriuretic peptide and cytokine plasma levels in patients with heart failure, after treatment with high dose of furosemide plus hypertonic saline solution (HSS) and after a saline loading.
Topics: Aged; Aged, 80 and over; Case-Control Studies; Cytokines; Female; Furosemide; Heart Failure; Humans; | 2011 |
Changes in natriuretic peptide and cytokine plasma levels in patients with heart failure, after treatment with high dose of furosemide plus hypertonic saline solution (HSS) and after a saline loading.
Topics: Aged; Aged, 80 and over; Case-Control Studies; Cytokines; Female; Furosemide; Heart Failure; Humans; | 2011 |
Changes in natriuretic peptide and cytokine plasma levels in patients with heart failure, after treatment with high dose of furosemide plus hypertonic saline solution (HSS) and after a saline loading.
Topics: Aged; Aged, 80 and over; Case-Control Studies; Cytokines; Female; Furosemide; Heart Failure; Humans; | 2011 |
Changes in natriuretic peptide and cytokine plasma levels in patients with heart failure, after treatment with high dose of furosemide plus hypertonic saline solution (HSS) and after a saline loading.
Topics: Aged; Aged, 80 and over; Case-Control Studies; Cytokines; Female; Furosemide; Heart Failure; Humans; | 2011 |
Changes in natriuretic peptide and cytokine plasma levels in patients with heart failure, after treatment with high dose of furosemide plus hypertonic saline solution (HSS) and after a saline loading.
Topics: Aged; Aged, 80 and over; Case-Control Studies; Cytokines; Female; Furosemide; Heart Failure; Humans; | 2011 |
Changes in natriuretic peptide and cytokine plasma levels in patients with heart failure, after treatment with high dose of furosemide plus hypertonic saline solution (HSS) and after a saline loading.
Topics: Aged; Aged, 80 and over; Case-Control Studies; Cytokines; Female; Furosemide; Heart Failure; Humans; | 2011 |
Changes in natriuretic peptide and cytokine plasma levels in patients with heart failure, after treatment with high dose of furosemide plus hypertonic saline solution (HSS) and after a saline loading.
Topics: Aged; Aged, 80 and over; Case-Control Studies; Cytokines; Female; Furosemide; Heart Failure; Humans; | 2011 |
Changes in natriuretic peptide and cytokine plasma levels in patients with heart failure, after treatment with high dose of furosemide plus hypertonic saline solution (HSS) and after a saline loading.
Topics: Aged; Aged, 80 and over; Case-Control Studies; Cytokines; Female; Furosemide; Heart Failure; Humans; | 2011 |
Changes in natriuretic peptide and cytokine plasma levels in patients with heart failure, after treatment with high dose of furosemide plus hypertonic saline solution (HSS) and after a saline loading.
Topics: Aged; Aged, 80 and over; Case-Control Studies; Cytokines; Female; Furosemide; Heart Failure; Humans; | 2011 |
Changes in natriuretic peptide and cytokine plasma levels in patients with heart failure, after treatment with high dose of furosemide plus hypertonic saline solution (HSS) and after a saline loading.
Topics: Aged; Aged, 80 and over; Case-Control Studies; Cytokines; Female; Furosemide; Heart Failure; Humans; | 2011 |
Changes in natriuretic peptide and cytokine plasma levels in patients with heart failure, after treatment with high dose of furosemide plus hypertonic saline solution (HSS) and after a saline loading.
Topics: Aged; Aged, 80 and over; Case-Control Studies; Cytokines; Female; Furosemide; Heart Failure; Humans; | 2011 |
Meals ready to eat: a brief history and clinical vignette with discussion on civilian applications.
Topics: Aged; Diagnosis, Differential; Diet, Sodium-Restricted; Disaster Medicine; Disasters; Diuretics; Ech | 2010 |
Meals ready to eat: a brief history and clinical vignette with discussion on civilian applications.
Topics: Aged; Diagnosis, Differential; Diet, Sodium-Restricted; Disaster Medicine; Disasters; Diuretics; Ech | 2010 |
Warning on diuretic use.
Topics: Aged; Aged, 80 and over; Angiotensin-Converting Enzyme Inhibitors; Chronic Disease; Cohort Studies; | 2010 |
Warning on diuretic use.
Topics: Aged; Aged, 80 and over; Angiotensin-Converting Enzyme Inhibitors; Chronic Disease; Cohort Studies; | 2010 |
Diagnosis and treatment of congestive heart failure secondary to hypertrophic cardiomyopathy in a kinkajou (Potos flavus).
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Anti-Infective Agents; Cardiomyopathy, Hypertroph | 2010 |
Diagnosis and treatment of congestive heart failure secondary to hypertrophic cardiomyopathy in a kinkajou (Potos flavus).
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Anti-Infective Agents; Cardiomyopathy, Hypertroph | 2010 |
Evaluation of acute congestive heart failure in dogs and cats: 145 cases (2007-2008).
Topics: Acute Disease; Animals; Cat Diseases; Cats; Diuretics; Dog Diseases; Dogs; Female; Furosemide; Heart | 2010 |
Evaluation of acute congestive heart failure in dogs and cats: 145 cases (2007-2008).
Topics: Acute Disease; Animals; Cat Diseases; Cats; Diuretics; Dog Diseases; Dogs; Female; Furosemide; Heart | 2010 |
[Application of cardiac resynchronization therapy and ivabradine in a patient with chronic heart failure].
Topics: Benzazepines; Cardiac Resynchronization Therapy; Cardiac Resynchronization Therapy Devices; Cardiova | 2010 |
[Application of cardiac resynchronization therapy and ivabradine in a patient with chronic heart failure].
Topics: Benzazepines; Cardiac Resynchronization Therapy; Cardiac Resynchronization Therapy Devices; Cardiova | 2010 |
Diuretic dose and long-term outcomes in elderly patients with heart failure after hospitalization.
Topics: Aged; Aged, 80 and over; Diuretics; Dose-Response Relationship, Drug; Female; Furosemide; Heart Fail | 2010 |
Diuretic dose and long-term outcomes in elderly patients with heart failure after hospitalization.
Topics: Aged; Aged, 80 and over; Diuretics; Dose-Response Relationship, Drug; Female; Furosemide; Heart Fail | 2010 |
A 19-year-old woman with intracranial hemorrhage and diffuse pulmonary infiltrates.
Topics: Diagnosis, Differential; Diuretics; Female; Furosemide; Heart Failure; Humans; Intracranial Hemorrha | 2010 |
A 19-year-old woman with intracranial hemorrhage and diffuse pulmonary infiltrates.
Topics: Diagnosis, Differential; Diuretics; Female; Furosemide; Heart Failure; Humans; Intracranial Hemorrha | 2010 |
Nebulised frusemide for the symptomatic treatment of end-stage congestive heart failure.
Topics: Aged, 80 and over; Diuretics; Dyspnea; Furosemide; Heart Failure; Humans; Male; Nebulizers and Vapor | 2010 |
Nebulised frusemide for the symptomatic treatment of end-stage congestive heart failure.
Topics: Aged, 80 and over; Diuretics; Dyspnea; Furosemide; Heart Failure; Humans; Male; Nebulizers and Vapor | 2010 |
Severe tricuspid regurgitation in a patient receiving low-dose cabergoline for the treatment of acromegaly.
Topics: Acromegaly; Cabergoline; Diuretics; Echocardiography, Doppler, Color; Ergolines; Female; Furosemide; | 2010 |
Severe tricuspid regurgitation in a patient receiving low-dose cabergoline for the treatment of acromegaly.
Topics: Acromegaly; Cabergoline; Diuretics; Echocardiography, Doppler, Color; Ergolines; Female; Furosemide; | 2010 |
Management of diuretic treatment: a challenge in the obese patient.
Topics: Acute Kidney Injury; Aged; Biomarkers; Comorbidity; Creatinine; Diuretics; Drug Overdose; Furosemide | 2011 |
Management of diuretic treatment: a challenge in the obese patient.
Topics: Acute Kidney Injury; Aged; Biomarkers; Comorbidity; Creatinine; Diuretics; Drug Overdose; Furosemide | 2011 |
In chronic heart failure with marked fluid retention, the i.v. high doses of loop diuretic are a predictor of aggravated renal dysfunction, especially in the set of heart failure with normal or only mildly impaired left ventricular systolic function.
Topics: Aged; Aged, 80 and over; Algorithms; Analysis of Variance; Biomarkers; Case-Control Studies; Chronic | 2011 |
In chronic heart failure with marked fluid retention, the i.v. high doses of loop diuretic are a predictor of aggravated renal dysfunction, especially in the set of heart failure with normal or only mildly impaired left ventricular systolic function.
Topics: Aged; Aged, 80 and over; Algorithms; Analysis of Variance; Biomarkers; Case-Control Studies; Chronic | 2011 |
Prognostic implications of diuretic dose in chronic heart failure.
Topics: Aged; Aged, 80 and over; Chronic Disease; Cohort Studies; Diuretics; Dose-Response Relationship, Dru | 2011 |
Prognostic implications of diuretic dose in chronic heart failure.
Topics: Aged; Aged, 80 and over; Chronic Disease; Cohort Studies; Diuretics; Dose-Response Relationship, Dru | 2011 |
Comparative effectiveness of diuretic regimens.
Topics: Acute Disease; Comparative Effectiveness Research; Drug Administration Schedule; Furosemide; Heart F | 2011 |
Comparative effectiveness of diuretic regimens.
Topics: Acute Disease; Comparative Effectiveness Research; Drug Administration Schedule; Furosemide; Heart F | 2011 |
The furosemide diagnostic test in suspected slow-onset heart failure: popular but not useful.
Topics: Aged; Female; Furosemide; General Practice; Heart Failure; Humans; Logistic Models; Male; Middle Age | 2011 |
The furosemide diagnostic test in suspected slow-onset heart failure: popular but not useful.
Topics: Aged; Female; Furosemide; General Practice; Heart Failure; Humans; Logistic Models; Male; Middle Age | 2011 |
Time to ferry heart failure onto new shores: the need to effectively customize long-term therapy.
Topics: Disease Progression; Diuretics; Furosemide; Heart Failure; Humans; Treatment Outcome | 2011 |
Time to ferry heart failure onto new shores: the need to effectively customize long-term therapy.
Topics: Disease Progression; Diuretics; Furosemide; Heart Failure; Humans; Treatment Outcome | 2011 |
Effect of adding nitroglycerin to early diuretic therapy on the morbidity and mortality of patients with chronic kidney disease presenting with acute decompensated heart failure.
Topics: Aged; Chi-Square Distribution; Cross-Sectional Studies; Emergency Service, Hospital; Female; Furosem | 2011 |
Effect of adding nitroglycerin to early diuretic therapy on the morbidity and mortality of patients with chronic kidney disease presenting with acute decompensated heart failure.
Topics: Aged; Chi-Square Distribution; Cross-Sectional Studies; Emergency Service, Hospital; Female; Furosem | 2011 |
Furosemide induces mortality in a rat model of chronic heart failure.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Chronic Disease; Disease Models, Animal; Diuretic | 2012 |
Furosemide induces mortality in a rat model of chronic heart failure.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Chronic Disease; Disease Models, Animal; Diuretic | 2012 |
Diuretic strategies in patients with acute heart failure.
Topics: Diuretics; Drug Administration Schedule; Furosemide; Heart Failure; Humans; Therapeutic Equivalency | 2011 |
Diuretic strategies in patients with acute heart failure.
Topics: Diuretics; Drug Administration Schedule; Furosemide; Heart Failure; Humans; Therapeutic Equivalency | 2011 |
Diuretic strategies in patients with acute heart failure.
Topics: Diuretics; Drug Administration Schedule; Drug Resistance; Furosemide; Heart Failure; Humans; Potassi | 2011 |
Diuretic strategies in patients with acute heart failure.
Topics: Diuretics; Drug Administration Schedule; Drug Resistance; Furosemide; Heart Failure; Humans; Potassi | 2011 |
Diuretic strategies in patients with acute heart failure.
Topics: Comparative Effectiveness Research; Cost-Benefit Analysis; Diuretics; Drug Administration Schedule; | 2011 |
Diuretic strategies in patients with acute heart failure.
Topics: Comparative Effectiveness Research; Cost-Benefit Analysis; Diuretics; Drug Administration Schedule; | 2011 |
Diuretic strategies in patients with acute heart failure.
Topics: Confounding Factors, Epidemiologic; Diuretics; Dyspnea; Furosemide; Heart Failure; Humans; Outcome A | 2011 |
Diuretic strategies in patients with acute heart failure.
Topics: Confounding Factors, Epidemiologic; Diuretics; Dyspnea; Furosemide; Heart Failure; Humans; Outcome A | 2011 |
Diuretic strategies in patients with acute heart failure.
Topics: Acute Disease; Diuretics; Drug Administration Schedule; Furosemide; Heart Failure; Humans | 2011 |
Diuretic strategies in patients with acute heart failure.
Topics: Acute Disease; Diuretics; Drug Administration Schedule; Furosemide; Heart Failure; Humans | 2011 |
Diuretics: are our ideas based on knowledge?
Topics: Acetylglucosaminidase; Comorbidity; Diuretics; Furosemide; Heart Failure; Hepatitis A Virus Cellular | 2011 |
Diuretics: are our ideas based on knowledge?
Topics: Acetylglucosaminidase; Comorbidity; Diuretics; Furosemide; Heart Failure; Hepatitis A Virus Cellular | 2011 |
Volume status and diuretic therapy in systolic heart failure and the detection of early abnormalities in renal and tubular function.
Topics: Acetylglucosaminidase; Aged; Aged, 80 and over; Atrial Natriuretic Factor; Comorbidity; Creatinine; | 2011 |
Volume status and diuretic therapy in systolic heart failure and the detection of early abnormalities in renal and tubular function.
Topics: Acetylglucosaminidase; Aged; Aged, 80 and over; Atrial Natriuretic Factor; Comorbidity; Creatinine; | 2011 |
Heart failure: furosemide--to DOSE or not to DOSE, that is the question.
Topics: Biomarkers; Disease Progression; Diuretics; Furosemide; Heart Failure; Humans | 2011 |
Heart failure: furosemide--to DOSE or not to DOSE, that is the question.
Topics: Biomarkers; Disease Progression; Diuretics; Furosemide; Heart Failure; Humans | 2011 |
Cardiac AA amyloidosis in a patient with rheumatoid arthritis and systemic sclerosis: the therapeutic potential of biological reagents.
Topics: Aged; Amyloidosis; Antibodies, Antinuclear; Antirheumatic Agents; Arthritis, Rheumatoid; Benzimidazo | 2011 |
Cardiac AA amyloidosis in a patient with rheumatoid arthritis and systemic sclerosis: the therapeutic potential of biological reagents.
Topics: Aged; Amyloidosis; Antibodies, Antinuclear; Antirheumatic Agents; Arthritis, Rheumatoid; Benzimidazo | 2011 |
Furosemide in chronic advanced heart failure: intimate friend or cunning foe?
Topics: Animals; Chronic Disease; Diuretics; Furosemide; Heart Failure; Humans; Severity of Illness Index | 2011 |
Furosemide in chronic advanced heart failure: intimate friend or cunning foe?
Topics: Animals; Chronic Disease; Diuretics; Furosemide; Heart Failure; Humans; Severity of Illness Index | 2011 |
Outcomes of furosemide-mannitol infusion in hospitalized patients with heart failure: an observational single-center cohort study of 122 patients.
Topics: Aged; Diuretics; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Follow-Up Stud | 2011 |
Outcomes of furosemide-mannitol infusion in hospitalized patients with heart failure: an observational single-center cohort study of 122 patients.
Topics: Aged; Diuretics; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Follow-Up Stud | 2011 |
Inhaled furosemide test in the diagnosis of acute dyspnoea.
Topics: Female; Furosemide; Heart Failure; Humans; Male; Practice Patterns, Physicians'; Sodium Potassium Ch | 2011 |
Inhaled furosemide test in the diagnosis of acute dyspnoea.
Topics: Female; Furosemide; Heart Failure; Humans; Male; Practice Patterns, Physicians'; Sodium Potassium Ch | 2011 |
Found in translation.
Topics: Diuretics; Female; Furosemide; Heart Failure; Humans; Motor Activity; Posture | 2011 |
Found in translation.
Topics: Diuretics; Female; Furosemide; Heart Failure; Humans; Motor Activity; Posture | 2011 |
Dangerous diuretics or death defying drugs?
Topics: Furosemide; Heart Failure; Humans; Sodium Potassium Chloride Symporter Inhibitors | 2011 |
Dangerous diuretics or death defying drugs?
Topics: Furosemide; Heart Failure; Humans; Sodium Potassium Chloride Symporter Inhibitors | 2011 |
Impact of diuretic dosing on mortality in acute heart failure using a propensity-matched analysis.
Topics: Acute Disease; Dose-Response Relationship, Drug; Furosemide; Health Care Surveys; Heart Failure; Hum | 2011 |
Impact of diuretic dosing on mortality in acute heart failure using a propensity-matched analysis.
Topics: Acute Disease; Dose-Response Relationship, Drug; Furosemide; Health Care Surveys; Heart Failure; Hum | 2011 |
Use of the loop diuretic torsemide in three dogs with advanced heart failure.
Topics: Animals; Diuretics; Dog Diseases; Dogs; Euthanasia, Animal; Fatal Outcome; Female; Furosemide; Heart | 2011 |
Use of the loop diuretic torsemide in three dogs with advanced heart failure.
Topics: Animals; Diuretics; Dog Diseases; Dogs; Euthanasia, Animal; Fatal Outcome; Female; Furosemide; Heart | 2011 |
Effects of tolvaptan on systemic and renal hemodynamic function in dogs with congestive heart failure.
Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Atrial Natriuretic Factor; | 2011 |
Effects of tolvaptan on systemic and renal hemodynamic function in dogs with congestive heart failure.
Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Atrial Natriuretic Factor; | 2011 |
Controlling the flood gates: vaptans, furosemide and the quest for a renal protective diuresis.
Topics: Antidiuretic Hormone Receptor Antagonists; Benzazepines; Diuretics; Female; Furosemide; Heart Failur | 2011 |
Controlling the flood gates: vaptans, furosemide and the quest for a renal protective diuresis.
Topics: Antidiuretic Hormone Receptor Antagonists; Benzazepines; Diuretics; Female; Furosemide; Heart Failur | 2011 |
Appropriate diuretic dosing: closed loop communication.
Topics: Female; Furosemide; Heart Failure; Humans; Infusions, Intravenous; Male | 2012 |
Appropriate diuretic dosing: closed loop communication.
Topics: Female; Furosemide; Heart Failure; Humans; Infusions, Intravenous; Male | 2012 |
[Occurrence of severe cardiac alterations in Amanita proxima poisoning: two original observations].
Topics: Adrenergic beta-Agonists; Adult; Amanita; Diuretics; Dobutamine; Electrocardiography; Female; Furose | 2012 |
[Occurrence of severe cardiac alterations in Amanita proxima poisoning: two original observations].
Topics: Adrenergic beta-Agonists; Adult; Amanita; Diuretics; Dobutamine; Electrocardiography; Female; Furose | 2012 |
Therapeutic challenges and management of heart failure during pregnancy (part I).
Topics: Adult; Digitalis; Drug Therapy, Combination; Enalapril; Female; Furosemide; Heart Failure; Humans; M | 2012 |
Therapeutic challenges and management of heart failure during pregnancy (part I).
Topics: Adult; Digitalis; Drug Therapy, Combination; Enalapril; Female; Furosemide; Heart Failure; Humans; M | 2012 |
Survival and echocardiographic data in dogs with congestive heart failure caused by mitral valve disease and treated by multiple drugs: a retrospective study of 21 cases.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Benzazepines; Cardiotonic Agents; Death, Sudden, | 2011 |
Survival and echocardiographic data in dogs with congestive heart failure caused by mitral valve disease and treated by multiple drugs: a retrospective study of 21 cases.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Benzazepines; Cardiotonic Agents; Death, Sudden, | 2011 |
Ultrasound evaluation of the inferior vena cava collapsibility index in congestive heart failure patients treated with intravenous diuretics: new insights about its relationship with renal function: an observational study.
Topics: Aged; Cardiac Output, Low; Cohort Studies; Diuretics; Echocardiography; Female; Furosemide; Heart Fa | 2012 |
Ultrasound evaluation of the inferior vena cava collapsibility index in congestive heart failure patients treated with intravenous diuretics: new insights about its relationship with renal function: an observational study.
Topics: Aged; Cardiac Output, Low; Cohort Studies; Diuretics; Echocardiography; Female; Furosemide; Heart Fa | 2012 |
Intravenous diuretic day-care treatment for patients with heart failure.
Topics: Aged; Aged, 80 and over; Cost Savings; Day Care, Medical; Disease Management; Disease Progression; D | 2012 |
Intravenous diuretic day-care treatment for patients with heart failure.
Topics: Aged; Aged, 80 and over; Cost Savings; Day Care, Medical; Disease Management; Disease Progression; D | 2012 |
Clinical experience with low-dose continuous infusion of furosemide in acute heart failure: assessment of efficacy and safety.
Topics: Acute Kidney Injury; Adult; Aged; Cohort Studies; Diuretics; Female; Furosemide; Heart Failure; Hear | 2012 |
Clinical experience with low-dose continuous infusion of furosemide in acute heart failure: assessment of efficacy and safety.
Topics: Acute Kidney Injury; Adult; Aged; Cohort Studies; Diuretics; Female; Furosemide; Heart Failure; Hear | 2012 |
Tako-Tsubo cardiomyopathy caused immediately following cesarean section delivery of triplets: a case report.
Topics: Adult; Atrial Natriuretic Factor; Catecholamines; Cesarean Section; Chest Pain; Female; Furosemide; | 2012 |
Tako-Tsubo cardiomyopathy caused immediately following cesarean section delivery of triplets: a case report.
Topics: Adult; Atrial Natriuretic Factor; Catecholamines; Cesarean Section; Chest Pain; Female; Furosemide; | 2012 |
When the heart runs out of heartbeats: treatment options for refractory end-stage heart failure.
Topics: Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Carbazoles; Cardiotonic Agent | 2012 |
When the heart runs out of heartbeats: treatment options for refractory end-stage heart failure.
Topics: Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Carbazoles; Cardiotonic Agent | 2012 |
Differential mortality association of loop diuretic dosage according to blood urea nitrogen and carbohydrate antigen 125 following a hospitalization for acute heart failure.
Topics: Acute Disease; Aged; Aged, 80 and over; Biomarkers; Blood Urea Nitrogen; CA-125 Antigen; Cohort Stud | 2012 |
Differential mortality association of loop diuretic dosage according to blood urea nitrogen and carbohydrate antigen 125 following a hospitalization for acute heart failure.
Topics: Acute Disease; Aged; Aged, 80 and over; Biomarkers; Blood Urea Nitrogen; CA-125 Antigen; Cohort Stud | 2012 |
CHF treatment: is furosemide on the way out? Rethinking the pulmonary edema cocktail.
Topics: Acute Disease; Analgesics, Opioid; Diuretics; Drug Therapy, Combination; Emergency Treatment; Furose | 2012 |
CHF treatment: is furosemide on the way out? Rethinking the pulmonary edema cocktail.
Topics: Acute Disease; Analgesics, Opioid; Diuretics; Drug Therapy, Combination; Emergency Treatment; Furose | 2012 |
Lowered N-terminal pro-B-type natriuretic peptide levels in response to treatment predict survival in dogs with symptomatic mitral valve disease.
Topics: Animals; Diuretics; Dog Diseases; Dogs; Female; Furosemide; Heart Failure; Male; Mitral Valve Insuff | 2012 |
Lowered N-terminal pro-B-type natriuretic peptide levels in response to treatment predict survival in dogs with symptomatic mitral valve disease.
Topics: Animals; Diuretics; Dog Diseases; Dogs; Female; Furosemide; Heart Failure; Male; Mitral Valve Insuff | 2012 |
Transthoracic echocardiographically-guided interventional cardiac procedures in the dog.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Balloon Valvuloplasty; Benzazepines; Cardiotonic | 2012 |
Transthoracic echocardiographically-guided interventional cardiac procedures in the dog.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Balloon Valvuloplasty; Benzazepines; Cardiotonic | 2012 |
TRV120027, a novel β-arrestin biased ligand at the angiotensin II type I receptor, unloads the heart and maintains renal function when added to furosemide in experimental heart failure.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Arrestins; Arterial Pressure; Atrial Natriuretic F | 2012 |
TRV120027, a novel β-arrestin biased ligand at the angiotensin II type I receptor, unloads the heart and maintains renal function when added to furosemide in experimental heart failure.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Arrestins; Arterial Pressure; Atrial Natriuretic F | 2012 |
[Intermittent intravenous infusion of high-dose loop diuretics and risk for iatrogenic ototoxicity: an unresolved issue from the DOSE study].
Topics: Furosemide; Heart Failure; Humans | 2012 |
[Intermittent intravenous infusion of high-dose loop diuretics and risk for iatrogenic ototoxicity: an unresolved issue from the DOSE study].
Topics: Furosemide; Heart Failure; Humans | 2012 |
Intermittent subcutaneous furosemide: parenteral diuretic rescue for hospice patients with congestive heart failure resistant to oral diuretic.
Topics: Diuretics; Furosemide; Heart Failure; Hospice Care; Hospices; Humans | 2013 |
Intermittent subcutaneous furosemide: parenteral diuretic rescue for hospice patients with congestive heart failure resistant to oral diuretic.
Topics: Diuretics; Furosemide; Heart Failure; Hospice Care; Hospices; Humans | 2013 |
Tolvaptan reduces the risk of worsening renal function in patients with acute decompensated heart failure in high-risk population.
Topics: Acute Disease; Aged; Aged, 80 and over; Benzazepines; Comparative Effectiveness Research; Creatinine | 2013 |
Tolvaptan reduces the risk of worsening renal function in patients with acute decompensated heart failure in high-risk population.
Topics: Acute Disease; Aged; Aged, 80 and over; Benzazepines; Comparative Effectiveness Research; Creatinine | 2013 |
Markers of decongestion, dyspnea relief, and clinical outcomes among patients hospitalized with acute heart failure.
Topics: Acute Disease; Aged; Biomarkers; Chi-Square Distribution; Diuretics; Drug Administration Schedule; D | 2013 |
Markers of decongestion, dyspnea relief, and clinical outcomes among patients hospitalized with acute heart failure.
Topics: Acute Disease; Aged; Biomarkers; Chi-Square Distribution; Diuretics; Drug Administration Schedule; D | 2013 |
Markers of decongestion, dyspnea relief, and clinical outcomes among patients hospitalized with acute heart failure.
Topics: Acute Disease; Aged; Biomarkers; Chi-Square Distribution; Diuretics; Drug Administration Schedule; D | 2013 |
Markers of decongestion, dyspnea relief, and clinical outcomes among patients hospitalized with acute heart failure.
Topics: Acute Disease; Aged; Biomarkers; Chi-Square Distribution; Diuretics; Drug Administration Schedule; D | 2013 |
Markers of decongestion, dyspnea relief, and clinical outcomes among patients hospitalized with acute heart failure.
Topics: Acute Disease; Aged; Biomarkers; Chi-Square Distribution; Diuretics; Drug Administration Schedule; D | 2013 |
Markers of decongestion, dyspnea relief, and clinical outcomes among patients hospitalized with acute heart failure.
Topics: Acute Disease; Aged; Biomarkers; Chi-Square Distribution; Diuretics; Drug Administration Schedule; D | 2013 |
Markers of decongestion, dyspnea relief, and clinical outcomes among patients hospitalized with acute heart failure.
Topics: Acute Disease; Aged; Biomarkers; Chi-Square Distribution; Diuretics; Drug Administration Schedule; D | 2013 |
Markers of decongestion, dyspnea relief, and clinical outcomes among patients hospitalized with acute heart failure.
Topics: Acute Disease; Aged; Biomarkers; Chi-Square Distribution; Diuretics; Drug Administration Schedule; D | 2013 |
Pregnancy and treatment outcome in a patient with left ventricular non-compaction.
Topics: Adult; Antihypertensive Agents; Bisoprolol; Diuretics; Drug Therapy, Combination; Echocardiography; | 2013 |
Pregnancy and treatment outcome in a patient with left ventricular non-compaction.
Topics: Adult; Antihypertensive Agents; Bisoprolol; Diuretics; Drug Therapy, Combination; Echocardiography; | 2013 |
Furosemide in acute decompensated heart failure.
Topics: Acute Disease; Diuretics; Dose-Response Relationship, Drug; Furosemide; Heart Failure; Humans; Rando | 2012 |
Furosemide in acute decompensated heart failure.
Topics: Acute Disease; Diuretics; Dose-Response Relationship, Drug; Furosemide; Heart Failure; Humans; Rando | 2012 |
An 82-year-old woman with progressive dyspnea and bilateral infiltrates.
Topics: Aged, 80 and over; Disease Progression; Diuretics; Dyspnea; Female; Furosemide; Heart Failure; Human | 2013 |
An 82-year-old woman with progressive dyspnea and bilateral infiltrates.
Topics: Aged, 80 and over; Disease Progression; Diuretics; Dyspnea; Female; Furosemide; Heart Failure; Human | 2013 |
Torasemide in chronic heart failure: results of the TORIC study.
Topics: Aged; Chronic Disease; Diuretics; Female; Furosemide; Heart Failure; Humans; Male; Middle Aged; Pota | 2002 |
Torasemide in chronic heart failure: results of the TORIC study.
Topics: Aged; Chronic Disease; Diuretics; Female; Furosemide; Heart Failure; Humans; Male; Middle Aged; Pota | 2002 |
[Long-term diuretic treatment in heart failure: are there differences between furosemide and torasemide?].
Topics: Adult; Aged; Aged, 80 and over; Chronic Disease; Cost-Benefit Analysis; Diuretics; Female; Furosemid | 2002 |
[Long-term diuretic treatment in heart failure: are there differences between furosemide and torasemide?].
Topics: Adult; Aged; Aged, 80 and over; Chronic Disease; Cost-Benefit Analysis; Diuretics; Female; Furosemid | 2002 |
Except for high cholesterol, I've always been pretty healthy for my age (72). But I recently started puffing on the stairs, so my doctor sent me for a set of tests. After the echocardiogram, he told me I had congestive heart failure. He gave me Lasix and
Topics: Aged; Diuretics; Furosemide; Heart Failure; Humans; Male | 2002 |
Except for high cholesterol, I've always been pretty healthy for my age (72). But I recently started puffing on the stairs, so my doctor sent me for a set of tests. After the echocardiogram, he told me I had congestive heart failure. He gave me Lasix and
Topics: Aged; Diuretics; Furosemide; Heart Failure; Humans; Male | 2002 |
Serum to urinary sodium concentration ratio is an estimate of plasma renin activity in congestive heart failure.
Topics: Adult; Aged; Biomarkers; Blood Pressure; Blood Urea Nitrogen; Creatinine; Diuretics; Female; Furosem | 2002 |
Serum to urinary sodium concentration ratio is an estimate of plasma renin activity in congestive heart failure.
Topics: Adult; Aged; Biomarkers; Blood Pressure; Blood Urea Nitrogen; Creatinine; Diuretics; Female; Furosem | 2002 |
[A better diuretic for patients with heart failure. Better control of potassium loss].
Topics: Diuretics; Furosemide; Heart Failure; Humans; Hypokalemia; Sulfonamides; Torsemide; Treatment Outcom | 2002 |
[A better diuretic for patients with heart failure. Better control of potassium loss].
Topics: Diuretics; Furosemide; Heart Failure; Humans; Hypokalemia; Sulfonamides; Torsemide; Treatment Outcom | 2002 |
[Which loop diuretic for heart failure? For prognosis the choices are not all the same].
Topics: Chronic Disease; Diuretics; Furosemide; Heart Failure; Humans; Prognosis; Randomized Controlled Tria | 2002 |
[Which loop diuretic for heart failure? For prognosis the choices are not all the same].
Topics: Chronic Disease; Diuretics; Furosemide; Heart Failure; Humans; Prognosis; Randomized Controlled Tria | 2002 |
Recombinant interferon alfa 2a in hepatic hemangiomatosis with congestive heart failure: a case report.
Topics: Abdominal Neoplasms; Angiogenesis Inhibitors; Digitalis Glycosides; Diuretics; Dyspnea; Female; Furo | 2003 |
Recombinant interferon alfa 2a in hepatic hemangiomatosis with congestive heart failure: a case report.
Topics: Abdominal Neoplasms; Angiogenesis Inhibitors; Digitalis Glycosides; Diuretics; Dyspnea; Female; Furo | 2003 |
A case of successful six consecutive deliveries in a 41-year-old woman with Uhl's anomaly.
Topics: Angiotensin-Converting Enzyme Inhibitors; Drug Therapy, Combination; Echocardiography, Transesophage | 2003 |
A case of successful six consecutive deliveries in a 41-year-old woman with Uhl's anomaly.
Topics: Angiotensin-Converting Enzyme Inhibitors; Drug Therapy, Combination; Echocardiography, Transesophage | 2003 |
Furosemide challenge in patients with heart failure and adverse reactions to sulfa-containing diuretics.
Topics: Aged; Bumetanide; Diuretics; Drug Hypersensitivity; Female; Furosemide; Heart Failure; Humans; Male | 2003 |
Furosemide challenge in patients with heart failure and adverse reactions to sulfa-containing diuretics.
Topics: Aged; Bumetanide; Diuretics; Drug Hypersensitivity; Female; Furosemide; Heart Failure; Humans; Male | 2003 |
[Reducing hospital stay and costs in heart failure. The proper diuretic makes the difference].
Topics: Clinical Trials as Topic; Cost Savings; Diuretics; Furosemide; Heart Failure; Hospital Costs; Humans | 2003 |
[Reducing hospital stay and costs in heart failure. The proper diuretic makes the difference].
Topics: Clinical Trials as Topic; Cost Savings; Diuretics; Furosemide; Heart Failure; Hospital Costs; Humans | 2003 |
Serum magnesium aberrations in furosemide (frusemide) treated patients with congestive heart failure: pathophysiological correlates and prognostic evaluation.
Topics: Aged; Diuretics; Female; Furosemide; Heart Failure; Humans; Magnesium; Magnesium Deficiency; Male; P | 2003 |
Serum magnesium aberrations in furosemide (frusemide) treated patients with congestive heart failure: pathophysiological correlates and prognostic evaluation.
Topics: Aged; Diuretics; Female; Furosemide; Heart Failure; Humans; Magnesium; Magnesium Deficiency; Male; P | 2003 |
Bedside B-type natriuretic peptide and functional capacity in chronic heart failure.
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Aged; Aged, 80 and over; Angiotensin-Converting Enzy | 2003 |
Bedside B-type natriuretic peptide and functional capacity in chronic heart failure.
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Aged; Aged, 80 and over; Angiotensin-Converting Enzy | 2003 |
Factors influencing the length of hospital stay of patients with heart failure.
Topics: Aged; Aged, 80 and over; Angiotensin-Converting Enzyme Inhibitors; Biomarkers; Blood Pressure; Cohor | 2003 |
Factors influencing the length of hospital stay of patients with heart failure.
Topics: Aged; Aged, 80 and over; Angiotensin-Converting Enzyme Inhibitors; Biomarkers; Blood Pressure; Cohor | 2003 |
A patient with chaotic atrial tachycardia.
Topics: Abnormalities, Multiple; Adenosine; Anti-Asthmatic Agents; Asthma; Bronchiolitis; Combined Modality | 2003 |
A patient with chaotic atrial tachycardia.
Topics: Abnormalities, Multiple; Adenosine; Anti-Asthmatic Agents; Asthma; Bronchiolitis; Combined Modality | 2003 |
Echocardiographic markers of severe tricuspid regurgitation associated with right-sided congestive heart failure.
Topics: Aged; Atrial Fibrillation; Diagnosis, Differential; Diastole; Diuretics; Echocardiography; Female; F | 2003 |
Echocardiographic markers of severe tricuspid regurgitation associated with right-sided congestive heart failure.
Topics: Aged; Atrial Fibrillation; Diagnosis, Differential; Diastole; Diuretics; Echocardiography; Female; F | 2003 |
Effects of diuretic treatment on cardiac and circulating RAS in chronic heart failure post-myocardial infarction in rats.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Chronic Disease; Disease Models, Animal; Diuretic | 2003 |
Effects of diuretic treatment on cardiac and circulating RAS in chronic heart failure post-myocardial infarction in rats.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Chronic Disease; Disease Models, Animal; Diuretic | 2003 |
Difficulties of introducing the National Service Framework for heart failure into general practice in the UK.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Amiloride; Angiotensin-Converting Enzyme Inhibitors; Di | 2003 |
Difficulties of introducing the National Service Framework for heart failure into general practice in the UK.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Amiloride; Angiotensin-Converting Enzyme Inhibitors; Di | 2003 |
[Hear failure. Indications for diuretic therapy in general practice].
Topics: Diuretics; Dose-Response Relationship, Drug; Furosemide; Heart Failure; Humans; Sulfonamides; Torsem | 2003 |
[Hear failure. Indications for diuretic therapy in general practice].
Topics: Diuretics; Dose-Response Relationship, Drug; Furosemide; Heart Failure; Humans; Sulfonamides; Torsem | 2003 |
[Favorable prognostic effect of heart failure therapy. Diuretic makes heart muscle more elastic].
Topics: Clinical Trials as Topic; Diuretics; Furosemide; Heart Failure; Humans; Myocardial Contraction; Prog | 2003 |
[Favorable prognostic effect of heart failure therapy. Diuretic makes heart muscle more elastic].
Topics: Clinical Trials as Topic; Diuretics; Furosemide; Heart Failure; Humans; Myocardial Contraction; Prog | 2003 |
[Plasma levels of brain natriuretic peptide, cyclic 3'5'-guanosine monophosphate, endothelin 1, and noradrenaline in patients with chronic congestive heart failure].
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Captopril; Case-Control Studies; Cyclic GMP; Diureti | 2003 |
[Plasma levels of brain natriuretic peptide, cyclic 3'5'-guanosine monophosphate, endothelin 1, and noradrenaline in patients with chronic congestive heart failure].
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Captopril; Case-Control Studies; Cyclic GMP; Diureti | 2003 |
[CLINICO-THERAPEUTIC OBSERVATIONS AND RENAL FUNCTION TESTS WITH THE NEW DIURETIC, FUROSEMIDE].
Topics: Diuretics; Edema; Furosemide; Heart Diseases; Heart Failure; Hepatitis; Hypertension; Kidney Functio | 1964 |
[CLINICO-THERAPEUTIC OBSERVATIONS AND RENAL FUNCTION TESTS WITH THE NEW DIURETIC, FUROSEMIDE].
Topics: Diuretics; Edema; Furosemide; Heart Diseases; Heart Failure; Hepatitis; Hypertension; Kidney Functio | 1964 |
[ANALYSIS, EFFECT AND MECHANISM OF ACTION OF A NEW DIURETIC (FUROSEMIDE)].
Topics: Biomedical Research; Blood Pressure; Blood Pressure Determination; Blood Protein Disorders; Diuretic | 1964 |
[ANALYSIS, EFFECT AND MECHANISM OF ACTION OF A NEW DIURETIC (FUROSEMIDE)].
Topics: Biomedical Research; Blood Pressure; Blood Pressure Determination; Blood Protein Disorders; Diuretic | 1964 |
A NEW EFFECTIVE DIURETIC--LASIX.
Topics: Chlorthalidone; Diuretics; Drug Therapy; Furosemide; Heart Failure; Hydrochlorothiazide; Hypokalemia | 1964 |
A NEW EFFECTIVE DIURETIC--LASIX.
Topics: Chlorthalidone; Diuretics; Drug Therapy; Furosemide; Heart Failure; Hydrochlorothiazide; Hypokalemia | 1964 |
THE DIURETIC RESPONSE TO FRUSEMIDE.
Topics: Chlorides; Diuretics; Fluids and Secretions; Furosemide; Heart Failure; Humans; Hydrochlorothiazide; | 1964 |
THE DIURETIC RESPONSE TO FRUSEMIDE.
Topics: Chlorides; Diuretics; Fluids and Secretions; Furosemide; Heart Failure; Humans; Hydrochlorothiazide; | 1964 |
A CLINICAL TRIAL OF FRUSEMIDE.
Topics: Biomedical Research; Blood Chemical Analysis; Chlorides; Chlorthalidone; Diuretics; Fluids and Secre | 1964 |
A CLINICAL TRIAL OF FRUSEMIDE.
Topics: Biomedical Research; Blood Chemical Analysis; Chlorides; Chlorthalidone; Diuretics; Fluids and Secre | 1964 |
EXPERIENCES WITH FUROSEMIDE IN RENAL DISEASE.
Topics: Biomedical Research; Blood Urea Nitrogen; Creatine; Creatinine; Diabetic Nephropathies; Diuretics; D | 1965 |
EXPERIENCES WITH FUROSEMIDE IN RENAL DISEASE.
Topics: Biomedical Research; Blood Urea Nitrogen; Creatine; Creatinine; Diabetic Nephropathies; Diuretics; D | 1965 |
[EXPERIENCES WITH FUROSEMIDE (LASIX) IN EDEMA OF VARIOUS ORIGINS].
Topics: Diabetes Mellitus; Diuretics; Edema; Furosemide; Heart Failure; Humans; Liver Cirrhosis | 1965 |
[EXPERIENCES WITH FUROSEMIDE (LASIX) IN EDEMA OF VARIOUS ORIGINS].
Topics: Diabetes Mellitus; Diuretics; Edema; Furosemide; Heart Failure; Humans; Liver Cirrhosis | 1965 |
DIURETIC ACTION OF FUROSEMIDE.
Topics: Acetazolamide; Bicarbonates; Biomedical Research; Blood Chemical Analysis; Carbonic Anhydrase Inhibi | 1965 |
DIURETIC ACTION OF FUROSEMIDE.
Topics: Acetazolamide; Bicarbonates; Biomedical Research; Blood Chemical Analysis; Carbonic Anhydrase Inhibi | 1965 |
[PRACTICAL EXPERIENCES WITH LASIX, A NEW SALURETIC].
Topics: Diuretics; Drug Therapy; Edema; Furosemide; Heart Failure; Humans; Kidney Diseases | 1965 |
[PRACTICAL EXPERIENCES WITH LASIX, A NEW SALURETIC].
Topics: Diuretics; Drug Therapy; Edema; Furosemide; Heart Failure; Humans; Kidney Diseases | 1965 |
[CLINICAL EXPERIENCES WITH THE NEW DIURETIC, FURSEMID].
Topics: Diuretics; Drug Therapy; Edema; Furosemide; Heart Failure; Humans; Liver Cirrhosis | 1964 |
[CLINICAL EXPERIENCES WITH THE NEW DIURETIC, FURSEMID].
Topics: Diuretics; Drug Therapy; Edema; Furosemide; Heart Failure; Humans; Liver Cirrhosis | 1964 |
[CLINICAL EXPERIENCE WITH 4-CHLORO-N-(2-FURFURYLMETHYL)-5-SULFAMOYLANTHRANILIC ACID (FUROSEMIDE)].
Topics: Diuretics; Furosemide; Heart Failure; Humans; Toxicology | 1965 |
[CLINICAL EXPERIENCE WITH 4-CHLORO-N-(2-FURFURYLMETHYL)-5-SULFAMOYLANTHRANILIC ACID (FUROSEMIDE)].
Topics: Diuretics; Furosemide; Heart Failure; Humans; Toxicology | 1965 |
FUROSEMIDE (LASIX) AS A DIURETIC.
Topics: Chlorothiazide; Chlorthalidone; Diuretics; Drug Therapy; Furosemide; Heart Failure; Hydrochlorothiaz | 1965 |
FUROSEMIDE (LASIX) AS A DIURETIC.
Topics: Chlorothiazide; Chlorthalidone; Diuretics; Drug Therapy; Furosemide; Heart Failure; Hydrochlorothiaz | 1965 |
[SALURETIC ACTION OF FUROSEMIDE IN SUBJECTS WITH SEVERE WATER RETENTION].
Topics: Diuretics; Edema; Furosemide; Heart Failure; Humans | 1965 |
[SALURETIC ACTION OF FUROSEMIDE IN SUBJECTS WITH SEVERE WATER RETENTION].
Topics: Diuretics; Edema; Furosemide; Heart Failure; Humans | 1965 |
[THE WATER-SALT RETENTION SYNDROME IN THE INJURED PATIENT: PATHOGENETIC AND THERAPEUTIC CONSIDERATIONS].
Topics: Diuretics; Edema; Furosemide; Heart Failure; Humans; Syndrome; Water; Water-Electrolyte Balance; Wou | 1965 |
[THE WATER-SALT RETENTION SYNDROME IN THE INJURED PATIENT: PATHOGENETIC AND THERAPEUTIC CONSIDERATIONS].
Topics: Diuretics; Edema; Furosemide; Heart Failure; Humans; Syndrome; Water; Water-Electrolyte Balance; Wou | 1965 |
[CLINICAL RESEARCH ON THE USE OF 4-CHLORO-N-(2-FURYLMETHYL)-5-SULFAMYL-ANTHRANILIC ACID].
Topics: Ascites; Diuretics; Edema; Furosemide; Heart Failure; Humans; Liver Cirrhosis; ortho-Aminobenzoates | 1965 |
[CLINICAL RESEARCH ON THE USE OF 4-CHLORO-N-(2-FURYLMETHYL)-5-SULFAMYL-ANTHRANILIC ACID].
Topics: Ascites; Diuretics; Edema; Furosemide; Heart Failure; Humans; Liver Cirrhosis; ortho-Aminobenzoates | 1965 |
[Diuretics in heart failure. Fewer electrolyte disorders -- better prognosis].
Topics: Chronic Disease; Clinical Trials as Topic; Diuretics; Furosemide; Heart Failure; Humans; Hypokalemia | 2003 |
[Diuretics in heart failure. Fewer electrolyte disorders -- better prognosis].
Topics: Chronic Disease; Clinical Trials as Topic; Diuretics; Furosemide; Heart Failure; Humans; Hypokalemia | 2003 |
What is your diagnosis? Dilated cardiomyopathy (DCM) causing congestive heart failure.
Topics: Animals; Cardiomyopathy, Dilated; Cat Diseases; Cats; Diagnosis, Differential; Digoxin; Enalapril; F | 2003 |
What is your diagnosis? Dilated cardiomyopathy (DCM) causing congestive heart failure.
Topics: Animals; Cardiomyopathy, Dilated; Cat Diseases; Cats; Diagnosis, Differential; Digoxin; Enalapril; F | 2003 |
[Heart failure therapy. Cheap can become expensive].
Topics: Clinical Trials as Topic; Cost Savings; Diuretics; Drug Costs; Furosemide; Germany; Heart Failure; H | 2003 |
[Heart failure therapy. Cheap can become expensive].
Topics: Clinical Trials as Topic; Cost Savings; Diuretics; Drug Costs; Furosemide; Germany; Heart Failure; H | 2003 |
A case of severe diabetes mellitus occurred during management of heart failure with carvedilol and furosemide.
Topics: Adrenergic beta-Antagonists; Adult; Carbazoles; Carvedilol; Diabetes Mellitus; Diuretics; Drug Thera | 2003 |
A case of severe diabetes mellitus occurred during management of heart failure with carvedilol and furosemide.
Topics: Adrenergic beta-Antagonists; Adult; Carbazoles; Carvedilol; Diabetes Mellitus; Diuretics; Drug Thera | 2003 |
Thiamine deficiency in congestive heart failure patients receiving long term furosemide therapy.
Topics: Aged; Diuretics; Female; Furosemide; Heart Failure; Humans; Male; Middle Aged; Prevalence; Thiamine | 2003 |
Thiamine deficiency in congestive heart failure patients receiving long term furosemide therapy.
Topics: Aged; Diuretics; Female; Furosemide; Heart Failure; Humans; Male; Middle Aged; Prevalence; Thiamine | 2003 |
Lowering of furosemide dosage after clinical stabilization in patients with congestive heart failure.
Topics: Adult; Aged; Cardiac Catheterization; Diuretics; Dose-Response Relationship, Drug; Female; Follow-Up | 2003 |
Lowering of furosemide dosage after clinical stabilization in patients with congestive heart failure.
Topics: Adult; Aged; Cardiac Catheterization; Diuretics; Dose-Response Relationship, Drug; Female; Follow-Up | 2003 |
Association of biochemical values with morbidity in the elderly: a population-based Swedish study of persons aged 82 or more years.
Topics: Aged; Aged, 80 and over; Biomarkers; Blood Chemical Analysis; Body Mass Index; Cholesterol; Creatine | 2003 |
Association of biochemical values with morbidity in the elderly: a population-based Swedish study of persons aged 82 or more years.
Topics: Aged; Aged, 80 and over; Biomarkers; Blood Chemical Analysis; Body Mass Index; Cholesterol; Creatine | 2003 |
Brain natriuretic peptide enhances renal actions of furosemide and suppresses furosemide-induced aldosterone activation in experimental heart failure.
Topics: Animals; Cardiac Output; Cardiac Pacing, Artificial; Cyclic GMP; Diuresis; Diuretics; Dogs; Drug Eva | 2004 |
Brain natriuretic peptide enhances renal actions of furosemide and suppresses furosemide-induced aldosterone activation in experimental heart failure.
Topics: Animals; Cardiac Output; Cardiac Pacing, Artificial; Cyclic GMP; Diuresis; Diuretics; Dogs; Drug Eva | 2004 |
Furosemide responsiveness, non-adherence and resistance during the chronic treatment of heart failure: a longitudinal study.
Topics: Administration, Oral; Aged; Angiotensin-Converting Enzyme Inhibitors; Chronic Disease; Cohort Studie | 2004 |
Furosemide responsiveness, non-adherence and resistance during the chronic treatment of heart failure: a longitudinal study.
Topics: Administration, Oral; Aged; Angiotensin-Converting Enzyme Inhibitors; Chronic Disease; Cohort Studie | 2004 |
Anesthesiology: perioperative medicine or "when the anesthetic is a diuretic".
Topics: Aged; Aged, 80 and over; Anesthetics; Angiotensin-Converting Enzyme Inhibitors; Cardiotonic Agents; | 2004 |
Anesthesiology: perioperative medicine or "when the anesthetic is a diuretic".
Topics: Aged; Aged, 80 and over; Anesthetics; Angiotensin-Converting Enzyme Inhibitors; Cardiotonic Agents; | 2004 |
Continuous spinal anesthesia for cesarean section in a parturient with severe recurrent peripartum cardiomyopathy.
Topics: Adult; Anesthesia, Obstetrical; Anesthesia, Spinal; Cardiomyopathy, Dilated; Cardiotonic Agents; Ces | 2004 |
Continuous spinal anesthesia for cesarean section in a parturient with severe recurrent peripartum cardiomyopathy.
Topics: Adult; Anesthesia, Obstetrical; Anesthesia, Spinal; Cardiomyopathy, Dilated; Cardiotonic Agents; Ces | 2004 |
Subcutaneous furosemide.
Topics: Ascites; Diuretics; Furosemide; Heart Failure; Hospice Care; Humans; Injections, Subcutaneous; Treat | 2004 |
Subcutaneous furosemide.
Topics: Ascites; Diuretics; Furosemide; Heart Failure; Hospice Care; Humans; Injections, Subcutaneous; Treat | 2004 |
Furosemide and the progression of left ventricular dysfunction in experimental heart failure.
Topics: Adrenergic beta-Agonists; Aldosterone; Animals; Biomarkers; Disease Models, Animal; Disease Progress | 2004 |
Furosemide and the progression of left ventricular dysfunction in experimental heart failure.
Topics: Adrenergic beta-Agonists; Aldosterone; Animals; Biomarkers; Disease Models, Animal; Disease Progress | 2004 |
Furosemide in the long-term management of heart failure: the good, the bad, and the uncertain.
Topics: Adrenergic beta-Agonists; Aldosterone; Animals; Diuretics; Electrolytes; Furosemide; Heart Failure; | 2004 |
Furosemide in the long-term management of heart failure: the good, the bad, and the uncertain.
Topics: Adrenergic beta-Agonists; Aldosterone; Animals; Diuretics; Electrolytes; Furosemide; Heart Failure; | 2004 |
[Fatal untoward effect of furosemide: immunocytopenic purpura and cerebral hemorrhage].
Topics: Aged; Autopsy; Bone Marrow; Cerebral Hemorrhage; Diuretics; Fatal Outcome; Furosemide; Heart Failure | 2004 |
[Fatal untoward effect of furosemide: immunocytopenic purpura and cerebral hemorrhage].
Topics: Aged; Autopsy; Bone Marrow; Cerebral Hemorrhage; Diuretics; Fatal Outcome; Furosemide; Heart Failure | 2004 |
Sex-related bedside clinical variables associated with survival of older inpatients with heart failure.
Topics: Aged; Aged, 80 and over; Comorbidity; Diuretics; Female; Furosemide; Heart Failure; Humans; Hypocalc | 2004 |
Sex-related bedside clinical variables associated with survival of older inpatients with heart failure.
Topics: Aged; Aged, 80 and over; Comorbidity; Diuretics; Female; Furosemide; Heart Failure; Humans; Hypocalc | 2004 |
Hypocalcaemic heart failure due to intestinal calcium malabsorption following small bowel resection.
Topics: Adult; Calcium; Digestive System Surgical Procedures; Female; Furosemide; Heart Failure; Humans; Hyp | 2004 |
Hypocalcaemic heart failure due to intestinal calcium malabsorption following small bowel resection.
Topics: Adult; Calcium; Digestive System Surgical Procedures; Female; Furosemide; Heart Failure; Humans; Hyp | 2004 |
Cardiac resynchronization therapy: an option for inotrope-supported patients with end-stage heart failure?
Topics: Aged; Atrial Fibrillation; Cardiac Pacing, Artificial; Cardiotonic Agents; Diuretics; Dose-Response | 2005 |
Cardiac resynchronization therapy: an option for inotrope-supported patients with end-stage heart failure?
Topics: Aged; Atrial Fibrillation; Cardiac Pacing, Artificial; Cardiotonic Agents; Diuretics; Dose-Response | 2005 |
Phenotype and genotype of Dent's disease in three Korean boys.
Topics: Arginine; Asian People; Child; Child, Preschool; Chloride Channels; Codon, Nonsense; Diuretics; Furo | 2005 |
Phenotype and genotype of Dent's disease in three Korean boys.
Topics: Arginine; Asian People; Child; Child, Preschool; Chloride Channels; Codon, Nonsense; Diuretics; Furo | 2005 |
Heart failure after Caesarean section for twin delivery.
Topics: Adult; Anesthesia, Obstetrical; Anesthesia, Spinal; Cardiotonic Agents; Catheterization, Swan-Ganz; | 2004 |
Heart failure after Caesarean section for twin delivery.
Topics: Adult; Anesthesia, Obstetrical; Anesthesia, Spinal; Cardiotonic Agents; Catheterization, Swan-Ganz; | 2004 |
Left ventricular conditioning in the elderly patient to prevent congestive heart failure after transcatheter closure of atrial septal defect.
Topics: Aged; Aged, 80 and over; Cardiac Catheterization; Cardiotonic Agents; Catheterization; Diuretics; Do | 2005 |
Left ventricular conditioning in the elderly patient to prevent congestive heart failure after transcatheter closure of atrial septal defect.
Topics: Aged; Aged, 80 and over; Cardiac Catheterization; Cardiotonic Agents; Catheterization; Diuretics; Do | 2005 |
[Peripartum heart failure: the underestimated role of frequent diseases in the Sudan-Sahelian area].
Topics: Adult; Africa, Northern; Anemia; Angiotensin-Converting Enzyme Inhibitors; Captopril; Cardiotonic Ag | 2000 |
[Peripartum heart failure: the underestimated role of frequent diseases in the Sudan-Sahelian area].
Topics: Adult; Africa, Northern; Anemia; Angiotensin-Converting Enzyme Inhibitors; Captopril; Cardiotonic Ag | 2000 |
Heart failure in diabetes mellitus: clinical features and prognostic implications.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Calcium Channel Blockers; Cardiotonic Agents; Diabet | 2005 |
Heart failure in diabetes mellitus: clinical features and prognostic implications.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Calcium Channel Blockers; Cardiotonic Agents; Diabet | 2005 |
Severe starvation hypoglycemia and congestive heart failure induced by thyroid crisis, with accidentally induced severe liver dysfunction and disseminated intravascular coagulation.
Topics: Aged; Blood Glucose; Blood Pressure; Chemical and Drug Induced Liver Injury; Disseminated Intravascu | 2005 |
Severe starvation hypoglycemia and congestive heart failure induced by thyroid crisis, with accidentally induced severe liver dysfunction and disseminated intravascular coagulation.
Topics: Aged; Blood Glucose; Blood Pressure; Chemical and Drug Induced Liver Injury; Disseminated Intravascu | 2005 |
[Effects of Accupro on structural and hemodynamic changes in patients with chronic heart failure].
Topics: Aged; Aged, 80 and over; Angiotensin-Converting Enzyme Inhibitors; Diuretics; Drug Therapy, Combinat | 2005 |
[Effects of Accupro on structural and hemodynamic changes in patients with chronic heart failure].
Topics: Aged; Aged, 80 and over; Angiotensin-Converting Enzyme Inhibitors; Diuretics; Drug Therapy, Combinat | 2005 |
Hypotension is associated with diuretic resistance in severe chronic heart failure, independent of renal function.
Topics: Aged; Blood Pressure; Creatinine; Diuretics; Feedback, Physiological; Furosemide; Heart Failure; Hum | 2005 |
Hypotension is associated with diuretic resistance in severe chronic heart failure, independent of renal function.
Topics: Aged; Blood Pressure; Creatinine; Diuretics; Feedback, Physiological; Furosemide; Heart Failure; Hum | 2005 |
More on morphine sulfate and furosemide use by EMS and the risks of adverse outcome.
Topics: Acute Disease; Analgesics, Opioid; Clinical Competence; Diuretics; Emergency Medical Services; Emerg | 2005 |
More on morphine sulfate and furosemide use by EMS and the risks of adverse outcome.
Topics: Acute Disease; Analgesics, Opioid; Clinical Competence; Diuretics; Emergency Medical Services; Emerg | 2005 |
Different effects of long- and short-acting loop diuretics on survival rate in Dahl high-salt heart failure model rats.
Topics: Animals; Echocardiography; Furosemide; Heart Failure; Interleukin-1; Norepinephrine; Rats; Rats, Inb | 2005 |
Different effects of long- and short-acting loop diuretics on survival rate in Dahl high-salt heart failure model rats.
Topics: Animals; Echocardiography; Furosemide; Heart Failure; Interleukin-1; Norepinephrine; Rats; Rats, Inb | 2005 |
Captopril-furosemide survival study in experimental heart failure.
Topics: Animals; Captopril; Diuresis; Drug Therapy, Combination; Echocardiography; Furosemide; Heart Failure | 2005 |
Captopril-furosemide survival study in experimental heart failure.
Topics: Animals; Captopril; Diuresis; Drug Therapy, Combination; Echocardiography; Furosemide; Heart Failure | 2005 |
Dissociation between improvement in left ventricular performance and functional class in patients with chronic heart failure.
Topics: Adrenergic beta-Antagonists; Aged; Angiotensin-Converting Enzyme Inhibitors; Cardiotonic Agents; Chr | 2005 |
Dissociation between improvement in left ventricular performance and functional class in patients with chronic heart failure.
Topics: Adrenergic beta-Antagonists; Aged; Angiotensin-Converting Enzyme Inhibitors; Cardiotonic Agents; Chr | 2005 |
Automated drug delivery system to control systemic arterial pressure, cardiac output, and left heart filling pressure in acute decompensated heart failure.
Topics: Animals; Antihypertensive Agents; Atrial Function, Left; Automation; Blood Pressure; Cardiac Output; | 2006 |
Automated drug delivery system to control systemic arterial pressure, cardiac output, and left heart filling pressure in acute decompensated heart failure.
Topics: Animals; Antihypertensive Agents; Atrial Function, Left; Automation; Blood Pressure; Cardiac Output; | 2006 |
A 74-year-old woman with increasing dyspnea. Wet berberi with fulminant (Shoshin) cardiac failure and elevated troponin I.
Topics: Aged; Beriberi; Drug Therapy, Combination; Dyspnea; Female; Furosemide; Heart Failure; Humans; Thiam | 2006 |
A 74-year-old woman with increasing dyspnea. Wet berberi with fulminant (Shoshin) cardiac failure and elevated troponin I.
Topics: Aged; Beriberi; Drug Therapy, Combination; Dyspnea; Female; Furosemide; Heart Failure; Humans; Thiam | 2006 |
Secondary hyperparathyroidism in patients with untreated and treated congestive heart failure.
Topics: Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Diuretics; Female; Furosemide; Heart Failure; | 2006 |
Secondary hyperparathyroidism in patients with untreated and treated congestive heart failure.
Topics: Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Diuretics; Female; Furosemide; Heart Failure; | 2006 |
Risk factors for acute renal insufficiency induced by diuretics in patients with congestive heart failure.
Topics: Acute Kidney Injury; Aged; Aged, 80 and over; Diuretics; Female; Furosemide; Heart Failure; Humans; | 2006 |
Risk factors for acute renal insufficiency induced by diuretics in patients with congestive heart failure.
Topics: Acute Kidney Injury; Aged; Aged, 80 and over; Diuretics; Female; Furosemide; Heart Failure; Humans; | 2006 |
Relation of loop diuretic dose to mortality in advanced heart failure.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Bumetanide; California; Creatinine; Diuretics; Dose-Resp | 2006 |
Relation of loop diuretic dose to mortality in advanced heart failure.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Bumetanide; California; Creatinine; Diuretics; Dose-Resp | 2006 |
Cutaneous adverse reaction to furosemide treatment: new clinical findings.
Topics: Alopecia; Animals; Diuretics; Dog Diseases; Dogs; Furosemide; Heart Failure; Male; Pruritus | 2006 |
Cutaneous adverse reaction to furosemide treatment: new clinical findings.
Topics: Alopecia; Animals; Diuretics; Dog Diseases; Dogs; Furosemide; Heart Failure; Male; Pruritus | 2006 |
Congenital right ventricular diverticulum associated with a ventricular septal defect: a rare echocardiographic finding.
Topics: Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhythmia Agents; Captopril; Cardiac Surgical Proced | 2006 |
Congenital right ventricular diverticulum associated with a ventricular septal defect: a rare echocardiographic finding.
Topics: Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhythmia Agents; Captopril; Cardiac Surgical Proced | 2006 |
Changes in plasma N-terminal proBNP levels and ventricular filling pressures during intensive unloading therapy in elderly with decompensated congestive heart failure and preserved left ventricular systolic function.
Topics: Aged; Aged, 80 and over; Cohort Studies; Coronary Circulation; Diuretics; Echocardiography; Furosemi | 2006 |
Changes in plasma N-terminal proBNP levels and ventricular filling pressures during intensive unloading therapy in elderly with decompensated congestive heart failure and preserved left ventricular systolic function.
Topics: Aged; Aged, 80 and over; Cohort Studies; Coronary Circulation; Diuretics; Echocardiography; Furosemi | 2006 |
[Heart failure in Eastern Veneto: prevalence, hospitalization rate, adherence to guidelines and social costs].
Topics: Adult; Aged; Aged, 80 and over; Cost of Illness; Costs and Cost Analysis; Diuretics; Echocardiograph | 2006 |
[Heart failure in Eastern Veneto: prevalence, hospitalization rate, adherence to guidelines and social costs].
Topics: Adult; Aged; Aged, 80 and over; Cost of Illness; Costs and Cost Analysis; Diuretics; Echocardiograph | 2006 |
Dose-dependent association between use of loop diuretics and mortality in advanced systolic heart failure.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Bumetanide; California; Creatinine; Diuretics; Dose-Resp | 2006 |
Dose-dependent association between use of loop diuretics and mortality in advanced systolic heart failure.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Bumetanide; California; Creatinine; Diuretics; Dose-Resp | 2006 |
Effects of standard heart failure therapy and concomitant treatment with intravenous furosemide or inotropes (dobutamine, dopamine, and/or milrinone) on renal function and mortality in patients treated with nesiritide.
Topics: Aged; Cardiotonic Agents; Creatinine; Diuretics; Dobutamine; Dopamine; Drug Therapy, Combination; Fe | 2006 |
Effects of standard heart failure therapy and concomitant treatment with intravenous furosemide or inotropes (dobutamine, dopamine, and/or milrinone) on renal function and mortality in patients treated with nesiritide.
Topics: Aged; Cardiotonic Agents; Creatinine; Diuretics; Dobutamine; Dopamine; Drug Therapy, Combination; Fe | 2006 |
Carvedilol accelerate elevation of serum potassium in chronic heart failure patients administered spironolactone plus furosemide and either enalapril maleate or candesartan cilexetil.
Topics: Adult; Aged; Aged, 80 and over; Benzimidazoles; Biphenyl Compounds; Carbazoles; Carvedilol; Drug The | 2006 |
Carvedilol accelerate elevation of serum potassium in chronic heart failure patients administered spironolactone plus furosemide and either enalapril maleate or candesartan cilexetil.
Topics: Adult; Aged; Aged, 80 and over; Benzimidazoles; Biphenyl Compounds; Carbazoles; Carvedilol; Drug The | 2006 |
A pilot study to assess the feasibility of a submaximal exercise test to measure individual response to cardiac medication in dogs with acquired heart failure.
Topics: Animals; Blood Chemical Analysis; Blood Gas Analysis; Blood Glucose; Cardiotonic Agents; Dog Disease | 2007 |
A pilot study to assess the feasibility of a submaximal exercise test to measure individual response to cardiac medication in dogs with acquired heart failure.
Topics: Animals; Blood Chemical Analysis; Blood Gas Analysis; Blood Glucose; Cardiotonic Agents; Dog Disease | 2007 |
Intermittent haemodiafiltration in refractory congestive heart failure: BNP and balance of inflammatory cytokines.
Topics: Adult; Body Fluids; Chemokine CCL2; Cytokines; Diuretics; Dose-Response Relationship, Drug; Furosemi | 2007 |
Intermittent haemodiafiltration in refractory congestive heart failure: BNP and balance of inflammatory cytokines.
Topics: Adult; Body Fluids; Chemokine CCL2; Cytokines; Diuretics; Dose-Response Relationship, Drug; Furosemi | 2007 |
Prevalence, predictors and prognostic value of acute impairment in renal function during intensive unloading therapy in a community population hospitalized for decompensated heart failure.
Topics: Aged; Aged, 80 and over; Diuretics; Furosemide; Heart Failure; Hospitals, Community; Humans; Nitropr | 2007 |
Prevalence, predictors and prognostic value of acute impairment in renal function during intensive unloading therapy in a community population hospitalized for decompensated heart failure.
Topics: Aged; Aged, 80 and over; Diuretics; Furosemide; Heart Failure; Hospitals, Community; Humans; Nitropr | 2007 |
Acute decompensated heart failure.
Topics: Acute Disease; Evidence-Based Medicine; Female; Furosemide; Heart Failure; Humans; Male; Prognosis; | 2007 |
Acute decompensated heart failure.
Topics: Acute Disease; Evidence-Based Medicine; Female; Furosemide; Heart Failure; Humans; Male; Prognosis; | 2007 |
[CME-EKG 17. Coronary heart disease and arrhythmia].
Topics: Aged; Coronary Disease; Diagnosis, Differential; Electrocardiography; Erythromycin; Furosemide; Hear | 2007 |
[CME-EKG 17. Coronary heart disease and arrhythmia].
Topics: Aged; Coronary Disease; Diagnosis, Differential; Electrocardiography; Erythromycin; Furosemide; Hear | 2007 |
Bloodletting-induced cardiomyopathy: reversible cardiac hypertrophy in severe chronic anaemia from long-term bloodletting with cupping.
Topics: Aged; Anemia, Iron-Deficiency; Angiotensin-Converting Enzyme Inhibitors; Cardiomegaly; Chronic Disea | 2008 |
Bloodletting-induced cardiomyopathy: reversible cardiac hypertrophy in severe chronic anaemia from long-term bloodletting with cupping.
Topics: Aged; Anemia, Iron-Deficiency; Angiotensin-Converting Enzyme Inhibitors; Cardiomegaly; Chronic Disea | 2008 |
Diuretics in obstructive sleep apnea with diastolic heart failure.
Topics: Adult; Aged; Blood Gas Analysis; Diastole; Diuretics; Drug Therapy, Combination; Echocardiography, D | 2007 |
Diuretics in obstructive sleep apnea with diastolic heart failure.
Topics: Adult; Aged; Blood Gas Analysis; Diastole; Diuretics; Drug Therapy, Combination; Echocardiography, D | 2007 |
Characteristics of ascitic fluid in cardiac ascites.
Topics: Aged; Albumins; Ascites; Ascitic Fluid; Diagnosis, Differential; Diuretics; Erythrocyte Count; Exuda | 2007 |
Characteristics of ascitic fluid in cardiac ascites.
Topics: Aged; Albumins; Ascites; Ascitic Fluid; Diagnosis, Differential; Diuretics; Erythrocyte Count; Exuda | 2007 |
Potent diuretic effects of prednisone in heart failure patients with refractory diuretic resistance.
Topics: Creatinine; Diuresis; Diuretics; Female; Furosemide; Glomerular Filtration Rate; Glucocorticoids; He | 2007 |
Potent diuretic effects of prednisone in heart failure patients with refractory diuretic resistance.
Topics: Creatinine; Diuresis; Diuretics; Female; Furosemide; Glomerular Filtration Rate; Glucocorticoids; He | 2007 |
Potent diuretic effects of prednisone in heart failure patients with refractory diuretic resistance.
Topics: Creatinine; Diuresis; Diuretics; Female; Furosemide; Glomerular Filtration Rate; Glucocorticoids; He | 2007 |
Potent diuretic effects of prednisone in heart failure patients with refractory diuretic resistance.
Topics: Creatinine; Diuresis; Diuretics; Female; Furosemide; Glomerular Filtration Rate; Glucocorticoids; He | 2007 |
Potent diuretic effects of prednisone in heart failure patients with refractory diuretic resistance.
Topics: Creatinine; Diuresis; Diuretics; Female; Furosemide; Glomerular Filtration Rate; Glucocorticoids; He | 2007 |
Potent diuretic effects of prednisone in heart failure patients with refractory diuretic resistance.
Topics: Creatinine; Diuresis; Diuretics; Female; Furosemide; Glomerular Filtration Rate; Glucocorticoids; He | 2007 |
Potent diuretic effects of prednisone in heart failure patients with refractory diuretic resistance.
Topics: Creatinine; Diuresis; Diuretics; Female; Furosemide; Glomerular Filtration Rate; Glucocorticoids; He | 2007 |
Potent diuretic effects of prednisone in heart failure patients with refractory diuretic resistance.
Topics: Creatinine; Diuresis; Diuretics; Female; Furosemide; Glomerular Filtration Rate; Glucocorticoids; He | 2007 |
Comparative effects of torasemide and furosemide in rats with heart failure.
Topics: Animals; Collagen Type III; Cytochrome P-450 CYP11B2; Diuretics; Furosemide; Heart Failure; Immunohi | 2008 |
Comparative effects of torasemide and furosemide in rats with heart failure.
Topics: Animals; Collagen Type III; Cytochrome P-450 CYP11B2; Diuretics; Furosemide; Heart Failure; Immunohi | 2008 |
Effects of V2-receptor antagonist tolvaptan and the loop diuretic furosemide in rats with heart failure.
Topics: Aldosterone; Animals; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Benzazepines; | 2008 |
Effects of V2-receptor antagonist tolvaptan and the loop diuretic furosemide in rats with heart failure.
Topics: Aldosterone; Animals; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Benzazepines; | 2008 |
Fluid removal: are we any wiser?
Topics: Edema, Cardiac; Female; Furosemide; Heart Failure; Humans; Kidney Function Tests; Male; Risk Assessm | 2008 |
Fluid removal: are we any wiser?
Topics: Edema, Cardiac; Female; Furosemide; Heart Failure; Humans; Kidney Function Tests; Male; Risk Assessm | 2008 |
Worsening renal function in patients hospitalised for acute heart failure: clinical implications and prognostic significance.
Topics: Aged; Creatinine; Diuretics; Female; Furosemide; Heart Failure; Hospitalization; Humans; Kidney; Mal | 2008 |
Worsening renal function in patients hospitalised for acute heart failure: clinical implications and prognostic significance.
Topics: Aged; Creatinine; Diuretics; Female; Furosemide; Heart Failure; Hospitalization; Humans; Kidney; Mal | 2008 |
Pharmacologic approaches for volume excess in acute kidney injury (AKI).
Topics: Acute Kidney Injury; Ascites; Bumetanide; Diuretics; Fluid Therapy; Furosemide; Heart Failure; Hepat | 2008 |
Pharmacologic approaches for volume excess in acute kidney injury (AKI).
Topics: Acute Kidney Injury; Ascites; Bumetanide; Diuretics; Fluid Therapy; Furosemide; Heart Failure; Hepat | 2008 |
[Recent advances in the physiopathology and therapy of edematogenic states].
Topics: Adrenal Cortex Hormones; Adult; Digitalis Glycosides; Diuretics; Edema; Female; Furosemide; Heart Fa | 1966 |
[Recent advances in the physiopathology and therapy of edematogenic states].
Topics: Adrenal Cortex Hormones; Adult; Digitalis Glycosides; Diuretics; Edema; Female; Furosemide; Heart Fa | 1966 |
[The hemodynamic action of diuretics].
Topics: Blood Volume; Cardiac Output; Digitalis Glycosides; Diuretics; Ethacrynic Acid; Furosemide; Glomerul | 1966 |
[The hemodynamic action of diuretics].
Topics: Blood Volume; Cardiac Output; Digitalis Glycosides; Diuretics; Ethacrynic Acid; Furosemide; Glomerul | 1966 |
[Saluretics in the treatment of cardiac and renal edema].
Topics: Blood Circulation; Body Weight; Chlorothiazide; Diuretics; Edema; Ethacrynic Acid; Furosemide; Heart | 1966 |
[Saluretics in the treatment of cardiac and renal edema].
Topics: Blood Circulation; Body Weight; Chlorothiazide; Diuretics; Edema; Ethacrynic Acid; Furosemide; Heart | 1966 |
[A comparative clinical investigation of the diuretic furosemide].
Topics: Acute Kidney Injury; Benzothiadiazines; Chlorides; Diuretics; Eclampsia; Edema; Female; Furosemide; | 1966 |
[A comparative clinical investigation of the diuretic furosemide].
Topics: Acute Kidney Injury; Benzothiadiazines; Chlorides; Diuretics; Eclampsia; Edema; Female; Furosemide; | 1966 |
Furosemide, a new diuretic in edematous states. Clinical studies in patients with congestive heart failure and cirrhosis of the liver.
Topics: Aged; Body Weight; Edema; Female; Furosemide; Heart Failure; Humans; Hypokalemia; Injections, Intrav | 1967 |
Furosemide, a new diuretic in edematous states. Clinical studies in patients with congestive heart failure and cirrhosis of the liver.
Topics: Aged; Body Weight; Edema; Female; Furosemide; Heart Failure; Humans; Hypokalemia; Injections, Intrav | 1967 |
Refractory heart failure.
Topics: Adult; Aged; Alkalosis; Digitalis Glycosides; Diuretics; Ethacrynic Acid; Furosemide; Heart Failure; | 1967 |
Refractory heart failure.
Topics: Adult; Aged; Alkalosis; Digitalis Glycosides; Diuretics; Ethacrynic Acid; Furosemide; Heart Failure; | 1967 |
Lasix.
Topics: Diuresis; Edema; Furosemide; Heart Failure; Humans; Kidney Diseases; Liver Cirrhosis; Potassium Defi | 1967 |
Lasix.
Topics: Diuresis; Edema; Furosemide; Heart Failure; Humans; Kidney Diseases; Liver Cirrhosis; Potassium Defi | 1967 |
Furosemide as a diuretic.
Topics: Aged; Female; Furosemide; Heart Failure; Humans; Male; Middle Aged | 1967 |
Furosemide as a diuretic.
Topics: Aged; Female; Furosemide; Heart Failure; Humans; Male; Middle Aged | 1967 |
Clinical evaluation of furosemide.
Topics: Adult; Aged; Edema; Female; Furosemide; Heart Failure; Humans; Hypertension; Liver Cirrhosis; Male; | 1967 |
Clinical evaluation of furosemide.
Topics: Adult; Aged; Edema; Female; Furosemide; Heart Failure; Humans; Hypertension; Liver Cirrhosis; Male; | 1967 |
[Observations on the diuretic activity of furosemide].
Topics: Diuresis; Edema; Furosemide; Heart Diseases; Heart Failure; Humans; Liver Cirrhosis; Water-Electroly | 1967 |
[Observations on the diuretic activity of furosemide].
Topics: Diuresis; Edema; Furosemide; Heart Diseases; Heart Failure; Humans; Liver Cirrhosis; Water-Electroly | 1967 |
[Metabolic balance in patients with cardiac cachexia].
Topics: Adult; Cachexia; Diet Therapy; Dietary Proteins; Diuretics; Female; Furosemide; Heart Failure; Human | 1967 |
[Metabolic balance in patients with cardiac cachexia].
Topics: Adult; Cachexia; Diet Therapy; Dietary Proteins; Diuretics; Female; Furosemide; Heart Failure; Human | 1967 |
Intravenous administration of furosemide in heart failure.
Topics: Blood Chemical Analysis; Blood Glucose; Blood Proteins; Blood Urea Nitrogen; Blood Volume; Ethacryni | 1967 |
Intravenous administration of furosemide in heart failure.
Topics: Blood Chemical Analysis; Blood Glucose; Blood Proteins; Blood Urea Nitrogen; Blood Volume; Ethacryni | 1967 |
Hemodynamic results of perorally administered converting enzyme inhibitors in congestive heart failure.
Topics: Administration, Oral; Angiotensin-Converting Enzyme Inhibitors; Captopril; Dipeptides; Enalapril; Ex | 1984 |
Hemodynamic results of perorally administered converting enzyme inhibitors in congestive heart failure.
Topics: Administration, Oral; Angiotensin-Converting Enzyme Inhibitors; Captopril; Dipeptides; Enalapril; Ex | 1984 |
Acute haemodynamic, hormonal and electrolyte effects and short-term clinical response to enalapril in heart failure.
Topics: Aged; Aldosterone; Angiotensin II; Blood Pressure; Chronic Disease; Electrolytes; Enalapril; Female; | 1983 |
Acute haemodynamic, hormonal and electrolyte effects and short-term clinical response to enalapril in heart failure.
Topics: Aged; Aldosterone; Angiotensin II; Blood Pressure; Chronic Disease; Electrolytes; Enalapril; Female; | 1983 |
Chlorpromazine and frusemide in treatment of acute left-ventricular failure.
Topics: Acute Disease; Aged; Blood Pressure; Carbon Dioxide; Chlorpromazine; Drug Therapy, Combination; Furo | 1980 |
Chlorpromazine and frusemide in treatment of acute left-ventricular failure.
Topics: Acute Disease; Aged; Blood Pressure; Carbon Dioxide; Chlorpromazine; Drug Therapy, Combination; Furo | 1980 |
[Vasodilators in heart failure? Basic principles and its role in practice].
Topics: Adrenergic alpha-Antagonists; Captopril; Diazoxide; Furosemide; Heart Failure; Humans; Hydralazine; | 1981 |
[Vasodilators in heart failure? Basic principles and its role in practice].
Topics: Adrenergic alpha-Antagonists; Captopril; Diazoxide; Furosemide; Heart Failure; Humans; Hydralazine; | 1981 |
The pharmacokinetic, pharmacodynamic and haemodynamic effects of acute and chronic alpha-adrenoceptor blockade in chronic heart failure.
Topics: Adrenergic alpha-Antagonists; Adult; Aged; Digoxin; Female; Furosemide; Heart Failure; Hemodynamics; | 1981 |
The pharmacokinetic, pharmacodynamic and haemodynamic effects of acute and chronic alpha-adrenoceptor blockade in chronic heart failure.
Topics: Adrenergic alpha-Antagonists; Adult; Aged; Digoxin; Female; Furosemide; Heart Failure; Hemodynamics; | 1981 |
[Long-term treatment with captopril in arterial hypertension complicated by renal failure].
Topics: Adrenergic beta-Antagonists; Adult; Aged; Blood Pressure; Captopril; Female; Furosemide; Heart Failu | 1982 |
[Long-term treatment with captopril in arterial hypertension complicated by renal failure].
Topics: Adrenergic beta-Antagonists; Adult; Aged; Blood Pressure; Captopril; Female; Furosemide; Heart Failu | 1982 |
Variable clinical response to long-term angiotensin inhibition in severe heart failure: demonstration of additive benefits of alpha-receptor blockade.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Aldosterone; Angiotensin-Converting Enzyme Inhibitors; Cap | 1982 |
Variable clinical response to long-term angiotensin inhibition in severe heart failure: demonstration of additive benefits of alpha-receptor blockade.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Aldosterone; Angiotensin-Converting Enzyme Inhibitors; Cap | 1982 |
Relationship between the enzymatically estimated infarct size and clinical findings in acute myocardial infarction.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Blood Pressure; Creatine Kinase; Follow-Up Studies; Furose | 1984 |
Relationship between the enzymatically estimated infarct size and clinical findings in acute myocardial infarction.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Blood Pressure; Creatine Kinase; Follow-Up Studies; Furose | 1984 |
[Therapy of acute myocardial infarct before hospital admission].
Topics: Aged; Atropine; Bradycardia; Cardiac Complexes, Premature; Diagnosis, Differential; First Aid; Furos | 1982 |
[Therapy of acute myocardial infarct before hospital admission].
Topics: Aged; Atropine; Bradycardia; Cardiac Complexes, Premature; Diagnosis, Differential; First Aid; Furos | 1982 |
[Behavior of salivary electrolytes in decompensated cardiology patients].
Topics: Adult; Aged; Calcium; Digitalis Glycosides; Diuretics; Female; Furosemide; Heart Failure; Humans; Ma | 1984 |
[Behavior of salivary electrolytes in decompensated cardiology patients].
Topics: Adult; Aged; Calcium; Digitalis Glycosides; Diuretics; Female; Furosemide; Heart Failure; Humans; Ma | 1984 |
[Dilatation (congestive) cardiomyopathy: clinical aspects, diagnosis and treatment].
Topics: Adolescent; Adult; Cardiomegaly; Cardiomyopathy, Dilated; Coronary Disease; Diagnosis, Differential; | 1984 |
[Dilatation (congestive) cardiomyopathy: clinical aspects, diagnosis and treatment].
Topics: Adolescent; Adult; Cardiomegaly; Cardiomyopathy, Dilated; Coronary Disease; Diagnosis, Differential; | 1984 |
[Effects of the PETN-piridoxylate combination in the long-term treatment of cardiac failure in the aged patient].
Topics: Aged; Coronary Disease; Digoxin; Drug Combinations; Drug Therapy, Combination; Furosemide; Heart Fai | 1983 |
[Effects of the PETN-piridoxylate combination in the long-term treatment of cardiac failure in the aged patient].
Topics: Aged; Coronary Disease; Digoxin; Drug Combinations; Drug Therapy, Combination; Furosemide; Heart Fai | 1983 |
Sonographic diagnosis of furosemide-induced nephrocalcinosis in newborn infants.
Topics: Female; Furosemide; Heart Failure; Humans; Infant, Newborn; Male; Nephrocalcinosis; Ultrasonography | 1984 |
Sonographic diagnosis of furosemide-induced nephrocalcinosis in newborn infants.
Topics: Female; Furosemide; Heart Failure; Humans; Infant, Newborn; Male; Nephrocalcinosis; Ultrasonography | 1984 |
[Captopril in the treatment of severe circulatory insufficiency resistant to digitalis preparations and diuretics].
Topics: Aged; Captopril; Cardiomyopathy, Dilated; Digoxin; Dihydralazine; Drug Resistance; Drug Therapy, Com | 1984 |
[Captopril in the treatment of severe circulatory insufficiency resistant to digitalis preparations and diuretics].
Topics: Aged; Captopril; Cardiomyopathy, Dilated; Digoxin; Dihydralazine; Drug Resistance; Drug Therapy, Com | 1984 |
[Heart failure and diuretics. Pharmacokinetics with furosemide].
Topics: Furosemide; Heart Failure; Humans; Kinetics; Metabolic Clearance Rate | 1983 |
[Heart failure and diuretics. Pharmacokinetics with furosemide].
Topics: Furosemide; Heart Failure; Humans; Kinetics; Metabolic Clearance Rate | 1983 |
Documented sudden cardiac death in prolonged QT syndrome.
Topics: Aged; Death, Sudden; Diabetes Complications; Digoxin; Electrocardiography; Epilepsy, Tonic-Clonic; F | 1984 |
Documented sudden cardiac death in prolonged QT syndrome.
Topics: Aged; Death, Sudden; Diabetes Complications; Digoxin; Electrocardiography; Epilepsy, Tonic-Clonic; F | 1984 |
Alkalemia in diabetic ketoacidosis.
Topics: Aged; Alkalosis; Diabetes Mellitus, Type 1; Diabetic Ketoacidosis; Diuretics; Female; Furosemide; He | 1984 |
Alkalemia in diabetic ketoacidosis.
Topics: Aged; Alkalosis; Diabetes Mellitus, Type 1; Diabetic Ketoacidosis; Diuretics; Female; Furosemide; He | 1984 |
Congestive heart failure due to giant cutaneous cavernous hemangioma.
Topics: Digoxin; Drug Resistance; Facial Neoplasms; Female; Furosemide; Heart Failure; Hemangioma, Cavernous | 1984 |
Congestive heart failure due to giant cutaneous cavernous hemangioma.
Topics: Digoxin; Drug Resistance; Facial Neoplasms; Female; Furosemide; Heart Failure; Hemangioma, Cavernous | 1984 |
Vasodilator treatment for mild to moderate heart failure. Effect of Ro 12-4713, a minoxidil analogue.
Topics: Adult; Aged; Blood Pressure; Cardiac Output; Digoxin; Drug Therapy, Combination; Female; Furosemide; | 1984 |
Vasodilator treatment for mild to moderate heart failure. Effect of Ro 12-4713, a minoxidil analogue.
Topics: Adult; Aged; Blood Pressure; Cardiac Output; Digoxin; Drug Therapy, Combination; Female; Furosemide; | 1984 |
[Therapy of heart failure with combined furosemide retard/triamterene].
Topics: Aged; Cholesterol; Creatinine; Delayed-Action Preparations; Drug Combinations; Female; Furosemide; H | 1984 |
[Therapy of heart failure with combined furosemide retard/triamterene].
Topics: Aged; Cholesterol; Creatinine; Delayed-Action Preparations; Drug Combinations; Female; Furosemide; H | 1984 |
Prolonged hemodynamic effect of furosemide in congestive heart failure.
Topics: Cardiac Output; Furosemide; Heart Failure; Humans; Natriuresis; Stroke Volume | 1984 |
Prolonged hemodynamic effect of furosemide in congestive heart failure.
Topics: Cardiac Output; Furosemide; Heart Failure; Humans; Natriuresis; Stroke Volume | 1984 |
Adverse drug reactions (ADRs) in patients with heart diseases. Comparison between patients without and with heart failure.
Topics: Acetyldigitoxins; Age Factors; Cardiovascular Agents; Drug Evaluation; Female; Furosemide; Heart Fai | 1984 |
Adverse drug reactions (ADRs) in patients with heart diseases. Comparison between patients without and with heart failure.
Topics: Acetyldigitoxins; Age Factors; Cardiovascular Agents; Drug Evaluation; Female; Furosemide; Heart Fai | 1984 |
Acute and chronic hemodynamic effects of the basic therapeutic regimen for congestive heart failure. Diuretics, low salt diet and bed rest.
Topics: Adult; Aged; Bed Rest; Blood Pressure; Diet, Sodium-Restricted; Diuretics; Female; Furosemide; Heart | 1984 |
Acute and chronic hemodynamic effects of the basic therapeutic regimen for congestive heart failure. Diuretics, low salt diet and bed rest.
Topics: Adult; Aged; Bed Rest; Blood Pressure; Diet, Sodium-Restricted; Diuretics; Female; Furosemide; Heart | 1984 |
High-dose furosemide in cardiac failure.
Topics: Adult; Dose-Response Relationship, Drug; Furosemide; Heart Failure; Humans | 1984 |
High-dose furosemide in cardiac failure.
Topics: Adult; Dose-Response Relationship, Drug; Furosemide; Heart Failure; Humans | 1984 |
[Serum concentration of digoxin in patients with congestive heart failure after intravenous furosemide].
Topics: Adolescent; Adult; Digoxin; Drug Interactions; Female; Furosemide; Heart Failure; Humans; Male; Midd | 1984 |
[Serum concentration of digoxin in patients with congestive heart failure after intravenous furosemide].
Topics: Adolescent; Adult; Digoxin; Drug Interactions; Female; Furosemide; Heart Failure; Humans; Male; Midd | 1984 |
Nitrates in acute myocardial infarction.
Topics: Blood Pressure; Cardiac Output; Drug Interactions; Furosemide; Heart Failure; Heart Rate; Humans; Hy | 1984 |
Nitrates in acute myocardial infarction.
Topics: Blood Pressure; Cardiac Output; Drug Interactions; Furosemide; Heart Failure; Heart Rate; Humans; Hy | 1984 |
[Effect of diuretics on myocardial function in chronic heart insufficiency].
Topics: Benzothiadiazines; Blood Pressure; Diuretics; Furosemide; Heart Failure; Heart Ventricles; Humans; N | 1983 |
[Effect of diuretics on myocardial function in chronic heart insufficiency].
Topics: Benzothiadiazines; Blood Pressure; Diuretics; Furosemide; Heart Failure; Heart Ventricles; Humans; N | 1983 |
Haemodynamic effects of frusemide and its influence on repetitive rapid volume loading in acute myocardial infarction.
Topics: Adult; Aged; Blood Pressure; Blood Volume; Cardiac Output; Female; Furosemide; Heart Failure; Heart | 1983 |
Haemodynamic effects of frusemide and its influence on repetitive rapid volume loading in acute myocardial infarction.
Topics: Adult; Aged; Blood Pressure; Blood Volume; Cardiac Output; Female; Furosemide; Heart Failure; Heart | 1983 |
Efficacy of two proprietary preparations of frusemide in patients with congestive heart failure.
Topics: Biological Availability; Body Weight; Double-Blind Method; Drug Evaluation; Furosemide; Heart Failur | 1984 |
Efficacy of two proprietary preparations of frusemide in patients with congestive heart failure.
Topics: Biological Availability; Body Weight; Double-Blind Method; Drug Evaluation; Furosemide; Heart Failur | 1984 |
Blood volume following diuresis induced by furosemide.
Topics: Adult; Aged; Blood Volume; Diuresis; Female; Furosemide; Heart Failure; Humans; Male; Middle Aged; P | 1984 |
Blood volume following diuresis induced by furosemide.
Topics: Adult; Aged; Blood Volume; Diuresis; Female; Furosemide; Heart Failure; Humans; Male; Middle Aged; P | 1984 |
Hypereosinophilic syndrome with pulmonary vascular involvement.
Topics: Aged; Autopsy; Bronchodilator Agents; Digoxin; Eosinophilia; Female; Furosemide; Heart Failure; Huma | 1984 |
Hypereosinophilic syndrome with pulmonary vascular involvement.
Topics: Aged; Autopsy; Bronchodilator Agents; Digoxin; Eosinophilia; Female; Furosemide; Heart Failure; Huma | 1984 |
Relationship between electrocardiographically estimated infarct size and clinical findings in inferior myocardial infarction.
Topics: Adult; Aged; Arrhythmias, Cardiac; Electrocardiography; Furosemide; Heart Failure; Hemodynamics; Hum | 1984 |
Relationship between electrocardiographically estimated infarct size and clinical findings in inferior myocardial infarction.
Topics: Adult; Aged; Arrhythmias, Cardiac; Electrocardiography; Furosemide; Heart Failure; Hemodynamics; Hum | 1984 |
Göteborg Metoprolol Trial: clinical observations.
Topics: Blood Pressure; Clinical Trials as Topic; Double-Blind Method; Furosemide; Heart Failure; Heart Rate | 1984 |
Göteborg Metoprolol Trial: clinical observations.
Topics: Blood Pressure; Clinical Trials as Topic; Double-Blind Method; Furosemide; Heart Failure; Heart Rate | 1984 |
Hypertensive left heart failure: pathogenesis and therapy.
Topics: Diuretics; Furosemide; Heart Failure; Hemodynamics; Humans; Hypertension; Male; Middle Aged; Nitropr | 1981 |
Hypertensive left heart failure: pathogenesis and therapy.
Topics: Diuretics; Furosemide; Heart Failure; Hemodynamics; Humans; Hypertension; Male; Middle Aged; Nitropr | 1981 |
Ineffectiveness of sublingual nitroglycerin in acute left ventricular failure in the presence of massive peripheral edema.
Topics: Administration, Oral; Adult; Aged; Digitalis Glycosides; Diuretics; Edema, Cardiac; Furosemide; Hear | 1980 |
Ineffectiveness of sublingual nitroglycerin in acute left ventricular failure in the presence of massive peripheral edema.
Topics: Administration, Oral; Adult; Aged; Digitalis Glycosides; Diuretics; Edema, Cardiac; Furosemide; Hear | 1980 |
Antagonistic effect of non-steroidal anti-inflammatory drugs on frusemide-induced diuresis in cardiac failure.
Topics: Aged; Diuresis; Female; Furosemide; Heart Failure; Humans; Ibuprofen; Male; Naproxen | 1981 |
Antagonistic effect of non-steroidal anti-inflammatory drugs on frusemide-induced diuresis in cardiac failure.
Topics: Aged; Diuresis; Female; Furosemide; Heart Failure; Humans; Ibuprofen; Male; Naproxen | 1981 |
[Acute exposure to CS tear gas and clinical studies].
Topics: Adult; Chemical and Drug Induced Liver Injury; Digoxin; Furosemide; Heart Failure; Humans; Male; Nit | 1981 |
[Acute exposure to CS tear gas and clinical studies].
Topics: Adult; Chemical and Drug Induced Liver Injury; Digoxin; Furosemide; Heart Failure; Humans; Male; Nit | 1981 |
[Long term experiences with a solid spironolactone-furosemide combination in heart insufficiency and hypertension].
Topics: Adult; Aged; Drug Combinations; Female; Furosemide; Heart Failure; Humans; Hypertension; Long-Term C | 1982 |
[Long term experiences with a solid spironolactone-furosemide combination in heart insufficiency and hypertension].
Topics: Adult; Aged; Drug Combinations; Female; Furosemide; Heart Failure; Humans; Hypertension; Long-Term C | 1982 |
Interaction of indomethacin with furosemide.
Topics: Aged; Arthritis; Drug Interactions; Female; Furosemide; Gout; Heart Failure; Humans; Indomethacin; W | 1983 |
Interaction of indomethacin with furosemide.
Topics: Aged; Arthritis; Drug Interactions; Female; Furosemide; Gout; Heart Failure; Humans; Indomethacin; W | 1983 |
Beta-blockers in dilated cardiomyopathies: they work.
Topics: Administration, Oral; Adult; Aged; Digoxin; Dilatation, Pathologic; Drug Therapy, Combination; Femal | 1983 |
Beta-blockers in dilated cardiomyopathies: they work.
Topics: Administration, Oral; Adult; Aged; Digoxin; Dilatation, Pathologic; Drug Therapy, Combination; Femal | 1983 |
Plasma norepinephrine concentration and plasma dopamine-beta-hydroxylase activity in patients with congestive heart failure.
Topics: Adolescent; Adult; Aged; Digoxin; Dopamine beta-Hydroxylase; Epinephrine; Female; Furosemide; Heart | 1983 |
Plasma norepinephrine concentration and plasma dopamine-beta-hydroxylase activity in patients with congestive heart failure.
Topics: Adolescent; Adult; Aged; Digoxin; Dopamine beta-Hydroxylase; Epinephrine; Female; Furosemide; Heart | 1983 |
Haemodynamic effects of prazosin in CHF.
Topics: Cardiac Catheterization; Cardiac Output; Digoxin; Drug Therapy, Combination; Furosemide; Heart Failu | 1981 |
Haemodynamic effects of prazosin in CHF.
Topics: Cardiac Catheterization; Cardiac Output; Digoxin; Drug Therapy, Combination; Furosemide; Heart Failu | 1981 |
Respiratory function following myocardial infarction.
Topics: Forced Expiratory Volume; Furosemide; Heart Failure; Humans; Lung; Myocardial Infarction; Oxygen; Pu | 1981 |
Respiratory function following myocardial infarction.
Topics: Forced Expiratory Volume; Furosemide; Heart Failure; Humans; Lung; Myocardial Infarction; Oxygen; Pu | 1981 |
The occurrence of hyperaldosteronism in infants with congestive heart failure.
Topics: Aldosterone; Body Weight; Epidemiologic Methods; Furosemide; Heart Failure; Humans; Hyperaldosteroni | 1980 |
The occurrence of hyperaldosteronism in infants with congestive heart failure.
Topics: Aldosterone; Body Weight; Epidemiologic Methods; Furosemide; Heart Failure; Humans; Hyperaldosteroni | 1980 |
Haemodynamic and hormone responses to acute and chronic frusemide therapy in congestive heart failure.
Topics: Adult; Aged; Aldosterone; Angiotensin II; Female; Furosemide; Heart Failure; Hemodynamics; Humans; H | 1980 |
Haemodynamic and hormone responses to acute and chronic frusemide therapy in congestive heart failure.
Topics: Adult; Aged; Aldosterone; Angiotensin II; Female; Furosemide; Heart Failure; Hemodynamics; Humans; H | 1980 |
[Right-heart failure due to right ventricular infarction. II. Prognosis and treatment].
Topics: Blood Pressure; Bradycardia; Cardiac Output; Dopamine; Furosemide; Heart Block; Heart Failure; Human | 1982 |
[Right-heart failure due to right ventricular infarction. II. Prognosis and treatment].
Topics: Blood Pressure; Bradycardia; Cardiac Output; Dopamine; Furosemide; Heart Block; Heart Failure; Human | 1982 |
Hemodynamic effects of nitroprusside and furosemide in left ventricular failure.
Topics: Aged; Blood Pressure; Ferricyanides; Furosemide; Heart Failure; Heart Ventricles; Hemodynamics; Huma | 1982 |
Hemodynamic effects of nitroprusside and furosemide in left ventricular failure.
Topics: Aged; Blood Pressure; Ferricyanides; Furosemide; Heart Failure; Heart Ventricles; Hemodynamics; Huma | 1982 |
Treatment of canine heartworm disease coexisting with right-side heart failure.
Topics: Animals; Aspirin; Digoxin; Dirofilariasis; Dog Diseases; Dogs; Furosemide; Heart Failure; Rest | 1982 |
Treatment of canine heartworm disease coexisting with right-side heart failure.
Topics: Animals; Aspirin; Digoxin; Dirofilariasis; Dog Diseases; Dogs; Furosemide; Heart Failure; Rest | 1982 |
Medical management of congestive heart failure in a horse.
Topics: Administration, Oral; Animals; Digoxin; Electrocardiography; Furosemide; Heart Failure; Horse Diseas | 1982 |
Medical management of congestive heart failure in a horse.
Topics: Administration, Oral; Animals; Digoxin; Electrocardiography; Furosemide; Heart Failure; Horse Diseas | 1982 |
Specimen handling and high-performance liquid chromatographic determination of furosemide.
Topics: Adult; Aged; Chromatography, High Pressure Liquid; Furosemide; Heart Failure; Humans; Male; Referenc | 1982 |
Specimen handling and high-performance liquid chromatographic determination of furosemide.
Topics: Adult; Aged; Chromatography, High Pressure Liquid; Furosemide; Heart Failure; Humans; Male; Referenc | 1982 |
Hydralazine and furosemide kinetics.
Topics: Adult; Creatinine; Drug Interactions; Female; Furosemide; Half-Life; Heart Failure; Humans; Hydralaz | 1982 |
Hydralazine and furosemide kinetics.
Topics: Adult; Creatinine; Drug Interactions; Female; Furosemide; Half-Life; Heart Failure; Humans; Hydralaz | 1982 |
Renal calcifications: a complication of long-term furosemide therapy in preterm infants.
Topics: Ductus Arteriosus, Patent; Furosemide; Heart Failure; Humans; Infant; Infant, Newborn; Infant, Prema | 1982 |
Renal calcifications: a complication of long-term furosemide therapy in preterm infants.
Topics: Ductus Arteriosus, Patent; Furosemide; Heart Failure; Humans; Infant; Infant, Newborn; Infant, Prema | 1982 |
Drug attributed alterations in potassium handling in congestive cardiac failure.
Topics: Adult; Aged; Blood Urea Nitrogen; Diuretics; Female; Furosemide; Heart Failure; Humans; Hyperkalemia | 1982 |
Drug attributed alterations in potassium handling in congestive cardiac failure.
Topics: Adult; Aged; Blood Urea Nitrogen; Diuretics; Female; Furosemide; Heart Failure; Humans; Hyperkalemia | 1982 |
[Therapy of cardiac insufficiency with diuretics].
Topics: Amiloride; Benzothiadiazines; Blood Glucose; Diuretics; Drug Administration Schedule; Female; Furose | 1982 |
[Therapy of cardiac insufficiency with diuretics].
Topics: Amiloride; Benzothiadiazines; Blood Glucose; Diuretics; Drug Administration Schedule; Female; Furose | 1982 |
Absorption and disposition of furosemide in congestive heart failure.
Topics: Absorption; Administration, Oral; Biological Availability; Creatinine; Furosemide; Heart Failure; Hu | 1982 |
Absorption and disposition of furosemide in congestive heart failure.
Topics: Absorption; Administration, Oral; Biological Availability; Creatinine; Furosemide; Heart Failure; Hu | 1982 |
[Effect of lasix on central and peripheral circulation in patients with chronic circulatory insufficiency].
Topics: Adolescent; Adult; Blood; Cardiac Output; Cardiomyopathies; Chronic Disease; Female; Furosemide; Hea | 1982 |
[Effect of lasix on central and peripheral circulation in patients with chronic circulatory insufficiency].
Topics: Adolescent; Adult; Blood; Cardiac Output; Cardiomyopathies; Chronic Disease; Female; Furosemide; Hea | 1982 |
Determinants of the diuretic response to furosemide in infants with congestive heart failure.
Topics: Diuresis; Furosemide; Heart Failure; Humans; Infant | 1982 |
Determinants of the diuretic response to furosemide in infants with congestive heart failure.
Topics: Diuresis; Furosemide; Heart Failure; Humans; Infant | 1982 |
Medical management of infants and children with congenital heart disease.
Topics: Alprostadil; Cardiac Output; Child, Preschool; Digoxin; Furosemide; Heart Defects, Congenital; Heart | 1981 |
Medical management of infants and children with congenital heart disease.
Topics: Alprostadil; Cardiac Output; Child, Preschool; Digoxin; Furosemide; Heart Defects, Congenital; Heart | 1981 |
[Tienilic acid, hyperuricemia and kidney function].
Topics: Aged; Creatinine; Female; Furosemide; Glycolates; Heart Failure; Humans; Hydrochlorothiazide; Kidney | 1981 |
[Tienilic acid, hyperuricemia and kidney function].
Topics: Aged; Creatinine; Female; Furosemide; Glycolates; Heart Failure; Humans; Hydrochlorothiazide; Kidney | 1981 |
Effect of furosemide in congestive heart failure.
Topics: Adult; Diuresis; Drug Therapy, Combination; Electrolytes; Female; Furosemide; Heart Failure; Humans; | 1981 |
Effect of furosemide in congestive heart failure.
Topics: Adult; Diuresis; Drug Therapy, Combination; Electrolytes; Female; Furosemide; Heart Failure; Humans; | 1981 |
[Clinical evaluation of bumetanide in the diuretic treatment of heart failure and liver cirrhosis].
Topics: Adult; Aged; Bumetanide; Diuresis; Diuretics; Electrolytes; Ethacrynic Acid; Female; Furosemide; Hea | 1981 |
[Clinical evaluation of bumetanide in the diuretic treatment of heart failure and liver cirrhosis].
Topics: Adult; Aged; Bumetanide; Diuresis; Diuretics; Electrolytes; Ethacrynic Acid; Female; Furosemide; Hea | 1981 |
[Diuretic effects of furosemide in patients with congestive heart failure (author's transl)].
Topics: Adult; Aged; Diuresis; Female; Furosemide; Heart Failure; Humans; Hydralazine; Male; Middle Aged; Ti | 1981 |
[Diuretic effects of furosemide in patients with congestive heart failure (author's transl)].
Topics: Adult; Aged; Diuresis; Female; Furosemide; Heart Failure; Humans; Hydralazine; Male; Middle Aged; Ti | 1981 |
The role of furosemide alone and in combination with digoxin in the relief of symptoms of congestive heart failure.
Topics: Adult; Aged; Creatine; Digoxin; Drug Therapy, Combination; Electrocardiography; Electrolytes; Female | 1980 |
The role of furosemide alone and in combination with digoxin in the relief of symptoms of congestive heart failure.
Topics: Adult; Aged; Creatine; Digoxin; Drug Therapy, Combination; Electrocardiography; Electrolytes; Female | 1980 |
Hemodynamic determinants of prognosis of aortic valve replacement in critical aortic stenosis and advanced congestive heart failure.
Topics: Adult; Aged; Aortic Valve; Aortic Valve Stenosis; Digoxin; Female; Furosemide; Heart Failure; Hemody | 1980 |
Hemodynamic determinants of prognosis of aortic valve replacement in critical aortic stenosis and advanced congestive heart failure.
Topics: Adult; Aged; Aortic Valve; Aortic Valve Stenosis; Digoxin; Female; Furosemide; Heart Failure; Hemody | 1980 |
Treatment of dilutional hyponatremia in congestive heart failure.
Topics: Adult; Aged; Body Weight; Diuretics; Female; Furosemide; Heart Failure; Humans; Hyponatremia; Infusi | 1980 |
Treatment of dilutional hyponatremia in congestive heart failure.
Topics: Adult; Aged; Body Weight; Diuretics; Female; Furosemide; Heart Failure; Humans; Hyponatremia; Infusi | 1980 |
Survey of cardiac failure therapy in Australian medical practice: dependence on digoxin level for diagnosis of toxicity.
Topics: Digoxin; Furosemide; Heart Failure; Humans | 1980 |
Survey of cardiac failure therapy in Australian medical practice: dependence on digoxin level for diagnosis of toxicity.
Topics: Digoxin; Furosemide; Heart Failure; Humans | 1980 |
Furosemide in patients with heart failure: shift in dose-response curves.
Topics: Adult; Aged; Dose-Response Relationship, Drug; Female; Furosemide; Heart Failure; Humans; Kidney Dis | 1980 |
Furosemide in patients with heart failure: shift in dose-response curves.
Topics: Adult; Aged; Dose-Response Relationship, Drug; Female; Furosemide; Heart Failure; Humans; Kidney Dis | 1980 |
Infarct expansion: the "second event" after acute myocardial infarction.
Topics: Arteriosclerosis; Blood Pressure; Electrocardiography; Furosemide; Heart Failure; Humans; Male; Midd | 1980 |
Infarct expansion: the "second event" after acute myocardial infarction.
Topics: Arteriosclerosis; Blood Pressure; Electrocardiography; Furosemide; Heart Failure; Humans; Male; Midd | 1980 |
[Treatment of low output syndrome in chronic Chagas cardiopathy].
Topics: Adolescent; Adult; Cardiac Output, Low; Chagas Cardiomyopathy; Chlorpromazine; Female; Furosemide; H | 1980 |
[Treatment of low output syndrome in chronic Chagas cardiopathy].
Topics: Adolescent; Adult; Cardiac Output, Low; Chagas Cardiomyopathy; Chlorpromazine; Female; Furosemide; H | 1980 |
Treatment of refractory congestive heart failure and normokalemic hypochloremic alkalosis with acetazolamide and spironolactone.
Topics: Acetazolamide; Aged; Alkalosis; Chlorides; Drug Therapy, Combination; Furosemide; Heart Failure; Hum | 1980 |
Treatment of refractory congestive heart failure and normokalemic hypochloremic alkalosis with acetazolamide and spironolactone.
Topics: Acetazolamide; Aged; Alkalosis; Chlorides; Drug Therapy, Combination; Furosemide; Heart Failure; Hum | 1980 |
[Evaluation of long-term treatment with isosorbide dinitrate and prazosin in cardiac insufficiency].
Topics: Adult; Aged; Digoxin; Drug Evaluation; Female; Furosemide; Heart Failure; Heart Rate; Hemodynamics; | 1980 |
[Evaluation of long-term treatment with isosorbide dinitrate and prazosin in cardiac insufficiency].
Topics: Adult; Aged; Digoxin; Drug Evaluation; Female; Furosemide; Heart Failure; Heart Rate; Hemodynamics; | 1980 |
Systolic time intervals. Noninvasive assessment of vasodilator therapy for congestive failure.
Topics: Adult; Digoxin; Echocardiography; Electrocardiography; Furosemide; Heart Failure; Humans; Hydralazin | 1981 |
Systolic time intervals. Noninvasive assessment of vasodilator therapy for congestive failure.
Topics: Adult; Digoxin; Echocardiography; Electrocardiography; Furosemide; Heart Failure; Humans; Hydralazin | 1981 |
[Effect of lasix on central hemodynamics in patients with cardiac insufficiency].
Topics: Diuretics; Furosemide; Heart Failure; Hemodynamics; Humans | 1980 |
[Effect of lasix on central hemodynamics in patients with cardiac insufficiency].
Topics: Diuretics; Furosemide; Heart Failure; Hemodynamics; Humans | 1980 |
[Renal function during treatment of chronic renal failure with angiotensin converting enzyme inhibitors].
Topics: Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Diuretics; Drug Therapy, Combination; Female; | 1995 |
[Renal function during treatment of chronic renal failure with angiotensin converting enzyme inhibitors].
Topics: Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Diuretics; Drug Therapy, Combination; Female; | 1995 |
[Outpatient diuretic treatment of terminal heart failure by a completely implantable venous infusion system].
Topics: Aged; Aged, 80 and over; Ambulatory Care; Angiotensin-Converting Enzyme Inhibitors; Digitalis Glycos | 1993 |
[Outpatient diuretic treatment of terminal heart failure by a completely implantable venous infusion system].
Topics: Aged; Aged, 80 and over; Ambulatory Care; Angiotensin-Converting Enzyme Inhibitors; Digitalis Glycos | 1993 |
Prolonged therapy by the combination of furosemide and thiazides in refractory heart failure and other fluid retaining conditions.
Topics: Aged; Aged, 80 and over; Cardiomyopathy, Dilated; Chlorothiazide; Diuretics; Drug Administration Sch | 1995 |
Prolonged therapy by the combination of furosemide and thiazides in refractory heart failure and other fluid retaining conditions.
Topics: Aged; Aged, 80 and over; Cardiomyopathy, Dilated; Chlorothiazide; Diuretics; Drug Administration Sch | 1995 |
High-dose frusemide for cardiac failure.
Topics: Aged; Aged, 80 and over; Angiotensin-Converting Enzyme Inhibitors; Atrial Fibrillation; Digoxin; Diu | 1995 |
High-dose frusemide for cardiac failure.
Topics: Aged; Aged, 80 and over; Angiotensin-Converting Enzyme Inhibitors; Atrial Fibrillation; Digoxin; Diu | 1995 |
Refractory oedema in congestive heart failure: a contributory role of loop diuretics.
Topics: Edema; Furosemide; Heart Failure; Humans; Prognosis; Risk Factors | 1995 |
Refractory oedema in congestive heart failure: a contributory role of loop diuretics.
Topics: Edema; Furosemide; Heart Failure; Humans; Prognosis; Risk Factors | 1995 |
Diuretics, ACE inhibitors, and cardiac failure.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Furosemide; Heart Failure; Humans; Kidney; Kidney Fa | 1995 |
Diuretics, ACE inhibitors, and cardiac failure.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Furosemide; Heart Failure; Humans; Kidney; Kidney Fa | 1995 |
Thiamin status, diuretic medications, and the management of congestive heart failure.
Topics: Adult; Aged; Bumetanide; Cross-Sectional Studies; Diet Records; Female; Food-Drug Interactions; Furo | 1995 |
Thiamin status, diuretic medications, and the management of congestive heart failure.
Topics: Adult; Aged; Bumetanide; Cross-Sectional Studies; Diet Records; Female; Food-Drug Interactions; Furo | 1995 |
Furosemide-associated fever.
Topics: Child, Preschool; Female; Fever of Unknown Origin; Follow-Up Studies; Furosemide; Heart Failure; Hum | 1995 |
Furosemide-associated fever.
Topics: Child, Preschool; Female; Fever of Unknown Origin; Follow-Up Studies; Furosemide; Heart Failure; Hum | 1995 |
Prolonged-release hard gelatin capsules of furosemide for the treatment of dogs.
Topics: Animals; Anticholesteremic Agents; Biological Availability; Capsules; Carboxymethylcellulose Sodium; | 1995 |
Prolonged-release hard gelatin capsules of furosemide for the treatment of dogs.
Topics: Animals; Anticholesteremic Agents; Biological Availability; Capsules; Carboxymethylcellulose Sodium; | 1995 |
Abetalipoproteinemia presenting with congestive cardiac failure.
Topics: Abetalipoproteinemia; Child; Furosemide; Heart Failure; Humans; Iron; Malabsorption Syndromes; Male; | 1994 |
Abetalipoproteinemia presenting with congestive cardiac failure.
Topics: Abetalipoproteinemia; Child; Furosemide; Heart Failure; Humans; Iron; Malabsorption Syndromes; Male; | 1994 |
A new visual analogue scale for assessment of dyspnoea in congestive heart failure.
Topics: Dyspnea; Furosemide; Heart Failure; Humans; Injections, Intravenous; Male; Pain Measurement; Quality | 1994 |
A new visual analogue scale for assessment of dyspnoea in congestive heart failure.
Topics: Dyspnea; Furosemide; Heart Failure; Humans; Injections, Intravenous; Male; Pain Measurement; Quality | 1994 |
Nephrocalcinosis and nephrolithiasis in infants with congestive heart failure treated with furosemide.
Topics: Female; Furosemide; Heart Failure; Humans; Infant; Infant, Newborn; Kidney Calculi; Male; Nephrocalc | 1994 |
Nephrocalcinosis and nephrolithiasis in infants with congestive heart failure treated with furosemide.
Topics: Female; Furosemide; Heart Failure; Humans; Infant; Infant, Newborn; Kidney Calculi; Male; Nephrocalc | 1994 |
Infantile hemangioendothelioma of the liver in a neonate.
Topics: Digoxin; Furosemide; Heart Failure; Hemangioendothelioma; Hepatomegaly; Humans; Infant, Newborn; Lap | 1993 |
Infantile hemangioendothelioma of the liver in a neonate.
Topics: Digoxin; Furosemide; Heart Failure; Hemangioendothelioma; Hepatomegaly; Humans; Infant, Newborn; Lap | 1993 |
[Effects of inhaled furosemide after indomethacin premedication on bronchial hyperresponsiveness in patients with chronic congestive heart failure].
Topics: Administration, Inhalation; Aged; Aged, 80 and over; Bronchial Hyperreactivity; Chronic Disease; Fem | 1994 |
[Effects of inhaled furosemide after indomethacin premedication on bronchial hyperresponsiveness in patients with chronic congestive heart failure].
Topics: Administration, Inhalation; Aged; Aged, 80 and over; Bronchial Hyperreactivity; Chronic Disease; Fem | 1994 |
[Acute mitral insufficiency in osteogenesis imperfecta].
Topics: Aortic Valve; Captopril; Cardiac Catheterization; Drug Therapy, Combination; Dyspnea; Echocardiograp | 1994 |
[Acute mitral insufficiency in osteogenesis imperfecta].
Topics: Aortic Valve; Captopril; Cardiac Catheterization; Drug Therapy, Combination; Dyspnea; Echocardiograp | 1994 |
Pulmonary function tests in patients with congestive heart failure: effects of medical therapy.
Topics: Adult; Aged; Captopril; Cardiovascular Agents; Digoxin; Dobutamine; Drug Therapy, Combination; Echoc | 1993 |
Pulmonary function tests in patients with congestive heart failure: effects of medical therapy.
Topics: Adult; Aged; Captopril; Cardiovascular Agents; Digoxin; Dobutamine; Drug Therapy, Combination; Echoc | 1993 |
Pharmacokinetics of digoxin administered to horses with congestive heart failure.
Topics: Animals; Biological Availability; Digoxin; Furosemide; Half-Life; Heart Failure; Horse Diseases; Hor | 1993 |
Pharmacokinetics of digoxin administered to horses with congestive heart failure.
Topics: Animals; Biological Availability; Digoxin; Furosemide; Half-Life; Heart Failure; Horse Diseases; Hor | 1993 |
Low-dose atrial natriuretic factor and furosemide in experimental acute congestive heart failure.
Topics: Acute Disease; Angiotensin II; Animals; Atrial Natriuretic Factor; Dogs; Drug Synergism; Drug Therap | 1993 |
Low-dose atrial natriuretic factor and furosemide in experimental acute congestive heart failure.
Topics: Acute Disease; Angiotensin II; Animals; Atrial Natriuretic Factor; Dogs; Drug Synergism; Drug Therap | 1993 |
Effect of enalapril on congestive heart failure treated with diuretics in elderly patients with prior myocardial infarction and normal left ventricular ejection fraction.
Topics: Aged; Aged, 80 and over; Echocardiography, Doppler; Enalapril; Exercise Test; Female; Furosemide; He | 1993 |
Effect of enalapril on congestive heart failure treated with diuretics in elderly patients with prior myocardial infarction and normal left ventricular ejection fraction.
Topics: Aged; Aged, 80 and over; Echocardiography, Doppler; Enalapril; Exercise Test; Female; Furosemide; He | 1993 |
A patient with congestive heart failure.
Topics: Adult; Captopril; Dose-Response Relationship, Drug; Furosemide; Heart Failure; Humans; Male; Postope | 1993 |
A patient with congestive heart failure.
Topics: Adult; Captopril; Dose-Response Relationship, Drug; Furosemide; Heart Failure; Humans; Male; Postope | 1993 |
[Effects of carperitide (alpha-human atrial natriuretic peptide) on acute congestive heart failure in dogs].
Topics: Animals; Atrial Natriuretic Factor; Disease Models, Animal; Dogs; Dose-Response Relationship, Drug; | 1993 |
[Effects of carperitide (alpha-human atrial natriuretic peptide) on acute congestive heart failure in dogs].
Topics: Animals; Atrial Natriuretic Factor; Disease Models, Animal; Dogs; Dose-Response Relationship, Drug; | 1993 |
Bioelectrical impedance analysis as an assessment of diuresis in congestive heart failure.
Topics: Administration, Oral; Aged; Body Composition; Body Water; Body Weight; Cohort Studies; Diuretics; El | 1995 |
Bioelectrical impedance analysis as an assessment of diuresis in congestive heart failure.
Topics: Administration, Oral; Aged; Body Composition; Body Water; Body Weight; Cohort Studies; Diuretics; El | 1995 |
Frusemide or nitrates for acute heart failure?
Topics: Acute Disease; Administration, Sublingual; Diuretics; Furosemide; Heart Failure; Hemodynamics; Human | 1996 |
Frusemide or nitrates for acute heart failure?
Topics: Acute Disease; Administration, Sublingual; Diuretics; Furosemide; Heart Failure; Hemodynamics; Human | 1996 |
Uveal effusion syndrome associated with primary pulmonary hypertension and vomiting.
Topics: Aged; Diuretics; Echocardiography; Exudates and Transudates; Female; Fluorescein Angiography; Fundus | 1996 |
Uveal effusion syndrome associated with primary pulmonary hypertension and vomiting.
Topics: Aged; Diuretics; Echocardiography; Exudates and Transudates; Female; Fluorescein Angiography; Fundus | 1996 |
How common is heart failure? Evidence from PACT (prescribing analysis and cost) data in Nottingham.
Topics: Adult; Aged; Aged, 80 and over; Costs and Cost Analysis; Cross-Sectional Studies; Diuretics; Dose-Re | 1995 |
How common is heart failure? Evidence from PACT (prescribing analysis and cost) data in Nottingham.
Topics: Adult; Aged; Aged, 80 and over; Costs and Cost Analysis; Cross-Sectional Studies; Diuretics; Dose-Re | 1995 |
Concurrent use of phenytoin and furosemide: problems in a patient with congestive cardiac failure, chronic renal failure, liver cirrhosis and fluid overload.
Topics: Anticonvulsants; Diuretics; Drug Interactions; Drug Therapy, Combination; Furosemide; Heart Failure; | 1996 |
Concurrent use of phenytoin and furosemide: problems in a patient with congestive cardiac failure, chronic renal failure, liver cirrhosis and fluid overload.
Topics: Anticonvulsants; Diuretics; Drug Interactions; Drug Therapy, Combination; Furosemide; Heart Failure; | 1996 |
Reversal of end-stage heart failure is predicted by long-term therapeutic response rather than initial hemodynamic and neurohormonal profile.
Topics: Adult; Cardiovascular Agents; Dobutamine; Dose-Response Relationship, Drug; Enalapril; Female; Follo | 1996 |
Reversal of end-stage heart failure is predicted by long-term therapeutic response rather than initial hemodynamic and neurohormonal profile.
Topics: Adult; Cardiovascular Agents; Dobutamine; Dose-Response Relationship, Drug; Enalapril; Female; Follo | 1996 |
Congestive cardiac failure following laxative withdrawal.
Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Cathartics; Diuretics; Female; Furosemide; Hear | 1996 |
Congestive cardiac failure following laxative withdrawal.
Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Cathartics; Diuretics; Female; Furosemide; Hear | 1996 |
Effect of furosemide oral solution versus furosemide tablets on diuresis and electrolytes in patients with moderate congestive heart failure.
Topics: Aged; Aged, 80 and over; Calcium; Diuresis; Electrolytes; Female; Furosemide; Heart Failure; Humans; | 1996 |
Effect of furosemide oral solution versus furosemide tablets on diuresis and electrolytes in patients with moderate congestive heart failure.
Topics: Aged; Aged, 80 and over; Calcium; Diuresis; Electrolytes; Female; Furosemide; Heart Failure; Humans; | 1996 |
Digoxin therapy and survival in heart failure in sinus rhythm.
Topics: Administration, Oral; Aged; Cardiotonic Agents; Case-Control Studies; Digoxin; Diuretics; Drug Thera | 1996 |
Digoxin therapy and survival in heart failure in sinus rhythm.
Topics: Administration, Oral; Aged; Cardiotonic Agents; Case-Control Studies; Digoxin; Diuretics; Drug Thera | 1996 |
Comparison of chronic neutral endopeptidase inhibition and furosemide in an ovine model of heart failure.
Topics: Animals; Atrial Natriuretic Factor; Captopril; Cyclic GMP; Dipeptides; Diuretics; Dose-Response Rela | 1996 |
Comparison of chronic neutral endopeptidase inhibition and furosemide in an ovine model of heart failure.
Topics: Animals; Atrial Natriuretic Factor; Captopril; Cyclic GMP; Dipeptides; Diuretics; Dose-Response Rela | 1996 |
Effects of long-term treatment with enalapril or hydralazine on the renin-angiotensin-aldosterone system and fluid balance in dogs with naturally acquired mitral valve regurgitation.
Topics: Aldosterone; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Body Weight; Dog Dis | 1996 |
Effects of long-term treatment with enalapril or hydralazine on the renin-angiotensin-aldosterone system and fluid balance in dogs with naturally acquired mitral valve regurgitation.
Topics: Aldosterone; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Body Weight; Dog Dis | 1996 |
The investigation and management of patients with heart failure.
Topics: Angiotensin-Converting Enzyme Inhibitors; Diuretics; Furosemide; Heart Failure; Humans | 1996 |
The investigation and management of patients with heart failure.
Topics: Angiotensin-Converting Enzyme Inhibitors; Diuretics; Furosemide; Heart Failure; Humans | 1996 |
Preferences of veterinarians for drugs to treat heart disease in dogs and cats.
Topics: Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Australia; Cardiotonic Agents; Cardiovascular | 1995 |
Preferences of veterinarians for drugs to treat heart disease in dogs and cats.
Topics: Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Australia; Cardiotonic Agents; Cardiovascular | 1995 |
[Hepatitis and furosemide].
Topics: Diuretics; Furosemide; Heart Failure; Humans; Ischemia; Liver; Male; Middle Aged | 1996 |
[Hepatitis and furosemide].
Topics: Diuretics; Furosemide; Heart Failure; Humans; Ischemia; Liver; Male; Middle Aged | 1996 |
The management of chronic heart failure.
Topics: Aged; Diuretics; Drug Resistance; Furosemide; Heart Failure; Humans | 1997 |
The management of chronic heart failure.
Topics: Aged; Diuretics; Drug Resistance; Furosemide; Heart Failure; Humans | 1997 |
Furosemide-associated fever: drug fever or dehydration fever?
Topics: Dehydration; Fever of Unknown Origin; Furosemide; Heart Failure; Humans; Infant | 1997 |
Furosemide-associated fever: drug fever or dehydration fever?
Topics: Dehydration; Fever of Unknown Origin; Furosemide; Heart Failure; Humans; Infant | 1997 |
Effects of digoxin on time domain measures of heart rate variability in patients with stable chronic cardiac failure: withdrawal and comparison group studies.
Topics: Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhythmia Agents; Digoxin; Diuretics; E | 1997 |
Effects of digoxin on time domain measures of heart rate variability in patients with stable chronic cardiac failure: withdrawal and comparison group studies.
Topics: Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhythmia Agents; Digoxin; Diuretics; E | 1997 |
Sequential nephron blockade breaks resistance to diuretics in edematous states.
Topics: Acetazolamide; Adult; Ascites; Diuresis; Diuretics; Edema; Female; Furosemide; Heart Failure; Humans | 1997 |
Sequential nephron blockade breaks resistance to diuretics in edematous states.
Topics: Acetazolamide; Adult; Ascites; Diuresis; Diuretics; Edema; Female; Furosemide; Heart Failure; Humans | 1997 |
Treatment of subclinical fluid retention in patients with symptomatic heart failure: effect on exercise performance.
Topics: Adult; Blood Pressure; Cardiomyopathy, Dilated; Diastole; Diuretics; Dose-Response Relationship, Dru | 1997 |
Treatment of subclinical fluid retention in patients with symptomatic heart failure: effect on exercise performance.
Topics: Adult; Blood Pressure; Cardiomyopathy, Dilated; Diastole; Diuretics; Dose-Response Relationship, Dru | 1997 |
[Acute tubular necrosis caused by combination of diuretics in the treatment of several heart failure. A call to attention].
Topics: Aged; Chlorthalidone; Diuretics; Furosemide; Heart Failure; Humans; Kidney Tubular Necrosis, Acute; | 1997 |
[Acute tubular necrosis caused by combination of diuretics in the treatment of several heart failure. A call to attention].
Topics: Aged; Chlorthalidone; Diuretics; Furosemide; Heart Failure; Humans; Kidney Tubular Necrosis, Acute; | 1997 |
[Non-invasive determination of the quantity of pleural effusion and evaluation of the beneficial effect of pleuracentesis in patients with acute exacerbation of chronic congestive heart failure].
Topics: Aged; Chronic Disease; Diuretics; Furosemide; Heart Failure; Humans; Middle Aged; Paracentesis; Pleu | 1997 |
[Non-invasive determination of the quantity of pleural effusion and evaluation of the beneficial effect of pleuracentesis in patients with acute exacerbation of chronic congestive heart failure].
Topics: Aged; Chronic Disease; Diuretics; Furosemide; Heart Failure; Humans; Middle Aged; Paracentesis; Pleu | 1997 |
[Heart failure after myocardial infarct in decompensated diabetes mellitus. Acute therapy with catecholamines--long-term therapy with ACE inhibitor-loop diuretic combination].
Topics: Angiotensin-Converting Enzyme Inhibitors; Catecholamines; Combined Modality Therapy; Diabetes Mellit | 1997 |
[Heart failure after myocardial infarct in decompensated diabetes mellitus. Acute therapy with catecholamines--long-term therapy with ACE inhibitor-loop diuretic combination].
Topics: Angiotensin-Converting Enzyme Inhibitors; Catecholamines; Combined Modality Therapy; Diabetes Mellit | 1997 |
No difference in blood thiamine diphosphate levels between Swedish Caucasian patients with congestive heart failure treated with furosemide and patients without heart failure.
Topics: Adult; Aged; Aged, 80 and over; Chromatography, High Pressure Liquid; Diuretics; Female; Furosemide; | 1997 |
No difference in blood thiamine diphosphate levels between Swedish Caucasian patients with congestive heart failure treated with furosemide and patients without heart failure.
Topics: Adult; Aged; Aged, 80 and over; Chromatography, High Pressure Liquid; Diuretics; Female; Furosemide; | 1997 |
[Perioperative management of two patients with severe dilated cardiomyopathy].
Topics: Aged; Aged, 80 and over; Anesthesia, General; Cardiomyopathy, Dilated; Cardiotonic Agents; Diuretics | 1998 |
[Perioperative management of two patients with severe dilated cardiomyopathy].
Topics: Aged; Aged, 80 and over; Anesthesia, General; Cardiomyopathy, Dilated; Cardiotonic Agents; Diuretics | 1998 |
[Pheochromocytoma and cardiac insufficiency].
Topics: Adrenal Gland Neoplasms; Angiotensin-Converting Enzyme Inhibitors; Captopril; Cardiomyopathies; Cate | 1998 |
[Pheochromocytoma and cardiac insufficiency].
Topics: Adrenal Gland Neoplasms; Angiotensin-Converting Enzyme Inhibitors; Captopril; Cardiomyopathies; Cate | 1998 |
Circulating tumor necrosis factor-alpha levels in chronic heart failure: relation to its soluble receptor II, interleukin-6, and neurohumoral variables.
Topics: Adrenergic Agonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Cardiotonic | 1998 |
Circulating tumor necrosis factor-alpha levels in chronic heart failure: relation to its soluble receptor II, interleukin-6, and neurohumoral variables.
Topics: Adrenergic Agonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Cardiotonic | 1998 |
The effects of diuresis on the pharmacokinetics of the loop diuretics furosemide and torsemide in patients with heart failure.
Topics: Aged; Diuresis; Diuretics; Female; Furosemide; Heart Failure; Humans; Male; Middle Aged; Severity of | 1998 |
The effects of diuresis on the pharmacokinetics of the loop diuretics furosemide and torsemide in patients with heart failure.
Topics: Aged; Diuresis; Diuretics; Female; Furosemide; Heart Failure; Humans; Male; Middle Aged; Severity of | 1998 |
How does treatment influence endocrine mechanisms in acute severe heart failure? Effects on cardiac natriuretic peptides, the renin system, neuropeptide Y and catecholamines.
Topics: Acute Disease; Aged; Aged, 80 and over; Aldosterone; Atrial Natriuretic Factor; Biomarkers; Diuretic | 1998 |
How does treatment influence endocrine mechanisms in acute severe heart failure? Effects on cardiac natriuretic peptides, the renin system, neuropeptide Y and catecholamines.
Topics: Acute Disease; Aged; Aged, 80 and over; Aldosterone; Atrial Natriuretic Factor; Biomarkers; Diuretic | 1998 |
[Evaluation of therapy for dilated cardiomyopathy with heart failure by iodine-123 metaiodobenzylguanidine imaging: comparison with heart rate variability power spectral analysis].
Topics: 3-Iodobenzylguanidine; Angiotensin-Converting Enzyme Inhibitors; Cardiomyopathy, Dilated; Cardiotoni | 1998 |
[Evaluation of therapy for dilated cardiomyopathy with heart failure by iodine-123 metaiodobenzylguanidine imaging: comparison with heart rate variability power spectral analysis].
Topics: 3-Iodobenzylguanidine; Angiotensin-Converting Enzyme Inhibitors; Cardiomyopathy, Dilated; Cardiotoni | 1998 |
Surgical successful treatment of Cushing's syndrome in a pregnant patient complicated with severe cardiac involvement.
Topics: Adenoma; Adrenal Gland Neoplasms; Adrenalectomy; Adult; Antihypertensive Agents; Cardiotonic Agents; | 1998 |
Surgical successful treatment of Cushing's syndrome in a pregnant patient complicated with severe cardiac involvement.
Topics: Adenoma; Adrenal Gland Neoplasms; Adrenalectomy; Adult; Antihypertensive Agents; Cardiotonic Agents; | 1998 |
Partial left ventriculectomy: preoperative risk factors for perioperative mortality.
Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Captopril; Cardiac Surgical Procedures; Cardiomyopa | 1998 |
Partial left ventriculectomy: preoperative risk factors for perioperative mortality.
Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Captopril; Cardiac Surgical Procedures; Cardiomyopa | 1998 |
Endothelin and von Willebrand factor as parameters of endothelial function in idiopathic dilated cardiomyopathy: different stimuli for release before and after heart transplantation?
Topics: Adult; Biomarkers; Cardiomyopathy, Dilated; Diuretics; Endothelin-1; Endothelium, Vascular; Female; | 1999 |
Endothelin and von Willebrand factor as parameters of endothelial function in idiopathic dilated cardiomyopathy: different stimuli for release before and after heart transplantation?
Topics: Adult; Biomarkers; Cardiomyopathy, Dilated; Diuretics; Endothelin-1; Endothelium, Vascular; Female; | 1999 |
Lung membrane diffusing capacity, heart failure, and heart transplantation.
Topics: Adult; Amiodarone; Anti-Arrhythmia Agents; Carbon Monoxide; Case-Control Studies; Cytomegalovirus In | 1999 |
Lung membrane diffusing capacity, heart failure, and heart transplantation.
Topics: Adult; Amiodarone; Anti-Arrhythmia Agents; Carbon Monoxide; Case-Control Studies; Cytomegalovirus In | 1999 |
Pharmacoeconomic comparison of loop diuretics in the treatment of congestive heart failure.
Topics: Aged; Cost Control; Diuretics; Drug Costs; Drug Utilization Review; Female; Furosemide; Health Care | 1996 |
Pharmacoeconomic comparison of loop diuretics in the treatment of congestive heart failure.
Topics: Aged; Cost Control; Diuretics; Drug Costs; Drug Utilization Review; Female; Furosemide; Health Care | 1996 |
Managed care clinical corner: a case of congestive heart failure--the managed care perspective.
Topics: Aged; Case Management; Critical Pathways; Female; Furosemide; Heart Failure; Humans; Managed Care Pr | 1997 |
Managed care clinical corner: a case of congestive heart failure--the managed care perspective.
Topics: Aged; Case Management; Critical Pathways; Female; Furosemide; Heart Failure; Humans; Managed Care Pr | 1997 |
Partial left ventriculectomy in a two-year-old girl with dilated cardiomyopathy.
Topics: Antihypertensive Agents; Captopril; Cardiomyopathy, Dilated; Cardiotonic Agents; Child, Preschool; D | 1999 |
Partial left ventriculectomy in a two-year-old girl with dilated cardiomyopathy.
Topics: Antihypertensive Agents; Captopril; Cardiomyopathy, Dilated; Cardiotonic Agents; Child, Preschool; D | 1999 |
An interaction between digoxin and acarbose.
Topics: Acarbose; Aged; Anticoagulants; Antihypertensive Agents; Atrial Fibrillation; Captopril; Diabetes Me | 1999 |
An interaction between digoxin and acarbose.
Topics: Acarbose; Aged; Anticoagulants; Antihypertensive Agents; Atrial Fibrillation; Captopril; Diabetes Me | 1999 |
Loop diuretics enhance the secretion of prostacyclin in vitro, in healthy persons, and in patients with chronic heart failure.
Topics: 6-Ketoprostaglandin F1 alpha; Diuretics; Endothelium, Vascular; Epithelium; Epoprostenol; Female; Fu | 1999 |
Loop diuretics enhance the secretion of prostacyclin in vitro, in healthy persons, and in patients with chronic heart failure.
Topics: 6-Ketoprostaglandin F1 alpha; Diuretics; Endothelium, Vascular; Epithelium; Epoprostenol; Female; Fu | 1999 |
Wernicke's encephalopathy induced by magnesium depletion.
Topics: Aged; Aged, 80 and over; Diuretics; Female; Furosemide; Heart Failure; Humans; Magnesium Deficiency; | 1999 |
Wernicke's encephalopathy induced by magnesium depletion.
Topics: Aged; Aged, 80 and over; Diuretics; Female; Furosemide; Heart Failure; Humans; Magnesium Deficiency; | 1999 |
Chronic eosinophilic pneumonia with pleural effusion.
Topics: Aged; Biopsy; Captopril; Chronic Disease; Dyspnea; Female; Furosemide; Heart Failure; Humans; Lung; | 1999 |
Chronic eosinophilic pneumonia with pleural effusion.
Topics: Aged; Biopsy; Captopril; Chronic Disease; Dyspnea; Female; Furosemide; Heart Failure; Humans; Lung; | 1999 |
Nephrocalcinosis in full-term infants receiving furosemide treatment for congestive heart failure: a study of the incidence and 2-year follow up.
Topics: Calcium; Diuretics; Female; Furosemide; Heart Failure; Humans; Infant; Kidney; Male; Nephrocalcinosi | 1999 |
Nephrocalcinosis in full-term infants receiving furosemide treatment for congestive heart failure: a study of the incidence and 2-year follow up.
Topics: Calcium; Diuretics; Female; Furosemide; Heart Failure; Humans; Infant; Kidney; Male; Nephrocalcinosi | 1999 |
Urinary loss of thiamine is increased by low doses of furosemide in healthy volunteers.
Topics: Adult; Animals; Diuresis; Diuretics; Dose-Response Relationship, Drug; Female; Furosemide; Heart Fai | 1999 |
Urinary loss of thiamine is increased by low doses of furosemide in healthy volunteers.
Topics: Adult; Animals; Diuresis; Diuretics; Dose-Response Relationship, Drug; Female; Furosemide; Heart Fai | 1999 |
Urinary thiamine excretion in the rat: effects of furosemide, other diuretics, and volume load.
Topics: Animals; Diuresis; Diuretics; Furosemide; Heart Failure; Humans; Kidney; Male; Mannitol; Natriuresis | 1999 |
Urinary thiamine excretion in the rat: effects of furosemide, other diuretics, and volume load.
Topics: Animals; Diuresis; Diuretics; Furosemide; Heart Failure; Humans; Kidney; Male; Mannitol; Natriuresis | 1999 |
Atrioventricular valvular insufficiency and congestive heart failure in a carpet python.
Topics: Animals; Boidae; Diuretics; Echocardiography, Doppler, Color; Electrocardiography; Fatal Outcome; Fu | 1999 |
Atrioventricular valvular insufficiency and congestive heart failure in a carpet python.
Topics: Animals; Boidae; Diuretics; Echocardiography, Doppler, Color; Electrocardiography; Fatal Outcome; Fu | 1999 |
Comparison of therapies with torasemide or furosemide in patients with congestive heart failure from a pharmacoeconomic viewpoint.
Topics: Adult; Aged; Aged, 80 and over; Cost-Benefit Analysis; Cross-Sectional Studies; Diuretics; Economics | 1998 |
Comparison of therapies with torasemide or furosemide in patients with congestive heart failure from a pharmacoeconomic viewpoint.
Topics: Adult; Aged; Aged, 80 and over; Cost-Benefit Analysis; Cross-Sectional Studies; Diuretics; Economics | 1998 |
Tumor necrosis factor-alpha serum activity during treatment of acute decompensation of cachectic and non-cachectic patients with advanced congestive heart failure.
Topics: Acute Disease; Adult; Aged; Biomarkers; Body Mass Index; Cachexia; Cardiotonic Agents; Digoxin; Diur | 1999 |
Tumor necrosis factor-alpha serum activity during treatment of acute decompensation of cachectic and non-cachectic patients with advanced congestive heart failure.
Topics: Acute Disease; Adult; Aged; Biomarkers; Body Mass Index; Cachexia; Cardiotonic Agents; Digoxin; Diur | 1999 |
Spironolactone in patients with heart failure.
Topics: Angiotensin-Converting Enzyme Inhibitors; Digoxin; Diuretics; Drug Therapy, Combination; Furosemide; | 2000 |
Spironolactone in patients with heart failure.
Topics: Angiotensin-Converting Enzyme Inhibitors; Digoxin; Diuretics; Drug Therapy, Combination; Furosemide; | 2000 |
Inverse relation between aldosterone and venous capacitance in chronically treated congestive heart failure.
Topics: Aldosterone; Angiotensin-Converting Enzyme Inhibitors; Diuretics; Extremities; Furosemide; Heart Fai | 2000 |
Inverse relation between aldosterone and venous capacitance in chronically treated congestive heart failure.
Topics: Aldosterone; Angiotensin-Converting Enzyme Inhibitors; Diuretics; Extremities; Furosemide; Heart Fai | 2000 |
Reduced thiamine phosphate, but not thiamine diphosphate, in erythrocytes in elderly patients with congestive heart failure treated with furosemide.
Topics: Aged; Case-Control Studies; Chromatography, High Pressure Liquid; Cross-Sectional Studies; Diuretics | 2000 |
Reduced thiamine phosphate, but not thiamine diphosphate, in erythrocytes in elderly patients with congestive heart failure treated with furosemide.
Topics: Aged; Case-Control Studies; Chromatography, High Pressure Liquid; Cross-Sectional Studies; Diuretics | 2000 |
Congestive heart failure and toxic digoxin levels: role of cholestyramine.
Topics: Aged; Aged, 80 and over; Anti-Arrhythmia Agents; Anticholesteremic Agents; Blood Chemical Analysis; | 2000 |
Congestive heart failure and toxic digoxin levels: role of cholestyramine.
Topics: Aged; Aged, 80 and over; Anti-Arrhythmia Agents; Anticholesteremic Agents; Blood Chemical Analysis; | 2000 |
Has an intensified treatment in the ambulance of patients with acute severe left heart failure improved the outcome?
Topics: Acute Disease; Adult; Aged; Aged, 80 and over; Ambulances; Combined Modality Therapy; Creatine Kinas | 2000 |
Has an intensified treatment in the ambulance of patients with acute severe left heart failure improved the outcome?
Topics: Acute Disease; Adult; Aged; Aged, 80 and over; Ambulances; Combined Modality Therapy; Creatine Kinas | 2000 |
Diuretic use: a risk for subclinical thiamine deficiency in elderly patients.
Topics: Aged; Aged, 80 and over; Aging; Diuretics; Dose-Response Relationship, Drug; Erythrocytes; Female; F | 2000 |
Diuretic use: a risk for subclinical thiamine deficiency in elderly patients.
Topics: Aged; Aged, 80 and over; Aging; Diuretics; Dose-Response Relationship, Drug; Erythrocytes; Female; F | 2000 |
Furosemide withdrawal in elderly heart failure patients with preserved left ventricular systolic function.
Topics: Aged; Blood Pressure; Diuretics; Female; Furosemide; Heart Failure; Heart Rate; Humans; Male; Pilot | 2000 |
Furosemide withdrawal in elderly heart failure patients with preserved left ventricular systolic function.
Topics: Aged; Blood Pressure; Diuretics; Female; Furosemide; Heart Failure; Heart Rate; Humans; Male; Pilot | 2000 |
Metabolic and clinical effects of oral magnesium supplementation in furosemide-treated patients with severe congestive heart failure.
Topics: Administration, Oral; Adult; Aged; Cardiomyopathy, Dilated; Citric Acid; Dietary Supplements; Diuret | 2000 |
Metabolic and clinical effects of oral magnesium supplementation in furosemide-treated patients with severe congestive heart failure.
Topics: Administration, Oral; Adult; Aged; Cardiomyopathy, Dilated; Citric Acid; Dietary Supplements; Diuret | 2000 |
[Unconventional treatment of severe heart failure in the elderly].
Topics: Aged; Aged, 80 and over; Diuresis; Diuretics; Dose-Response Relationship, Drug; Female; Furosemide; | 2000 |
[Unconventional treatment of severe heart failure in the elderly].
Topics: Aged; Aged, 80 and over; Diuresis; Diuretics; Dose-Response Relationship, Drug; Female; Furosemide; | 2000 |
[Decreased mortality. Help for the failing heart].
Topics: Diuretics; Furosemide; Heart Failure; Humans; Sulfonamides; Survival Rate; Torsemide; Treatment Outc | 2000 |
[Decreased mortality. Help for the failing heart].
Topics: Diuretics; Furosemide; Heart Failure; Humans; Sulfonamides; Survival Rate; Torsemide; Treatment Outc | 2000 |
[Unclear lactate acidosis in a patient with heart failure under long-term diuretic therapy].
Topics: Acidosis, Lactic; Aged; Aged, 80 and over; Diuretics; Dyspnea; Furosemide; Heart Failure; Humans; La | 2000 |
[Unclear lactate acidosis in a patient with heart failure under long-term diuretic therapy].
Topics: Acidosis, Lactic; Aged; Aged, 80 and over; Diuretics; Dyspnea; Furosemide; Heart Failure; Humans; La | 2000 |
Acute congestive heart failure associated with a limited form of systemic sclerosis and primary biliary cirrhosis.
Topics: Acute Disease; Antibody Specificity; Autoantibodies; Autoimmune Diseases; Centromere; Coronary Circu | 2001 |
Acute congestive heart failure associated with a limited form of systemic sclerosis and primary biliary cirrhosis.
Topics: Acute Disease; Antibody Specificity; Autoantibodies; Autoimmune Diseases; Centromere; Coronary Circu | 2001 |
Congestive heart failure associated with myxomatous degeneration of the left atrioventricular valve in a parakeet.
Topics: Animals; Bird Diseases; Digoxin; Diuretics; Echocardiography, Doppler, Color; Electrocardiography; F | 2001 |
Congestive heart failure associated with myxomatous degeneration of the left atrioventricular valve in a parakeet.
Topics: Animals; Bird Diseases; Digoxin; Diuretics; Echocardiography, Doppler, Color; Electrocardiography; F | 2001 |
Aggressive diuresis for severe heart failure in the elderly.
Topics: Aged; Cost Savings; Diuretics; Female; Furosemide; Heart Failure; Hospital Charges; Humans; Infusion | 2001 |
Aggressive diuresis for severe heart failure in the elderly.
Topics: Aged; Cost Savings; Diuretics; Female; Furosemide; Heart Failure; Hospital Charges; Humans; Infusion | 2001 |
Towards evidence based emergency medicine: best BETs from the Manchester Royal Infirmary. Frusemide or nitrates in acute left ventricular failure.
Topics: Aged; Aged, 80 and over; Evidence-Based Medicine; Furosemide; Heart Failure; Humans; Male; Nitrates; | 2001 |
Towards evidence based emergency medicine: best BETs from the Manchester Royal Infirmary. Frusemide or nitrates in acute left ventricular failure.
Topics: Aged; Aged, 80 and over; Evidence-Based Medicine; Furosemide; Heart Failure; Humans; Male; Nitrates; | 2001 |
The effects of enalapril-digoxin-diuretic combination therapy on nutritional and anthropometric indices in chronic congestive heart failure: preliminary findings in cardiac cachexia.
Topics: Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Anthropometry; Body Mass Index; Cachexia; Car | 2001 |
The effects of enalapril-digoxin-diuretic combination therapy on nutritional and anthropometric indices in chronic congestive heart failure: preliminary findings in cardiac cachexia.
Topics: Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Anthropometry; Body Mass Index; Cachexia; Car | 2001 |
Selective renal vasodilation and active renal artery perfusion improve renal function in dogs with acute heart failure.
Topics: Acute Disease; Animals; Diuretics; Dogs; Drug Synergism; Furosemide; Heart Failure; Injections; Kidn | 2001 |
Selective renal vasodilation and active renal artery perfusion improve renal function in dogs with acute heart failure.
Topics: Acute Disease; Animals; Diuretics; Dogs; Drug Synergism; Furosemide; Heart Failure; Injections; Kidn | 2001 |
Cost-effectiveness of beta-blocker therapy with metoprolol or with carvedilol for treatment of heart failure in Canada.
Topics: Adrenergic beta-Antagonists; Aged; Aged, 80 and over; Angiotensin-Converting Enzyme Inhibitors; Cana | 2001 |
Cost-effectiveness of beta-blocker therapy with metoprolol or with carvedilol for treatment of heart failure in Canada.
Topics: Adrenergic beta-Antagonists; Aged; Aged, 80 and over; Angiotensin-Converting Enzyme Inhibitors; Cana | 2001 |
Heart failure in beta thalassemia: a 5-year follow-up study.
Topics: Adult; Antihypertensive Agents; beta-Thalassemia; Diuretics; Echocardiography, Doppler; Electrocardi | 2001 |
Heart failure in beta thalassemia: a 5-year follow-up study.
Topics: Adult; Antihypertensive Agents; beta-Thalassemia; Diuretics; Echocardiography, Doppler; Electrocardi | 2001 |
[Emergency care in acute left heart failure. Decreasing preload, oxygen inhalation].
Topics: Administration, Inhalation; Aged; Combined Modality Therapy; Emergency Medical Services; Family Prac | 2001 |
[Emergency care in acute left heart failure. Decreasing preload, oxygen inhalation].
Topics: Administration, Inhalation; Aged; Combined Modality Therapy; Emergency Medical Services; Family Prac | 2001 |
Optimal diuretic therapy for heart failure.
Topics: Biological Availability; Diuretics; Furosemide; Heart Failure; Humans; Sulfonamides; Torsemide | 2001 |
Optimal diuretic therapy for heart failure.
Topics: Biological Availability; Diuretics; Furosemide; Heart Failure; Humans; Sulfonamides; Torsemide | 2001 |
Cardiac autonomic function in Blacks with congestive heart failure: vagomimetic action, alteration in sympathovagal balance, and the effect of ACE inhibition on central and peripheral vagal tone.
Topics: Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhythmia Agents; Antihypertensive Agen | 2001 |
Cardiac autonomic function in Blacks with congestive heart failure: vagomimetic action, alteration in sympathovagal balance, and the effect of ACE inhibition on central and peripheral vagal tone.
Topics: Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhythmia Agents; Antihypertensive Agen | 2001 |
Diuretic therapy and resistance in congestive heart failure.
Topics: Benzothiadiazines; Bumetanide; Diuretics; Drug Resistance; Drug Synergism; Drug Therapy, Combination | 2001 |
Diuretic therapy and resistance in congestive heart failure.
Topics: Benzothiadiazines; Bumetanide; Diuretics; Drug Resistance; Drug Synergism; Drug Therapy, Combination | 2001 |
Diuretic therapy and resistance in congestive heart failure.
Topics: Benzothiadiazines; Bumetanide; Diuretics; Drug Resistance; Drug Synergism; Drug Therapy, Combination | 2001 |
Diuretic therapy and resistance in congestive heart failure.
Topics: Benzothiadiazines; Bumetanide; Diuretics; Drug Resistance; Drug Synergism; Drug Therapy, Combination | 2001 |
Diuretic therapy and resistance in congestive heart failure.
Topics: Benzothiadiazines; Bumetanide; Diuretics; Drug Resistance; Drug Synergism; Drug Therapy, Combination | 2001 |
Diuretic therapy and resistance in congestive heart failure.
Topics: Benzothiadiazines; Bumetanide; Diuretics; Drug Resistance; Drug Synergism; Drug Therapy, Combination | 2001 |
Diuretic therapy and resistance in congestive heart failure.
Topics: Benzothiadiazines; Bumetanide; Diuretics; Drug Resistance; Drug Synergism; Drug Therapy, Combination | 2001 |
Diuretic therapy and resistance in congestive heart failure.
Topics: Benzothiadiazines; Bumetanide; Diuretics; Drug Resistance; Drug Synergism; Drug Therapy, Combination | 2001 |
Comparison of neurohumoral effects of short-acting and long-acting loop diuretics in patients with chronic congestive heart failure.
Topics: Administration, Oral; Aged; Chi-Square Distribution; Chronic Disease; Diuretics; Dosage Forms; Femal | 2001 |
Comparison of neurohumoral effects of short-acting and long-acting loop diuretics in patients with chronic congestive heart failure.
Topics: Administration, Oral; Aged; Chi-Square Distribution; Chronic Disease; Diuretics; Dosage Forms; Femal | 2001 |
Effect of ramipril and furosemide treatment on interstitial remodeling in post-infarction heart failure rat hearts.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Diuretics; Extracellular Matrix; Extracellular Ma | 2002 |
Effect of ramipril and furosemide treatment on interstitial remodeling in post-infarction heart failure rat hearts.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Diuretics; Extracellular Matrix; Extracellular Ma | 2002 |
Intensive blood pressure reduction is beneficial in patients with impaired cardiac function coexisting with chronic renal insufficiency.
Topics: Aged; Aged, 80 and over; Amlodipine; Antihypertensive Agents; Blood Pressure; Circadian Rhythm; Crea | 2002 |
Intensive blood pressure reduction is beneficial in patients with impaired cardiac function coexisting with chronic renal insufficiency.
Topics: Aged; Aged, 80 and over; Amlodipine; Antihypertensive Agents; Blood Pressure; Circadian Rhythm; Crea | 2002 |
Hypomagnesemia and concurrent acid-base and electrolyte abnormalities in patients with congestive heart failure.
Topics: Acid-Base Imbalance; Aged; Cohort Studies; Diuretics; Dose-Response Relationship, Drug; Female; Foll | 2002 |
Hypomagnesemia and concurrent acid-base and electrolyte abnormalities in patients with congestive heart failure.
Topics: Acid-Base Imbalance; Aged; Cohort Studies; Diuretics; Dose-Response Relationship, Drug; Female; Foll | 2002 |
Implications of the hemodynamic optimization approach guided by right heart catheterization in patients with severe heart failure.
Topics: Adult; Aged; Blood Pressure; Cardiac Catheterization; Cardiac Output, Low; Diuretics; Female; Furose | 2002 |
Implications of the hemodynamic optimization approach guided by right heart catheterization in patients with severe heart failure.
Topics: Adult; Aged; Blood Pressure; Cardiac Catheterization; Cardiac Output, Low; Diuretics; Female; Furose | 2002 |
A case report of acute heart failure caused by a patient delaying taking his diuretic medication.
Topics: Acute Disease; Dental Care for Chronically Ill; Diuretics; Emergency Treatment; Furosemide; Heart Fa | 2002 |
A case report of acute heart failure caused by a patient delaying taking his diuretic medication.
Topics: Acute Disease; Dental Care for Chronically Ill; Diuretics; Emergency Treatment; Furosemide; Heart Fa | 2002 |
[Medium-term results of multisite biventricular stimulation in severe cardiac failure].
Topics: Aged; Aged, 80 and over; Cardiac Pacing, Artificial; Disease Progression; Diuretics; Female; Follow- | 2002 |
[Medium-term results of multisite biventricular stimulation in severe cardiac failure].
Topics: Aged; Aged, 80 and over; Cardiac Pacing, Artificial; Disease Progression; Diuretics; Female; Follow- | 2002 |
The pharmacologic effects of furosemide therapy in the low-birth-weight infant.
Topics: Furosemide; Heart Failure; Humans; Hydrogen-Ion Concentration; Infant; Infant, Low Birth Weight; Inf | 1978 |
The pharmacologic effects of furosemide therapy in the low-birth-weight infant.
Topics: Furosemide; Heart Failure; Humans; Hydrogen-Ion Concentration; Infant; Infant, Low Birth Weight; Inf | 1978 |
Discontinuation of maintenance digoxin.
Topics: Digoxin; Furosemide; Heart Failure; Humans; Long-Term Care; Substance Withdrawal Syndrome | 1977 |
Discontinuation of maintenance digoxin.
Topics: Digoxin; Furosemide; Heart Failure; Humans; Long-Term Care; Substance Withdrawal Syndrome | 1977 |
[Therapeutic experience with osyrol 100/Lasix in the treatment of congestive heart failure (author's transl)].
Topics: Digitalis Glycosides; Drug Combinations; Drug Evaluation; Furosemide; Heart Failure; Humans; Potassi | 1979 |
[Therapeutic experience with osyrol 100/Lasix in the treatment of congestive heart failure (author's transl)].
Topics: Digitalis Glycosides; Drug Combinations; Drug Evaluation; Furosemide; Heart Failure; Humans; Potassi | 1979 |
Cardiomegaly of unknown origin among Nigerian adults: role of hypertension in its aetiology.
Topics: Adolescent; Adult; Aged; Alcoholic Beverages; Benzothiadiazines; Blood Pressure; Cardiomegaly; Cardi | 1977 |
Cardiomegaly of unknown origin among Nigerian adults: role of hypertension in its aetiology.
Topics: Adolescent; Adult; Aged; Alcoholic Beverages; Benzothiadiazines; Blood Pressure; Cardiomegaly; Cardi | 1977 |
[Emergency medicine. Use of furosemide (Lasilix) in resuscitation. Pharmacology of dopamine].
Topics: Dopamine; Emergencies; Furosemide; Heart Failure; Humans; Hypertension; Pulmonary Edema; Resuscitati | 1979 |
[Emergency medicine. Use of furosemide (Lasilix) in resuscitation. Pharmacology of dopamine].
Topics: Dopamine; Emergencies; Furosemide; Heart Failure; Humans; Hypertension; Pulmonary Edema; Resuscitati | 1979 |
Treatment of complicated hypertension.
Topics: Acute Disease; Cerebral Hemorrhage; Cerebrovascular Disorders; Chronic Disease; Coronary Disease; Di | 1977 |
Treatment of complicated hypertension.
Topics: Acute Disease; Cerebral Hemorrhage; Cerebrovascular Disorders; Chronic Disease; Coronary Disease; Di | 1977 |
[Nitroglycerin in research and clinical use (proceedings)].
Topics: Aged; Blood Pressure; Cardiac Output; Digitalis Glycosides; Furosemide; Heart Failure; Heart Rate; H | 1978 |
[Nitroglycerin in research and clinical use (proceedings)].
Topics: Aged; Blood Pressure; Cardiac Output; Digitalis Glycosides; Furosemide; Heart Failure; Heart Rate; H | 1978 |
Precipitation of heart failure following sudden withdrawal of hydralazine.
Topics: Administration, Oral; Aged; Aortic Valve Insufficiency; Digoxin; Furosemide; Heart Failure; Hemodyna | 1979 |
Precipitation of heart failure following sudden withdrawal of hydralazine.
Topics: Administration, Oral; Aged; Aortic Valve Insufficiency; Digoxin; Furosemide; Heart Failure; Hemodyna | 1979 |
The use of alpha blockade in the treatment of congestive heart failure associated with dirofilariasis and mitral valvular incompetence.
Topics: Animals; Digoxin; Dirofilariasis; Dog Diseases; Dogs; Female; Furosemide; Heart Failure; Male; Mitra | 1979 |
The use of alpha blockade in the treatment of congestive heart failure associated with dirofilariasis and mitral valvular incompetence.
Topics: Animals; Digoxin; Dirofilariasis; Dog Diseases; Dogs; Female; Furosemide; Heart Failure; Male; Mitra | 1979 |
Pharmacokinetics/pharmacodynamics of furosemide in man: a review.
Topics: Biological Availability; Dose-Response Relationship, Drug; Drug Interactions; Furosemide; Heart Fail | 1979 |
Pharmacokinetics/pharmacodynamics of furosemide in man: a review.
Topics: Biological Availability; Dose-Response Relationship, Drug; Drug Interactions; Furosemide; Heart Fail | 1979 |
[Therapy of cardiac edema using Lasix long 30].
Topics: Body Weight; Delayed-Action Preparations; Furosemide; Heart Failure; Hemodynamics; Humans | 1979 |
[Therapy of cardiac edema using Lasix long 30].
Topics: Body Weight; Delayed-Action Preparations; Furosemide; Heart Failure; Hemodynamics; Humans | 1979 |
The effect on plasma potassium of a combined preparation of frusemide and slow-release potassium chloride (Diumide-K Continus tablets).
Topics: Administration, Oral; Aged; Delayed-Action Preparations; Female; Furosemide; Heart Failure; Humans; | 1979 |
The effect on plasma potassium of a combined preparation of frusemide and slow-release potassium chloride (Diumide-K Continus tablets).
Topics: Administration, Oral; Aged; Delayed-Action Preparations; Female; Furosemide; Heart Failure; Humans; | 1979 |
[Treatment of refractory forms of congestive heart failure].
Topics: Adult; Digoxin; Drug Resistance; Drug Therapy, Combination; Female; Furosemide; Heart Failure; Hepar | 1979 |
[Treatment of refractory forms of congestive heart failure].
Topics: Adult; Digoxin; Drug Resistance; Drug Therapy, Combination; Female; Furosemide; Heart Failure; Hepar | 1979 |
[Hemodynamic consequences of the furosemide treatment of cardiac insufficiency in recent myocardial infarct].
Topics: Aged; Diuresis; Female; Furosemide; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Myocardi | 1979 |
[Hemodynamic consequences of the furosemide treatment of cardiac insufficiency in recent myocardial infarct].
Topics: Aged; Diuresis; Female; Furosemide; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Myocardi | 1979 |
[Echocardiographic changes in severe congestive heart failure treated with prazosin].
Topics: Aged; Drug Therapy, Combination; Echocardiography; Female; Furosemide; Heart Failure; Humans; Male; | 1979 |
[Echocardiographic changes in severe congestive heart failure treated with prazosin].
Topics: Aged; Drug Therapy, Combination; Echocardiography; Female; Furosemide; Heart Failure; Humans; Male; | 1979 |
Contraindications to digitalis in congestive "heart" failure.
Topics: Diazoxide; Digitalis Glycosides; Furosemide; Heart Failure; Humans; Hypertension; Male; Methyldopa; | 1977 |
Contraindications to digitalis in congestive "heart" failure.
Topics: Diazoxide; Digitalis Glycosides; Furosemide; Heart Failure; Humans; Hypertension; Male; Methyldopa; | 1977 |
Hyperosmolar non-ketotic diabetic coma induced by furosemide in modest dosage.
Topics: Diabetic Coma; Furosemide; Heart Failure; Humans; Hyperglycemic Hyperosmolar Nonketotic Coma; Hypert | 1978 |
Hyperosmolar non-ketotic diabetic coma induced by furosemide in modest dosage.
Topics: Diabetic Coma; Furosemide; Heart Failure; Humans; Hyperglycemic Hyperosmolar Nonketotic Coma; Hypert | 1978 |
Medical management of small preterm infants with symptomatic patent ductus arteriosus.
Topics: Blood Transfusion; Digoxin; Ductus Arteriosus, Patent; Furosemide; Heart Failure; Hematocrit; Humans | 1978 |
Medical management of small preterm infants with symptomatic patent ductus arteriosus.
Topics: Blood Transfusion; Digoxin; Ductus Arteriosus, Patent; Furosemide; Heart Failure; Hematocrit; Humans | 1978 |
Severe electrolyte disturbances associated with metolazone and furosemide.
Topics: Adult; Aged; Diuretics; Drug Therapy, Combination; Female; Furosemide; Heart Failure; Humans; Hypert | 1978 |
Severe electrolyte disturbances associated with metolazone and furosemide.
Topics: Adult; Aged; Diuretics; Drug Therapy, Combination; Female; Furosemide; Heart Failure; Humans; Hypert | 1978 |
Right-sided heart failure and the use of diuretics.
Topics: Adaptation, Physiological; Cardiac Output; Diuretics; Ethacrynic Acid; Furosemide; Heart Failure; Hu | 1978 |
Right-sided heart failure and the use of diuretics.
Topics: Adaptation, Physiological; Cardiac Output; Diuretics; Ethacrynic Acid; Furosemide; Heart Failure; Hu | 1978 |
Hydralazine-induced tachycardia and sodium retention in heart failure. Hemodynamic and symptomatic correction by prazosin therapy.
Topics: Aged; Coronary Disease; Digitalis Glycosides; Female; Furosemide; Heart Failure; Humans; Hydralazine | 1978 |
Hydralazine-induced tachycardia and sodium retention in heart failure. Hemodynamic and symptomatic correction by prazosin therapy.
Topics: Aged; Coronary Disease; Digitalis Glycosides; Female; Furosemide; Heart Failure; Humans; Hydralazine | 1978 |
Continuous infusion of frusemide in refractory oedema.
Topics: Aged; Edema, Cardiac; Female; Furosemide; Heart Failure; Humans; Infusions, Parenteral; Length of St | 1978 |
Continuous infusion of frusemide in refractory oedema.
Topics: Aged; Edema, Cardiac; Female; Furosemide; Heart Failure; Humans; Infusions, Parenteral; Length of St | 1978 |
Management of intractable heart failure with hyponatremia.
Topics: Adult; Aged; Dexamethasone; Drug Therapy, Combination; Female; Furosemide; Heart Failure; Humans; Hy | 1978 |
Management of intractable heart failure with hyponatremia.
Topics: Adult; Aged; Dexamethasone; Drug Therapy, Combination; Female; Furosemide; Heart Failure; Humans; Hy | 1978 |
Ventricular tachyarrhythmia due to cardiac sarcoidosis in a child.
Topics: Cardiomyopathies; Child; Electrocardiography; Female; Furosemide; Heart Failure; Heart Ventricles; H | 1978 |
Ventricular tachyarrhythmia due to cardiac sarcoidosis in a child.
Topics: Cardiomyopathies; Child; Electrocardiography; Female; Furosemide; Heart Failure; Heart Ventricles; H | 1978 |
Effect of afterload reduction on plasma volume during acute heart failure.
Topics: Acute Disease; Aged; Blood Pressure; Cardiac Output; Coronary Disease; Diastole; Drug Evaluation; Fe | 1978 |
Effect of afterload reduction on plasma volume during acute heart failure.
Topics: Acute Disease; Aged; Blood Pressure; Cardiac Output; Coronary Disease; Diastole; Drug Evaluation; Fe | 1978 |
[On the pathogenesis and treatment of cardiac insufficiency].
Topics: Chlorthalidone; Digoxin; Furosemide; Heart Failure; Humans; Water-Electrolyte Balance | 1978 |
[On the pathogenesis and treatment of cardiac insufficiency].
Topics: Chlorthalidone; Digoxin; Furosemide; Heart Failure; Humans; Water-Electrolyte Balance | 1978 |
[Furosemide].
Topics: Acute Kidney Injury; Drug Interactions; Edema; Furosemide; Heart Failure; Hemodynamics; Hypertension | 1978 |
[Furosemide].
Topics: Acute Kidney Injury; Drug Interactions; Edema; Furosemide; Heart Failure; Hemodynamics; Hypertension | 1978 |
[Various causes of refractory course of chronic cardiac insufficiency].
Topics: Adult; Aged; Blood Coagulation; Chronic Disease; Female; Furosemide; Heart Failure; Heparin; Humans; | 1978 |
[Various causes of refractory course of chronic cardiac insufficiency].
Topics: Adult; Aged; Blood Coagulation; Chronic Disease; Female; Furosemide; Heart Failure; Heparin; Humans; | 1978 |
The clinical value of digoxin in patients with heart failure and sinus rhythm.
Topics: Adult; Aged; Arrhythmia, Sinus; Body Water; Body Weight; Digoxin; Drug Therapy, Combination; Exercis | 1978 |
The clinical value of digoxin in patients with heart failure and sinus rhythm.
Topics: Adult; Aged; Arrhythmia, Sinus; Body Water; Body Weight; Digoxin; Drug Therapy, Combination; Exercis | 1978 |
Effect of furosemide on hemodynamics and lung water in acute pulmonary edema secondary to myocardial infarction.
Topics: Adult; Aged; Body Water; Diuresis; Female; Furosemide; Heart Failure; Hemodynamics; Humans; Male; Mi | 1979 |
Effect of furosemide on hemodynamics and lung water in acute pulmonary edema secondary to myocardial infarction.
Topics: Adult; Aged; Body Water; Diuresis; Female; Furosemide; Heart Failure; Hemodynamics; Humans; Male; Mi | 1979 |
Clinical use of diuretics in congestive heart failure.
Topics: Amiloride; Benzothiadiazines; Diuretics; Ethacrynic Acid; Female; Furosemide; Heart Failure; Humans; | 1979 |
Clinical use of diuretics in congestive heart failure.
Topics: Amiloride; Benzothiadiazines; Diuretics; Ethacrynic Acid; Female; Furosemide; Heart Failure; Humans; | 1979 |
Editorial: Use and abuse of diuretics.
Topics: Benzothiadiazines; Diuretics; Edema; Ethacrynic Acid; Furosemide; Heart Failure; Humans; Hypertensio | 1975 |
Editorial: Use and abuse of diuretics.
Topics: Benzothiadiazines; Diuretics; Edema; Ethacrynic Acid; Furosemide; Heart Failure; Humans; Hypertensio | 1975 |
[Assessment of the coronary circulation regulation by means of the so-called isometric contraction index].
Topics: Coronary Circulation; Furosemide; Heart Failure; Heart Function Tests; Humans; Myocardial Contractio | 1976 |
[Assessment of the coronary circulation regulation by means of the so-called isometric contraction index].
Topics: Coronary Circulation; Furosemide; Heart Failure; Heart Function Tests; Humans; Myocardial Contractio | 1976 |
Frusemide and lithium toxicity.
Topics: Bipolar Disorder; Blood Urea Nitrogen; Consciousness; Creatinine; Diuresis; Drug Synergism; Furosemi | 1977 |
Frusemide and lithium toxicity.
Topics: Bipolar Disorder; Blood Urea Nitrogen; Consciousness; Creatinine; Diuresis; Drug Synergism; Furosemi | 1977 |
What is the role of positive inotropic agents in the treatment of acute myocardial infarction?
Topics: Acute Disease; Cardiac Output; Digitalis Glycosides; Digoxin; Furosemide; Heart Failure; Heart Rate; | 1977 |
What is the role of positive inotropic agents in the treatment of acute myocardial infarction?
Topics: Acute Disease; Cardiac Output; Digitalis Glycosides; Digoxin; Furosemide; Heart Failure; Heart Rate; | 1977 |
Panniculitis of the legs with urate crystal deposition.
Topics: Aged; Arthritis; Diagnosis, Differential; Female; Furosemide; Gout; Heart Failure; Humans; Lipase; S | 1977 |
Panniculitis of the legs with urate crystal deposition.
Topics: Aged; Arthritis; Diagnosis, Differential; Female; Furosemide; Gout; Heart Failure; Humans; Lipase; S | 1977 |
[The therapy of edematous diseases].
Topics: Antihypertensive Agents; Bed Rest; Diabetes Insipidus; Diuretics; Diuretics, Osmotic; Edema; Ethacry | 1977 |
[The therapy of edematous diseases].
Topics: Antihypertensive Agents; Bed Rest; Diabetes Insipidus; Diuretics; Diuretics, Osmotic; Edema; Ethacry | 1977 |
Distribution, elimination and effect of furosemide in normal subjects and in patients with heart failure.
Topics: Adult; Aged; Female; Furosemide; Glucuronates; Heart Failure; Humans; Male; Middle Aged; Protein Bin | 1977 |
Distribution, elimination and effect of furosemide in normal subjects and in patients with heart failure.
Topics: Adult; Aged; Female; Furosemide; Glucuronates; Heart Failure; Humans; Male; Middle Aged; Protein Bin | 1977 |
[Combined treatment with furosemide, aldactone and hygroton in chronic right-ventricular circulatory failure].
Topics: Chlorthalidone; Drug Therapy, Combination; Female; Furosemide; Heart Failure; Heart Ventricles; Huma | 1977 |
[Combined treatment with furosemide, aldactone and hygroton in chronic right-ventricular circulatory failure].
Topics: Chlorthalidone; Drug Therapy, Combination; Female; Furosemide; Heart Failure; Heart Ventricles; Huma | 1977 |
[Use of high doses of furosemide in treatment of congestive circulatory insufficiency].
Topics: Adult; Aged; Blood Circulation; Female; Furosemide; Heart Failure; Humans; Male; Middle Aged | 1977 |
[Use of high doses of furosemide in treatment of congestive circulatory insufficiency].
Topics: Adult; Aged; Blood Circulation; Female; Furosemide; Heart Failure; Humans; Male; Middle Aged | 1977 |
Potassium supplements in patients receiving long-term diuretics for oedema.
Topics: Bendroflumethiazide; Body Composition; Bumetanide; Diuretics; Edema, Cardiac; Female; Furosemide; He | 1976 |
Potassium supplements in patients receiving long-term diuretics for oedema.
Topics: Bendroflumethiazide; Body Composition; Bumetanide; Diuretics; Edema, Cardiac; Female; Furosemide; He | 1976 |
[Therapeutic report on an injectable aldosterone antagonist (K-canrenoate) in states of water-salf retention].
Topics: Adult; Aged; Ascites; Canrenoic Acid; Drug Evaluation; Drug Therapy, Combination; Edema; Ethacrynic | 1976 |
[Therapeutic report on an injectable aldosterone antagonist (K-canrenoate) in states of water-salf retention].
Topics: Adult; Aged; Ascites; Canrenoic Acid; Drug Evaluation; Drug Therapy, Combination; Edema; Ethacrynic | 1976 |
Premature infants with patent ductus arteriosus and respiratory distress: selection for ductal ligation.
Topics: Digitalis Glycosides; Ductus Arteriosus, Patent; Echocardiography; Female; Furosemide; Heart Failure | 1976 |
Premature infants with patent ductus arteriosus and respiratory distress: selection for ductal ligation.
Topics: Digitalis Glycosides; Ductus Arteriosus, Patent; Echocardiography; Female; Furosemide; Heart Failure | 1976 |
Effect of potassium-sparing diuretics on the renin-angiotensin-aldosterone system and potassium retention in heart failure.
Topics: Adult; Aged; Aldosterone; Amiloride; Angiotensin II; Digoxin; Female; Furosemide; Heart Failure; Hum | 1976 |
Effect of potassium-sparing diuretics on the renin-angiotensin-aldosterone system and potassium retention in heart failure.
Topics: Adult; Aged; Aldosterone; Amiloride; Angiotensin II; Digoxin; Female; Furosemide; Heart Failure; Hum | 1976 |
[Effect of furanthril on several hemodynamic indices during the acute stage of myocardial infarction].
Topics: Acute Disease; Adult; Aged; Blood Pressure; Female; Furosemide; Heart Failure; Heart Rate; Humans; I | 1976 |
[Effect of furanthril on several hemodynamic indices during the acute stage of myocardial infarction].
Topics: Acute Disease; Adult; Aged; Blood Pressure; Female; Furosemide; Heart Failure; Heart Rate; Humans; I | 1976 |
[Hormonal disturbances and the treatment of refractory forms of congestive circulatory insufficiency].
Topics: Aldosterone; Body Water; Circadian Rhythm; Diuresis; Drug Therapy, Combination; Furosemide; Glucocor | 1976 |
[Hormonal disturbances and the treatment of refractory forms of congestive circulatory insufficiency].
Topics: Aldosterone; Body Water; Circadian Rhythm; Diuresis; Drug Therapy, Combination; Furosemide; Glucocor | 1976 |
Lactic acidosis in acute congestive heart failure.
Topics: Acidosis; Adult; Aged; Digoxin; Female; Furosemide; Heart Failure; Humans; Lactates; Male; Middle Ag | 1976 |
Lactic acidosis in acute congestive heart failure.
Topics: Acidosis; Adult; Aged; Digoxin; Female; Furosemide; Heart Failure; Humans; Lactates; Male; Middle Ag | 1976 |
Dosage titration with furosemide in congestive heart failure patients.
Topics: Adult; Aged; Dose-Response Relationship, Drug; Female; Furosemide; Heart Failure; Humans; Male; Midd | 1975 |
Dosage titration with furosemide in congestive heart failure patients.
Topics: Adult; Aged; Dose-Response Relationship, Drug; Female; Furosemide; Heart Failure; Humans; Male; Midd | 1975 |
Occurrence of bullous pemphigoid after furosemide therapy.
Topics: Aged; Female; Furosemide; Heart Failure; Humans; Skin Diseases, Vesiculobullous | 1976 |
Occurrence of bullous pemphigoid after furosemide therapy.
Topics: Aged; Female; Furosemide; Heart Failure; Humans; Skin Diseases, Vesiculobullous | 1976 |
Maternal cardiomyopathy of pregnancy causing stillbirth.
Topics: Adult; Blood; Epistaxis; Female; Fetal Death; Fetus; Furosemide; Heart Failure; Humans; Immunoglobul | 1975 |
Maternal cardiomyopathy of pregnancy causing stillbirth.
Topics: Adult; Blood; Epistaxis; Female; Fetal Death; Fetus; Furosemide; Heart Failure; Humans; Immunoglobul | 1975 |
[Changes in electrolytes in urine, blood and edema fluid after administration of some diuretics].
Topics: Adult; Aged; Calcium; Diuretics; Ethacrynic Acid; Female; Furosemide; Heart Failure; Humans; Hydroch | 1975 |
[Changes in electrolytes in urine, blood and edema fluid after administration of some diuretics].
Topics: Adult; Aged; Calcium; Diuretics; Ethacrynic Acid; Female; Furosemide; Heart Failure; Humans; Hydroch | 1975 |
Some aspects of diuretic therapy.
Topics: Aged; Amiloride; Benzothiadiazines; Digitalis Glycosides; Diuretics; Drug Therapy, Combination; Etha | 1975 |
Some aspects of diuretic therapy.
Topics: Aged; Amiloride; Benzothiadiazines; Digitalis Glycosides; Diuretics; Drug Therapy, Combination; Etha | 1975 |
[Use of aldactone-saltucine for patients with chronic circulatory insufficiency].
Topics: Adult; Aged; Butanes; Creatinine; Diuresis; Diuretics; Drug Combinations; Drug Evaluation; Female; F | 1975 |
[Use of aldactone-saltucine for patients with chronic circulatory insufficiency].
Topics: Adult; Aged; Butanes; Creatinine; Diuresis; Diuretics; Drug Combinations; Drug Evaluation; Female; F | 1975 |
Increased salivary calcium levels as an indicator of digoxin intoxication.
Topics: Adult; Aged; Calcium; Digoxin; Drug Therapy, Combination; Electrocardiography; Furosemide; Heart Fai | 1975 |
Increased salivary calcium levels as an indicator of digoxin intoxication.
Topics: Adult; Aged; Calcium; Digoxin; Drug Therapy, Combination; Electrocardiography; Furosemide; Heart Fai | 1975 |
Minoxidil in severe hypertension: value when conventional drugs have failed.
Topics: Adult; Dose-Response Relationship, Drug; Drug Evaluation; Drug Therapy, Combination; Edema; Female; | 1975 |
Minoxidil in severe hypertension: value when conventional drugs have failed.
Topics: Adult; Dose-Response Relationship, Drug; Drug Evaluation; Drug Therapy, Combination; Edema; Female; | 1975 |
[Hemodynamics of the insufficient heart following myocardial infarct during diuresis with furosemide].
Topics: Adult; Diuresis; Furosemide; Heart Failure; Hemodynamics; Humans; Myocardial Infarction; Shock | 1975 |
[Hemodynamics of the insufficient heart following myocardial infarct during diuresis with furosemide].
Topics: Adult; Diuresis; Furosemide; Heart Failure; Hemodynamics; Humans; Myocardial Infarction; Shock | 1975 |
The pathogenesis and management of massive pulmonary hemorrhage in the neonate. Case report of a normal survivor.
Topics: Asphyxia; Atropine; Blood Transfusion; Furosemide; Heart Failure; Hemorrhage; Humans; Infant, Newbor | 1976 |
The pathogenesis and management of massive pulmonary hemorrhage in the neonate. Case report of a normal survivor.
Topics: Asphyxia; Atropine; Blood Transfusion; Furosemide; Heart Failure; Hemorrhage; Humans; Infant, Newbor | 1976 |
[Acute renal failure secondary to hyperuricemia after the use of a diuretic].
Topics: Acute Kidney Injury; Aged; Furosemide; Heart Failure; Humans; Male; Peritoneal Dialysis; Uric Acid | 1976 |
[Acute renal failure secondary to hyperuricemia after the use of a diuretic].
Topics: Acute Kidney Injury; Aged; Furosemide; Heart Failure; Humans; Male; Peritoneal Dialysis; Uric Acid | 1976 |
Acute hemodynamic, hormonal, and renal effects of neutral endopeptidase inhibition in ovine heart failure.
Topics: Analysis of Variance; Animals; Atrial Natriuretic Factor; Blood Pressure; Cattle; Cyclic GMP; Dipept | 1992 |
Acute hemodynamic, hormonal, and renal effects of neutral endopeptidase inhibition in ovine heart failure.
Topics: Analysis of Variance; Animals; Atrial Natriuretic Factor; Blood Pressure; Cattle; Cyclic GMP; Dipept | 1992 |
Differences in blood pressure regulation of congestive heart failure, before and after treatment, correlate with changes in the circulating pattern of atrial natriuretic peptide.
Topics: Aged; Atrial Natriuretic Factor; Blood Pressure; Cardiotonic Agents; Digoxin; Drug Therapy, Combinat | 1992 |
Differences in blood pressure regulation of congestive heart failure, before and after treatment, correlate with changes in the circulating pattern of atrial natriuretic peptide.
Topics: Aged; Atrial Natriuretic Factor; Blood Pressure; Cardiotonic Agents; Digoxin; Drug Therapy, Combinat | 1992 |
[A case of dilated cardiomyopathy with intractable heart failure treated with adjunctive therapy of pimobendan and denopamine].
Topics: Cardiomyopathy, Dilated; Chemotherapy, Adjuvant; Ethanolamines; Furosemide; Heart Failure; Humans; I | 1992 |
[A case of dilated cardiomyopathy with intractable heart failure treated with adjunctive therapy of pimobendan and denopamine].
Topics: Cardiomyopathy, Dilated; Chemotherapy, Adjuvant; Ethanolamines; Furosemide; Heart Failure; Humans; I | 1992 |
[Effects of inhaled and intravenous furosemide on bronchial hyperresponsiveness in patients with chronic congestive heart failure].
Topics: Administration, Inhalation; Adult; Aged; Aged, 80 and over; Bronchial Hyperreactivity; Chronic Disea | 1992 |
[Effects of inhaled and intravenous furosemide on bronchial hyperresponsiveness in patients with chronic congestive heart failure].
Topics: Administration, Inhalation; Adult; Aged; Aged, 80 and over; Bronchial Hyperreactivity; Chronic Disea | 1992 |
[Atrial natriuretic factor in patients with cardiac decompensation before and after chronic therapy with an angiotensin-converting enzyme inhibitor].
Topics: Acute Disease; Aged; Atrial Natriuretic Factor; Biomarkers; Digoxin; Drug Therapy, Combination; Enal | 1992 |
[Atrial natriuretic factor in patients with cardiac decompensation before and after chronic therapy with an angiotensin-converting enzyme inhibitor].
Topics: Acute Disease; Aged; Atrial Natriuretic Factor; Biomarkers; Digoxin; Drug Therapy, Combination; Enal | 1992 |
Hemofiltration as treatment for patients with refractory heart failure.
Topics: Adult; Aged; Combined Modality Therapy; Creatinine; Female; Follow-Up Studies; Furosemide; Heart Fai | 1992 |
Hemofiltration as treatment for patients with refractory heart failure.
Topics: Adult; Aged; Combined Modality Therapy; Creatinine; Female; Follow-Up Studies; Furosemide; Heart Fai | 1992 |
Perioperative management of a case of severe peripartum cardiomyopathy.
Topics: Adult; Captopril; Cardiomegaly; Cesarean Section; Critical Care; Digoxin; Dobutamine; Dopamine; Fema | 1992 |
Perioperative management of a case of severe peripartum cardiomyopathy.
Topics: Adult; Captopril; Cardiomegaly; Cesarean Section; Critical Care; Digoxin; Dobutamine; Dopamine; Fema | 1992 |
[Restrictive cardiomyopathy caused by cardiac amyloidosis in multiple myeloma].
Topics: Aged; Amyloidosis; Biopsy; Captopril; Cardiomyopathy, Restrictive; Diagnosis, Differential; Digitoxi | 1992 |
[Restrictive cardiomyopathy caused by cardiac amyloidosis in multiple myeloma].
Topics: Aged; Amyloidosis; Biopsy; Captopril; Cardiomyopathy, Restrictive; Diagnosis, Differential; Digitoxi | 1992 |
Geriatrics nephrology.
Topics: Aged; Aging; Captopril; Digoxin; Furosemide; Heart Failure; Humans; Hypertension; Kidney Diseases; L | 1992 |
Geriatrics nephrology.
Topics: Aged; Aging; Captopril; Digoxin; Furosemide; Heart Failure; Humans; Hypertension; Kidney Diseases; L | 1992 |
Intracellular free magnesium in lymphocytes from patients with congestive cardiac failure treated with loop diuretics with and without amiloride.
Topics: Amiloride; Bumetanide; Cations, Divalent; Drug Therapy, Combination; Furosemide; Heart Failure; Huma | 1992 |
Intracellular free magnesium in lymphocytes from patients with congestive cardiac failure treated with loop diuretics with and without amiloride.
Topics: Amiloride; Bumetanide; Cations, Divalent; Drug Therapy, Combination; Furosemide; Heart Failure; Huma | 1992 |
Effects of prehospital medications on mortality and length of stay in congestive heart failure.
Topics: Academic Medical Centers; Aged; Cardiovascular Agents; Confidence Intervals; Emergency Medical Servi | 1992 |
Effects of prehospital medications on mortality and length of stay in congestive heart failure.
Topics: Academic Medical Centers; Aged; Cardiovascular Agents; Confidence Intervals; Emergency Medical Servi | 1992 |
Absorption of high dose furosemide (frusemide) in congestive heart failure.
Topics: Administration, Oral; Aged; Algorithms; Edema; Female; Furosemide; Heart Failure; Humans; Male; Midd | 1992 |
Absorption of high dose furosemide (frusemide) in congestive heart failure.
Topics: Administration, Oral; Aged; Algorithms; Edema; Female; Furosemide; Heart Failure; Humans; Male; Midd | 1992 |
Effect of captopril therapy on lymphocyte potassium and magnesium concentrations in patients with congestive heart failure.
Topics: Adult; Aged; Captopril; Drug Therapy, Combination; Female; Furosemide; Heart Failure; Humans; Lympho | 1992 |
Effect of captopril therapy on lymphocyte potassium and magnesium concentrations in patients with congestive heart failure.
Topics: Adult; Aged; Captopril; Drug Therapy, Combination; Female; Furosemide; Heart Failure; Humans; Lympho | 1992 |
The relationship between diuretic dose, and the haemodynamic response to captopril in patients with cardiac failure.
Topics: Adult; Aged; Aldosterone; Angiotensin II; Blood Pressure; Captopril; Cardiac Output; Dose-Response R | 1992 |
The relationship between diuretic dose, and the haemodynamic response to captopril in patients with cardiac failure.
Topics: Adult; Aged; Aldosterone; Angiotensin II; Blood Pressure; Captopril; Cardiac Output; Dose-Response R | 1992 |
Effect of drugs on a noninvasive index of arterial compliance in healthy and heart failure patients.
Topics: Adult; Aged; Aged, 80 and over; Captopril; Cardiography, Impedance; Drug Therapy, Combination; Furos | 1991 |
Effect of drugs on a noninvasive index of arterial compliance in healthy and heart failure patients.
Topics: Adult; Aged; Aged, 80 and over; Captopril; Cardiography, Impedance; Drug Therapy, Combination; Furos | 1991 |
Diuretics as initial and sole treatment in chronic cardiac failure.
Topics: Extracellular Space; Furosemide; Glomerular Filtration Rate; Heart Failure; Hemodynamics; Humans; Ki | 1991 |
Diuretics as initial and sole treatment in chronic cardiac failure.
Topics: Extracellular Space; Furosemide; Glomerular Filtration Rate; Heart Failure; Hemodynamics; Humans; Ki | 1991 |
[A clinico-therapeutic study of the Bulgarian preparation fupiram].
Topics: Aged; Aged, 80 and over; Amiloride; Capsules; Diuresis; Drug Combinations; Drug Evaluation; Female; | 1991 |
[A clinico-therapeutic study of the Bulgarian preparation fupiram].
Topics: Aged; Aged, 80 and over; Amiloride; Capsules; Diuresis; Drug Combinations; Drug Evaluation; Female; | 1991 |
Left atrial myxomas--a case report.
Topics: Digoxin; Drug Therapy, Combination; Echocardiography; Female; Furosemide; Heart Atria; Heart Auscult | 1991 |
Left atrial myxomas--a case report.
Topics: Digoxin; Drug Therapy, Combination; Echocardiography; Female; Furosemide; Heart Atria; Heart Auscult | 1991 |
[Thrombocytopenia induced by treatment with furosemide].
Topics: Aged; Aged, 80 and over; Female; Furosemide; Heart Failure; Humans; Thrombocytopenia | 1991 |
[Thrombocytopenia induced by treatment with furosemide].
Topics: Aged; Aged, 80 and over; Female; Furosemide; Heart Failure; Humans; Thrombocytopenia | 1991 |
Cardiac remodelling and myocardial contractility in patients with congestive heart failure treated with furosemide and enalapril.
Topics: Aged; Angiotensin II; Cardiomegaly; Drug Therapy, Combination; Enalapril; Furosemide; Heart Failure; | 1991 |
Cardiac remodelling and myocardial contractility in patients with congestive heart failure treated with furosemide and enalapril.
Topics: Aged; Angiotensin II; Cardiomegaly; Drug Therapy, Combination; Enalapril; Furosemide; Heart Failure; | 1991 |
Effects of dobutamine and salbutamol on haemodynamics and atrial natriuretic factor in patients with severe congestive heart failure.
Topics: Adult; Aged; Albuterol; Atrial Natriuretic Factor; Blood Pressure; Cardiac Output; Dobutamine; Femal | 1991 |
Effects of dobutamine and salbutamol on haemodynamics and atrial natriuretic factor in patients with severe congestive heart failure.
Topics: Adult; Aged; Albuterol; Atrial Natriuretic Factor; Blood Pressure; Cardiac Output; Dobutamine; Femal | 1991 |
Thiamine deficiency in patients with congestive heart failure receiving long-term furosemide therapy: a pilot study.
Topics: Adult; Aged; Aged, 80 and over; Erythrocytes; Female; Furosemide; Heart Failure; Humans; Injections, | 1991 |
Thiamine deficiency in patients with congestive heart failure receiving long-term furosemide therapy: a pilot study.
Topics: Adult; Aged; Aged, 80 and over; Erythrocytes; Female; Furosemide; Heart Failure; Humans; Injections, | 1991 |
Observed changes in serum potassium concentration following repeat centrifugation of Sarstedt Serum Gel Safety Monovettes after storage.
Topics: Aged; Aged, 80 and over; Blood Preservation; Blood Specimen Collection; Centrifugation; Female; Furo | 1991 |
Observed changes in serum potassium concentration following repeat centrifugation of Sarstedt Serum Gel Safety Monovettes after storage.
Topics: Aged; Aged, 80 and over; Blood Preservation; Blood Specimen Collection; Centrifugation; Female; Furo | 1991 |
[Metolazone in the treatment of advanced therapy-resistant dilated cardiomyopathy].
Topics: Aged; Aged, 80 and over; Cardiomyopathy, Dilated; Drug Therapy, Combination; Edema, Cardiac; Female; | 1991 |
[Metolazone in the treatment of advanced therapy-resistant dilated cardiomyopathy].
Topics: Aged; Aged, 80 and over; Cardiomyopathy, Dilated; Drug Therapy, Combination; Edema, Cardiac; Female; | 1991 |
Acute administration of captopril lowers the natriuretic and diuretic response to a loop diuretic in patients with chronic cardiac failure.
Topics: Aged; Aged, 80 and over; Aldosterone; Angiotensin II; Blood Pressure; Captopril; Creatinine; Diuresi | 1991 |
Acute administration of captopril lowers the natriuretic and diuretic response to a loop diuretic in patients with chronic cardiac failure.
Topics: Aged; Aged, 80 and over; Aldosterone; Angiotensin II; Blood Pressure; Captopril; Creatinine; Diuresi | 1991 |
Glomerular and vascular atrial natriuretic factor receptors in cardiomyopathic hamsters: correlation with the peptide biological effects.
Topics: Animals; Aorta; Atrial Natriuretic Factor; Blood Pressure; Cricetinae; Diuresis; Furosemide; Heart F | 1990 |
Glomerular and vascular atrial natriuretic factor receptors in cardiomyopathic hamsters: correlation with the peptide biological effects.
Topics: Animals; Aorta; Atrial Natriuretic Factor; Blood Pressure; Cricetinae; Diuresis; Furosemide; Heart F | 1990 |
Thiazides with loop diuretics for severe congestive heart failure.
Topics: Aged; Bendroflumethiazide; Diuresis; Drug Administration Schedule; Drug Therapy, Combination; Female | 1990 |
Thiazides with loop diuretics for severe congestive heart failure.
Topics: Aged; Bendroflumethiazide; Diuresis; Drug Administration Schedule; Drug Therapy, Combination; Female | 1990 |
Transient pulsus alternans induced by isosorbide dinitrate: echocardiographic and hemodynamic evidence of reduced venous return--a case report.
Topics: Adult; Drug Therapy, Combination; Echocardiography; Furosemide; Heart Failure; Hemodynamics; Humans; | 1991 |
Transient pulsus alternans induced by isosorbide dinitrate: echocardiographic and hemodynamic evidence of reduced venous return--a case report.
Topics: Adult; Drug Therapy, Combination; Echocardiography; Furosemide; Heart Failure; Hemodynamics; Humans; | 1991 |
[The effect of combined treatment in chronic congestive heart failure with digoxin, furosemide and pentoxifylline upon blood viscosity].
Topics: Adult; Aged; Blood Viscosity; Digoxin; Drug Therapy, Combination; Female; Furosemide; Heart Failure; | 1990 |
[The effect of combined treatment in chronic congestive heart failure with digoxin, furosemide and pentoxifylline upon blood viscosity].
Topics: Adult; Aged; Blood Viscosity; Digoxin; Drug Therapy, Combination; Female; Furosemide; Heart Failure; | 1990 |
[Possibilities of the method of dilution of electro-impedance indicators in the assessment of volume dynamics of extravascular lung fluid in intensive care and resuscitation units].
Topics: Body Fluids; Furosemide; Heart Failure; Hemofiltration; Humans; Intensive Care Units; Lung; Models, | 1990 |
[Possibilities of the method of dilution of electro-impedance indicators in the assessment of volume dynamics of extravascular lung fluid in intensive care and resuscitation units].
Topics: Body Fluids; Furosemide; Heart Failure; Hemofiltration; Humans; Intensive Care Units; Lung; Models, | 1990 |
[Pulmo cardialis: effect of inhaled bronchodilators on airway resistance of acute left ventricular dysfunction].
Topics: Airway Resistance; Atropine Derivatives; Fenoterol; Furosemide; Heart Failure; Humans; Ipratropium; | 1990 |
[Pulmo cardialis: effect of inhaled bronchodilators on airway resistance of acute left ventricular dysfunction].
Topics: Airway Resistance; Atropine Derivatives; Fenoterol; Furosemide; Heart Failure; Humans; Ipratropium; | 1990 |
[Bumetanide as replacement therapy in furosemide-induced vasculitis].
Topics: Aged; Bumetanide; Female; Furosemide; Heart Failure; Humans; Vasculitis, Leukocytoclastic, Cutaneous | 1990 |
[Bumetanide as replacement therapy in furosemide-induced vasculitis].
Topics: Aged; Bumetanide; Female; Furosemide; Heart Failure; Humans; Vasculitis, Leukocytoclastic, Cutaneous | 1990 |
[Metabolic and acid-base changes in intensive diuretic therapy in heart failure].
Topics: Acid-Base Equilibrium; Aged; Aged, 80 and over; Amiloride; Blood Glucose; Captopril; Creatinine; Ele | 1990 |
[Metabolic and acid-base changes in intensive diuretic therapy in heart failure].
Topics: Acid-Base Equilibrium; Aged; Aged, 80 and over; Amiloride; Blood Glucose; Captopril; Creatinine; Ele | 1990 |
[Evaluation of the effectiveness of calcium antagonists combined with digoxin and furosemide in hypertension complicated by circulatory insufficiency in elderly patients].
Topics: Aged; Digoxin; Drug Therapy, Combination; Furosemide; Heart Failure; Hemodynamics; Humans; Hypertens | 1990 |
[Evaluation of the effectiveness of calcium antagonists combined with digoxin and furosemide in hypertension complicated by circulatory insufficiency in elderly patients].
Topics: Aged; Digoxin; Drug Therapy, Combination; Furosemide; Heart Failure; Hemodynamics; Humans; Hypertens | 1990 |
[Changes in left-ventricular function in chronic congestive heart failure treated with digoxin, furosemide and vasodilators].
Topics: Adult; Aged; Chronic Disease; Digoxin; Drug Interactions; Drug Therapy, Combination; Furosemide; Hea | 1990 |
[Changes in left-ventricular function in chronic congestive heart failure treated with digoxin, furosemide and vasodilators].
Topics: Adult; Aged; Chronic Disease; Digoxin; Drug Interactions; Drug Therapy, Combination; Furosemide; Hea | 1990 |
[Results of treatment for severe congestive heart failure with digoxin, furosemide and vasodilating agents].
Topics: Adult; Aged; Aged, 80 and over; Digoxin; Echocardiography; Female; Follow-Up Studies; Furosemide; He | 1990 |
[Results of treatment for severe congestive heart failure with digoxin, furosemide and vasodilating agents].
Topics: Adult; Aged; Aged, 80 and over; Digoxin; Echocardiography; Female; Follow-Up Studies; Furosemide; He | 1990 |
Afterload reduction with vasodilators and diuretics decreases mitral regurgitation during upright exercise in advanced heart failure.
Topics: Bumetanide; Diuretics; Exercise; Female; Ferricyanides; Furosemide; Heart; Heart Failure; Humans; Ma | 1990 |
Afterload reduction with vasodilators and diuretics decreases mitral regurgitation during upright exercise in advanced heart failure.
Topics: Bumetanide; Diuretics; Exercise; Female; Ferricyanides; Furosemide; Heart; Heart Failure; Humans; Ma | 1990 |
[Furosemide capsules in the treatment of hypertension or heart failure in the elderly in general practice].
Topics: Aged; Capsules; Family Practice; Furosemide; Heart Failure; Humans; Hypertension; Middle Aged | 1990 |
[Furosemide capsules in the treatment of hypertension or heart failure in the elderly in general practice].
Topics: Aged; Capsules; Family Practice; Furosemide; Heart Failure; Humans; Hypertension; Middle Aged | 1990 |
[Idiopathic infantile arterial calcification: diagnosis and treatment].
Topics: Age Factors; Arteriosclerosis; Cardiomyopathy, Hypertrophic; Digoxin; Furosemide; Heart Failure; Hum | 1990 |
[Idiopathic infantile arterial calcification: diagnosis and treatment].
Topics: Age Factors; Arteriosclerosis; Cardiomyopathy, Hypertrophic; Digoxin; Furosemide; Heart Failure; Hum | 1990 |
Daily administration of furosemide in dilated cardiomyopathy--yes or no?
Topics: Adult; Aged; Blood Pressure; Cardiac Output; Cardiac Volume; Cardiomyopathy, Dilated; Drug Administr | 1990 |
Daily administration of furosemide in dilated cardiomyopathy--yes or no?
Topics: Adult; Aged; Blood Pressure; Cardiac Output; Cardiac Volume; Cardiomyopathy, Dilated; Drug Administr | 1990 |
[The 25th birthday of Lasilix: contributions of furosemide to renal physiology and therapy].
Topics: Diuretics; Furosemide; Heart Failure; Humans; Hypertension; Kidney Diseases | 1990 |
[The 25th birthday of Lasilix: contributions of furosemide to renal physiology and therapy].
Topics: Diuretics; Furosemide; Heart Failure; Humans; Hypertension; Kidney Diseases | 1990 |
Severe pulmonary hypertension in a patient with Whipple's disease.
Topics: Drug Combinations; Furosemide; Heart Failure; Heart Murmurs; Humans; Hypertension, Pulmonary; Male; | 1985 |
Severe pulmonary hypertension in a patient with Whipple's disease.
Topics: Drug Combinations; Furosemide; Heart Failure; Heart Murmurs; Humans; Hypertension, Pulmonary; Male; | 1985 |
A one-sided affair? Myocardial infarction with pulmonary edema and forward failure.
Topics: Aged; Dobutamine; Female; Furosemide; Heart Failure; Humans; Myocardial Infarction; Nitroglycerin; P | 1989 |
A one-sided affair? Myocardial infarction with pulmonary edema and forward failure.
Topics: Aged; Dobutamine; Female; Furosemide; Heart Failure; Humans; Myocardial Infarction; Nitroglycerin; P | 1989 |
Inefficacy of daily single bolus dose atrial natriuretic factor in chronic congestive heart failure.
Topics: Aged; Atrial Natriuretic Factor; Chronic Disease; Drug Administration Schedule; Electrocardiography, | 1989 |
Inefficacy of daily single bolus dose atrial natriuretic factor in chronic congestive heart failure.
Topics: Aged; Atrial Natriuretic Factor; Chronic Disease; Drug Administration Schedule; Electrocardiography, | 1989 |
Home intravenous diuretic therapy for patient with refractory heart failure.
Topics: Ambulatory Care; Drug Administration Schedule; Female; Furosemide; Heart Failure; Humans; Injections | 1989 |
Home intravenous diuretic therapy for patient with refractory heart failure.
Topics: Ambulatory Care; Drug Administration Schedule; Female; Furosemide; Heart Failure; Humans; Injections | 1989 |
Oral metolazone plus frusemide for home therapy in patients with refractory heart failure.
Topics: Administration, Oral; Adult; Aged; Ambulatory Care; Diuretics; Drug Evaluation; Drug Therapy, Combin | 1989 |
Oral metolazone plus frusemide for home therapy in patients with refractory heart failure.
Topics: Administration, Oral; Adult; Aged; Ambulatory Care; Diuretics; Drug Evaluation; Drug Therapy, Combin | 1989 |
Sodium balance in infants with severe congestive heart failure.
Topics: Failure to Thrive; Furosemide; Heart Failure; Humans; Infant, Newborn; Sodium | 1989 |
Sodium balance in infants with severe congestive heart failure.
Topics: Failure to Thrive; Furosemide; Heart Failure; Humans; Infant, Newborn; Sodium | 1989 |
Neuroendocrine response in acute heart failure and the influence of treatment.
Topics: Acute Disease; Aged; Aldosterone; Angiotensin II; Arginine Vasopressin; Atrial Natriuretic Factor; C | 1989 |
Neuroendocrine response in acute heart failure and the influence of treatment.
Topics: Acute Disease; Aged; Aldosterone; Angiotensin II; Arginine Vasopressin; Atrial Natriuretic Factor; C | 1989 |
[The efficacy of calcium antagonists in circulatory failure in elderly patients with hypertension].
Topics: Aged; Calcium Channel Blockers; Digoxin; Dose-Response Relationship, Drug; Drug Evaluation; Drug The | 1989 |
[The efficacy of calcium antagonists in circulatory failure in elderly patients with hypertension].
Topics: Aged; Calcium Channel Blockers; Digoxin; Dose-Response Relationship, Drug; Drug Evaluation; Drug The | 1989 |
[Metolazone in the treatment of refractory heart insufficiency. Experience of 10 cases].
Topics: Aged; Diuresis; Diuretics; Drug Evaluation; Drug Therapy, Combination; Female; Furosemide; Heart Fai | 1989 |
[Metolazone in the treatment of refractory heart insufficiency. Experience of 10 cases].
Topics: Aged; Diuresis; Diuretics; Drug Evaluation; Drug Therapy, Combination; Female; Furosemide; Heart Fai | 1989 |
Efficacy of medical therapy tailored for severe congestive heart failure in patients transferred for urgent cardiac transplantation.
Topics: Actuarial Analysis; Adolescent; Adult; Aged; Cardiovascular Agents; Combined Modality Therapy; Drug | 1989 |
Efficacy of medical therapy tailored for severe congestive heart failure in patients transferred for urgent cardiac transplantation.
Topics: Actuarial Analysis; Adolescent; Adult; Aged; Cardiovascular Agents; Combined Modality Therapy; Drug | 1989 |
[The use of digoxin, lasix and finoptin in treating circulatory failure in hypertension].
Topics: Aged; Aldosterone; Digoxin; Drug Therapy, Combination; Female; Furosemide; Heart Failure; Humans; Hy | 1989 |
[The use of digoxin, lasix and finoptin in treating circulatory failure in hypertension].
Topics: Aged; Aldosterone; Digoxin; Drug Therapy, Combination; Female; Furosemide; Heart Failure; Humans; Hy | 1989 |
Attenuation of the pressor response to intravenous furosemide by angiotensin converting enzyme inhibition in congestive heart failure.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Captopril; Female; Furosemide; Heart | 1989 |
Attenuation of the pressor response to intravenous furosemide by angiotensin converting enzyme inhibition in congestive heart failure.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Captopril; Female; Furosemide; Heart | 1989 |
[Effect of digoxin, furosemide and finoptin on the central hemodynamics in hypertension].
Topics: Aged; Chronic Disease; Digoxin; Drug Evaluation; Drug Therapy, Combination; Female; Furosemide; Hear | 1989 |
[Effect of digoxin, furosemide and finoptin on the central hemodynamics in hypertension].
Topics: Aged; Chronic Disease; Digoxin; Drug Evaluation; Drug Therapy, Combination; Female; Furosemide; Hear | 1989 |
Acute vasoconstrictor response to intravenous furosemide in patients with chronic congestive heart failure. Activation of the neurohumoral axis.
Topics: Adult; Aged; Arginine Vasopressin; Female; Furosemide; Heart Failure; Hemodynamics; Humans; Male; Mi | 1985 |
Acute vasoconstrictor response to intravenous furosemide in patients with chronic congestive heart failure. Activation of the neurohumoral axis.
Topics: Adult; Aged; Arginine Vasopressin; Female; Furosemide; Heart Failure; Hemodynamics; Humans; Male; Mi | 1985 |
Spironolactone in the management of congestive cardiac failure: a review.
Topics: Adrenergic alpha-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Benzothiadiazines; Cardioton | 1986 |
Spironolactone in the management of congestive cardiac failure: a review.
Topics: Adrenergic alpha-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Benzothiadiazines; Cardioton | 1986 |
Treatment of congestive heart failure. Its effect on pleural fluid chemistry.
Topics: Aged; Follow-Up Studies; Furosemide; Heart Failure; Humans; L-Lactate Dehydrogenase; Middle Aged; Pl | 1989 |
Treatment of congestive heart failure. Its effect on pleural fluid chemistry.
Topics: Aged; Follow-Up Studies; Furosemide; Heart Failure; Humans; L-Lactate Dehydrogenase; Middle Aged; Pl | 1989 |
The effect of treatment of congestive heart failure on plasma atrial natriuretic peptide concentration: a longitudinal study.
Topics: Adult; Aged; Aged, 80 and over; Atrial Natriuretic Factor; Body Weight; Female; Furosemide; Heart Fa | 1988 |
The effect of treatment of congestive heart failure on plasma atrial natriuretic peptide concentration: a longitudinal study.
Topics: Adult; Aged; Aged, 80 and over; Atrial Natriuretic Factor; Body Weight; Female; Furosemide; Heart Fa | 1988 |
Reversible renal failure after combined treatment with enalapril and frusemide in a patient with congestive heart failure.
Topics: Acute Kidney Injury; Aged; Drug Therapy, Combination; Enalapril; Furosemide; Heart Failure; Humans; | 1986 |
Reversible renal failure after combined treatment with enalapril and frusemide in a patient with congestive heart failure.
Topics: Acute Kidney Injury; Aged; Drug Therapy, Combination; Enalapril; Furosemide; Heart Failure; Humans; | 1986 |
Reversible renal failure after combined treatment with enalapril and frusemide in a patient with congestive heart failure.
Topics: Acute Kidney Injury; Aged; Enalapril; Female; Furosemide; Heart Failure; Humans; Male | 1986 |
Reversible renal failure after combined treatment with enalapril and frusemide in a patient with congestive heart failure.
Topics: Acute Kidney Injury; Aged; Enalapril; Female; Furosemide; Heart Failure; Humans; Male | 1986 |
Renal effects of angiotensin-converting enzyme inhibition in cardiac failure.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Enalapril; Furosemide; Glomerular Filt | 1987 |
Renal effects of angiotensin-converting enzyme inhibition in cardiac failure.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Enalapril; Furosemide; Glomerular Filt | 1987 |
Role of diuretics, hormonal derangements, and clinical setting of hyponatremia in medical patients.
Topics: Aldosterone; Arginine Vasopressin; Diuretics; Electrolytes; Epinephrine; Furosemide; Heart Failure; | 1988 |
Role of diuretics, hormonal derangements, and clinical setting of hyponatremia in medical patients.
Topics: Aldosterone; Arginine Vasopressin; Diuretics; Electrolytes; Epinephrine; Furosemide; Heart Failure; | 1988 |
Pompe's disease in identical twins.
Topics: Echocardiography; Female; Furosemide; Glycogen; Glycogen Storage Disease; Glycogen Storage Disease T | 1986 |
Pompe's disease in identical twins.
Topics: Echocardiography; Female; Furosemide; Glycogen; Glycogen Storage Disease; Glycogen Storage Disease T | 1986 |
A long, thin infant with congestive heart failure.
Topics: Digoxin; Furosemide; Heart Failure; Humans; Infant; Male; Marfan Syndrome | 1987 |
A long, thin infant with congestive heart failure.
Topics: Digoxin; Furosemide; Heart Failure; Humans; Infant; Male; Marfan Syndrome | 1987 |
Acute and long-term renal and metabolic effects of piretanide in congestive cardiac failure.
Topics: Adult; Aged; Diuretics; Electrolytes; Female; Furosemide; Heart Failure; Humans; Kidney; Male; Middl | 1988 |
Acute and long-term renal and metabolic effects of piretanide in congestive cardiac failure.
Topics: Adult; Aged; Diuretics; Electrolytes; Female; Furosemide; Heart Failure; Humans; Kidney; Male; Middl | 1988 |
An open study to evaluate the long term tolerability of Frumil in patients with congestive cardiac failure.
Topics: Adult; Aged; Aged, 80 and over; Amiloride; Drug Combinations; Drug Evaluation; Drug Tolerance; Femal | 1988 |
An open study to evaluate the long term tolerability of Frumil in patients with congestive cardiac failure.
Topics: Adult; Aged; Aged, 80 and over; Amiloride; Drug Combinations; Drug Evaluation; Drug Tolerance; Femal | 1988 |
Loop diuretics cause less postural hypotension than thiazide diuretics in the frail elderly.
Topics: Aged; Benzothiadiazines; Diuretics; Female; Furosemide; Heart Failure; Humans; Hypotension, Orthosta | 1988 |
Loop diuretics cause less postural hypotension than thiazide diuretics in the frail elderly.
Topics: Aged; Benzothiadiazines; Diuretics; Female; Furosemide; Heart Failure; Humans; Hypotension, Orthosta | 1988 |
[Hypocalcemia and cardiac insufficiency: a reciprocal influence].
Topics: Aged; Aged, 80 and over; Female; Furosemide; Heart Failure; Humans; Hypocalcemia | 1988 |
[Hypocalcemia and cardiac insufficiency: a reciprocal influence].
Topics: Aged; Aged, 80 and over; Female; Furosemide; Heart Failure; Humans; Hypocalcemia | 1988 |
Arrhythmias during concurrent therapy with captopril and frusemide.
Topics: Aged; Arrhythmias, Cardiac; Captopril; Drug Therapy, Combination; Furosemide; Heart Failure; Humans; | 1987 |
Arrhythmias during concurrent therapy with captopril and frusemide.
Topics: Aged; Arrhythmias, Cardiac; Captopril; Drug Therapy, Combination; Furosemide; Heart Failure; Humans; | 1987 |
Acute hemodynamic action of captopril in congestive heart failure: contrasts between refractory and untreated patients.
Topics: Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Captopril; Cardiomyopathies; Digoxin; Drug Th | 1987 |
Acute hemodynamic action of captopril in congestive heart failure: contrasts between refractory and untreated patients.
Topics: Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Captopril; Cardiomyopathies; Digoxin; Drug Th | 1987 |
High-dose furosemide in the treatment of refractory congestive heart failure.
Topics: Aged; Aged, 80 and over; Chronic Disease; Creatinine; Drug Administration Schedule; Female; Furosemi | 1988 |
High-dose furosemide in the treatment of refractory congestive heart failure.
Topics: Aged; Aged, 80 and over; Chronic Disease; Creatinine; Drug Administration Schedule; Female; Furosemi | 1988 |
[Digitalis therapy in chronic heart failure. Digitoxin in patients in sinus rhythm pretreated with diuretics].
Topics: Adult; Aged; Digitoxin; Diuretics; Drug Evaluation; Drug Therapy, Combination; Echocardiography; Fem | 1988 |
[Digitalis therapy in chronic heart failure. Digitoxin in patients in sinus rhythm pretreated with diuretics].
Topics: Adult; Aged; Digitoxin; Diuretics; Drug Evaluation; Drug Therapy, Combination; Echocardiography; Fem | 1988 |
Cleidocranial dysplasia.
Topics: Aged; Cleidocranial Dysplasia; Furosemide; Heart Failure; Humans; Kyphosis; Male; Radiography, Thora | 1988 |
Cleidocranial dysplasia.
Topics: Aged; Cleidocranial Dysplasia; Furosemide; Heart Failure; Humans; Kyphosis; Male; Radiography, Thora | 1988 |
A long-term open study of a frusemide/amiloride combination ('Frumil') in elderly patients with congestive cardiac failure.
Topics: Adult; Aged; Aged, 80 and over; Amiloride; Drug Combinations; Female; Furosemide; Heart Failure; Hum | 1988 |
A long-term open study of a frusemide/amiloride combination ('Frumil') in elderly patients with congestive cardiac failure.
Topics: Adult; Aged; Aged, 80 and over; Amiloride; Drug Combinations; Female; Furosemide; Heart Failure; Hum | 1988 |
Untreated heart failure: clinical and neuroendocrine effects of introducing diuretics.
Topics: Adult; Aged; Aldosterone; Amiloride; Diuretics; Female; Furosemide; Heart Failure; Heart Function Te | 1987 |
Untreated heart failure: clinical and neuroendocrine effects of introducing diuretics.
Topics: Adult; Aged; Aldosterone; Amiloride; Diuretics; Female; Furosemide; Heart Failure; Heart Function Te | 1987 |
Untreated heart failure: clinical and neuroendocrine effects of introducing diuretics.
Topics: Adult; Aged; Aldosterone; Amiloride; Diuretics; Female; Furosemide; Heart Failure; Heart Function Te | 1987 |
Untreated heart failure: clinical and neuroendocrine effects of introducing diuretics.
Topics: Adult; Aged; Aldosterone; Amiloride; Diuretics; Female; Furosemide; Heart Failure; Heart Function Te | 1987 |
Untreated heart failure: clinical and neuroendocrine effects of introducing diuretics.
Topics: Adult; Aged; Aldosterone; Amiloride; Diuretics; Female; Furosemide; Heart Failure; Heart Function Te | 1987 |
Untreated heart failure: clinical and neuroendocrine effects of introducing diuretics.
Topics: Adult; Aged; Aldosterone; Amiloride; Diuretics; Female; Furosemide; Heart Failure; Heart Function Te | 1987 |
Untreated heart failure: clinical and neuroendocrine effects of introducing diuretics.
Topics: Adult; Aged; Aldosterone; Amiloride; Diuretics; Female; Furosemide; Heart Failure; Heart Function Te | 1987 |
Untreated heart failure: clinical and neuroendocrine effects of introducing diuretics.
Topics: Adult; Aged; Aldosterone; Amiloride; Diuretics; Female; Furosemide; Heart Failure; Heart Function Te | 1987 |
A correctable complication of advanced congestive heart failure.
Topics: Captopril; Female; Furosemide; Heart Failure; Humans; Hyponatremia; Middle Aged; Sodium | 1987 |
A correctable complication of advanced congestive heart failure.
Topics: Captopril; Female; Furosemide; Heart Failure; Humans; Hyponatremia; Middle Aged; Sodium | 1987 |
Acute changes in plasma renin activity, plasma aldosterone concentration and plasma electrolyte concentrations following furosemide administration in patients with congestive heart failure--interrelationships and diuretic response.
Topics: Aged; Aged, 80 and over; Aldosterone; Diuresis; Electrolytes; Female; Furosemide; Heart Failure; Hum | 1987 |
Acute changes in plasma renin activity, plasma aldosterone concentration and plasma electrolyte concentrations following furosemide administration in patients with congestive heart failure--interrelationships and diuretic response.
Topics: Aged; Aged, 80 and over; Aldosterone; Diuresis; Electrolytes; Female; Furosemide; Heart Failure; Hum | 1987 |
Steady state absorption kinetics and pharmacodynamics of furosemide in congestive heart failure.
Topics: Aged; Diuresis; Female; Furosemide; Half-Life; Heart Failure; Humans; Intestinal Absorption; Kinetic | 1987 |
Steady state absorption kinetics and pharmacodynamics of furosemide in congestive heart failure.
Topics: Aged; Diuresis; Female; Furosemide; Half-Life; Heart Failure; Humans; Intestinal Absorption; Kinetic | 1987 |
Stopping CHF while there's still time (continuing education credit).
Topics: Aged; Digoxin; Dopamine; Education, Nursing, Continuing; Female; Furosemide; Heart Failure; Humans; | 1986 |
Stopping CHF while there's still time (continuing education credit).
Topics: Aged; Digoxin; Dopamine; Education, Nursing, Continuing; Female; Furosemide; Heart Failure; Humans; | 1986 |
Effect of oral frusemide on diagnostic indices of thyroid function.
Topics: Administration, Oral; Furosemide; Heart Failure; Humans; Thyroid Function Tests; Thyroid Gland; Thyr | 1987 |
Effect of oral frusemide on diagnostic indices of thyroid function.
Topics: Administration, Oral; Furosemide; Heart Failure; Humans; Thyroid Function Tests; Thyroid Gland; Thyr | 1987 |
Urea treatment for water retention in hyponatremic congestive heart failure.
Topics: Aged; Drug Therapy, Combination; Furosemide; Heart Failure; Humans; Hyponatremia; Male; Urea | 1987 |
Urea treatment for water retention in hyponatremic congestive heart failure.
Topics: Aged; Drug Therapy, Combination; Furosemide; Heart Failure; Humans; Hyponatremia; Male; Urea | 1987 |
[Hemofiltration as an acute remedy in intractable cardiac decompensation. Guidelines for correct application].
Topics: Aged; Diuresis; Female; Furosemide; Heart Failure; Hemodynamics; Hemofiltration; Humans; Male; Middl | 1987 |
[Hemofiltration as an acute remedy in intractable cardiac decompensation. Guidelines for correct application].
Topics: Aged; Diuresis; Female; Furosemide; Heart Failure; Hemodynamics; Hemofiltration; Humans; Male; Middl | 1987 |
A fixed-dose combination of furosemide and spironolactone in digitalized congestive heart failure patients.
Topics: Aged; Digitalis Glycosides; Drug Combinations; Drug Therapy, Combination; Echocardiography; Female; | 1986 |
A fixed-dose combination of furosemide and spironolactone in digitalized congestive heart failure patients.
Topics: Aged; Digitalis Glycosides; Drug Combinations; Drug Therapy, Combination; Echocardiography; Female; | 1986 |
The treatment of non-digitalized congestive heart failure patients with a fixed-dose combination of furosemide and spironolactone.
Topics: Aged; Drug Combinations; Echocardiography; Female; Furosemide; Heart Failure; Humans; Male; Spironol | 1986 |
The treatment of non-digitalized congestive heart failure patients with a fixed-dose combination of furosemide and spironolactone.
Topics: Aged; Drug Combinations; Echocardiography; Female; Furosemide; Heart Failure; Humans; Male; Spironol | 1986 |
Study to compare the relative hyperuricaemic effects of frusemide and bumetanide.
Topics: Aged; Bumetanide; Diuretics; Edema; Female; Furosemide; Heart Failure; Humans; Hypertension; Male; M | 1986 |
Study to compare the relative hyperuricaemic effects of frusemide and bumetanide.
Topics: Aged; Bumetanide; Diuretics; Edema; Female; Furosemide; Heart Failure; Humans; Hypertension; Male; M | 1986 |
[Furosemide].
Topics: Furosemide; Heart Failure; Humans; Intestinal Absorption; Nephrotic Syndrome; Water-Electrolyte Imba | 1986 |
[Furosemide].
Topics: Furosemide; Heart Failure; Humans; Intestinal Absorption; Nephrotic Syndrome; Water-Electrolyte Imba | 1986 |
[Furotriam in chronic circulatory failure].
Topics: Adult; Atrial Fibrillation; Chronic Disease; Diuresis; Drug Combinations; Drug Evaluation; Female; F | 1986 |
[Furotriam in chronic circulatory failure].
Topics: Adult; Atrial Fibrillation; Chronic Disease; Diuresis; Drug Combinations; Drug Evaluation; Female; F | 1986 |
Echocardiographic determination of left ventricular haemodynamics following acute and chronic administration of frusemide (Lasix) to patients with heart failure.
Topics: Coronary Circulation; Echocardiography; Female; Furosemide; Heart Failure; Heart Ventricles; Hemodyn | 1986 |
Echocardiographic determination of left ventricular haemodynamics following acute and chronic administration of frusemide (Lasix) to patients with heart failure.
Topics: Coronary Circulation; Echocardiography; Female; Furosemide; Heart Failure; Heart Ventricles; Hemodyn | 1986 |
Combination of furosemide and metolazone in the treatment of severe congestive heart failure.
Topics: Aged; Body Weight; Diuretics; Drug Therapy, Combination; Female; Furosemide; Heart Failure; Humans; | 1986 |
Combination of furosemide and metolazone in the treatment of severe congestive heart failure.
Topics: Aged; Body Weight; Diuretics; Drug Therapy, Combination; Female; Furosemide; Heart Failure; Humans; | 1986 |
Aspects of the effects of NSAID's on renal function in congestive heart failure.
Topics: Anti-Inflammatory Agents; Arthritis; Diuresis; Drug Interactions; Furosemide; Heart Failure; Humans; | 1985 |
Aspects of the effects of NSAID's on renal function in congestive heart failure.
Topics: Anti-Inflammatory Agents; Arthritis; Diuresis; Drug Interactions; Furosemide; Heart Failure; Humans; | 1985 |
Furosemide during sustained left atrial hypertension in functionally anephric dogs: intravascular and extravascular pulmonary fluid volumes. V.
Topics: Animals; Aorta; Blood Pressure; Blood Volume; Dogs; Dye Dilution Technique; Furosemide; Heart Atria; | 1985 |
Furosemide during sustained left atrial hypertension in functionally anephric dogs: intravascular and extravascular pulmonary fluid volumes. V.
Topics: Animals; Aorta; Blood Pressure; Blood Volume; Dogs; Dye Dilution Technique; Furosemide; Heart Atria; | 1985 |
Influence of heart failure and sodium content in the diet on the natriuretic response to furosemide in hamsters.
Topics: Animals; Arginine Vasopressin; Cardiomyopathy, Dilated; Cricetinae; Diet, Sodium-Restricted; Female; | 1985 |
Influence of heart failure and sodium content in the diet on the natriuretic response to furosemide in hamsters.
Topics: Animals; Arginine Vasopressin; Cardiomyopathy, Dilated; Cricetinae; Diet, Sodium-Restricted; Female; | 1985 |
Girth increase, sudden pain in a cardiac patient.
Topics: Ascites; Colonic Neoplasms; Female; Furosemide; Heart Failure; Heart Valve Prosthesis; Humans; Middl | 1985 |
Girth increase, sudden pain in a cardiac patient.
Topics: Ascites; Colonic Neoplasms; Female; Furosemide; Heart Failure; Heart Valve Prosthesis; Humans; Middl | 1985 |
Urinary electrolyte excretion after frusemide, amiloride and Frumil: single dose studies.
Topics: Aged; Amiloride; Drug Combinations; Female; Furosemide; Heart Failure; Humans; Male; Potassium; Sodi | 1985 |
Urinary electrolyte excretion after frusemide, amiloride and Frumil: single dose studies.
Topics: Aged; Amiloride; Drug Combinations; Female; Furosemide; Heart Failure; Humans; Male; Potassium; Sodi | 1985 |
Urinary electrolyte excretion after frusemide and Frumil: multiple dose study.
Topics: Amiloride; Drug Combinations; Furosemide; Heart Failure; Humans; Potassium; Sodium | 1985 |
Urinary electrolyte excretion after frusemide and Frumil: multiple dose study.
Topics: Amiloride; Drug Combinations; Furosemide; Heart Failure; Humans; Potassium; Sodium | 1985 |
The short and long term effects of a frusemide/amiloride combination tablet (Frumil) on plasma electrolytes.
Topics: Aged; Amiloride; Drug Combinations; Electrolytes; Furosemide; Heart Failure; Humans; Time Factors | 1985 |
The short and long term effects of a frusemide/amiloride combination tablet (Frumil) on plasma electrolytes.
Topics: Aged; Amiloride; Drug Combinations; Electrolytes; Furosemide; Heart Failure; Humans; Time Factors | 1985 |
Ultrafiltration in the management of refractory congestive heart failure.
Topics: Blood Pressure; Female; Furosemide; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Sodium; | 1986 |
Ultrafiltration in the management of refractory congestive heart failure.
Topics: Blood Pressure; Female; Furosemide; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Sodium; | 1986 |
Furosemide absorption altered in decompensated congestive heart failure.
Topics: Adult; Aged; Dose-Response Relationship, Drug; Furosemide; Half-Life; Heart Failure; Humans; Intesti | 1985 |
Furosemide absorption altered in decompensated congestive heart failure.
Topics: Adult; Aged; Dose-Response Relationship, Drug; Furosemide; Half-Life; Heart Failure; Humans; Intesti | 1985 |
Muzolimine therapy in patients with congestive heart failure in comparison with furosemide pretreatment. Effect on digoxin plasma concentration.
Topics: Adult; Aged; Digoxin; Drug Interactions; Epinephrine; Female; Furosemide; Heart Failure; Humans; Mal | 1985 |
Muzolimine therapy in patients with congestive heart failure in comparison with furosemide pretreatment. Effect on digoxin plasma concentration.
Topics: Adult; Aged; Digoxin; Drug Interactions; Epinephrine; Female; Furosemide; Heart Failure; Humans; Mal | 1985 |
Pathophysiology of cardiac failure.
Topics: Aminopyridines; Amrinone; Blood Pressure; Cardiac Output; Cardiotonic Agents; Dobutamine; Dopamine; | 1985 |
Pathophysiology of cardiac failure.
Topics: Aminopyridines; Amrinone; Blood Pressure; Cardiac Output; Cardiotonic Agents; Dobutamine; Dopamine; | 1985 |
Oral liquid furosemide in congestive heart failure.
Topics: Administration, Oral; Furosemide; Heart Failure; Humans; Solutions | 1985 |
Oral liquid furosemide in congestive heart failure.
Topics: Administration, Oral; Furosemide; Heart Failure; Humans; Solutions | 1985 |
Rapid development of gouty tophi after diuretic therapy.
Topics: Aged; Diuretics; Female; Furosemide; Gout; Heart Failure; Humans; Uric Acid | 1985 |
Rapid development of gouty tophi after diuretic therapy.
Topics: Aged; Diuretics; Female; Furosemide; Gout; Heart Failure; Humans; Uric Acid | 1985 |
Effect of furosemide on urinary excretion of 4-hydroxy-3-methoxymandelic acid (VMA).
Topics: Catecholamines; Creatinine; Furosemide; Heart Failure; Humans; Vanilmandelic Acid | 1985 |
Effect of furosemide on urinary excretion of 4-hydroxy-3-methoxymandelic acid (VMA).
Topics: Catecholamines; Creatinine; Furosemide; Heart Failure; Humans; Vanilmandelic Acid | 1985 |
High dose furosemide in refractory cardiac failure.
Topics: Blood Pressure; Dose-Response Relationship, Drug; Female; Furosemide; Heart Failure; Heart Rate; Hum | 1985 |
High dose furosemide in refractory cardiac failure.
Topics: Blood Pressure; Dose-Response Relationship, Drug; Female; Furosemide; Heart Failure; Heart Rate; Hum | 1985 |
Renal excretion of electrolytes in patients on long-term diuretic therapy for arterial hypertension and/or congestive heart failure.
Topics: Aged; Bendroflumethiazide; Diuretics; Electrolytes; Extracellular Space; Female; Furosemide; Heart F | 1985 |
Renal excretion of electrolytes in patients on long-term diuretic therapy for arterial hypertension and/or congestive heart failure.
Topics: Aged; Bendroflumethiazide; Diuretics; Electrolytes; Extracellular Space; Female; Furosemide; Heart F | 1985 |
Bilateral loin pain after oral frusemide.
Topics: Dilatation; Furosemide; Heart Failure; Humans; Kidney; Kidney Diseases; Male; Middle Aged; Pain | 1973 |
Bilateral loin pain after oral frusemide.
Topics: Dilatation; Furosemide; Heart Failure; Humans; Kidney; Kidney Diseases; Male; Middle Aged; Pain | 1973 |
The value of diuretics in respiratory failure.
Topics: Aged; Blood Gas Analysis; Bronchitis; Diuretics; Female; Furosemide; Heart Failure; Humans; Male; Mi | 1966 |
The value of diuretics in respiratory failure.
Topics: Aged; Blood Gas Analysis; Bronchitis; Diuretics; Female; Furosemide; Heart Failure; Humans; Male; Mi | 1966 |
[Clinical study of amiloride hydrochloride, a diuretic with low potassium loss].
Topics: Arrhythmias, Cardiac; Blood Urea Nitrogen; Cardiac Complexes, Premature; Diuretics; Drug Synergism; | 1970 |
[Clinical study of amiloride hydrochloride, a diuretic with low potassium loss].
Topics: Arrhythmias, Cardiac; Blood Urea Nitrogen; Cardiac Complexes, Premature; Diuretics; Drug Synergism; | 1970 |
[Medical therapy of cardiac insufficiency in the initial stage of myocardial infarct].
Topics: Aged; Digoxin; Diuretics; Female; Furosemide; Heart Failure; Humans; Male; Middle Aged; Myocardial I | 1973 |
[Medical therapy of cardiac insufficiency in the initial stage of myocardial infarct].
Topics: Aged; Digoxin; Diuretics; Female; Furosemide; Heart Failure; Humans; Male; Middle Aged; Myocardial I | 1973 |
Congestive heart failure secondary to idiopathic hypoparathyroidism.
Topics: Adolescent; Calcium; Diagnostic Errors; Digoxin; Electrocardiography; Electroencephalography; Epilep | 1974 |
Congestive heart failure secondary to idiopathic hypoparathyroidism.
Topics: Adolescent; Calcium; Diagnostic Errors; Digoxin; Electrocardiography; Electroencephalography; Epilep | 1974 |
Diuretics, cardiac failure and potassium depletion: a rational approach.
Topics: Aged; Amiloride; Body Weight; Diet, Sodium-Restricted; Diuretics; Edema; Furosemide; Heart Failure; | 1974 |
Diuretics, cardiac failure and potassium depletion: a rational approach.
Topics: Aged; Amiloride; Body Weight; Diet, Sodium-Restricted; Diuretics; Edema; Furosemide; Heart Failure; | 1974 |
Pulmonary edema following direct current cardioversion for atrial arrhythmias.
Topics: Aged; Atrial Fibrillation; Cardiomegaly; Electric Countershock; Female; Furosemide; Heart Atria; Hea | 1971 |
Pulmonary edema following direct current cardioversion for atrial arrhythmias.
Topics: Aged; Atrial Fibrillation; Cardiomegaly; Electric Countershock; Female; Furosemide; Heart Atria; Hea | 1971 |
[Another case of malignant hyperpyrexia caused by general anesthesia].
Topics: Anesthesia, Inhalation; Child; Female; Fever; Furosemide; Glucose; Heart Failure; Humans; Intubation | 1971 |
[Another case of malignant hyperpyrexia caused by general anesthesia].
Topics: Anesthesia, Inhalation; Child; Female; Fever; Furosemide; Glucose; Heart Failure; Humans; Intubation | 1971 |
Generalised pustular drug rash.
Topics: Adult; Aged; Biguanides; Chloramphenicol; Chloroquine; Cross Reactions; Digoxin; Drug Eruptions; Fur | 1973 |
Generalised pustular drug rash.
Topics: Adult; Aged; Biguanides; Chloramphenicol; Chloroquine; Cross Reactions; Digoxin; Drug Eruptions; Fur | 1973 |
Typhoid fever with myocarditis.
Topics: Adult; Ampicillin; Cardiomegaly; Chloramphenicol; Digitalis Glycosides; Electrocardiography; Female; | 1974 |
Typhoid fever with myocarditis.
Topics: Adult; Ampicillin; Cardiomegaly; Chloramphenicol; Digitalis Glycosides; Electrocardiography; Female; | 1974 |
[Medical treatment of heart failure in infants and young children].
Topics: Anti-Bacterial Agents; Anticoagulants; Aortic Coarctation; Bradycardia; Chlorothiazide; Diet, Sodium | 1969 |
[Medical treatment of heart failure in infants and young children].
Topics: Anti-Bacterial Agents; Anticoagulants; Aortic Coarctation; Bradycardia; Chlorothiazide; Diet, Sodium | 1969 |
Plasma renin in congestive heart failure in man.
Topics: Aged; Aldosterone; Angiotensin II; Diet, Sodium-Restricted; Digoxin; Female; Furosemide; Heart Failu | 1970 |
Plasma renin in congestive heart failure in man.
Topics: Aged; Aldosterone; Angiotensin II; Diet, Sodium-Restricted; Digoxin; Female; Furosemide; Heart Failu | 1970 |
Effect of furosemide and hydrochlorothiazide on plasma renin activity in man.
Topics: Administration, Oral; Aldosterone; Angiotensin II; Furosemide; Heart Failure; Humans; Hydrochlorothi | 1970 |
Effect of furosemide and hydrochlorothiazide on plasma renin activity in man.
Topics: Administration, Oral; Aldosterone; Angiotensin II; Furosemide; Heart Failure; Humans; Hydrochlorothi | 1970 |
[Regulation of the renin-angiotensin system in congestive heart failure: indications for a total body sodium-dependent regulation of the renin secretion].
Topics: Adult; Aged; Angiotensin II; Female; Furosemide; Heart Failure; Humans; Injections, Intravenous; Mal | 1972 |
[Regulation of the renin-angiotensin system in congestive heart failure: indications for a total body sodium-dependent regulation of the renin secretion].
Topics: Adult; Aged; Angiotensin II; Female; Furosemide; Heart Failure; Humans; Injections, Intravenous; Mal | 1972 |
Response of plasma aldosterone to postural change, diuretica, angiotensin II, sodium restriction or loading and prostaglandin.
Topics: Adrenocortical Hyperfunction; Aldosterone; Angiotensin II; Ascites; Cushing Syndrome; Diet; Diet, So | 1973 |
Response of plasma aldosterone to postural change, diuretica, angiotensin II, sodium restriction or loading and prostaglandin.
Topics: Adrenocortical Hyperfunction; Aldosterone; Angiotensin II; Ascites; Cushing Syndrome; Diet; Diet, So | 1973 |
Glucagon in heart failure and in cardiogenic shock. Experience in 50 patients.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Arrhythmias, Cardiac; Blood Pressure; Body Weight; Digital | 1972 |
Glucagon in heart failure and in cardiogenic shock. Experience in 50 patients.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Arrhythmias, Cardiac; Blood Pressure; Body Weight; Digital | 1972 |
Diuretic agents: inciting factor in nonocclusive mesenteric infarction?
Topics: Aged; Blood Urea Nitrogen; Body Weight; Digitalis; Diuretics; Female; Furosemide; Heart Failure; Hem | 1974 |
Diuretic agents: inciting factor in nonocclusive mesenteric infarction?
Topics: Aged; Blood Urea Nitrogen; Body Weight; Digitalis; Diuretics; Female; Furosemide; Heart Failure; Hem | 1974 |
Bilateral chemosis and conjunctival venous engorgement in cardiopulmonary failure.
Topics: Aged; Asthma; Bronchitis; Carbon Dioxide; Cardiac Catheterization; Conjunctiva; Diet, Sodium-Restric | 1974 |
Bilateral chemosis and conjunctival venous engorgement in cardiopulmonary failure.
Topics: Aged; Asthma; Bronchitis; Carbon Dioxide; Cardiac Catheterization; Conjunctiva; Diet, Sodium-Restric | 1974 |
[Proceedings: Hemodynamic effects of intravenously given furosemide as a sign of direct venodilator mechanism].
Topics: Animals; Furosemide; Heart Failure; Hemodynamics; Humans; Male; Rats; Vasodilator Agents; Veins | 1974 |
[Proceedings: Hemodynamic effects of intravenously given furosemide as a sign of direct venodilator mechanism].
Topics: Animals; Furosemide; Heart Failure; Hemodynamics; Humans; Male; Rats; Vasodilator Agents; Veins | 1974 |
Chronic vasodilator therapy in the management of cardiogenic shock and intractable left ventricular failure.
Topics: Blood Pressure; Cardiac Output; Digoxin; Drug Evaluation; Ferricyanides; Furosemide; Heart Failure; | 1974 |
Chronic vasodilator therapy in the management of cardiogenic shock and intractable left ventricular failure.
Topics: Blood Pressure; Cardiac Output; Digoxin; Drug Evaluation; Ferricyanides; Furosemide; Heart Failure; | 1974 |
[Hemodynamics of the insufficient heart following myocardial infarct during diuresis with furosemide].
Topics: Adult; Aged; Blood Pressure; Brachial Artery; Cardiac Catheterization; Cardiac Output; Diuresis; Fem | 1974 |
[Hemodynamics of the insufficient heart following myocardial infarct during diuresis with furosemide].
Topics: Adult; Aged; Blood Pressure; Brachial Artery; Cardiac Catheterization; Cardiac Output; Diuresis; Fem | 1974 |
[My prescription of diuretics].
Topics: Adolescent; Aged; Ascites; Diuretics; Edema, Cardiac; Female; Furosemide; Heart Failure; Humans; Kid | 1974 |
[My prescription of diuretics].
Topics: Adolescent; Aged; Ascites; Diuretics; Edema, Cardiac; Female; Furosemide; Heart Failure; Humans; Kid | 1974 |
Aggressive drug therapy in accelerated hypertension.
Topics: Antihypertensive Agents; Aortic Aneurysm; Brain Diseases; Cerebrovascular Disorders; Diazoxide; Ferr | 1974 |
Aggressive drug therapy in accelerated hypertension.
Topics: Antihypertensive Agents; Aortic Aneurysm; Brain Diseases; Cerebrovascular Disorders; Diazoxide; Ferr | 1974 |
[Comparison of the combination of hydrochlorothiazide and amiloride (Moduretic) and furosemide in the treatment of cardiac edema].
Topics: Aged; Amiloride; Diuretics; Drug Combinations; Female; Furosemide; Heart Failure; Humans; Hydrochlor | 1973 |
[Comparison of the combination of hydrochlorothiazide and amiloride (Moduretic) and furosemide in the treatment of cardiac edema].
Topics: Aged; Amiloride; Diuretics; Drug Combinations; Female; Furosemide; Heart Failure; Humans; Hydrochlor | 1973 |
Intrarenal blood flow in congestive heart failure.
Topics: Adult; Diagnosis, Computer-Assisted; Edema; Female; Furosemide; Heart Failure; Humans; Kidney; Male; | 1973 |
Intrarenal blood flow in congestive heart failure.
Topics: Adult; Diagnosis, Computer-Assisted; Edema; Female; Furosemide; Heart Failure; Humans; Kidney; Male; | 1973 |
Managing pulmonary edema.
Topics: Antihypertensive Agents; Bloodletting; Bronchodilator Agents; Digitalis; Digoxin; Furosemide; Heart | 1973 |
Managing pulmonary edema.
Topics: Antihypertensive Agents; Bloodletting; Bronchodilator Agents; Digitalis; Digoxin; Furosemide; Heart | 1973 |
Cardiac asystole due to lignocaine in a patient with digitalis toxicity.
Topics: Arrhythmias, Cardiac; Digoxin; Female; Furosemide; Heart Arrest; Heart Failure; Humans; Lidocaine; M | 1974 |
Cardiac asystole due to lignocaine in a patient with digitalis toxicity.
Topics: Arrhythmias, Cardiac; Digoxin; Female; Furosemide; Heart Arrest; Heart Failure; Humans; Lidocaine; M | 1974 |
Diuretic therapy in experimental right heart failure of the rhesus monkey.
Topics: Animals; Benzoates; Body Weight; Chlorothiazide; Diuretics; Edema; Furosemide; Haplorhini; Heart Fai | 1972 |
Diuretic therapy in experimental right heart failure of the rhesus monkey.
Topics: Animals; Benzoates; Body Weight; Chlorothiazide; Diuretics; Edema; Furosemide; Haplorhini; Heart Fai | 1972 |
[Changes in the activity of the renin-aldosterone system under the effect of diuretics in patients with circulatory insufficiency].
Topics: Adult; Aldosterone; Diuresis; Ethacrynic Acid; Female; Furosemide; Heart Failure; Humans; Male; Midd | 1972 |
[Changes in the activity of the renin-aldosterone system under the effect of diuretics in patients with circulatory insufficiency].
Topics: Adult; Aldosterone; Diuresis; Ethacrynic Acid; Female; Furosemide; Heart Failure; Humans; Male; Midd | 1972 |
Blood transfusion reactions in children.
Topics: Aspirin; Benzyl Compounds; Child; Child, Preschool; Ethylenediamines; Fever; Furosemide; Heart Failu | 1972 |
Blood transfusion reactions in children.
Topics: Aspirin; Benzyl Compounds; Child; Child, Preschool; Ethylenediamines; Fever; Furosemide; Heart Failu | 1972 |
[Diuretic treatment of heart failure].
Topics: Bloodletting; Chronic Disease; Diuretics; Dyspnea, Paroxysmal; Furosemide; Heart Failure; Humans; Pu | 1972 |
[Diuretic treatment of heart failure].
Topics: Bloodletting; Chronic Disease; Diuretics; Dyspnea, Paroxysmal; Furosemide; Heart Failure; Humans; Pu | 1972 |
Recent advances in therapy for refractory congestive heart failure.
Topics: Adrenal Cortex Hormones; Aminophylline; Cardiac Catheterization; Cardiomyopathies; Dextrothyroxine; | 1973 |
Recent advances in therapy for refractory congestive heart failure.
Topics: Adrenal Cortex Hormones; Aminophylline; Cardiac Catheterization; Cardiomyopathies; Dextrothyroxine; | 1973 |
Renal and extrarenal hemodynamic effects of furosemide in congestive heart failure after acute myocardial infarction.
Topics: Adult; Aged; Blood Pressure; Cardiac Output; Diuresis; Female; Furosemide; Glomerular Filtration Rat | 1973 |
Renal and extrarenal hemodynamic effects of furosemide in congestive heart failure after acute myocardial infarction.
Topics: Adult; Aged; Blood Pressure; Cardiac Output; Diuresis; Female; Furosemide; Glomerular Filtration Rat | 1973 |
Prophylactic total coronary care.
Topics: Arrhythmias, Cardiac; Atropine; Diet Therapy; Digoxin; Electrocardiography; Female; Furosemide; Hear | 1973 |
Prophylactic total coronary care.
Topics: Arrhythmias, Cardiac; Atropine; Diet Therapy; Digoxin; Electrocardiography; Female; Furosemide; Hear | 1973 |
Lactic acidosis in pulmonary edema due to left ventricular failure.
Topics: Acidosis; Aged; Aminophylline; Blood; Blood Pressure; Carbon Dioxide; Digitalis Glycosides; Female; | 1973 |
Lactic acidosis in pulmonary edema due to left ventricular failure.
Topics: Acidosis; Aged; Aminophylline; Blood; Blood Pressure; Carbon Dioxide; Digitalis Glycosides; Female; | 1973 |
[Acute left heart failure, pulmonary edema].
Topics: Acute Disease; Aged; Furosemide; Heart Failure; Humans; Lanatosides; Male; Morphine; Oxygen Inhalati | 1973 |
[Acute left heart failure, pulmonary edema].
Topics: Acute Disease; Aged; Furosemide; Heart Failure; Humans; Lanatosides; Male; Morphine; Oxygen Inhalati | 1973 |
Management of acute renal failure in infants and children.
Topics: Acidosis; Acute Kidney Injury; Anemia; Bicarbonates; Calcium; Child, Preschool; Dehydration; Furosem | 1973 |
Management of acute renal failure in infants and children.
Topics: Acidosis; Acute Kidney Injury; Anemia; Bicarbonates; Calcium; Child, Preschool; Dehydration; Furosem | 1973 |
Serum calcium and phosphorus in patients treated with thiazides and furosemide.
Topics: Adult; Aged; Calcium; Chlorothiazide; Depression, Chemical; Female; Furosemide; Heart Failure; Human | 1973 |
Serum calcium and phosphorus in patients treated with thiazides and furosemide.
Topics: Adult; Aged; Calcium; Chlorothiazide; Depression, Chemical; Female; Furosemide; Heart Failure; Human | 1973 |
[Hyponatremia syndrome in congestive heart failure].
Topics: Female; Furosemide; Heart Failure; Humans; Hyponatremia; Middle Aged; Sodium; Spironolactone; Syndro | 1973 |
[Hyponatremia syndrome in congestive heart failure].
Topics: Female; Furosemide; Heart Failure; Humans; Hyponatremia; Middle Aged; Sodium; Spironolactone; Syndro | 1973 |
Diuretics and renal pain.
Topics: Abdomen; Aged; Calcium; Diuretics; Edema; Ethacrynic Acid; Female; Furosemide; Heart Failure; Humans | 1973 |
Diuretics and renal pain.
Topics: Abdomen; Aged; Calcium; Diuretics; Edema; Ethacrynic Acid; Female; Furosemide; Heart Failure; Humans | 1973 |
[Effects of hydrochlorothiazide, furosemide and ethacrynic acid on the electrolyte composition of the urine, plasma and edema fluid].
Topics: Adult; Aged; Body Fluids; Edema; Electrolytes; Ethacrynic Acid; Female; Furosemide; Heart Failure; H | 1973 |
[Effects of hydrochlorothiazide, furosemide and ethacrynic acid on the electrolyte composition of the urine, plasma and edema fluid].
Topics: Adult; Aged; Body Fluids; Edema; Electrolytes; Ethacrynic Acid; Female; Furosemide; Heart Failure; H | 1973 |
[Tachysystolic Morgagni-Adams-Stokes syndrome].
Topics: Adams-Stokes Syndrome; Cardiomyopathies; Electrocardiography; Female; Furosemide; Heart Failure; Hum | 1973 |
[Tachysystolic Morgagni-Adams-Stokes syndrome].
Topics: Adams-Stokes Syndrome; Cardiomyopathies; Electrocardiography; Female; Furosemide; Heart Failure; Hum | 1973 |
[Acute myocardial infarction (author's transl)].
Topics: Acute Disease; Adult; Aged; Blood Pressure; Cardiac Catheterization; Digoxin; Female; Furosemide; Ge | 1974 |
[Acute myocardial infarction (author's transl)].
Topics: Acute Disease; Adult; Aged; Blood Pressure; Cardiac Catheterization; Digoxin; Female; Furosemide; Ge | 1974 |
Letter: Lithium toxicity enhanced by diuresis.
Topics: Aged; Bipolar Disorder; Diet; Diuresis; Drug Interactions; Female; Furosemide; Heart Failure; Humans | 1974 |
Letter: Lithium toxicity enhanced by diuresis.
Topics: Aged; Bipolar Disorder; Diet; Diuresis; Drug Interactions; Female; Furosemide; Heart Failure; Humans | 1974 |
Nonketotic hyperosmolar coma and frusemide therapy.
Topics: Aged; Diabetic Coma; Furosemide; Heart Failure; Humans; Male; Pulmonary Edema | 1974 |
Nonketotic hyperosmolar coma and frusemide therapy.
Topics: Aged; Diabetic Coma; Furosemide; Heart Failure; Humans; Male; Pulmonary Edema | 1974 |
Haemodynamic effects of intravenous frusemide in patients with myocardial infarction and left ventricular failure.
Topics: Blood Pressure; Cardiac Output; Diuresis; Furosemide; Heart Failure; Heart Rate; Hematocrit; Hemodyn | 1974 |
Haemodynamic effects of intravenous frusemide in patients with myocardial infarction and left ventricular failure.
Topics: Blood Pressure; Cardiac Output; Diuresis; Furosemide; Heart Failure; Heart Rate; Hematocrit; Hemodyn | 1974 |
Contraction alkalosis during recovery of cardio-respiratory failure.
Topics: Acid-Base Equilibrium; Alkalosis; Bronchitis; Chronic Disease; Furosemide; Heart Failure; Humans; Wa | 1974 |
Contraction alkalosis during recovery of cardio-respiratory failure.
Topics: Acid-Base Equilibrium; Alkalosis; Bronchitis; Chronic Disease; Furosemide; Heart Failure; Humans; Wa | 1974 |
Letter: Allergic interstitial nephritis with diuretics.
Topics: Aged; Drug Hypersensitivity; Furosemide; Heart Failure; Humans; Male; Nephritis, Interstitial | 1974 |
Letter: Allergic interstitial nephritis with diuretics.
Topics: Aged; Drug Hypersensitivity; Furosemide; Heart Failure; Humans; Male; Nephritis, Interstitial | 1974 |
Hyperkalemic intermittent paralysis associated with spironolactone in a patient with cardiac cirrhosis.
Topics: Acetazolamide; Adult; Aldosterone; Ascites; Female; Furosemide; Heart Failure; Heart Valve Diseases; | 1968 |
Hyperkalemic intermittent paralysis associated with spironolactone in a patient with cardiac cirrhosis.
Topics: Acetazolamide; Adult; Aldosterone; Ascites; Female; Furosemide; Heart Failure; Heart Valve Diseases; | 1968 |
Bullous haemorrhagic eruption associated with frusemide.
Topics: Aged; Blister; Erythema Multiforme; Furosemide; Heart Failure; Hemorrhage; Humans; Immunodiffusion; | 1969 |
Bullous haemorrhagic eruption associated with frusemide.
Topics: Aged; Blister; Erythema Multiforme; Furosemide; Heart Failure; Hemorrhage; Humans; Immunodiffusion; | 1969 |
[Malignant arterial hypertension. Intensive treatment by acute sodium depletion and antihypertensive agents].
Topics: Adult; Antihypertensive Agents; Body Weight; Creatinine; Diet, Sodium-Restricted; Diuretics; Female; | 1972 |
[Malignant arterial hypertension. Intensive treatment by acute sodium depletion and antihypertensive agents].
Topics: Adult; Antihypertensive Agents; Body Weight; Creatinine; Diet, Sodium-Restricted; Diuretics; Female; | 1972 |
The renal functional response to furosemide in children with acute glomerulonephritis.
Topics: Acute Disease; Aminohippuric Acids; Body Water; Creatinine; Furosemide; Glomerular Filtration Rate; | 1972 |
The renal functional response to furosemide in children with acute glomerulonephritis.
Topics: Acute Disease; Aminohippuric Acids; Body Water; Creatinine; Furosemide; Glomerular Filtration Rate; | 1972 |
Treatment of heart failure. 2.
Topics: Acetazolamide; Diuretics; Ethacrynic Acid; Furosemide; Heart Failure; Humans; Morphine; Pulmonary Ed | 1972 |
Treatment of heart failure. 2.
Topics: Acetazolamide; Diuretics; Ethacrynic Acid; Furosemide; Heart Failure; Humans; Morphine; Pulmonary Ed | 1972 |
Effects of frusemide on gas exchange in left ventricular failure.
Topics: Furosemide; Heart Failure; Humans; Myocardial Infarction; Oxygen; Pulmonary Edema; Respiration; Resp | 1972 |
Effects of frusemide on gas exchange in left ventricular failure.
Topics: Furosemide; Heart Failure; Humans; Myocardial Infarction; Oxygen; Pulmonary Edema; Respiration; Resp | 1972 |
Preferences of veterinarians for drugs used to treat heart failure in dogs.
Topics: Animals; Diet, Sodium-Restricted; Digitoxin; Digoxin; Dog Diseases; Dogs; Furosemide; Heart Failure; | 1972 |
Preferences of veterinarians for drugs used to treat heart failure in dogs.
Topics: Animals; Diet, Sodium-Restricted; Digitoxin; Digoxin; Dog Diseases; Dogs; Furosemide; Heart Failure; | 1972 |
Effect of frusemide on serum calcium.
Topics: Calcium; Furosemide; Heart Failure; Humans | 1971 |
Effect of frusemide on serum calcium.
Topics: Calcium; Furosemide; Heart Failure; Humans | 1971 |
[Use of large doses of furosemide in the treatment of severe pulmonary edema and in refractory cardiac failure].
Topics: Aged; Furosemide; Heart Failure; Humans; Male; Pulmonary Edema | 1971 |
[Use of large doses of furosemide in the treatment of severe pulmonary edema and in refractory cardiac failure].
Topics: Aged; Furosemide; Heart Failure; Humans; Male; Pulmonary Edema | 1971 |
[Comparison of the effectiveness and mechanism of action of the saluretics lasix, ethacrynic acid, brinaldix and triamterene in congestive cardiac insufficiency].
Topics: Adolescent; Adult; Aged; Arteriosclerosis; Coronary Disease; Diuretics; Ethacrynic Acid; Female; Fur | 1971 |
[Comparison of the effectiveness and mechanism of action of the saluretics lasix, ethacrynic acid, brinaldix and triamterene in congestive cardiac insufficiency].
Topics: Adolescent; Adult; Aged; Arteriosclerosis; Coronary Disease; Diuretics; Ethacrynic Acid; Female; Fur | 1971 |
[Effect of euphylline and lasix on the urea-excretion function of the kidneys in cardiac insufficiency].
Topics: Aminophylline; Furosemide; Heart Failure; Humans; Kidney; Urea | 1971 |
[Effect of euphylline and lasix on the urea-excretion function of the kidneys in cardiac insufficiency].
Topics: Aminophylline; Furosemide; Heart Failure; Humans; Kidney; Urea | 1971 |
[Clinical evaluation of a new diuretic: furosemide].
Topics: Diuretics; Furosemide; Heart Failure; Humans; Liver Cirrhosis; Nephrotic Syndrome | 1965 |
[Clinical evaluation of a new diuretic: furosemide].
Topics: Diuretics; Furosemide; Heart Failure; Humans; Liver Cirrhosis; Nephrotic Syndrome | 1965 |
[Clinical experimentation with furosemide].
Topics: Ascites; Female; Furosemide; Heart Failure; Humans; Male | 1966 |
[Clinical experimentation with furosemide].
Topics: Ascites; Female; Furosemide; Heart Failure; Humans; Male | 1966 |
Diuretics in cardiac edema--1969.
Topics: Benzothiadiazines; Carbonic Anhydrase Inhibitors; Diuretics; Ethacrynic Acid; Furosemide; Glucocorti | 1969 |
Diuretics in cardiac edema--1969.
Topics: Benzothiadiazines; Carbonic Anhydrase Inhibitors; Diuretics; Ethacrynic Acid; Furosemide; Glucocorti | 1969 |
[Acid-base equilibrium in patients with cardiac insufficiency during treatment with lasix].
Topics: Acid-Base Equilibrium; Adult; Aged; Alkalosis; Carbon Dioxide; Chlorine; Depression, Chemical; Diure | 1969 |
[Acid-base equilibrium in patients with cardiac insufficiency during treatment with lasix].
Topics: Acid-Base Equilibrium; Adult; Aged; Alkalosis; Carbon Dioxide; Chlorine; Depression, Chemical; Diure | 1969 |
The effect of aldosterone on sodium and potassium metabolism in congestive cardiac failure.
Topics: Aldosterone; Furosemide; Heart Failure; Humans; Hypokalemia; Potassium; Sodium; Water-Electrolyte Ba | 1969 |
The effect of aldosterone on sodium and potassium metabolism in congestive cardiac failure.
Topics: Aldosterone; Furosemide; Heart Failure; Humans; Hypokalemia; Potassium; Sodium; Water-Electrolyte Ba | 1969 |
The value of aggressive therapy in the hypertensive patient with azotemia.
Topics: Administration, Oral; Adult; Antihypertensive Agents; Arteries; Blood Pressure; Blood Urea Nitrogen; | 1969 |
The value of aggressive therapy in the hypertensive patient with azotemia.
Topics: Administration, Oral; Adult; Antihypertensive Agents; Arteries; Blood Pressure; Blood Urea Nitrogen; | 1969 |
[Treatment of cardiac patients with furosemide. Effect on hemodynamics, water and electrolyte balance].
Topics: Adult; Aged; Diuresis; Female; Furosemide; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; P | 1969 |
[Treatment of cardiac patients with furosemide. Effect on hemodynamics, water and electrolyte balance].
Topics: Adult; Aged; Diuresis; Female; Furosemide; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; P | 1969 |
Diuretics in cardiac edema.
Topics: Diuretics; Furosemide; Heart Failure; Humans; Hydrochlorothiazide | 1970 |
Diuretics in cardiac edema.
Topics: Diuretics; Furosemide; Heart Failure; Humans; Hydrochlorothiazide | 1970 |
Dynamic aspects of volume and osmoregulation in congestive heart failure during furosemide diuresis.
Topics: Bicarbonates; Body Composition; Chlorides; Creatinine; Diuresis; Extracellular Space; Furosemide; He | 1970 |
Dynamic aspects of volume and osmoregulation in congestive heart failure during furosemide diuresis.
Topics: Bicarbonates; Body Composition; Chlorides; Creatinine; Diuresis; Extracellular Space; Furosemide; He | 1970 |
Experiences with high doses of furosemide in renal disease and resistant edematous states.
Topics: Adult; Aged; Female; Furosemide; Heart Failure; Humans; Injections, Intravenous; Kidney Failure, Chr | 1970 |
Experiences with high doses of furosemide in renal disease and resistant edematous states.
Topics: Adult; Aged; Female; Furosemide; Heart Failure; Humans; Injections, Intravenous; Kidney Failure, Chr | 1970 |
Frusemide after recent myocardial infarction.
Topics: Female; Furosemide; Heart Failure; Humans; Injections, Intravenous; Male; Myocardial Infarction; Pot | 1970 |
Frusemide after recent myocardial infarction.
Topics: Female; Furosemide; Heart Failure; Humans; Injections, Intravenous; Male; Myocardial Infarction; Pot | 1970 |
Congestive heart failure. Clinical evaluation of furosemide in congestive heart failure.
Topics: Adult; Aged; Blood Pressure; Body Weight; Female; Furosemide; Heart Failure; Humans; Male; Middle Ag | 1970 |
Congestive heart failure. Clinical evaluation of furosemide in congestive heart failure.
Topics: Adult; Aged; Blood Pressure; Body Weight; Female; Furosemide; Heart Failure; Humans; Male; Middle Ag | 1970 |
Erythema multiforme and furosemide therapy.
Topics: Aged; Erythema Multiforme; Furosemide; Heart Failure; Humans; Male | 1970 |
Erythema multiforme and furosemide therapy.
Topics: Aged; Erythema Multiforme; Furosemide; Heart Failure; Humans; Male | 1970 |
[Comparative study of the effectiveness of Lasix in the treatment of edema of various origins].
Topics: Adolescent; Adult; Aged; Child; Edema; Female; Furosemide; Heart Failure; Humans; Liver Cirrhosis; M | 1970 |
[Comparative study of the effectiveness of Lasix in the treatment of edema of various origins].
Topics: Adolescent; Adult; Aged; Child; Edema; Female; Furosemide; Heart Failure; Humans; Liver Cirrhosis; M | 1970 |
[Acute pulmonary edema in subjects of geriatric age. (Modern therapeutic trends)].
Topics: Aged; Diuretics; Female; Furosemide; Heart Failure; Humans; Hypertension; Male; Middle Aged; Pulmona | 1970 |
[Acute pulmonary edema in subjects of geriatric age. (Modern therapeutic trends)].
Topics: Aged; Diuretics; Female; Furosemide; Heart Failure; Humans; Hypertension; Male; Middle Aged; Pulmona | 1970 |
Thrombocytopenia in heart failure. Preliminary report.
Topics: Blood Cell Count; Blood Platelets; Digitoxin; Furosemide; Heart Failure; Humans; Thrombocytopenia | 1970 |
Thrombocytopenia in heart failure. Preliminary report.
Topics: Blood Cell Count; Blood Platelets; Digitoxin; Furosemide; Heart Failure; Humans; Thrombocytopenia | 1970 |
Congenital atrial flutter and cardiac failure presenting as hydrops foetalis at birth.
Topics: Atrial Flutter; Birth Weight; Body Weight; Digoxin; Edema; Electrocardiography; Female; Fetal Diseas | 1970 |
Congenital atrial flutter and cardiac failure presenting as hydrops foetalis at birth.
Topics: Atrial Flutter; Birth Weight; Body Weight; Digoxin; Edema; Electrocardiography; Female; Fetal Diseas | 1970 |
Therapeutic conferences. Heart failure--I.
Topics: Aged; Bendroflumethiazide; Diet; Digoxin; Diuretics; Female; Furosemide; Heart; Heart Failure; Human | 1971 |
Therapeutic conferences. Heart failure--I.
Topics: Aged; Bendroflumethiazide; Diet; Digoxin; Diuretics; Female; Furosemide; Heart; Heart Failure; Human | 1971 |
[Secondary gout caused by drugs].
Topics: Aged; Anemia; Furosemide; Gout; Heart Failure; Humans; Male; Middle Aged; Transfusion Reaction | 1971 |
[Secondary gout caused by drugs].
Topics: Aged; Anemia; Furosemide; Gout; Heart Failure; Humans; Male; Middle Aged; Transfusion Reaction | 1971 |
Heart failure. II.
Topics: Aged; Aortic Valve Insufficiency; Digitoxin; Digoxin; Ethacrynic Acid; Female; Furosemide; Heart Fai | 1971 |
Heart failure. II.
Topics: Aged; Aortic Valve Insufficiency; Digitoxin; Digoxin; Ethacrynic Acid; Female; Furosemide; Heart Fai | 1971 |
[Clinical study of the use of "Spirolang" 50].
Topics: Adult; Aged; Ascites; Chronic Disease; Digitalis Glycosides; Diuresis; Electrolytes; Ethacrynic Acid | 1971 |
[Clinical study of the use of "Spirolang" 50].
Topics: Adult; Aged; Ascites; Chronic Disease; Digitalis Glycosides; Diuresis; Electrolytes; Ethacrynic Acid | 1971 |
Frusemide in heart failure of infancy.
Topics: Administration, Oral; Aortic Coarctation; Body Weight; Chlorides; Ductus Arteriosus, Patent; Female; | 1971 |
Frusemide in heart failure of infancy.
Topics: Administration, Oral; Aortic Coarctation; Body Weight; Chlorides; Ductus Arteriosus, Patent; Female; | 1971 |
[Furosemide in the treatment of cardiac insufficiency].
Topics: Adult; Aged; Chlorothiazide; Chlorthalidone; Diuresis; Electrolytes; Female; Furosemide; Heart Failu | 1967 |
[Furosemide in the treatment of cardiac insufficiency].
Topics: Adult; Aged; Chlorothiazide; Chlorthalidone; Diuresis; Electrolytes; Female; Furosemide; Heart Failu | 1967 |
[Changes in hemodynamics in patients with circulatory insufficiency after the administration of saluretic agents].
Topics: Adolescent; Adult; Aged; Blood Circulation Time; Blood Pressure Determination; Blood Volume Determin | 1967 |
[Changes in hemodynamics in patients with circulatory insufficiency after the administration of saluretic agents].
Topics: Adolescent; Adult; Aged; Blood Circulation Time; Blood Pressure Determination; Blood Volume Determin | 1967 |
[Clinical and metabolic study of furosemide].
Topics: Adolescent; Adult; Aged; Child; Chlorine; Diuresis; Female; Furosemide; Heart Failure; Humans; Male; | 1967 |
[Clinical and metabolic study of furosemide].
Topics: Adolescent; Adult; Aged; Child; Chlorine; Diuresis; Female; Furosemide; Heart Failure; Humans; Male; | 1967 |
[Comparative assessment of the efficacy of diuretic action of aldoctone A and lasix in cardiac insufficiency].
Topics: Aged; Diuresis; Female; Furosemide; Heart Failure; Humans; Middle Aged; Spironolactone | 1967 |
[Comparative assessment of the efficacy of diuretic action of aldoctone A and lasix in cardiac insufficiency].
Topics: Aged; Diuresis; Female; Furosemide; Heart Failure; Humans; Middle Aged; Spironolactone | 1967 |
[Prevention of potassium metabolism disorders arising during the treatment of cardiac insufficiency with diuretics].
Topics: Adult; Digitalis Glycosides; Diuretics; Drug Synergism; Female; Furosemide; Heart Failure; Humans; H | 1967 |
[Prevention of potassium metabolism disorders arising during the treatment of cardiac insufficiency with diuretics].
Topics: Adult; Digitalis Glycosides; Diuretics; Drug Synergism; Female; Furosemide; Heart Failure; Humans; H | 1967 |
[Use of lasix in the treatment of the edema syndrome].
Topics: Furosemide; Heart Failure; Humans | 1967 |
[Use of lasix in the treatment of the edema syndrome].
Topics: Furosemide; Heart Failure; Humans | 1967 |
[Clinical study of the new diuretic furosemide (Lasix)].
Topics: Adolescent; Adult; Aged; Edema; Female; Furosemide; Heart Failure; Humans; Male; Middle Aged | 1967 |
[Clinical study of the new diuretic furosemide (Lasix)].
Topics: Adolescent; Adult; Aged; Edema; Female; Furosemide; Heart Failure; Humans; Male; Middle Aged | 1967 |
[Effect of furosemide on the course of experimental cardiac insufficiency].
Topics: Animals; Female; Furosemide; Gelatin; Heart Failure; Plasma Substitutes; Rats | 1967 |
[Effect of furosemide on the course of experimental cardiac insufficiency].
Topics: Animals; Female; Furosemide; Gelatin; Heart Failure; Plasma Substitutes; Rats | 1967 |
Amiloride. A potassium-sparing natriuretic agent.
Topics: Acetazolamide; Aldosterone; Ammonia; Ascites; Bicarbonates; Blood Pressure; Chlorides; Chlorothiazid | 1968 |
Amiloride. A potassium-sparing natriuretic agent.
Topics: Acetazolamide; Aldosterone; Ammonia; Ascites; Bicarbonates; Blood Pressure; Chlorides; Chlorothiazid | 1968 |
Ethacrynic acid and furosemide.
Topics: Ethacrynic Acid; Furosemide; Heart Failure; Humans; Liver Cirrhosis; Nephrosis | 1968 |
Ethacrynic acid and furosemide.
Topics: Ethacrynic Acid; Furosemide; Heart Failure; Humans; Liver Cirrhosis; Nephrosis | 1968 |
Long-term maintenance therapy with a new diuretic, furosemide.
Topics: Adult; Aged; Female; Furosemide; Heart Failure; Humans; Male; Middle Aged | 1968 |
Long-term maintenance therapy with a new diuretic, furosemide.
Topics: Adult; Aged; Female; Furosemide; Heart Failure; Humans; Male; Middle Aged | 1968 |
The use of furosemide in refractory heart failure.
Topics: Furosemide; Heart Failure; Hemodynamics; Humans; Pulmonary Edema | 1968 |
The use of furosemide in refractory heart failure.
Topics: Furosemide; Heart Failure; Hemodynamics; Humans; Pulmonary Edema | 1968 |
[Hemodynamic effects of acute diuresis in cardiac insufficiency].
Topics: Adult; Blood Pressure; Blood Volume; Diuresis; Ethacrynic Acid; Female; Furosemide; Heart Failure; H | 1968 |
[Hemodynamic effects of acute diuresis in cardiac insufficiency].
Topics: Adult; Blood Pressure; Blood Volume; Diuresis; Ethacrynic Acid; Female; Furosemide; Heart Failure; H | 1968 |
Clinical experience with furosemide.
Topics: Adolescent; Adult; Aged; Ascites; Carbon Dioxide; Chlorides; Diabetes Complications; Diuresis; Edema | 1968 |
Clinical experience with furosemide.
Topics: Adolescent; Adult; Aged; Ascites; Carbon Dioxide; Chlorides; Diabetes Complications; Diuresis; Edema | 1968 |
Plasma ADH level in patients with chronic congestive heart failure.
Topics: Adult; Aged; Blood Pressure; Blood Volume; Chronic Disease; Female; Furosemide; Heart Failure; Human | 1968 |
Plasma ADH level in patients with chronic congestive heart failure.
Topics: Adult; Aged; Blood Pressure; Blood Volume; Chronic Disease; Female; Furosemide; Heart Failure; Human | 1968 |
[Effect of furosemide on the respiratory gas exchange and the acid-base balance].
Topics: Acid-Base Equilibrium; Adult; Aged; Alkalosis; Blood Gas Analysis; Digitalis Glycosides; Diuretics; | 1968 |
[Effect of furosemide on the respiratory gas exchange and the acid-base balance].
Topics: Acid-Base Equilibrium; Adult; Aged; Alkalosis; Blood Gas Analysis; Digitalis Glycosides; Diuretics; | 1968 |
Frusemide for cardiac failure in infancy.
Topics: Anemia; Aortic Coarctation; Blood Transfusion; Furosemide; Heart Failure; Humans; Infant, Newborn; I | 1969 |
Frusemide for cardiac failure in infancy.
Topics: Anemia; Aortic Coarctation; Blood Transfusion; Furosemide; Heart Failure; Humans; Infant, Newborn; I | 1969 |
Furosemide in anaemia with congestive cardiac failure.
Topics: Anemia; Female; Furosemide; Heart Failure; Humans; Male; Transfusion Reaction | 1969 |
Furosemide in anaemia with congestive cardiac failure.
Topics: Anemia; Female; Furosemide; Heart Failure; Humans; Male; Transfusion Reaction | 1969 |
[On the management of renal acidosis using sodium bicarbonate and ethacrynic acid].
Topics: Acidosis, Renal Tubular; Acute Kidney Injury; Adult; Bicarbonates; Blood Pressure; Body Weight; Etha | 1969 |
[On the management of renal acidosis using sodium bicarbonate and ethacrynic acid].
Topics: Acidosis, Renal Tubular; Acute Kidney Injury; Adult; Bicarbonates; Blood Pressure; Body Weight; Etha | 1969 |
Clinical evaluation of diuretics in congestive heart failure. A detailed study in four patients.
Topics: Aged; Arrhythmias, Cardiac; Chlorides; Diuretics; Drug Synergism; Furosemide; Heart Failure; Humans; | 1969 |
Clinical evaluation of diuretics in congestive heart failure. A detailed study in four patients.
Topics: Aged; Arrhythmias, Cardiac; Chlorides; Diuretics; Drug Synergism; Furosemide; Heart Failure; Humans; | 1969 |
[Trial of furosemide in cardiac insufficiency].
Topics: Female; Furosemide; Heart Failure; Humans; Male; Middle Aged | 1969 |
[Trial of furosemide in cardiac insufficiency].
Topics: Female; Furosemide; Heart Failure; Humans; Male; Middle Aged | 1969 |
The use of amiloride in potassium depletion before cardiac surgery.
Topics: Adult; Cardiac Surgical Procedures; Diuretics; Furosemide; Heart Failure; Humans; Hypokalemia; Middl | 1969 |
The use of amiloride in potassium depletion before cardiac surgery.
Topics: Adult; Cardiac Surgical Procedures; Diuretics; Furosemide; Heart Failure; Humans; Hypokalemia; Middl | 1969 |
Management of congestive heart failure in acute myocardial infarction.
Topics: Furosemide; Heart Failure; Humans; Myocardial Infarction; Water-Electrolyte Balance | 1969 |
Management of congestive heart failure in acute myocardial infarction.
Topics: Furosemide; Heart Failure; Humans; Myocardial Infarction; Water-Electrolyte Balance | 1969 |
[Intensive treatment of severe congestive cardiac insufficiency].
Topics: Aged; Cardanolides; Drug Synergism; Female; Furosemide; Heart Failure; Humans; Male; Mannitol; Middl | 1969 |
[Intensive treatment of severe congestive cardiac insufficiency].
Topics: Aged; Cardanolides; Drug Synergism; Female; Furosemide; Heart Failure; Humans; Male; Mannitol; Middl | 1969 |
Treatment of congestive heart failure with furosemide.
Topics: Aged; Female; Furosemide; Heart Failure; Humans; Male; Middle Aged | 1969 |
Treatment of congestive heart failure with furosemide.
Topics: Aged; Female; Furosemide; Heart Failure; Humans; Male; Middle Aged | 1969 |
Clinical studies on the acid-base balance disturbance in congestive heart failure.
Topics: Acid-Base Equilibrium; Acidosis, Respiratory; Adult; Aldosterone; Alkalosis; Arteries; Benzothiadiaz | 1969 |
Clinical studies on the acid-base balance disturbance in congestive heart failure.
Topics: Acid-Base Equilibrium; Acidosis, Respiratory; Adult; Aldosterone; Alkalosis; Arteries; Benzothiadiaz | 1969 |
[Diuretic action of fursemid in heart disease patients].
Topics: Diuretics; Furosemide; Heart Failure; Humans | 1965 |
[Diuretic action of fursemid in heart disease patients].
Topics: Diuretics; Furosemide; Heart Failure; Humans | 1965 |
[Clinical observations on the efficacy of a new diuretic: furosemide].
Topics: Adult; Aged; Ascites; Diabetes Insipidus; Diuretics; Furosemide; Heart Failure; Humans; Liver Cirrho | 1965 |
[Clinical observations on the efficacy of a new diuretic: furosemide].
Topics: Adult; Aged; Ascites; Diabetes Insipidus; Diuretics; Furosemide; Heart Failure; Humans; Liver Cirrho | 1965 |
[Action of furosemide on edema in cardiac patients].
Topics: Adolescent; Adult; Aged; Child; Diuretics; Edema; Furosemide; Heart Failure; Humans; Middle Aged | 1965 |
[Action of furosemide on edema in cardiac patients].
Topics: Adolescent; Adult; Aged; Child; Diuretics; Edema; Furosemide; Heart Failure; Humans; Middle Aged | 1965 |
Furosemide in the treatment of geriatric patients.
Topics: Adult; Aged; Female; Furosemide; Heart Failure; Humans; Hypertension; Male; Middle Aged | 1966 |
Furosemide in the treatment of geriatric patients.
Topics: Adult; Aged; Female; Furosemide; Heart Failure; Humans; Hypertension; Male; Middle Aged | 1966 |
[Furosemide therapy of edematogenic syndromes].
Topics: Diuretics; Edema; Furosemide; Heart Failure; Humans; Liver Cirrhosis | 1966 |
[Furosemide therapy of edematogenic syndromes].
Topics: Diuretics; Edema; Furosemide; Heart Failure; Humans; Liver Cirrhosis | 1966 |
[Fursemid in cardiac insufficiency. Comparative studies of other diuretics].
Topics: Diuretics; Edema; Furosemide; Heart Failure; Humans | 1966 |
[Fursemid in cardiac insufficiency. Comparative studies of other diuretics].
Topics: Diuretics; Edema; Furosemide; Heart Failure; Humans | 1966 |
[Lasix and its use in pulmonary edema].
Topics: Adult; Aged; Female; Furosemide; Heart Failure; Humans; Male; Middle Aged; Pulmonary Edema | 1966 |
[Lasix and its use in pulmonary edema].
Topics: Adult; Aged; Female; Furosemide; Heart Failure; Humans; Male; Middle Aged; Pulmonary Edema | 1966 |
[Experience with a new diuretic Furosemide].
Topics: Edema; Furosemide; Heart Failure; Humans; Kidney Diseases; Liver Diseases | 1966 |
[Experience with a new diuretic Furosemide].
Topics: Edema; Furosemide; Heart Failure; Humans; Kidney Diseases; Liver Diseases | 1966 |